Citrus Sinensis ID: 010329
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 513 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GYA4 | 669 | Cysteine-rich receptor-li | yes | no | 0.927 | 0.711 | 0.598 | 1e-156 | |
| Q9M0X5 | 675 | Cysteine-rich receptor-li | no | no | 0.976 | 0.742 | 0.540 | 1e-152 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.920 | 0.752 | 0.546 | 1e-140 | |
| Q9C5S8 | 659 | Cysteine-rich receptor-li | no | no | 0.922 | 0.717 | 0.573 | 1e-140 | |
| O65482 | 830 | Putative cysteine-rich re | no | no | 0.939 | 0.580 | 0.510 | 1e-140 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.935 | 0.710 | 0.518 | 1e-138 | |
| O65479 | 666 | Putative cysteine-rich re | no | no | 0.916 | 0.705 | 0.526 | 1e-138 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.933 | 0.710 | 0.510 | 1e-134 | |
| Q9LZU4 | 676 | Cysteine-rich receptor-li | no | no | 0.962 | 0.730 | 0.512 | 1e-133 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.925 | 0.720 | 0.513 | 1e-133 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 551 bits (1421), Expect = e-156, Method: Compositional matrix adjust.
Identities = 295/493 (59%), Positives = 356/493 (72%), Gaps = 17/493 (3%)
Query: 25 AAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRGNGFSRGFFNATAGQDPNR 84
+A DPTYVYH C +TAN+T NST+ +NL LL SL +SR +S GF NAT GQ P+R
Sbjct: 33 SAQDPTYVYHTCQNTANYTSNSTYNNNLKTLLASL---SSRNASYSTGFQNATVGQAPDR 89
Query: 85 VYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYDECLLRYSNRYIFSTRETT 144
V LF CRGD +T C+ CV+FA D + RCP K+ ++YDEC+LRYSN+ I ST TT
Sbjct: 90 VTGLFNCRGDVSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITT 149
Query: 145 RTVYLWNTQNATDPVK--FNDLVGSLMGEAASQAVNDPKKFATKMANFTSFQKLYALAQC 202
V L NT+N T +DLV + +AA+ A+N KKF T+ NFT+ Q Y L QC
Sbjct: 150 GGVILVNTRNVTSNQLDLLSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQC 209
Query: 203 TQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPFYNEPATPAPAPTPV 262
T DL+ DC+ CL+ I Q+PT + G R++ PSC RYE+Y FY E A P P P P
Sbjct: 210 TPDLTRQDCSRCLQLVINQIPT---DRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPS 266
Query: 263 LLSP---PPPSSVIRPRGKSGISSSTIIAIVAPIAVAAVLFVACLCFLRRRAKKKYNAVP 319
+ +P PP S GK G S +IAIV PI VA +LF+A CFL RRA+K Y P
Sbjct: 267 ISTPPVSAPPRS-----GKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRARKSY-YTP 320
Query: 320 EENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSA 379
A +D+T +SLQ D+ TI+ AT+ F NK+G+GGFGEVYKG L G E+AVKRLS
Sbjct: 321 SAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSK 380
Query: 380 SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG 439
SSGQG EFKNEVVLVAKLQHRNLVRLLGFCL+GEE++LVYE+VPNKSLDYFL+DP K+G
Sbjct: 381 SSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKG 440
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
QLDW+RRYKIIGG+ARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI+DFGMARIFG+
Sbjct: 441 QLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGL 500
Query: 500 DQTQGNTSRIVGT 512
DQT+ NTSRIVGT
Sbjct: 501 DQTEENTSRIVGT 513
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 540 bits (1390), Expect = e-152, Method: Compositional matrix adjust.
Identities = 276/511 (54%), Positives = 350/511 (68%), Gaps = 10/511 (1%)
Query: 7 SVLFLFVIYLSSFQFSFTAAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRG 66
S + LF ++L F T +DPTY+YH C +T ++RNS++ +NL +L+SL +S
Sbjct: 7 SSVSLFSVFL--FMILKTVTSDPTYLYHICPNTTTYSRNSSYLTNLRTVLSSL---SSPN 61
Query: 67 NGFSRGFFNATAGQ--DPNRVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVW 124
++ F NA AG+ D NRVY +FLCRGD + C++CV FA + + RCP K ++W
Sbjct: 62 AAYASLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIW 121
Query: 125 YDECLLRYSNRYIFSTRETTRTVYLWNTQNATDP--VKFNDLVGSLMGEAASQAVNDPKK 182
YDEC++RYSN+ I V+L N QN T+ +FN+ + +L+ + A +A +K
Sbjct: 122 YDECMVRYSNQSIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRK 181
Query: 183 FATKMANFTSFQKLYALAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVR 242
FAT+ ANFT FQ +Y+L QCT DL++ DC CLR I LP CC GGRV+ PSC+ R
Sbjct: 182 FATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFR 241
Query: 243 YEVYPFYNEPATPAPAPTPVLLS-PPPPSSVIRPRGKSGISSSTIIAIVAPIAVAAVLFV 301
YE+YPFYNE AP P + PP ++ +GK + + AI P++V +L
Sbjct: 242 YELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLG 301
Query: 302 ACLCFLRRRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEV 361
A L RR K +A E+ ++ +T E+LQF F IE ATNKFS NKLG GGFGEV
Sbjct: 302 AMCWLLARRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEV 361
Query: 362 YKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421
YKG L +G+ +A+KRLS S QGA+EFKNEV +VAKLQHRNL +LLG+CL+GEEKILVYE
Sbjct: 362 YKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYE 421
Query: 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481
FVPNKSLDYFL+D EK+ LDW RRYKII GIARGILYLH DSRL IIHRDLKASNILLD
Sbjct: 422 FVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLD 481
Query: 482 AEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
A+M+PKISDFGMARIFGVDQTQ NT RIVGT
Sbjct: 482 ADMHPKISDFGMARIFGVDQTQANTKRIVGT 512
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 499 bits (1284), Expect = e-140, Method: Compositional matrix adjust.
Identities = 267/489 (54%), Positives = 330/489 (67%), Gaps = 17/489 (3%)
Query: 31 YVYHFCSDTANFTRNSTFESNLNRLLTSLPT-NASRGNGFSRGFFNATAGQDPNRVYSLF 89
Y+ H C +T ++RNS + +NL LL+SL NAS +S GF +A AGQ P+RV LF
Sbjct: 26 YIKHICPNTTTYSRNSPYLTNLRTLLSSLSAPNAS----YSTGFQSARAGQAPDRVTGLF 81
Query: 90 LCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYDECLLRYSNRYIFSTRETTRTVYL 149
LCRGD + C+NCV F+ D + +CP + ++ +YDEC+LRYS++ I ST
Sbjct: 82 LCRGDVSPAVCRNCVAFSINDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAWIR 141
Query: 150 WNTQNATDP---VKFNDLVGSLMGEAASQAVNDPKKFATKMANFTSFQKLYALAQCTQDL 206
N + D +F D V S M +AA +A + P+KF T A +T+ Q LY L QCT DL
Sbjct: 142 MNGNISIDQNQMNRFKDFVSSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCTPDL 201
Query: 207 SSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPFYNEPATPAPAPTPVLLSP 266
+ DC CL +I +P K GGR L SCN RYE++ FYNE T P L P
Sbjct: 202 TRQDCFSCLESSIKLMPLY---KTGGRTLYSSCNSRYELFAFYNE-TTVRTQQAPPPLPP 257
Query: 267 PPPSSVIRPR--GKSGISSSTIIAIVAPIAVAAVLFVACLCFLRRRAKKKYNAVPEENAD 324
V P GKS S+ ++AIV I VAA+L +A CF +R NA P + D
Sbjct: 258 SSTPLVTSPSLPGKSWNSNVLVVAIVLTILVAALLLIAGYCFAKRVKNSSDNA-PAFDGD 316
Query: 325 NDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQG 384
+ T ESLQ D+ I ATNKFS +NK+G+GGFGEVYKG +G E+AVKRLS SSGQG
Sbjct: 317 DITT--ESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKSSGQG 374
Query: 385 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
EFKNEVV+VAKLQHRNLVRLLGF + G E+ILVYE++PNKSLDYFL+DP KQ QLDW+
Sbjct: 375 DTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQLDWT 434
Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
RRYK+IGGIARGILYLH+DSRL IIHRDLKASNILLDA+MNPK++DFG+ARIFG+DQTQ
Sbjct: 435 RRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMDQTQE 494
Query: 505 NTSRIVGTL 513
NTSRIVGT
Sbjct: 495 NTSRIVGTF 503
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1283), Expect = e-140, Method: Compositional matrix adjust.
Identities = 281/490 (57%), Positives = 343/490 (70%), Gaps = 17/490 (3%)
Query: 28 DPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRGNGFSRGFFNATAGQDPNRVYS 87
DPTYV H C T +RNS + SNL LLTSL +N + FS G + T GQ+ + V+
Sbjct: 28 DPTYVGHVC--TNRISRNSIYFSNLQTLLTSLSSNNAY---FSLGSHSLTKGQNSDMVFG 82
Query: 88 LFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYDECLLRYSNRYIFSTRETTRTV 147
L+LC+GD + SC+ CV FA +D RCP K+ ++ YDEC+L YS+R IF TT T+
Sbjct: 83 LYLCKGDLSPESCRECVIFAAKDTRSRCPGGKEFLIQYDECMLGYSDRNIFMDTVTTTTI 142
Query: 148 YLWNTQNAT--DPVKFNDLVGSLMGEAASQAVND-PKKFATKMANFTSFQKLYALAQCTQ 204
WNTQ T +FND V SLM ++A +A N KKFA K ++F+S Q LYA QC
Sbjct: 143 ITWNTQKVTADQSDRFNDAVLSLMKKSAEEAANSTSKKFAVKKSDFSSSQSLYASVQCIP 202
Query: 205 DLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPFYNEPATPAPAPTPVLL 264
DL+S DC +CL+ +I +L K GGR L PSCN RYEVYPFY E P PV
Sbjct: 203 DLTSEDCVMCLQQSIKELYF---NKVGGRFLVPSCNSRYEVYPFYKETIEGTVLPPPVSA 259
Query: 265 SPPPPSSVIR-PRGKSGISSSTIIAIVAPIAVAAVLFVACLCF-LRRRAKKKYNAVPEEN 322
P P S P GK S+ IIAIV P+A++ ++ VA F +RAKK Y+ PEE+
Sbjct: 260 PPLPLVSTPSFPPGKGKNSTVIIIAIVVPVAISVLICVAVFSFHASKRAKKTYD-TPEED 318
Query: 323 ADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSG 382
D+T SLQFDF+ IE AT+KFS NKLG+GGFG+VYKG LP+G ++AVKRLS +SG
Sbjct: 319 ---DITTAGSLQFDFKVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQVAVKRLSKTSG 375
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLD 442
QG +EFKNEVV+VAKLQHRNLV+LLGFCLE EEKILVYEFV NKSLDYFL+D Q QLD
Sbjct: 376 QGEKEFKNEVVVVAKLQHRNLVKLLGFCLEREEKILVYEFVSNKSLDYFLFDSRMQSQLD 435
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
W+ RYKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA+MNPK++DFGMARIF +DQT
Sbjct: 436 WTTRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFEIDQT 495
Query: 503 QGNTSRIVGT 512
+ +T R+VGT
Sbjct: 496 EAHTRRVVGT 505
|
Involved in multiple distinct defense responses. May function as a disease resistance (R) protein. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65482|CRK23_ARATH Putative cysteine-rich receptor-like protein kinase 23 OS=Arabidopsis thaliana GN=CRK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1283), Expect = e-140, Method: Compositional matrix adjust.
Identities = 279/547 (51%), Positives = 343/547 (62%), Gaps = 65/547 (11%)
Query: 24 TAAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRGNGFSRGFFNATAGQDPN 83
T+A DPTYVYH C A F R+ST+ +NL LL++L +S +S GF NATAG+ P+
Sbjct: 134 TSALDPTYVYHVCPSWATFPRSSTYMTNLITLLSTL---SSPSASYSTGFQNATAGKHPD 190
Query: 84 RVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYDECLLRYSNRYIFSTRET 143
RV LF CRGD + C+ CV+FA + RCP+ K+ ++YD+C LRYSNR I ST T
Sbjct: 191 RVTGLFNCRGDVSPEVCRRCVSFAVNETSTRCPIEKEVTLYYDQCTLRYSNRNILSTSNT 250
Query: 144 TRTVYLWNTQNAT--DPVKFNDLVGSLMGEAASQAVNDPKKFATKMANFTSFQKLYALAQ 201
+ L N+QN T + +F DLV + M +A A N K+F + ANFT+ LY L Q
Sbjct: 251 NGGIILANSQNMTSNEQARFKDLVLTTMNQATIAAANSSKRFDARSANFTTLHSLYTLVQ 310
Query: 202 CTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPFYNEPATPAPAPT- 260
CT DL+ DC CL+ I QLPT K GG+ + PSC+ R+E+ FYN+ A P P
Sbjct: 311 CTHDLTRQDCLSCLQQIINQLPT---EKIGGQFIVPSCSSRFELCLFYNQSAVTTPQPQQ 367
Query: 261 ----------------------PV--------------LLSPPPPSSVIR----PRGKSG 280
P+ LL P +I+ GK G
Sbjct: 368 NSAPPPPPTSIPSPRPGLNSRFPLITCLSAVSFEKFKDLLKPGFICILIKIVSENTGKGG 427
Query: 281 ISSSTIIAIVAPIAVAAVLFVACLCFLRRRAKKKYNAVP---------------EENADN 325
SS IIA+V I +LFVA +R KK A+P EN D+
Sbjct: 428 NSSVIIIAVVVSITALLLLFVAVFSVRTKRRKKMIGAIPLLNVKRKDTEVTEPLAENGDS 487
Query: 326 DLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGA 385
+T SLQFDF+ I ATN F NKLG+GGFGEVYKG PSG ++AVKRLS +SGQG
Sbjct: 488 -ITTAGSLQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGE 546
Query: 386 QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
+EF+NEVV+VAKLQHRNLVRLLG+CLEGEEKILVYEFV NKSLDYFL+D + QLDW+R
Sbjct: 547 REFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTR 606
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
RYKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA+MNPK++DFGMARIFG+DQT+ N
Sbjct: 607 RYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEAN 666
Query: 506 TSRIVGT 512
T R+VGT
Sbjct: 667 TRRVVGT 673
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 493 bits (1268), Expect = e-138, Method: Compositional matrix adjust.
Identities = 256/494 (51%), Positives = 327/494 (66%), Gaps = 14/494 (2%)
Query: 25 AAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRGNGFSRGFFNATAGQDPNR 84
+A +P Y+ H C + ++ NST+ +NL LL+S ASR +S GF N AGQ P+R
Sbjct: 33 SAQNPFYLNHDCPNRTTYSSNSTYSTNLKTLLSSF---ASRNASYSTGFQNIRAGQTPDR 89
Query: 85 VYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYDECLLRYSNRYIFSTRETT 144
V LFLCRGD + C NCV F+ + + RCP ++ + +Y+EC+LRYS++ ST
Sbjct: 90 VTGLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYEECILRYSHKNFLSTVTYE 149
Query: 145 RTVYLWN------TQNATDPVKFNDLVGSLMGEAASQAVNDPKKFATKMANFTSFQKLYA 198
+ + N QN D +F DLV S M +AA++A N +KF+T TS Q LY
Sbjct: 150 GELIMRNPNNISSIQNQRD--QFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYG 207
Query: 199 LAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPFYNEPATPAPA 258
L QCT DL+ DC CL +I ++ + G R PSCN RYE+Y FYNE A P+
Sbjct: 208 LVQCTPDLARQDCFSCLTSSINRMMPLF--RIGARQFWPSCNSRYELYAFYNETAIGTPS 265
Query: 259 PTPVLLSPPPPSSVIRPRGKSGISSSTIIAIVAPIAVAAVLFVACLCFLRRRAKKKYNAV 318
P P+ PP + GKSG S+ ++AIV + + V CFL +R KK ++
Sbjct: 266 PPPLFPGSTPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIALVG-YCFLAQRTKKTFDTA 324
Query: 319 PEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS 378
+D+ +SLQ D+ TI+ ATN F+ NK+G GGFGEVYKG +G+E+AVKRLS
Sbjct: 325 SASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLS 384
Query: 379 ASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ 438
+S QG EFK EVV+VAKLQHRNLVRLLGF L+GEE+ILVYE++PNKSLD L+DP KQ
Sbjct: 385 KNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQ 444
Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
QLDW +RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA++NPKI+DFGMARIFG
Sbjct: 445 TQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFG 504
Query: 499 VDQTQGNTSRIVGT 512
+DQTQ NTSRIVGT
Sbjct: 505 LDQTQDNTSRIVGT 518
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 491 bits (1264), Expect = e-138, Method: Compositional matrix adjust.
Identities = 270/513 (52%), Positives = 339/513 (66%), Gaps = 43/513 (8%)
Query: 22 SFTAAA-DPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRGNGFSRGFFNATAGQ 80
SFTA+A +P Y+YH CS T ++ NST+ +NL T L + +SR +S GF NATAGQ
Sbjct: 18 SFTASAQNPFYLYHNCSITTTYSSNSTYSTNLK---TLLSSLSSRNASYSTGFQNATAGQ 74
Query: 81 DPNRVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYDECLLRYSNRYIFST 140
P+ V LFLCRG+ + C++C+ + + + RCP ++ + +Y++C+LRYSNR I ST
Sbjct: 75 APDMVTGLFLCRGNVSPEVCRSCIALSVNESLSRCPNEREAVFYYEQCMLRYSNRNILST 134
Query: 141 RETTRTVYLWNTQNATDPV-----KFNDLVGSLMGEAASQAVNDPKKFATKMANFTSFQK 195
T V++ QNA +P+ +F DLV + M AA +A K+FA + + Q
Sbjct: 135 LNTDGGVFM---QNARNPISVKQDRFRDLVLNPMNLAAIEAARSIKRFAVTKFDLNALQS 191
Query: 196 LYALAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPFYNEPATP 255
LY + QCT DL+ DC CL+ +I Q+ K GGR PSC RY+ Y FYNE
Sbjct: 192 LYGMVQCTPDLTEQDCLDCLQQSINQVTY---DKIGGRTFLPSCTSRYDNYEFYNEFNVG 248
Query: 256 APAPTPVLLSPPPPSSVIRPRGKSGISSSTIIAIVAPIAVAAVLFVACLCFLRRRAKKKY 315
P + SP P GK G SS +IA+V PI V +LFVA R + KK
Sbjct: 249 TPQDS----SPRP--------GKGGNSSVIVIAVVVPITVLFLLFVAFFSVRRAKRKKTI 296
Query: 316 NAVP----------------EENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFG 359
A+P E +D+T SLQFDF+ I AT+ F NKLG+GGFG
Sbjct: 297 GAIPLFKVKRKETEVTEPPAETTDGDDITTAGSLQFDFKAIVAATDIFLPINKLGQGGFG 356
Query: 360 EVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419
EVYKG PSG ++AVKRLS +SGQG +EF+NEVV+VAKLQHRNLV+LLG+CLEGEEKILV
Sbjct: 357 EVYKGTFPSGVQVAVKRLSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILV 416
Query: 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 479
YEFVPNKSLDYFL+DP QGQLDWSRRYKIIGGIARGILYLH+DSRL IIHRDLKA NIL
Sbjct: 417 YEFVPNKSLDYFLFDPTMQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNIL 476
Query: 480 LDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
LDA+MNPK++DFGMARIFG+DQT+ NT R+VGT
Sbjct: 477 LDADMNPKVADFGMARIFGMDQTEANTRRVVGT 509
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1231), Expect = e-134, Method: Compositional matrix adjust.
Identities = 257/503 (51%), Positives = 333/503 (66%), Gaps = 24/503 (4%)
Query: 25 AAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPT-NASRGNGFSRGFFNATAGQDPN 83
+A DP Y+ H+C +T ++ NST+ +NL LL+SL + NAS +S GF NATAG+ P+
Sbjct: 23 SAQDPFYLNHYCPNTTTYSSNSTYSTNLRTLLSSLSSRNAS----YSTGFQNATAGKAPD 78
Query: 84 RVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYDECLLRYSNRYIFSTRET 143
RV LFLCRGD + C+NCV F+ + CP ++ + +Y++C+LRYS++ I ST T
Sbjct: 79 RVTGLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYEQCILRYSHKNILSTAIT 138
Query: 144 TRTVYLWNTQNATDPVK-----FNDLVGSLMGEAASQAVNDPKKFATKMANFTSFQKLYA 198
++ + N P + F V S M EAA +A N +K T T++Q LY
Sbjct: 139 NEGEFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKLYTVNTELTAYQNLYG 198
Query: 199 LAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPFYNEPATPAPA 258
L QCT DL+ +DC CL+ +I + + G R+ PSC RYE+YPFYNE A P
Sbjct: 199 LLQCTPDLTRADCLSCLQSSINGMAL---SRIGARLYWPSCTARYELYPFYNESAIETPP 255
Query: 259 PTPV---------LLSPPPPSSVIRPRGKSGISSSTIIAIVAPIAVAAVLFVACLCFLRR 309
P L+S PP SS P GKSG S+ ++A+V + + V CFL +
Sbjct: 256 LPPPPPPPPPRESLVSTPPISSSSLP-GKSGNSTVLVVAVVVLAVLLFIALVG-YCFLAK 313
Query: 310 RAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
+ KK ++ +D+ +SLQ D+ TI+ ATN F+ NK+G GGFGEVYKG +G
Sbjct: 314 KKKKTFDTASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNG 373
Query: 370 QEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429
+E+AVKRLS +S QG EFK EVV+VAKLQHRNLVRLLGF L+GEE+ILVYE++PNKSLD
Sbjct: 374 KEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLD 433
Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
L+DP KQ QLDW +RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA++NPKI+
Sbjct: 434 CLLFDPTKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIA 493
Query: 490 DFGMARIFGVDQTQGNTSRIVGT 512
DFGMARIFG+DQTQ NTSRIVGT
Sbjct: 494 DFGMARIFGLDQTQDNTSRIVGT 516
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LZU4|CRK4_ARATH Cysteine-rich receptor-like protein kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 476 bits (1225), Expect = e-133, Method: Compositional matrix adjust.
Identities = 272/531 (51%), Positives = 344/531 (64%), Gaps = 37/531 (6%)
Query: 4 LKFSVLFLFVIYLSSFQFSFTAAADPT----YVYHFC-SDTANFTRNSTFESNLNRLLTS 58
+ F LF F+++LS F S + + P ++ H C S ++RNST+ +NL T
Sbjct: 1 MSFFWLFPFLLHLS-FADSLSPLSAPVQNFIHLNHSCPSSILTYSRNSTYFTNLK---TL 56
Query: 59 LPTNASRGNGFSRGFFNATAGQDPNRVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVS 118
L + +SR +S GF ATAGQ P+RV LFLCRGD + C+NCV F+ ++ + CP +
Sbjct: 57 LSSLSSRNASYSTGFQTATAGQAPDRVTGLFLCRGDVSQEVCRNCVAFSVKETLYWCPYN 116
Query: 119 KDTIVWYDECLLRYSNRYIFSTRETTRTVYLWN-------TQNATDPVKFNDLVGSLMGE 171
K+ +++YDEC+LRYS+R I ST + L N QN D +F DLV S +
Sbjct: 117 KEVVLYYDECMLRYSHRNILSTVTYDGSAILLNGANISSSNQNQVD--EFRDLVSSTLNL 174
Query: 172 AASQAVNDPKKFATKMANFTSFQKLYALAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQG 231
AA +A N KKF T+ + Q LY L QCT DL+ DC CL+ +I + + G
Sbjct: 175 AAVEAANSSKKFYTR--KVITPQPLYLLVQCTPDLTRQDCLRCLQKSIKGMSLY---RIG 229
Query: 232 GRVLTPSCNVRYEVYPFYNEPATPAPA----------PTPVLLSPPPPSSVIRPRGKSGI 281
GR PSCN RYE Y FYNE AT + + + L+PPP +I RGK G
Sbjct: 230 GRFFYPSCNSRYENYSFYNETATRSSSPPSLPPRSTPQQQLKLAPPP---LISERGK-GR 285
Query: 282 SSSTIIAIVAPIAVAAVLFVACLCFLRRRAKKKYNAVPEENADNDLTILESLQFDFETIE 341
+SS II +V PI +LFVA ++ + Y P +D+T SLQFDF+ IE
Sbjct: 286 NSSVIIVVVVPIIALLLLFVAFFSLRAKKTRTNYEREPLTEESDDITTAGSLQFDFKAIE 345
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHR 401
ATNKF NKLG+GGFGEVYKG+ PSG ++AVKRLS +SGQG +EF NEV++VAKLQHR
Sbjct: 346 AATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHR 405
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
NLVRLLGFCLE +E+ILVYEFVPNKSLDYF++D Q LDW+RRYKIIGGIARGILYLH
Sbjct: 406 NLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLH 465
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+DSRL IIHRDLKA NILL +MN KI+DFGMARIFG+DQT+ NT RIVGT
Sbjct: 466 QDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGT 516
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1221), Expect = e-133, Method: Compositional matrix adjust.
Identities = 253/493 (51%), Positives = 330/493 (66%), Gaps = 18/493 (3%)
Query: 25 AAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRGNGFSRGFFNATAGQDPNR 84
+A DP ++ ++C + ++ NST+ +NL T L + +SR +S GF NAT GQ +R
Sbjct: 22 SAQDPRFLAYYCPNATTYSSNSTYLTNLK---TLLSSLSSRNASYSTGFQNATVGQALDR 78
Query: 85 VYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYDECLLRYSNRYIFSTRETT 144
V LFLCRGD + C+NCVTFA + RCP ++ + +Y+EC+LRYS++ I ST T
Sbjct: 79 VTGLFLCRGDVSPEVCRNCVTFAVNNTFSRCPNQREAVFYYEECILRYSHKNILSTAITN 138
Query: 145 RTVYLWNTQNATDPVK-----FNDLVGSLMGEAASQAVNDPKKFATKMANFTSFQKLYAL 199
++ N P++ F +LV S M + A +A ++P+KF+T T+ Q Y L
Sbjct: 139 EGEFILRNPNHISPIQNQINQFTNLVLSNMNQIAIEAADNPRKFSTIKTELTALQTFYGL 198
Query: 200 AQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPFYNEPATPAPAP 259
QCT DLS +C CL +I ++P + G R PSCN RYE+Y FYNE A P P
Sbjct: 199 VQCTPDLSRQNCMNCLTSSINRMPF---SRIGARQFWPSCNSRYELYDFYNETAIGTPPP 255
Query: 260 TPVLLSPPPPSSVIRPRGKSGISSSTIIAIVAPIAVAAVLFVACLCFLRRRAKKKYNAVP 319
+ KSG S+ ++A+V PI VA ++F+A CF +RAKK Y P
Sbjct: 256 PLPP------LASPSLSDKSGNSNVVVVAVVVPIIVAVLIFIAGYCFFAKRAKKTYGTTP 309
Query: 320 EENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSA 379
+ D D T +ESLQ D+ I+ ATN FS +NK+G GGFG+VYKG +G E+AVKRLS
Sbjct: 310 ALDED-DKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSK 368
Query: 380 SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG 439
+S QG EFKNEVV+VA L+H+NLVR+LGF +E EE+ILVYE+V NKSLD FL+DP K+G
Sbjct: 369 TSEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKG 428
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
QL W++RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI+DFGMARIFG+
Sbjct: 429 QLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGM 488
Query: 500 DQTQGNTSRIVGT 512
DQTQ NTSRIVGT
Sbjct: 489 DQTQQNTSRIVGT 501
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 513 | ||||||
| 255555033 | 579 | ATP binding protein, putative [Ricinus c | 0.925 | 0.820 | 0.684 | 0.0 | |
| 255555035 | 671 | ATP binding protein, putative [Ricinus c | 0.972 | 0.743 | 0.635 | 1e-179 | |
| 255555031 | 674 | ATP binding protein, putative [Ricinus c | 0.945 | 0.719 | 0.644 | 1e-176 | |
| 359474717 | 663 | PREDICTED: cysteine-rich receptor-like p | 0.922 | 0.713 | 0.626 | 1e-170 | |
| 359474715 | 684 | PREDICTED: cysteine-rich receptor-like p | 0.984 | 0.738 | 0.603 | 1e-169 | |
| 224113935 | 674 | predicted protein [Populus trichocarpa] | 0.986 | 0.750 | 0.608 | 1e-169 | |
| 359496581 | 666 | PREDICTED: cysteine-rich receptor-like p | 0.964 | 0.743 | 0.572 | 1e-165 | |
| 351721533 | 667 | cysteine-rich protein precursor [Glycine | 0.935 | 0.719 | 0.615 | 1e-162 | |
| 296088180 | 699 | unnamed protein product [Vitis vinifera] | 0.964 | 0.708 | 0.535 | 1e-159 | |
| 224145816 | 668 | predicted protein [Populus trichocarpa] | 0.974 | 0.748 | 0.548 | 1e-158 |
| >gi|255555033|ref|XP_002518554.1| ATP binding protein, putative [Ricinus communis] gi|223542399|gb|EEF43941.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 642 bits (1655), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/491 (68%), Positives = 385/491 (78%), Gaps = 16/491 (3%)
Query: 32 VYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRGNGFSRGFFNATAGQDPNRVYSLFLC 91
+Y+ CS+T FT NST+++NLN+LL+SL NA+ S GFFN +GQ P+ VY FLC
Sbjct: 30 LYYVCSNTTAFTPNSTYQTNLNKLLSSLSNNANN----SIGFFNIPSGQQPDDVYGSFLC 85
Query: 92 RGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYDECLLRYSNRYIFSTRETTRTVYLWN 151
RGD +T+ CQ+CVTFAT+D++ RCP+ K IVWYDECLLRY N+ ST + T +Y+WN
Sbjct: 86 RGDVSTDVCQDCVTFATQDIVKRCPIEKVAIVWYDECLLRYENQSFISTMDQTPGLYMWN 145
Query: 152 TQN--ATDPVKFNDLVGSLM---GEAASQAVNDPKKFATKMANFTSFQKLYALAQCTQDL 206
TQN +D V+FN L+ S M AS A + KKFA K +FTSFQKLY+L QCT DL
Sbjct: 146 TQNISTSDQVRFNALLASTMNNLATEASTAASGEKKFAVKEDSFTSFQKLYSLVQCTPDL 205
Query: 207 SSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPFYNEPATPAPAPTPVLLSP 266
S+SDC CL+ AI+ LP+CCGGKQGGRVL PSCN+RYEVY F+N A P P P + P
Sbjct: 206 STSDCGQCLQTAISNLPSCCGGKQGGRVLYPSCNIRYEVYLFFNATALEPPPPAPSPVVP 265
Query: 267 PPPSSV---IRPR--GKSGISSSTIIAIVAPIAVAAVLFVACLCFLRRRAKKKYNAVPEE 321
PP +P+ GK GIS+ TIIAIVAPIAVA VLF C+LRRR KKY AV E+
Sbjct: 266 LPPPPTGLGAKPQIEGKRGISTVTIIAIVAPIAVATVLFSLGCCYLRRR--KKYEAVQED 323
Query: 322 NADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS 381
+A N++T ESLQ D TIEVATNKFS DNKLGEGGFGEVYKG LP+GQEIAVK+LS SS
Sbjct: 324 DARNEITTAESLQIDLNTIEVATNKFSADNKLGEGGFGEVYKGTLPNGQEIAVKKLSRSS 383
Query: 382 GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL 441
GQGA+EFKNEV L+AKLQHRNLVRLLGFCLEG EKILVYEFVPNKSLDYFL+DPEKQ QL
Sbjct: 384 GQGAEEFKNEVALLAKLQHRNLVRLLGFCLEGAEKILVYEFVPNKSLDYFLFDPEKQAQL 443
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
DWSRRYKIIGGIARGI+YLHEDSRLRIIHRDLKASNILLD MN KISDFGMARIFGVDQ
Sbjct: 444 DWSRRYKIIGGIARGIVYLHEDSRLRIIHRDLKASNILLDRNMNSKISDFGMARIFGVDQ 503
Query: 502 TQGNTSRIVGT 512
TQGNTSRIVGT
Sbjct: 504 TQGNTSRIVGT 514
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555035|ref|XP_002518555.1| ATP binding protein, putative [Ricinus communis] gi|223542400|gb|EEF43942.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1632), Expect = e-179, Method: Compositional matrix adjust.
Identities = 328/516 (63%), Positives = 394/516 (76%), Gaps = 17/516 (3%)
Query: 4 LKFSVLFLFVIYLSSFQFSFTAAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNA 63
++F ++ LF++ L+ A P Y YHFCS+T FT NST+++NLN++L+SL NA
Sbjct: 5 IRFPIILLFLLRLAII----VKAESPEYRYHFCSNTTTFTPNSTYQTNLNQVLSSLSNNA 60
Query: 64 SRGNGFSRGFFNATAGQDPNRVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIV 123
+ S GFFN +GQ P+ VY FLCRGD +T+ CQ+CVTFAT+D++ RCP+ K IV
Sbjct: 61 NN----SIGFFNIPSGQQPDDVYGSFLCRGDVSTDVCQDCVTFATQDIVKRCPIEKVAIV 116
Query: 124 WYDECLLRYSNRYIFSTRETTRTVYLWNTQNATDPVKFNDLVGSLM---GEAASQAVNDP 180
WYD+CLLRY N+ ST + T V+L NTQ+ +DP +F++L+ + M AS A +
Sbjct: 117 WYDQCLLRYENQSFISTMDQTPGVFLSNTQDISDPDRFDNLLATTMENLATDASSAASGE 176
Query: 181 KKFATKMANFTSFQKLYALAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCN 240
KKFA NFT+FQKLY+L QCT DLS+ C CLRGAI+ LP+CCGGK+G VL PSCN
Sbjct: 177 KKFAATDDNFTAFQKLYSLVQCTPDLSNPGCRQCLRGAISNLPSCCGGKRGANVLYPSCN 236
Query: 241 VRYEVYPFYNEPATPAPAPTPVLLSPPP--PSSVIRPR--GKSGISSSTIIAIVAPIAVA 296
VRYEVYPF+N A P P+P PPP S RP G+SGIS+ I+AIVAP+A+A
Sbjct: 237 VRYEVYPFFNATAVEPPPPSPSPAVPPPPPTGSGTRPETEGQSGISTVIIVAIVAPVAIA 296
Query: 297 AVLFVACLCFLRRRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEG 356
VLF C+LRRR +KKY+AV E+ N++T +ESLQ D T+E ATNKFS DNKLGEG
Sbjct: 297 IVLFSLAYCYLRRRPRKKYDAVQEDG--NEITTVESLQIDLNTVEAATNKFSADNKLGEG 354
Query: 357 GFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416
GFGEVYKG+LP+GQEIAVK+LS SSGQGAQEFKNEVVL+AKLQHRNLVRLLGFCLEG EK
Sbjct: 355 GFGEVYKGILPNGQEIAVKKLSRSSGQGAQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEK 414
Query: 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
ILVYEFV NKSLDYFL+DPEKQ QLDWS RYKI+GGIARGILYLHEDS+LRI+HRDLK S
Sbjct: 415 ILVYEFVSNKSLDYFLFDPEKQRQLDWSTRYKIVGGIARGILYLHEDSQLRIVHRDLKVS 474
Query: 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
NILLD MNPKISDFG ARIFGVDQ+QGNT RIVGT
Sbjct: 475 NILLDRNMNPKISDFGTARIFGVDQSQGNTKRIVGT 510
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555031|ref|XP_002518553.1| ATP binding protein, putative [Ricinus communis] gi|223542398|gb|EEF43940.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 624 bits (1609), Expect = e-176, Method: Compositional matrix adjust.
Identities = 319/495 (64%), Positives = 392/495 (79%), Gaps = 10/495 (2%)
Query: 24 TAAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRGNGFSRGFFNATAGQDPN 83
+ + +P Y+YH CS+T F NST+++NLN+L SL NA+ S GF+N ++GQDP+
Sbjct: 23 SQSPEPVYLYHVCSNTTTFAPNSTYQTNLNQLFPSLSNNANN----SIGFYNRSSGQDPD 78
Query: 84 RVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYDECLLRYSNRYIFSTRET 143
+Y LFLCRGD +T+ CQ+CVTFA++D++ RCP+ K IVWYDECLL Y+NR ++S
Sbjct: 79 DIYGLFLCRGDVSTDVCQDCVTFASQDIVKRCPIEKVAIVWYDECLLHYANRSLYSIMAQ 138
Query: 144 TRTVYLWNTQNATDPVKFNDLVGSLMGEAASQAVN---DPKKFATKMANFTSFQKLYALA 200
V+L N QN D +FN+L+ + MG+ A++A + KKFA K+ NFT+F+KLY+L
Sbjct: 139 EPGVFLLNVQNIADQDRFNNLLATTMGKLATEAASAASGEKKFAVKIDNFTAFEKLYSLV 198
Query: 201 QCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPFYNEPATPAPAPT 260
QCT DLS+ DC CL+ AI+ LPTCC GK+GGRVL PSCN+RYEVYPF+N A P P+
Sbjct: 199 QCTPDLSNLDCGRCLQAAISNLPTCCDGKRGGRVLYPSCNIRYEVYPFFNVTALEPPPPS 258
Query: 261 PVLLSPPP-PSSVIRP--RGKSGISSSTIIAIVAPIAVAAVLFVACLCFLRRRAKKKYNA 317
P + PPP SS RP +GKSG+S+ TI+AIVAP+AVA V F C+LRRRA+KKY+A
Sbjct: 259 PSPVVPPPPTSSGTRPETKGKSGLSTVTIVAIVAPVAVAIVFFFLGCCYLRRRARKKYDA 318
Query: 318 VPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL 377
E++A N++T +ESLQ D TIE AT+KFS NKLGEGGFG+VYKG LP+GQEIAVK+L
Sbjct: 319 GQEDDAGNEITTVESLQIDLNTIEAATDKFSAANKLGEGGFGKVYKGTLPNGQEIAVKKL 378
Query: 378 SASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEK 437
S SS QGAQEFKNEVVL+AKLQHRNLVRLLGFCLEG EKILVYEFVPNKSLDYFL+D +K
Sbjct: 379 SRSSVQGAQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEKILVYEFVPNKSLDYFLFDAKK 438
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
QGQLDW RYKI+GGIARGI+YLHEDS+L+IIHRDLK SNILLD +MNPKISDFGMARIF
Sbjct: 439 QGQLDWQTRYKIVGGIARGIIYLHEDSQLKIIHRDLKVSNILLDKDMNPKISDFGMARIF 498
Query: 498 GVDQTQGNTSRIVGT 512
GVDQTQGNT+RIVGT
Sbjct: 499 GVDQTQGNTNRIVGT 513
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474717|ref|XP_002267916.2| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1560), Expect = e-170, Method: Compositional matrix adjust.
Identities = 308/492 (62%), Positives = 360/492 (73%), Gaps = 19/492 (3%)
Query: 29 PTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRGNGFSRGFFNATAGQDPNRV-YS 87
P Y+YH C +T F NS++E+NLN L+SL +NA+R GF +N TAG+ P V Y
Sbjct: 22 PGYLYHICPNTTTFNPNSSYETNLNFALSSLSSNATRDTGF----YNVTAGRTPPDVAYG 77
Query: 88 LFLCRGDQTTNSCQNCVTFATRDVI-GRCPVSKDTIVWYDECLLRYSNRYIFSTRETTRT 146
LFLCRGD T+ CQ+CV A + + RC K I+WYDEC+LRYSN FS +
Sbjct: 78 LFLCRGDVTSQVCQDCVATAVNETVRQRCRGFKQAIIWYDECMLRYSNESFFSQVSESPR 137
Query: 147 VYLWNTQNATDPVKFNDLVGSLMGEAASQAVNDP--KKFATKMANFTSFQKLYALAQCTQ 204
V +WNTQN T+P +FN ++G + +QAVND KKFATK NFT FQ++Y+L QCT
Sbjct: 138 VSMWNTQNITEPDQFNQVLGDTLDSIRTQAVNDQSGKKFATKEENFTGFQRVYSLVQCTP 197
Query: 205 DLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPFYNEPATPAPAPTPVLL 264
DLS C+ CL G IA LP CCGGKQG RVL PSCNVRYE+YPFY A P P
Sbjct: 198 DLSPDQCDRCLIGTIAILPDCCGGKQGARVLFPSCNVRYELYPFYQSVAAPPSPPPAR-- 255
Query: 265 SPPPPSSVIRPRGKSGISSSTIIAIVAPIAVAAVLF-VACLCFLRRRAKKKYNAVPEENA 323
S GK GISS TI+ IV P V+ V+F + C CF+RR AKK+Y+ + EN
Sbjct: 256 -----PSEPSTEGKGGISSKTIVIIVVPTFVSVVIFSILCYCFIRRCAKKRYDTLEAENV 310
Query: 324 DNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ 383
+ ++T +SLQFD TI+ ATN FS NK+GEGGFG VYKG L SGQEIA+KRLS SSGQ
Sbjct: 311 EFNITTEQSLQFDLATIQAATNNFSDHNKIGEGGFGAVYKGTLSSGQEIAIKRLSKSSGQ 370
Query: 384 GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY---DPEKQGQ 440
GA EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE+VPNKSLDYFL+ P K+GQ
Sbjct: 371 GAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDYFLFGLAQPTKRGQ 430
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
LDWSRRYKIIGGIARGILYLHEDSRLR+IHRDLKASN+LLD +MNPKISDFGMARIFGVD
Sbjct: 431 LDWSRRYKIIGGIARGILYLHEDSRLRVIHRDLKASNVLLDGDMNPKISDFGMARIFGVD 490
Query: 501 QTQGNTSRIVGT 512
QTQGNT+R+VGT
Sbjct: 491 QTQGNTNRVVGT 502
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474715|ref|XP_003631522.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 603 bits (1554), Expect = e-169, Method: Compositional matrix adjust.
Identities = 317/525 (60%), Positives = 373/525 (71%), Gaps = 20/525 (3%)
Query: 4 LKFSVLFLFVIYLSSFQFSFTAAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNA 63
+ FS LF+ L A P Y++H CS+T NST+++NLN LL+SL +NA
Sbjct: 3 VSFSRNLLFLCALGLAISCLAIQAAPDYIHHVCSNTTTIQPNSTYQTNLNSLLSSLSSNA 62
Query: 64 SRGNGFSRGFFNATAGQDPNRVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIV 123
+R NGF +NATAGQ P+ Y LFLCRGD + C++CV A+ +++ +C K I+
Sbjct: 63 TRANGF----YNATAGQSPDVAYGLFLCRGDVAIDDCRDCVANASAEILQQCSGVKKAII 118
Query: 124 WYDECLLRYSNRYIFSTRETTRTVYLWNTQNATDPVKFNDLVGSLMGEAASQAVNDP--K 181
WYD+C+L YSNR IFS E + L+N QN TDP FN LV M A+ A ND K
Sbjct: 119 WYDQCMLHYSNRSIFSRVEENPMLQLYNLQNVTDPGPFNQLVVDTMNATATLAANDESGK 178
Query: 182 KFATKMANFTSFQKLYALAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNV 241
KFATK NFT Q LY+L QCT DLS +DC+ CL GAI L CC GKQG R LTPSCN
Sbjct: 179 KFATKEENFTGSQTLYSLVQCTPDLSIADCSKCLEGAIGALSLCCSGKQGARTLTPSCNA 238
Query: 242 RYEVYPFYNEPA-----------TPAPAPTPVLLSPPPPSSVIRP--RGKSGISSSTIIA 288
RYE+YPFY A T A P +P SS P GK GISS TI+
Sbjct: 239 RYELYPFYQLEAGPLAPALAPAPTSATVLLPPPPAPSSKSSATEPSTEGKGGISSKTIVI 298
Query: 289 IVAPIAVAAVLF-VACLCFLRRRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKF 347
IV P V+ V+F + C CF+RR AKK+Y+ + EN + ++T +SLQFD TI+ ATN F
Sbjct: 299 IVVPTFVSVVIFSILCYCFIRRCAKKRYDTLEAENVEFNITTEQSLQFDLATIQAATNNF 358
Query: 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
S NK+GEGGFG VYKG L SGQEIA+KRLS SSGQGA EFKNEVVLVAKLQHRNLVRLL
Sbjct: 359 SDHNKIGEGGFGAVYKGTLSSGQEIAIKRLSKSSGQGAVEFKNEVVLVAKLQHRNLVRLL 418
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
GFCLEGEEKILVYE+VPNKSLDYFL+DP+K+GQLDWSRRYKIIGGIARGILYLHEDSRLR
Sbjct: 419 GFCLEGEEKILVYEYVPNKSLDYFLFDPDKRGQLDWSRRYKIIGGIARGILYLHEDSRLR 478
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+IHRDLKASN+LLD +MNPKISDFGMARIFGVDQTQGNT+R+VGT
Sbjct: 479 VIHRDLKASNVLLDGDMNPKISDFGMARIFGVDQTQGNTNRVVGT 523
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113935|ref|XP_002316618.1| predicted protein [Populus trichocarpa] gi|222859683|gb|EEE97230.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1548), Expect = e-169, Method: Compositional matrix adjust.
Identities = 315/518 (60%), Positives = 383/518 (73%), Gaps = 12/518 (2%)
Query: 1 MTPLKFSVLFLFVIYLSSFQFSFTAAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLP 60
M LKFS V+ T A DPT++Y +C +T FTRNST+++NLN LL+SL
Sbjct: 1 MDSLKFST----VLLSLLSLAIITQAQDPTFLYPYCPNTTTFTRNSTYQANLNLLLSSLS 56
Query: 61 TNASRGNGFSRGFFNATAGQDPNRVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKD 120
+NA+R N GF+N +AGQDP+ VY +FLCRGD + + C+NCV FA +DV+ RCP+ K
Sbjct: 57 SNATRNN--INGFYNVSAGQDPDAVYGMFLCRGDVSNSVCRNCVNFAAKDVLERCPIEKV 114
Query: 121 TIVWYDECLLRYSNRYIFSTRETTRTVYLWNTQNAT-DPVKFNDLVGSLMGEAASQAVND 179
++W+DEC LRYSNR IFST + T+++ + N T P +FN LV + + + A++A +
Sbjct: 115 AMIWFDECELRYSNRNIFSTVDQDFTLFMMSPNNVTVQPDRFNQLVETTINDIAARAASA 174
Query: 180 P---KKFATKMANFTSFQKLYALAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLT 236
P KKFA + N+T QKLY L QCT DLS+ DC+ CL+GAI++L CC KQGGRVL
Sbjct: 175 PSGAKKFAVQQVNYTGIQKLYTLVQCTPDLSTPDCSRCLQGAISKLGNCCNRKQGGRVLF 234
Query: 237 PSCNVRYEVYPFYNEPATPAPAPTPVLLSPPP--PSSVIRPRGKSGISSSTIIAIVAPIA 294
SCN RYE+Y FYN A AP P ++ P S +GK G+S+ IIAI+ P+
Sbjct: 235 ASCNFRYELYEFYNATAAAEAAPPPPPVALSPPPTSGPETRKGKGGVSTVLIIAILIPVT 294
Query: 295 VAAVLFVACLCFLRRRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLG 354
V+ VLF CFL RRAK N+ E + N++T +ESLQFD +I+ ATN FS DNKLG
Sbjct: 295 VSLVLFCLGFCFLSRRAKSNKNSAQENDVGNEITNVESLQFDLSSIQDATNHFSADNKLG 354
Query: 355 EGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414
EGGFGEVYKG LP+GQ IAVKRLS SGQGA EFKNEV+LVAKLQHRNLVRLLGFCLEGE
Sbjct: 355 EGGFGEVYKGTLPNGQAIAVKRLSKGSGQGAAEFKNEVILVAKLQHRNLVRLLGFCLEGE 414
Query: 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK 474
EKILVYEFVPNKSLDYF++DPEKQG LDWS+RYKIIGGIARGILYLHEDSRLR+IHRDLK
Sbjct: 415 EKILVYEFVPNKSLDYFVFDPEKQGLLDWSKRYKIIGGIARGILYLHEDSRLRVIHRDLK 474
Query: 475 ASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
ASNILLD +MN K+SDFGMARIFGVDQTQG T+RIVGT
Sbjct: 475 ASNILLDGDMNAKVSDFGMARIFGVDQTQGCTNRIVGT 512
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496581|ref|XP_002270035.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1511), Expect = e-165, Method: Compositional matrix adjust.
Identities = 292/510 (57%), Positives = 373/510 (73%), Gaps = 15/510 (2%)
Query: 7 SVLFLFVIYLSSFQFSFTAAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRG 66
+++ LF +LSS + PT +Y FC++ +N+ NST++S+LN LLTSL ++A+
Sbjct: 8 TIVLLF--FLSSLIIH--GSPKPTLLYSFCTENSNYVPNSTYQSSLNVLLTSLSSDATIL 63
Query: 67 NGFSRGFFNATAGQDPNRVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYD 126
NG R F N TAGQ P+ VY L+LCRGD T CQ+CV A+++++ +CP K+ + WYD
Sbjct: 64 NG--RKFHNTTAGQAPDMVYGLYLCRGDVTDAVCQDCVQTASQEILTKCPNRKEALSWYD 121
Query: 127 ECLLRYSNRYIFSTRETTRTVYLWNTQNATDPVKFNDLVGSLMG---EAASQAVNDPKKF 183
+C+LRYSNR IFS E + + N+ + DP +F+ +V M E A+ ++ F
Sbjct: 122 QCMLRYSNRSIFSIMEERPMLTMSNSLDMDDPDRFDQIVNKTMVGLIEKATHNSSERDMF 181
Query: 184 ATKMANFTSFQKLYALAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRY 243
T ANF + K+Y L QCT DLS S+C+ CL +++ CC GKQG R+L PSCN RY
Sbjct: 182 ETGEANFNASTKIYGLVQCTPDLSGSNCSTCLENIFSRITNCCLGKQGARILVPSCNFRY 241
Query: 244 EVYPFYNEPATPAPAPTPVLLSPPPPSSVIRPRGKSGISSSTIIAIVAPIAVAAVLF-VA 302
E+YPFY + A P S++ P GK G SS +IAI+ P+AV+ V+F +
Sbjct: 242 ELYPFYGDLAAATPPAPAPSPL-----SLLSPPGKKGNSSQLLIAIIVPVAVSVVIFSIL 296
Query: 303 CLCFLRRRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVY 362
C CF+ R+AKKKY++ EE +ND+T ++SLQFDF T+E ATN FS DNK+GEGGFG+VY
Sbjct: 297 CYCFICRKAKKKYSSTEEEKVENDITTVQSLQFDFGTLEAATNNFSDDNKIGEGGFGDVY 356
Query: 363 KGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422
KG L SG+EIA+KRLS SS QGA EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE+
Sbjct: 357 KGTLSSGKEIAIKRLSRSSAQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEY 416
Query: 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482
VPNKSLD FL+DP+KQGQLDWSRRYKIIGGIARGILYLHEDS+L++IHRDLKASN+LLD
Sbjct: 417 VPNKSLDCFLFDPDKQGQLDWSRRYKIIGGIARGILYLHEDSQLKVIHRDLKASNVLLDG 476
Query: 483 EMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+MNPKISDFGMARIFG DQT+G+T R+VGT
Sbjct: 477 DMNPKISDFGMARIFGGDQTRGSTKRVVGT 506
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721533|ref|NP_001238492.1| cysteine-rich protein precursor [Glycine max] gi|223452302|gb|ACM89479.1| cysteine-rich protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 579 bits (1493), Expect = e-162, Method: Compositional matrix adjust.
Identities = 304/494 (61%), Positives = 354/494 (71%), Gaps = 14/494 (2%)
Query: 26 AADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRGNGFSRGFFNATAG---QDP 82
++ P Y+YH CS N T NS ++ NL LLTSL +NA+ + F N T G
Sbjct: 25 SSTPVYLYHNCSG-GNTTANSAYQLNLRTLLTSLSSNAT-----TTEFSNNTVGLGTSPS 78
Query: 83 NRVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYDECLLRYSNRYIFSTRE 142
+RVY LF+CRGD + CQ CV AT + +C ++K ++WYDEC +RYSNR FST +
Sbjct: 79 DRVYGLFMCRGDVPSALCQQCVVNATGRLRSQCSLAKQAVIWYDECTVRYSNRSFFSTVD 138
Query: 143 TTRTVYLWNTQNATDPVKFNDLVGSLMGEAASQAVN---DPKKFATKMANFTSFQKLYAL 199
T V L NT N ++ F L+ + A +A N KK+A AN + FQ LY L
Sbjct: 139 TRPRVGLLNTANISNQDSFMRLLFQTINRTADEAANFSVGLKKYAVNQANISGFQSLYCL 198
Query: 200 AQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPFYNEPATPAPAP 259
AQCT DLS +C CL G I LP CC GKQGGRVL PSCNVRYE+YPFY A+P +
Sbjct: 199 AQCTPDLSQENCRSCLSGVIGDLPWCCQGKQGGRVLYPSCNVRYELYPFYRVTASPPSSS 258
Query: 260 TPVLLSPPPPSSVIRPRGKSGISSSTIIAIVAPIAVAAVLFVACLCFLRRRAKKKYN-AV 318
PPP+S I P G SGIS+ TI+AIV PI VA ++F+ +CFL RRA+KK +V
Sbjct: 259 PSPPTLLPPPTSPISP-GSSGISAGTIVAIVVPITVAVLIFIVGICFLSRRARKKQQGSV 317
Query: 319 PEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS 378
E D+ ++SLQFDF TIE ATNKFS DNKLGEGGFGEVYKG L SGQ +AVKRLS
Sbjct: 318 KEGKTAYDIPTVDSLQFDFSTIEAATNKFSADNKLGEGGFGEVYKGTLSSGQVVAVKRLS 377
Query: 379 ASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ 438
SSGQG +EFKNEVV+VAKLQHRNLVRLLGFCL+GEEKILVYE+VPNKSLDY L+DPEKQ
Sbjct: 378 KSSGQGGEEFKNEVVVVAKLQHRNLVRLLGFCLQGEEKILVYEYVPNKSLDYILFDPEKQ 437
Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
+LDW RRYKIIGGIARGI YLHEDSRLRIIHRDLKASNILLD +MNPKISDFGMARIFG
Sbjct: 438 RELDWGRRYKIIGGIARGIQYLHEDSRLRIIHRDLKASNILLDGDMNPKISDFGMARIFG 497
Query: 499 VDQTQGNTSRIVGT 512
VDQTQGNTSRIVGT
Sbjct: 498 VDQTQGNTSRIVGT 511
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088180|emb|CBI35672.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1461), Expect = e-159, Method: Compositional matrix adjust.
Identities = 291/543 (53%), Positives = 373/543 (68%), Gaps = 48/543 (8%)
Query: 7 SVLFLFVIYLSSFQFSFTAAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRG 66
+++ LF +LSS + PT +Y FC++ +N+ NST++S+LN LLTSL ++A+
Sbjct: 8 TIVLLF--FLSSLIIH--GSPKPTLLYSFCTENSNYVPNSTYQSSLNVLLTSLSSDATIL 63
Query: 67 NGFSRGFFNATAGQDPNRVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYD 126
NG R F N TAGQ P+ VY L+LCRGD T CQ+CV A+++++ +CP K+ + WYD
Sbjct: 64 NG--RKFHNTTAGQAPDMVYGLYLCRGDVTDAVCQDCVQTASQEILTKCPNRKEALSWYD 121
Query: 127 ECLLRYSNRYIFSTRETTRTVYLWNTQNATDPVKFNDLVGSLMG---EAASQAVNDPKKF 183
+C+LRYSNR IFS E + + N+ + DP +F+ +V M E A+ ++ F
Sbjct: 122 QCMLRYSNRSIFSIMEERPMLTMSNSLDMDDPDRFDQIVNKTMVGLIEKATHNSSERDMF 181
Query: 184 ATKMANFTSFQKLYALAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRY 243
T ANF + K+Y L QCT DLS S+C+ CL +++ CC GKQG R+L PSCN RY
Sbjct: 182 ETGEANFNASTKIYGLVQCTPDLSGSNCSTCLENIFSRITNCCLGKQGARILVPSCNFRY 241
Query: 244 EVYPFYNEPATPAPAPTPVLLSPPPPSSVIRPRGKSGISSSTIIAIVAPIA--------- 294
E+YPFY + A P S++ P GK G SS +IAI+ P+A
Sbjct: 242 ELYPFYGDLAAATPPAPAPSP-----LSLLSPPGKKGNSSQLLIAIIVPVAGTLIISGFL 296
Query: 295 ------------------------VAAVLF-VACLCFLRRRAKKKYNAVPEENADNDLTI 329
++ V+F + C CF+ R+AKKKY++ EE +ND+T
Sbjct: 297 CYCWLNRKRWNIFTNNYHHSYSNNLSVVIFSILCYCFICRKAKKKYSSTEEEKVENDITT 356
Query: 330 LESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFK 389
++SLQFDF T+E ATN FS DNK+GEGGFG+VYKG L SG+EIA+KRLS SS QGA EFK
Sbjct: 357 VQSLQFDFGTLEAATNNFSDDNKIGEGGFGDVYKGTLSSGKEIAIKRLSRSSAQGAVEFK 416
Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449
NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE+VPNKSLD FL+DP+KQGQLDWSRRYKI
Sbjct: 417 NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDCFLFDPDKQGQLDWSRRYKI 476
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI 509
IGGIARGILYLHEDS+L++IHRDLKASN+LLD +MNPKISDFGMARIFG DQT+G+T R+
Sbjct: 477 IGGIARGILYLHEDSQLKVIHRDLKASNVLLDGDMNPKISDFGMARIFGGDQTRGSTKRV 536
Query: 510 VGT 512
VGT
Sbjct: 537 VGT 539
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224145816|ref|XP_002336265.1| predicted protein [Populus trichocarpa] gi|222833109|gb|EEE71586.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1455), Expect = e-158, Method: Compositional matrix adjust.
Identities = 279/509 (54%), Positives = 357/509 (70%), Gaps = 9/509 (1%)
Query: 9 LFLFVIYLSSFQFSFTAAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRGNG 68
++L V Y AA Y YH C++ + +T NS+F NLN L+SL NASR N
Sbjct: 5 IWLSVFYTVILFIPLIAAQQFEYRYHMCTNDSTYTTNSSFPLNLNASLSSLYENASRSND 64
Query: 69 FSRGFFNATAGQDPNRVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYDEC 128
FS + + GQ+ +RVY+LFLCRGD + CQ C+ D++ RCP K+ I+WYD C
Sbjct: 65 FS----SISVGQNSDRVYALFLCRGDNSPELCQGCIKTTREDIMIRCPNYKEAIIWYDRC 120
Query: 129 LLRYSNRYIFSTRETTRTVYLWNTQNATDPV---KFNDLVGSLMGEAASQAVNDPKKFAT 185
+LRYSNR IFS +E ++WN + D +FN +G LM + ++A + FA
Sbjct: 121 MLRYSNRSIFSVKEEWPKAWMWNVNDIGDVTGQNQFNANLGGLMNQLITRAASSSNLFAM 180
Query: 186 KMANFTSFQKLYALAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEV 245
N T+F +Y + QCT D+S S C ICL G ++ +P CC GKQGG VLTPSC++R+E
Sbjct: 181 GDTNGTAFNIIYGMVQCTPDISPSQCRICLSGCVSDIPRCCNGKQGGNVLTPSCSMRFET 240
Query: 246 YPFYNEPATPAPAPTPVLLSPPPPSSVIRPRGKSGISSSTIIAIVAPI-AVAAVLFVACL 304
YPFY P P P + PP ++ + P G+ SS TI+ I P A +LF C
Sbjct: 241 YPFYTAPPAPPPPASSPSPPTPP-ATSLNPSGERKASSRTIVYISVPTGAFVVLLFSLCY 299
Query: 305 CFLRRRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKG 364
C++ ++A+K+YNA+ E N +++T ++SLQF TIE ATN F+ +NK+G+GGFG+VY+G
Sbjct: 300 CYVHQKARKEYNAIQEGNVGDEITSVQSLQFQLGTIEAATNTFAEENKIGKGGFGDVYRG 359
Query: 365 VLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424
LP+GQ+IAVKRLS SGQGA EFKNEVVLVA+LQHRNLVRLLG+CLEGEEKIL+YEFVP
Sbjct: 360 TLPNGQQIAVKRLSKYSGQGAAEFKNEVVLVARLQHRNLVRLLGYCLEGEEKILIYEFVP 419
Query: 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484
NKSLDYFL+DP KQG L+WS RYKIIGGIARG+LYLHEDSRLRIIHRDLKASN+LLD EM
Sbjct: 420 NKSLDYFLFDPAKQGLLNWSSRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNVLLDGEM 479
Query: 485 NPKISDFGMARIFGVDQTQGNTSRIVGTL 513
NPKI+DFGMA+IFG DQ+QGNTS+I GT
Sbjct: 480 NPKIADFGMAKIFGGDQSQGNTSKIAGTF 508
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 513 | ||||||
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.395 | 0.303 | 0.754 | 9.1e-141 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.397 | 0.302 | 0.735 | 3.6e-135 | |
| TAIR|locus:2121626 | 830 | CRK23 "cysteine-rich RLK (RECE | 0.391 | 0.242 | 0.729 | 4.8e-129 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.395 | 0.308 | 0.700 | 9.2e-124 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.978 | 0.742 | 0.486 | 4.6e-121 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.945 | 0.751 | 0.512 | 2.5e-120 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.972 | 0.738 | 0.490 | 4.7e-119 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.393 | 0.301 | 0.763 | 1.3e-115 | |
| TAIR|locus:2121691 | 667 | CRK11 "cysteine-rich RLK (RECE | 0.393 | 0.302 | 0.743 | 4.9e-112 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.395 | 0.305 | 0.629 | 1.5e-106 |
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 809 (289.8 bits), Expect = 9.1e-141, Sum P(2) = 9.1e-141
Identities = 154/204 (75%), Positives = 177/204 (86%)
Query: 309 RRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS 368
RRA+K Y P A +D+T +SLQ D+ TI+ AT+ F NK+G+GGFGEVYKG L
Sbjct: 311 RRARKSYYT-PSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSD 369
Query: 369 GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
G E+AVKRLS SSGQG EFKNEVVLVAKLQHRNLVRLLGFCL+GEE++LVYE+VPNKSL
Sbjct: 370 GTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSL 429
Query: 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
DYFL+DP K+GQLDW+RRYKIIGG+ARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI
Sbjct: 430 DYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKI 489
Query: 489 SDFGMARIFGVDQTQGNTSRIVGT 512
+DFGMARIFG+DQT+ NTSRIVGT
Sbjct: 490 ADFGMARIFGLDQTEENTSRIVGT 513
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 766 (274.7 bits), Expect = 3.6e-135, Sum P(2) = 3.6e-135
Identities = 150/204 (73%), Positives = 169/204 (82%)
Query: 309 RRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS 368
RR K +A E+ ++ +T E+LQF F IE ATNKFS NKLG GGFGEVYKG L +
Sbjct: 309 RRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLIT 368
Query: 369 GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
G+ +A+KRLS S QGA+EFKNEV +VAKLQHRNL +LLG+CL+GEEKILVYEFVPNKSL
Sbjct: 369 GETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSL 428
Query: 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
DYFL+D EK+ LDW RRYKII GIARGILYLH DSRL IIHRDLKASNILLDA+M+PKI
Sbjct: 429 DYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKI 488
Query: 489 SDFGMARIFGVDQTQGNTSRIVGT 512
SDFGMARIFGVDQTQ NT RIVGT
Sbjct: 489 SDFGMARIFGVDQTQANTKRIVGT 512
|
|
| TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 759 (272.2 bits), Expect = 4.8e-129, Sum P(2) = 4.8e-129
Identities = 148/203 (72%), Positives = 170/203 (83%)
Query: 312 KKKYNAVPEENADN--DLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
K+K V E A+N +T SLQFDF+ I ATN F NKLG+GGFGEVYKG PSG
Sbjct: 471 KRKDTEVTEPLAENGDSITTAGSLQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSG 530
Query: 370 QEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429
++AVKRLS +SGQG +EF+NEVV+VAKLQHRNLVRLLG+CLEGEEKILVYEFV NKSLD
Sbjct: 531 VQVAVKRLSKTSGQGEREFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLD 590
Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
YFL+D + QLDW+RRYKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA+MNPK++
Sbjct: 591 YFLFDTTMKRQLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVA 650
Query: 490 DFGMARIFGVDQTQGNTSRIVGT 512
DFGMARIFG+DQT+ NT R+VGT
Sbjct: 651 DFGMARIFGMDQTEANTRRVVGT 673
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 737 (264.5 bits), Expect = 9.2e-124, Sum P(2) = 9.2e-124
Identities = 143/204 (70%), Positives = 169/204 (82%)
Query: 309 RRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS 368
+RAKK Y P + D D T +ESLQ D+ I+ ATN FS +NK+G GGFG+VYKG +
Sbjct: 299 KRAKKTYGTTPALDED-DKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSN 357
Query: 369 GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
G E+AVKRLS +S QG EFKNEVV+VA L+H+NLVR+LGF +E EE+ILVYE+V NKSL
Sbjct: 358 GTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSL 417
Query: 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
D FL+DP K+GQL W++RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI
Sbjct: 418 DNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKI 477
Query: 489 SDFGMARIFGVDQTQGNTSRIVGT 512
+DFGMARIFG+DQTQ NTSRIVGT
Sbjct: 478 ADFGMARIFGMDQTQQNTSRIVGT 501
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1191 (424.3 bits), Expect = 4.6e-121, P = 4.6e-121
Identities = 250/514 (48%), Positives = 321/514 (62%)
Query: 4 LKFSVLFLFVIYLSSFQFSFTAAA-DPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTN 62
L+ + F+F ++L SF SF A+A +P Y+ H C + ++ NST+ +NL LL+S
Sbjct: 12 LEALICFIF-LFLFSFLTSFKASAQNPFYLNHDCPNRTTYSSNSTYSTNLKTLLSSF--- 67
Query: 63 ASRGNGFSRGFFNATAGQDPNRVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTI 122
ASR +S GF N AGQ P+RV LFLCRGD + C NCV F+ + + RCP ++ +
Sbjct: 68 ASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAV 127
Query: 123 VWYDECLLRYSNRYIFSTRETTRTVYLWNTQNATDPV----KFNDLVGSLMGEAASQAVN 178
+Y+EC+LRYS++ ST + + N N + +F DLV S M +AA++A N
Sbjct: 128 FYYEECILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQRDQFIDLVQSNMNQAANEAAN 187
Query: 179 DPKKFATKMANFTSFQKLYALAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPS 238
+KF+T TS Q LY L QCT DL+ DC CL +I ++ + G R PS
Sbjct: 188 SSRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMPLF--RIGARQFWPS 245
Query: 239 CNVRYEVYPFYNEXXXXXXXXXXXXXXXXXXXXXIRPRGKSGISSSTXXXXXXXXXXXXX 298
CN RYE+Y FYNE GKSG +S+
Sbjct: 246 CNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSG-NSTVLVVAIVVLAVLLF 304
Query: 299 XXXXXXXXXRRRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGF 358
+R KK ++ +D+ +SLQ D+ TI+ ATN F+ NK+G GGF
Sbjct: 305 IALVGYCFLAQRTKKTFDTASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGF 364
Query: 359 GEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418
GEVYKG +G+E+AVKRLS +S QG EFK EVV+VAKLQHRNLVRLLGF L+GEE+IL
Sbjct: 365 GEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERIL 424
Query: 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
VYE++PNKSLD L+DP KQ QLDW +RY IIGGIARGILYLH+DSRL IIHRDLKASNI
Sbjct: 425 VYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNI 484
Query: 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
LLDA++NPKI+DFGMARIFG+DQTQ NTSRIVGT
Sbjct: 485 LLDADINPKIADFGMARIFGLDQTQDNTSRIVGT 518
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1184 (421.8 bits), Expect = 2.5e-120, P = 2.5e-120
Identities = 262/511 (51%), Positives = 328/511 (64%)
Query: 7 SVLFLFVIYLSSFQFSFTAAADPT-YVYHFCSDTANFTRNSTFESNLNRLLTSLPT-NAS 64
S L F I+L F S TA+A T Y+YH CS T F+ NST+ +NL LL+SL + NAS
Sbjct: 2 SSLISF-IFLFLFS-SITASAQNTFYLYHNCSVTTTFSSNSTYSTNLKTLLSSLSSLNAS 59
Query: 65 RGNGFSRGFFNATAGQDPNRVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVW 124
+S GF ATAGQ P+RV LFLCR D ++ C++CVTFA + + RCP K+ + +
Sbjct: 60 ---SYSTGFQTATAGQAPDRVTGLFLCRVDVSSEVCRSCVTFAVNETLTRCPKDKEGVFY 116
Query: 125 YDECLLRYSNRYIFSTRETTRTVYLWNTQN--ATDPVKFNDLVGSLMGEAASQAVNDPKK 182
Y++CLLRYSNR I +T T +++ + +N + +F DLV + M AA +A KK
Sbjct: 117 YEQCLLRYSNRNIVATLNTDGGMFMQSARNPLSVKQDQFRDLVLTPMNLAAVEAARSFKK 176
Query: 183 FATKMANFTSFQKLYALAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGRVLTPSCNVR 242
+A + + + Q LY + +CT DL DC CL+ I Q+ K GGR+L PSC R
Sbjct: 177 WAVRKIDLNASQSLYGMVRCTPDLREQDCLDCLKIGINQVTY---DKIGGRILLPSCASR 233
Query: 243 YEVYPFYNEXXXXXXXXXXXXXXXXXXXXXIRPRGKSGISSSTXXXXXXXXXXXXXXXXX 302
Y+ Y FYNE RP GK G +SS
Sbjct: 234 YDNYAFYNESNVGTPQDSSP-----------RP-GKGG-NSSVIIIAVVVPITVLFLLLV 280
Query: 303 XXXXXRRRAKKKYNAV-PEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEV 361
R + K+ N P ND+T SLQFDF+ IE ATN F NKLG+GGFGEV
Sbjct: 281 AVFSVRAKNKRTLNEKEPVAEDGNDITTAGSLQFDFKAIEAATNCFLPINKLGQGGFGEV 340
Query: 362 YKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421
YKG L SG ++AVKRLS +SGQG +EF+NEVV+VAKLQHRNLV+LLG+CLEGEEKILVYE
Sbjct: 341 YKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYE 400
Query: 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481
FVPNKSLD+FL+D + +LDW+RRYKIIGGIARGILYLH+DSRL IIHRDLKA NILLD
Sbjct: 401 FVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLD 460
Query: 482 AEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+MNPKI+DFGMARIFG+DQT+ T R+VGT
Sbjct: 461 DDMNPKIADFGMARIFGMDQTEAMTRRVVGT 491
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1172 (417.6 bits), Expect = 4.7e-119, P = 4.7e-119
Identities = 258/526 (49%), Positives = 324/526 (61%)
Query: 4 LKFSVLFLFVIYLSSFQFSFTAAADPT--YVY--HFC-SDTANFTRNSTFESNLNRLLTS 58
+ F LF F+++LS F S + + P +++ H C S ++RNST+ +NL LL+S
Sbjct: 1 MSFFWLFPFLLHLS-FADSLSPLSAPVQNFIHLNHSCPSSILTYSRNSTYFTNLKTLLSS 59
Query: 59 LPTNASRGNGFSRGFFNATAGQDPNRVYSLFLCRGDQTTNSCQNCVTFATRDVIGRCPVS 118
L +SR +S GF ATAGQ P+RV LFLCRGD + C+NCV F+ ++ + CP +
Sbjct: 60 L---SSRNASYSTGFQTATAGQAPDRVTGLFLCRGDVSQEVCRNCVAFSVKETLYWCPYN 116
Query: 119 KDTIVWYDECLLRYSNRYIFSTRETTRTVYLWN-----TQNATDPVKFNDLVGSLMGEAA 173
K+ +++YDEC+LRYS+R I ST + L N + N +F DLV S + AA
Sbjct: 117 KEVVLYYDECMLRYSHRNILSTVTYDGSAILLNGANISSSNQNQVDEFRDLVSSTLNLAA 176
Query: 174 SQAVNDPKKFATKMANFTSFQKLYALAQCTQDLSSSDCNICLRGAIAQLPTCCGGKQGGR 233
+A N KKF T+ T Q LY L QCT DL+ DC CL+ +I + + GGR
Sbjct: 177 VEAANSSKKFYTRKV-ITP-QPLYLLVQCTPDLTRQDCLRCLQKSIKGMSLY---RIGGR 231
Query: 234 VLTPSCNVRYEVYPFYNEXXXXXXX-------XXXXXXXXXXXXXXIRPRGKSGISSSTX 286
PSCN RYE Y FYNE I RGK G +SS
Sbjct: 232 FFYPSCNSRYENYSFYNETATRSSSPPSLPPRSTPQQQLKLAPPPLISERGK-GRNSSVI 290
Query: 287 XXXXXXXXXXXXXXXXXXXXXRRRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNK 346
++ + Y P +D+T SLQFDF+ IE ATNK
Sbjct: 291 IVVVVPIIALLLLFVAFFSLRAKKTRTNYEREPLTEESDDITTAGSLQFDFKAIEAATNK 350
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
F NKLG+GGFGEVYKG+ PSG ++AVKRLS +SGQG +EF NEV++VAKLQHRNLVRL
Sbjct: 351 FCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRL 410
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
LGFCLE +E+ILVYEFVPNKSLDYF++D Q LDW+RRYKIIGGIARGILYLH+DSRL
Sbjct: 411 LGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRL 470
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
IIHRDLKA NILL +MN KI+DFGMARIFG+DQT+ NT RIVGT
Sbjct: 471 TIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGT 516
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 806 (288.8 bits), Expect = 1.3e-115, Sum P(2) = 1.3e-115
Identities = 155/203 (76%), Positives = 174/203 (85%)
Query: 310 RAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
R KK Y E A +++T SLQF F+TIE AT+KFS N +G GGFGEVY+G L SG
Sbjct: 309 RRKKSYKTT-EVQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSG 367
Query: 370 QEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429
E+AVKRLS +SGQGA+EFKNE VLV+KLQH+NLVRLLGFCLEGEEKILVYEFVPNKSLD
Sbjct: 368 PEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLD 427
Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
YFL+DP KQG+LDW+RRY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI+
Sbjct: 428 YFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIA 487
Query: 490 DFGMARIFGVDQTQGNTSRIVGT 512
DFGMARIFGVDQ+Q NT RI GT
Sbjct: 488 DFGMARIFGVDQSQANTRRIAGT 510
|
|
| TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 796 (285.3 bits), Expect = 4.9e-112, Sum P(2) = 4.9e-112
Identities = 151/203 (74%), Positives = 176/203 (86%)
Query: 310 RAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
R +K Y E+ ++D++ +SL +DF+TIE ATNKFST NKLGEGGFG VYKG L +G
Sbjct: 314 RRRKSYQRTKTES-ESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNG 372
Query: 370 QEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429
++AVKRLS SGQG +EF+NE VLV KLQHRNLVRLLGFCLE EE+IL+YEFV NKSLD
Sbjct: 373 TDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLD 432
Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
YFL+DPEKQ QLDW+RRYKIIGGIARGILYLH+DSRL+IIHRDLKASNILLDA+MNPKI+
Sbjct: 433 YFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIA 492
Query: 490 DFGMARIFGVDQTQGNTSRIVGT 512
DFG+A IFGV+QTQGNT+RI GT
Sbjct: 493 DFGLATIFGVEQTQGNTNRIAGT 515
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 664 (238.8 bits), Expect = 1.5e-106, Sum P(2) = 1.5e-106
Identities = 129/205 (62%), Positives = 164/205 (80%)
Query: 310 RAKKKYNAVPEENA-DNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS 368
+ ++K N EN +N+ +S++FDF ++ AT+ FS +NKLGEGGFG VYKGVL
Sbjct: 306 KLRRKENIRNSENKHENENISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSD 365
Query: 369 GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
GQ+IAVKRLS ++ QG EFKNE +LVAKLQHRNLV+LLG+ +EG E++LVYEF+P+ SL
Sbjct: 366 GQKIAVKRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSL 425
Query: 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
D F++DP + +L+W RYKIIGG+ARG+LYLH+DSRLRIIHRDLKASNILLD EM PKI
Sbjct: 426 DKFIFDPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKI 485
Query: 489 SDFGMARIFGVDQT-QGNTSRIVGT 512
+DFGMAR+F +D T Q T+RIVGT
Sbjct: 486 ADFGMARLFDIDHTTQRYTNRIVGT 510
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8GYA4 | CRK10_ARATH | 2, ., 7, ., 1, 1, ., - | 0.5983 | 0.9278 | 0.7115 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00001153001 | SubName- Full=Chromosome chr2 scaffold_113, whole genome shotgun sequence; (663 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 513 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-37 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-36 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 3e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-25 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 8e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.001 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| COG1718 | 268 | COG1718, RIO1, Serine/threonine protein kinase inv | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.003 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.003 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.003 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.004 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 4e-42
Identities = 59/152 (38%), Positives = 79/152 (51%), Gaps = 11/152 (7%)
Query: 350 DNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSASSGQGA-QEFKNEVVLVAKLQHRNL 403
KLGEG FGEVYKG L E+AVK L + + +EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
V+LLG C E E +V E++ L +L + + +L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
IHRDL A N L+ + KISDFG++R
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 8e-42
Identities = 62/152 (40%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 350 DNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNL 403
KLGEG FGEVYKG L E+AVK L S Q +EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
V+LLG C E E ++V E++P L +L + L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE-- 120
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
IHRDL A N L+ + KISDFG++R
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 5e-41
Identities = 59/164 (35%), Positives = 87/164 (53%), Gaps = 10/164 (6%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
LGEGGFG VY +G+++A+K + S +E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
+ LV E+ SL L E +G+L +I+ I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 471 RDLKASNILLDA-EMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
RDLK NILLD+ K++DFG++++ D++ T IVGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTP 157
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 58/150 (38%), Positives = 82/150 (54%), Gaps = 11/150 (7%)
Query: 352 KLGEGGFGEVYKGVL-----PSGQEIAVKRLSASSGQGA-QEFKNEVVLVAKLQHRNLVR 405
KLGEG FGEVYKG L + ++AVK L + + +EF E ++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
LLG C +GE +V E++P L FL + +L ++ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES--- 120
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+HRDL A N L+ + KISDFG++R
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 60/166 (36%), Positives = 82/166 (49%), Gaps = 13/166 (7%)
Query: 352 KLGEGGFGEVYKGVLPS-GQEIAVKRL---SASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
KLG G FG VYK G+ +AVK L S S + Q + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPNIVRLI 64
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ + LV E+ L +L + G L KI I RG+ YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NG 118
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
IIHRDLK NILLD KI+DFG+A+ + + + VGT
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTP 162
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 57/156 (36%), Positives = 80/156 (51%), Gaps = 14/156 (8%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQEI--AVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVR 405
KLGEG FGEVYKG L G+ AVK L + + + +F E ++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL------YDPEKQGQLDWSRRYKIIGGIARGILY 459
LLG C E E LV E++ L +L + ++ L IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
L + +HRDL A N L+ ++ KISDFG++R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 56/171 (32%), Positives = 87/171 (50%), Gaps = 15/171 (8%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLV 404
+ KLGEG FG+VY +G+ +A+K + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHE 462
RL + ++ LV E+ L L +K+G+L D +R Y + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFY--LRQILSALEYLHS 115
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
I+HRDLK NILLD + + K++DFG+AR + VGT
Sbjct: 116 ---KGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTP 160
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-31
Identities = 47/109 (43%), Positives = 65/109 (59%), Gaps = 6/109 (5%)
Query: 33 YHFCSDTAN---FTRNSTFESNLNRLLTSLPTNASRGNGFSRGFFNATAGQDPNRVYSLF 89
+H CS + T NSTFESNLN LL+SL +NA+ +G +GF T+G P+ VY L
Sbjct: 1 FHLCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSG--KGFAAGTSGAAPDTVYGLA 58
Query: 90 LCRGDQTTNSCQNCVTFATRDVIGRCPVSKDTIVWYDECLLRYSNRYIF 138
CRGD + + C++C+ A ++ CP K +WYD C LRY + Y F
Sbjct: 59 QCRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYES-YPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 57/169 (33%), Positives = 90/169 (53%), Gaps = 15/169 (8%)
Query: 351 NKLGEGGFGEVYKGVLP-SGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
LG G FG VY + +G+ +AVK LS S + + + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 408 GFCLEGEEK-ILVY-EFVPNKSLDYFLYDPEKQGQLDWS--RRYKIIGGIARGILYLHED 463
G + E+ + ++ E+V SL L +K G+L R+Y I G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKY--TRQILEGLAYLH-- 118
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
I+HRD+K +NIL+D++ K++DFG A+ G +T T + GT
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 55/161 (34%), Positives = 90/161 (55%), Gaps = 20/161 (12%)
Query: 353 LGEGGFGEVYKGV-LPSGQ----EIAVKRLSASSGQGA-QEFKNEVVLVAKLQHRNLVRL 406
LG G FG VYKGV +P G+ +A+K L + A +E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHE 462
LG CL + L+ + +P L ++ + + Q L+W + IA+G+ YL E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
R++HRDL A N+L+ + KI+DFG+A++ VD+ +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-28
Identities = 51/154 (33%), Positives = 85/154 (55%), Gaps = 13/154 (8%)
Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLV 404
+LGEG FG+V +G+++AVK L+ S + + +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 405 RLLGFCLEGEEKI--LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ G C + + L+ E++P+ SL +L + Q++ R I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
R IHRDL A NIL+++E KISDFG+A++
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 6e-27
Identities = 53/150 (35%), Positives = 84/150 (56%), Gaps = 4/150 (2%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
F+ + KLG G FGEV++G+ + +A+K L + Q+F+ EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
C GE ++ E + SL FL PE Q L + + +A G+ YL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARI 496
IHRDL A NIL+ ++ K++DFG+AR+
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 58/160 (36%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 351 NKLGEGGFGEVYKGV--LPSGQEI--AVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVR 405
+LG G FG V KGV + SG+E+ AVK L G +EF E ++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 406 LLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQ--LDWSRRYKIIGGIARGILYLHE 462
L+G C GE +LV E P L Y E + + + +A G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
+HRDL A N+LL KISDFGM+R G
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 53/152 (34%), Positives = 85/152 (55%), Gaps = 10/152 (6%)
Query: 350 DNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLV 404
+ +G G FGEV +G L P +EI A+K L A S + +F E ++ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
RL G + +++ E++ N SLD FL E G+ + ++ GIA G+ YL S
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYL---S 123
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
+ +HRDL A NIL+++ + K+SDFG++R
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 21/161 (13%)
Query: 353 LGEGGFGEVYKGVLPSGQE------IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVR 405
LGEG FG+V+ G + +AVK L ++ A++ F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDPE---------KQGQLDWSRRYKIIGGIA 454
G C EG+ I+V+E++ + L+ FL + P+ G+L S+ +I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
G++YL + +HRDL N L+ ++ KI DFGM+R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 11/170 (6%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRN 402
+ + +G G FG VYKG+ L +G +A+K++S + + E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+ +G + ++ E+ N SL + +K G S + + +G+ YLHE
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+IHRD+KA+NIL + K++DFG+A + +VGT
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-25
Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 2/95 (2%)
Query: 155 ATDPVKFNDLVGSLMGEAASQAV-NDPKKFATKMANFTSFQKLYALAQCTQDLSSSDCNI 213
T F + +L+ +S A + K FA + + +Y LAQC DLS+SDC
Sbjct: 13 TTANSTFESNLNALLSSLSSNAASSSGKGFAA-GTSGAAPDTVYGLAQCRGDLSASDCRS 71
Query: 214 CLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPF 248
CL A+++L CC K+GGR+ SC +RYE YPF
Sbjct: 72 CLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 55/160 (34%), Positives = 79/160 (49%), Gaps = 5/160 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG G FGEV+ G ++AVK L + + F E ++ KL+H
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRH 60
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+L C E E +V E++ SL FL E + +L + + IA G+ YL
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYL 119
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
IHRDL A NIL+ + KI+DFG+AR+ D
Sbjct: 120 E---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 9e-24
Identities = 57/179 (31%), Positives = 87/179 (48%), Gaps = 31/179 (17%)
Query: 346 KFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
F K+G+GGFGEVYK +G+E+A+K + S + ++ NE+ ++ K +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLD-----YFLYDPEKQGQLDWSRRYKIIGGIARGIL- 458
+ G L+ +E +V EF SL E Q I + + +L
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----------IAYVCKELLK 109
Query: 459 ---YLHEDSRLRIIHRDLKASNILL--DAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
YLH IIHRD+KA+NILL D E+ K+ DFG++ + +VGT
Sbjct: 110 GLEYLHS---NGIIHRDIKAANILLTSDGEV--KLIDFGLSAQL---SDTKARNTMVGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 57/163 (34%), Positives = 83/163 (50%), Gaps = 23/163 (14%)
Query: 353 LGEGGFGEVYKG--VLPSGQE----IAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVR 405
LGEG FG+VYKG P+ + +A+K L + + QEF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQLDWSRRYKIIGG 452
LLG C + + +++E++ + L FL D + LD S I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
IA G+ YL S +HRDL A N L+ + KISDFG++R
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 51/148 (34%), Positives = 77/148 (52%), Gaps = 16/148 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 412
+G+G FG+V G GQ++AVK L S AQ F E ++ L+H NLV+LLG L+
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 413 GEEKILVYEFVPNKSLDYFLYDP-----EKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
G +V E++ SL +L QL ++ + G+ YL E
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD------VCEGMEYLEEK---N 122
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMAR 495
+HRDL A N+L+ ++ K+SDFG+A+
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 99.8 bits (247), Expect = 1e-22
Identities = 58/177 (32%), Positives = 84/177 (47%), Gaps = 14/177 (7%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVAKLQH-R 401
+ KLGEG FGEVY + +A+K L+ S + + F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
N+V+L F + LV E+V SL+ L ++G L S I+ I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 462 EDSRLRIIHRDLKASNILLDAEMN-PKISDFGMARIFGVDQT----QGNTSRIVGTL 513
IIHRD+K NILLD + K+ DFG+A++ + S VGT
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 19/168 (11%)
Query: 352 KLGEGGFGEVYKGVL-PSGQEIAVKRL-SASSGQGAQEFKNEVVLVAKLQHRNLVRLLG- 408
LG+G G VYK P+G+ A+K++ + ++ E+ + + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHEDS 464
F EGE I V E++ SL L K ++ IAR IL YLH +
Sbjct: 68 FYKEGEISI-VLEYMDGGSLADLLKKVGK-----IPEP--VLAYIARQILKGLDYLH--T 117
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ IIHRD+K SN+L++++ KI+DFG++++ ++ T + VGT
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGT 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 4e-22
Identities = 59/163 (36%), Positives = 98/163 (60%), Gaps = 20/163 (12%)
Query: 353 LGEGGFGEVYKGV-LPSGQEI----AVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRL 406
LG G FG VYKG+ +P G+ + A+K L+ ++G A EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHE 462
LG CL + LV + +P+ L ++++ + Q L+W + IA+G++YL E
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
R++HRDL A N+L+ + + KI+DFG+AR+ D+ + N
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (238), Expect = 6e-22
Identities = 57/178 (32%), Positives = 92/178 (51%), Gaps = 27/178 (15%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN---------EVVLVA 396
+ KLGEG +G VYK +G+ +A+K++ + + E+ L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-------RLDNEEEGIPSTALREISLLK 53
Query: 397 KLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+L+H N+V+LL E K+ LV+E+ + L +L + G L + I+ + R
Sbjct: 54 ELKHPNIVKLLDVIH-TERKLYLVFEYC-DMDLKKYLDK--RPGPLSPNLIKSIMYQLLR 109
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
G+ Y H S RI+HRDLK NIL++ + K++DFG+AR FG+ T +V TL
Sbjct: 110 GLAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TL 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 8e-22
Identities = 58/168 (34%), Positives = 90/168 (53%), Gaps = 22/168 (13%)
Query: 352 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
+LGEG FG+V+ +LP + +AVK L +S Q+F+ E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDPEKQ----------GQLDWSRRYKIIGGI 453
G C EG ++V+E++ + L+ FL + P+ + GQL + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD 500
A G++YL + L +HRDL N L+ + KI DFGM+R I+ D
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 59/153 (38%), Positives = 80/153 (52%), Gaps = 20/153 (13%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLS-ASSGQGAQE----FKNEVVLVAKLQHRNLVRL 406
LG G FG VY+G+ L G AVK +S A GQ QE + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHE 462
LG E + + E VP SL L +K G +I R IL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL---KKYGSFP----EPVIRLYTRQILLGLEYLHD 120
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+HRD+K +NIL+D K++DFGMA+
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 51/174 (29%), Positives = 91/174 (52%), Gaps = 24/174 (13%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEF----KNEVVLVAKLQHRNLVR 405
++GEG +G+VYK +G+ +A+K++ + F E+ L+ KL+H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQ---GQLDWSRRYK-IIGGIARGILY 459
L + +V+E++ + L L PE + Q+ K + + G+ Y
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQI------KCYMKQLLEGLQY 115
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
LH + I+HRD+K SNIL++ + K++DFG+AR + + T+R++ TL
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-21
Identities = 50/162 (30%), Positives = 93/162 (57%), Gaps = 10/162 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQE--IAVKRLSAS-SGQGAQEFKNEVVLV 395
E+ + + +G G FGEV++G+L P +E +A+K L + + Q+F +E ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+ H N++RL G + + +++ E++ N +LD +L D G+ + ++ GIA
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAA 118
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
G+ YL S + +HRDL A NIL+++ + K+SDFG++R+
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 5e-21
Identities = 53/145 (36%), Positives = 81/145 (55%), Gaps = 6/145 (4%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLLGFC 410
K+G+G FG+VYKGVL E+AVK ++ ++F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
++ + +V E VP SL FL + +L + ++ A G+ YL +S+ IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116
Query: 471 RDLKASNILLDAEMNPKISDFGMAR 495
RDL A N L+ KISDFGM+R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 57/176 (32%), Positives = 85/176 (48%), Gaps = 20/176 (11%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + + LG G FGEVY+G+ ++AVK L + S Q +F E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
+++K H+N+VRL+G E + ++ E + L FL + PE+ L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMAR-IFGVD 500
+A+G YL E+ IHRD+ A N LL + P KI+DFGMAR I+
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRAS 173
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (227), Expect = 1e-20
Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 21/172 (12%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKR--LSASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
++G+G FG+VY G+ +K LS S + ++ NEV ++ KL H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-------LDWSRRYKIIGGIARGILYL 460
E + +V E+ L + +K+G+ LDW + + + YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKYL 119
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
H +I+HRD+K NI L + K+ DFG++++ T +VGT
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 48/162 (29%), Positives = 89/162 (54%), Gaps = 9/162 (5%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG GEVYK +G+E+A+K++ Q + NE++++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
L G+E +V E++ SL + + +++ + + + +G+ YLH +IH
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIIT--QNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIH 139
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
RD+K+ NILL + + K++DFG A ++++ N+ +VGT
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 5/149 (3%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 411
KLG G FGEV++G+ + +AVK L + ++F E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
E +V E + SL +L L + + +A G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 472 DLKASNILLDAEMNPKISDFGMARIFGVD 500
DL A N+L+ K++DFG+AR+ D
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKED 156
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 5e-20
Identities = 54/170 (31%), Positives = 87/170 (51%), Gaps = 24/170 (14%)
Query: 353 LGEGGFGEVY----KGVLPSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVR 405
LG+G FG+V K +G+ A+K L + + E +++++ H +V+
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 406 LLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHE 462
L + + EEK+ LV E+ P L L K+G+ + +R Y I + YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFSEERARFY--AAEIVLALEYLH- 110
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
L II+RDLK NILLDA+ + K++DFG+A+ + ++ NT GT
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 58/170 (34%), Positives = 92/170 (54%), Gaps = 23/170 (13%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SASSGQGAQEFKNE 391
D+ IE K+GEG +G VYKG +GQ +A+K++ S G + + E
Sbjct: 1 DYTKIE----------KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-E 49
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-DPEKQGQ-LDWSRRYKI 449
+ L+ +LQH N+V L ++ L++EF+ S+D Y D +GQ +D
Sbjct: 50 ISLLKELQHPNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSY 106
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
+ I +GIL+ H R++HRDLK N+L+D + K++DFG+AR FG+
Sbjct: 107 LYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 6e-20
Identities = 56/157 (35%), Positives = 84/157 (53%), Gaps = 8/157 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV KLG G FGEV+ G ++A+K L S + F E L+ +LQH
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQH 60
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
LVRL + + +E I ++ E++ N SL FL PE +L ++ + IA G+ +
Sbjct: 61 PRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPEGI-KLTINKLIDMAAQIAEGMAF 117
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
+ R IHRDL+A+NIL+ + KI+DFG+AR+
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 56/168 (33%), Positives = 93/168 (55%), Gaps = 20/168 (11%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQ---LDWSRRYKIIGGIAR 455
+ ++ RLLG CL + L+ + +P L DY + G L+W + IA+
Sbjct: 68 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 120
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
G+ YL E R++HRDL A N+L+ + KI+DFG+A++ G D+ +
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 32/178 (17%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
F KLGEG +G VYK + +GQ +A+K + + QE E+ ++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 406 LLGFCLEGEEKILVYEF-----------VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
G + + +V E+ + NK+L E++ I+
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT------EEEIAA-------ILYQTL 109
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+G+ YLH + IHRD+KA NILL+ E K++DFG++ T + ++GT
Sbjct: 110 KGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 56/152 (36%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLG 408
K+GEG +G VYK +G+ +A+K RL E+ L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLY-DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ LV+EF+ LD Y D LD + + +GI Y H S R
Sbjct: 66 VVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH-R 119
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
++HRDLK N+L+D E K++DFG+AR FGV
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGV 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 19/170 (11%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV---LPSGQ---EIAVKRLS--ASSGQGAQEFKNEV 392
E+ K + +LG+G FG VY+G+ + G+ +A+K ++ AS + EF NE
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE-RIEFLNEA 60
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PE-----KQGQLDWSR 445
++ + ++VRLLG G+ ++V E + L +L PE G +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
++ IA G+ YL + +HRDL A N ++ ++ KI DFGM R
Sbjct: 121 FIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 6/155 (3%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 411
++G G FG V+ G +++A+K + + ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
E LV+EF+ + L +L ++G+ + + G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
DL A N L+ K+SDFGM R DQ +T
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 55/161 (34%), Positives = 90/161 (55%), Gaps = 10/161 (6%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLL 407
+G G FGEV G L P +EI A+K L A + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
G + + ++V E++ N SLD FL + GQ + ++ GIA G+ YL S +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLR--KHDGQFTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
+HRDL A NIL+++ + K+SDFG++R+ D T+R
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 6e-19
Identities = 54/153 (35%), Positives = 67/153 (43%), Gaps = 10/153 (6%)
Query: 352 KLGEGGFGEVYKG--VLPSGQEI--AVKRLSASSGQGA-QEFKNEVVLVAKLQHRNLVRL 406
KLG+G FG V +G G+ I AVK L + +F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
G L +V E P SL L G S IA G+ YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKD-ALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
R IHRDL A NILL ++ KI DFG+ R
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 32/195 (16%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYK----GVLPSGQE---IAVKRL-SASSGQGAQEFKNEV 392
E N +G+G FG V++ G+LP + +AVK L +S +F+ E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREA 59
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD------------------ 434
L+A+ H N+V+LLG C G+ L++E++ L+ FL
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 435 -PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
L + + I +A G+ YL E + +HRDL N L+ M KI+DFG+
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 494 AR-IFGVDQTQGNTS 507
+R I+ D + + +
Sbjct: 177 SRNIYSADYYKASEN 191
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 46/162 (28%), Positives = 87/162 (53%), Gaps = 9/162 (5%)
Query: 352 KLGEGGFGEVYK-GVLPSGQEIAVKRLSASSGQG--AQEFKNEVVLVAKLQHRNLVRLLG 408
++GEG G V+K +G+ +A+K+++ +G + E+ + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
G +LV E++P+ L L D E+ + Y + + +G+ Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NGI 120
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
+HRDLK +N+L+ A+ KI+DFG+AR+F ++ + + ++
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 50/148 (33%), Positives = 85/148 (57%), Gaps = 10/148 (6%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLL 407
+G G FGEV +G L P +EI A+K L + + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
G + +++ EF+ N +LD FL + GQ + ++ GIA G+ YL E +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLSE---MN 126
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMAR 495
+HRDL A NIL+++ + K+SDFG++R
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 52/168 (30%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKR-----LSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LG+G FG VY + +G+E+AVK+ S + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 407 LGFCLEGEEKILVY-EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
G CL +E + ++ E++P S+ L + G L + K I G+ YLH +
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYTRQILEGVEYLHSN-- 123
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMA-RIFGVDQTQGNTSRIVGT 512
I+HRD+K +NIL D+ N K+ DFG + R+ + + + GT
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 53/157 (33%), Positives = 84/157 (53%), Gaps = 14/157 (8%)
Query: 353 LGEGGFGEV----YKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
LG+G FG V Y + + G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 408 GFCLE-GEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
G C G + LV E++P SL DY E+ LD + I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL---G 125
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
R +HRDL NIL+++E KI DFG+ ++ D+
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 54/176 (30%), Positives = 81/176 (46%), Gaps = 31/176 (17%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVL 394
DF+ ++ +GEG F V + +E A+K L Q +E K + V
Sbjct: 2 DFKFGKI----------IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVK 49
Query: 395 VAKL------QHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLD--WSR 445
+ K H +++L + + EE + V E+ PN L ++ K G LD +R
Sbjct: 50 IEKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTR 105
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
Y I + YLH IIHRDLK NILLD +M+ KI+DFG A++ +
Sbjct: 106 FY--AAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 51/156 (32%), Positives = 78/156 (50%), Gaps = 16/156 (10%)
Query: 353 LGEGGFGEVY----KGVLPSGQE--IAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVR 405
LG G FGEV+ KG+ G E + VK L + + Q EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL------YDPEKQGQLDWSRRYKIIGGIARGILY 459
LLG C E E ++ E+ L FL + K L ++ + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
L S R +HRDL A N L+ ++ K+S +++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 56/161 (34%), Positives = 92/161 (57%), Gaps = 20/161 (12%)
Query: 353 LGEGGFGEVYKGV-LPSGQEI----AVKRLSA-SSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LG G FG VYKG+ +P G+ + A+K L +S + +E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 407 LGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQ---LDWSRRYKIIGGIARGILYLHE 462
LG CL + LV + +P L DY + ++ G L+W + IA+G+ YL E
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
+R++HRDL A N+L+ + + KI+DFG+AR+ +D+T+
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 9e-18
Identities = 53/161 (32%), Positives = 80/161 (49%), Gaps = 5/161 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ KLG G FGEV+ G + ++AVK L + Q F E L+ LQH
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQH 60
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LVRL + E ++ E++ SL FL E G++ + IA G+ Y+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYI 119
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
R IHRDL+A+N+L+ + KI+DFG+AR+ ++
Sbjct: 120 E---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 9e-18
Identities = 56/160 (35%), Positives = 80/160 (50%), Gaps = 20/160 (12%)
Query: 353 LGEGGFGEVYKG----VLPSG---QEIAVKRL-SASSGQGAQEFKNEVVLVAKLQHRNLV 404
LG G FGEVY+G +L G +AVK L ++ Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ----LDWSRRYKIIGGIARGILYL 460
+LLG CL E + ++ E + L +L D + L I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 461 HEDSRLRIIHRDLKASNILL-----DAEMNPKISDFGMAR 495
++ IHRDL A N L+ DA+ KI DFG+AR
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQEFKN----EVVLVAKLQ 399
NK+ +GEG +G V K +G+ +A+K+ S + ++ K EV ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES--EDDEDVKKTALREVKVLRQLR 58
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
H N+V L LV+E+V L+ G L I + + I Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
H IIHRD+K NIL+ K+ DFG AR
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 55/166 (33%), Positives = 89/166 (53%), Gaps = 20/166 (12%)
Query: 352 KLGEGGFGEVY----KGVLPSGQEI--AVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
+LGEG FG+V+ + P +I AVK L +S ++F E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDPE----KQG----QLDWSRRYKIIGGIAR 455
G C+EG+ I+V+E++ + L+ FL + P+ +G +L S+ I IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD 500
G++YL + +HRDL N L+ + KI DFGM+R ++ D
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 174
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 53/169 (31%), Positives = 90/169 (53%), Gaps = 23/169 (13%)
Query: 352 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
+LGEG FG+V+ + P+ + +AVK L + ++F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDP-----------EKQGQLDWSRRYKIIGG 452
G C +G+ I+V+E++ + L+ FL + P + +G+L S+ I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD 500
IA G++YL + +HRDL N L+ A + KI DFGM+R ++ D
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 47/157 (29%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ 399
E+ + +KLG G +GEVY+GV +AVK L + +EF E ++ +++
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIK 60
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
H NLV+LLG C ++ EF+ +L +L + +Q +++ + I+ + Y
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEY 119
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
L + + IHRDL A N L+ K++DFG++R+
Sbjct: 120 LEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 153
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 13/155 (8%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN--EVVLVAKLQHRNLVRLLG 408
K+GEG +G VYK +G+ +A+K++ E+ L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ--LDWSRRYKIIGGIARGILYLHEDSRL 466
+ LV+EF +D LY K Q L S + + +G+ + H
Sbjct: 66 VFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SH 117
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
I+HRDLK N+L++ E K++DFG+AR FG
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 55/154 (35%), Positives = 78/154 (50%), Gaps = 21/154 (13%)
Query: 353 LGEGGFGEV----YKGVLP----SGQEIAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNL 403
LGEG FG+V Y P +G+ +AVK L GQ +K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYD---PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 404 VRLLGFCLEGEEKI--LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
V+ G C E K L+ E+VP SL +L + +L+ ++ I G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
IHRDL A N+LLD + KI DFG+A+
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 54/159 (33%), Positives = 87/159 (54%), Gaps = 16/159 (10%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGA--QEFKNEVVLVAKLQ---HRNLV 404
++GEG +G VYK L +G+ +A+K++ + E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 405 RLLGFC----LEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
RLL C + E K+ LV+E V ++ L +L K G L ++ + RG+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDF 122
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
LH RI+HRDLK NIL+ ++ KI+DFG+ARI+
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 52/169 (30%), Positives = 86/169 (50%), Gaps = 9/169 (5%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPS-GQEIAVKR--LSASSGQGAQEFKNEVVLVAKLQHRNL 403
F NK+G+G FG V+K V + + A+K+ LS + + +E +E ++AKL +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
+R L+ + +V E+ N L L + L + ++ I G+ +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSK 120
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+I+HRD+K+ N+ LDA N KI D G+A++ + NT IVGT
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 56/172 (32%), Positives = 89/172 (51%), Gaps = 17/172 (9%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRL---SASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
KLGEG FGEVYK + +G+ +A+K++ + G + E+ ++ KL+H N+V L+
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLI 73
Query: 408 GFCLE-----GEEKILVYEFVP--NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
+E ++ VY P + L L +P + L S+ + + GI YL
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYMLQLLEGINYL 131
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
HE+ I+HRD+KA+NIL+D + KI+DFG+AR + GT
Sbjct: 132 HEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 412
LG G FG V+ G ++A+K + + +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 472
+V E++ N L +L + + + +W + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 473 LKASNILLDAEMNPKISDFGMARIFGVDQ 501
L A N L+ + K+SDFG+AR DQ
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQ 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ KLG G FGEV+ G ++AVK L + + F E ++ KL+H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRH 60
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
LV+L + + EE I +V E++ SL FL D E + L + +A G+ Y
Sbjct: 61 DKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAY 117
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
+ R+ IHRDL+++NIL+ + KI+DFG+AR+
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 7e-17
Identities = 53/151 (35%), Positives = 77/151 (50%), Gaps = 12/151 (7%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSA-SSGQGAQE-----FKNEVVLVAKLQHRNLV 404
LG+G +G VY G+ GQ IAVK++ +S A E + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
+ LG CL+ + EFVP S+ L + G L K I G+ YLH +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
++HRD+K +N++L K+ DFG AR
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 353 LGEGGFGEVYKGVL----PSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LGEG FG V +G L S ++AVK +L + +EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 407 LGFCLEGEEK------ILVYEFVPNKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIARGI 457
+G C E +++ F+ + L FL G L K + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
YL S IHRDL A N +L +M ++DFG+++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 28/180 (15%)
Query: 341 EVATNKFSTDNKLGEGGFGEV----------YKGVLPSGQE-----IAVKRLSASSGQGA 385
E + KLGEG FGEV + G + +AVK L A + A
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 386 Q-EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
+ +F E+ ++++L++ N++RLLG C+ + ++ E++ N L+ FL E + +
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 445 RRYKIIG---------GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ IA G+ YL + L +HRDL N L+ KI+DFGM+R
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 34/174 (19%)
Query: 346 KFSTDNKLGEGGFGEVYKGVL---PSGQEIAVKRLSASSGQGA---QEFKNEVVLVAKLQ 399
K+ + +G G +G VYK G+E A+K+ Q Q E+ L+ +L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYK---------- 448
H N+V L+ LE +K + F DY +D Q + + R+ K
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLF------DYAEHD---LWQIIKFHRQAKRVSIPPSMVK 111
Query: 449 -IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIF 497
++ I G+ YLH + ++HRDLK +NIL+ E KI D G+AR+F
Sbjct: 112 SLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 9e-17
Identities = 50/151 (33%), Positives = 78/151 (51%), Gaps = 13/151 (8%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
NK+G G FG+VY V L +G+ +AVK R+ + + +E +E+ ++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS--RRYKIIGGIARGILYLHEDSR 465
G + E+ + E+ +L+ L E LD R Y + + G+ YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTL--QLLEGLAYLHSH-- 118
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARI 496
I+HRD+K +NI LD K+ DFG A
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 52/181 (28%), Positives = 76/181 (41%), Gaps = 29/181 (16%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY------------KGVLPSGQE-----IAVKRLSASSGQ 383
E + KLGEG FGEV+ K + +AVK L +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 384 GA-QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY--------D 434
A ++F EV ++++L N+ RLLG C ++ E++ N L+ FL
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
L +S + IA G+ YL L +HRDL N L+ KI+DFGM+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 495 R 495
R
Sbjct: 178 R 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 30/168 (17%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN-----EVVLVAKLQ 399
++ KLGEG + VYK +G+ +A+K++ + A++ N E+ L+ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP--------NKSLDYFLYDPEKQGQLDWSRRYK-II 450
H N++ LL LV+EF+ +KS+ D K +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD------------IKSYM 108
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
RG+ YLH I+HRDLK +N+L+ ++ K++DFG+AR FG
Sbjct: 109 LMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 55/157 (35%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN----EVVLVAKLQ 399
K+ +GEG +G V K +GQ +A+K+ S + K E+ ++ +L+
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLR 58
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEK-QGQLDWSRRYKIIGGIARGIL 458
H NLV L+ + LV+EFV + LD D EK LD SR K + I RGI
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIE 114
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ H + IIHRD+K NIL+ K+ DFG AR
Sbjct: 115 FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 50/144 (34%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLGFCL 411
LG+G FGEV+KG L +AVK Q + +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
+ + +V E VP D+ + +K+ +L + K A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 472 DLKASNILLDAEMNPKISDFGMAR 495
DL A N L+ KISDFGM+R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 56/166 (33%), Positives = 81/166 (48%), Gaps = 13/166 (7%)
Query: 353 LGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 411
LG+G +G VY S Q IA+K + + Q E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG--IARGILYLHEDSRLRII 469
E + E VP SL L K G L + + I I G+ YLH+ +I+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLR--SKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130
Query: 470 HRDLKASNILLDAEMNP-KISDFGMA-RIFGVDQTQGNTSRIVGTL 513
HRD+K N+L++ KISDFG + R+ G++ T GTL
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTL 173
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 54/160 (33%), Positives = 87/160 (54%), Gaps = 16/160 (10%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 404 VRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQG---QLDWSRRYKIIGGIARGILY 459
V+LL + E K+ LV+EF+ ++ L F+ G L S ++++ G+A +
Sbjct: 62 VKLLD-VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
H R++HRDLK N+L++ E K++DFG+AR FGV
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 56/160 (35%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
K + +GEG FG V +G +GQ++AVK + AQ F E ++ KL H+NLVR
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVR 63
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
LLG L I V E + +L FL + + + + +A G+ YL
Sbjct: 64 LLGVILHNGLYI-VMELMSKGNLVNFLRT-RGRALVSVIQLLQFSLDVAEGMEYLESK-- 119
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARI--FGVDQTQ 503
+++HRDL A NIL+ + K+SDFG+AR+ GVD ++
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK 158
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 51/153 (33%), Positives = 82/153 (53%), Gaps = 16/153 (10%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE---------FKNEVVLVAKLQHRN 402
+G G FG VY G+ SG+ +AVK++ S + + E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+ LG L+ + + E+VP S+ L G + + + I +G+ YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+R IIHRD+K +NIL+D + KISDFG+++
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 12/153 (7%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGA---QEFKNEVVLVAKLQHRNLVRLLG 408
+LG G FG V+ G + ++A+K ++ +GA ++F E ++ KL H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAIN----EGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
C + + +V EF+ N L +L ++QG+L + + G+ YL +S
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYLERNS---F 121
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
IHRDL A N L+ + K+SDFGM R D+
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 56/157 (35%), Positives = 82/157 (52%), Gaps = 12/157 (7%)
Query: 353 LGEGGFGEVYKGV-LPSGQEI----AVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRL 406
LG G FG V+KG+ +P G I A+K + SG Q QE + ++ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
LG C G LV + P SL + + + LD R IA+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
R++HR+L A NILL ++ +I+DFG+A + D +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 45/152 (29%), Positives = 80/152 (52%), Gaps = 11/152 (7%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSA-SSGQGAQEFK-NEVVLVAKLQHRNLVRLLG 408
K+GEG +G V+K + + +A+KR+ +G E+ L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
L ++K+ LV+E+ YF G +D + + +G+ + H
Sbjct: 67 -VLHSDKKLTLVFEYCDQDLKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
++HRDLK N+L++ K++DFG+AR FG+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 10/174 (5%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVAKLQ 399
F + K+G+G F VYK + L G+ +A+K++ + Q+ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR-YKIIGGIARGIL 458
H N+++ L +E E +V E L + +KQ +L R +K + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
++H RI+HRD+K +N+ + A K+ D G+ R F T ++ +VGT
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-16
Identities = 49/145 (33%), Positives = 79/145 (54%), Gaps = 10/145 (6%)
Query: 353 LGEGGFGEVYKGVL--PSGQE--IAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLL 407
LG G FGE+ +G L PS +E +A+ L A S + + F E + + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
G G ++V E++ N +LD FL E GQL + ++ G+A G+ YL E +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSE---MG 127
Query: 468 IIHRDLKASNILLDAEMNPKISDFG 492
+H+ L A +L+++++ KIS F
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 54/152 (35%), Positives = 87/152 (57%), Gaps = 10/152 (6%)
Query: 352 KLGEGGFGEVYKGVLPSGQEI-AVK--RLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLG 408
KLGEG + VYKG + EI A+K L A G + + E+ L+ +L+H N+VRL
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHD 65
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ E K+ LV+E++ +K L ++ +G LD + + +GI + HE+ R
Sbjct: 66 -VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---R 120
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
++HRDLK N+L++ K++DFG+AR FG+
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGI 152
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 16/161 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG G FGEV+ ++AVK + S + F E ++ LQH
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 60
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-----LDWSRRYKIIGGIAR 455
LV+L + E ++ EF+ SL FL E Q +D+S + IA
Sbjct: 61 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAE 113
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
G+ ++ + + IHRDL+A+NIL+ A + KI+DFG+AR+
Sbjct: 114 GMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV 151
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 52/167 (31%), Positives = 90/167 (53%), Gaps = 25/167 (14%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRL---SASSGQGAQE-------FKNEVVLVAKLQHR 401
+G+G +G VY + + +G+ +AVK++ + +G+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 402 NLVRLLGFCLEGEEKILVY-EFVPNKSLDYFLYDPEK-QGQLDWSRRYKIIGGIARGILY 459
N+V+ LGF EE + ++ E+VP S+ L + + QL +++ G+A Y
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA----Y 123
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR----IFGVDQT 502
LH I+HRDLKA N+L+DA+ KISDFG+++ I+ DQ
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN---EVVLVAKLQHRNLVRL 406
+LG G G V K + P+G+ +AVK + + K E+ ++ K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGF 64
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
G + + E++ SLD L E QG++ KI + +G+ YLHE
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEK--H 120
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMAR 495
+IIHRD+K SNIL+++ K+ DFG++
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 54/157 (34%), Positives = 84/157 (53%), Gaps = 8/157 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ D KLG+G FGEV+ G ++A+K L + + F E ++ KL+H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRH 60
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
LV L + + EE I +V EF+ SL FL + + + L + + IA G+ Y
Sbjct: 61 DKLVPL--YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAY 117
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
+ R+ IHRDL+A+NIL+ + KI+DFG+AR+
Sbjct: 118 IE---RMNYIHRDLRAANILVGDNLVCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 17/169 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSASSGQGAQ-EFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K ++ ++ + EF NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQGQL-----DWSRR 446
++ + ++VRLLG +G+ +++ E + L +L PE + +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
++ G IA G+ YL+ + + +HRDL A N ++ + KI DFGM R
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 51/157 (32%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 60
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
LV+L + + EE I +V E++ SL FL E L + + IA G+ Y
Sbjct: 61 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 117
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
+ R+ +HRDL+A+NIL+ + K++DFG+AR+
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 29/181 (16%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVL----------PSGQE---IAVKRLSASSGQ 383
E + + KLGEG FGEV+ +G+ SG + +AVK L + +
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 384 GAQ-EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLD 442
A+ +F E+ ++++L+ N++RLL C+ + ++ E++ N L+ FL E Q +
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 443 WSRRYKIIGG--------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ I IA G+ YL S L +HRDL N L+ KI+DFGM+
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 495 R 495
R
Sbjct: 178 R 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 57/178 (32%), Positives = 88/178 (49%), Gaps = 26/178 (14%)
Query: 352 KLGEGGFGEVYKG--VLPS---GQEIAVKRLS-ASSGQGAQEFKNEVVLVAKLQHRNLVR 405
+LGE FG++YKG LP Q +A+K L ++ Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLY--------------DPEKQGQLDWSRRYKIIG 451
LLG + + +++E++ L FL D + LD I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD--QTQGNT 506
IA G+ YL S +H+DL A NIL+ +++ KISD G++R I+ D + Q +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 54/160 (33%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 353 LGEGGFGEV----YKGVLP----SGQEIAVKRLSASSGQG-AQEFKNEVVLVAKLQHRNL 403
LGEG FG+V Y P +G+++AVK L SG + K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 404 VRLLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
V+ G C E L+ EF+P+ SL +L P + +++ ++ K I +G+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL- 125
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
SR + +HRDL A N+L+++E KI DFG+ + D+
Sbjct: 126 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 6e-15
Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN--------EVVLVAKLQ-HR 401
+LG+G FG VY +G+ +A+K++ ++F + EV + KL H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHP 58
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
N+V+L E +E V+E++ +L Y L K S II I +G+ ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ HRDLK N+L+ KI+DFG+AR
Sbjct: 117 ---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 28/190 (14%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLS-ASSGQGAQEFKNEV 392
I ++T +F + LGE FG+VYKG L Q +A+K L + G +EFK+E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------------DPEKQG 439
++ ++LQH N+V LLG + + +++ + + L FL D +
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFG 498
L+ + I+ IA G+ +L S ++H+DL N+L+ ++N KISD G+ R ++
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 499 VD--QTQGNT 506
D + GN+
Sbjct: 177 ADYYKLMGNS 186
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 57/166 (34%), Positives = 88/166 (53%), Gaps = 23/166 (13%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQE-IAVK--RLSASSGQGAQEFKNEVVLVAKLQHR 401
+++ K+GEG +G VYK E IA+K RL E+ L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 402 NLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQ--GQLDWSRRYKIIGG----IA 454
N+VRL + E+++ LV+E+ LD D +K D+++ ++I I
Sbjct: 62 NIVRLQD-VVHSEKRLYLVFEY-----LDL---DLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGV 499
RGI Y H S R++HRDLK N+L+D N K++DFG+AR FG+
Sbjct: 113 RGIAYCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155
|
Length = 294 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 52/174 (29%), Positives = 90/174 (51%), Gaps = 22/174 (12%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLS----ASSGQGA--QEFKNEVVLVAKLQHRNLVR 405
LG G F Y+ + +G +AVK+++ SS Q + + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
+LG E L E++ S+ + L K G + + RG+ YLHE+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 466 LRIIHRDLKASNILLDAE-MNPKISDFGMA-----RIFGVDQTQGNTSRIVGTL 513
+IIHRD+K +N+L+D+ +I+DFG A + G + QG +++GT+
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTI 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 49/156 (31%), Positives = 73/156 (46%), Gaps = 21/156 (13%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIA---VKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRL 406
+++G G FG+V G G A VK L AS+ Q F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFL--------YDPEKQGQLDWSRRYKIIGGIARGIL 458
LG C+E +LV EF P L +L +K ++ +A G+L
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASGLL 114
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+LH + IH DL N L A+++ KI D+G+A
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 37/178 (20%)
Query: 352 KLGEGGFGEVYKGVLPSGQE-----------------IAVKRLSASSGQGAQ-EFKNEVV 393
KLGEG FGEV+ + + Q+ +AVK L + + A+ +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-----DPEKQGQ-------- 440
++++L+ N++RLLG C++ + ++ E++ N L+ FL D E+ G
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 441 ---LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ +S + IA G+ YL S L +HRDL N L+ + KI+DFGM+R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 55/192 (28%), Positives = 100/192 (52%), Gaps = 19/192 (9%)
Query: 326 DLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQG 384
D ILE L+ ++ K++ K+G+G G VY + + +GQE+A+K+++
Sbjct: 1 DEEILEKLR-TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK 59
Query: 385 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
+ NE++++ + +H N+V L L G+E +V E++ SL D + +D
Sbjct: 60 KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEG 115
Query: 445 RRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
I + R L +LH + ++IHRD+K+ NILL + + K++DFG +
Sbjct: 116 ----QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168
Query: 501 QTQGNTSRIVGT 512
Q++ +T +VGT
Sbjct: 169 QSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 15/158 (9%)
Query: 347 FSTDNKLGEGGFGEVYK-GVLPSGQEIAVKR--LSASSGQGAQEFKNEVVLVAKLQHRNL 403
F KLG+G +G VYK L Q A+K L + S + ++ NE+ ++A + H N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-----QLDWSRRYKIIGGIARGIL 458
+ L+G + +V E+ P L + +K+ Q W R I + RG+
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW--RIFI--QLLRGLQ 117
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
LHE +I+HRDLK++NILL A KI D G++++
Sbjct: 118 ALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV 152
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 52/175 (29%), Positives = 88/175 (50%), Gaps = 21/175 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKR--LSASSGQGAQEFKNEVVLVAKLQHR 401
F+ +G+G FGEVYK + + Q +A+K L + + ++ + E+ +++ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL--- 458
+ + G L+G + ++ E+ S L K G+LD I I R +L
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLD----ETYIAFILREVLLGL 111
Query: 459 -YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
YLHE+ IHRD+KA+NILL E + K++DFG++ ++ NT VGT
Sbjct: 112 EYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGT 161
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 11/161 (6%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGV--LPSGQEI--AVKRLSA-SSGQGAQEFKNEVVL 394
E+ + +GEG FG+VY+GV P ++I AVK +S ++F E +
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+ + H ++V+L+G E +V E P L +L + LD + ++
Sbjct: 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLS 117
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ YL R +HRD+ A N+L+ + K+ DFG++R
Sbjct: 118 TALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 41/148 (27%), Positives = 77/148 (52%), Gaps = 12/148 (8%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 409
++G G +G+VYK + +G+ +A+K + G + + E+ ++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 410 CLEGEEKILVYEFVPNKSLD---YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
L ++ +V E+ SL P + Q+ + R + +G+ YLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE---T 120
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMA 494
IHRD+K +NILL + + K++DFG++
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 51/168 (30%), Positives = 91/168 (54%), Gaps = 11/168 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA-QEFKNEVVLVAKLQHRNLV 404
F+ ++G+G FGEVYKG+ +E+ A+K + + ++ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
R G L+G + ++ E++ S D K G L+ + I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
R IHRD+KA+N+LL + + K++DFG+A Q + NT VGT
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 49/155 (31%), Positives = 83/155 (53%), Gaps = 10/155 (6%)
Query: 352 KLGEGGFGEVYKGV--LPSGQ-EIAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLL 407
+LG G FG V KGV + Q ++A+K L + + + E E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
G C E E +LV E L+ FL K+ ++ S +++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
+HRDL A N+LL + KISDFG+++ G D +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 49/157 (31%), Positives = 72/157 (45%), Gaps = 16/157 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQ-EFKNEVVLVAKLQHRN 402
K ++LGEG G V K L + I A+K ++ Q + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 403 LVRLLG-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSR-RYKIIGGIARGIL- 458
+V+ G F E I + E+ SLD +K+G R K++G IA +L
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRG----GRIGEKVLGKIAESVLK 116
Query: 459 ---YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
YLH +IIHRD+K SNILL + K+ DFG
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 45/147 (30%), Positives = 80/147 (54%), Gaps = 14/147 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLL-GFC 410
LG+G FG+VYK +G A K + S + ++F E+ ++++ +H N+V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEK---QGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
E + IL+ EF +LD + + E+ + Q+ + R + + +LH +
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQ-----MLEALNFLHSH---K 123
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMA 494
+IHRDLKA NILL + + K++DFG++
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 17/157 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQEI---AVK--RLSASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
LGEG FG V +G L I AVK +++ + ++F +E V + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 408 GFCLEGEEK------ILVYEFVPNKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIARGIL 458
G CL+ E +++ F+ + L FL L K + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
YL S IHRDL A N +L+ MN ++DFG+++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 22/169 (13%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQG-AQEFKNEVVLVAKLQH---RNLVRLL 407
+G G +G VY+G +P+G+ +A+K ++ + + + EV L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHED 463
G L+G ++ E+ S+ + K G + +Y I I R +L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIA--EKY--ISVIIREVLVALKYIHKV 120
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+IHRD+KA+NIL+ N K+ DFG+A + +Q S VGT
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 50/149 (33%), Positives = 82/149 (55%), Gaps = 16/149 (10%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLG-F 409
+LG+G FG+VYK +G A K + S + +++ E+ ++A H +V+LLG F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHEDSR 465
+G+ I++ EF P ++D + +LD I I R +L YLH
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIML------ELDRGLTEPQIQVICRQMLEALQYLHS--- 128
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMA 494
++IIHRDLKA N+LL + + K++DFG++
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 352 KLGEGGFGEVYKGVL---PSGQEIAVKRLSASSGQGA--QEFKNEVVLVAKLQHRNLVRL 406
+LG G FG V KG+ S + +AVK L + A E E ++ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
+G C E E +LV E L+ FL +K + +++ ++ G+ YL E +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+HRDL A N+LL + KISDFG+++ G D+
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 31/178 (17%)
Query: 346 KFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSASSGQGA-QEFKNEVVLVAKL 398
LGEG FG+V K +AVK L ++ ++ +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG----QLDWSRRYKIIGG-- 452
H ++++L G C + +L+ E+ SL FL + K G D +R +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 453 ---------------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
I+RG+ YL E ++++HRDL A N+L+ KISDFG++R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSA-SSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
+G+G FG VY G L GQ+I AVK L+ + + ++F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILYLHED 463
G CL E ++V ++ + L F+ + +IG +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK-----DLIGFGLQVAKGMEYLASK 117
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ +HRDL A N +LD K++DFG+AR
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 52/184 (28%), Positives = 82/184 (44%), Gaps = 25/184 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QH 400
T F +GEG +G+VYK +GQ +A+K + +E K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNH 62
Query: 401 RNLVRLLGFCL------EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK------ 448
N+ G + ++ LV E S+ + +G +R K
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAY 117
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
I+ RG+ YLHE+ ++IHRD+K NILL K+ DFG++ +D T G +
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNT 172
Query: 509 IVGT 512
+GT
Sbjct: 173 FIGT 176
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 34/181 (18%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASSGQGAQEFKNEVVL 394
E+ ++ + LGEG FG+V K +AVK L + + ++ + L
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSD---L 62
Query: 395 VAKL-------QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
V+++ +H+N++ LLG C + +V E+ + +L FL G+
Sbjct: 63 VSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP 122
Query: 448 KIIGG-------------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ +ARG+ +L S+ + IHRDL A N+L+ + KI+DFG+A
Sbjct: 123 RPPEETLTQKDLVSFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLA 179
Query: 495 R 495
R
Sbjct: 180 R 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 42/143 (29%), Positives = 74/143 (51%), Gaps = 8/143 (5%)
Query: 351 NKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 409
K+GEG G V +G+++AVK++ Q + NEVV++ QH N+V +
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
L G+E +V EF+ +L D +++ + + + + + +LH +I
Sbjct: 85 YLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVI 137
Query: 470 HRDLKASNILLDAEMNPKISDFG 492
HRD+K+ +ILL ++ K+SDFG
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 51/166 (30%), Positives = 88/166 (53%), Gaps = 7/166 (4%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGA-QEFKNEVVLVAKLQHRNLVRLLG 408
+G G VY + LP+ +++A+KR+ Q + E + EV +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
+ G+E LV ++ SL + +G LD + ++ + +G+ YLH + +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 469 IHRDLKASNILLDAEMNPKISDFGM-ARIF-GVDQTQGNTSRIVGT 512
IHRD+KA NILL + + KI+DFG+ A + G D+T+ VGT
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 51/149 (34%), Positives = 77/149 (51%), Gaps = 9/149 (6%)
Query: 352 KLGEGGFGEVYKGVLPSG---QEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLL 407
++G G FG+V G + SG ++ VK L S+ Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSR 465
G C E +LV EF P L +L K + D + ++ IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMA 494
IH DL N LL A++ KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 4e-13
Identities = 50/188 (26%), Positives = 102/188 (54%), Gaps = 11/188 (5%)
Query: 326 DLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQG 384
D I+E L+ +I K++ K+G+G G V+ + + +GQE+A+K+++
Sbjct: 1 DEEIMEKLR-TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK 59
Query: 385 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
+ NE++++ +L++ N+V L L G+E +V E++ SL D + +D +
Sbjct: 60 KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEA 115
Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
+ + + + +LH + ++IHRD+K+ N+LL + + K++DFG +Q++
Sbjct: 116 QIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 505 NTSRIVGT 512
+T +VGT
Sbjct: 173 ST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 6/144 (4%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 411
+LG G FG V G ++A+K + S EF E ++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
+ +V E++ N L +L E + S+ ++ + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLR--EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 472 DLKASNILLDAEMNPKISDFGMAR 495
DL A N L+D + K+SDFG++R
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 53/172 (30%), Positives = 87/172 (50%), Gaps = 28/172 (16%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLG 408
N++G G G VYK + P+G+ A+K + + + + E+ ++ + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 409 FCLEGEEKILVYEFVPNKSLD-------YFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
E ++ EF+ SL+ FL D +Q I+ GIA YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------ILSGIA----YLH 185
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
R I+HRD+K SN+L+++ N KI+DFG++RI + QT + VGT+
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTI 232
|
Length = 353 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 53/184 (28%), Positives = 93/184 (50%), Gaps = 23/184 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SASSGQGAQEFKNEVVLVAKLQH 400
+K+ K+G+G FGEV+K + Q +A+K++ + G + E+ ++ L+H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKH 70
Query: 401 RNLVRLLGFCLEGEEK--------ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
N+V L+ C LV+EF + L L + + S K++
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKM 127
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV---DQTQGNTSRI 509
+ G+ Y+H R +I+HRD+KA+NIL+ + K++DFG+AR F + + T+R+
Sbjct: 128 LLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 510 VGTL 513
V TL
Sbjct: 185 V-TL 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 49/187 (26%), Positives = 99/187 (52%), Gaps = 27/187 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFK----NEVVLV 395
+ +KF ++GEG +G+VYK +G+ +A+K++ + + + F E+ ++
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60
Query: 396 AKLQHRNLVRL----------LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
+L HRN+V L L F + LV+E++ D+ L + G + +S
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSE 115
Query: 446 RY--KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
+ + + G+ Y H+ + L HRD+K SNILL+ + K++DFG+AR++ ++++
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 504 GNTSRIV 510
T++++
Sbjct: 173 PYTNKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 7e-13
Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 65/182 (35%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN---------EVVLVAKLQHRN 402
+G G +G V V +G+++A+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 403 LVRLL---------GFCLEGEEKILVYEFVP---------NKSLD-----YFLYDPEKQG 439
++ LL F + +V E + + L YFLY
Sbjct: 61 IIGLLDILRPPSPEDF----NDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY------ 110
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
Q I RG+ YLH + +IHRDLK SNIL+++ + KI DFG+AR
Sbjct: 111 Q------------ILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155
Query: 500 DQ 501
D+
Sbjct: 156 DE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 16/223 (7%)
Query: 267 PPPSSVIRPRGKSGISSSTIIAIVAPIAVAAVLFVACLCFLRRRAKKKYNAVPEENADND 326
PP V + + T+ A + +A+ A FV F+R R + V E+ +
Sbjct: 617 PPCKRVRKTPSWWFYITCTLGAFLV-LALVAFGFV----FIRGRNNLELKRVENEDGTWE 671
Query: 327 LTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGA 385
L +S TI + +N + G G YKG + +G + VK ++ + +
Sbjct: 672 LQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS 731
Query: 386 QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
E + + KLQH N+V+L+G C + L++E++ K+L L + L W R
Sbjct: 732 SEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWER 781
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
R KI GIA+ + +LH ++ +L I++D + P +
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLL 407
+G+G FG V K G+ + K + + + Q+ +EV ++ +L+H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 408 G-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLH--E 462
+ + +V E+ L + +K+ + ++ ++I+ + + H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
D ++HRDLK +NI LDA N K+ DFG+A+I G D + T VGT
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 34/160 (21%)
Query: 353 LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQ-EFKNEVVLVAKLQH-RNLVRLLG- 408
+G G FG V K + PSG +AVKR+ ++ + Q ++ +V + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 409 --------FCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA---- 454
C+E + L Y++V PE+ I+G IA
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVI---PEE-----------ILGKIAVATV 117
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ + YL E+ L+IIHRD+K SNILLD N K+ DFG++
Sbjct: 118 KALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 45/182 (24%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLV 404
+ + +GEG +G V P+G ++A+K++S Q Q E+ ++ + +H N++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 405 RLL------GFCLEGEEKILVYEFVP-------------NKSLDYFLYDPEKQGQLDWSR 445
+L F + +V E + N + YFLY
Sbjct: 67 GILDIIRPPSFE-SFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ----------- 114
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
I RG+ Y+H + ++HRDLK SN+LL+ + KI DFG+ARI D +
Sbjct: 115 -------ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDH 162
Query: 506 TS 507
T
Sbjct: 163 TG 164
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 51/188 (27%), Positives = 100/188 (53%), Gaps = 11/188 (5%)
Query: 326 DLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQG 384
D ILE L+ ++ K++ K+G+G G VY + + +GQE+A+K+++
Sbjct: 1 DEEILEKLR-SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK 59
Query: 385 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
+ NE++++ + ++ N+V L L G+E +V E++ SL D + +D
Sbjct: 60 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEG 115
Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
+ + + + +LH + ++IHRD+K+ NILL + + K++DFG +Q++
Sbjct: 116 QIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 505 NTSRIVGT 512
+T +VGT
Sbjct: 173 ST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 50/169 (29%), Positives = 92/169 (54%), Gaps = 13/169 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA-QEFKNEVVLVAKLQHRNLV 404
F+ K+G+G FGEV+KG+ Q++ A+K + + ++ + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 405 RLLGFCLEGEEKILVYEFVPNKS-LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
+ G L+ + ++ E++ S LD L +P G LD ++ I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 120
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ IHRD+KA+N+LL K++DFG+A + TQ + VGT
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 17/169 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV---LPSGQ---EIAVKRLSASSGQGAQ-EFKNEVV 393
EV+ K + +LG+G FG VY+G + G+ +AVK ++ S+ + EF NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY----DPEK-QGQLDWSRRYK 448
++ ++VRLLG +G+ ++V E + + L +L + E G+ + +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 449 I--IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
I IA G+ YL+ + +HRDL A N ++ + KI DFGM R
Sbjct: 122 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 46/168 (27%), Positives = 90/168 (53%), Gaps = 11/168 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA-QEFKNEVVLVAKLQHRNLV 404
F+ ++G+G FGEV+KG+ Q++ A+K + + ++ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
+ G L+G + ++ E++ S D + G D + ++ I +G+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ IHRD+KA+N+LL + + K++DFG+A Q + NT VGT
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRL-----SASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LG+G FG VY +G+E+AVK++ S + + + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 407 LGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
G + E+ L E +P S+ L + G L + K I G+ YLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHSN- 125
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
I+HRD+K +NIL D+ N K+ DFG ++
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 52/177 (29%), Positives = 90/177 (50%), Gaps = 23/177 (12%)
Query: 353 LGEGGFGEVYK-GVLPSGQEI-AVKRLSASS---GQGAQE-------FKNEVVLVAK-LQ 399
LG G FG VYK +GQ + A+K ++ + G+ +E +EV ++ + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
H N+VR LE + +V + + L ++F EK+ + R + I + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT--SRIVGTL 513
YLH++ R I+HRDL +NI+L + I+DFG+A+ Q Q + + +VGT+
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTI 177
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 17/154 (11%)
Query: 355 EGGFGEVYKGVL-----PSGQEIAVKRLS--ASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
EG FG ++ G+L +E+ VK + AS Q E L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGLSHQNILPIL 74
Query: 408 GFCLEGEEKILVYEFVPNKS-LDYFLYDP---EKQGQLDWSRRYKIIGG--IARGILYLH 461
C+E E V N L FL E S + + IA G+ YLH
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ +IH+D+ A N ++D E+ KI+D ++R
Sbjct: 135 ---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 16/157 (10%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKN--EVVLVAKLQ---HRNLVR 405
++G G +G VYK P SG +A+K + + + EV L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 406 LLGFC----LEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
L+ C + E K+ LV+E V Y P + + ++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDFL 124
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
H + I+HRDLK NIL+ + K++DFG+ARI+
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 3e-12
Identities = 50/189 (26%), Positives = 100/189 (52%), Gaps = 11/189 (5%)
Query: 325 NDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQ 383
+D ILE L+ ++ K++ K+G+G G VY + + +GQE+A+++++
Sbjct: 1 SDEEILEKLR-SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 384 GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDW 443
+ NE++++ + ++ N+V L L G+E +V E++ SL D + +D
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDE 115
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
+ + + + +LH + ++IHRD+K+ NILL + + K++DFG +Q++
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 504 GNTSRIVGT 512
S +VGT
Sbjct: 173 --RSTMVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 48/164 (29%), Positives = 81/164 (49%), Gaps = 21/164 (12%)
Query: 334 QFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEV 392
Q D+E I+ ++G G +G+VYK L +G+ AVK + G + E+
Sbjct: 8 QHDYELIQ----------RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEI 57
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD--YFLYDPEKQGQLDWSRRYKII 450
+V + +H N+V G L E+ + E+ SL Y + P + Q+ + R +
Sbjct: 58 FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL- 116
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+G+ YLH ++ HRD+K +NILL + K++DFG+A
Sbjct: 117 ----QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 28/154 (18%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 412
+G+G FG+V G G ++AVK + + AQ F E ++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 413 GEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGG---------IARGILYLH 461
+ + +V E++ SL DY SR ++GG + + YL
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLR-----------SRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
++ +HRDL A N+L+ + K+SDFG+ +
Sbjct: 120 ANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 52/153 (33%), Positives = 82/153 (53%), Gaps = 18/153 (11%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRL-----SASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LG G FGEVY +G+E+AVK++ S + + + E+ L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 407 LGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHE 462
G + EEK L E++P S+ L + G L + +RRY I +G+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYT--RQILQGVSYLHS 124
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ I+HRD+K +NIL D+ N K+ DFG ++
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 21/164 (12%)
Query: 334 QFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEV 392
Q DFE I+ ++G G +G+VYK + +G+ A+K + G+ + E+
Sbjct: 8 QEDFELIQ----------RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI 57
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD--YFLYDPEKQGQLDWSRRYKII 450
+++ +H N+V G L ++ + EF SL Y + P + Q+ + R +
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL- 116
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+G+ YLH + +HRD+K +NILL + K++DFG++
Sbjct: 117 ----QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 353 LGEGGFGEVYKGVLPSG---QEIAVKRLSASSGQG-AQEFKNEVVLVAKL-QHRNLVRLL 407
+GEG FG+V K + + A+KR+ + + ++F E+ ++ KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFL-------YDP------EKQGQLDWSRRYKIIGGIA 454
G C L E+ P+ +L FL DP L + +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
RG+ YL S+ + IHRDL A NIL+ KI+DFG++R
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 59/194 (30%), Positives = 86/194 (44%), Gaps = 54/194 (27%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSASSGQGAQE 387
F ++EV + F+ + +G G G V Y V GQ +A+K+LS +
Sbjct: 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLS-------RP 52
Query: 388 FKN---------EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF------- 431
F+N E+VL+ + H+N++ LL F P KSL+ F
Sbjct: 53 FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVM 100
Query: 432 -LYDPEK----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486
L D Q LD R ++ + GI +LH IIHRDLK SNI++ ++
Sbjct: 101 ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 157
Query: 487 KISDFGMARIFGVD 500
KI DFG+AR G
Sbjct: 158 KILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 48/147 (32%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFK--NEVVLVAKLQHRNLVRLLG 408
KLGEG + VYKG+ +GQ +A+K +S + +G F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHD 70
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
E V+E++ Y + P G L + + RG+ Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIH---GQHI 124
Query: 469 IHRDLKASNILLDAEMNPKISDFGMAR 495
+HRDLK N+L+ K++DFG+AR
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 54/180 (30%), Positives = 85/180 (47%), Gaps = 20/180 (11%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQH 400
F+ LG+G FG V + L S Q++AVK L A S +EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 401 RNLVRLLGFCLEGEEK------ILVYEFVPNKSLDYFLYDP---EKQGQLDWSRRYKIIG 451
N+++L+G L K +++ F+ + L FL E+ L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD-QTQGNTSRI 509
IA G+ YL S IHRDL A N +L+ M ++DFG+++ I+ D QG S++
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 8e-12
Identities = 49/152 (32%), Positives = 80/152 (52%), Gaps = 16/152 (10%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRL-----SASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LG+G FG VY + +G+E+A K++ S + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 407 LGFCLE--GEEKILVY-EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
G CL E+ + ++ E++P S+ L + G L S K I G+ YLH +
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
I+HRD+K +NIL D+ N K+ DFG ++
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 9e-12
Identities = 53/174 (30%), Positives = 96/174 (55%), Gaps = 18/174 (10%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL--SASSGQGAQEFKNEVVLVAKL-QHR 401
K+ KLG+G +G V+K + + + +A+K++ + + AQ E++ + +L H
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 402 NLVRLLG-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL-DWSRRYKIIGGIARGIL 458
N+V+LL E ++ I LV+E+ ++ L+ + L D +RY I+ + + +
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRY-IMYQLLKALK 121
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
Y+H S +IHRDLK SNILL+++ K++DFG+AR + + + N V T
Sbjct: 122 YIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLAR--SLSELEENPENPVLT 170
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 49/147 (33%), Positives = 75/147 (51%), Gaps = 10/147 (6%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 408
LG+GGFGEV V +G+ A K+L +G Q NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ E ++ + LV + L Y +Y+ + G +R I G+ +LH + R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLH---QRR 115
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMA 494
I++RDLK N+LLD N +ISD G+A
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 51/177 (28%), Positives = 78/177 (44%), Gaps = 42/177 (23%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSA--SSGQGAQEFKNEVV 393
FE TN++ +G G FG V +GQ +A+K++ S+ A+ E+
Sbjct: 6 FEI----TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKI-LVYEF-------------VPNKSLDYFLYDPEKQG 439
L+ L+H N++ L + E I V E + + + YFLY
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ----- 116
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
I RG+ Y+H ++HRDLK SNIL++ + KI DFG+ARI
Sbjct: 117 -------------ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 46/146 (31%), Positives = 70/146 (47%), Gaps = 7/146 (4%)
Query: 352 KLGEGGFGEVYKGVLPSGQE-IAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGF 409
++G G FGEV+ G L + +AVK + +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
C + + +V E V FL + +L +++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 470 HRDLKASNILLDAEMNPKISDFGMAR 495
HRDL A N L+ + KISDFGM+R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 47/145 (32%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLL-GF 409
+LG+G FG+VYK +G A K + S + +++ E+ ++A H N+V+LL F
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
E IL+ EF ++D + + E+ L + + + YLHE+ +II
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 470 HRDLKASNILLDAEMNPKISDFGMA 494
HRDLKA NIL + + K++DFG++
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 52/163 (31%), Positives = 87/163 (53%), Gaps = 29/163 (17%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLS-ASSGQGAQEFK----NEVVLVAKLQHRNLV 404
N++ EG +G VY+ +G+ +A+K+L +G F E+ ++ KLQH N+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIV 67
Query: 405 RL----LGFCLEGEEKI-LVYEFVPN--KSLDYFLYDPEKQGQLDWSRRYK-IIGGIARG 456
+ +G +KI +V E+V + KSL + P Q ++ K ++ + G
Sbjct: 68 TVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEV------KCLMLQLLSG 118
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
+ +LH++ I+HRDLK SN+LL+ KI DFG+AR +G
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 10/171 (5%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVAKLQHRN 402
F + K+G G F EVY+ L + +A+K++ + Q+ E+ L+ +L H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR-YKIIGGIARGILYLH 461
+++ L +E E +V E L + +KQ +L R +K + + ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
SR R++HRD+K +N+ + A K+ D G+ R F T ++ +VGT
Sbjct: 124 --SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 50/174 (28%), Positives = 86/174 (49%), Gaps = 31/174 (17%)
Query: 353 LGEGGFGE--VYK----GVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LG+G FGE +Y+ L +E+ + RLS + A NE+V+++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL---NEIVILSLLQHPNIIAY 64
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYF----LYDP--EKQGQLDWSRRYKI--IGGIARGIL 458
++ + L+ E ++Y LYD ++GQL + + + I +
Sbjct: 65 YNHFMD--DNTLLIE------MEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVS 115
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
Y+H+ I+HRD+K NI L K+ DFG+++I G + + T +VGT
Sbjct: 116 YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 53/174 (30%), Positives = 89/174 (51%), Gaps = 20/174 (11%)
Query: 352 KLGEGGFGEVYKG--VLPSGQEIAVKRLSASSGQGAQEFKN--EVVLVAKLQ---HRNLV 404
++GEG +G+V+K + G+ +A+KR+ +G+ EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 405 RLLGFCL----EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
RL C + E K+ LV+E V Y PE + + ++ + RG+ +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDF 125
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
LH R++HRDLK NIL+ + K++DFG+ARI+ Q + +V TL
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTL 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 26/166 (15%)
Query: 353 LGEGGFGEVYK----GVLPSGQE----IAVKRLS-ASSGQGAQEFKNEVVLVAKL-QHRN 402
LGEG FG+V + G+ S + +AVK L ++ + + +E+ L+ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFL---------YDPE----KQGQLDWSRRYKI 449
++ LLG C + ++ E+ +L FL Y + + QL +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ARG+ YL +SR R IHRDL A N+L+ + KI+DFG+AR
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 46/154 (29%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN---EVVLVAKLQHRN 402
FS ++G G FG VY + + + +A+K++S S Q +++++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
++ G L LV E+ + D + +++ + + G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AVTHGALQGLAYLHS 133
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
+ +IHRD+KA NILL K+ DFG A I
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 52/157 (33%), Positives = 83/157 (52%), Gaps = 19/157 (12%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN--EVVLVAKLQHRNLVRLL 407
N++GEG +G VY+ SG+ +A+K++ + + + E+ L+ L+H N+V L
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 408 ----GFCLEGEEKILVYEFVPNK--SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
G L+ LV E+ SL + P + Q+ ++ + RG+ YLH
Sbjct: 73 EVVVGKHLD--SIFLVMEYCEQDLASLLDNMPTPFSESQVK-----CLMLQLLRGLQYLH 125
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
E+ IIHRDLK SN+LL + KI+DFG+AR +G
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 46/142 (32%), Positives = 74/142 (52%), Gaps = 8/142 (5%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V SG+++AVK + Q + NEVV++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
L GEE ++ EF+ +L D Q +L+ + + + + + YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 471 RDLKASNILLDAEMNPKISDFG 492
RD+K+ +ILL + K+SDFG
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFG 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 5e-11
Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN---EVVLVAKLQHRN 402
F+ ++G G FG VY + + + +A+K++S S Q +++++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ G L LV E+ + D + +++ + I G +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLHS 143
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
+ +IHRD+KA NILL K++DFG A I
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 43/142 (30%), Positives = 73/142 (51%), Gaps = 8/142 (5%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V +G+++AVK++ Q + NEVV++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
L G+E +V EF+ +L D +++ + + + R + YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 471 RDLKASNILLDAEMNPKISDFG 492
RD+K+ +ILL ++ K+SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 10/150 (6%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEFKN---EVVLVAKLQHRNLVRL 406
+++G G FG VY E+ AVK++S S Q +++++ EV + +L+H N +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
G L+ LV E+ + D + +++ + I G +G+ YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLHSHN-- 141
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARI 496
+IHRD+KA NILL K++DFG A
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASK 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSA--SSGQGAQEFKNEVV 393
+T+ +++ + +G G +G+V +G+++A+K+LS S A+ E+
Sbjct: 7 NKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR 66
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQ 440
L+ + H N++ LL F P SL+ F L + K +
Sbjct: 67 LLKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQK 114
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
L ++ I RG+ Y+H IIHRDLK SNI ++ + KI DFG+AR
Sbjct: 115 LSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 29/173 (16%)
Query: 353 LGEGGFGEVYKGVLPSGQ------EIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+G G FG V+ + Q +I V++++ AQ NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYD------PEKQGQLDWSRRYKIIGGIARGILYL 460
LE + ++V E+ P +L ++ E I+ + +L L
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT----------ILHFFVQILLAL 114
Query: 461 HEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
H I+HRDLK NILLD +M KI DFG+++I ++ +VGT
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 23/160 (14%)
Query: 353 LGEGGFGEVYKGVL---------PSGQEIAVKR-LSASSGQGAQEFKNEVVLVAKLQHRN 402
LG+G F +YKGVL GQE++V + S + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
LV+L G C+ +E I+V E+V LD FL+ + L W + + +A + YL +
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 463 DSRLRIIHRDLKASNILL----DAEMNP---KISDFGMAR 495
+++H ++ NIL+ E K+SD G+
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 48/148 (32%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 351 NKLGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLG 408
KLGEG + V+KG + +A+K + +GA EV L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-IGGIARGILYLHEDSRLR 467
+ LV+E++ +K L ++ D G + KI + I RG+ Y H R +
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCH---RRK 124
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMAR 495
++HRDLK N+L++ K++DFG+AR
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 48/148 (32%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLG 408
+KLGEG + VYKG + +A+K + +GA EV L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-IGGIARGILYLHEDSRLR 467
+ LV+E++ +K L +L D G K+ + + RG+ Y H R +
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCH---RRK 124
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMAR 495
++HRDLK N+L++ K++DFG+AR
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 49/147 (33%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLG 408
KLGEG + VYKG +G+ +A+K RL G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
E LV+E+V Y P G L + + RG+ Y+H+ I
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 469 IHRDLKASNILLDAEMNPKISDFGMAR 495
+HRDLK N+L+ K++DFG+AR
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 17/172 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGV--LPSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHR 401
F +G+G FG+V V + + A+K ++ + NE ++ +L H
Sbjct: 2 FELLRVIGKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 402 NLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV L + + EE + LV + + L Y L ++ + + I I + YL
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLALEYL 116
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
H IIHRD+K NILLD + + I+DF +A T+ GT
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGT 162
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 1e-10
Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 15/168 (8%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 410
+G G +G+VYKG + +GQ A+K + + G +E K E+ ++ K HRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 411 LE------GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
++ ++ LV EF S+ + + K L I I RG+ +LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQH- 130
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
++IHRD+K N+LL K+ DFG++ +D+T G + +GT
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGT 174
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEFK---NEVVLVAKLQH 400
F ++G+GG+G+V+ EI A+KR+ S E + E ++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGI 457
LV+LL + + +E + L E+VP L + G L D +R Y +A
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNN---LGVLSEDHARFY-----MAEMF 111
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ L IHRDLK N L+DA + K++DFG++
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 28/174 (16%)
Query: 356 GGFGEVY---KGVLPSGQEIAVKRLSASSGQGA---QEFKNEVVLVAKLQHRNLVRLLGF 409
G +G V+ K +G A+K + + + E ++++ Q +V+L +
Sbjct: 4 GAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-Y 60
Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLD--WSRRYKIIGGIARGILYLHEDSRL 466
+G++ + LV E++P L L E G LD +R Y I I + YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVARIY--IAEIVLALEYLH---SN 112
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN-------TSRIVGTL 513
IIHRDLK NIL+D+ + K++DFG+++ G+ + Q N RIVGT
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTP 165
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 54/172 (31%), Positives = 81/172 (47%), Gaps = 35/172 (20%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVL 394
D E IE +LG G +G V K +P+G +AVKR+ A+ +QE K +++
Sbjct: 2 DLEVIE----------ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQK-RLLM 48
Query: 395 VAKLQHR-----NLVRLLGFCLEGEEKILVYEFVPNKSLDYF---LYDPEKQGQLDWSRR 446
+ R V G L E + + V + SLD F +YD D
Sbjct: 49 DLDISMRSVDCPYTVTFYG-ALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPED---- 103
Query: 447 YKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
I+G IA I+ YLH +L +IHRD+K SN+L++ K+ DFG++
Sbjct: 104 --ILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLG 408
+KLGEG + V+KG + +A+K + +GA EV L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-IGGIARGILYLHEDSRLR 467
LV+E++ + Y + G L KI + + RG+ Y H + +
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYL----DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMAR 495
I+HRDLK N+L++ + K++DFG+AR
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 353 LGEGGFGEV------YKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LG+GGFGEV G + + +++ KRL SG+ + E++ + + +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL---EKVNSPFIVN 57
Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
L + E + + LV + L Y +Y+ ++G L+ R I GIL+LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS--- 113
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ I++RD+K N+LLD + N ++SD G+A
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 43/158 (27%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 353 LGEGGFGEVYKG----VLPSGQ----EIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
LG+G F +++KG V G+ E+ +K L S ++ F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
G C+ G+E I+V E+V SLD +L + + W + ++ +A + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 465 RLRIIHRDLKASNILL-----DAEMNP---KISDFGMA 494
+ H ++ A N+LL NP K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 44/142 (30%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V V SG+ +AVK++ Q + NEVV++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
L G+E +V EF+ +L D +++ + + + + + LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 471 RDLKASNILLDAEMNPKISDFG 492
RD+K+ +ILL + K+SDFG
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 45/171 (26%), Positives = 82/171 (47%), Gaps = 10/171 (5%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSA---SSGQGAQEFKNEVVLVAKLQHRN 402
F + K+G G F EVY+ L G +A+K++ + + E+ L+ +L H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR-YKIIGGIARGILYLH 461
+++ +E E +V E L + +KQ +L + +K + + ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
SR R++HRD+K +N+ + A K+ D G+ R F T ++ +VGT
Sbjct: 124 --SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN---EVVLVAKLQHRN 402
F+ ++G G FG VY + + + +A+K++S S Q +++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ G L LV E+ + D + + K+ L I G +G+ YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKP-LQEVEIAAICHGALQGLAYLHS 133
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
R IHRD+KA NILL K++DFG A +
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 59/187 (31%), Positives = 83/187 (44%), Gaps = 37/187 (19%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLS----ASSGQGAQE 387
DFE I+ LG G FG V +K SG+ A+K LS Q +
Sbjct: 2 DFEFIKT----------LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQ-VEH 47
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSR 445
NE ++ ++H LV L G + LV E+VP L L K G+ +R
Sbjct: 48 VLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVAR 104
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
Y + + YLH L I++RDLK N+LLD++ KI+DFG A+ +G
Sbjct: 105 FY--AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-----VKGR 154
Query: 506 TSRIVGT 512
T + GT
Sbjct: 155 TYTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 27/198 (13%)
Query: 324 DNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSG 382
D DL+ L FE +EV +G G +G+VYKG + +GQ A+K + +
Sbjct: 5 DIDLSALRDPAGIFELVEV----------VGNGTYGQVYKGRHVKTGQLAAIKVMDVTED 54
Query: 383 QGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE------GEEKILVYEFVPNKSLDYFLYDP 435
+ +E K E+ ++ K HRN+ G ++ ++ LV EF S+ + +
Sbjct: 55 E-EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT 113
Query: 436 EKQG-QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ + DW I I RG+ +LH ++IHRD+K N+LL K+ DFG++
Sbjct: 114 KGNALKEDWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168
Query: 495 RIFGVDQTQGNTSRIVGT 512
+D+T G + +GT
Sbjct: 169 A--QLDRTVGRRNTFIGT 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 47/175 (26%), Positives = 69/175 (39%), Gaps = 35/175 (20%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSASS--GQGAQE-FKNEVVLVAKLQHRNLVRLLG 408
LG GGFG V V + A+K + G QE +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL-----------DWSRRYKIIGGIARGI 457
F K + Y L + G+L +++ R+ I +
Sbjct: 59 ----------YRTFKDKKYI-YMLMEYCLGGELWTILRDRGLFDEYTARF-YIACVVLAF 106
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
YLH II+RDLK N+LLD+ K+ DFG A+ Q T GT
Sbjct: 107 EYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGT 155
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 16/160 (10%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLL---- 407
LG G G V+ V + +AVK++ + Q + E+ ++ +L H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 408 --GFCLEGEEKILVY---EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
G L + L ++ + ++ L + +QG L + + RG+ Y+H
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS 132
Query: 463 DSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQ 501
+ ++HRDLK +N+ ++ E + KI DFG+ARI VD
Sbjct: 133 AN---VLHRDLKPANVFINTEDLVLKIGDFGLARI--VDP 167
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 12/148 (8%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFK--NEVVLVAKLQHRNLVRLLG 408
KLGEG + VYKG +GQ +A+K + +GA F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-IGGIARGILYLHEDSRLR 467
+ LV+E++ + L ++ + G ++ + + RG+ Y H + R
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYM---DDCGGGLSMHNVRLFLFQLLRGLAYCH---QRR 123
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMAR 495
++HRDLK N+L+ K++DFG+AR
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN----EVVLVAKLQHRNLVRL 406
K+GEG +G V+K +GQ +A+K+ S K E+ ++ +L+H NLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV--IKKIALREIRMLKQLKHPNLVNL 65
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
+ + LV+E+ + L+ +P + KII + + + H +
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCH---KH 119
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARI 496
IHRD+K NIL+ + K+ DFG ARI
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 7e-10
Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 352 KLGEGGFGEVYKGVL---PSGQEIAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLL 407
++G G FG+V + + VK L A++ Q EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR-------YKIIGGIARGILYL 460
G C+E +LV+E+ L +L Q W RR ++ IA G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
H + +H DL N L +++ K+ D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 6/105 (5%)
Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
E +L+ + H +++R+ + G +V +P+ S D + Y ++ L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
I G+ YLH RIIHRD+K NI ++ I D G A+
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 52/151 (34%), Positives = 73/151 (48%), Gaps = 16/151 (10%)
Query: 353 LGEGGFGEVY------KGVLPSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVR 405
LG+GGFGEV G L + +++ KRL G +GA K ++AK+ R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR---ILAKVHSRFIVS 57
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLY--DPEKQGQLDWSRRYKIIGGIARGILYLHED 463
L + LV + L Y +Y D E G R I G+ +LH+
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQR 116
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
RII+RDLK N+LLD + N +ISD G+A
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 30/178 (16%)
Query: 350 DNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVV--------------L 394
LGEG +G+V K +G+ +A+K++ ++V +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEK----QGQLDWSRRYKII 450
+ +++H N++ L+ +EG+ F+ N +D D +K + +L S+ I+
Sbjct: 74 MNEIKHENIMGLVDVYVEGD-------FI-NLVMDIMASDLKKVVDRKIRLTESQVKCIL 125
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
I G+ LH+ +HRDL +NI ++++ KI+DFG+AR +G S+
Sbjct: 126 LQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
|
Length = 335 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 55/186 (29%), Positives = 87/186 (46%), Gaps = 40/186 (21%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSA--SSGQG 384
+F ++E+ + F+ + +G G G V Y +L + +A+K+LS +
Sbjct: 9 NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTH 66
Query: 385 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
A+ E+VL+ + H+N++ LL F P KSL+ F L D
Sbjct: 67 AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
Q +LD R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 493 MARIFG 498
+AR G
Sbjct: 172 LARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 57/185 (30%), Positives = 86/185 (46%), Gaps = 40/185 (21%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSA--SSGQGA 385
F ++EV + F+ + +G G G V Y VL + +A+K+LS + A
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 60
Query: 386 QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
+ E+VL+ + H+N++ LL F P KSL+ F L D
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANL 108
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
Q +LD R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+
Sbjct: 109 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 494 ARIFG 498
AR G
Sbjct: 166 ARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 21/164 (12%)
Query: 350 DNKLGEGGFGEVYKGVLPSG---QEIAVKRLSA-SSGQGAQEFKNEVVLVAKL-QHRNLV 404
++ +GEG FG+V + ++ A+K L +S ++F E+ ++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL-------YDPE------KQGQLDWSRRYKIIG 451
LLG C + E+ P +L FL DP L + +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+A G+ YL E + IHRDL A N+L+ + KI+DFG++R
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 49/156 (31%), Positives = 79/156 (50%), Gaps = 17/156 (10%)
Query: 352 KLGEGGFGEVY-----KGV----LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
+LG+G FG VY K V L +EI V L+ + A + E L++KL H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ---EAQLLSKLDHPA 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLH 461
+V+ LE + ++ E+ + LD L + + G+ L ++ + + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
+ RI+HRDLKA NI L + KI DFG++R+
Sbjct: 124 QR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 346 KFSTDNKLGEGGFGEVY--KGVLPSGQ----EIAVKRLSASSGQGAQEFKNEVVLVAKLQ 399
++ K+GEG FG++Y K S EI + ++ + + K EV+L+AK++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS---KKEVILLAKMK 57
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARG 456
H N+V E +V E+ L + +Q + +S +I+ I+ G
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDL---MKRINRQRGVLFSED-QILSWFVQISLG 113
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIF 497
+ ++H+ +I+HRD+K+ NI L M K+ DFG+AR
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 13/187 (6%)
Query: 318 VPEENADNDLTILESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSGQ-- 370
V E N+ ++ Q + E N S LG G FG+V + G+ S
Sbjct: 7 VIESINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVM 66
Query: 371 EIAVKRLSASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
++AVK L ++ +E +E+ +++ L H N+V LLG C G +++ E+ L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
FL +++ L +A+G+ +L + IHRDL A N+LL KI
Sbjct: 127 LNFLRR-KRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182
Query: 489 SDFGMAR 495
DFG+AR
Sbjct: 183 CDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 56/182 (30%), Positives = 85/182 (46%), Gaps = 40/182 (21%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSA--SSGQGA 385
F +++VA + F+ + +G G G V + VL G +AVK+LS + A
Sbjct: 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHA 64
Query: 386 QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
+ E+VL+ + H+N++ LL F P KSL+ F L D
Sbjct: 65 KRAYRELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANL 112
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
+LD R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+
Sbjct: 113 CQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169
Query: 494 AR 495
AR
Sbjct: 170 AR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 353 LGEGGFGEVYKGVLPSG---QEIAVKRLSA-SSGQGAQEFKNEVVLVAKL-QHRNLVRLL 407
+GEG FG+V K + + A+KR+ +S ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFL-------YDPE------KQGQLDWSRRYKIIGGIA 454
G C L E+ P+ +L FL DP L + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
RG+ YL + + IHRDL A NIL+ KI+DFG++R
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 57/190 (30%), Positives = 89/190 (46%), Gaps = 14/190 (7%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFK 389
S E++ T+ + +G+G +G+VYK G AVK L S +E +
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIE 66
Query: 390 NEVVLVAKL-QHRNLVRLLGFCLEGEEKI-----LVYEFVPNKSLDYFLYDPEKQGQ-LD 442
E ++ L H N+V+ G + ++ + LV E S+ + GQ LD
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
+ I+ G G+ +LH + RIIHRD+K +NILL E K+ DFG++ +
Sbjct: 127 EAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 503 QGNTSRIVGT 512
+ NTS VGT
Sbjct: 184 RRNTS--VGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 26/178 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
EV ++ LGEG FG+V K ++AVK L S ++ + + +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YDPEK-- 437
+ ++ + +H+N++ LLG C + ++ E+ +L +L Y+P +
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ QL + +ARG+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 28/167 (16%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSAS----SGQGAQEFKN 390
DFE I+V +G G FGEV+ ++ A+K L S Q +
Sbjct: 2 DFEVIKV----------IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRA 50
Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLD--WSRRY 447
E ++A +V+L + + EE + LV E++P L L ++ +R Y
Sbjct: 51 ERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLI---RKDVFPEETARFY 106
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
IA +L L +L IHRD+K NIL+DA+ + K++DFG+
Sbjct: 107 -----IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 48/182 (26%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSG--QGAQEFKNE 391
FD + ++ +G G +G V + SG+++A+K++ + A+ E
Sbjct: 1 FDVGS------RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE 54
Query: 392 VVLVAKLQHRNLVRLLG-FCLEGEEKILVY-----------------EFVPNKSLDYFLY 433
+ ++ +H N++ + G + VY + + + + YFLY
Sbjct: 55 LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLY 114
Query: 434 DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
+ RG+ Y+H + +IHRDLK SN+L++ + +I DFGM
Sbjct: 115 Q------------------LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGM 153
Query: 494 AR 495
AR
Sbjct: 154 AR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 23/165 (13%)
Query: 356 GGFGEVY--KGVLPSGQEIAVKRLSASSGQGAQEFKN----EVVLVAKLQHRNLVRLLGF 409
G FG VY K +G A+K L S + N +++ + + + +L
Sbjct: 7 GAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRLR 467
+ LV E++ + + G L DW+++Y I + G+ LH+
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG--- 117
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
IIHRD+K N+L+D + K++DFG++R ++ + VGT
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGT 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 30/165 (18%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSA--SSGQGAQEFKNEVVLVAKLQHRN 402
++++ ++G G +G V + +G+++A+K+LS S A+ E+ L+ +QH N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL----DYFLYDPEKQGQLDWSRRYK--------II 450
++ LL F S D++L P Q L + ++
Sbjct: 76 VIGLLDV------------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ G+ Y+H IIHRDLK N+ ++ + KI DFG+AR
Sbjct: 124 YQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 36/183 (19%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRLSASSGQGAQEFKNEV 392
E + +K + LGEG FG+V K +AVK L + + K+
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-----KDLS 65
Query: 393 VLVAKLQ-------HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YD 434
LV++++ H+N++ LLG C + ++ E+ +L +L YD
Sbjct: 66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 435 PEK--QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
+ Q+ + +ARG+ YL + + IHRDL A N+L+ KI+DFG
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFG 182
Query: 493 MAR 495
+AR
Sbjct: 183 LAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 18/161 (11%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKR-LSASSGQGAQEFK-NEVVLVAKLQHRN-LVRLL 407
K+GEG +G+VYK +G+ +A+K+ +G E+ L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 408 GFCLEG-EEKI------LVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILY 459
+E EEK LV+E++ + + + G+ L + + +G+ +
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGV 499
H + ++HRDLK N+L+D + KI+D G+ R F +
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 41/163 (25%)
Query: 353 LGEGGFGEV----YKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVL-------------V 395
LG+G FG+V KG + + AVK L K +V+L V
Sbjct: 3 LGKGSFGKVLLAELKG---TDELYAVKVL-----------KKDVILQDDDVECTMTEKRV 48
Query: 396 AKLQHRN--LVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
L ++ L +L C + ++++ V E+V L ++ ++ G+ D R
Sbjct: 49 LALAGKHPFLTQLHS-CFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAE 104
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
I G+ +LHE II+RDLK N+LLD+E + KI+DFGM +
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 26/155 (16%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 408
+G G FG V+ S A+K ++ + Q NE ++ ++ H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 409 FCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG------IARGILYL 460
F E +++ L + E+VP L F Y L S R+ G I + YL
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGEL--FSY-------LRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
H I++RDLK NILLD E + K++DFG A+
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 45/171 (26%), Positives = 84/171 (49%), Gaps = 39/171 (22%)
Query: 346 KFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQ 399
K+ K+GEG FG K +L G++ +K ++ S S + +E + EV +++ ++
Sbjct: 1 KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK 57
Query: 400 HRNLVR-------------LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
H N+V+ ++ +C G+ +Y+ + + F PE Q LDW +
Sbjct: 58 HPNIVQYQESFEENGNLYIVMDYCEGGD----LYKKINAQRGVLF---PEDQ-ILDWFVQ 109
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
I + ++H+ +I+HRD+K+ NI L + K+ DFG+AR+
Sbjct: 110 ------ICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 49/155 (31%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 408
LG+GGFGEV V +G+ A K+L +G NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ E ++ + LV + L + +Y + G + R I G+ LH++ R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-FEEGRAVFYAAEICCGLEDLHQE---R 122
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
I++RDLK NILLD + +ISD G+A QT
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 54/167 (32%), Positives = 80/167 (47%), Gaps = 15/167 (8%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 408
LG+GGFGEV V +G+ A K+L +G NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ E ++ + LV + L + +Y+ G D R + G+ L R R
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQ---RER 122
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTL 513
I++RDLK NILLD + +ISD G+A V +G T R VGT+
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTV 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 46/180 (25%)
Query: 351 NKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQEFK--------NEVVLVAKLQ-H 400
K+GEG F EV K +G+ A+K + + FK E+ + +L H
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRLSPH 57
Query: 401 RNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFLYD---------PEKQGQLDWSRRYKI 449
N++RL+ + + LV+E +D LY+ PEK+ + Y
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFEL-----MDMNLYELIKGRKRPLPEKR-----VKSY-- 105
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI 509
+ + + + ++H R I HRD+K NIL+ + K++DFG R G+ T I
Sbjct: 106 MYQLLKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI 159
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 49/147 (33%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 408
LG+GGFGEV V +G+ A K+L +G NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ E ++ + LV + L + +Y+ G D R I G+ LH R R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-FDEERAVFYAAEITCGLEDLH---RER 122
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMA 494
I++RDLK NILLD + +ISD G+A
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 26/178 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRLSA-SSGQGAQEFKNE 391
E++ + + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG----------- 439
+ ++ + +H+N++ LLG C + ++ E+ +L +L G
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 440 --QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
QL + +ARG+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 31/159 (19%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSA--SSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 409
+G G +G V + +G ++A+K+L S A+ E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 410 CLEGEEKILVYEFVPNKSLD----YFLYDP---------EKQGQLDWSRRYKIIGGIARG 456
F P+ SLD ++L P K +L R ++ + +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ Y+H IIHRDLK N+ ++ + KI DFG+AR
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 31/174 (17%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSA--SSGQGAQEFKNEVVL 394
+TI ++ + +G G +G V +G +AVK+LS S A+ E+ L
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
+ ++H N++ LL F P +SL+ F L + K +L
Sbjct: 70 LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 117
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+I I RG+ Y+H IIHRDLK SN+ ++ + KI DFG+AR
Sbjct: 118 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 26/53 (49%), Positives = 35/53 (66%), Gaps = 5/53 (9%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQ 503
IA G+ +LH II+RDLK N++LDAE + KI+DFGM + IFG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 28/158 (17%)
Query: 353 LGEGGFGEVYKGVL----PSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+GEG FG + +L S Q+ A+K RL SS ++ + E VL+AK++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 407 L-GFCLEGEEKILVYEFVPNKSLDYFLYD------PEKQGQLDWSRRYKIIGGIARGILY 459
F +G I V E+ L + PE L W + + G+ +
Sbjct: 64 KESFEADGHLYI-VMEYCDGGDLMQKIKLQRGKLFPE-DTILQWFVQ------MCLGVQH 115
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
+HE R++HRD+K+ NI L K+ DFG AR+
Sbjct: 116 IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEFKNEV----VLVAKLQHRNLVRLL 407
+G+G FG+V + + AVK L + +E K+ + VL+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
+ + +K+ V ++V L +F E+ +R Y IA + YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL-FFHLQRERSFPEPRARFYA--AEIASALGYLHS---L 115
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
II+RDLK NILLD++ + ++DFG+ + G+ + TS GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGI-EHSKTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 47/158 (29%), Positives = 66/158 (41%), Gaps = 34/158 (21%)
Query: 353 LGEGGFGEV----YKGVLPSGQEIAVKRLSASSGQGAQEF------KNEVVLVAKLQHRN 402
LG G FG+V YK +G+ A+K L E K +H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 403 LVRLLGFCLEGEEKI-LVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIAR 455
LV L C + E+ + V E+ L D F E + Y +
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRAVF-----Y--AACVVL 112
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
G+ YLHE+ +I++RDLK N+LLD E KI+DFG+
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 368 SGQEIAVKRLSASSGQGAQE---FKNEVVLVAKLQHRNLVRLLGFCLEGEEK----ILVY 420
+G E+A+K L + + + F+ E L A+L H N+V LL GE V+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD---SGEAPPGLLFAVF 58
Query: 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480
E+VP ++L L G L +++ + + H I+HRDLK NI++
Sbjct: 59 EYVPGRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMV 112
Query: 481 ---DAEMNPKISDFGM 493
+ K+ DFG+
Sbjct: 113 SQTGVRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAK------LQHRNLVR 405
LG+G FG+V L SG+ AVK L Q+ E + K H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 406 LLGFCLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
L C + +++ V EFV L ++ +K + D +R I +++LH+
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
II+RDLK N+LLD E + K++DFGM +
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 17/159 (10%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLLG-F 409
K+G G +G VYK G++ L G G + E+ L+ +L+H N++ L F
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYD-----PEKQGQLDWSRRYKIIGGIARGILYLHED 463
+ K+ L++++ + + +K QL S ++ I GI YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 464 SRLRIIHRDLKASNILLDAEMNP-----KISDFGMARIF 497
++HRDLK +NIL+ E P KI+D G AR+F
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 16/152 (10%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
++LG+G +G VYK VL P+G +A+K RL + Q E+ ++ K +V
Sbjct: 7 DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYIVDF 64
Query: 407 LG-FCLEGEEKILVY---EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
G F +EG VY E++ SLD + +I + +G+ +L E
Sbjct: 65 YGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ IIHRD+K +N+L++ K+ DFG++
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 40/172 (23%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSASS----GQGAQE 387
DFE+I+V +G G FGEV K +G A+K+L S Q A
Sbjct: 2 DFESIKV----------IGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAH- 47
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFL--YD--PEKQGQL 441
+ E ++A+ + +V+L + +E L+ E++P + L D E++
Sbjct: 48 VRAERDILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE--- 102
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
+R Y IA IL + +L IHRD+K N+LLDA+ + K+SDFG+
Sbjct: 103 --TRFY-----IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 23/58 (39%), Positives = 36/58 (62%), Gaps = 3/58 (5%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
I RG+ YLH I+HRD+K N+L+++ KI DFG+AR+ D+++ T +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 408
LG+GGFGEV V +G+ A KRL +G NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ E ++ + LV + L + +Y+ G + R I G+ LH ++
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLHREN--- 122
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMA 494
++RDLK NILLD + +ISD G+A
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 21/43 (48%), Positives = 31/43 (72%), Gaps = 3/43 (6%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ RG+ Y+H + ++HRDLK SN+LL+A + KI DFG+AR
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 46/185 (24%), Positives = 80/185 (43%), Gaps = 23/185 (12%)
Query: 321 ENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSA 379
E+ D + I D + + N +G G FG VY+ + + + +++A+K++
Sbjct: 48 EDEDEEKMI------DNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL- 100
Query: 380 SSGQGAQEFKNEVVLVAKLQHRNLVRLLGF----CLEGEEKIL----VYEFVPNKSLDYF 431
Q Q E++++ L H N++ L + C + EK + V EF+P Y
Sbjct: 101 ---QDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYM 157
Query: 432 LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISD 490
+ L + R + Y+H I HRDLK N+L+D + K+ D
Sbjct: 158 KHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214
Query: 491 FGMAR 495
FG A+
Sbjct: 215 FGSAK 219
|
Length = 440 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 44/177 (24%), Positives = 84/177 (47%), Gaps = 25/177 (14%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSASS----GQGAQE 387
+FE + V LG G +G+V+ G +G+ A+K L ++ + A+
Sbjct: 1 NFELLRV----------LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH 50
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
+ E ++ ++ + L + + + K+ L+ ++V L LY E S
Sbjct: 51 TRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEV 107
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
I I + +LH+ L II+RD+K NILLD+E + ++DFG+++ F ++ +
Sbjct: 108 RVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLLG-F 409
K+G G +G VYK G++ L G G + E+ L+ +L+H N++ L F
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYD-----PEKQGQLDWSRRYKIIGGIARGILYLHED 463
+ K+ L++++ + + +K QL ++ I GI YLH +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 464 SRLRIIHRDLKASNILLDAEMNP-----KISDFGMARIF 497
++HRDLK +NIL+ E P KI+D G AR+F
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEFKN----EVVLVAKLQ 399
NKF +GEG +G V K +EI A+K+ S + +E K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLK 58
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL-DWSRRYKIIGGIARGIL 458
N+V L + LV+E+V L+ L + G + R Y I + + I
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSY--IYQLIKAIH 114
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ H++ I+HRD+K N+L+ K+ DFG AR + + N + V T
Sbjct: 115 WCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVAT 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 50/164 (30%), Positives = 72/164 (43%), Gaps = 35/164 (21%)
Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV--RLLGF 409
LG+G FG+V L G+ AVK L K +VVL+ +V R+L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKAL-----------KKDVVLIDDDVECTMVEKRVLAL 51
Query: 410 CLEG-------------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
E E V EF+ L + + D +G+ D R I G
Sbjct: 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD---KGRFDLYRATFYAAEIVCG 108
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFG 498
+ +LH II+RDLK N++LD + + KI+DFGM + +FG
Sbjct: 109 LQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG 149
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 55/191 (28%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 321 ENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSA 379
+N DN L E + +++ + +G G FGEV S Q++ A+K LS
Sbjct: 19 KNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSK 78
Query: 380 SS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFL-- 432
+ F E ++A +V+L FC ++K L V E++P L +
Sbjct: 79 FEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSN 136
Query: 433 YD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
YD PEK W++ Y A +L L + +IHRD+K N+LLD + K++DF
Sbjct: 137 YDVPEK-----WAKFYT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADF 186
Query: 492 GMARIFGVDQT 502
G +D+T
Sbjct: 187 GTC--MKMDET 195
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 22/150 (14%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLG-F 409
LG G G VYK L + + +AVK + Q + +E+ ++ K ++ G F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA----RGILYLHEDSR 465
+E I EF+ SLD + PE ++G IA +G+ YL
Sbjct: 69 FVENRISICT-EFMDGGSLDVYRKIPEH-----------VLGRIAVAVVKGLTYLWS--- 113
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMAR 495
L+I+HRD+K SN+L++ K+ DFG++
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 45/183 (24%), Positives = 71/183 (38%), Gaps = 44/183 (24%)
Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQEFKN- 390
L D + N ++G G G+VYK +G +AVK++ + +E K
Sbjct: 3 LTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRI 60
Query: 391 ----EVVL---------------VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 431
+VVL + + L+ CL+ + + +P L
Sbjct: 61 LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLD-KLLKRIQGPIPEDILG-- 117
Query: 432 LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
K+ I + + YL E +IHRD+K SNILLDA N K+ DF
Sbjct: 118 ----------------KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDF 159
Query: 492 GMA 494
G++
Sbjct: 160 GIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 32/175 (18%)
Query: 353 LGEGGFGEV----YKGVLPSGQEIAVKRLS--ASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+G+G +GEV ++ G++ +K+L+ +S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-A 63
Query: 407 LGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQL-------DWSRRYKIIGGIARGI 457
EGE+ +L V F L + L E++G+L +W + IA +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQ------IAMAL 115
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
YLHE I+HRDLK N+ L K+ D G+AR+ ++ S ++GT
Sbjct: 116 QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 37/140 (26%), Positives = 67/140 (47%), Gaps = 21/140 (15%)
Query: 367 PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE---FV 423
P + + KR+ A S + A + +NE++ + +L H N++++ E+IL E ++
Sbjct: 190 PKCERLIAKRVKAGS-RAAIQLENEILALGRLNHENILKI--------EEILRSEANTYM 240
Query: 424 PNKSLDYFLYDPEKQGQLDWSRR------YKIIGGIARGILYLHEDSRLRIIHRDLKASN 477
+ D+ LY DW R I+ + + Y+H+ ++IHRD+K N
Sbjct: 241 ITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLEN 297
Query: 478 ILLDAEMNPKISDFGMARIF 497
I L+ + + DFG A F
Sbjct: 298 IFLNCDGKIVLGDFGTAMPF 317
|
Length = 501 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 353 LGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEV----VLVAKLQHRNLVRLL 407
+G+G FG+V S G AVK L + +E + + VL+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
+ + EK+ V ++V L +F E+ +R Y +A I YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFLEPRARFYA--AEVASAIGYLHS---L 115
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
II+RDLK NILLD++ + ++DFG+ + GV+ + TS GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEP-EETTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 31/159 (19%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSA--SSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 409
+G G +G V Q++AVK+LS S A+ E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 410 CLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQLDWSRRYKIIGGIARG 456
F P S++ F L + K +L +I + RG
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ Y+H IIHRDLK SN+ ++ + +I DFG+AR
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 25/161 (15%)
Query: 353 LGEGGFGEVYKGVL-----------PSGQEIAV--KRLSASSGQGAQEFKNEVVLVAKLQ 399
LG G ++Y G+L +EI V K L S + F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
H+++V L G C+ E I+V EFV LD F++ K L ++K+ +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSY 120
Query: 460 LHEDSRLRIIHRDLKASNILL-----DAEMNP--KISDFGM 493
L ED L +H ++ NILL D E P K+SD G+
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 43/148 (29%), Positives = 64/148 (43%), Gaps = 11/148 (7%)
Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFK----NEVVLVAKLQHRNLVRLL 407
LG+G FG+V+ L + Q A+K L + + + VL +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
E V E++ L + + K D R I G+ +LH
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG--- 116
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMAR 495
I++RDLK NILLD + + KI+DFGM +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 34/160 (21%)
Query: 353 LGEGGFGEVY--KGVLP--SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRL 406
LG+G FG+V+ + + +GQ A+K L ++ + K E ++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK-----------IIGGIAR 455
+ + E K+ Y + D + G L ++R K + +A
Sbjct: 64 -HYAFQTEGKL------------YLILDFLRGGDL-FTRLSKEVMFTEEDVKFYLAELAL 109
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ +LH L II+RDLK NILLD E + K++DFG+++
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 26/161 (16%)
Query: 347 FSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQ 399
F LG G FG V +KG +G+ A+K L + Q E ++ +L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGI 457
H +V ++ + + EFV L L K G+ D ++ Y A +
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYH-----AELV 128
Query: 458 L---YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
L YLH II+RDLK N+LLD + + K++DFG A+
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 44/151 (29%), Positives = 71/151 (47%), Gaps = 17/151 (11%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEF------KNEVVLVAKLQHRNLVR 405
LG+G FG+V L E+ A+K L + K + L AK H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTA 60
Query: 406 LLGFCLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
L C + ++++ V E+V L ++ ++ + D R + +++LH
Sbjct: 61 LHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+I+RDLK NILLDAE + K++DFGM +
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 52/187 (27%), Positives = 86/187 (45%), Gaps = 20/187 (10%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSASSGQGAQEFKNEVVL 394
F++ ++ + +G+G +G+V+K VL +G + AVK L + +L
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNIL 68
Query: 395 VAKLQHRNLVRLLGFCLE-----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449
A H N+V+ G + G++ LV E S+ + K+G+ I
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE---RMEEPI 125
Query: 450 IGGIAR----GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
I I G+ +LH + + IHRD+K +NILL E K+ DFG++ + + N
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182
Query: 506 TSRIVGT 512
TS VGT
Sbjct: 183 TS--VGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 31/89 (34%), Positives = 51/89 (57%), Gaps = 11/89 (12%)
Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRL 466
C + E ++ V EFV L ++ ++Q +L + +R Y I+ + +LHE
Sbjct: 64 CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYS--AEISLALNFLHERG-- 116
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMAR 495
II+RDLK N+LLDAE + K++D+GM +
Sbjct: 117 -IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 20/52 (38%), Positives = 32/52 (61%), Gaps = 3/52 (5%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
I G+ Y+H + ++HRDLK N+L++A+ KI DFG+AR F + +
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 18/161 (11%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV--LPSGQEIAVKRLSASS----GQGAQEFKNEVVLVAKL 398
F T +G+G FGEV + V +G+ A+K L S Q A K E ++A+
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAH-VKAERDVLAES 58
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--YDPEKQGQLDWSRRYKIIGGIARG 456
+V L + + L+ EF+P L L YD + D +R Y +A
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE---DVTRFY-----MAEC 110
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
+L + +L IHRD+K NIL+D + K+SDFG++ F
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 14/161 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEFKNEVV---LVAKLQHRNLVRLLG 408
LG+G FG+V E+ A+K L + + +V ++A + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
C + +++ V E+V L +Y ++ G+ + I+ G+ +LH
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--- 121
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
II+RDLK N++LD+E + KI+DFGM + VD G T+R
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTTR 159
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 31/150 (20%), Positives = 63/150 (42%), Gaps = 11/150 (7%)
Query: 348 STDNKLGE----GGFGEVYKGVLPSGQEIAVKR--LSASSGQGAQEFKNEVVLVAKLQHR 401
+G+ + K P+ +AVK+ L + S + + + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
N++ + + E +V + S + L +G + + + I+ + + Y+H
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIH 118
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDF 491
IHR +KAS+ILL + +S
Sbjct: 119 ---SKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 7/144 (4%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLGFC 410
LG G G V K +P+G +A K + + + + E+ ++ + + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
L + EF+ SLD +K G + KI + G+ YL+ RI+H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMH 127
Query: 471 RDLKASNILLDAEMNPKISDFGMA 494
RD+K SNIL+++ K+ DFG++
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
IA G+ +LH II+RDLK N++LD+E + KI+DFGM +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 52/182 (28%), Positives = 79/182 (43%), Gaps = 21/182 (11%)
Query: 320 EENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLS 378
+N DN L+ E + + F +G G FGEV S +++ A+K LS
Sbjct: 18 NKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS 77
Query: 379 ASSGQGAQE---FKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFL- 432
+ F E ++A +V+L ++K L V E++P L +
Sbjct: 78 KFEMIKRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMS 135
Query: 433 -YD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490
YD PEK W+R Y A +L L + IHRD+K N+LLD + K++D
Sbjct: 136 NYDIPEK-----WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD 185
Query: 491 FG 492
FG
Sbjct: 186 FG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 37/161 (22%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEFKNEVVL-------------VAKL 398
LG+G FG+V L E A+K L K +VVL V L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKAL-----------KKDVVLEDDDVECTMVERRVLAL 51
Query: 399 --QHRNLVRLLGFC-LEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+H L L FC + +E + V E++ L ++ + G+ D +R I
Sbjct: 52 AWEHPFLTHL--FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEII 106
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
G+ +LH+ II+RDLK N+LLD + + KI+DFGM +
Sbjct: 107 CGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 7/101 (6%)
Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
L F + EK+ LV F+ L + L +++G+ D SR + + LH+
Sbjct: 58 LKFSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCALENLHK--- 111
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
+I+RDLK NILLD + + + DFG+ ++ D + NT
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 39/142 (27%), Positives = 60/142 (42%), Gaps = 9/142 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 412
L G GEV+ V + K++ + G + E+ ++ + HR ++ L+
Sbjct: 100 LTPGSEGEVF--VCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIH---A 154
Query: 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 472
K V +P D F Y ++ G L + I + + YLH IIHRD
Sbjct: 155 YRWKSTVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRD 210
Query: 473 LKASNILLDAEMNPKISDFGMA 494
+K NI LD N + DFG A
Sbjct: 211 VKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 14/161 (8%)
Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEV----VLVAKLQHRNLVRLL 407
+G+G FG+V G+ AVK L +E K+ + VL+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
+ + EK+ V +FV L + L +++ R IA + YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---I 115
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
I++RDLK NILLD++ + ++DFG+ + G+ Q+ T+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTT 155
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 31/149 (20%), Positives = 56/149 (37%), Gaps = 19/149 (12%)
Query: 352 KLGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV--RLLG 408
L G VY L + E +K S + + + EV ++ L + L ++L
Sbjct: 5 LLKGGLTNRVYL--LGTKDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG-IARGILYLHEDSRLR 467
L+ E++ ++LD + + + + +A+ LH+ L
Sbjct: 61 SGESDGWSYLLMEWIEGETLD-----EVSEEEKEDIAE--QLAELLAK----LHQLPLLV 109
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARI 496
+ H DL NIL+D I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 31/86 (36%), Positives = 50/86 (58%), Gaps = 6/86 (6%)
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
F +GE I + E + SLD L +K G++ + KI + RG+ YL E + +I
Sbjct: 68 FYSDGEISICM-EHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLRE--KHKI 121
Query: 469 IHRDLKASNILLDAEMNPKISDFGMA 494
+HRD+K SNIL+++ K+ DFG++
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 50/178 (28%), Positives = 68/178 (38%), Gaps = 38/178 (21%)
Query: 347 FSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSASSGQGAQE-FKNEVVL------ 394
F KLGEG FG VYK L + +K+ ++ GA E + NE V
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK---ATEYGAVEIWMNERVRRACPNS 190
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPE-----------KQGQL-- 441
A + L + + +E LV+ + +L + E K L
Sbjct: 191 CADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPK 248
Query: 442 DWSRRYKIIGGIARGILY----LHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMA 494
R KII I R IL+ LH I+HRD+K NI+ KI D G A
Sbjct: 249 GLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 35/123 (28%), Positives = 56/123 (45%), Gaps = 8/123 (6%)
Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
E ++ + H ++++L G + L+ +P D + Y K+ + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKR-NIAICDILAIE 188
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
+ R I YLHE+ RIIHRD+KA NI ++ + + DFG A F VD
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWA 244
Query: 511 GTL 513
GT+
Sbjct: 245 GTI 247
|
Length = 391 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 15/160 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ 399
E+ + F ++LG G G V+K PSG +A K + + +N+++ ++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL---EIKPAIRNQIIRELQVL 57
Query: 400 HR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
H N ++GF +GE I + E + SLD L +K G++ K+ +
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAGRIPEQILGKVSIAVI 113
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+G+ YL E + +I+HRD+K SNIL+++ K+ DFG++
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 19/42 (45%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
R + Y+H + + HRDLK NIL +A+ KI DFG+AR+
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 43/153 (28%), Positives = 78/153 (50%), Gaps = 18/153 (11%)
Query: 353 LGEGGFGEVYKGVLPSGQE----IAVKRLS----ASSGQGAQEFKNEVVLVAKLQHRNLV 404
LG+GG+G+V++ +G + A+K L + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHE 462
L+ G + L+ E++ L L E++G D + Y + I+ + +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFY--LSEISLALEHLH- 117
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ II+RDLK NILLDA+ + K++DFG+ +
Sbjct: 118 --QQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 11/89 (12%)
Query: 410 CLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRL 466
C + E ++ V E+V L ++ ++Q +L + +R Y I+ + YLHE
Sbjct: 64 CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYS--AEISLALNYLHERG-- 116
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMAR 495
II+RDLK N+LLD+E + K++D+GM +
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 40/170 (23%), Positives = 81/170 (47%), Gaps = 16/170 (9%)
Query: 353 LGEGGFGEVYKGVLPSGQE----IAVKRLSASS----GQGAQEFKNEVVLVAKLQHRNLV 404
LG G +G+V+ SG + A+K L ++ + + + E ++ ++ +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 405 RLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
L + + + K+ L+ +++ L L E+ + + G I + +LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQ---IYSGEIVLALEHLH-- 122
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
+L II+RD+K NILLD+ + ++DFG+++ F D+ + S GT+
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTI 170
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 20/49 (40%), Positives = 31/49 (63%), Gaps = 3/49 (6%)
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
K I +A + YLH IIHRDLK N+L+ E + K++DFG++++
Sbjct: 108 KYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 23/43 (53%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ARG+ +L SR + IHRDL A NILL KI DFG+AR
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 7/114 (6%)
Query: 369 GQEIAV--KRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426
G+E+ V K L S A F L++++ H +L + G C+ G E I+V EFV +
Sbjct: 42 GRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHG 101
Query: 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480
LD L + + + W + + +A + YL ED L +H ++ A NILL
Sbjct: 102 PLDVCLRKEKGRVPVAW--KITVAQQLASALSYL-EDKNL--VHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 26/124 (20%), Positives = 45/124 (36%), Gaps = 32/124 (25%)
Query: 389 KNEVVLVAKLQHRNLVRLLGFC------LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLD 442
+ E ++AK R G ++ + ++V E++ + L L
Sbjct: 47 RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL---------- 90
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI------ 496
R ++ + R + LH+ I+H DL SNI+L DFG+
Sbjct: 91 EEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVED 146
Query: 497 FGVD 500
VD
Sbjct: 147 KAVD 150
|
Length = 204 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 26/184 (14%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQE---FKNE 391
DFE I+V +G G FGEV + + I A+K L+ E F+ E
Sbjct: 2 DFEIIKV----------IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE 51
Query: 392 --VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
V++ Q + L + + E + LV ++ L L E + D +R Y
Sbjct: 52 RNVLVNGDCQ---WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY- 107
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
IA +L +H +L +HRD+K N+LLD + +++DFG D T +S
Sbjct: 108 ----IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSV 162
Query: 509 IVGT 512
VGT
Sbjct: 163 AVGT 166
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 53/172 (30%), Positives = 76/172 (44%), Gaps = 35/172 (20%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEFKNEVVLVAKLQH----RN-LVRL 406
+G+G FG+VY+ + I A+K LS K E+V ++ H RN LVR
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS----------KKEIVAKKEVAHTIGERNILVR- 49
Query: 407 LGFCLEGEEKILV---YEFVPNKSLDYFLYDPEKQGQLDW---------SRRYKIIGGIA 454
L E +V + F + L Y + D G+L W R K IA
Sbjct: 50 ---TLLDESPFIVGLKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAKFY--IA 103
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
+L L + I++RDLK NILLDA + + DFG+++ D NT
Sbjct: 104 ELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 15/155 (9%)
Query: 352 KLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGA---QEFKNEVVLVAKLQHRNLVRLL 407
+G+GG GEVY P + +A+K++ + + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK--------IIGGIARGILY 459
C +G+ ++ +L L ++ L K I I I Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+H S+ ++HRDLK NILL I D+G A
Sbjct: 129 VH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAA 160
|
Length = 932 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEFKNEV----VLVAKLQHRNLVRLL 407
+G+G FG+V + ++ AVK L + +E K+ + VL+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
F + +K+ V +++ L Y L +++ R IA + YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS---L 115
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
I++RDLK NILLD++ + ++DFG+ + + G TS GT
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 45/187 (24%), Positives = 90/187 (48%), Gaps = 26/187 (13%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSASS----GQGAQE 387
+FE ++V LG G +G+V+ +G+ A+K L ++ + +
Sbjct: 1 NFELLKV----------LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEH 50
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
+ E ++ ++ + L + + E K+ L+ ++V + LY + + D R
Sbjct: 51 TRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-DEVRF 109
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
Y G I + +LH +L I++RD+K NILLD+E + ++DFG+++ F + + + T
Sbjct: 110 Y--SGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERT 163
Query: 507 SRIVGTL 513
GT+
Sbjct: 164 YSFCGTI 170
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 42/163 (25%), Positives = 73/163 (44%), Gaps = 11/163 (6%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQE----FKNEVVLVAKLQ 399
F + +G G FGEV + +I A+K + S AQE F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV-LLAQETVSFFEEERDILSISN 59
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
+ +L + + LV E+ P L L E Q D ++ Y +A +L
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----LAELVLA 114
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
+H ++ +HRD+K N+L+D + K++DFG A ++
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 7/87 (8%)
Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
C + ++ LV E+V L ++ ++Q +L I + +LHE I
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---I 117
Query: 469 IHRDLKASNILLDAEMNPKISDFGMAR 495
I+RDLK N+LLDA+ + K++D+GM +
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 31/189 (16%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKN-----EVVLV 395
E N++ K+G G FGEV+ QE + A S +G +E + EV ++
Sbjct: 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVM 66
Query: 396 AKLQHRNLVRLLG-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQ-GQLDWSRRYKIIGG 452
+L+H+N+VR + F + +K+ ++ EF L + K G+++ I
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 453 IARGILYLHE----DSRLRIIHRDLKASNILLD----------AEMN-------PKISDF 491
+ + Y H + R++HRDLK NI L A+ N KI DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 492 GMARIFGVD 500
G+++ G++
Sbjct: 187 GLSKNIGIE 195
|
Length = 1021 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 46/183 (25%), Positives = 71/183 (38%), Gaps = 63/183 (34%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLV 395
DFE ++V +G G FGEV AV ++ ++GQ V
Sbjct: 2 DFEILKV----------IGRGAFGEV-----------AVVKMK-NTGQ---------VYA 30
Query: 396 AKLQHR--NLVRLLGFCLEGEEKILV-----------YEFVPNKSLDYFLYDPEKQGQL- 441
K+ ++ L R C E +LV Y F +L Y + D G L
Sbjct: 31 MKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNL-YLVMDYYVGGDLL 89
Query: 442 ------------DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
D +R Y +A +L + +L +HRD+K N+LLD + +++
Sbjct: 90 TLLSKFEDRLPEDMARFY-----LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLA 144
Query: 490 DFG 492
DFG
Sbjct: 145 DFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 23/43 (53%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ARG+ +L SR + IHRDL A NILL KI DFG+AR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 30/157 (19%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVL-------------VAKLQ 399
LG+G FG+V I V+ ++ + K EV++ V K
Sbjct: 3 LGKGTFGKV----------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 400 HRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
+ L + + ++++ V E+V L +F E+ D +R Y I +
Sbjct: 53 RHPFLTSLKYSFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSEDRTRFYG--AEIVSALD 109
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
YLH +I++RDLK N++LD + + KI+DFG+ +
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 46/164 (28%), Positives = 83/164 (50%), Gaps = 23/164 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ 399
E+ + F ++LG G G V K PSG +A K + + +N+++ ++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL---EIKPAIRNQIIRELQVL 57
Query: 400 HR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
H N ++GF +GE I + E + SLD L + ++ + +I+G ++
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPE-------EILGKVS 109
Query: 455 ----RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
RG+ YL E + +I+HRD+K SNIL+++ K+ DFG++
Sbjct: 110 IAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 19/41 (46%), Positives = 28/41 (68%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
IA +L + +L IHRD+K N+LLDA+ + K+SDFG+
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|224632 COG1718, RIO1, Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 48/216 (22%), Positives = 75/216 (34%), Gaps = 45/216 (20%)
Query: 307 LRRRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGE---VYK 363
+R K K + + + T+ ET+ ++ +G G+ VY
Sbjct: 15 REKREKDKEDRKVVDEVFDKRTL--------ETLRRLLSRGVITELVGCISTGKEANVYL 66
Query: 364 GVLPSGQEIAVK--RLSASSG-------QGAQEFKNEVVLVAKLQH-------RNLVRLL 407
G+ +AVK R S S QG F+N KL RNL R
Sbjct: 67 AETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAY 126
Query: 408 GFC------LEGEEKILVYEFVPNKSLDY-FLYDPEKQGQLDWSRRY--KIIGGIARGIL 458
+ +LV EF+ + L L D + L+ + ++ + R L
Sbjct: 127 EAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLE--LEEAEGLYEDVVEYMRR--L 182
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
Y ++H DL NIL+ + P I D A
Sbjct: 183 Y----KEAGLVHGDLSEYNILVH-DGEPYIIDVSQA 213
|
Length = 268 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 22/43 (51%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+A+G+ +L SR + IHRDL A NILL KI DFG+AR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 18/41 (43%), Positives = 28/41 (68%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
IA +L + +L IHRD+K N+LLD++ + K+SDFG+
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 35/163 (21%), Positives = 62/163 (38%), Gaps = 35/163 (21%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEV------------VLVA 396
K+G G +VY + P G+++AVK RL +S + + ++ + L A
Sbjct: 97 TKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAA 156
Query: 397 KLQHRNLVRLLGFC------LEGEEKILVYEFVPNKSLDYF-LYD-PEKQGQLDWSRRYK 448
+ + L RL + +V E++ + LY D K
Sbjct: 157 EREFEALQRLYPEGVKVPKPIAWNRHAVVMEYI-----EGVELYRLRLDVENPD-EILDK 210
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
I+ + Y R I+H DL NIL+ + + + D+
Sbjct: 211 ILEEVR--KAY-----RRGIVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 33/121 (27%), Positives = 58/121 (47%), Gaps = 10/121 (8%)
Query: 367 PSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424
P+G + V+ L + + + +NEVVL +H N++ G ++ F+
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 425 NKSLDYFL--YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482
S + L Y PE + + I+ G RG+ YLH++ IHR++KAS+IL+
Sbjct: 83 YGSANSLLKTYFPEGMSE---ALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISG 136
Query: 483 E 483
+
Sbjct: 137 D 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 43/155 (27%), Positives = 64/155 (41%), Gaps = 11/155 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQ--EIAVKRLSASS---GQGAQEFKNEVVLVAKLQHR 401
F+ LG G FG V + +A+KR S + +E ++ + H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
V L G + LV EFV FL K+ D Y A+ +L
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYA-----AQIVLIFE 145
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
L I++RDLK N+LLD + K++DFG A++
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRN--LVRL 406
+G GGFGEVY +G+ A+K L QG NE ++++ + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
+ + +K+ + + + L Y L + G I G+ ++H +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--NR 116
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMA 494
+++RDLK +NILLD + +ISD G+A
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 9/117 (7%)
Query: 325 NDLTILESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRL 377
N+ T ++ Q + E E + LG G FG+V + G + +AVK L
Sbjct: 17 NNYTFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML 76
Query: 378 SASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
AS+ +E +E+ +++ L QH+N+V LLG C G +++ E+ L FL
Sbjct: 77 KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 16/43 (37%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
I + YLH +++RDLK N++LD + + KI+DFG+ +
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 513 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.95 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.95 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.95 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.95 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.94 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.94 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.94 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.94 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.94 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.94 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.93 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.93 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.93 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.92 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.92 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.92 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.92 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.92 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.92 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.92 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.92 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.92 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.92 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.92 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.92 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.92 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.92 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.92 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.92 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.92 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.92 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.92 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.92 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.92 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.91 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.91 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.91 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.91 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.91 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.91 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.91 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.91 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.91 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.91 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.91 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.91 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.91 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.91 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.91 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.91 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.91 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.91 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.91 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.91 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.91 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.9 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.9 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.9 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.9 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.9 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.9 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.9 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.9 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.9 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.9 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.9 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.9 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.9 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.9 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.9 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.9 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.9 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.9 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.9 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.9 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.9 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.9 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.9 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.9 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.9 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.9 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.9 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.9 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.89 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.89 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.89 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.89 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.89 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.89 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.89 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.89 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.89 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.89 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.89 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.89 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.89 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.89 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.89 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.89 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.89 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.89 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.89 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.89 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.89 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.89 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.89 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.89 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.89 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.89 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.89 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.89 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.89 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.89 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.89 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.89 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.88 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.88 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.88 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.88 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.88 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.88 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.88 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.88 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.88 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.88 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.88 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.88 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.88 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.88 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.88 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.88 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.88 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.88 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.88 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.87 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.87 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.87 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.87 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.87 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.87 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.87 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.87 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.87 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.87 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.87 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.87 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.87 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.87 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.87 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.87 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.87 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.87 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.87 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.87 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.87 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.87 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.87 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.87 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.87 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.87 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.86 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.86 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.86 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.86 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.86 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.86 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.86 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.86 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.86 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.86 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.86 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.86 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.86 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.86 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.86 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.86 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.85 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.85 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.85 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.85 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.85 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.85 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.85 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.85 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.85 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.85 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.85 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.85 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.85 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.85 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.85 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.85 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.85 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.85 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.85 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.84 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.84 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.84 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.84 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.84 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.84 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.84 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.84 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.84 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.84 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.84 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.84 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.84 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.84 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.83 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.83 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.83 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.83 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.83 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.83 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.83 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.83 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.83 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.83 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.83 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.83 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.82 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.82 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.82 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.82 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.82 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.81 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.81 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.81 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.8 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.8 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.8 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.8 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.78 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.78 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.77 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.7 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.69 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.65 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.59 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.57 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.27 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.11 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.1 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.91 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.74 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.73 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.71 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.61 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.46 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.42 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.41 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.29 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.28 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.24 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.08 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.95 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.86 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.82 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.68 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.67 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.58 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.58 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.41 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.15 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.03 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.0 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.99 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.94 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.93 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.87 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.83 | |
| PLN02236 | 344 | choline kinase | 96.82 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.66 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.36 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.35 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.26 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.14 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.75 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.65 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.54 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.46 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.06 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.9 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.88 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.49 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.45 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 94.2 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.84 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 93.42 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 93.39 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.94 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=307.60 Aligned_cols=168 Identities=53% Similarity=0.902 Sum_probs=153.4
Q ss_pred cccccchHHHHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEE
Q 010329 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410 (513)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 410 (513)
....|.+.+++.+|++|+..+.||+|+||.||+|.+++|..||||++.....+..++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34568999999999999999999999999999999999999999988776543156699999999999999999999999
Q ss_pred EeCC-eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEe
Q 010329 411 LEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (513)
Q Consensus 411 ~~~~-~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 489 (513)
.+.+ +.+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||+...++|+||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875444 89999999999999999999999988899999999999999999999999
Q ss_pred eccCccccCC
Q 010329 490 DFGMARIFGV 499 (513)
Q Consensus 490 DfGla~~~~~ 499 (513)
|||||+....
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999976543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=266.05 Aligned_cols=161 Identities=34% Similarity=0.556 Sum_probs=141.2
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHh--CCCCCccceeeEEEeCC----eeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAK--LQHRNLVRLLGFCLEGE----EKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~----~~~l 418 (513)
....+.+++|+|.||.||||.+ +++.||||++.... .+.|++|-++.+. ++|+||++|++.-..++ +.+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3455678899999999999999 45999999987643 4567777776654 58999999999987766 8899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC------CCCCeeecCCcCCcEEECCCCCeEEeecc
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED------SRLRIIHRDLKASNILLDAEMNPKISDFG 492 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrdlk~~Nill~~~~~~ki~DfG 492 (513)
|+||.++|||.+|| +...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 456799999999999999999999975 46789999999999999999999999999
Q ss_pred CccccCCCCCccccceeeecC
Q 010329 493 MARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 493 la~~~~~~~~~~~~~~~~Gt~ 513 (513)
||.++..+..++.+..-+||.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~ 382 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTR 382 (534)
T ss_pred eeEEecCCCCCcchhhhhhhh
Confidence 999999888888887888883
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=262.26 Aligned_cols=160 Identities=31% Similarity=0.521 Sum_probs=139.6
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.+|...++||.|+|++||+|++ .++.+||||.+... .....+.+..|+++|+.++|||||+|+++++.++..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 5678888899999999999996 45789999998766 44556778899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC------CCeEEeeccCcc
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE------MNPKISDFGMAR 495 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~------~~~ki~DfGla~ 495 (513)
||.+|+|.+||+. .+.+++.....++.|||.||++||+++ ||||||||.||||+.. -.+||+|||+||
T Consensus 90 yC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999953 457999999999999999999999998 9999999999999765 458999999999
Q ss_pred ccCCCCCccccceeeecC
Q 010329 496 IFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 496 ~~~~~~~~~~~~~~~Gt~ 513 (513)
.+.++. ....++||+
T Consensus 164 ~L~~~~---~a~tlcGSp 178 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSP 178 (429)
T ss_pred hCCchh---HHHHhhCCc
Confidence 997443 233456654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=266.37 Aligned_cols=157 Identities=36% Similarity=0.619 Sum_probs=140.1
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++..+.+.+.++||+|.||.||.|.++....||+|.++... ...+.|.+|+.+|++|+|+|||+|+|+|..++..+|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 34444556678999999999999999877899999998763 34578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|||++|+|.+||.+ ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||||...++
T Consensus 281 E~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999999965 34567899999999999999999999987 999999999999999999999999999976655
Q ss_pred CC
Q 010329 501 QT 502 (513)
Q Consensus 501 ~~ 502 (513)
.-
T Consensus 357 ~Y 358 (468)
T KOG0197|consen 357 EY 358 (468)
T ss_pred ce
Confidence 43
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=262.68 Aligned_cols=160 Identities=36% Similarity=0.596 Sum_probs=137.0
Q ss_pred cccccCccCceeEEEEEeCCCcEEEEEEecccCccC--HHHHHHHHHHHHhCCCCCccceeeEEEeCC-eeEEEEecCCC
Q 010329 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQG--AQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-EKILVYEFVPN 425 (513)
Q Consensus 349 ~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lv~ey~~~ 425 (513)
..+.||+|+||+||+|.+.+...||||++....... .++|.+|+.+|.+++|||||+|+|+|.+.. ...+|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345599999999999999655559999998653222 569999999999999999999999999988 79999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC-CeEEeeccCccccCCCCCcc
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQTQG 504 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~~~~~~~ 504 (513)
|+|.++++.. ....+++..+++|+.|||+||.|||++++ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999764 46789999999999999999999999863 99999999999999998 99999999999876432 2
Q ss_pred ccceeeecC
Q 010329 505 NTSRIVGTL 513 (513)
Q Consensus 505 ~~~~~~Gt~ 513 (513)
..+...||+
T Consensus 200 ~~~~~~GT~ 208 (362)
T KOG0192|consen 200 SMTSVAGTY 208 (362)
T ss_pred cccCCCCCc
Confidence 233366764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=256.55 Aligned_cols=160 Identities=29% Similarity=0.480 Sum_probs=140.3
Q ss_pred cCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--CeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv 419 (513)
+.|+..++||+|+||.|||++ ..+|+.||+|+++.+. +.......+||.+|++|+||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456777899999999999999 5679999999997654 34456788999999999999999999999887 689999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+|||++ +|.-++.. ..-.++..++..++.|++.||+|+|..+ |+|||||.+|||||.+|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999986 67777733 3457999999999999999999999998 99999999999999999999999999999988
Q ss_pred CCCccccceee
Q 010329 500 DQTQGNTSRIV 510 (513)
Q Consensus 500 ~~~~~~~~~~~ 510 (513)
+..+..|++++
T Consensus 271 ~~~~~~T~rVv 281 (560)
T KOG0600|consen 271 SGSAPYTSRVV 281 (560)
T ss_pred CCCcccccceE
Confidence 88777777665
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=259.30 Aligned_cols=161 Identities=30% Similarity=0.486 Sum_probs=146.0
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
..|...+.||+|+|.+||+++. ..|+.||+|.+.+. .....+...+||++.+.|+|||||+|+++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999996 88999999999763 3445678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|+|++++|.+++. ..+.+++.++..+..||+.||.|||+.+ |+|||||..|++|++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999994 5678999999999999999999999987 999999999999999999999999999999866
Q ss_pred CCccccceeeecC
Q 010329 501 QTQGNTSRIVGTL 513 (513)
Q Consensus 501 ~~~~~~~~~~Gt~ 513 (513)
..... .++||+
T Consensus 172 ~Erk~--TlCGTP 182 (592)
T KOG0575|consen 172 GERKK--TLCGTP 182 (592)
T ss_pred ccccc--eecCCC
Confidence 54433 489986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=268.15 Aligned_cols=158 Identities=35% Similarity=0.582 Sum_probs=139.4
Q ss_pred hHHHHHHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCcc-CHHHHHHHHHHHHhCCCCCccceeeE
Q 010329 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGF 409 (513)
Q Consensus 337 ~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~ 409 (513)
....+..+.+....++||+|+||+||+|+.. +...||||.+++.... ..++|++|++++..++|||||+|+|+
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 3345566777888899999999999999853 2456999999987665 67899999999999999999999999
Q ss_pred EEeCCeeEEEEecCCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcE
Q 010329 410 CLEGEEKILVYEFVPNKSLDYFLYDPE-----------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (513)
Q Consensus 410 ~~~~~~~~lv~ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Ni 478 (513)
|.+++..+||+|||..|+|.+||+... ...+|+..+.+.|+.|||.||+||-++. +|||||..||+
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNC 634 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNC 634 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhc
Confidence 999999999999999999999995211 1344899999999999999999999876 99999999999
Q ss_pred EECCCCCeEEeeccCcccc
Q 010329 479 LLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 479 ll~~~~~~ki~DfGla~~~ 497 (513)
||.++..+||+||||+|.+
T Consensus 635 LVge~l~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDI 653 (774)
T ss_pred eeccceEEEecccccchhh
Confidence 9999999999999999955
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=247.38 Aligned_cols=162 Identities=28% Similarity=0.440 Sum_probs=138.7
Q ss_pred HhcCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccCc-------cCHHHHHHHHHHHHhCCCCCccceeeEEEeCC
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSG-------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 414 (513)
..+.|.+.+.||+|+||.|-+|. -++|+.||||.+.+... .......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 44667888999999999999998 45799999999876421 12234579999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC---CCeEEeec
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDF 491 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~Df 491 (513)
..||||||+++|+|.+.+- ..+.+.+..-..++.|++.|+.|||+++ |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999983 4566788888889999999999999998 9999999999999655 77999999
Q ss_pred cCccccCCCCCccccceeeecC
Q 010329 492 GMARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~Gt~ 513 (513)
|||++.+... .+..++||+
T Consensus 324 GlAK~~g~~s---fm~TlCGTp 342 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGTP 342 (475)
T ss_pred chhhccccce---ehhhhcCCc
Confidence 9999987333 355688886
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=240.46 Aligned_cols=158 Identities=30% Similarity=0.425 Sum_probs=136.4
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC-eeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-EKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lv~ey 422 (513)
+++..+.||+|..|+|||+.++ +++.+|+|.+... .+...+++.+|++++++.+||+||+++|.|.... +..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3445678999999999999964 5778999999544 3445678999999999999999999999999988 59999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 502 (513)
|++|||+.++. ..+.+++...-+|+.+|++||.|||+.. +||||||||+||||+..|++||+|||.++.+...
T Consensus 160 MDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999994 3467999999999999999999999742 4999999999999999999999999999988543
Q ss_pred ccccceeeec
Q 010329 503 QGNTSRIVGT 512 (513)
Q Consensus 503 ~~~~~~~~Gt 512 (513)
....++||
T Consensus 233 --~a~tfvGT 240 (364)
T KOG0581|consen 233 --IANTFVGT 240 (364)
T ss_pred --hccccccc
Confidence 23356676
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=249.87 Aligned_cols=157 Identities=32% Similarity=0.541 Sum_probs=139.0
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccC-HHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
.+.+++...+.++||+|.||.|..+....+..||||+++...... ..+|..|+++|.+++||||++|+|+|..++..++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 456777888899999999999999999888999999999875544 5899999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|+|||++|+|..|+....... +.-+...+|+.||+.||+||.+-. +|||||.++|+|+|.++++||+|||++|-+-
T Consensus 613 I~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999996533222 456677889999999999998765 9999999999999999999999999999664
Q ss_pred CC
Q 010329 499 VD 500 (513)
Q Consensus 499 ~~ 500 (513)
++
T Consensus 689 sg 690 (807)
T KOG1094|consen 689 SG 690 (807)
T ss_pred cC
Confidence 43
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=226.40 Aligned_cols=151 Identities=32% Similarity=0.575 Sum_probs=134.7
Q ss_pred cCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccCcc-C-HHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQ-G-AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|...++||+|.||.||+|+ ..+|+.||||+++..... + .....+|++.|+.++|+||+.|++++...+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 457778899999999999999 467999999999865322 2 3467899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
||+ .+|+..+++ +...++..++..++.++++||+|||++. |+||||||.|+||+++|.+||+|||+||.+.+..
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 997 689999965 4567999999999999999999999998 9999999999999999999999999999997543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=238.54 Aligned_cols=162 Identities=29% Similarity=0.435 Sum_probs=142.8
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|+..+.||+|+||+||.++. +.++.+|+|.+++.. ....+....|..+|.+++||.||+++-.+++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46788999999999999999985 457889999997652 23456788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+||+.||.|...| .+++.+++..+..++.+|+.||.|||+.+ ||||||||+|||||++|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999 45678999999999999999999999998 99999999999999999999999999997765
Q ss_pred CCCccccceeeecC
Q 010329 500 DQTQGNTSRIVGTL 513 (513)
Q Consensus 500 ~~~~~~~~~~~Gt~ 513 (513)
+... +..++||+
T Consensus 178 ~~~~--t~tfcGT~ 189 (357)
T KOG0598|consen 178 DGDA--TRTFCGTP 189 (357)
T ss_pred CCCc--cccccCCc
Confidence 5433 34589985
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=254.07 Aligned_cols=155 Identities=32% Similarity=0.561 Sum_probs=138.6
Q ss_pred hcCCCcccccCccCceeEEEEEeCC----CcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~----~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
.....+++.||.|.||.|++|+++- ...||||.|+.... ..+.+|..|+.+|.+++||||++|.|+.......++
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 3456678899999999999999742 34699999998644 456789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|+|||++|+|+.||+.. .+.+++.+..-|.++||.||.||.+.+ .|||||.++|||++.+..+||+||||+|++.
T Consensus 708 iTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999999653 356999999999999999999999877 9999999999999999999999999999997
Q ss_pred CCCCc
Q 010329 499 VDQTQ 503 (513)
Q Consensus 499 ~~~~~ 503 (513)
++...
T Consensus 783 dd~~~ 787 (996)
T KOG0196|consen 783 DDPEA 787 (996)
T ss_pred cCCCc
Confidence 76633
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=226.75 Aligned_cols=149 Identities=28% Similarity=0.416 Sum_probs=131.7
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|+...++|+|+||.|||++.+ +|+.||||++.+... ...+-..+|+++|+.++|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35677789999999999999964 699999999876533 233557899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|++..-|+++- +....++.....++++|+++|+.|+|+++ ++||||||+||||..++.+||+|||+||.+..
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99987776665 34556899999999999999999999987 99999999999999999999999999999873
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=232.99 Aligned_cols=168 Identities=26% Similarity=0.379 Sum_probs=138.0
Q ss_pred hHHHHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHH--hCCCCCccceeeEEEeCC
Q 010329 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVA--KLQHRNLVRLLGFCLEGE 414 (513)
Q Consensus 337 ~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~--~l~H~nIv~l~g~~~~~~ 414 (513)
+-......+...+.+.||+|.||.||+|.| .|+.||||++...++ +.+.+|.++.. .|+|+||+.|++.-..+.
T Consensus 203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 334455667888999999999999999999 689999999865433 34555655554 579999999999876653
Q ss_pred ----eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-----CCCCCeeecCCcCCcEEECCCCC
Q 010329 415 ----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-----DSRLRIIHRDLKASNILLDAEMN 485 (513)
Q Consensus 415 ----~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrdlk~~Nill~~~~~ 485 (513)
++|||++|.++|||.+||. ...++....++++..+|.||++||- +++|.|.|||||+.|||+.+++.
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 6899999999999999993 3679999999999999999999995 47899999999999999999999
Q ss_pred eEEeeccCccccCCCCCcc--ccceeeec
Q 010329 486 PKISDFGMARIFGVDQTQG--NTSRIVGT 512 (513)
Q Consensus 486 ~ki~DfGla~~~~~~~~~~--~~~~~~Gt 512 (513)
+.|+|+|||....++.++. ....-+||
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGT 383 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGT 383 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccce
Confidence 9999999999887664332 23334555
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=246.39 Aligned_cols=153 Identities=36% Similarity=0.533 Sum_probs=133.9
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeCC--C---cEEEEEEecc---cCccCHHHHHHHHHHHHhCCCCCccceeeEEE
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPS--G---QEIAVKRLSA---SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 411 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~--~---~~VavK~l~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 411 (513)
++...++..+.++||+|+||.||+|.+.. + ..||||..+. ......++|.+|+++|+.++|||||+|+|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 44445556667899999999999999643 2 2389999885 33566789999999999999999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeec
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df 491 (513)
.....++|||+++||+|+++|.+. ...++..+++.++.+.|.||+|||+++ ++||||.+||+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999542 226999999999999999999999987 999999999999999999999999
Q ss_pred cCcccc
Q 010329 492 GMARIF 497 (513)
Q Consensus 492 Gla~~~ 497 (513)
||++.-
T Consensus 307 GLs~~~ 312 (474)
T KOG0194|consen 307 GLSRAG 312 (474)
T ss_pred ccccCC
Confidence 998854
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=238.70 Aligned_cols=152 Identities=33% Similarity=0.460 Sum_probs=136.1
Q ss_pred hcCCCcccccCccCceeEEEEE-eCCCcEEEEEEeccc---CccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 418 (513)
.++|..++.||+|+|++|++|+ ...++++|||++.+. .....+-...|-..|.+| .||.|++|+-.|.+...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 3578889999999999999999 457889999998653 233345677888899999 79999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|+||.++|+|.++|. +.+.+++.....++.+|+.||+|||+++ ||||||||+|||||++|++||+|||-|+.+.
T Consensus 152 vLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999994 4578999999999999999999999998 9999999999999999999999999999997
Q ss_pred CCC
Q 010329 499 VDQ 501 (513)
Q Consensus 499 ~~~ 501 (513)
+.+
T Consensus 226 ~~~ 228 (604)
T KOG0592|consen 226 PSQ 228 (604)
T ss_pred hhh
Confidence 654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=220.16 Aligned_cols=158 Identities=32% Similarity=0.434 Sum_probs=140.0
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|+..+.||.|+||.|..++. .+|..+|+|.+....- .+.+...+|..+|+.+.||+++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4567788999999999999995 4578899999976532 33456778999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|.|..+| ++.+++++.....++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+.+.
T Consensus 124 eyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 999999999999 45667999999999999999999999987 9999999999999999999999999999875
Q ss_pred CCccccceeeecC
Q 010329 501 QTQGNTSRIVGTL 513 (513)
Q Consensus 501 ~~~~~~~~~~Gt~ 513 (513)
..+-.++||+
T Consensus 196 ---~rT~TlCGTP 205 (355)
T KOG0616|consen 196 ---GRTWTLCGTP 205 (355)
T ss_pred ---CcEEEecCCc
Confidence 2355688885
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=227.11 Aligned_cols=166 Identities=28% Similarity=0.456 Sum_probs=139.5
Q ss_pred cCCCcccccCccCceeEEEEE-eCCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceee-EEEeCCe-eEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLG-FCLEGEE-KILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g-~~~~~~~-~~lv 419 (513)
.+|.+.++||.|.||.|||+. +.+|..||.|.+.-. +....+....|+.+|+.|+|||||++++ .+.+..+ +.||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 356778899999999999998 678999999988733 3344578899999999999999999999 4444445 7899
Q ss_pred EecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCC--eeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 420 YEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLR--IIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
|||+..|+|...+...+ ....+++..++++..|++.||..+|..- ++ |+||||||.||+|+.+|.+||.||||+|+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999886433 3456899999999999999999999842 23 99999999999999999999999999999
Q ss_pred cCCCCCccccceeeecC
Q 010329 497 FGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 497 ~~~~~~~~~~~~~~Gt~ 513 (513)
+..+.+ .+...+|||
T Consensus 178 l~s~~t--fA~S~VGTP 192 (375)
T KOG0591|consen 178 LSSKTT--FAHSLVGTP 192 (375)
T ss_pred hcchhH--HHHhhcCCC
Confidence 975543 445688886
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=230.84 Aligned_cols=151 Identities=25% Similarity=0.516 Sum_probs=137.1
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.+|++.+.||+|.||+|-++.. ..|+.||||.++++. .++.-.+++|+++|+.|+||||++++.+|...+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677888999999999999984 679999999987653 344556899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||-.+|.|.+|+. ..+.|++....++++||..++.|+|.+. ++|||||.+|||+|.++++||+||||+-.+..+
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999994 4667999999999999999999999986 999999999999999999999999999988655
Q ss_pred C
Q 010329 501 Q 501 (513)
Q Consensus 501 ~ 501 (513)
.
T Consensus 207 k 207 (668)
T KOG0611|consen 207 K 207 (668)
T ss_pred c
Confidence 4
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=237.07 Aligned_cols=162 Identities=31% Similarity=0.518 Sum_probs=145.7
Q ss_pred HhcCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
+...|...++||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||.++..+..++++|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 44567888899999999999998 56788999999987766666778999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
||++|+|.+.+ ....+++.++..|++++++||+|||.++ |+|||||++|||++.++.+||+|||++..+...+
T Consensus 351 ym~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 351 YMEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred ecCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999988 3445999999999999999999999998 9999999999999999999999999999998666
Q ss_pred CccccceeeecC
Q 010329 502 TQGNTSRIVGTL 513 (513)
Q Consensus 502 ~~~~~~~~~Gt~ 513 (513)
.. -+.++||+
T Consensus 424 ~K--R~TmVGTP 433 (550)
T KOG0578|consen 424 SK--RSTMVGTP 433 (550)
T ss_pred Cc--cccccCCC
Confidence 53 34589986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-28 Score=236.36 Aligned_cols=151 Identities=29% Similarity=0.439 Sum_probs=133.5
Q ss_pred HhcCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccCccCHHH--HHHHHHHHHhCC-CCCccceeeEEEeCC-eeE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE--FKNEVVLVAKLQ-HRNLVRLLGFCLEGE-EKI 417 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~~~~~~--~~~E~~~l~~l~-H~nIv~l~g~~~~~~-~~~ 417 (513)
..++|...++||.|+||.||+|+ ...++.||||+++..-.. +++ =.+|+..|++|. ||||++|.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34678889999999999999999 567889999999875432 333 367999999998 999999999999988 899
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+|||||+ .+|..++.+. +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+||||||.+
T Consensus 87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 9999996 6798888664 678999999999999999999999998 999999999999999999999999999987
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
.+.
T Consensus 161 ~Sk 163 (538)
T KOG0661|consen 161 RSK 163 (538)
T ss_pred ccC
Confidence 643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=237.92 Aligned_cols=153 Identities=34% Similarity=0.598 Sum_probs=136.9
Q ss_pred hHHHHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC
Q 010329 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (513)
Q Consensus 337 ~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 414 (513)
.+++++..+.+.+.+.||+|.||+||+|+|.+ .||||.+... ..+..+.|++|+..+++-+|.||+-|.|+|....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 35566677777888999999999999999853 6999998765 4456789999999999999999999999999887
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
. .+|+.|+++-+|..+||..+ .+++..+.+.|+.||++||.|||.++ |||||||+.||++.+++++||+||||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 7 99999999999999998644 56999999999999999999999987 999999999999999999999999999
Q ss_pred ccc
Q 010329 495 RIF 497 (513)
Q Consensus 495 ~~~ 497 (513)
..-
T Consensus 536 tvk 538 (678)
T KOG0193|consen 536 TVK 538 (678)
T ss_pred eee
Confidence 743
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=225.92 Aligned_cols=165 Identities=28% Similarity=0.456 Sum_probs=134.3
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc--------------cCHHHHHHHHHHHHhCCCCCcccee
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG--------------QGAQEFKNEVVLVAKLQHRNLVRLL 407 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~nIv~l~ 407 (513)
.-+.|++.+.||+|.||.|-+|+. .+++.||||.+.+... ...+..++||.+|++++|+|||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 346799999999999999999995 4688999999865311 1235788999999999999999999
Q ss_pred eEEEe--CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC
Q 010329 408 GFCLE--GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485 (513)
Q Consensus 408 g~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~ 485 (513)
.+.-+ .+..|||+|||..|.+...= .....+...+..++..++..||+|||.++ |+||||||+|+||+++++
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 99865 45789999999999874322 12223899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCccccCCCCC---ccccceeeecC
Q 010329 486 PKISDFGMARIFGVDQT---QGNTSRIVGTL 513 (513)
Q Consensus 486 ~ki~DfGla~~~~~~~~---~~~~~~~~Gt~ 513 (513)
+||+|||.+-....... .....+.+||+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTP 279 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTP 279 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCc
Confidence 99999999998733221 22233578875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=233.82 Aligned_cols=160 Identities=30% Similarity=0.468 Sum_probs=141.0
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|...+.||+|.||.||||+- .+.+.||+|.+.+.. ....+.+++|++++++++||||+.++++++...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4677788999999999999984 457889999987653 3346789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
|+.+ +|..+|. ..+.++++.+..|+.++..||.|||++. |+|||+||+|||++.++.+|++|||+||....
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-- 152 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--
Confidence 9976 9999994 4567999999999999999999999987 99999999999999999999999999998864
Q ss_pred CccccceeeecC
Q 010329 502 TQGNTSRIVGTL 513 (513)
Q Consensus 502 ~~~~~~~~~Gt~ 513 (513)
++...+++-||+
T Consensus 153 ~t~vltsikGtP 164 (808)
T KOG0597|consen 153 NTSVLTSIKGTP 164 (808)
T ss_pred CceeeeeccCcc
Confidence 344556777875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=222.49 Aligned_cols=150 Identities=30% Similarity=0.513 Sum_probs=131.6
Q ss_pred cCCCcccccCccCceeEEEEEeCC-CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC--eeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lv~e 421 (513)
.+|...+.||+|+||.||++...+ |+..|||.+...+....+.+.+|+.+|++++|||||+.+|.....+ ...+.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778899999999999999654 8999999987654333677999999999999999999999855544 5889999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC-CCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~~~ 499 (513)
|+++|+|.+++.+. ++.|++..+.++..||++||.|||+++ |+|+||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~--g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRY--GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999542 227999999999999999999999987 999999999999999 79999999999998874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=217.69 Aligned_cols=153 Identities=31% Similarity=0.526 Sum_probs=130.3
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCcc-C-HHHHHHHHHHHHhCCCCC-ccceeeEEEeCC------
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQ-G-AQEFKNEVVLVAKLQHRN-LVRLLGFCLEGE------ 414 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~-~-~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~------ 414 (513)
..|...++||+|+||+||+|+. .+|+.||+|+++....+ + -....+|+.++++++|+| |++|++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3456667899999999999994 57889999999866442 2 356689999999999999 999999999877
Q ss_pred eeEEEEecCCCCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQ-GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
..++|+||++ -+|..++...... ..++...+..++.||++||+|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 6899998543321 45777889999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCC
Q 010329 494 ARIFGVDQ 501 (513)
Q Consensus 494 a~~~~~~~ 501 (513)
|+.+.-+.
T Consensus 167 Ara~~ip~ 174 (323)
T KOG0594|consen 167 ARAFSIPM 174 (323)
T ss_pred HHHhcCCc
Confidence 99776443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=229.73 Aligned_cols=164 Identities=28% Similarity=0.480 Sum_probs=139.2
Q ss_pred HHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc----Cc-cCHHHHHHHHHHHHhCC-CCCccceeeEEEeCC
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS----SG-QGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGE 414 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~ 414 (513)
...++|.+.+.||+|.||+|+.|.. .+++.||+|.+... .. ...+.+.+|+.+++.++ ||||++++.+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456889999999999999999984 46899999976553 11 23456778999999999 999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC-CCeEEeeccC
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGM 493 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGl 493 (513)
..++||||+.+|+|.+++.+ .+.+.+....+++.|++.|++|||+.+ |+||||||+|||+|.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999943 567889999999999999999999987 9999999999999999 9999999999
Q ss_pred ccccCCCCCccccceeeecC
Q 010329 494 ARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 494 a~~~~~~~~~~~~~~~~Gt~ 513 (513)
+.... ..........||+
T Consensus 168 s~~~~--~~~~~l~t~cGsp 185 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSP 185 (370)
T ss_pred ccccC--CCCCcccCCCCCc
Confidence 99884 1112233456663
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=216.43 Aligned_cols=151 Identities=28% Similarity=0.458 Sum_probs=129.3
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc-cC-HHHHHHHHHHHHhCCCCCccceeeEEEeC--CeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG-QG-AQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~-~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv 419 (513)
++|+..+.|++|+||.||+|+. .+++.||+|+++.... ++ --.-.+||.+|.+.+|||||.+-.+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 3567788999999999999996 4578899999986532 11 23467899999999999999998887654 568999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++ +|..++.. ...++...+...++.|+++|++|||.+. |+|||||++|+|++..|.+||+||||||.+++
T Consensus 156 Me~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999975 78888854 3357889999999999999999999998 99999999999999999999999999999987
Q ss_pred CC
Q 010329 500 DQ 501 (513)
Q Consensus 500 ~~ 501 (513)
..
T Consensus 230 p~ 231 (419)
T KOG0663|consen 230 PL 231 (419)
T ss_pred Cc
Confidence 64
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=226.10 Aligned_cols=151 Identities=26% Similarity=0.364 Sum_probs=136.4
Q ss_pred HHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
...++|.+...||+|+||.||.++- .+|..+|+|+|++.. ..+.+..+.|-.+|...+++.||+|+-.|.+.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3457899999999999999999994 568999999998753 344567888999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|||||++||++..+| .+.+.|++.....++.+++.|++-||+.+ +|||||||+|+|||..|++||+||||+.-+
T Consensus 218 LiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999999 45677999999999999999999999988 999999999999999999999999999765
Q ss_pred C
Q 010329 498 G 498 (513)
Q Consensus 498 ~ 498 (513)
.
T Consensus 292 ~ 292 (550)
T KOG0605|consen 292 D 292 (550)
T ss_pred h
Confidence 4
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-26 Score=218.87 Aligned_cols=155 Identities=23% Similarity=0.359 Sum_probs=138.4
Q ss_pred HhcCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
..+.|++.++||.|.-++||+|+ .+.++.||||++..... ...+.+++|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34678999999999999999998 67789999999875433 34689999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
.||.+||+.+++...-. ..+++..+..|..++++||.|||.++ .||||||+.||||+++|.+||+|||.+..+-+.
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999965433 34899999999999999999999998 899999999999999999999999999877554
Q ss_pred C
Q 010329 501 Q 501 (513)
Q Consensus 501 ~ 501 (513)
.
T Consensus 180 G 180 (516)
T KOG0582|consen 180 G 180 (516)
T ss_pred C
Confidence 3
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=228.59 Aligned_cols=156 Identities=30% Similarity=0.451 Sum_probs=131.3
Q ss_pred HHHhcCCCcccccCccCceeEEEEEe------CCCcEEEEEEecccCc-cCHHHHHHHHHHHHhC-CCCCccceeeEEEe
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE 412 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~------~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 412 (513)
+++.++|.+.++||+|+||.||+|.. ..++.||||+++.... ...+.+.+|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567889999999999999999974 2346799999875432 3346789999999999 89999999999876
Q ss_pred CC-eeEEEEecCCCCChhhhhcCCCC------------------------------------------------------
Q 010329 413 GE-EKILVYEFVPNKSLDYFLYDPEK------------------------------------------------------ 437 (513)
Q Consensus 413 ~~-~~~lv~ey~~~gsL~~~l~~~~~------------------------------------------------------ 437 (513)
.+ ..+++|||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 57899999999999999854211
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 438 -----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 438 -----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 134888999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=222.21 Aligned_cols=153 Identities=31% Similarity=0.508 Sum_probs=131.7
Q ss_pred hcCCCcccccCccCceeEEEEEeCC-----------------CcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccc
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPS-----------------GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVR 405 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~-----------------~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 405 (513)
.++|.+.++||+|+||.||++.+.+ +..||+|.+.... .....+|.+|+.++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4578888999999999999998532 3369999987643 334567999999999999999999
Q ss_pred eeeEEEeCCeeEEEEecCCCCChhhhhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCee
Q 010329 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPE----------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469 (513)
Q Consensus 406 l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 469 (513)
+++++.+.+..++||||+++|+|.+++.... ....++|....+++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999884321 1235788999999999999999999987 99
Q ss_pred ecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 470 HRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 470 Hrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||||||+|||+++++.+||+|||+++.+..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~ 190 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYA 190 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceeccc
Confidence 999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=206.70 Aligned_cols=162 Identities=30% Similarity=0.473 Sum_probs=138.6
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
-++|.+++.||+|.||.||.|+. +++..||+|.+.+.. ....+.+.+|+++-+.|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35788899999999999999995 467789999986542 23346789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+||.++|+|...|.+ .....+++.....++.|+|.||.|+|..+ ++||||||+|+|++.++..||+|||-+..-..
T Consensus 101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999954 34556888999999999999999999876 99999999999999999999999999886542
Q ss_pred CCCccccceeeecC
Q 010329 500 DQTQGNTSRIVGTL 513 (513)
Q Consensus 500 ~~~~~~~~~~~Gt~ 513 (513)
+. -..++||+
T Consensus 177 ~k----R~tlcgt~ 186 (281)
T KOG0580|consen 177 NK----RKTLCGTL 186 (281)
T ss_pred CC----ceeeeccc
Confidence 22 23467774
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=246.42 Aligned_cols=153 Identities=35% Similarity=0.597 Sum_probs=135.4
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCC--C----cEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPS--G----QEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~--~----~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 414 (513)
+..++..+.+.||+|.||.||+|+..+ + ..||||.+++.. .+...+|.+|..+|++++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 345667788999999999999999642 3 348999998764 455679999999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEee
Q 010329 415 EKILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D 490 (513)
..++++|||++|+|..||++.+ ....++..+.+.|+.|||+||.||++++ +|||||.+||+||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999997642 2456899999999999999999999987 99999999999999999999999
Q ss_pred ccCcccc
Q 010329 491 FGMARIF 497 (513)
Q Consensus 491 fGla~~~ 497 (513)
|||||.+
T Consensus 846 FGlArDi 852 (1025)
T KOG1095|consen 846 FGLARDI 852 (1025)
T ss_pred cchhHhh
Confidence 9999944
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-26 Score=193.64 Aligned_cols=149 Identities=30% Similarity=0.543 Sum_probs=129.6
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|...++||+|.||+|||++. +.++.||+|+++.+.. ..-....+|+.+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678999999999999994 5678999999875432 2235678999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+. .+|..+... -++.++.+....++.|+++||.|+|+++ +.||||||.|.||+.+|+.|++|||++|.++-+
T Consensus 83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 95 578777632 3567999999999999999999999987 999999999999999999999999999988643
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-25 Score=223.47 Aligned_cols=148 Identities=24% Similarity=0.346 Sum_probs=132.0
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|+..+.||+|+||+||++.. .+++.||+|.++... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688889999999999999985 458899999987532 233457888999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999843 456899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-25 Score=217.99 Aligned_cols=141 Identities=25% Similarity=0.300 Sum_probs=125.8
Q ss_pred cccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCC
Q 010329 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 426 (513)
+.||+|+||.||++.. .+++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 468899999987542 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+|.+++. ....+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 9998884 3456899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=219.91 Aligned_cols=149 Identities=28% Similarity=0.405 Sum_probs=132.9
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 58899999987542 233467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++|+|.+++. ....+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999994 3456899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-26 Score=232.80 Aligned_cols=151 Identities=34% Similarity=0.599 Sum_probs=132.8
Q ss_pred CcccccCccCceeEEEEEe-CCCc----EEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 348 STDNKLGEGGFGEVYKGVL-PSGQ----EIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~-~~~~----~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
...++||+|+||+||||.| ++|+ +||+|.+... ..+..+++.+|+.+|.+++|||+++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 4567899999999999985 4444 6899988654 4455689999999999999999999999998876 889999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
||+.|+|.++++. .+..+-.+..+.|..|||+||.|||++. ++||||.++|||+.+-..+||+|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999965 3456888999999999999999999876 9999999999999999999999999999998776
Q ss_pred Ccc
Q 010329 502 TQG 504 (513)
Q Consensus 502 ~~~ 504 (513)
.+.
T Consensus 853 ~ey 855 (1177)
T KOG1025|consen 853 KEY 855 (1177)
T ss_pred ccc
Confidence 654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-25 Score=223.51 Aligned_cols=153 Identities=22% Similarity=0.279 Sum_probs=134.1
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 415 (513)
+....++|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445578999999999999999999964 5788999998642 22234568899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||||+++|+|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999999842 35788999999999999999999987 9999999999999999999999999999
Q ss_pred ccCC
Q 010329 496 IFGV 499 (513)
Q Consensus 496 ~~~~ 499 (513)
.+..
T Consensus 191 ~~~~ 194 (370)
T cd05621 191 KMDE 194 (370)
T ss_pred eccc
Confidence 7753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=220.13 Aligned_cols=149 Identities=27% Similarity=0.337 Sum_probs=131.8
Q ss_pred cCCCcccccCccCceeEEEEEeCC--CcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPS--GQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~--~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
++|...+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998543 358999988643 223456788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999843 456899999999999999999999987 99999999999999999999999999987653
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=223.86 Aligned_cols=147 Identities=28% Similarity=0.337 Sum_probs=130.9
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|...++||+|+||.||++.. .+++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688889999999999999985 468899999986532 233467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999843 456889999999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=223.27 Aligned_cols=148 Identities=26% Similarity=0.356 Sum_probs=132.6
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|+..+.||+|+||.||+++.. +++.||||.+.... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999964 68899999987532 233456888999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999843 446899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=223.52 Aligned_cols=146 Identities=25% Similarity=0.339 Sum_probs=130.4
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.|...+.||+|+||+||+++. .+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999985 467899999986532 2334678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+++|+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999999843 346889999999999999999999987 999999999999999999999999998755
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=226.77 Aligned_cols=162 Identities=31% Similarity=0.486 Sum_probs=138.8
Q ss_pred CCCcccccCccCceeEEEEE-eCCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC------eeE
Q 010329 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------EKI 417 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~ 417 (513)
.|...+.||+|+||.||+|+ -..|+.||||...... ....+...+|+++|++++|+|||+++++-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35566889999999999999 4579999999987643 344567889999999999999999999876543 568
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC--CCC--CeEEeeccC
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEM--NPKISDFGM 493 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~--~~~--~~ki~DfGl 493 (513)
+|||||.+|||...|.+.+....|++...+.+..++..||.|||+++ |+||||||.||++- +++ .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999998888888999999999999999999999987 99999999999993 333 479999999
Q ss_pred ccccCCCCCccccceeeecC
Q 010329 494 ARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 494 a~~~~~~~~~~~~~~~~Gt~ 513 (513)
||.++++. ....++||.
T Consensus 171 Arel~d~s---~~~S~vGT~ 187 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTE 187 (732)
T ss_pred cccCCCCC---eeeeecCch
Confidence 99997655 344688884
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-25 Score=218.56 Aligned_cols=149 Identities=27% Similarity=0.372 Sum_probs=132.9
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||++... +++.||+|.++... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999964 57899999986532 233467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999843 456889999999999999999999987 99999999999999999999999999997753
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=216.58 Aligned_cols=142 Identities=27% Similarity=0.306 Sum_probs=126.3
Q ss_pred cccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCC
Q 010329 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 426 (513)
+.||+|+||.||++.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 46889999998754 2234467889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 99988843 456899999999999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=215.77 Aligned_cols=149 Identities=28% Similarity=0.368 Sum_probs=132.4
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999964 68899999986432 223457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++|+|.+++.. .+.+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999843 456899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=223.17 Aligned_cols=163 Identities=28% Similarity=0.372 Sum_probs=139.6
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCee
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~ 416 (513)
..-++|.+.++||+|.||+|+++.++ +++.+|||.+++.. .+..+..+.|-+++.... ||.++.|+.++.+.+.+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34467899999999999999999965 57789999998763 345567788888877774 99999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+.||++..+. ....+++..+..++.+|+.||+|||+++ ||+||||.+|||||.+|.+||+||||++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999954444 3467999999999999999999999998 99999999999999999999999999996
Q ss_pred cCCCCCccccceeeecC
Q 010329 497 FGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 497 ~~~~~~~~~~~~~~Gt~ 513 (513)
--.... .|+.++||+
T Consensus 518 ~m~~g~--~TsTfCGTp 532 (694)
T KOG0694|consen 518 GMGQGD--RTSTFCGTP 532 (694)
T ss_pred cCCCCC--ccccccCCh
Confidence 542222 466799996
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=222.86 Aligned_cols=158 Identities=32% Similarity=0.460 Sum_probs=134.4
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEe------CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEEE
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~------~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 411 (513)
+....++|++.+.||+|+||.||++++ ..+..||||.++... ....+.+.+|+.++..+ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 344566788999999999999999973 235689999987543 23446788999999999 8999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCC-------------------------------------------------------
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPE------------------------------------------------------- 436 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~------------------------------------------------------- 436 (513)
+++..++||||+++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999885321
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 437 -----------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 437 -----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
....++|..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 1125789999999999999999999987 99999999999999999999999999987654
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 267 ~ 267 (375)
T cd05104 267 D 267 (375)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=228.04 Aligned_cols=164 Identities=16% Similarity=0.217 Sum_probs=137.7
Q ss_pred CCCcccccCccCceeEEEEEeC-C-CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-S-GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~-~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
.|.+.+.||+|+||.||++... + ++.|++|.+..........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4788899999999999999843 3 5788888776555444567888999999999999999999999999999999999
Q ss_pred CCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCC
Q 010329 424 PNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (513)
Q Consensus 424 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 502 (513)
++|+|.+++.+. .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999888542 23456899999999999999999999987 99999999999999999999999999998764433
Q ss_pred ccccceeeec
Q 010329 503 QGNTSRIVGT 512 (513)
Q Consensus 503 ~~~~~~~~Gt 512 (513)
........||
T Consensus 225 ~~~~~~~~gt 234 (478)
T PTZ00267 225 LDVASSFCGT 234 (478)
T ss_pred cccccccCCC
Confidence 2223344555
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=184.15 Aligned_cols=103 Identities=47% Similarity=0.895 Sum_probs=78.3
Q ss_pred cccCC-C-CCcc-CCCChHHHHHHHHHHhcccccCCCCCccCCeeeeecCCCCCeEEEEEecCCCCChhhhHHHHHHHHH
Q 010329 33 YHFCS-D-TANF-TRNSTFESNLNRLLTSLPTNASRGNGFSRGFFNATAGQDPNRVYSLFLCRGDQTTNSCQNCVTFATR 109 (513)
Q Consensus 33 ~~~C~-~-~~~~-~~~s~~~~~l~~~~~~l~~~a~~~~~~~~~~~~~~~g~~~~~vy~~~qC~~D~~~~~C~~Cl~~a~~ 109 (513)
|+.|+ + .++| +++++|+++|+.||+.|..+++.. ...+|++++.|.++++|||++||++|+++.||..||+.|+.
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~--~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~ 78 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASS--SSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVA 78 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGT--T-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhc--cccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHH
Confidence 47898 4 3567 678889999999999999998632 13689999989999999999999999999999999999999
Q ss_pred HHHhcCCCCcceEEEcceeEEEEecccc
Q 010329 110 DVIGRCPVSKDTIVWYDECLLRYSNRYI 137 (513)
Q Consensus 110 ~~~~~C~~~~~~~~~~~~C~~ry~~~~f 137 (513)
++.++|+.+++|+||++.|+||||+++|
T Consensus 79 ~~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 79 NISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp CHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHHhCCCCceEEEECCCEEEEEECCCC
Confidence 9999999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=221.25 Aligned_cols=147 Identities=25% Similarity=0.361 Sum_probs=130.6
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.+|++.+.||+|+||.||+++. .+++.||||.+.... ....+.+.+|++++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688899999999999999995 458899999986532 233467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
||+++|+|.+++.. .+.+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999943 456888999999999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=216.51 Aligned_cols=141 Identities=24% Similarity=0.305 Sum_probs=125.5
Q ss_pred cccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCC
Q 010329 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 426 (513)
+.||+|+||.||++.. .+|..||+|.++.. .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999985 46889999998754 2233456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99888843 456899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=223.97 Aligned_cols=161 Identities=29% Similarity=0.497 Sum_probs=143.6
Q ss_pred chHHHHHHhcCCCcccccCccCceeEEEEEeCC-CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC
Q 010329 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (513)
Q Consensus 336 ~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 414 (513)
..++++..+.++...++||-|.||.||.|.|+. .-.||||.|+++. ...++|..|+.+|+.++|||+|+|+|+|..+.
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 345677777788888999999999999999865 4679999998765 45789999999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..|+|+|||..|+|.+||++-. +..++....+.|+.||..||+||...+ +|||||.++|+|+.++..+||+||||+
T Consensus 337 PFYIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchh
Confidence 9999999999999999997543 345778888999999999999999876 999999999999999999999999999
Q ss_pred cccCCCC
Q 010329 495 RIFGVDQ 501 (513)
Q Consensus 495 ~~~~~~~ 501 (513)
|++..+.
T Consensus 413 RlMtgDT 419 (1157)
T KOG4278|consen 413 RLMTGDT 419 (1157)
T ss_pred hhhcCCc
Confidence 9997553
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=214.46 Aligned_cols=140 Identities=26% Similarity=0.323 Sum_probs=125.1
Q ss_pred cCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCCh
Q 010329 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (513)
Q Consensus 353 Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 428 (513)
||+|+||.||++... +++.||+|.++.. .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999964 5789999998653 233446788899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 999843 456899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=222.21 Aligned_cols=146 Identities=25% Similarity=0.358 Sum_probs=130.0
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.|...++||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999985 467899999987532 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+++|+|.+++.+ .+.+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999999843 346888999999999999999999987 999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-23 Score=218.57 Aligned_cols=156 Identities=25% Similarity=0.304 Sum_probs=130.8
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
..|.+.+.||+|+||.||++... .++.|+||.... ..+.+|++++++++|+||+++++++..++..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 46888899999999999999964 478899996422 34678999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCCc
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~ 503 (513)
. ++|..++.. ....++|.+++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 243 ~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 243 R-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred C-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 5 788888743 2346999999999999999999999987 999999999999999999999999999977543332
Q ss_pred cccceeeec
Q 010329 504 GNTSRIVGT 512 (513)
Q Consensus 504 ~~~~~~~Gt 512 (513)
.....+.||
T Consensus 317 ~~~~~~~GT 325 (461)
T PHA03211 317 PFHYGIAGT 325 (461)
T ss_pred ccccccCCC
Confidence 222234555
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=215.50 Aligned_cols=151 Identities=23% Similarity=0.287 Sum_probs=132.8
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999964 5889999998642 2233456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|.+++.+ ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999843 2346899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=222.23 Aligned_cols=151 Identities=32% Similarity=0.469 Sum_probs=131.4
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
+.+...+-||.|+-|.||+|++ .++.||||+++... ..+|+-|++|+|+||+.|.|+|....-.++|||||+
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred HHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 3344567799999999999999 57899999986543 236888999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCCcc
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~~ 504 (513)
.|-|...|+ ....++......+..+||.||.|||.+. |||||||+-||||..+..+||+|||-++.+.+..+.
T Consensus 196 ~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk- 268 (904)
T KOG4721|consen 196 QGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK- 268 (904)
T ss_pred cccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhh-
Confidence 999999994 4567889999999999999999999986 999999999999999999999999999988655332
Q ss_pred ccceeeec
Q 010329 505 NTSRIVGT 512 (513)
Q Consensus 505 ~~~~~~Gt 512 (513)
..++||
T Consensus 269 --MSFaGT 274 (904)
T KOG4721|consen 269 --MSFAGT 274 (904)
T ss_pred --hhhhhh
Confidence 246776
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=210.50 Aligned_cols=149 Identities=29% Similarity=0.393 Sum_probs=130.5
Q ss_pred CCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999985 578999999886532 22334678999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++|+|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999998887532 2346899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-24 Score=213.20 Aligned_cols=142 Identities=25% Similarity=0.291 Sum_probs=125.0
Q ss_pred cccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCC
Q 010329 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 426 (513)
+.||+|+||.||++.. .+++.||+|.++.. .......+.+|++++..++|+||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999985 46889999998753 2233456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 99988843 4568999999999999999999997 45 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=221.50 Aligned_cols=158 Identities=28% Similarity=0.401 Sum_probs=134.6
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCC-CCCccceeeEE
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQ-HRNLVRLLGFC 410 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~ 410 (513)
.++...++|.+.++||+|+||.||+|... .+..||||+++.... ...+.+.+|+.+++++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34556778899999999999999999852 134699999975433 33467999999999996 99999999999
Q ss_pred EeCCeeEEEEecCCCCChhhhhcCCC------------------------------------------------------
Q 010329 411 LEGEEKILVYEFVPNKSLDYFLYDPE------------------------------------------------------ 436 (513)
Q Consensus 411 ~~~~~~~lv~ey~~~gsL~~~l~~~~------------------------------------------------------ 436 (513)
.+....++||||+++|+|.++|+...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999998885321
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCc
Q 010329 437 ---------------------------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (513)
Q Consensus 437 ---------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~N 477 (513)
....+++..+..++.||++||.|||+.+ |+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence 0124788899999999999999999987 9999999999
Q ss_pred EEECCCCCeEEeeccCccccCC
Q 010329 478 ILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 478 ill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++++.+||+|||+++.+..
T Consensus 268 ill~~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMH 289 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccc
Confidence 9999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=220.48 Aligned_cols=150 Identities=24% Similarity=0.279 Sum_probs=131.8
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
..++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3457888999999999999999864 5789999998643 22234567889999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++|+|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999843 35788888999999999999999987 9999999999999999999999999998775
Q ss_pred C
Q 010329 499 V 499 (513)
Q Consensus 499 ~ 499 (513)
.
T Consensus 194 ~ 194 (370)
T cd05596 194 A 194 (370)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=221.44 Aligned_cols=149 Identities=32% Similarity=0.451 Sum_probs=134.0
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
-|++++.||+|+-|.|-.|+. .+|+.+|||.+... .......+.+|+.+|+.+.||||++|++++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 467889999999999999994 67999999998654 22334568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|+++|.|.++| ...+++++.+..+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|.+-.++
T Consensus 93 yv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999 45678999999999999999999999877 999999999999999999999999999876544
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=215.45 Aligned_cols=151 Identities=24% Similarity=0.313 Sum_probs=133.7
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||++.. .+++.||+|.++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999985 468899999987542 234467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998542 346899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=218.83 Aligned_cols=155 Identities=21% Similarity=0.262 Sum_probs=135.1
Q ss_pred HHHHHHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC
Q 010329 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (513)
Q Consensus 338 ~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 413 (513)
..++...++|...+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344556688999999999999999999964 5788999998642 222345678899999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999999843 35788889999999999999999987 99999999999999999999999999
Q ss_pred ccccCC
Q 010329 494 ARIFGV 499 (513)
Q Consensus 494 a~~~~~ 499 (513)
++.+..
T Consensus 189 a~~~~~ 194 (371)
T cd05622 189 CMKMNK 194 (371)
T ss_pred eeEcCc
Confidence 987753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=220.77 Aligned_cols=157 Identities=31% Similarity=0.474 Sum_probs=133.5
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEe------CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEEE
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~------~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 411 (513)
+....++|.+.+.||+|+||.||++.. .++..||+|+++... ....+.+.+|+.+++.+ +|+||+++++++.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 345566888999999999999999874 223579999997543 23345788999999999 8999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCC-------------------------------------------------------
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPE------------------------------------------------------- 436 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~------------------------------------------------------- 436 (513)
..+..++||||+++|+|.++++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999999885321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 437 ------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 437 ------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
....+++..+.+|+.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 1134788999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=217.03 Aligned_cols=151 Identities=26% Similarity=0.372 Sum_probs=134.6
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||++... +++.||||.++... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999964 68899999987532 234567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999954 357899999999999999999999977 999999999999999999999999999977544
Q ss_pred C
Q 010329 501 Q 501 (513)
Q Consensus 501 ~ 501 (513)
.
T Consensus 155 ~ 155 (350)
T cd05573 155 K 155 (350)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=214.22 Aligned_cols=151 Identities=22% Similarity=0.261 Sum_probs=132.3
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999964 5788999998652 2223456888999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999542 346899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=213.42 Aligned_cols=148 Identities=24% Similarity=0.339 Sum_probs=129.4
Q ss_pred CCCcccccCccCceeEEEEEe----CCCcEEEEEEecccC----ccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCee
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSASS----GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~----~~~~~VavK~l~~~~----~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~ 416 (513)
+|++.+.||+|+||.||+++. .+++.||+|.+.... ....+.+.+|+.++..++ |+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 357899999986532 223456788999999995 99999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999843 456899999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 010329 497 FGV 499 (513)
Q Consensus 497 ~~~ 499 (513)
+..
T Consensus 155 ~~~ 157 (332)
T cd05614 155 FLS 157 (332)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=212.57 Aligned_cols=142 Identities=28% Similarity=0.415 Sum_probs=124.8
Q ss_pred cccCccCceeEEEEEe----CCCcEEEEEEecccC----ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 351 NKLGEGGFGEVYKGVL----PSGQEIAVKRLSASS----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~----~~~~~VavK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+.||+|+||.||++.. ..++.||+|.++... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357889999987532 22335678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++++|.+++. ..+.+.+.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 99999999884 3456888899999999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=205.52 Aligned_cols=149 Identities=30% Similarity=0.484 Sum_probs=129.7
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecc--cCccCHHHHHHHHHHHHhCCCCCccceeeEEEe-----CCee
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSA--SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-----GEEK 416 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~~~~ 416 (513)
..|...+.||+|+||.|.++.. .+|+.||||++.. .+....++-.+|+++|+.++|+||+.++++... -...
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4555578899999999999995 4689999999974 344456788999999999999999999999876 2468
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
|+|+|+| ..+|...++ .+..|+......+++||++||.|+|+.+ |+||||||+|+|++.+...||+||||||.
T Consensus 102 YiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred EEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 9999999 578999883 3445999999999999999999999987 99999999999999999999999999999
Q ss_pred cCCC
Q 010329 497 FGVD 500 (513)
Q Consensus 497 ~~~~ 500 (513)
....
T Consensus 175 ~~~~ 178 (359)
T KOG0660|consen 175 LDKF 178 (359)
T ss_pred cccc
Confidence 8654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=212.57 Aligned_cols=151 Identities=31% Similarity=0.585 Sum_probs=130.1
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCc----EEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~----~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
..+|+..+.||+|+||.||+|.+. +++ .||+|.++... ....+++.+|+.+++.++|+||++++|++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356888999999999999999853 333 48999987543 33456899999999999999999999999864 577
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+++||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999998542 345889999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
..+
T Consensus 160 ~~~ 162 (316)
T cd05108 160 GAD 162 (316)
T ss_pred cCC
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=213.08 Aligned_cols=151 Identities=26% Similarity=0.351 Sum_probs=132.9
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
..++|+..++||+|+||.||++... ++..+++|.+.... ....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3468899999999999999999965 57788999877542 233467899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||+++++|.+++.. .+.+++.....++.+++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 83 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999999843 446889999999999999999999753 49999999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=209.92 Aligned_cols=148 Identities=30% Similarity=0.486 Sum_probs=121.6
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe-----eEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-----KILV 419 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-----~~lv 419 (513)
.|...+++|.|+||.||+|.+. ++++||||++-.+.. .-.+|+++|++++|||||+|+-++....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566789999999999999964 468999999865543 22458999999999999999988875432 3489
Q ss_pred EecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC-CCeEEeeccCcccc
Q 010329 420 YEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIF 497 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGla~~~ 497 (513)
|||||. +|.+++++. ..+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||+|||-|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999984 688877532 12456777888889999999999999976 9999999999999976 89999999999999
Q ss_pred CCCC
Q 010329 498 GVDQ 501 (513)
Q Consensus 498 ~~~~ 501 (513)
..+.
T Consensus 177 ~~~e 180 (364)
T KOG0658|consen 177 VKGE 180 (364)
T ss_pred ccCC
Confidence 6554
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=208.17 Aligned_cols=148 Identities=28% Similarity=0.450 Sum_probs=129.3
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|...++||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999864 678999999875432 2345778999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++ +|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 974 89888743 2345789999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=216.02 Aligned_cols=144 Identities=29% Similarity=0.444 Sum_probs=125.7
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
+|+..++||+|+||.||++... +++.||||.+..... ...+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556788999999999999964 688999999865432 33467899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++|+|.... ..++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999985432 3567788899999999999999987 99999999999999999999999999987653
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=215.47 Aligned_cols=148 Identities=25% Similarity=0.358 Sum_probs=131.9
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|+..+.||+|+||.||++... +++.||+|.++.. .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999864 5889999998753 2234567888999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999843 456899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=210.82 Aligned_cols=144 Identities=28% Similarity=0.296 Sum_probs=126.6
Q ss_pred cccCccCceeEEEEEe----CCCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 351 NKLGEGGFGEVYKGVL----PSGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~----~~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
+.||+|+||.||++.. .+|+.+|+|.++.... .....+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3578999999875422 233567789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 9999999843 456899999999999999999999987 999999999999999999999999999876433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=206.98 Aligned_cols=149 Identities=30% Similarity=0.509 Sum_probs=131.2
Q ss_pred hcCCCcccccCccCceeEEEEEeC----CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~----~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+.++.+++||||++++|++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356788899999999999999853 356899999876532 334578999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998542 346899999999999999999999887 999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.8e-24 Score=211.25 Aligned_cols=141 Identities=26% Similarity=0.347 Sum_probs=124.0
Q ss_pred cccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 5788999998754 223345678888888776 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 99988884 3456899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=211.85 Aligned_cols=151 Identities=26% Similarity=0.317 Sum_probs=133.3
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.++|+..+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467888999999999999999964 57889999887542 2334679999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||+++++.+||+|||+++.+..
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999843 346899999999999999999999853 499999999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=206.13 Aligned_cols=154 Identities=33% Similarity=0.568 Sum_probs=139.1
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.+..+|...++||+|+||.||+|...++..+++|.+..........+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567888899999999999999988889999999887665556789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+++++|.+++.+. ....+++..+..++.+|+.||.|||+.+ ++||||||+||++++++.+||+|||++..+..
T Consensus 83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 83 LMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999653 3456899999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-24 Score=207.00 Aligned_cols=149 Identities=26% Similarity=0.390 Sum_probs=130.5
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|.+.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999975 57889999987542 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|++++++..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999887765542 2346899999999999999999999887 99999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=211.75 Aligned_cols=150 Identities=21% Similarity=0.252 Sum_probs=131.1
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.++||+|+||.||++... .++.+|+|.+... .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999965 4678999998642 2223356888999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++|+|.+++.+ ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999953 2346899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-24 Score=216.04 Aligned_cols=157 Identities=28% Similarity=0.431 Sum_probs=133.9
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCC-CCCccceeeEEE
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQ-HRNLVRLLGFCL 411 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~ 411 (513)
++...++|.+.++||+|+||.||+|++. .+..||+|+++.... ...+.+.+|+.++.++. |+||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4556677888999999999999999863 245799999976432 23457889999999997 999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCC-------------------------------------------------------
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPE------------------------------------------------------- 436 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~------------------------------------------------------- 436 (513)
..+..++|+||+++|+|.++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986421
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCC
Q 010329 437 ----------------------------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476 (513)
Q Consensus 437 ----------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~ 476 (513)
....+++.....|+.||+.||.|||+.+ |+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 1124678889999999999999999876 999999999
Q ss_pred cEEECCCCCeEEeeccCccccCC
Q 010329 477 NILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 477 Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++++.+||+|||+++.+..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~ 291 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMR 291 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccc
Confidence 99999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=210.67 Aligned_cols=141 Identities=27% Similarity=0.343 Sum_probs=124.7
Q ss_pred cccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||.||++... +++.||+|.++... ....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999964 57899999997532 23345688899999988 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 99998884 3456999999999999999999999987 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=206.15 Aligned_cols=152 Identities=34% Similarity=0.509 Sum_probs=131.3
Q ss_pred cCCCcccccCccCceeEEEEEe-----CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-----~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
+.|++.++||+|+||.||+|.+ ..+..|++|.++... .....++.+|+.+++.++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567789999999999999984 245789999987533 3344678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC
Q 010329 419 VYEFVPNKSLDYFLYDPE--------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~ 484 (513)
+|||+++++|.+++.... ....+++.+.+.++.|++.||.|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999984221 1235889999999999999999999987 99999999999999999
Q ss_pred CeEEeeccCccccCC
Q 010329 485 NPKISDFGMARIFGV 499 (513)
Q Consensus 485 ~~ki~DfGla~~~~~ 499 (513)
.+||+|||+++....
T Consensus 162 ~~kl~dfg~~~~~~~ 176 (283)
T cd05090 162 HVKISDLGLSREIYS 176 (283)
T ss_pred cEEeccccccccccC
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=210.29 Aligned_cols=146 Identities=29% Similarity=0.366 Sum_probs=127.1
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCC-CccceeeEEEeCCeeEEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHR-NLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lv~ 420 (513)
+|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999964 4678999998753 223446788899999999765 5888999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999998884 3456899999999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=227.17 Aligned_cols=156 Identities=29% Similarity=0.427 Sum_probs=135.7
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeCCC-cEEEEEEecccCccCHHHHHHHHHHHHhCC-CCCccceeeE-EEe----
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSG-QEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGF-CLE---- 412 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~-~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~-~~~---- 412 (513)
+++...++++.+.|.+|+|+.||.++...+ .++|+|++-..++...+.+.+|+++|++|+ |+|||.+++. ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 345556778889999999999999997665 999999998778888899999999999998 9999999993 322
Q ss_pred --CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEee
Q 010329 413 --GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (513)
Q Consensus 413 --~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D 490 (513)
.-+.+|.||||++|+|-++|..... ..|++.++++|+.++++|+.+||... ++|||||||-+||||+.+++.||+|
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence 1367899999999999999965433 34999999999999999999999974 7899999999999999999999999
Q ss_pred ccCcccc
Q 010329 491 FGMARIF 497 (513)
Q Consensus 491 fGla~~~ 497 (513)
||-|.-.
T Consensus 190 FGSatt~ 196 (738)
T KOG1989|consen 190 FGSATTK 196 (738)
T ss_pred ccccccc
Confidence 9988633
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=209.66 Aligned_cols=142 Identities=28% Similarity=0.373 Sum_probs=124.2
Q ss_pred cccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||.||+|+.. +++.||+|.++... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 57899999987542 23345677888888866 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 999988843 456899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=210.61 Aligned_cols=144 Identities=28% Similarity=0.385 Sum_probs=124.6
Q ss_pred CCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHH---HhCCCCCccceeeEEEeCCeeEEE
Q 010329 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLV---AKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
|.+.+.||+|+||.||++... +++.||||.++... ....+.+.+|++++ ..++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999864 68899999987532 22345566676654 567899999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|||+++++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999988873 346899999999999999999999987 999999999999999999999999998854
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=207.18 Aligned_cols=148 Identities=30% Similarity=0.473 Sum_probs=129.3
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|...+.||+|+||.||+|... +++.||||.++.... .....+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 57888999999999999999964 688999999875432 2234678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++ ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 85 VH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 96 677777743 2356889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=214.85 Aligned_cols=142 Identities=23% Similarity=0.308 Sum_probs=126.0
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
..+|+..++||+|+||.||++.. ..++.||+|.... +.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 45799999999999999999995 4678999996532 3578899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+. ++|..++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 95 688888743 346899999999999999999999987 9999999999999999999999999998653
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=208.96 Aligned_cols=142 Identities=30% Similarity=0.411 Sum_probs=121.8
Q ss_pred cccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHh-CCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAK-LQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||.||++... +++.||+|.++... ....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 57889999987532 2233455666666665 4899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|+|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999988843 346899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=203.07 Aligned_cols=153 Identities=30% Similarity=0.498 Sum_probs=136.6
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
...++|+..+.||+|++|.||++...+++.|++|.++... ...+++.+|+.++++++|+||+++++++...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3456788899999999999999998778889999987643 345679999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999985432 346899999999999999999999987 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=205.21 Aligned_cols=150 Identities=31% Similarity=0.560 Sum_probs=131.9
Q ss_pred cCCCcccccCccCceeEEEEEe-----CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--CeeE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKI 417 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-----~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~ 417 (513)
++|++.+.||+|+||.||++.. .+++.|++|.+........+.+.+|+++++.++|+||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677889999999999999974 25778999998876666667899999999999999999999987643 4678
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+|+||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998532 346899999999999999999999987 999999999999999999999999999977
Q ss_pred CC
Q 010329 498 GV 499 (513)
Q Consensus 498 ~~ 499 (513)
..
T Consensus 159 ~~ 160 (284)
T cd05081 159 PQ 160 (284)
T ss_pred cC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=209.25 Aligned_cols=141 Identities=29% Similarity=0.368 Sum_probs=121.5
Q ss_pred cccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHH-HHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVV-LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||+||++.. .+|+.+|+|.+.... ....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4689999999999985 468899999986532 222345555554 56789999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 99988884 3456899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=201.84 Aligned_cols=148 Identities=32% Similarity=0.509 Sum_probs=132.3
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
++|...+.||+|+||.||++.+.++..+++|.++... ...+.+.+|+.++++++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577788999999999999998888899999886443 334678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 99999998542 246899999999999999999999987 9999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=208.71 Aligned_cols=141 Identities=28% Similarity=0.369 Sum_probs=121.3
Q ss_pred cccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHH-HHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVV-LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||+||++... +++.||+|.+.... ....+++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999964 68899999986532 122344555544 56789999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999998843 456899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=203.34 Aligned_cols=144 Identities=31% Similarity=0.475 Sum_probs=123.1
Q ss_pred cccCccCceeEEEEEeCC---CcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCC
Q 010329 351 NKLGEGGFGEVYKGVLPS---GQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~---~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 426 (513)
++||+|+||.||+|...+ ...+++|.+..... .....+.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997543 34688888765432 23457889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 427 SLDYFLYDPEK--QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 427 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+|.+++..... ....++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 99999965332 234578888999999999999999987 999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=201.77 Aligned_cols=149 Identities=28% Similarity=0.446 Sum_probs=134.1
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.++|+..+.||+|+||.||+|+. .+++.|++|.+..........+.+|+.++.+++|+||+++++.+..++..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45788899999999999999995 56788999998765544556788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999998843 356899999999999999999999886 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-24 Score=204.87 Aligned_cols=145 Identities=42% Similarity=0.685 Sum_probs=126.0
Q ss_pred cccccCccCceeEEEEEeC-----CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 349 TDNKLGEGGFGEVYKGVLP-----SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 349 ~~~~Lg~G~fG~Vy~~~~~-----~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
..+.||+|.||.||+|.+. .+..|+||.++... ....++|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999976 25689999996643 33468899999999999999999999999988889999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+++|+|.++|... ....+++..+..|+.||++||.|||+++ ++|+||+++||++++++.+||+|||+++..
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999999653 2456899999999999999999999987 999999999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=205.09 Aligned_cols=143 Identities=16% Similarity=0.316 Sum_probs=125.5
Q ss_pred cccCccCceeEEEEEeCCCcEEEEEEecccCccC---HHHHHHHHHHHHhCCCCCccceeeEEEe----CCeeEEEEecC
Q 010329 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQG---AQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVYEFV 423 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~ey~ 423 (513)
..|++|++|.||+|.+ +|+.||||.++...... .+.|.+|+.+|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999997654333 4678899999999999999999999977 34678999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++|+|.+++.. ...++|.....++.+++.||.|||+.. +++||||||+|||+++++.+||+|||+++.+..
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999953 356899999999999999999999742 278999999999999999999999999997643
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=208.63 Aligned_cols=141 Identities=30% Similarity=0.426 Sum_probs=123.8
Q ss_pred cccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||.||++... +++.||+|.++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999964 5789999998753 223445677888888876 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 999988843 456899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=203.41 Aligned_cols=152 Identities=33% Similarity=0.532 Sum_probs=135.6
Q ss_pred HhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
..++|++.++||+|+||.||+|...++..|++|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 345788899999999999999998888899999886543 3357899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999998542 3456889999999999999999999876 99999999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=213.27 Aligned_cols=163 Identities=25% Similarity=0.396 Sum_probs=140.6
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe-eEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-KILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-~~lv~ 420 (513)
++|...+++|+|+||.++..+.+ ++..+++|++... .....+...+|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46788899999999999988743 5678999987654 33334577899999999999999999999999988 99999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+|++||+|.+.+.+.+ ...++++.+..++.|++.|+.|||++. |+|||||+.||++..+..+||.|||+|+.+.++
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999996543 567899999999999999999999776 999999999999999999999999999999876
Q ss_pred CCccccceeeecC
Q 010329 501 QTQGNTSRIVGTL 513 (513)
Q Consensus 501 ~~~~~~~~~~Gt~ 513 (513)
.. .....+||+
T Consensus 160 ~~--~a~tvvGTp 170 (426)
T KOG0589|consen 160 DS--LASTVVGTP 170 (426)
T ss_pred hh--hhheecCCC
Confidence 63 234578875
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=210.32 Aligned_cols=161 Identities=29% Similarity=0.423 Sum_probs=139.9
Q ss_pred HhcCCCcccccCccCceeEEEEEeCC-CcEEEEEEecccCc---cCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~ 417 (513)
....|.+.+.||+|.||.||+++.+. |+.+|+|.+.+... ...+.+.+|+.+|+++. ||||+.+.+.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34578888999999999999999654 99999999976543 23468999999999998 999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC----CCeEEeeccC
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----MNPKISDFGM 493 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~----~~~ki~DfGl 493 (513)
+|||++.+|.|.+.+... .+++.....++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998543 3999999999999999999999987 9999999999999533 4799999999
Q ss_pred ccccCCCCCccccceeeecC
Q 010329 494 ARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 494 a~~~~~~~~~~~~~~~~Gt~ 513 (513)
+.+... ......++||+
T Consensus 186 a~~~~~---~~~~~~~~Gtp 202 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTP 202 (382)
T ss_pred ceEccC---CceEeeecCCc
Confidence 999976 22345678875
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.2e-24 Score=222.13 Aligned_cols=169 Identities=20% Similarity=0.265 Sum_probs=137.6
Q ss_pred HHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC---
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE--- 414 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 414 (513)
+...++|.+.+.||+|+||+||++.. .+++.||||.+... .......+.+|+.++..++|+||++++..+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999984 56899999998654 2334567889999999999999999988775433
Q ss_pred -----eeEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEE
Q 010329 415 -----EKILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488 (513)
Q Consensus 415 -----~~~lv~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki 488 (513)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 3579999999999999986422 3456899999999999999999999987 999999999999999999999
Q ss_pred eeccCccccCCCCCccccceeeec
Q 010329 489 SDFGMARIFGVDQTQGNTSRIVGT 512 (513)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~~Gt 512 (513)
+|||+++.+.............||
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt 208 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGT 208 (496)
T ss_pred EecccCeeccccccccccccccCC
Confidence 999999987543332222234454
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=203.66 Aligned_cols=145 Identities=32% Similarity=0.420 Sum_probs=126.3
Q ss_pred cCccCceeEEEEEeC-CCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCCh
Q 010329 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (513)
Q Consensus 353 Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 428 (513)
||+|+||+||++... +++.+|+|.+..... ...+.+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999854 688999999865322 2335678899999999999999999999999999999999999999
Q ss_pred hhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 429 DYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 429 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 8887532 23456899999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=210.66 Aligned_cols=146 Identities=25% Similarity=0.473 Sum_probs=125.9
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC-----eeE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKI 417 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~ 417 (513)
+|++.++||+|+||.||+|.. .+++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999995 46889999998743 2233457889999999999999999999886533 479
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+||||++ ++|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888884 3446899999999999999999999987 999999999999999999999999999865
Q ss_pred C
Q 010329 498 G 498 (513)
Q Consensus 498 ~ 498 (513)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=205.57 Aligned_cols=154 Identities=30% Similarity=0.555 Sum_probs=132.0
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 414 (513)
+..++|+..+.||+|+||.||+|... .+..||+|++.... .....++.+|+.+++.++|+||+++++++.++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35677899999999999999999753 24679999886432 233457899999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeE
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEK-------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 487 (513)
..++||||+++++|.+++.+... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999999854221 234688899999999999999999976 99999999999999999999
Q ss_pred EeeccCccccC
Q 010329 488 ISDFGMARIFG 498 (513)
Q Consensus 488 i~DfGla~~~~ 498 (513)
|+|||+++.+.
T Consensus 160 l~dfg~~~~~~ 170 (277)
T cd05062 160 IGDFGMTRDIY 170 (277)
T ss_pred ECCCCCccccC
Confidence 99999998664
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=208.70 Aligned_cols=147 Identities=28% Similarity=0.345 Sum_probs=126.8
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
+|...+.||+|+||.||++... +++.||+|.++... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677899999999999999864 56799999987542 22334567788888777 5899999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999988843 356899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-23 Score=233.93 Aligned_cols=143 Identities=27% Similarity=0.529 Sum_probs=123.6
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
...+...+.||+|+||.||+|+. .++..||||+++..... ..+|++.+++++||||++++|++.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 45677788999999999999996 57889999998754322 23468899999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+++|+|.++++ .++|.++.+|+.||++||+|||....++|+||||||+||+++.++..++. ||.....
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 99999999993 38999999999999999999997656679999999999999999988875 6666543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=201.48 Aligned_cols=149 Identities=33% Similarity=0.594 Sum_probs=132.1
Q ss_pred cCCCcccccCccCceeEEEEEeCC----CcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~----~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
++|+..+.||+|+||.||+|.+.. ...|+||.++.... ....+|.+|+.++++++|+||+++++.+.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999999742 35799998875432 3346789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|||+++++|.+++... .+.+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998542 347899999999999999999999977 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=200.89 Aligned_cols=149 Identities=30% Similarity=0.482 Sum_probs=132.6
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
++|...+.||+|+||.||++...++..+|+|.++... ...+++.+|+.++.+++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577788999999999999998777789999987543 334679999999999999999999999999889999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+|+|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 99999998542 236899999999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-25 Score=217.26 Aligned_cols=156 Identities=33% Similarity=0.452 Sum_probs=135.6
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.|...+.||.|+||.||-++. .+.+.||||++.-. +.+.++++..|+..|.+++|||++.+.|++......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 466678999999999999995 46788999998754 34557889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
||- ||-.+++.- ...++.+..+..|..+.+.||.|||+.+ .||||||+.|||+.+.+.+||+|||-|.+..+.+
T Consensus 107 YCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 107 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred HHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 994 677777732 3457889999999999999999999987 8999999999999999999999999999886554
Q ss_pred CccccceeeecC
Q 010329 502 TQGNTSRIVGTL 513 (513)
Q Consensus 502 ~~~~~~~~~Gt~ 513 (513)
.++||+
T Consensus 181 ------sFvGTP 186 (948)
T KOG0577|consen 181 ------SFVGTP 186 (948)
T ss_pred ------cccCCc
Confidence 367765
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=204.51 Aligned_cols=150 Identities=30% Similarity=0.390 Sum_probs=130.9
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.|+..+.||+|+||+||++.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 367788999999999999996 4688999999875321 223457789999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999888542 2346899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=211.98 Aligned_cols=152 Identities=30% Similarity=0.466 Sum_probs=135.2
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
...|.+...||+|.|++|..++. ..+.+||||.+.+..- ...+.+.+|+++|+.++|||||+++.+......+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 35688899999999999999994 4689999999877532 33456899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||..+|.+.+++. +.+...+.....+..|+..+++|||++. |+|||||++||||+.++++||+|||++.++...
T Consensus 135 eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999994 3455666888889999999999999998 999999999999999999999999999999754
Q ss_pred C
Q 010329 501 Q 501 (513)
Q Consensus 501 ~ 501 (513)
.
T Consensus 209 ~ 209 (596)
T KOG0586|consen 209 L 209 (596)
T ss_pred c
Confidence 4
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=207.58 Aligned_cols=141 Identities=30% Similarity=0.379 Sum_probs=120.6
Q ss_pred cccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHH-HHHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~-~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||.||+++.. +++.||+|.+.... ......+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 57899999986532 12234455554 467889999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+|...+. ....+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 99988884 3456888889999999999999999887 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=208.02 Aligned_cols=147 Identities=27% Similarity=0.355 Sum_probs=127.1
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ 420 (513)
+|...+.||+|+||.||++.. .+++.||+|.+.... ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 366778999999999999985 468899999987532 233456788888888886 577888999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||+++|+|.+++. ....+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999999884 3456999999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=206.11 Aligned_cols=153 Identities=31% Similarity=0.492 Sum_probs=130.8
Q ss_pred hcCCCcccccCccCceeEEEEEeCC---------------CcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcccee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPS---------------GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLL 407 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~---------------~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~ 407 (513)
.++|++.++||+|+||.||++...+ ...||+|.++... ......|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578889999999999999987532 2248999987642 33346799999999999999999999
Q ss_pred eEEEeCCeeEEEEecCCCCChhhhhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcE
Q 010329 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPE---------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (513)
Q Consensus 408 g~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Ni 478 (513)
+++...+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999985421 1124789999999999999999999987 99999999999
Q ss_pred EECCCCCeEEeeccCccccCC
Q 010329 479 LLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 479 ll~~~~~~ki~DfGla~~~~~ 499 (513)
++++++.+||+|||+++.+..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~ 181 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYS 181 (295)
T ss_pred EEcCCCcEEeccccccccccc
Confidence 999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=203.51 Aligned_cols=153 Identities=33% Similarity=0.574 Sum_probs=133.7
Q ss_pred hcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
.++|.+.+.||+|+||+||++... ++..+++|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 356788899999999999999842 24568999987765555678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeE
Q 010329 418 LVYEFVPNKSLDYFLYDPE----------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 487 (513)
++|||+++++|.+++.... ....+++..+..++.|++.+|+|||+++ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999985321 2235899999999999999999999987 99999999999999999999
Q ss_pred EeeccCccccCC
Q 010329 488 ISDFGMARIFGV 499 (513)
Q Consensus 488 i~DfGla~~~~~ 499 (513)
|+|||+++....
T Consensus 161 l~dfg~~~~~~~ 172 (288)
T cd05093 161 IGDFGMSRDVYS 172 (288)
T ss_pred eccCCccccccC
Confidence 999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=225.24 Aligned_cols=150 Identities=25% Similarity=0.403 Sum_probs=131.4
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.++||+|+||.||+|... +++.||+|++..... ...+++.+|++++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999964 588999999875422 23467899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeecc
Q 010329 421 EFVPNKSLDYFLYDPE--------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG 492 (513)
||+++|+|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1234677888999999999999999987 9999999999999999999999999
Q ss_pred Ccccc
Q 010329 493 MARIF 497 (513)
Q Consensus 493 la~~~ 497 (513)
+++..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99977
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=210.85 Aligned_cols=155 Identities=28% Similarity=0.424 Sum_probs=130.0
Q ss_pred HHhcCCCcccccCccCceeEEEEEe------CCCcEEEEEEecccCc-cCHHHHHHHHHHHHhC-CCCCccceeeEEEeC
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEG 413 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~------~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 413 (513)
.+.++|.+.+.||+|+||.||+|.. .+++.||||.++.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3456789999999999999999973 3467899999976432 3346788999999999 689999999988654
Q ss_pred -CeeEEEEecCCCCChhhhhcCCCC-------------------------------------------------------
Q 010329 414 -EEKILVYEFVPNKSLDYFLYDPEK------------------------------------------------------- 437 (513)
Q Consensus 414 -~~~~lv~ey~~~gsL~~~l~~~~~------------------------------------------------------- 437 (513)
...+++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 457899999999999999853210
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 438 ---------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 438 ---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
...+++.++..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~ 231 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 231 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEeccccccccc
Confidence 124788899999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=216.81 Aligned_cols=158 Identities=27% Similarity=0.461 Sum_probs=132.3
Q ss_pred CcccccCccCceeEEEEEeC-CCcEEEEEEecc----cCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe--eEEEE
Q 010329 348 STDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSA----SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE--KILVY 420 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~----~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~--~~lv~ 420 (513)
+..++||+|+|-+||||... +|.+||--.++. .++...+.|.+|+.+|+.|+|+||++|+.+|.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34578999999999999963 467777443332 234556899999999999999999999999988665 67999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC-CCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGla~~~~~ 499 (513)
|.+..|+|..|+. +.+.++.+.+..|++||++||.|||++. |||+|||||..||+|+.+ |.+||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999994 4556889999999999999999999986 789999999999999754 7999999999999864
Q ss_pred CCCccccceeeecC
Q 010329 500 DQTQGNTSRIVGTL 513 (513)
Q Consensus 500 ~~~~~~~~~~~Gt~ 513 (513)
... ..++|||
T Consensus 199 s~a----ksvIGTP 208 (632)
T KOG0584|consen 199 SHA----KSVIGTP 208 (632)
T ss_pred ccc----ceeccCc
Confidence 332 2488886
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=205.87 Aligned_cols=141 Identities=29% Similarity=0.414 Sum_probs=122.6
Q ss_pred cccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHh-CCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAK-LQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||.||+|... +++.||||.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999964 47889999987642 2334556677777776 4899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+|.+++.+ ...+++.+...++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999999843 356899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=206.97 Aligned_cols=142 Identities=27% Similarity=0.344 Sum_probs=120.1
Q ss_pred cccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHH-HHHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~-~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||.||++... +++.||+|.+.... ......+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999964 56789999986532 12223444444 457889999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|+|.+++.. ...+.+.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 999999843 445788888899999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=204.97 Aligned_cols=154 Identities=30% Similarity=0.505 Sum_probs=131.4
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCC
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 414 (513)
+..++|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678899999999999999999753 245799998865432 23356889999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeE
Q 010329 415 EKILVYEFVPNKSLDYFLYDPE-------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 487 (513)
..++||||+++|+|.+++.+.. ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999995422 1234678889999999999999999987 99999999999999999999
Q ss_pred EeeccCccccC
Q 010329 488 ISDFGMARIFG 498 (513)
Q Consensus 488 i~DfGla~~~~ 498 (513)
|+|||+++.+.
T Consensus 160 L~Dfg~~~~~~ 170 (288)
T cd05061 160 IGDFGMTRDIY 170 (288)
T ss_pred ECcCCcccccc
Confidence 99999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=210.77 Aligned_cols=157 Identities=29% Similarity=0.443 Sum_probs=130.9
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCc-cCHHHHHHHHHHHHhC-CCCCccceeeEEEe
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE 412 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 412 (513)
+++.++|++.+.||+|+||.||+|... .++.||+|+++.... ...+.+..|+.++.++ +|+||+++++++..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 345567889999999999999999742 246899999875432 2345678899999999 79999999998875
Q ss_pred C-CeeEEEEecCCCCChhhhhcCCCC------------------------------------------------------
Q 010329 413 G-EEKILVYEFVPNKSLDYFLYDPEK------------------------------------------------------ 437 (513)
Q Consensus 413 ~-~~~~lv~ey~~~gsL~~~l~~~~~------------------------------------------------------ 437 (513)
. ...++++||+++++|.+++.....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 467899999999999998853211
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 438 ----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
...++|..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..+
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~ 226 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKD 226 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccC
Confidence 136899999999999999999999887 999999999999999999999999999987443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=207.21 Aligned_cols=141 Identities=26% Similarity=0.331 Sum_probs=124.4
Q ss_pred cccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||+||++... +++.||+|.++... ....+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57889999997542 23345688899999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+|..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 99988884 3456999999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=205.74 Aligned_cols=141 Identities=31% Similarity=0.437 Sum_probs=122.6
Q ss_pred cccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||.||++... +++.||+|.++... ....+.+..|..++... +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999964 57899999987542 23345567777777754 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999988843 456899999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=202.08 Aligned_cols=151 Identities=34% Similarity=0.612 Sum_probs=132.5
Q ss_pred cCCCcccccCccCceeEEEEEeCC------CcEEEEEEecccCcc-CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~------~~~VavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
++|.+.+.||+|+||.||+|...+ ++.|+||.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998633 478999998765443 4578999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCe
Q 010329 418 LVYEFVPNKSLDYFLYDPE-----------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 486 (513)
++|||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999985421 2345889999999999999999999987 9999999999999999999
Q ss_pred EEeeccCccccC
Q 010329 487 KISDFGMARIFG 498 (513)
Q Consensus 487 ki~DfGla~~~~ 498 (513)
||+|||+++.+.
T Consensus 162 kl~d~g~~~~~~ 173 (280)
T cd05049 162 KIGDFGMSRDVY 173 (280)
T ss_pred EECCcccceecc
Confidence 999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=203.34 Aligned_cols=153 Identities=33% Similarity=0.569 Sum_probs=133.4
Q ss_pred cCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
.+|.+.+.||+|+||.||++... ++..+++|.++.......+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777899999999999999742 345689999877665556789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC
Q 010329 419 VYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~ 485 (513)
||||+++++|.+++.... ....++|..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985421 2245899999999999999999999987 999999999999999999
Q ss_pred eEEeeccCccccCCC
Q 010329 486 PKISDFGMARIFGVD 500 (513)
Q Consensus 486 ~ki~DfGla~~~~~~ 500 (513)
+||+|||+++.....
T Consensus 162 ~~l~dfg~a~~~~~~ 176 (291)
T cd05094 162 VKIGDFGMSRDVYST 176 (291)
T ss_pred EEECCCCcccccCCC
Confidence 999999999876443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=200.21 Aligned_cols=145 Identities=34% Similarity=0.473 Sum_probs=124.4
Q ss_pred cccCccCceeEEEEEeCC---CcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCC
Q 010329 351 NKLGEGGFGEVYKGVLPS---GQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~---~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 426 (513)
+.||+|+||.||+|.+.+ +..+++|.++.... .....+.+|+.+++.++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 35789998876432 23357889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 427 SLDYFLYDPE--KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 427 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+|.+++.... .....++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999986432 2235678888899999999999999987 9999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=201.67 Aligned_cols=150 Identities=35% Similarity=0.550 Sum_probs=126.6
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCc----EEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~----~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
++|+..+.||+|+||.||+|.+. +++ .+++|.+..... ....++..|+..+++++|+||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46777889999999999999863 344 477888754432 23467888888999999999999999875 456789
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++||+++|+|.+++.. ....++|..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999954 2346899999999999999999999987 9999999999999999999999999999775
Q ss_pred CC
Q 010329 499 VD 500 (513)
Q Consensus 499 ~~ 500 (513)
++
T Consensus 161 ~~ 162 (279)
T cd05111 161 PD 162 (279)
T ss_pred CC
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=200.65 Aligned_cols=149 Identities=24% Similarity=0.283 Sum_probs=132.5
Q ss_pred cCCCcccccCccCceeEEEEEeCC-CcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
+.|++.+.||.|.-|+||.+++.+ +..+|+|.+.+.. .+...+.+.|-+||+.++||.++.|++.+..++..+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345667899999999999999854 4789999997653 334456778999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|||+||+|..+++. +..+.+++..+..++.+|+.||+|||-.| ||.|||||+||||-++|++.|+||.|+...
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999888754 55678999999999999999999999887 999999999999999999999999999876
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=210.81 Aligned_cols=155 Identities=28% Similarity=0.544 Sum_probs=134.1
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeCC---Cc--EEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS---GQ--EIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~---~~--~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 414 (513)
+..++...+.++||+|.||.||+|...+ |+ .||||.-+.+ ..+..+.|..|..+|+.++||||++|+|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 4445556677899999999999998532 32 5899998874 45567889999999999999999999999976 4
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..|+|||..+.|.|..||.. ....|+......++.||..+|.|||+.. +|||||.++|||+.+..-+|++||||+
T Consensus 464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence 68999999999999999954 3456888999999999999999999876 999999999999999999999999999
Q ss_pred cccCCCC
Q 010329 495 RIFGVDQ 501 (513)
Q Consensus 495 ~~~~~~~ 501 (513)
|.+.++.
T Consensus 539 R~~ed~~ 545 (974)
T KOG4257|consen 539 RYLEDDA 545 (974)
T ss_pred hhccccc
Confidence 9987653
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=210.21 Aligned_cols=148 Identities=26% Similarity=0.431 Sum_probs=128.4
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC-----eeE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKI 417 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~ 417 (513)
+|+..+.||+|+||.||++.. .+++.||||++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467789999999999999995 46899999998653 2233467889999999999999999999998776 789
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+|+||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 57877773 3456899999999999999999999987 999999999999999999999999999876
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
...
T Consensus 154 ~~~ 156 (372)
T cd07853 154 EPD 156 (372)
T ss_pred ccC
Confidence 533
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=198.68 Aligned_cols=149 Identities=30% Similarity=0.490 Sum_probs=132.1
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
.+|++.+.||+|+||.||++.+.++..+++|.+.... ....++.+|+.+++.++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577789999999999999998777789999886533 234578899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++|.+++... ...+++.....++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...+
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 99999998542 236899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=201.06 Aligned_cols=150 Identities=29% Similarity=0.519 Sum_probs=123.7
Q ss_pred cCCCcccccCccCceeEEEEEe--CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhC---CCCCccceeeEEEe-----
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKL---QHRNLVRLLGFCLE----- 412 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~--~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~----- 412 (513)
++|...+.||+|+||.||++.. .+++.||+|.++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688889999999999999985 246789999886542 22234566777777665 69999999999863
Q ss_pred CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeecc
Q 010329 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (513)
Q Consensus 413 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG 492 (513)
....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999996 6898888542 2345899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCC
Q 010329 493 MARIFGV 499 (513)
Q Consensus 493 la~~~~~ 499 (513)
+++....
T Consensus 156 ~~~~~~~ 162 (290)
T cd07862 156 LARIYSF 162 (290)
T ss_pred ceEeccC
Confidence 9987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-23 Score=199.24 Aligned_cols=149 Identities=32% Similarity=0.553 Sum_probs=125.1
Q ss_pred CcccccCccCceeEEEEEeCCCc---EEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC------Cee
Q 010329 348 STDNKLGEGGFGEVYKGVLPSGQ---EIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------EEK 416 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~~~~~---~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~ 416 (513)
.+.++||+|+||.||+|.+.+.. .||+|.++.. +....+.+.+|+.+++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45688999999999999975432 5899988654 234456789999999999999999999988543 246
Q ss_pred EEEEecCCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 417 ILVYEFVPNKSLDYFLYDP---EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
++++||+++|+|.+++... .....+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887422 12345899999999999999999999986 99999999999999999999999999
Q ss_pred ccccCC
Q 010329 494 ARIFGV 499 (513)
Q Consensus 494 a~~~~~ 499 (513)
++.+..
T Consensus 159 ~~~~~~ 164 (272)
T cd05075 159 SKKIYN 164 (272)
T ss_pred ccccCc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=198.42 Aligned_cols=153 Identities=34% Similarity=0.557 Sum_probs=136.9
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
...++|.+.+.||+|+||.||++..++++.|+||.+.... ...+++.+|+.++++++|+||+++++++......+++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4567888999999999999999998888899999987543 345789999999999999999999999998889999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+++++|.+++.+. ....+++.++..++.+++.||.|||+++ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999552 2346899999999999999999999987 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=201.35 Aligned_cols=141 Identities=28% Similarity=0.440 Sum_probs=121.1
Q ss_pred ccCccCceeEEEEEeCC-------------------------CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccce
Q 010329 352 KLGEGGFGEVYKGVLPS-------------------------GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~~~-------------------------~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 406 (513)
+||+|+||.||+|.+.. ...|++|.+.........+|.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588998876554445678999999999999999999
Q ss_pred eeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC--
Q 010329 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-- 484 (513)
Q Consensus 407 ~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-- 484 (513)
++++.+....++||||+++|+|..++.. ..+.+++..+..++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999853 2456899999999999999999999886 99999999999997644
Q ss_pred -----CeEEeeccCcccc
Q 010329 485 -----NPKISDFGMARIF 497 (513)
Q Consensus 485 -----~~ki~DfGla~~~ 497 (513)
.+|++|||+++..
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 3899999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-23 Score=223.30 Aligned_cols=149 Identities=27% Similarity=0.365 Sum_probs=132.7
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.++||+|+||.||+|... +++.||||.++... ......+.+|+.++..++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999965 68899999987542 222467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++++|.+++.. .+.+++..++.|+.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++....
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 99999999999843 346889999999999999999999986 99999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-23 Score=200.61 Aligned_cols=152 Identities=36% Similarity=0.587 Sum_probs=131.0
Q ss_pred cCCCcccccCccCceeEEEEEeCC------CcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~------~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
++|++.+.||+|+||.||+|.... ...|++|.++.... .....|.+|+.++.+++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 367788999999999999998633 25799998875432 33467899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC
Q 010329 418 LVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~ 484 (513)
++|||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999854211 145889999999999999999999987 99999999999999999
Q ss_pred CeEEeeccCccccCC
Q 010329 485 NPKISDFGMARIFGV 499 (513)
Q Consensus 485 ~~ki~DfGla~~~~~ 499 (513)
.+||+|||+++....
T Consensus 162 ~~~L~dfg~~~~~~~ 176 (283)
T cd05048 162 TVKISDFGLSRDIYS 176 (283)
T ss_pred cEEECCCcceeeccc
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-23 Score=202.49 Aligned_cols=154 Identities=30% Similarity=0.494 Sum_probs=131.8
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-----------------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcc
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-----------------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLV 404 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-----------------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv 404 (513)
+.++|++.++||+|+||.||++... ++..||+|.++... ....+.+.+|+.+++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3457889999999999999998532 23468999987543 33456899999999999999999
Q ss_pred ceeeEEEeCCeeEEEEecCCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCC
Q 010329 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPE--------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476 (513)
Q Consensus 405 ~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~ 476 (513)
++++++...+..+++|||+++++|.+++.+.. ....+++.+...++.||+.||.|||+.+ ++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 99999999999999999999999999986422 1234788899999999999999999987 999999999
Q ss_pred cEEECCCCCeEEeeccCccccCC
Q 010329 477 NILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 477 Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++++.+||+|||+++.+..
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred eEEEcCCCCEEeccCcccccccC
Confidence 99999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=204.10 Aligned_cols=141 Identities=32% Similarity=0.430 Sum_probs=124.2
Q ss_pred cccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||+||++... +++.||+|.++... ....+.+.+|.+++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 47899999987542 23345677888888888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+|..++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 999988843 446999999999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=199.52 Aligned_cols=148 Identities=27% Similarity=0.473 Sum_probs=132.8
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
++|...+.||+|+||.||++.. .+++.|++|.++.........+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4677788999999999999985 458899999987665445567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++++|.+++. ..+.+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 89 GGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 9999999984 3456899999999999999999999987 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=203.25 Aligned_cols=156 Identities=29% Similarity=0.482 Sum_probs=134.1
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEEEe
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE 412 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 412 (513)
+...++|+..+.||+|+||.||++... ....+++|.+.... .....++.+|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 445567888899999999999999853 23578999887542 23346788999999999 79999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEE
Q 010329 413 GEEKILVYEFVPNKSLDYFLYDP-------------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 479 (513)
Q Consensus 413 ~~~~~lv~ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nil 479 (513)
++..+++|||+++|+|..++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 99999999999999999998532 22456899999999999999999999887 999999999999
Q ss_pred ECCCCCeEEeeccCccccCC
Q 010329 480 LDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 480 l~~~~~~ki~DfGla~~~~~ 499 (513)
++.++.+||+|||+++.+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHH 184 (293)
T ss_pred EcCCCeEEeCcccccccccc
Confidence 99999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=201.36 Aligned_cols=154 Identities=29% Similarity=0.506 Sum_probs=132.9
Q ss_pred HhcCCCcccccCccCceeEEEEEeCC------CcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~------~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 415 (513)
..++|.+.+.||+|+||.||++...+ +..|++|.+.... ......+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45678888999999999999998642 3679999987543 2334578899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEE
Q 010329 416 KILVYEFVPNKSLDYFLYDPE-------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki 488 (513)
.++||||+++|+|.+++.... ....++|..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 999999999999999985422 1234789999999999999999999887 999999999999999999999
Q ss_pred eeccCccccCC
Q 010329 489 SDFGMARIFGV 499 (513)
Q Consensus 489 ~DfGla~~~~~ 499 (513)
+|||+++.+..
T Consensus 161 ~dfg~~~~~~~ 171 (277)
T cd05032 161 GDFGMTRDIYE 171 (277)
T ss_pred CCcccchhhcc
Confidence 99999986643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=201.23 Aligned_cols=154 Identities=27% Similarity=0.470 Sum_probs=133.2
Q ss_pred HhcCCCcccccCccCceeEEEEEeCC-----CcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEe-CCe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPS-----GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEE 415 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~-----~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~ 415 (513)
..++|.+.+.||+|+||.||+|...+ +..|++|+++... ....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45678889999999999999999755 6789999887542 2335678899999999999999999999876 467
Q ss_pred eEEEEecCCCCChhhhhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEee
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQ-----GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D 490 (513)
.++++||+++++|.+++...... ..+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998543222 56899999999999999999999887 99999999999999999999999
Q ss_pred ccCccccCC
Q 010329 491 FGMARIFGV 499 (513)
Q Consensus 491 fGla~~~~~ 499 (513)
||+++.+..
T Consensus 161 ~g~~~~~~~ 169 (280)
T cd05043 161 NALSRDLFP 169 (280)
T ss_pred CCCcccccC
Confidence 999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-24 Score=193.64 Aligned_cols=161 Identities=29% Similarity=0.468 Sum_probs=135.6
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC----ccCH----HHHHHHHHHHHhC-CCCCccceeeEEEeC
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS----GQGA----QEFKNEVVLVAKL-QHRNLVRLLGFCLEG 413 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~----~~~~----~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 413 (513)
-.+|...+.||.|..+.|.++.. ++|.+.|+|++.... .+.. +.-..|+.+|+++ .||+|+++.+++...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 45677778999999999988875 467889999876431 1222 3446689999998 499999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
...++|+|.|+.|.|.++|. ..-.++++...+|+.|+..|++|||..+ ||||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 99999999999999999993 4456899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCccccceeeecC
Q 010329 494 ARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 494 a~~~~~~~~~~~~~~~~Gt~ 513 (513)
+..+.++.... .++||+
T Consensus 170 a~~l~~GekLr---elCGTP 186 (411)
T KOG0599|consen 170 ACQLEPGEKLR---ELCGTP 186 (411)
T ss_pred eeccCCchhHH---HhcCCC
Confidence 99998766533 346664
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=202.42 Aligned_cols=149 Identities=28% Similarity=0.352 Sum_probs=130.7
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|+..+.||+|+||.||++... ++..+++|.+.... ......+.+|++++.+++|+||+++++++.+++..++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999854 57788899886542 23345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++++|.+++.. ...+++.....++.||++||.|||+.. +++||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 999999999943 356899999999999999999999742 39999999999999999999999999998664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-23 Score=202.38 Aligned_cols=148 Identities=28% Similarity=0.463 Sum_probs=128.8
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|...++||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999864 577899999875432 2335678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++ +|..++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 975 78777743 2345889999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=199.06 Aligned_cols=151 Identities=30% Similarity=0.500 Sum_probs=131.4
Q ss_pred HhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
..++|.+.++||+|+||.||+|...+...|++|.++... ...+.+.+|++++++++|+||+++++.+. .+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 345688999999999999999998777789999987533 23467899999999999999999999874 4567999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++|+|.+++.+. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 82 MSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred CCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 9999999999542 2346899999999999999999999987 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=203.99 Aligned_cols=155 Identities=28% Similarity=0.467 Sum_probs=132.8
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC--------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEEE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~--------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 411 (513)
+..++|.+.+.||+|+||.||+++.. ++..|++|.+.... ....+++.+|+.+++.+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44567788899999999999999741 23479999887542 33456789999999999 8999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcE
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Ni 478 (513)
.....+++|||+++|+|.+++.+... ...+++.++..++.||+.||.|||+++ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999864321 235889999999999999999999987 99999999999
Q ss_pred EECCCCCeEEeeccCccccCC
Q 010329 479 LLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 479 ll~~~~~~ki~DfGla~~~~~ 499 (513)
|+++++.+||+|||+++.+..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNN 189 (304)
T ss_pred EEcCCCcEEECCCccceeccc
Confidence 999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-24 Score=207.12 Aligned_cols=161 Identities=27% Similarity=0.443 Sum_probs=140.8
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
..|+..+.||+|.||.||||.. ..++.||+|.+... .....+++++|+.++..++++||.+++|.+..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4567778999999999999995 45788999998754 445568899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 502 (513)
+.+|++.+.| +....+++..+.-|..+++.||.|||.++ .+|||||+.|||+.++|.+|+.|||.+-.+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999999 33445588888889999999999999987 99999999999999999999999999998875554
Q ss_pred ccccceeeecC
Q 010329 503 QGNTSRIVGTL 513 (513)
Q Consensus 503 ~~~~~~~~Gt~ 513 (513)
.. ..++||+
T Consensus 167 rr--~tfvGTP 175 (467)
T KOG0201|consen 167 RR--KTFVGTP 175 (467)
T ss_pred cc--ccccccc
Confidence 33 4688886
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=198.73 Aligned_cols=151 Identities=32% Similarity=0.571 Sum_probs=131.6
Q ss_pred cCCCcccccCccCceeEEEEEeC----CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~----~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
.+|.+.+.||+|+||.||+|... .+..+++|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999853 23378999887543 23356789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999542 346899999999999999999999987 99999999999999999999999999997754
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 159 ~ 159 (267)
T cd05066 159 D 159 (267)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=198.05 Aligned_cols=151 Identities=29% Similarity=0.511 Sum_probs=128.5
Q ss_pred CCcccccCccCceeEEEEEeCC----CcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe-----
Q 010329 347 FSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE----- 415 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~~----~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~----- 415 (513)
|.+.+.||+|+||.||+|.+.. +..||+|+++... ....+.+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 3679999987542 2334678999999999999999999999877554
Q ss_pred -eEEEEecCCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeec
Q 010329 416 -KILVYEFVPNKSLDYFLYDPE---KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (513)
Q Consensus 416 -~~lv~ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df 491 (513)
.++++||+++|+|..++.... ....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999998885432 2346899999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCC
Q 010329 492 GMARIFGVD 500 (513)
Q Consensus 492 Gla~~~~~~ 500 (513)
|+++.+...
T Consensus 158 g~~~~~~~~ 166 (273)
T cd05035 158 GLSKKIYSG 166 (273)
T ss_pred cceeecccc
Confidence 999976543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=201.24 Aligned_cols=153 Identities=31% Similarity=0.480 Sum_probs=132.5
Q ss_pred hcCCCcccccCccCceeEEEEEeCC-----------------CcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccc
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPS-----------------GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVR 405 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~-----------------~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 405 (513)
.++|++.++||+|+||.||++...+ +..|++|.+.... ....+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999998542 2458999987653 334568899999999999999999
Q ss_pred eeeEEEeCCeeEEEEecCCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCc
Q 010329 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPE--------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (513)
Q Consensus 406 l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~N 477 (513)
+++++..++..++++||+++++|.+++.+.. ....+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985422 1236899999999999999999999887 9999999999
Q ss_pred EEECCCCCeEEeeccCccccCC
Q 010329 478 ILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 478 ill~~~~~~ki~DfGla~~~~~ 499 (513)
|+++.++.+||+|||+++.+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred eeecCCCceEEccccceeeccc
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=198.93 Aligned_cols=151 Identities=30% Similarity=0.512 Sum_probs=133.3
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
..+|...++||+|+||.||+|... .++.|++|.++... ...+++.+|+++++.++|+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345777889999999999999964 47889999887543 3456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++++|.+++... ....+++..++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999998542 3346899999999999999999999887 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-24 Score=200.43 Aligned_cols=158 Identities=27% Similarity=0.481 Sum_probs=138.5
Q ss_pred CCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
|.+.++||+|+||.|||+.. ..|+.||||.+...+ +.+++..|+.+|...+.++||+++|.+.....+|+|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 55678999999999999985 468999999986543 578999999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCCccc
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~~~ 505 (513)
||+.++++- ++.+|.+..+..+..+.++||+|||.-. -+|||||+.|||++.+|.+||+|||.|-.+.+--...
T Consensus 113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR- 186 (502)
T KOG0574|consen 113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR- 186 (502)
T ss_pred CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh-
Confidence 999999953 4567999999999999999999999865 7899999999999999999999999999886443332
Q ss_pred cceeeecC
Q 010329 506 TSRIVGTL 513 (513)
Q Consensus 506 ~~~~~Gt~ 513 (513)
..++||+
T Consensus 187 -NTVIGTP 193 (502)
T KOG0574|consen 187 -NTVIGTP 193 (502)
T ss_pred -CccccCc
Confidence 2477775
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-23 Score=199.69 Aligned_cols=151 Identities=34% Similarity=0.569 Sum_probs=132.5
Q ss_pred cCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
+++...++||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999732 355789998887665666789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCe
Q 010329 419 VYEFVPNKSLDYFLYDPEK------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 486 (513)
++||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135899999999999999999999887 9999999999999999999
Q ss_pred EEeeccCccccC
Q 010329 487 KISDFGMARIFG 498 (513)
Q Consensus 487 ki~DfGla~~~~ 498 (513)
||+|||+++...
T Consensus 162 kL~dfg~~~~~~ 173 (280)
T cd05092 162 KIGDFGMSRDIY 173 (280)
T ss_pred EECCCCceeEcC
Confidence 999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=200.14 Aligned_cols=150 Identities=30% Similarity=0.479 Sum_probs=128.9
Q ss_pred CCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
+|.+.+.||+|+||.||+|... ....+++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999852 235688888865432 334678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCc
Q 010329 419 VYEFVPNKSLDYFLYDPE---------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~N 477 (513)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235889999999999999999999887 9999999999
Q ss_pred EEECCCCCeEEeeccCccccC
Q 010329 478 ILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 478 ill~~~~~~ki~DfGla~~~~ 498 (513)
||+++++.+||+|||+++.+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-23 Score=204.53 Aligned_cols=140 Identities=26% Similarity=0.333 Sum_probs=119.6
Q ss_pred cCccCceeEEEEEeC-CCcEEEEEEecccCc---cCHHHHHHHHHHHHhC---CCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSASSG---QGAQEFKNEVVLVAKL---QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 353 Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
||+|+||+||++... +++.||||.+..... .....+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999854 588999999864321 2223445566666655 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 99998884 3456899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=195.86 Aligned_cols=143 Identities=32% Similarity=0.511 Sum_probs=126.8
Q ss_pred cccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCCh
Q 010329 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 428 (513)
+.||+|+||.||++... +++.|++|.+.... .+....+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999964 68899999876542 33456799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 999853 2346899999999999999999999887 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=201.07 Aligned_cols=151 Identities=31% Similarity=0.494 Sum_probs=129.5
Q ss_pred CCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCcc-CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
+|.+.++||+|+||.||+|... .+..||+|+++..... ..+.+.+|+.++..++|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4566789999999999999853 2468999998755332 24568899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC
Q 010329 419 VYEFVPNKSLDYFLYDP-------------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~ 485 (513)
++||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998421 11245889999999999999999999887 999999999999999999
Q ss_pred eEEeeccCccccCC
Q 010329 486 PKISDFGMARIFGV 499 (513)
Q Consensus 486 ~ki~DfGla~~~~~ 499 (513)
+||+|||+++.+..
T Consensus 163 ~kl~Dfg~~~~~~~ 176 (283)
T cd05091 163 VKISDLGLFREVYA 176 (283)
T ss_pred eEeccccccccccc
Confidence 99999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=200.11 Aligned_cols=150 Identities=27% Similarity=0.428 Sum_probs=135.1
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.++|.+.+.||+|+||.||++... ++..+++|.++.......+.+.+|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888899999999999999964 5789999998766655667899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999998532 346899999999999999999999987 9999999999999999999999999987664
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=198.88 Aligned_cols=147 Identities=29% Similarity=0.452 Sum_probs=131.2
Q ss_pred CCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
|+..+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|+||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999965 4678899988766555567899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++|..++.+ ....+++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 999988753 2346899999999999999999999987 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-23 Score=198.24 Aligned_cols=149 Identities=32% Similarity=0.578 Sum_probs=131.1
Q ss_pred CCCcccccCccCceeEEEEEeCC-C---cEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLPS-G---QEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~~-~---~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.|++.+.||+|+||.||+|.+.. + ..|+||.++.. .....++|.+|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999999643 2 36999998754 3334568999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++++|.+++... .+.+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998542 346899999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=200.64 Aligned_cols=151 Identities=26% Similarity=0.466 Sum_probs=135.4
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
..++|...+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 346788899999999999999995 5789999999876555556778999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|+++++|.+++.+ ..+++.++..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999999842 45889999999999999999999987 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-23 Score=197.01 Aligned_cols=151 Identities=34% Similarity=0.556 Sum_probs=133.5
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
+..+.|.+.++||+|+||.||++..++++.|++|.+.... ...+.+.+|+.++++++|+||+++++++ ..+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEE
Confidence 4456788899999999999999998888999999987544 3356789999999999999999999986 4567899999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|+++++|.+++... ....+++.++..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++.+.
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 81 YMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred cCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999999998543 3456899999999999999999999887 9999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=200.46 Aligned_cols=149 Identities=26% Similarity=0.463 Sum_probs=134.3
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
..+|+..+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788889999999999999985 46889999998766555567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++++|.+++.+ ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999999842 35889999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=203.95 Aligned_cols=155 Identities=29% Similarity=0.483 Sum_probs=132.8
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeC--------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEE
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 410 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~--------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 410 (513)
++..++|.+.+.||+|+||.||++... ....+|+|.++... .....++.+|+.++.++ +|+||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 344567889999999999999999742 23469999987542 33446788999999999 799999999999
Q ss_pred EeCCeeEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCc
Q 010329 411 LEGEEKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (513)
Q Consensus 411 ~~~~~~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~N 477 (513)
...+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence 999999999999999999999964321 235899999999999999999999886 9999999999
Q ss_pred EEECCCCCeEEeeccCccccC
Q 010329 478 ILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 478 ill~~~~~~ki~DfGla~~~~ 498 (513)
||++.++.+||+|||+++.+.
T Consensus 171 ill~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIH 191 (307)
T ss_pred eEEcCCCcEEECCCccccccc
Confidence 999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=198.43 Aligned_cols=142 Identities=25% Similarity=0.441 Sum_probs=120.9
Q ss_pred ccCccCceeEEEEEeCCC---cEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCC
Q 010329 352 KLGEGGFGEVYKGVLPSG---QEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 427 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~~~~---~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gs 427 (513)
+||+|+||.||++...++ ..+++|.++... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999985433 345677665443 2345689999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 428 LDYFLYDPEK-QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 428 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
|.+++.+... ...+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 9999964322 234677788899999999999999876 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=196.04 Aligned_cols=149 Identities=33% Similarity=0.570 Sum_probs=133.9
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
.++|...+.||+|+||.||++.. .++.|++|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45678889999999999999997 478999999976543 4678999999999999999999999999989999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 999999998542 2236899999999999999999999987 9999999999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=196.76 Aligned_cols=144 Identities=28% Similarity=0.451 Sum_probs=123.9
Q ss_pred cccCccCceeEEEEEeCC-------------CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 351 NKLGEGGFGEVYKGVLPS-------------GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~-------------~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
+.||+|+||.||+|.+.. ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258889877655555568899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC-------eEEee
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-------PKISD 490 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~-------~ki~D 490 (513)
++|||+++|+|..++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988853 2346899999999999999999999987 999999999999987664 89999
Q ss_pred ccCccccCC
Q 010329 491 FGMARIFGV 499 (513)
Q Consensus 491 fGla~~~~~ 499 (513)
||++..+..
T Consensus 156 ~g~~~~~~~ 164 (262)
T cd05077 156 PGIPITVLS 164 (262)
T ss_pred CCCCccccC
Confidence 999986643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-23 Score=197.33 Aligned_cols=151 Identities=32% Similarity=0.507 Sum_probs=132.4
Q ss_pred HhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
..++|++.++||+|+||.||++...++..+++|.++.... ..+.+.+|+.++++++|+|++++++++. ....+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3456788899999999999999988888999999876433 3467999999999999999999999875 4568999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++++|.+++.+. ....+++.++..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999998542 2345899999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=199.56 Aligned_cols=150 Identities=31% Similarity=0.393 Sum_probs=133.2
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|++.+.||+|+||.||++... +++.|++|.+.... ....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999964 57899999886532 233467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999843 357899999999999999999999987 999999999999999999999999999977543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=209.72 Aligned_cols=158 Identities=23% Similarity=0.339 Sum_probs=132.5
Q ss_pred HhcCCCcccccCccCceeEEEEEeC---CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP---SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~---~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
...+|.+.+.||+|+||.||++... .+..|++|.+... +...+|++++++++|+||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3467999999999999999999753 3568999987643 2356899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||++. ++|.+++ .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99996 6788887 23457999999999999999999999987 99999999999999999999999999987765
Q ss_pred CCCccccceeeec
Q 010329 500 DQTQGNTSRIVGT 512 (513)
Q Consensus 500 ~~~~~~~~~~~Gt 512 (513)
...........||
T Consensus 238 ~~~~~~~~~~~gt 250 (392)
T PHA03207 238 HPDTPQCYGWSGT 250 (392)
T ss_pred ccccccccccccc
Confidence 4433323334454
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=198.73 Aligned_cols=148 Identities=29% Similarity=0.393 Sum_probs=129.4
Q ss_pred CCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
|+..+.||+|+||+||++.. .+++.+|+|.+.... ......+.+|+++++.++|+||+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999986 468899999986542 12234578899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 9999999888542 2346999999999999999999999887 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=197.23 Aligned_cols=155 Identities=29% Similarity=0.384 Sum_probs=133.1
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
+..++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..+++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345566666778999999999999954 5778999998876655667899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC-CCCeEEeeccCccccC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFG 498 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~~ 498 (513)
+||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999864322212378889999999999999999887 999999999999976 6799999999998664
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=198.27 Aligned_cols=150 Identities=29% Similarity=0.449 Sum_probs=134.3
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.+.|++.++||+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 456888899999999999999964 4789999998876666677899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++++|..++.+. ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999998887432 346899999999999999999999987 9999999999999999999999999987653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=198.96 Aligned_cols=151 Identities=23% Similarity=0.375 Sum_probs=132.3
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
+|++.+.||+|+||.||++... .+..|++|.++.. .......+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778899999999999999975 6889999988654 2233467899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++++|..++........+++..+..++.+++.||.|||+.. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999998854333447899999999999999999999742 39999999999999999999999999998663
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=195.84 Aligned_cols=142 Identities=28% Similarity=0.500 Sum_probs=122.8
Q ss_pred cccCccCceeEEEEEeCCCc-----------EEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 351 NKLGEGGFGEVYKGVLPSGQ-----------EIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~~-----------~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999975433 4778877654433 6789999999999999999999999988 778999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC-------CeEEeecc
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-------NPKISDFG 492 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-------~~ki~DfG 492 (513)
+||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999542 226899999999999999999999887 99999999999999888 79999999
Q ss_pred CccccCC
Q 010329 493 MARIFGV 499 (513)
Q Consensus 493 la~~~~~ 499 (513)
+++....
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9997643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=201.22 Aligned_cols=156 Identities=31% Similarity=0.488 Sum_probs=131.7
Q ss_pred ccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCC
Q 010329 350 DNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 426 (513)
.+.||+|.||+||-|.. ++|+.||||.+.+. ...+...+++|+.+|..++||.||.|.-.|++.+..++|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 47899999999999985 57999999998754 33455789999999999999999999999999999999999995 5
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC---CCeEEeeccCccccCCCCCc
Q 010329 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMARIFGVDQTQ 503 (513)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~DfGla~~~~~~~~~ 503 (513)
+..+.+... ..+.|++..-..++.||+.||.|||.++ |+|.||||+|||+.+. -.+||+|||+||++++.+..
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 665665443 3467888888889999999999999987 9999999999999644 36999999999999876543
Q ss_pred cccceeeecC
Q 010329 504 GNTSRIVGTL 513 (513)
Q Consensus 504 ~~~~~~~Gt~ 513 (513)
. .++||+
T Consensus 724 r---sVVGTP 730 (888)
T KOG4236|consen 724 R---SVVGTP 730 (888)
T ss_pred h---hhcCCc
Confidence 2 467775
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=197.33 Aligned_cols=149 Identities=34% Similarity=0.544 Sum_probs=131.2
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|+..+.||+|++|.||+|+.. +++.|++|.++... ....+.+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999964 68899999986532 22346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++ ++|.+++........+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 688888865444567999999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=193.14 Aligned_cols=143 Identities=36% Similarity=0.535 Sum_probs=127.5
Q ss_pred cccCccCceeEEEEEeCCCcEEEEEEecccCcc-CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCChh
Q 010329 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~ 429 (513)
+.||+|+||.||+|...++..+++|.++..... ....+.+|+++++.++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888899999998765432 2357889999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++.. ....+++..+..++.+++.+|.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 99853 2345899999999999999999999887 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=198.13 Aligned_cols=150 Identities=32% Similarity=0.563 Sum_probs=130.1
Q ss_pred cCCCcccccCccCceeEEEEEe-----CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--Cee
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK 416 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-----~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 416 (513)
+.|...++||+|+||.||++.+ .++..|++|.++... ....+.+.+|+.+++.++|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467788999999999999974 347789999987553 33446799999999999999999999998875 567
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+++++|.+++... ...++|..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998432 235899999999999999999999987 99999999999999999999999999997
Q ss_pred cCC
Q 010329 497 FGV 499 (513)
Q Consensus 497 ~~~ 499 (513)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=188.66 Aligned_cols=155 Identities=29% Similarity=0.355 Sum_probs=138.5
Q ss_pred HHhcCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC-----e
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----E 415 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~ 415 (513)
+..++|.+.++||+|+|..||.++ +.+++.+|+|++.-.+.++.+..++|++..++++||||++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 456789999999999999999998 6788899999998877778889999999999999999999999876544 4
Q ss_pred eEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 416 KILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
.||+++|...|||.+.+.... ++..+++.+.+.|+.+|++||++||+.. ++..||||||.|||+.+.+.++|.|||-+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999886433 4447999999999999999999999986 57999999999999999999999999988
Q ss_pred ccc
Q 010329 495 RIF 497 (513)
Q Consensus 495 ~~~ 497 (513)
...
T Consensus 177 ~~a 179 (302)
T KOG2345|consen 177 TQA 179 (302)
T ss_pred ccc
Confidence 754
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=212.81 Aligned_cols=153 Identities=36% Similarity=0.527 Sum_probs=135.4
Q ss_pred cCCCcccccCccCceeEEEEEeC--CCc--EEEEEEecccCcc-CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP--SGQ--EIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~--~~~--~VavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
+.+.+.++||+|.||.|++|.|. +|. .||||.++..... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 34456789999999999999974 343 5899999887654 56899999999999999999999999988 778899
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+|..+.|||.+.|++ .....|-......++.|||.||.||..+. +|||||.++|+||-....+||+||||.|-++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999987 55667888999999999999999999876 99999999999999999999999999999976
Q ss_pred CCC
Q 010329 500 DQT 502 (513)
Q Consensus 500 ~~~ 502 (513)
...
T Consensus 265 ned 267 (1039)
T KOG0199|consen 265 NED 267 (1039)
T ss_pred CCc
Confidence 654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=195.97 Aligned_cols=152 Identities=23% Similarity=0.433 Sum_probs=132.4
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||+|+. .+++.|+||.+... .......+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688899999999999999995 46889999987642 2233457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++++|.+++.... ....+++.....++.||++||.|||+++ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885322 2345889999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=195.58 Aligned_cols=150 Identities=33% Similarity=0.510 Sum_probs=130.6
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
.++|.+.++||+|++|.||++.+.++..+++|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35678889999999999999998777789999886543 33467899999999999999999999875 45688999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++++|.+++... ....+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999999542 2345899999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=194.40 Aligned_cols=143 Identities=33% Similarity=0.577 Sum_probs=123.6
Q ss_pred ccCccCceeEEEEEeC---CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCC
Q 010329 352 KLGEGGFGEVYKGVLP---SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 427 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~~---~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gs 427 (513)
.||+|+||.||+|.+. .+..||+|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999763 345799998876533 33467999999999999999999999875 457899999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|.+++.. ....+++..+++++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9999853 2346899999999999999999999987 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=201.19 Aligned_cols=154 Identities=30% Similarity=0.456 Sum_probs=132.8
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeC
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEG 413 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 413 (513)
...++|...+.||+|+||.||++... .+..||||.++... ....+.+.+|+.+++++ +|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44457888999999999999999741 24579999887543 23346789999999999 799999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
+..+++|||+++|+|.+++... ....+++.++..++.+|+.||.|||+++ |+|+||||+|||++.++.+||+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999998542 2234899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCC
Q 010329 494 ARIFGV 499 (513)
Q Consensus 494 a~~~~~ 499 (513)
++.+..
T Consensus 188 ~~~~~~ 193 (302)
T cd05055 188 ARDIMN 193 (302)
T ss_pred cccccC
Confidence 987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=193.89 Aligned_cols=148 Identities=34% Similarity=0.537 Sum_probs=131.5
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-----ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++..++..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999975 78899999886533 22456789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+||+++++|.+++.+ ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 345889999999999999999999987 99999999999999999999999999987644
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=194.13 Aligned_cols=152 Identities=24% Similarity=0.455 Sum_probs=134.2
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|++.+.||+|+||.||+|... +++.|++|.++.. .....+.+.+|++++++++|+||+++++.+.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999975 7899999988642 2233568899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++++|..++.+. .....+++.++..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988542 23456899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=196.98 Aligned_cols=150 Identities=31% Similarity=0.579 Sum_probs=128.8
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCc----EEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQ----EIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~----~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
.++|...++||+|+||.||+|.+ .+++ .||+|.++... ....+++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35678889999999999999985 3444 48999887543 3345678899999999999999999999875 4578
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+++||+++|+|.+++.+ ....+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999854 2346899999999999999999999987 999999999999999999999999999977
Q ss_pred CC
Q 010329 498 GV 499 (513)
Q Consensus 498 ~~ 499 (513)
..
T Consensus 160 ~~ 161 (279)
T cd05109 160 DI 161 (279)
T ss_pred cc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=195.75 Aligned_cols=144 Identities=24% Similarity=0.357 Sum_probs=127.6
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
+|+..+.||+|+||.||++.. .+++.|++|.+... .....+++.+|+.++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567788999999999999985 56789999988654 2333467899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999996543 4688889999999999999999987 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=203.70 Aligned_cols=156 Identities=28% Similarity=0.469 Sum_probs=132.4
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeC--------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEE
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 410 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~--------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 410 (513)
+....+|.+.+.||+|+||.||++... .+..|++|.++... ....+++.+|+.+++++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 344456888999999999999999742 12368999887542 23456889999999999 799999999999
Q ss_pred EeCCeeEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCc
Q 010329 411 LEGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (513)
Q Consensus 411 ~~~~~~~lv~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~N 477 (513)
...+..++++||+++|+|.+++.... ....++|.++..++.||+.||.|||+++ ++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 99999999999999999999985421 2345889999999999999999999987 9999999999
Q ss_pred EEECCCCCeEEeeccCccccCC
Q 010329 478 ILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 478 ill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++++.+||+|||+++.+..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHN 186 (334)
T ss_pred EEEcCCCcEEECCcccceeccc
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=192.88 Aligned_cols=147 Identities=39% Similarity=0.607 Sum_probs=130.8
Q ss_pred cccCccCceeEEEEEeCC----CcEEEEEEecccCcc-CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLPS----GQEIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~----~~~VavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||.||++.... +..|++|.++..... ..+.+.+|++++..++|+||+++++++..+...+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 778999998765433 367899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 426 KSLDYFLYDPEK------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 426 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++|.+++..... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999965321 367999999999999999999999987 99999999999999999999999999998765
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=199.20 Aligned_cols=153 Identities=31% Similarity=0.550 Sum_probs=132.4
Q ss_pred HhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 415 (513)
..++|+..+.||+|+||.||++... ++..|++|.++... ....+++.+|+.++++++|+||+++++++.+++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888899999999999999853 35789999987543 2334679999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCC
Q 010329 416 KILVYEFVPNKSLDYFLYDPE-------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~ 476 (513)
.++++||+++|+|.+++.+.. ....+++..++.++.|++.||.|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999985321 1234788999999999999999999987 999999999
Q ss_pred cEEECCCCCeEEeeccCccccC
Q 010329 477 NILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 477 Nill~~~~~~ki~DfGla~~~~ 498 (513)
||++++++.+||+|||+++.+.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred heEecCCCceEECccccceecc
Confidence 9999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=194.52 Aligned_cols=153 Identities=30% Similarity=0.506 Sum_probs=127.1
Q ss_pred cCCCcccccCccCceeEEEEEeC---C--CcEEEEEEecccCc-cC-HHHHHHHHHHHHhCCCCCccceeeEEEe-CCee
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP---S--GQEIAVKRLSASSG-QG-AQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEK 416 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~---~--~~~VavK~l~~~~~-~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~ 416 (513)
..|+....||+|+||.|||+.-. + ...+|+|+++.... .+ .....+|+.+++.++|+||+.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 45778889999999999999632 2 23689999876532 12 2567889999999999999999999988 7789
Q ss_pred EEEEecCCCCChhhhhc--CCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC----CCeEEee
Q 010329 417 ILVYEFVPNKSLDYFLY--DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----MNPKISD 490 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~----~~~ki~D 490 (513)
+|++||.++ +|..+++ +..+...++......|..||+.|+.|||++- |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999986 5666664 2334457899999999999999999999998 9999999999999776 8999999
Q ss_pred ccCccccCCCC
Q 010329 491 FGMARIFGVDQ 501 (513)
Q Consensus 491 fGla~~~~~~~ 501 (513)
|||+|++...-
T Consensus 180 lGlaR~~~~pl 190 (438)
T KOG0666|consen 180 LGLARLFNNPL 190 (438)
T ss_pred ccHHHHhhccc
Confidence 99999997553
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=196.50 Aligned_cols=150 Identities=29% Similarity=0.412 Sum_probs=132.0
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|+..+.||+|+||.||++... +++.|++|++.... ....+.+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999975 58899999886542 2234568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|+++++|..++. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999999888773 2346899999999999999999999977 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=200.42 Aligned_cols=150 Identities=33% Similarity=0.562 Sum_probs=128.5
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCc--EEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQ--EIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~--~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv 419 (513)
++|++.+.||+|+||.||+|.+. ++. .+++|.++... ....+.+.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46788899999999999999964 343 46788776532 33446788999999999 899999999999999999999
Q ss_pred EecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCe
Q 010329 420 YEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 486 (513)
+||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986422 1235889999999999999999999887 9999999999999999999
Q ss_pred EEeeccCcccc
Q 010329 487 KISDFGMARIF 497 (513)
Q Consensus 487 ki~DfGla~~~ 497 (513)
||+|||+++..
T Consensus 164 kl~dfg~~~~~ 174 (303)
T cd05088 164 KIADFGLSRGQ 174 (303)
T ss_pred EeCccccCccc
Confidence 99999999743
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=201.21 Aligned_cols=154 Identities=29% Similarity=0.483 Sum_probs=131.7
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC--------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEEE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~--------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 411 (513)
...++|.+.++||+|+||.||+++.. ....+++|.++... .....++.+|+.+++.+ +|+||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34457788999999999999999742 23468999887543 23456788999999999 6999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcE
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Ni 478 (513)
.....++++||+++|+|.+++.... ....++|.++..++.||+.||.|||+++ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 9999999999999999999985422 1245899999999999999999999987 99999999999
Q ss_pred EECCCCCeEEeeccCccccC
Q 010329 479 LLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 479 ll~~~~~~ki~DfGla~~~~ 498 (513)
|+++++.+||+|||+++...
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVH 185 (314)
T ss_pred EEcCCCcEEEcccccccccc
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=196.23 Aligned_cols=152 Identities=30% Similarity=0.483 Sum_probs=131.1
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEeC------C
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEG------E 414 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~------~ 414 (513)
+++.|+..+.||+|+||.||+|... +++.|++|.+.... ....++.+|+.++.++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999864 57889999886543 3456788999999998 699999999998763 3
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 578999999999999998542 3356899999999999999999999987 999999999999999999999999999
Q ss_pred cccCC
Q 010329 495 RIFGV 499 (513)
Q Consensus 495 ~~~~~ 499 (513)
+.+..
T Consensus 159 ~~~~~ 163 (272)
T cd06637 159 AQLDR 163 (272)
T ss_pred eeccc
Confidence 87643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=195.43 Aligned_cols=143 Identities=30% Similarity=0.415 Sum_probs=124.1
Q ss_pred cCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCCh
Q 010329 353 LGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (513)
Q Consensus 353 Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 428 (513)
||+|+||.||++.. .+|+.+|+|.+.... ....+.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999985 458899999986432 12234566799999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 9888542 2345899999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=195.06 Aligned_cols=152 Identities=31% Similarity=0.512 Sum_probs=134.0
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
+..++|.+.++||+|+||.||++.+.++..+++|.++... ...+.+.+|++++++++|+||+++++.+.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4567889999999999999999998778889999887543 234678999999999999999999999887 77899999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999998543 3456899999999999999999999876 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=198.91 Aligned_cols=150 Identities=31% Similarity=0.549 Sum_probs=128.6
Q ss_pred cCCCcccccCccCceeEEEEEeCC-C--cEEEEEEeccc-CccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPS-G--QEIAVKRLSAS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~-~--~~VavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv 419 (513)
++|++.+.||+|+||.||+|.+.+ + ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999998743 3 24788888753 233456789999999999 799999999999999999999
Q ss_pred EecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCe
Q 010329 420 YEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 486 (513)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985421 1235889999999999999999999987 9999999999999999999
Q ss_pred EEeeccCcccc
Q 010329 487 KISDFGMARIF 497 (513)
Q Consensus 487 ki~DfGla~~~ 497 (513)
||+|||+++..
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998744
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.4e-23 Score=196.60 Aligned_cols=145 Identities=35% Similarity=0.547 Sum_probs=128.9
Q ss_pred CCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCH--HHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGA--QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~--~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
|+..+.||+|+||+||++... +++.+|+|.+........ ....+|+.++++++|+||+++++++.+....+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999965 456899999987654332 23456999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
++++|.+++. ....+++..+..++.||++||.|||+.+ |+|+||||+||++++++.++|+|||++...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999995 4567899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=210.07 Aligned_cols=149 Identities=25% Similarity=0.445 Sum_probs=122.9
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--------
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-------- 413 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-------- 413 (513)
..++|...+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 456799999999999999999996 468899999886432 2345799999999999999999887542
Q ss_pred CeeEEEEecCCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC-CeEEeec
Q 010329 414 EEKILVYEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDF 491 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~Df 491 (513)
...++||||+++ +|.+++.. ......+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 66666532 223457899999999999999999999987 99999999999998665 7999999
Q ss_pred cCccccCC
Q 010329 492 GMARIFGV 499 (513)
Q Consensus 492 Gla~~~~~ 499 (513)
|+++.+..
T Consensus 216 Gla~~~~~ 223 (440)
T PTZ00036 216 GSAKNLLA 223 (440)
T ss_pred ccchhccC
Confidence 99997754
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=195.09 Aligned_cols=147 Identities=34% Similarity=0.581 Sum_probs=130.6
Q ss_pred CCCcccccCccCceeEEEEEeCCCcEEEEEEecccCc------cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSG------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
+|...+.||+|+||.||+|...+++.+|+|.++.... ...+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3677889999999999999988899999998864321 1235688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+||+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++...
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999843 346889999999999999999999887 9999999999999999999999999998763
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=193.91 Aligned_cols=149 Identities=31% Similarity=0.509 Sum_probs=131.5
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc-----cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG-----QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
++|...+.||+|++|.||++.. .+++++++|.+..... ...+.+.+|+.++++++|+||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999985 4688999998764321 223578899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 346889999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 010329 499 V 499 (513)
Q Consensus 499 ~ 499 (513)
.
T Consensus 156 ~ 156 (263)
T cd06625 156 T 156 (263)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-24 Score=194.84 Aligned_cols=161 Identities=29% Similarity=0.396 Sum_probs=134.1
Q ss_pred hcCCCcccccCccCceeEEEEE-eCCCcEEEEEEecc--cCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSA--SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.+.|++.+.||+|.|+.|++.. .+.|+.+++|.+.. -+..+.+++.+|+++.+.|+||||++|.....+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4567788899999999999987 45788888887643 23346788999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC---CCCeEEeeccCcccc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DfGla~~~ 497 (513)
|+|.+++|..-+- .+...++...-..+.||+++|.|+|.++ |||||+||.|+|+-+ .--+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999965552 2234677888899999999999999998 999999999999943 345899999999999
Q ss_pred CCCCCccccceeeecC
Q 010329 498 GVDQTQGNTSRIVGTL 513 (513)
Q Consensus 498 ~~~~~~~~~~~~~Gt~ 513 (513)
.+ .....+.+||+
T Consensus 164 ~~---g~~~~G~~GtP 176 (355)
T KOG0033|consen 164 ND---GEAWHGFAGTP 176 (355)
T ss_pred CC---ccccccccCCC
Confidence 72 23455678875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=196.06 Aligned_cols=150 Identities=29% Similarity=0.465 Sum_probs=131.3
Q ss_pred cCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCcc-CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
++|+....||+|+||.||+++.. +...|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56788899999999999999853 2457899988654433 3578999999999999999999999999989999
Q ss_pred EEEecCCCCChhhhhcCCCCC------CCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeec
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQ------GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df 491 (513)
+||||+++|+|.+++...... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999643322 26899999999999999999999987 999999999999999999999999
Q ss_pred cCcccc
Q 010329 492 GMARIF 497 (513)
Q Consensus 492 Gla~~~ 497 (513)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=193.78 Aligned_cols=148 Identities=34% Similarity=0.587 Sum_probs=130.3
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCcc---------CHHHHHHHHHHHHhCCCCCccceeeEEEeCCe
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQ---------GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 415 (513)
+|.+...||+|++|.||+|.. .+++.+++|.+...... ..+.+.+|+.++++++|+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467788999999999999985 45789999988654321 12568899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999943 356889999999999999999999987 9999999999999999999999999999
Q ss_pred ccCC
Q 010329 496 IFGV 499 (513)
Q Consensus 496 ~~~~ 499 (513)
.+..
T Consensus 155 ~~~~ 158 (267)
T cd06628 155 KLEA 158 (267)
T ss_pred cccc
Confidence 8763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=196.49 Aligned_cols=146 Identities=36% Similarity=0.556 Sum_probs=126.8
Q ss_pred CCcccccCccCceeEEEEEe-----CCCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeC--CeeEE
Q 010329 347 FSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL 418 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~-----~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l 418 (513)
|...+.||+|+||+||++.. .++..||+|.++.... .....+.+|++++++++|+||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988653 3577899999876432 3456788999999999999999999988764 35789
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+|||+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999843 35899999999999999999999987 9999999999999999999999999998775
Q ss_pred C
Q 010329 499 V 499 (513)
Q Consensus 499 ~ 499 (513)
.
T Consensus 159 ~ 159 (283)
T cd05080 159 E 159 (283)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=192.33 Aligned_cols=151 Identities=23% Similarity=0.372 Sum_probs=133.0
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|+..+.||+|+||.||.+.. .+++.+++|.+... +....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999884 46888999987653 334456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+++++|.+++.+. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999998543 2456899999999999999999999887 999999999999999999999999999877443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-23 Score=207.27 Aligned_cols=155 Identities=34% Similarity=0.492 Sum_probs=134.7
Q ss_pred ccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCChhh
Q 010329 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDY 430 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~ 430 (513)
.||+|.||+||-|+.. +...+|||-+........+.+.+||.+.+.|+|+|||+++|.+.+++..-+.||-+|||||..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999964 455789999988877778889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCC--CHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC-CCCCeEEeeccCccccCCCCCccccc
Q 010329 431 FLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARIFGVDQTQGNTS 507 (513)
Q Consensus 431 ~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~DfGla~~~~~~~~~~~~~ 507 (513)
+|+. +=+++ .+.+.-.+..||++||.|||++. |||||||-.||||+ -.|.+||+|||-++++. .-..-|.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcccc
Confidence 9964 33445 77888889999999999999987 99999999999995 57899999999999884 2233455
Q ss_pred eeeecC
Q 010329 508 RIVGTL 513 (513)
Q Consensus 508 ~~~Gt~ 513 (513)
.+.||+
T Consensus 735 TFTGTL 740 (1226)
T KOG4279|consen 735 TFTGTL 740 (1226)
T ss_pred ccccch
Confidence 677775
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=195.55 Aligned_cols=152 Identities=22% Similarity=0.434 Sum_probs=133.0
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|++.+.||+|+||.||++.. .+++.++||.+.... ....+++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788999999999999995 578899999876532 223467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++++|.+++... .....+++.....++.+|+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988532 23456899999999999999999999987 99999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=193.04 Aligned_cols=142 Identities=33% Similarity=0.565 Sum_probs=123.5
Q ss_pred ccCccCceeEEEEEe---CCCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCC
Q 010329 352 KLGEGGFGEVYKGVL---PSGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~---~~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 426 (513)
+||+|+||.||+|.+ .++..+++|.++.... ...+++.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999975 3567899998865432 33567899999999999999999999875 45678999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 99999843 346899999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=195.62 Aligned_cols=150 Identities=33% Similarity=0.597 Sum_probs=130.0
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCc----EEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~----~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
.+|...+.||+|+||.||+|.+. +++ .+++|.+..... ....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56778899999999999999863 233 589998876543 345678999999999999999999999987 78899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998542 345899999999999999999999976 9999999999999999999999999998775
Q ss_pred CC
Q 010329 499 VD 500 (513)
Q Consensus 499 ~~ 500 (513)
..
T Consensus 161 ~~ 162 (279)
T cd05057 161 VD 162 (279)
T ss_pred Cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=195.89 Aligned_cols=151 Identities=31% Similarity=0.623 Sum_probs=132.1
Q ss_pred hcCCCcccccCccCceeEEEEEeCC-C---cEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPS-G---QEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~-~---~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
.++|+..+.||+|+||.||+|.+.. + ..+++|.++... ....+++.+|++++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3467788999999999999999642 3 368999887542 3335678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++++|.+++.. ....+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999854 2356899999999999999999999987 9999999999999999999999999998775
Q ss_pred C
Q 010329 499 V 499 (513)
Q Consensus 499 ~ 499 (513)
.
T Consensus 159 ~ 159 (268)
T cd05063 159 D 159 (268)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=196.44 Aligned_cols=149 Identities=30% Similarity=0.399 Sum_probs=129.2
Q ss_pred CCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
|+..+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|+.+++.++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566788999999999999864 678999999865422 2234577899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 9999999888532 2345899999999999999999999876 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=194.55 Aligned_cols=147 Identities=31% Similarity=0.517 Sum_probs=128.8
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc--c--------CHHHHHHHHHHHHhCCCCCccceeeEEEeCC
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG--Q--------GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~--~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 414 (513)
+|...+.||+|+||.||+|.. .+++.|++|.++.... . ..+.+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466788999999999999985 4688999998764211 0 1246788999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999843 357899999999999999999999987 999999999999999999999999999
Q ss_pred cccC
Q 010329 495 RIFG 498 (513)
Q Consensus 495 ~~~~ 498 (513)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=192.93 Aligned_cols=151 Identities=26% Similarity=0.473 Sum_probs=135.6
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.++|...+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++|+||+++++++..+...+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467888999999999999999964 5778999998876555678899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999988542 256899999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=197.08 Aligned_cols=149 Identities=31% Similarity=0.485 Sum_probs=131.0
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQ-----GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
+|...+.||+|+||.||+|... +++.|+||.++..... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999964 6889999998765322 235677899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+ +++|.+++.+.. ..+++..+..++.||++||.|||+++ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999995422 36999999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 155 ~ 155 (298)
T cd07841 155 P 155 (298)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=191.96 Aligned_cols=151 Identities=30% Similarity=0.443 Sum_probs=133.3
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|+..+.||+|++|.||++... +++.|++|.+... .....+++.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999964 6789999988643 233457889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999998643 2456899999999999999999999886 999999999999999999999999999977543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=192.99 Aligned_cols=144 Identities=36% Similarity=0.515 Sum_probs=127.7
Q ss_pred cccCccCceeEEEEEeCC--C--cEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLPS--G--QEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~--~--~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
++||+|++|.||+|.+.+ + ..|++|.+..... ...+.+.+|+.++++++|+||+++++.+.+ ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3689999987655 556789999999999999999999999988 889999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++|.+++.+... ..++|.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999865332 56899999999999999999999987 99999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=196.36 Aligned_cols=153 Identities=33% Similarity=0.555 Sum_probs=130.9
Q ss_pred HhcCCCcccccCccCceeEEEEEeCC------CcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~------~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 415 (513)
..++|.+.+.||+|+||.||+|.+.+ +..|++|.+.... ......|.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999999743 4678999876543 2334578999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC---CeEE
Q 010329 416 KILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKI 488 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki 488 (513)
.++||||+++++|.+++.... ....++|..++.++.||+.||.|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 999999999999999985432 1235899999999999999999999987 99999999999998654 5999
Q ss_pred eeccCccccC
Q 010329 489 SDFGMARIFG 498 (513)
Q Consensus 489 ~DfGla~~~~ 498 (513)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05036 161 ADFGMARDIY 170 (277)
T ss_pred ccCccccccC
Confidence 9999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=197.39 Aligned_cols=149 Identities=26% Similarity=0.494 Sum_probs=134.5
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
++|+..+.||.|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++.+...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 5688889999999999999984 578899999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
++++|..++. ...+++.++..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+...
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999999884 235899999999999999999999987 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=197.48 Aligned_cols=145 Identities=29% Similarity=0.467 Sum_probs=129.1
Q ss_pred CCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
|.....||+|+||.||++.. .++..|+||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 34456799999999999985 45789999998765555567789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++|.+++. ...+++.....++.+|+.||.|||+.+ |+||||||+||++++++.+||+|||++..+.
T Consensus 104 ~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 104 GALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 99999883 235889999999999999999999987 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=197.04 Aligned_cols=146 Identities=23% Similarity=0.345 Sum_probs=129.7
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|...+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+.+++.++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788899999999999999964 57889999887543 223457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999943 356899999999999999999999987 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=193.77 Aligned_cols=149 Identities=34% Similarity=0.582 Sum_probs=131.0
Q ss_pred cCCCcccccCccCceeEEEEEeC-----CCcEEEEEEecccCcc-CHHHHHHHHHHHHhCCCCCccceeeEEEe--CCee
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-----SGQEIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEK 416 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-----~~~~VavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~ 416 (513)
+.|...+.||+|+||.||++.+. .+..+|||.++..... ..+.|.+|+++++.++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999853 3678999998765443 45789999999999999999999999887 5578
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
+++|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999542 235999999999999999999999987 99999999999999999999999999998
Q ss_pred cC
Q 010329 497 FG 498 (513)
Q Consensus 497 ~~ 498 (513)
+.
T Consensus 159 ~~ 160 (284)
T cd05038 159 LP 160 (284)
T ss_pred cc
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=201.80 Aligned_cols=147 Identities=31% Similarity=0.434 Sum_probs=125.3
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC-----
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----- 414 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----- 414 (513)
..++|+..+.||+|+||.||++.. ..++.||+|.+... .....+.+.+|+.+++.++|+||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 347899999999999999999985 45889999998653 2233567889999999999999999999986543
Q ss_pred -eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 415 -EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 415 -~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
..++||||+++ +|...+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999975 5655552 24788999999999999999999987 99999999999999999999999999
Q ss_pred ccccC
Q 010329 494 ARIFG 498 (513)
Q Consensus 494 a~~~~ 498 (513)
++...
T Consensus 170 a~~~~ 174 (359)
T cd07876 170 ARTAC 174 (359)
T ss_pred ccccc
Confidence 98654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-22 Score=195.55 Aligned_cols=148 Identities=29% Similarity=0.476 Sum_probs=129.5
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|...++||+|+||.||++... +++.||+|.++... ......+.+|+.+++.++|+||+++++++..+...++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999864 57899999987543 23345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++ ++|..++.+. ...+++..+..++.||++||.|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 5888888542 346889999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-22 Score=190.10 Aligned_cols=148 Identities=30% Similarity=0.481 Sum_probs=128.8
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEe-CCeeEEEEecC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFV 423 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lv~ey~ 423 (513)
++|...+.||+|+||.||++.. .+..|++|.++... ..+.+.+|+.++++++|+|++++++++.. ++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4678889999999999999987 47789999886543 34678999999999999999999998654 45689999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++++|.+++... ....+++..+..++.+|+.||.|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999998542 2345899999999999999999999987 99999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.7e-22 Score=189.26 Aligned_cols=150 Identities=25% Similarity=0.362 Sum_probs=131.8
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
+|+..++||+|+||.||++... +++.+++|.++.. .....+.+.+|+.+++.++|+||+++++.+.+++..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999854 6889999988643 2334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++++|.+++... ....+++.....++.|++.||.|||+++ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999999888532 3446889999999999999999999987 99999999999999999999999999987753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-22 Score=191.06 Aligned_cols=149 Identities=30% Similarity=0.485 Sum_probs=133.1
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|...+.||+|+||.||++... +++.|++|.++.... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999864 678999999876543 2567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999843 345889999999999999999999987 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-22 Score=196.23 Aligned_cols=145 Identities=29% Similarity=0.461 Sum_probs=119.7
Q ss_pred ccccCccCceeEEEEEeC---CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEe--CCeeEEEEecCC
Q 010329 350 DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVYEFVP 424 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~---~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~ey~~ 424 (513)
.++||+|+||.||+|... +++.+|+|.++... ....+.+|+.++++++||||+++++++.. +...++++||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 45789999986542 23567889999999999999999998865 446789999986
Q ss_pred CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE----CCCCCeEEeeccCc
Q 010329 425 NKSLDYFLYDP------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMA 494 (513)
Q Consensus 425 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~DfGla 494 (513)
++|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5777776421 12235889999999999999999999987 9999999999999 46678999999999
Q ss_pred cccCCC
Q 010329 495 RIFGVD 500 (513)
Q Consensus 495 ~~~~~~ 500 (513)
+.+...
T Consensus 160 ~~~~~~ 165 (317)
T cd07868 160 RLFNSP 165 (317)
T ss_pred eccCCC
Confidence 987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.5e-22 Score=189.49 Aligned_cols=143 Identities=36% Similarity=0.578 Sum_probs=128.5
Q ss_pred cccCccCceeEEEEEeCCCcEEEEEEecccCcc-CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCChh
Q 010329 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~ 429 (513)
++||+|+||.||++...+++.|++|.++..... ..+.+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999988765433 4568999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++.+. ...+++.....++.+++.+|.|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 998542 346889999999999999999999987 9999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=194.25 Aligned_cols=150 Identities=27% Similarity=0.451 Sum_probs=129.2
Q ss_pred hcCCCcccccCccCceeEEEEEeCC----CcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~----~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
.++|.+.++||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++|+||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4567888999999999999998643 2468999887654 3445689999999999999999999998875 55789
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++++|.+++... ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999999532 335899999999999999999999887 9999999999999999999999999998764
Q ss_pred C
Q 010329 499 V 499 (513)
Q Consensus 499 ~ 499 (513)
.
T Consensus 159 ~ 159 (270)
T cd05056 159 D 159 (270)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=192.42 Aligned_cols=148 Identities=30% Similarity=0.478 Sum_probs=127.7
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-----ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--Cee
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK 416 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 416 (513)
.+|...+.||+|+||.||++.. .++..|++|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999996 458899999875321 12245788899999999999999999988764 457
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
+++|||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999999843 345788899999999999999999987 99999999999999999999999999986
Q ss_pred cC
Q 010329 497 FG 498 (513)
Q Consensus 497 ~~ 498 (513)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-22 Score=191.71 Aligned_cols=143 Identities=34% Similarity=0.585 Sum_probs=123.1
Q ss_pred cccCccCceeEEEEEeCC-Cc--EEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLPS-GQ--EIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~-~~--~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||.||+|.+.+ +. .+++|.++... ....+.+.+|+.++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 33 46888887533 33456789999999999 799999999999999999999999999
Q ss_pred CChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeecc
Q 010329 426 KSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (513)
Q Consensus 426 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG 492 (513)
|+|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985422 1235889999999999999999999976 9999999999999999999999999
Q ss_pred Cccc
Q 010329 493 MARI 496 (513)
Q Consensus 493 la~~ 496 (513)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=200.36 Aligned_cols=149 Identities=28% Similarity=0.418 Sum_probs=127.5
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC------
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 413 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------ 413 (513)
..++|...+.||+|+||.||++.. .+++.||||.+.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 346789999999999999999985 467899999987532 22345678899999999999999999987643
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
...++++|++ +++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 788988773 346899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCC
Q 010329 494 ARIFGV 499 (513)
Q Consensus 494 a~~~~~ 499 (513)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07878 165 ARQADD 170 (343)
T ss_pred ceecCC
Confidence 997654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=189.82 Aligned_cols=154 Identities=27% Similarity=0.465 Sum_probs=136.0
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|++.+.||+|+||+||+|.. .++..+++|.+.... ....+.+.+|+++++.++|+||+++++.+..++..++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688899999999999999995 467889999986543 23557899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
+++++|.+++........+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999965433456899999999999999999999887 9999999999999999999999999998776543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=195.95 Aligned_cols=145 Identities=31% Similarity=0.456 Sum_probs=128.9
Q ss_pred CcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCC
Q 010329 348 STDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 426 (513)
.....||+|+||.||++.. .+++.|++|.+........+.+.+|+.++..++||||+++++.+..++..++++||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 3345799999999999986 468899999987655455677889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+|..++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 104 ~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 104 ALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 9998873 245899999999999999999999987 99999999999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=195.26 Aligned_cols=149 Identities=34% Similarity=0.479 Sum_probs=131.1
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|+..++||+|+||.||++... +++.|++|.+..... ...+.+.+|+++++.++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999975 578999998765322 234678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+++++|..+... ...++|..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999887732 345899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-22 Score=200.34 Aligned_cols=145 Identities=24% Similarity=0.347 Sum_probs=125.8
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
....+|.+.+.||+|+||.||+|... .++.||+|..... ....|+.++++++|+||+++++++..+...++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999964 4678999975432 2356899999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||+. ++|.+++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9995 678887743 3456899999999999999999999987 9999999999999999999999999998643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-22 Score=197.09 Aligned_cols=144 Identities=21% Similarity=0.255 Sum_probs=115.3
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeC--CCcEEEEEEeccc-----CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLP--SGQEIAVKRLSAS-----SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~--~~~~VavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 413 (513)
....++|.+.+.||+|+||+||+|... +++.||||++... .....+.|.+|+++|++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999864 5777899987533 11224568999999999999999853322 2
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCC-cCCcEEECCCCCeEEeecc
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDL-KASNILLDAEMNPKISDFG 492 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdl-k~~Nill~~~~~~ki~DfG 492 (513)
+..++||||+++++|.... ... ...++.+++++|.|||+.+ |+|||| ||+|||++.++++||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4679999999999996321 111 1457889999999999987 999999 9999999999999999999
Q ss_pred CccccCCC
Q 010329 493 MARIFGVD 500 (513)
Q Consensus 493 la~~~~~~ 500 (513)
+|+.+...
T Consensus 158 lA~~~~~~ 165 (365)
T PRK09188 158 LASVFRRR 165 (365)
T ss_pred cceecccC
Confidence 99987543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-23 Score=198.29 Aligned_cols=168 Identities=30% Similarity=0.410 Sum_probs=136.8
Q ss_pred HHhcCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccC--cc-----CHHHHHHHHHHHHhCCCCCccceeeEEEe-
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASS--GQ-----GAQEFKNEVVLVAKLQHRNLVRLLGFCLE- 412 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~--~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~- 412 (513)
...++|.+..+||+|+|+.|||+. +...+.||||+-.... .+ -.+...+|-++.+.|+||.||++++++.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 445678888999999999999998 5667889999754321 11 12345678999999999999999999864
Q ss_pred CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC---CCCCeEEe
Q 010329 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKIS 489 (513)
Q Consensus 413 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~ 489 (513)
.+..+-|+||+++.+|+.+|. ....++++.+..|+.||+.+|.||.+. ++||||-||||.||||- .-|.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 456789999999999999994 455689999999999999999999987 47899999999999994 44689999
Q ss_pred eccCccccCCCCCc-----cccceeeecC
Q 010329 490 DFGMARIFGVDQTQ-----GNTSRIVGTL 513 (513)
Q Consensus 490 DfGla~~~~~~~~~-----~~~~~~~Gt~ 513 (513)
||||+++++++... ..++..+|||
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTY 644 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTY 644 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCcee
Confidence 99999999766432 2455677775
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.6e-22 Score=193.57 Aligned_cols=148 Identities=30% Similarity=0.498 Sum_probs=129.4
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|+..+.||+|++|.||++... +++.|++|.+..... .....+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999964 678999999875432 2234577899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++ +|.+++.+. ...+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccC
Confidence 984 898888542 336899999999999999999999987 9999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-22 Score=195.62 Aligned_cols=149 Identities=34% Similarity=0.633 Sum_probs=126.4
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCc----EEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~----~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
++|+..+.||+|+||.||+|.+. +++ .|++|.+..... ....++.+|+.+++.++|+||++++|++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677889999999999999853 343 478888765432 2234788999999999999999999998754 4679
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999853 2335899999999999999999999987 9999999999999999999999999999775
Q ss_pred C
Q 010329 499 V 499 (513)
Q Consensus 499 ~ 499 (513)
.
T Consensus 161 ~ 161 (303)
T cd05110 161 G 161 (303)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=200.71 Aligned_cols=148 Identities=30% Similarity=0.433 Sum_probs=125.8
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC-----
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----- 414 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----- 414 (513)
..++|...+.||+|+||.||++.. ..++.||||++.... ....+.+.+|+.+++.++|+||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 446899999999999999999985 357899999987542 233467888999999999999999999886543
Q ss_pred -eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 415 -EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 415 -~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
..++||||+++ +|...+. ..+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999975 5666662 24889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCC
Q 010329 494 ARIFGV 499 (513)
Q Consensus 494 a~~~~~ 499 (513)
++....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=189.13 Aligned_cols=149 Identities=29% Similarity=0.464 Sum_probs=134.3
Q ss_pred hcCCCcccccCccCceeEEEEEeCC-CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.++|+..+.||+|+||.||++...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++...+..++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3578889999999999999999754 78999999875533 67899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++++|.+++.. ....+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++..+..
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999999843 2356899999999999999999999987 99999999999999999999999999997754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.4e-22 Score=194.43 Aligned_cols=160 Identities=26% Similarity=0.412 Sum_probs=134.1
Q ss_pred chHHHHHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEe-
Q 010329 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE- 412 (513)
Q Consensus 336 ~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~- 412 (513)
.++.+..+.++|+..+.||+|+||.||++.. .+++.+++|.++... ....++.+|+.++..+ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3445556778899999999999999999986 457889999876532 2235688899999999 69999999998853
Q ss_pred ----CCeeEEEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeE
Q 010329 413 ----GEEKILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (513)
Q Consensus 413 ----~~~~~lv~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 487 (513)
++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 35689999999999999887532 23456889999999999999999999886 99999999999999999999
Q ss_pred EeeccCccccCC
Q 010329 488 ISDFGMARIFGV 499 (513)
Q Consensus 488 i~DfGla~~~~~ 499 (513)
|+|||+++.+..
T Consensus 165 l~dfg~~~~~~~ 176 (286)
T cd06638 165 LVDFGVSAQLTS 176 (286)
T ss_pred EccCCceeeccc
Confidence 999999987643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-22 Score=194.01 Aligned_cols=149 Identities=28% Similarity=0.484 Sum_probs=133.2
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
++|...+.||+|+||.||++.. .++..|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788889999999999999985 467889999987554445577899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
++++|.+++.+ ..+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+...
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 99999999842 35789999999999999999999987 999999999999999999999999998866543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=191.81 Aligned_cols=150 Identities=31% Similarity=0.563 Sum_probs=131.7
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
+|+..++||+|++|.||+|+.. +++.|+||.++.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999974 588999999876533 23467788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++ +|.+++........+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 85 88888755444456899999999999999999999887 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=194.52 Aligned_cols=151 Identities=26% Similarity=0.291 Sum_probs=133.3
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCcc---CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQ---GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|...+.||+|++|.||++... +++.+++|.+...... ..+.+.+|+++++.++|+||+++++.+.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999965 4889999998764322 4467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++++|.+++.. .....+++.....++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999853 23457899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=191.71 Aligned_cols=149 Identities=30% Similarity=0.518 Sum_probs=132.5
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|++.+.||+|+||.||+|.. .+++.|++|.+.... ....+.+.+|+.++++++|+||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477888999999999999996 468899999987653 23346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+ +++|.+++... ...+++.++..++.||+++|.|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999998543 256999999999999999999999987 999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-23 Score=209.92 Aligned_cols=162 Identities=25% Similarity=0.406 Sum_probs=138.1
Q ss_pred cCCCcccccCccCceeEEEEEeCCCc-EEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~-~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
+-|.++..||.|+||+|||+..++.. .-|.|.+...+.+..++|.-||++|+..+||+||+|++.+...+.+|++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 44566778999999999999965433 34677777777788899999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCCc
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~ 503 (513)
.||-.+.++.. -...|++.++.-++++++.+|.|||++. |||||||+.|||+.-+|.++|+|||.+.........
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 99999988854 3457999999999999999999999987 999999999999999999999999998766433222
Q ss_pred cccceeeecC
Q 010329 504 GNTSRIVGTL 513 (513)
Q Consensus 504 ~~~~~~~Gt~ 513 (513)
. -.++||+
T Consensus 187 R--DsFIGTP 194 (1187)
T KOG0579|consen 187 R--DSFIGTP 194 (1187)
T ss_pred h--ccccCCc
Confidence 1 2467775
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=189.06 Aligned_cols=149 Identities=30% Similarity=0.533 Sum_probs=132.1
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
.+|+..+.||+|+||.||++.+.++..+++|.++... .....+.+|++++++++|+||+++++++......++++||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3567788999999999999998778899999887543 234678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++|.+++.. ....+++..+..++.+++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 9999999853 2346889999999999999999999887 99999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-22 Score=191.74 Aligned_cols=148 Identities=29% Similarity=0.508 Sum_probs=130.0
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc------cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
+|+..+.||+|++|.||++.. .+++.|++|.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999985 5688999998864321 124678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC-CeEEeeccCcccc
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIF 497 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~ 497 (513)
|+||+++++|.+++.+ ...+++.....++.||+.||.|||+.+ ++|+||+|+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 346899999999999999999999987 99999999999998776 5999999999877
Q ss_pred CC
Q 010329 498 GV 499 (513)
Q Consensus 498 ~~ 499 (513)
..
T Consensus 155 ~~ 156 (268)
T cd06630 155 AA 156 (268)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=190.22 Aligned_cols=148 Identities=30% Similarity=0.493 Sum_probs=128.0
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-----ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--Cee
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK 416 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 416 (513)
.+|...+.||+|+||.||++.. .++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688889999999999999986 458899999886432 12235688999999999999999999988763 567
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999843 345889999999999999999999876 99999999999999999999999999986
Q ss_pred cC
Q 010329 497 FG 498 (513)
Q Consensus 497 ~~ 498 (513)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=192.63 Aligned_cols=148 Identities=25% Similarity=0.321 Sum_probs=129.5
Q ss_pred CCCcccccCccCceeEEEEEe----CCCcEEEEEEecccCc----cCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCee
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSASSG----QGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~----~~~~~VavK~l~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 416 (513)
+|+..+.||+|+||.||++.. .+|+.||+|.+..... ...+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999985 3688999999875321 2346688899999999 599999999999998899
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999843 356889999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 010329 497 FGV 499 (513)
Q Consensus 497 ~~~ 499 (513)
+..
T Consensus 155 ~~~ 157 (290)
T cd05613 155 FHE 157 (290)
T ss_pred ccc
Confidence 754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-22 Score=193.96 Aligned_cols=147 Identities=29% Similarity=0.512 Sum_probs=129.8
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
.|+..+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4556778999999999999864 57789999887443 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++++|.+++. ...+++..+..++.++++||.|||+++ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999883 346899999999999999999999987 99999999999999999999999999987653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.4e-22 Score=216.35 Aligned_cols=159 Identities=26% Similarity=0.411 Sum_probs=130.8
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--Ce
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EE 415 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~ 415 (513)
+...++|.+.++||+|+||+||++... .+..|++|.+... .......|..|+.++..++||||+++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345568999999999999999999964 4678899988643 223356789999999999999999999988654 46
Q ss_pred eEEEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCC----CCeeecCCcCCcEEECC--------
Q 010329 416 KILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSR----LRIIHRDLKASNILLDA-------- 482 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrdlk~~Nill~~-------- 482 (513)
.+|||||+++|+|.++|... .....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999998542 223569999999999999999999998531 24999999999999964
Q ss_pred ---------CCCeEEeeccCccccCC
Q 010329 483 ---------EMNPKISDFGMARIFGV 499 (513)
Q Consensus 483 ---------~~~~ki~DfGla~~~~~ 499 (513)
...+||+|||+++.+..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred cccccccCCCCceEEccCCccccccc
Confidence 33489999999987753
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-22 Score=199.68 Aligned_cols=148 Identities=30% Similarity=0.434 Sum_probs=126.0
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC------
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 413 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------ 413 (513)
..++|...+.||+|+||.||++.. ..++.||||++... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 346899999999999999999985 35788999998753 223346788999999999999999999987643
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
...++||||+++ +|..++. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346999999975 6766662 24789999999999999999999987 99999999999999999999999999
Q ss_pred ccccCC
Q 010329 494 ARIFGV 499 (513)
Q Consensus 494 a~~~~~ 499 (513)
++....
T Consensus 173 a~~~~~ 178 (364)
T cd07875 173 ARTAGT 178 (364)
T ss_pred ccccCC
Confidence 987653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=190.62 Aligned_cols=148 Identities=27% Similarity=0.521 Sum_probs=131.5
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc-CccCHHHHHHHHHHHHhCC---CCCccceeeEEEeCCeeEEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.|+..+.||+|+||.||+|.. .+++.|++|.+... .....+++.+|+.+++.++ |+|++++++++..+...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999995 56889999998654 3344567889999999997 999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++++|.+++.. ..+++.....++.+++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998843 36899999999999999999999987 999999999999999999999999999887544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=194.26 Aligned_cols=151 Identities=30% Similarity=0.486 Sum_probs=127.9
Q ss_pred CCCcccccCccCceeEEEEEeC---CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--CeeE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP---SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKI 417 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~---~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~ 417 (513)
+|...++||+|+||.||+|... .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4677889999999999999964 47899999987632 33346788899999999999999999999988 7899
Q ss_pred EEEecCCCCChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC----CCCeEEeec
Q 010329 418 LVYEFVPNKSLDYFLYDPE--KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA----EMNPKISDF 491 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~----~~~~ki~Df 491 (513)
+||||+++ +|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++ ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5666653222 2236889999999999999999999987 999999999999999 999999999
Q ss_pred cCccccCCC
Q 010329 492 GMARIFGVD 500 (513)
Q Consensus 492 Gla~~~~~~ 500 (513)
|+++.+...
T Consensus 157 g~~~~~~~~ 165 (316)
T cd07842 157 GLARLFNAP 165 (316)
T ss_pred ccccccCCC
Confidence 999977543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=189.01 Aligned_cols=146 Identities=36% Similarity=0.579 Sum_probs=127.8
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
++|.+.+.||+|+||.||++.. .++.|++|.++... ..+.+.+|+.++++++|+||+++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999986 67889999886542 346789999999999999999999998654 5799999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 99999998543 2346899999999999999999999887 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=189.28 Aligned_cols=143 Identities=29% Similarity=0.492 Sum_probs=121.4
Q ss_pred cccCccCceeEEEEEeC----CCcEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEe-CCeeEEEEecCC
Q 010329 351 NKLGEGGFGEVYKGVLP----SGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVP 424 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~----~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lv~ey~~ 424 (513)
+.||+|+||.||+|.+. ++..|++|++... .....+.+.+|+.+++.++|+||+++++++.. +...++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2357999988643 23345678899999999999999999998764 456789999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+|+|.+++... ...+++...+.++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999998532 334678888999999999999999886 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=192.60 Aligned_cols=149 Identities=30% Similarity=0.468 Sum_probs=128.2
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.++|...+.||+|+||.||+|.. .+++.|++|.+..... .....+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46788899999999999999985 4688999999875432 223467889999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|++ ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 84 YMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred ccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 996 677666633 2345788889999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-22 Score=193.10 Aligned_cols=149 Identities=26% Similarity=0.353 Sum_probs=130.8
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|++.+.||+|+||+||++... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++.+......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777889999999999999954 58889999876543 33457899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++++|.+++.. .+.+++.....++.+++.+|.|||+.. +++||||||+||++++++.++|+|||+++.+.
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 999999998843 356899999999999999999999742 39999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=191.91 Aligned_cols=151 Identities=26% Similarity=0.375 Sum_probs=126.1
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHH-HHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVL-VAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|+..+.||+|+||.||++... +|+.||+|+++... .....++..|+.. ++.++|+||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999964 58999999987542 2233455556654 666789999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 422 FVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 422 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|++ |+|.+++... .....+++..+..++.||+.||.|||++. +++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 6887777432 23456899999999999999999999862 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=188.09 Aligned_cols=143 Identities=39% Similarity=0.621 Sum_probs=124.0
Q ss_pred cccCccCceeEEEEEeCC----CcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLPS----GQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~----~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
++||+|+||.||+|.+.. +..+++|.+..... ...+++.+|+.+++.++|+||+++++++. .+..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997522 26899999876543 24567899999999999999999999875 5568999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
++|.+++.. ...+++..+..++.|++.+|.|||..+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 999999954 336899999999999999999999887 999999999999999999999999999977544
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-22 Score=190.69 Aligned_cols=149 Identities=28% Similarity=0.372 Sum_probs=132.9
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
+|...+.||+|+||.||++... +++.|++|.+.... ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999975 58899999987542 2345789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|+++++|.+++.. ...+++.....++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999843 357899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=188.01 Aligned_cols=149 Identities=40% Similarity=0.619 Sum_probs=130.8
Q ss_pred CcccccCccCceeEEEEEeCC-----CcEEEEEEecccCcc-CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 348 STDNKLGEGGFGEVYKGVLPS-----GQEIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~~~-----~~~VavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++.+.||+|+||.||++...+ +..|++|.++..... ..+.+.+|+.++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456889999999999999643 378999999765433 56789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999985422 122899999999999999999999987 999999999999999999999999999877543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=189.72 Aligned_cols=150 Identities=31% Similarity=0.500 Sum_probs=125.7
Q ss_pred CCcccccCccCceeEEEEEeC----CCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC------
Q 010329 347 FSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 414 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~----~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------ 414 (513)
|.+.+.||+|+||.||+|.+. .++.|+||.++.. .....+++.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 3678999988754 2334567889999999999999999999887543
Q ss_pred eeEEEEecCCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeec
Q 010329 415 EKILVYEFVPNKSLDYFLYDPE---KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df 491 (513)
..++++||+++|+|.+++.... ....+++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988874321 2235789999999999999999999887 999999999999999999999999
Q ss_pred cCccccCC
Q 010329 492 GMARIFGV 499 (513)
Q Consensus 492 Gla~~~~~ 499 (513)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05074 158 GLSKKIYS 165 (273)
T ss_pred cccccccC
Confidence 99997643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=195.65 Aligned_cols=145 Identities=19% Similarity=0.270 Sum_probs=125.3
Q ss_pred cccccCcc--CceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 349 TDNKLGEG--GFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 349 ~~~~Lg~G--~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
+.++||+| +|++||++.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999985 568899999987542 223456788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++||+.....
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 999999998432 2335899999999999999999999987 999999999999999999999999875543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-22 Score=181.07 Aligned_cols=142 Identities=18% Similarity=0.192 Sum_probs=110.6
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCcc--C-------HHHH-----------------HHHHHHHHhCCCCCc
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ--G-------AQEF-----------------KNEVVLVAKLQHRNL 403 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~--~-------~~~~-----------------~~E~~~l~~l~H~nI 403 (513)
...||+|+||.||+|...+|+.||||.++..... . ...| ..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999998754211 1 1122 349999999988877
Q ss_pred cceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHh-HcCCCCCeeecCCcCCcEEECC
Q 010329 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL-HEDSRLRIIHRDLKASNILLDA 482 (513)
Q Consensus 404 v~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrdlk~~Nill~~ 482 (513)
.....+. ....+|||||++++++...+. ....+++.....++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 5433332 233489999999887765432 234688999999999999999999 6766 99999999999998
Q ss_pred CCCeEEeeccCccccCCC
Q 010329 483 EMNPKISDFGMARIFGVD 500 (513)
Q Consensus 483 ~~~~ki~DfGla~~~~~~ 500 (513)
++.++|+|||+|.....+
T Consensus 153 ~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 153 DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred CCcEEEEEccccccCCCc
Confidence 478999999999876443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=191.03 Aligned_cols=149 Identities=32% Similarity=0.557 Sum_probs=122.7
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhC---CCCCccceeeEEEeC-----C
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKL---QHRNLVRLLGFCLEG-----E 414 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~-----~ 414 (513)
+|+..+.||+|+||.||++... +++.||+|.++.... .....+.+|+.+++.+ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777899999999999999864 688999998875322 2234566777776665 699999999988652 3
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..++++||++ ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999998 4888887542 2345899999999999999999999987 999999999999999999999999999
Q ss_pred cccCC
Q 010329 495 RIFGV 499 (513)
Q Consensus 495 ~~~~~ 499 (513)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-22 Score=191.97 Aligned_cols=143 Identities=28% Similarity=0.480 Sum_probs=123.1
Q ss_pred cccCccCceeEEEEEeCC--------CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 351 NKLGEGGFGEVYKGVLPS--------GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~--------~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+.||+|+||.||+|.... ..+|++|.+........+++.+|+.+++.++|+||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888887655444557889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC--------eEEeeccCc
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--------PKISDFGMA 494 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~--------~ki~DfGla 494 (513)
+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999542 236899999999999999999999987 999999999999987765 699999998
Q ss_pred cccC
Q 010329 495 RIFG 498 (513)
Q Consensus 495 ~~~~ 498 (513)
....
T Consensus 156 ~~~~ 159 (258)
T cd05078 156 ITVL 159 (258)
T ss_pred cccC
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=189.48 Aligned_cols=148 Identities=27% Similarity=0.496 Sum_probs=131.2
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
..|+..+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+.++++++|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667788999999999999964 57899999887542 34456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++++|.+++. ...+++.+...++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999999884 245889999999999999999999886 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=192.38 Aligned_cols=145 Identities=30% Similarity=0.465 Sum_probs=119.2
Q ss_pred ccccCccCceeEEEEEeC---CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEe--CCeeEEEEecCC
Q 010329 350 DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVYEFVP 424 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~---~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~ey~~ 424 (513)
..+||+|+||.||+|... ++..||+|.+.... ....+.+|+.++++++|+||+++++++.. +...++++||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999964 34689999886543 23467889999999999999999999864 456789999987
Q ss_pred CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE----CCCCCeEEeeccCc
Q 010329 425 NKSLDYFLYDP------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMA 494 (513)
Q Consensus 425 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~DfGla 494 (513)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 676665311 12335889999999999999999999987 9999999999999 56779999999999
Q ss_pred cccCCC
Q 010329 495 RIFGVD 500 (513)
Q Consensus 495 ~~~~~~ 500 (513)
+.+...
T Consensus 160 ~~~~~~ 165 (317)
T cd07867 160 RLFNSP 165 (317)
T ss_pred eccCCC
Confidence 987543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=188.94 Aligned_cols=147 Identities=28% Similarity=0.491 Sum_probs=130.2
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
-|+..++||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 466778999999999999985 467899999876432 233467889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++++|..++. ...+++.....++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999999883 346899999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=191.01 Aligned_cols=151 Identities=30% Similarity=0.426 Sum_probs=131.9
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|+..+.||+|+||.||++... +++.|++|.++.. .....+.+.+|++++++++|+||+++++++..++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999965 5789999988653 23345788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
|++++.+..++. ....+++..+..++.+|+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877776653 3345899999999999999999999987 9999999999999999999999999998875443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=186.58 Aligned_cols=150 Identities=24% Similarity=0.393 Sum_probs=131.8
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|+..+.||+|+||.+|++.. .+++.|++|.+... .....+++.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999985 46789999998643 223346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++++|.+++... ....+++.+.+.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999988532 2345789999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=187.16 Aligned_cols=150 Identities=27% Similarity=0.409 Sum_probs=134.8
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
+|+..+.||+|++|.||++... +++.|++|++..... ...+.+.+|+..+.+++|+||+++++++......++++||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5778899999999999999975 488999999876543 34578999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
++++|.+++.. ...+++..+..++.|+++||.|||+ .+ ++||||+|+||+++.++.++|+|||+++.+....
T Consensus 82 ~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 82 DGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999943 3668999999999999999999999 76 9999999999999999999999999999775433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=189.05 Aligned_cols=149 Identities=29% Similarity=0.480 Sum_probs=133.0
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|+..+.||.|++|.||+|... +++.|++|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778889999999999999964 57899999987543 33456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999843 27899999999999999999999987 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=202.95 Aligned_cols=154 Identities=26% Similarity=0.430 Sum_probs=122.3
Q ss_pred HhcCCCcccccCccCceeEEEEEe-----------------CCCcEEEEEEecccCccCHHHH--------------HHH
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-----------------PSGQEIAVKRLSASSGQGAQEF--------------KNE 391 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-----------------~~~~~VavK~l~~~~~~~~~~~--------------~~E 391 (513)
..++|++.++||+|+||.||+|.+ ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2346799999875433222333 346
Q ss_pred HHHHHhCCCCCc-----cceeeEEEe--------CCeeEEEEecCCCCChhhhhcCCC---------------------C
Q 010329 392 VVLVAKLQHRNL-----VRLLGFCLE--------GEEKILVYEFVPNKSLDYFLYDPE---------------------K 437 (513)
Q Consensus 392 ~~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lv~ey~~~gsL~~~l~~~~---------------------~ 437 (513)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788877654 678888753 356899999999999999986321 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 438 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
...++|..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 361 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT 361 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCcccccc
Confidence 123578889999999999999999987 99999999999999999999999999986643
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=187.59 Aligned_cols=148 Identities=30% Similarity=0.500 Sum_probs=128.3
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc-----CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--Cee
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS-----SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK 416 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 416 (513)
.+|.+.+.||+|+||.||++.. .++..|++|.+... .....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999995 45889999987532 123345788999999999999999999998764 457
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++++||+++++|.+++.. ...+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998843 345889999999999999999999887 99999999999999999999999999987
Q ss_pred cC
Q 010329 497 FG 498 (513)
Q Consensus 497 ~~ 498 (513)
..
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=190.22 Aligned_cols=149 Identities=30% Similarity=0.537 Sum_probs=130.1
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|+..+.||+|++|.||++... +++.|+||.+.... ....+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999864 68899999886542 22346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+. ++|..++... ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 96 6888888542 3456899999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=185.12 Aligned_cols=150 Identities=26% Similarity=0.352 Sum_probs=129.3
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC-CeeEEEEe
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-EEKILVYE 421 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lv~e 421 (513)
.|++.+.||+|++|.||++... +++.|++|++.... ....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999954 57889999986532 23456788999999999999999999887643 45789999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+++++|.+++... ....+++.++..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999998542 3446899999999999999999999987 99999999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=187.29 Aligned_cols=153 Identities=27% Similarity=0.487 Sum_probs=128.2
Q ss_pred CCCcccccCccCceeEEEEEeCC--CcEEEEEEecccC----------ccCHHHHHHHHHHHHh-CCCCCccceeeEEEe
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLPS--GQEIAVKRLSASS----------GQGAQEFKNEVVLVAK-LQHRNLVRLLGFCLE 412 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~~--~~~VavK~l~~~~----------~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~ 412 (513)
.|+..+.||+|+||.||++.... ++.+++|.+.... .....++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999999754 6789999875321 1223557788888865 799999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeec
Q 010329 413 GEEKILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (513)
Q Consensus 413 ~~~~~lv~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df 491 (513)
++..+++|||+++++|.+++... .....+++..+..++.|++.||.|||+.. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887432 23456899999999999999999999632 3999999999999999999999999
Q ss_pred cCccccCCC
Q 010329 492 GMARIFGVD 500 (513)
Q Consensus 492 Gla~~~~~~ 500 (513)
|++......
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=190.24 Aligned_cols=150 Identities=29% Similarity=0.445 Sum_probs=129.5
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeC--CeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv 419 (513)
++|+..+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46778899999999999999975 578899999875432 2234577899999999999999999999887 789999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+||++ ++|.+++... ...+++.....++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 5898888542 236899999999999999999999987 99999999999999999999999999997754
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=190.78 Aligned_cols=157 Identities=30% Similarity=0.427 Sum_probs=133.5
Q ss_pred HHHHHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCC-
Q 010329 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGE- 414 (513)
Q Consensus 338 ~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~- 414 (513)
..+..+.++|...+.||+|+||.||++.. .+++.+++|.+.... .....+.+|+.++.++ +|+||+++++++...+
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 34445678899999999999999999996 467899999886542 2345678899999998 7999999999987643
Q ss_pred ----eeEEEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEe
Q 010329 415 ----EKILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (513)
Q Consensus 415 ----~~~lv~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 489 (513)
..++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 579999999999999988532 23456899999999999999999999886 9999999999999999999999
Q ss_pred eccCccccC
Q 010329 490 DFGMARIFG 498 (513)
Q Consensus 490 DfGla~~~~ 498 (513)
|||+++.+.
T Consensus 171 dfg~~~~~~ 179 (291)
T cd06639 171 DFGVSAQLT 179 (291)
T ss_pred ecccchhcc
Confidence 999998764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=202.39 Aligned_cols=172 Identities=27% Similarity=0.489 Sum_probs=146.1
Q ss_pred cchHHHHHHhcCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEe
Q 010329 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE 412 (513)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 412 (513)
.+++.+..+++.|.+.+.||+|.+|.||+++ .++++.+|+|++.... +..+++..|..+++.. .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3445555677889999999999999999998 5678899999887654 3446778888888888 59999999999975
Q ss_pred -----CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeE
Q 010329 413 -----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (513)
Q Consensus 413 -----~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 487 (513)
++++|||||||.+||..+++.... ...+.|..+..|+++++.||.+||.+. ++|||||-.|||++.++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 568999999999999999997654 778999999999999999999999886 99999999999999999999
Q ss_pred EeeccCccccCCCCCccccceeeecC
Q 010329 488 ISDFGMARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~Gt~ 513 (513)
+.|||++..++... +.....+||+
T Consensus 164 LvDFGvSaQldsT~--grRnT~iGtP 187 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV--GRRNTFIGTP 187 (953)
T ss_pred Eeeeeeeeeeeccc--ccccCcCCCc
Confidence 99999999886443 3344467774
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=191.35 Aligned_cols=148 Identities=28% Similarity=0.540 Sum_probs=128.5
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|+..+.||+|+||.||++... +|+.+++|.++... ......+.+|+.++++++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999964 68899999986532 22235678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++ ++|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 97 578777743 2356899999999999999999999987 99999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=189.42 Aligned_cols=143 Identities=29% Similarity=0.440 Sum_probs=128.0
Q ss_pred ccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCCh
Q 010329 350 DNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 428 (513)
..+||+|+||.||++.. .+++.|++|++........+.+.+|+.+++.++|+||+++++.+...+..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999986 46889999998665545566799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
.+++. ...+++.....++.|++.+|.|||+.+ ++||||+|+||++++++.++|+|||++..+..
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 98873 235899999999999999999999987 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-21 Score=183.42 Aligned_cols=149 Identities=30% Similarity=0.492 Sum_probs=133.4
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|+..+.||+|.+|.||++... +++.+++|.+..... ...+.+.+|++++.+++|+|++++++++.++...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999864 578999999876543 3456899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+++++|.+++.. ...+++..+..++.|++.+|.|||+.+ |+||||+|+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999999843 357899999999999999999999887 999999999999999999999999999987543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=190.39 Aligned_cols=150 Identities=31% Similarity=0.434 Sum_probs=129.4
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
.+.|...+.||+|+||.||+|... +++.|++|.+..... ...+++.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999964 688999998864322 2345788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++....
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 567666632 2346899999999999999999999887 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.7e-21 Score=181.48 Aligned_cols=150 Identities=35% Similarity=0.561 Sum_probs=134.9
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
+|...+.||+|++|.||++... +++.+++|++........+.+.+|+++++.++|+||+++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999975 688999999987655566789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+++|.+++... ...+++..+..++.+++.+|.|||+.+ ++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999998542 256899999999999999999999976 999999999999999999999999999887654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=187.19 Aligned_cols=142 Identities=28% Similarity=0.433 Sum_probs=126.5
Q ss_pred cCccCceeEEEEEeC-CCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCCh
Q 010329 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (513)
Q Consensus 353 Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 428 (513)
||+|+||.||++... +++.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999975 488999999875433 3456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
.+++.+ ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 999854 236899999999999999999999987 999999999999999999999999999866433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-21 Score=187.22 Aligned_cols=146 Identities=28% Similarity=0.452 Sum_probs=130.1
Q ss_pred CCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
|...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++|+||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999985 46889999998765545556789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++....
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 999999843 46899999999999999999999987 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=188.67 Aligned_cols=145 Identities=37% Similarity=0.563 Sum_probs=124.7
Q ss_pred cccCccCceeEEEEEeCC-------CcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 351 NKLGEGGFGEVYKGVLPS-------GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~-------~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+.||+|+||.||+|+..+ ++.+++|.+.... .....++.+|+.+++.++|+||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2578999876543 23456889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC-----CeEEeeccC
Q 010329 423 VPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-----NPKISDFGM 493 (513)
Q Consensus 423 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-----~~ki~DfGl 493 (513)
+++++|.+++.+.. ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986422 2235889999999999999999999876 99999999999999877 899999999
Q ss_pred ccccC
Q 010329 494 ARIFG 498 (513)
Q Consensus 494 a~~~~ 498 (513)
++.+.
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 98653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=184.16 Aligned_cols=151 Identities=26% Similarity=0.412 Sum_probs=131.0
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|...+.||+|+||.||++.. .+++.+++|.+... .....+.+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999985 46788999988654 233456899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC-CCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGla~~~~~~ 500 (513)
+++++|.+++... ....+++..+..++.+++.+|.|||+++ ++|+||+|+||+++++ +.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999542 2345899999999999999999999987 9999999999999855 46899999999977543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=188.52 Aligned_cols=150 Identities=27% Similarity=0.433 Sum_probs=127.5
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCe-----
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEE----- 415 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~----- 415 (513)
++|+..+.||+|+||.||++... +++.|++|.++.... .....+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999964 688999998765432 23467888999999995 6999999999987665
Q ss_pred eEEEEecCCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC-CCCeEEeecc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEK--QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFG 492 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfG 492 (513)
.+++|||+++ +|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78888754322 346899999999999999999999987 999999999999998 8899999999
Q ss_pred CccccC
Q 010329 493 MARIFG 498 (513)
Q Consensus 493 la~~~~ 498 (513)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998664
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=198.45 Aligned_cols=148 Identities=29% Similarity=0.424 Sum_probs=128.1
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-C-----CCccceeeEEEeCCeeEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-H-----RNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~g~~~~~~~~~l 418 (513)
+|.+.+.||+|+||.|.|+.. .+++.||||+++... ....+-..|+.+|..|+ | -|+|++++++...+..+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788899999999999999995 568999999998754 23455677999999997 4 389999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC--CeEEeeccCccc
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM--NPKISDFGMARI 496 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~--~~ki~DfGla~~ 496 (513)
|+|.++ .+|.++|.. .+...++...+..|+.||+.||.+||+.+ |||.||||+||||.+-. .+||+|||.|..
T Consensus 266 VfELL~-~NLYellK~-n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKN-NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999884 789999965 44556999999999999999999999887 99999999999996443 799999999987
Q ss_pred cCC
Q 010329 497 FGV 499 (513)
Q Consensus 497 ~~~ 499 (513)
...
T Consensus 341 ~~q 343 (586)
T KOG0667|consen 341 ESQ 343 (586)
T ss_pred cCC
Confidence 653
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=186.10 Aligned_cols=148 Identities=28% Similarity=0.398 Sum_probs=131.6
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
+|+..+.||+|++|.||++... +++.|++|.+.... ....+++.+|++++++++|+||+++++.+..+...++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999975 58899999987653 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++++|.+++.... ..+++.....++.|++.+|.|||+ .+ ++|+||||+||++++++.+||+|||++..+.
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 9999999985422 578999999999999999999998 65 9999999999999999999999999998664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-21 Score=186.65 Aligned_cols=142 Identities=32% Similarity=0.444 Sum_probs=124.5
Q ss_pred cCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCCh
Q 010329 353 LGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (513)
Q Consensus 353 Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 428 (513)
||+|+||+||++.. .+++.+++|.+.... ....+.+.+|+++++.++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999985 468899999886532 22345677899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
.+++.... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 99985432 246899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=205.86 Aligned_cols=153 Identities=23% Similarity=0.413 Sum_probs=119.2
Q ss_pred HhcCCCcccccCccCceeEEEEEeCC--CcEEEEE------------------EecccCccCHHHHHHHHHHHHhCCCCC
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPS--GQEIAVK------------------RLSASSGQGAQEFKNEVVLVAKLQHRN 402 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~--~~~VavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~n 402 (513)
..++|.+.++||+|+||+||++.+.. +...++| .++. .......+.+|+.++++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 34689999999999999999987532 1112211 1111 1123456889999999999999
Q ss_pred ccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE
Q 010329 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEK--QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480 (513)
Q Consensus 403 Iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill 480 (513)
|+++++++...+..++++|++. ++|.+++..... ...........|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999995 566666643211 122345667789999999999999987 9999999999999
Q ss_pred CCCCCeEEeeccCccccCCC
Q 010329 481 DAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 481 ~~~~~~ki~DfGla~~~~~~ 500 (513)
+.++.+||+|||+++.+...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCCEEEEeCCCceecCcc
Confidence 99999999999999987543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.9e-21 Score=186.69 Aligned_cols=151 Identities=28% Similarity=0.481 Sum_probs=134.7
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.++.|+..+.||+|++|.||++... ++..|++|.+..... ..+.+.+|+++++.++|+||+++++.+...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4456778889999999999999975 588999999876544 45678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999995422 37999999999999999999999976 99999999999999999999999999876643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=189.40 Aligned_cols=153 Identities=27% Similarity=0.478 Sum_probs=130.4
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC---
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE--- 414 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 414 (513)
+...++|++.+.||+|+||.||+|... +++.|++|.++... ......+.+|+++++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678889999999999999999974 57899999987543 223356788999999999999999999987655
Q ss_pred -------eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeE
Q 010329 415 -------EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (513)
Q Consensus 415 -------~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 487 (513)
..++++||+++ +|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 68999999986 66666643 2346899999999999999999999987 99999999999999999999
Q ss_pred EeeccCccccCC
Q 010329 488 ISDFGMARIFGV 499 (513)
Q Consensus 488 i~DfGla~~~~~ 499 (513)
|+|||+++.+..
T Consensus 157 l~dfg~~~~~~~ 168 (302)
T cd07864 157 LADFGLARLYNS 168 (302)
T ss_pred eCcccccccccC
Confidence 999999987753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-22 Score=185.46 Aligned_cols=163 Identities=25% Similarity=0.278 Sum_probs=137.5
Q ss_pred HhcCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccCccCHH---HHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQ---EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~~~~~---~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
.-++|...++||+|.||+|..++ ...++.+|+|++++..-...+ .-..|-++|..-+||.+..|--.+...+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 34678888999999999999998 446889999999875433323 34568899999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||..+|.|...|. ....+++.....+..+|..+|.|||+++ ||.||||.+|.|+|.+|++||+||||++.-.
T Consensus 246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999988883 3556888888889999999999999987 9999999999999999999999999999655
Q ss_pred CCCCccccceeeecC
Q 010329 499 VDQTQGNTSRIVGTL 513 (513)
Q Consensus 499 ~~~~~~~~~~~~Gt~ 513 (513)
..... ++.++||+
T Consensus 320 ~~g~t--~kTFCGTP 332 (516)
T KOG0690|consen 320 KYGDT--TKTFCGTP 332 (516)
T ss_pred cccce--eccccCCh
Confidence 44433 44688885
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=192.76 Aligned_cols=149 Identities=30% Similarity=0.520 Sum_probs=127.6
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc--CccCHHHHHHHHHHHHhC-CCCCccceeeEEEeC--CeeE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEG--EEKI 417 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~--~~~~ 417 (513)
.++|...+.||+|+||.||+|... +++.+++|++... .......+.+|+.+++++ +|+||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888899999999999999965 5788999988543 223345678899999999 999999999998654 3679
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+||||++ ++|..++.. ..++|..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 589888843 26889999999999999999999987 999999999999999999999999999977
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
...
T Consensus 158 ~~~ 160 (337)
T cd07852 158 SEL 160 (337)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.7e-21 Score=183.77 Aligned_cols=142 Identities=27% Similarity=0.354 Sum_probs=126.2
Q ss_pred cCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCCh
Q 010329 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (513)
Q Consensus 353 Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 428 (513)
||+|++|.||++... +++.+++|.+.... ....+.+.+|+.+++.++|+||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999974 48899999986532 23346799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
.+++.+ ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 999943 345899999999999999999999987 999999999999999999999999999977543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-21 Score=174.46 Aligned_cols=142 Identities=20% Similarity=0.217 Sum_probs=113.0
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCcc--C------------------------HHHHHHHHHHHHhCCCCCc
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ--G------------------------AQEFKNEVVLVAKLQHRNL 403 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~--~------------------------~~~~~~E~~~l~~l~H~nI 403 (513)
...||+|+||.||+|...+|+.||||.++..... . ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998764211 0 1224578999999999988
Q ss_pred cceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeecCCcCCcEEECC
Q 010329 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDA 482 (513)
Q Consensus 404 v~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrdlk~~Nill~~ 482 (513)
.....+... ..+|||||++++++..... ....++......++.+++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 655444333 3589999999886543321 23457788899999999999999999 76 99999999999998
Q ss_pred CCCeEEeeccCccccCCC
Q 010329 483 EMNPKISDFGMARIFGVD 500 (513)
Q Consensus 483 ~~~~ki~DfGla~~~~~~ 500 (513)
++.++|+|||+++.+..+
T Consensus 153 ~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCCEEEEEcccceecCCC
Confidence 889999999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=185.13 Aligned_cols=152 Identities=30% Similarity=0.474 Sum_probs=132.3
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCC------
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGE------ 414 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~------ 414 (513)
++++|++.+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999974 577899998875543 346789999999999 6999999999997654
Q ss_pred eeEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 415 EKILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999885422 2457899999999999999999999987 99999999999999999999999999
Q ss_pred ccccC
Q 010329 494 ARIFG 498 (513)
Q Consensus 494 a~~~~ 498 (513)
+....
T Consensus 160 ~~~~~ 164 (275)
T cd06608 160 SAQLD 164 (275)
T ss_pred ceecc
Confidence 98664
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-21 Score=184.15 Aligned_cols=156 Identities=26% Similarity=0.456 Sum_probs=130.2
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEe--CCeeEEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVY 420 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~ 420 (513)
+|+..+.||.|+||.||++.. .+++.+++|.+... .....+.+.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 467788999999999999985 46788999988653 23334678899999999999999999998764 34578999
Q ss_pred ecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCC--CCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 421 EFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
||+++++|.+++... .....+++..+..++.+|+.||.|||..+ ..+++|+||+|+||++++++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998542 23457999999999999999999999322 234999999999999999999999999999987
Q ss_pred CCCC
Q 010329 498 GVDQ 501 (513)
Q Consensus 498 ~~~~ 501 (513)
....
T Consensus 161 ~~~~ 164 (265)
T cd08217 161 GHDS 164 (265)
T ss_pred cCCc
Confidence 5443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-21 Score=185.68 Aligned_cols=141 Identities=28% Similarity=0.369 Sum_probs=118.1
Q ss_pred ccCccCceeEEEEEe-CCCcEEEEEEecccCc---cCHHHHHHHHHHH---HhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 352 KLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG---QGAQEFKNEVVLV---AKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~---~~~~~~~~E~~~l---~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
.||+|+||.||++.. .+++.+|+|.+..... .....+.+|..++ ...+|+||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999996 4588999998865321 1123344554433 34479999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 9999998843 456999999999999999999999987 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.4e-21 Score=182.03 Aligned_cols=150 Identities=32% Similarity=0.520 Sum_probs=133.7
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeC--CeeEEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILVY 420 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~ 420 (513)
+|...+.||+|++|.||+|... ++..|++|.+..... ...+.+.+|+.++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999975 688999999876542 4467899999999999999999999999988 8899999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++++|.+++.. ...+++..+..++.+++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999853 237999999999999999999999976 999999999999999999999999999988654
Q ss_pred C
Q 010329 501 Q 501 (513)
Q Consensus 501 ~ 501 (513)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-22 Score=212.11 Aligned_cols=171 Identities=24% Similarity=0.268 Sum_probs=146.4
Q ss_pred chHHHHHHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEE
Q 010329 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 411 (513)
Q Consensus 336 ~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 411 (513)
....++...++|.+.+.||+|+||.|..++.. .++.+|+|++.+- ......-|.+|-.+|..-+.+=|++|+-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34456667788999999999999999999964 4677899998762 2334467899999999999999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeec
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df 491 (513)
+...+|+|||||+||+|-.+|.+ ...+++.-+..++.+|..||+-||+-| +|||||||.|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999943 336888888899999999999999877 999999999999999999999999
Q ss_pred cCccccCCCCCccccceeeecC
Q 010329 492 GMARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~Gt~ 513 (513)
|-+-.+..+.. ..++..+|||
T Consensus 220 GsClkm~~dG~-V~s~~aVGTP 240 (1317)
T KOG0612|consen 220 GSCLKMDADGT-VRSSVAVGTP 240 (1317)
T ss_pred hhHHhcCCCCc-EEeccccCCC
Confidence 99999875554 3345678986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=190.95 Aligned_cols=153 Identities=25% Similarity=0.342 Sum_probs=133.1
Q ss_pred cCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccCcc--CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQ--GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.-|.+.+.||+|-|..|-.++ .-.|+.||||.+.+..-+ ....+..|++.|+.++|||||+|+.+.-++..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 457788899999999999887 348999999999765433 23568889999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC-CCCeEEeeccCccccCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGVD 500 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~~~~ 500 (513)
.=++|+|.+|+.+.. ..+.+....+++.||+.++.|+|+-+ +|||||||+||.+.+ -|-+||+|||++-.+.++
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999996543 45889999999999999999999876 999999999998854 568999999999988776
Q ss_pred CC
Q 010329 501 QT 502 (513)
Q Consensus 501 ~~ 502 (513)
+.
T Consensus 173 ~k 174 (864)
T KOG4717|consen 173 KK 174 (864)
T ss_pred ch
Confidence 64
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=187.78 Aligned_cols=150 Identities=31% Similarity=0.475 Sum_probs=133.0
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv 419 (513)
++|...+.||+|+||.||++... +++.|++|.+... .....+.+.+|..++.+++ |+||+++++++..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788899999999999999964 6889999988653 2233467889999999998 99999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999943 347999999999999999999999987 99999999999999999999999999997754
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 155 ~ 155 (280)
T cd05581 155 N 155 (280)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=7e-21 Score=186.80 Aligned_cols=151 Identities=28% Similarity=0.401 Sum_probs=129.3
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeC--CeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~ 420 (513)
++|...+.||.|.+|.||++... +++.+++|.+..... .....+.+|++++++++|+||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999974 578899998875432 3456789999999999999999999998654 3689999
Q ss_pred ecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 421 EFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 421 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||+++++|.+++... .....+++.....++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999887432 23456889999999999999999999987 9999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-21 Score=191.46 Aligned_cols=150 Identities=26% Similarity=0.441 Sum_probs=128.6
Q ss_pred HHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC----
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE---- 414 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---- 414 (513)
...++|...+.||+|+||.||++.. .++..||||++.... ....+.+.+|+.++++++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999984 468899999986432 223456889999999999999999999987654
Q ss_pred --eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeecc
Q 010329 415 --EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (513)
Q Consensus 415 --~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG 492 (513)
..++||||+ +++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 678988873 246899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCC
Q 010329 493 MARIFGV 499 (513)
Q Consensus 493 la~~~~~ 499 (513)
+++....
T Consensus 164 ~~~~~~~ 170 (343)
T cd07880 164 LARQTDS 170 (343)
T ss_pred ccccccc
Confidence 9987643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-21 Score=185.30 Aligned_cols=148 Identities=30% Similarity=0.507 Sum_probs=129.5
Q ss_pred CCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--CeeEEEEe
Q 010329 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILVYE 421 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~e 421 (513)
|...++||+|+||.||+|... +++.+++|.+.... ....+.+.+|+.+++.++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999965 47899999998653 33446788999999999999999999999988 78999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|+++ +|.+++... ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9974 888888432 246899999999999999999999987 999999999999999999999999999977554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=191.70 Aligned_cols=148 Identities=24% Similarity=0.444 Sum_probs=127.9
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEe----CCeeE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKI 417 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~ 417 (513)
++|+..+.||+|+||.||++.. .+++.|++|++.... ....+.+.+|+.++++++|+||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6788889999999999999995 468899999987542 2345677889999999999999999998763 34679
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+|+||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999996 689888843 445899999999999999999999987 999999999999999999999999999876
Q ss_pred CC
Q 010329 498 GV 499 (513)
Q Consensus 498 ~~ 499 (513)
..
T Consensus 158 ~~ 159 (334)
T cd07855 158 SS 159 (334)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=210.13 Aligned_cols=148 Identities=32% Similarity=0.482 Sum_probs=120.8
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC-------
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------- 413 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------- 413 (513)
-..+|+..+.||+|+||.|||++.+ +|+.+|||++.... ......+.+|+.++++|+|||||+++..|.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3456778889999999999999943 89999999987653 33346788999999999999999987632210
Q ss_pred --------------------------------------------------------------------------------
Q 010329 414 -------------------------------------------------------------------------------- 413 (513)
Q Consensus 414 -------------------------------------------------------------------------------- 413 (513)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeeEEEEecCCCCChhhhhcCCCCCCCC-CHHHHHHHHHHHHHHHHHh
Q 010329 414 --------------------------------EEKILVYEFVPNKSLDYFLYDPEKQGQL-DWSRRYKIIGGIARGILYL 460 (513)
Q Consensus 414 --------------------------------~~~~lv~ey~~~gsL~~~l~~~~~~~~l-~~~~~~~i~~~ia~gL~yL 460 (513)
..+|+-||||+..+|.+++++ +... .....++++.+|++||.|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~---N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR---NHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh---cccchhhHHHHHHHHHHHHHHHHH
Confidence 113677888888888877743 2222 4566788999999999999
Q ss_pred HcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 461 H~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
|+.+ ||||||||.||++|++..+||.|||+|..
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 9998 99999999999999999999999999997
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=185.11 Aligned_cols=150 Identities=30% Similarity=0.490 Sum_probs=126.8
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|+..+.||+|.+|.||+|... +++.|++|.+..... ...+.+.+|++++++++|+||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999964 688999998865422 234678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC-CCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~~~ 499 (513)
|++ ++|.+++.. .....+++.....++.||+.||.|||+.+ ++||||+|+||++++ ++.+||+|||+++....
T Consensus 82 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 577777643 22334688888899999999999999986 999999999999985 56799999999987643
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.1e-21 Score=182.47 Aligned_cols=151 Identities=25% Similarity=0.428 Sum_probs=130.7
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|...+.||+|+||.||++... ++..+++|.+.... ....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999964 57889999886532 23446788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC-CeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~~~ 500 (513)
+++++|.+++.+. ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++ .+||+|||++..+...
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998542 2345899999999999999999999987 99999999999998886 4699999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=184.13 Aligned_cols=147 Identities=33% Similarity=0.537 Sum_probs=128.2
Q ss_pred CCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
|+..++||+|.+|.||+|.. .+|..|++|++.... ....+.+.+|++++++++|+|++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45678899999999999986 468999999987543 223467889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+ ++|.+++... ....+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.+||+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 6899888432 2246899999999999999999999876 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=187.34 Aligned_cols=151 Identities=33% Similarity=0.518 Sum_probs=128.6
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeC--CeeEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL 418 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l 418 (513)
.++|+..+.||+|+||.||+|... +|+.||+|.++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999964 588999999865432 2234567899999999999999999998765 46899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||++ ++|.+++... ...+++.++..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999997 4788887432 356899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 010329 499 VD 500 (513)
Q Consensus 499 ~~ 500 (513)
..
T Consensus 160 ~~ 161 (309)
T cd07845 160 LP 161 (309)
T ss_pred Cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=180.08 Aligned_cols=152 Identities=24% Similarity=0.399 Sum_probs=134.5
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|...+.||+|+||.||++... +++.+++|++..... ...+++.+|+++++.++|+|++++++.+..++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999964 588999999876533 4557789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999985422 2467999999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=186.79 Aligned_cols=148 Identities=31% Similarity=0.452 Sum_probs=127.4
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.|...+.||+|+||.||++.. .++..|++|.+..... ...+.+.+|++++++++|+|++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 366678899999999999995 4678999999864322 234578899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|++ |+|.+++.. ....++|.++..++.+|+.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 997 577776643 2456899999999999999999999987 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=200.60 Aligned_cols=149 Identities=23% Similarity=0.329 Sum_probs=120.4
Q ss_pred HHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCC------CccceeeEEEeC
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHR------NLVRLLGFCLEG 413 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~------nIv~l~g~~~~~ 413 (513)
....++|.+.++||+|+||+||++.. ..++.||||+++... ...+++..|+.++..++|. +++++++++...
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 34567899999999999999999986 457889999986532 2234566788887777654 588888888764
Q ss_pred -CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeecCCcCCcEEECCCC-------
Q 010329 414 -EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEM------- 484 (513)
Q Consensus 414 -~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrdlk~~Nill~~~~------- 484 (513)
...++|||++ +++|.+++.+ .+.+++..+..|+.||+.||.|||++ + |+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 4678999988 6788888743 35699999999999999999999974 5 99999999999998765
Q ss_pred ---------CeEEeeccCcccc
Q 010329 485 ---------NPKISDFGMARIF 497 (513)
Q Consensus 485 ---------~~ki~DfGla~~~ 497 (513)
.+||+|||++...
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred ccccCCCCceEEECCCCccccC
Confidence 4999999988643
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-21 Score=190.61 Aligned_cols=148 Identities=28% Similarity=0.488 Sum_probs=126.9
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC-----ee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EK 416 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~ 416 (513)
.++|++.++||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46789999999999999999985 468899999986532 233466888999999999999999999876543 47
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++++||++ ++|..++. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999997 47777763 346899999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 010329 497 FGV 499 (513)
Q Consensus 497 ~~~ 499 (513)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=184.80 Aligned_cols=157 Identities=29% Similarity=0.473 Sum_probs=132.4
Q ss_pred hHHHHHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEe--
Q 010329 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE-- 412 (513)
Q Consensus 337 ~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~-- 412 (513)
+..+..+.+.|+..+.||+|+||.||+|.. .+++.+++|.+.... ....++..|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 334445667888899999999999999996 457889999876543 2345788899999998 69999999999863
Q ss_pred ----CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEE
Q 010329 413 ----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488 (513)
Q Consensus 413 ----~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki 488 (513)
....+++|||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||+|+||++++++.+||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 35679999999999999988542 2345888889999999999999999987 999999999999999999999
Q ss_pred eeccCccccC
Q 010329 489 SDFGMARIFG 498 (513)
Q Consensus 489 ~DfGla~~~~ 498 (513)
+|||+++...
T Consensus 163 ~dfg~~~~~~ 172 (282)
T cd06636 163 VDFGVSAQLD 172 (282)
T ss_pred eeCcchhhhh
Confidence 9999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-20 Score=182.51 Aligned_cols=141 Identities=29% Similarity=0.380 Sum_probs=118.3
Q ss_pred ccCccCceeEEEEEe-CCCcEEEEEEecccCc---cCHHHHHHHHH---HHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 352 KLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG---QGAQEFKNEVV---LVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~---~~~~~~~~E~~---~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
.||+|+||.||++.. .+++.||+|.+..... .....+.+|.. .++...|+||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4588999998865421 11223444443 4445679999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++|.+++. ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999998884 3456999999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=186.29 Aligned_cols=149 Identities=32% Similarity=0.538 Sum_probs=126.2
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe------
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE------ 415 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------ 415 (513)
++|+..++||+|+||.||++... +++.||||.+.... ......+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999964 68899999886432 2223456789999999999999999999876543
Q ss_pred --eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 416 --KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 416 --~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
.++||||+. ++|.+++.. ....+++.++..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 499999997 478777743 2346899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCC
Q 010329 494 ARIFGV 499 (513)
Q Consensus 494 a~~~~~ 499 (513)
++.+..
T Consensus 166 ~~~~~~ 171 (310)
T cd07865 166 ARAFSL 171 (310)
T ss_pred cccccC
Confidence 987743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=181.26 Aligned_cols=142 Identities=29% Similarity=0.445 Sum_probs=127.2
Q ss_pred ccccCccCceeEEEEE-eCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEEecCCCCC
Q 010329 350 DNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKS 427 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey~~~gs 427 (513)
.+.||+|+|+.|--+. +.+|.++|||++.+.....+.+..+|++++..-+ |+||++|+.++++++..|||||-|.+|+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3679999999999887 6789999999998876667788999999998886 9999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC---CeEEeeccCcccc
Q 010329 428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMARIF 497 (513)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DfGla~~~ 497 (513)
|...++ +...+++.+..++..+|+.||+|||.++ |.||||||+|||-..-. -+||+||.|..-+
T Consensus 163 lLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 163 LLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred HHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence 998884 4567999999999999999999999998 99999999999985443 4899999988754
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=185.36 Aligned_cols=148 Identities=27% Similarity=0.351 Sum_probs=128.2
Q ss_pred CCCcccccCccCceeEEEEEe----CCCcEEEEEEecccC----ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCee
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSASS----GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~----~~~~~VavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 416 (513)
+|+..+.||+|++|.||++.. .+++.|+||.++... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999984 356789999987532 12335688999999999 599999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+++++|.+++.. ...+++.....++.|++++|.|||+.+ ++||||+|+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998843 346889999999999999999999876 99999999999999999999999999987
Q ss_pred cCC
Q 010329 497 FGV 499 (513)
Q Consensus 497 ~~~ 499 (513)
+..
T Consensus 155 ~~~ 157 (288)
T cd05583 155 FLA 157 (288)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-21 Score=205.17 Aligned_cols=158 Identities=30% Similarity=0.436 Sum_probs=136.6
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEeC--------CCcEEEEEEecccCc-cCHHHHHHHHHHHHhC-CCCCccceee
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKL-QHRNLVRLLG 408 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~--------~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g 408 (513)
.++...++..+.+.||+|.||.|++|.+. ....||||.++.... .+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 66777777777889999999999999843 135799999986533 4567899999999998 5999999999
Q ss_pred EEEeCCeeEEEEecCCCCChhhhhcCCC-----------CC--CCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcC
Q 010329 409 FCLEGEEKILVYEFVPNKSLDYFLYDPE-----------KQ--GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKA 475 (513)
Q Consensus 409 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~ 475 (513)
+|.+++..++|+||++.|+|.++|+..+ .. ..++..+.+.++.|||.||+||++.. ++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999996543 00 23889999999999999999999876 99999999
Q ss_pred CcEEECCCCCeEEeeccCccccCC
Q 010329 476 SNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 476 ~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||||+.++..+||+||||||....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~ 470 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYN 470 (609)
T ss_pred hhEEecCCCEEEEccccceeccCC
Confidence 999999999999999999996543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.6e-22 Score=175.48 Aligned_cols=147 Identities=23% Similarity=0.477 Sum_probs=127.8
Q ss_pred hcCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCC--eeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGE--EKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~--~~~lv 419 (513)
.++|++.+++|+|.++.||.|. ..+.++++||.+++.. .+.+.+|+.+|..|+ ||||++|+++..+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3578888999999999999998 5678899999998754 367899999999998 999999999987754 46799
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC-CCeEEeeccCccccC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFG 498 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGla~~~~ 498 (513)
+||+.+.+...+. ..|+...+..++.++++||.|+|+.| |+|||+||.||+||.. -.++|+|+|||.+++
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998876655 34777888899999999999999988 9999999999999865 479999999999998
Q ss_pred CCCC
Q 010329 499 VDQT 502 (513)
Q Consensus 499 ~~~~ 502 (513)
++..
T Consensus 185 p~~e 188 (338)
T KOG0668|consen 185 PGKE 188 (338)
T ss_pred CCce
Confidence 7653
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=188.85 Aligned_cols=152 Identities=30% Similarity=0.433 Sum_probs=128.9
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-- 413 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-- 413 (513)
++...+++|...+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|+.++.+++|+||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 4455678899999999999999999985 568899999987532 22346788899999999999999999988643
Q ss_pred ----CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEe
Q 010329 414 ----EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (513)
Q Consensus 414 ----~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 489 (513)
...+++++++ +++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence 2357788876 789988873 235899999999999999999999987 9999999999999999999999
Q ss_pred eccCccccC
Q 010329 490 DFGMARIFG 498 (513)
Q Consensus 490 DfGla~~~~ 498 (513)
|||+++...
T Consensus 163 dfg~~~~~~ 171 (345)
T cd07877 163 DFGLARHTD 171 (345)
T ss_pred ccccccccc
Confidence 999998654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-21 Score=159.04 Aligned_cols=100 Identities=43% Similarity=0.742 Sum_probs=76.8
Q ss_pred EeeC---CCCC-CChhhHHHHHHHHHHHHHHHhccC-CCcceeeccccCCcccEEEEEecccCCChhhHHHHHHHHHhhc
Q 010329 148 YLWN---TQNA-TDPVKFNDLVGSLMGEAASQAVND-PKKFATKMANFTSFQKLYALAQCTQDLSSSDCNICLRGAIAQL 222 (513)
Q Consensus 148 ~~~~---~~~~-~~~~~f~~~~~~l~~~l~~~a~~~-~~~fa~~~~~~~~~~~vy~l~QC~~Dl~~~~C~~Cl~~a~~~~ 222 (513)
..|+ .++. +++..|+++++.||..|...++.+ +.+|+++.. ..+.++||||+||++||++.||..||+.++.++
T Consensus 2 ~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~ 80 (106)
T PF01657_consen 2 HFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVANI 80 (106)
T ss_dssp --E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred CcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence 4566 2333 445569999999999999998865 578999876 468889999999999999999999999999999
Q ss_pred ccccCCCCCCeeeccccccccccCCC
Q 010329 223 PTCCGGKQGGRVLTPSCNVRYEVYPF 248 (513)
Q Consensus 223 ~~~~~~~~~g~v~~~~C~~r~~~~~f 248 (513)
+.+|+.+.||+|+.++|++||+.++|
T Consensus 81 ~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 81 SSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHhCCCCceEEEECCCEEEEEECCCC
Confidence 99999999999999999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=189.40 Aligned_cols=148 Identities=32% Similarity=0.462 Sum_probs=126.6
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC------
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 413 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------ 413 (513)
..++|+..+.||+|+||.||++.. .+++.||+|.+... .....+++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999995 46889999998643 223345778899999999999999999988644
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
...++||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 24689999996 578777732 2889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCC
Q 010329 494 ARIFGV 499 (513)
Q Consensus 494 a~~~~~ 499 (513)
++....
T Consensus 165 ~~~~~~ 170 (353)
T cd07850 165 ARTAGT 170 (353)
T ss_pred ceeCCC
Confidence 997754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=181.72 Aligned_cols=146 Identities=25% Similarity=0.374 Sum_probs=123.4
Q ss_pred CCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCC-CCCccceeeEEEeC--CeeEEEEe
Q 010329 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEG--EEKILVYE 421 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lv~e 421 (513)
|+..++||+|+||.||++.. .+++.|++|.++... ........+|+.++.++. |+||+++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 45678899999999999995 468899999987542 222234557888888885 99999999999987 88999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|++ ++|.+++.. ....++|..+..++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 577777743 2346899999999999999999999987 999999999999999 9999999999987743
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=188.42 Aligned_cols=149 Identities=26% Similarity=0.468 Sum_probs=127.8
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC-----e
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----E 415 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~ 415 (513)
.++|...+.||+|+||.||++.. .++..|+||.++.. .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688899999999999999985 46889999998753 2233456788999999999999999999886543 4
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++++||+. ++|.+++. ....+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 68888884 3456999999999999999999999987 9999999999999999999999999998
Q ss_pred ccCC
Q 010329 496 IFGV 499 (513)
Q Consensus 496 ~~~~ 499 (513)
....
T Consensus 157 ~~~~ 160 (337)
T cd07858 157 TTSE 160 (337)
T ss_pred ccCC
Confidence 7644
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-21 Score=187.06 Aligned_cols=158 Identities=29% Similarity=0.388 Sum_probs=137.0
Q ss_pred HHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
+..+.|+.-+.||+|+||.|+-++. .+|.-+|.|++.+. ...+.....+|-.+|.++..+.||.+--.+.+.+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 3446688889999999999999885 45777888887553 2334456788999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
||+..|.||+|..+|++... ..+++...+.++.+|+.||++||... ||.|||||+|||+|+.|+++|+|+|||..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999976433 56999999999999999999999886 999999999999999999999999999998
Q ss_pred CCCCCc
Q 010329 498 GVDQTQ 503 (513)
Q Consensus 498 ~~~~~~ 503 (513)
..++..
T Consensus 338 ~~g~~~ 343 (591)
T KOG0986|consen 338 PEGKPI 343 (591)
T ss_pred CCCCcc
Confidence 766543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=179.91 Aligned_cols=142 Identities=25% Similarity=0.356 Sum_probs=119.7
Q ss_pred cccCccCceeEEEEEe-CCCcEEEEEEecccCc---cCHHHHHHHHHH-HHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG---QGAQEFKNEVVL-VAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+|+||.||+|.. .+++.||+|.+..... .....+..|..+ ....+|+||+++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999986 4578999999865432 122334445444 4455899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999843 346899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=210.64 Aligned_cols=164 Identities=31% Similarity=0.448 Sum_probs=137.2
Q ss_pred hcCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
+-+|.....||.|.||.||.+. .++|+..|+|-++... ....+...+|+.++..++|||+|+.+|+-...+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4467778899999999999998 5678889999776432 334467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|||++|+|.+++. ..+-.++.....+..|++.|+.|||+++ ||||||||.||+|+.+|.+|+.|||-|+.+..+
T Consensus 1314 EyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999993 3445667777778899999999999998 999999999999999999999999999988654
Q ss_pred CC--ccccceeeecC
Q 010329 501 QT--QGNTSRIVGTL 513 (513)
Q Consensus 501 ~~--~~~~~~~~Gt~ 513 (513)
.. .+.-...+||+
T Consensus 1388 ~~~~~~el~~~~GT~ 1402 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTP 1402 (1509)
T ss_pred hhcCCHHHHhhcCCc
Confidence 31 12222456663
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=180.31 Aligned_cols=152 Identities=30% Similarity=0.479 Sum_probs=132.4
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|++.++||+|+||.||++.. .+++.+++|.+.... .....++.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 467788999999999999985 467899999987532 23346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+++++|..++.+.. ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999885422 2356899999999999999999999987 999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=187.24 Aligned_cols=147 Identities=27% Similarity=0.436 Sum_probs=126.3
Q ss_pred cCCC-cccccCccCceeEEEEEeC-CCcEEEEEEecccCccC--------------HHHHHHHHHHHHhCCCCCccceee
Q 010329 345 NKFS-TDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQG--------------AQEFKNEVVLVAKLQHRNLVRLLG 408 (513)
Q Consensus 345 ~~~~-~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~g 408 (513)
++|. ..+.||+|+||.||++... +++.||||.++...... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3467999999999999954 68899999886542211 125778999999999999999999
Q ss_pred EEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEE
Q 010329 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488 (513)
Q Consensus 409 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki 488 (513)
++..++..+++|||++ |+|.+++. ....+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 68988884 3446899999999999999999999987 999999999999999999999
Q ss_pred eeccCccccC
Q 010329 489 SDFGMARIFG 498 (513)
Q Consensus 489 ~DfGla~~~~ 498 (513)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998765
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=188.16 Aligned_cols=148 Identities=30% Similarity=0.481 Sum_probs=130.2
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC-----eeE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKI 417 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~ 417 (513)
+|.+.+.||+|++|.||++... +++.|++|++.... ....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999964 48899999987643 344568999999999999999999999998775 789
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
++|||++ ++|.+++.+ ...+++..+..++.+|+.||.|||+.+ |+||||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 578888843 347999999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-21 Score=168.76 Aligned_cols=159 Identities=28% Similarity=0.407 Sum_probs=132.1
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-ccCHHHHHHHHHHHHh-CCCCCccceeeEEEeCCe
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAK-LQHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~ 415 (513)
.++++.+.......||+|++|.|-+-++ .+|..+|+|+++..- .+..+...+|+.+..+ ...|.+|.|+|.......
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 3566667777788999999999988884 578999999997653 3445677788876554 579999999999999999
Q ss_pred eEEEEecCCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 416 KILVYEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
.|+.||.|. .||+.+-.+ ..+++.+++...-+|+..|.+||.|||++ +.++|||+||+||||+.+|++||+|||++
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccc
Confidence 999999995 678776532 23556789999999999999999999986 46999999999999999999999999999
Q ss_pred cccCCC
Q 010329 495 RIFGVD 500 (513)
Q Consensus 495 ~~~~~~ 500 (513)
-.+.+.
T Consensus 197 G~L~dS 202 (282)
T KOG0984|consen 197 GYLVDS 202 (282)
T ss_pred eeehhh
Confidence 887543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=185.59 Aligned_cols=147 Identities=27% Similarity=0.407 Sum_probs=123.4
Q ss_pred CCCcccccCccCceeEEEEEeC-C--CcEEEEEEecccC--ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeC----Ce
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-S--GQEIAVKRLSASS--GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEG----EE 415 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~--~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~----~~ 415 (513)
+|.+.+.||+|+||.||++... . +..||+|++.... ....+.+.+|+.++.++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999964 3 6789999887532 22346788899999999 599999999976543 34
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++++||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678889886 68988884 3456899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCC
Q 010329 496 IFGV 499 (513)
Q Consensus 496 ~~~~ 499 (513)
.+..
T Consensus 154 ~~~~ 157 (332)
T cd07857 154 GFSE 157 (332)
T ss_pred eccc
Confidence 7654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=184.79 Aligned_cols=144 Identities=19% Similarity=0.211 Sum_probs=123.3
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCC
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 427 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gs 427 (513)
.+.+|.|+++.|+++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 44455666666666655 6889999998754 33455789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|.+++... ....+++.....++.|+++||.|||+++ |+||||||+||+++.++.+||+|||.+..+.
T Consensus 86 l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 86 CEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred HHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 99998543 2345889999999999999999999987 9999999999999999999999999987653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.3e-21 Score=192.42 Aligned_cols=149 Identities=25% Similarity=0.359 Sum_probs=129.8
Q ss_pred hcCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
...|..++.||-|+||+|.++. .+....+|.|.|++.+. ......+.|-+||...+.+=||+|+-.|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3457778899999999999998 44556789999876532 3344567899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|||++||++-.+| .+.+.+.+..+..++.++..++++.|.-+ +|||||||.|||||.+|++||+||||+.-+.
T Consensus 708 MdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence 9999999999998 44567888888889999999999999877 9999999999999999999999999997553
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=181.77 Aligned_cols=148 Identities=30% Similarity=0.429 Sum_probs=127.4
Q ss_pred CCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEEecC
Q 010329 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
|.+.+.||+|++|.||+|... +++.|+||++..... .......+|+..+.+++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456789999999999999975 478899999875432 22234567899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+|+|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||+++....
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 789988885422 346899999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=182.35 Aligned_cols=151 Identities=28% Similarity=0.442 Sum_probs=126.4
Q ss_pred hcCCCcccccCccCceeEEEEEeCC-CcEEEEEEecccC-ccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.++|...+.||+|+||.||++...+ ++.|+||.++... .....++.+|+.++.+.. |+||+++++++.++...+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567888999999999999999764 8899999987543 233456777887777765 999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||++ ++|.+++.. ....+++..+..++.+|++||.|||+.. +|+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 467776643 2347899999999999999999999742 399999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=185.42 Aligned_cols=149 Identities=31% Similarity=0.469 Sum_probs=128.2
Q ss_pred HHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEe-CCeeE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKI 417 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~ 417 (513)
..+++|+..+.||+|+||.||++.. .+++.|++|++... .....+.+.+|++++..++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3567899999999999999999985 47889999987643 22334678899999999999999999999876 55788
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+++||+ +++|..++. ...+++.....++.|+++||.|||+.+ |+||||+|+|||+++++.+||+|||+++..
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 568988873 345788888999999999999999987 999999999999999999999999999865
Q ss_pred C
Q 010329 498 G 498 (513)
Q Consensus 498 ~ 498 (513)
.
T Consensus 159 ~ 159 (328)
T cd07856 159 D 159 (328)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=185.22 Aligned_cols=142 Identities=24% Similarity=0.330 Sum_probs=122.7
Q ss_pred cccCcc--CceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEG--GFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G--~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.||+| +||+||++.. ..++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 9999999996 478999999986532 23346789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++||+.+..
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 99999885432 335899999999999999999999887 99999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.7e-20 Score=176.83 Aligned_cols=146 Identities=23% Similarity=0.354 Sum_probs=119.7
Q ss_pred hcCCCccccc--CccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKL--GEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~L--g~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|.+.+.+ |+|+||.||++.. .++..+++|.+........ |+.....+ +|+||+++++.+...+..++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 3456666665 9999999999985 4577889998765422111 22222222 699999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC-CeEEeeccCccccC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFG 498 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~ 498 (513)
|||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 88 MDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 999999999999843 337999999999999999999999987 99999999999999998 99999999998765
Q ss_pred CC
Q 010329 499 VD 500 (513)
Q Consensus 499 ~~ 500 (513)
..
T Consensus 162 ~~ 163 (267)
T PHA03390 162 TP 163 (267)
T ss_pred CC
Confidence 43
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=186.73 Aligned_cols=158 Identities=27% Similarity=0.405 Sum_probs=132.5
Q ss_pred cCCCcccccCccCceeEEEEEeCC-CcEEEEEEecccCc--------cCHHHHHHHHHHHHhCC---CCCccceeeEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSG--------QGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLE 412 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~~--------~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~ 412 (513)
.+|.....+|+|+||.|+.+..+. ..+|+||.+.+..- ...-..-.|+.+|+.++ |+||++++.++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 358888999999999999999754 56789998876421 11123456999999998 9999999999999
Q ss_pred CCeeEEEEecC-CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeec
Q 010329 413 GEEKILVYEFV-PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (513)
Q Consensus 413 ~~~~~lv~ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df 491 (513)
.+..+|+||-. ++.+|.+++ +....+++.....|..||+.|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999976 466888888 34567999999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCCccccceeeec
Q 010329 492 GMARIFGVDQTQGNTSRIVGT 512 (513)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~Gt 512 (513)
|-|.....+... .++||
T Consensus 715 gsaa~~ksgpfd----~f~gt 731 (772)
T KOG1152|consen 715 GSAAYTKSGPFD----VFVGT 731 (772)
T ss_pred cchhhhcCCCcc----eeeee
Confidence 999987655543 35665
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-19 Score=180.55 Aligned_cols=145 Identities=32% Similarity=0.459 Sum_probs=125.1
Q ss_pred CCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
|...++||+|+||.||+|.. .+++.|++|.+..... ...+.+.+|+++++.++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55667899999999999986 4678899999864322 2335788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+. |+|.+++.. ....+++.++..++.||+.+|.|||+.+ ++||||+|+||+++.++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 96 577777643 2346899999999999999999999987 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=182.62 Aligned_cols=148 Identities=33% Similarity=0.461 Sum_probs=126.7
Q ss_pred CCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.|...+.||+|+||.||+|... +++.+++|.+... .....+++.+|+++++.++|+|++++++++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999964 5788999988642 22234578899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+. |+|.+++.. ....+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..+..
T Consensus 96 ~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 997 677776643 2345899999999999999999999887 99999999999999999999999999987653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=181.99 Aligned_cols=151 Identities=28% Similarity=0.399 Sum_probs=124.2
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+|...++||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 345567899999999999995 457899999987543 234467889999999996 99999999999999999999999
Q ss_pred CCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYD--PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++ +++.++... ......+++.....++.+++.||+|||+.. +++||||||+||++++++.+||+|||+++.+..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 455443311 122356899999999999999999999752 399999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.9e-20 Score=180.95 Aligned_cols=151 Identities=19% Similarity=0.265 Sum_probs=112.0
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCCC----cEEEEEEecccCccCH-----------HHHHHHHHHHHhCCCCCccce
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPSG----QEIAVKRLSASSGQGA-----------QEFKNEVVLVAKLQHRNLVRL 406 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~----~~VavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~l 406 (513)
+..++|.+.++||+|+||.||+|...++ ..+++|.......... .....+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3446899999999999999999996543 4556664332221111 112233345566789999999
Q ss_pred eeEEEeCC----eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC
Q 010329 407 LGFCLEGE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482 (513)
Q Consensus 407 ~g~~~~~~----~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~ 482 (513)
++++.... ..++++|++. .++.+.+.. ....++..+..|+.|++.||.|||+.+ |+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 99876554 3467788764 356565522 233578888999999999999999987 999999999999999
Q ss_pred CCCeEEeeccCccccCC
Q 010329 483 EMNPKISDFGMARIFGV 499 (513)
Q Consensus 483 ~~~~ki~DfGla~~~~~ 499 (513)
++.+||+|||+++.+..
T Consensus 162 ~~~~~l~DFGla~~~~~ 178 (294)
T PHA02882 162 NNRGYIIDYGIASHFII 178 (294)
T ss_pred CCcEEEEEcCCceeecc
Confidence 99999999999998754
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.5e-20 Score=178.38 Aligned_cols=149 Identities=32% Similarity=0.546 Sum_probs=124.5
Q ss_pred CCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhC---CCCCccceeeEEEeCCe-----
Q 010329 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKL---QHRNLVRLLGFCLEGEE----- 415 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~----- 415 (513)
|+..+.||+|+||.||++... +++.+++|.++.... .....+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456789999999999999975 488999999874322 2234566787776665 59999999999998776
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.+++|||++ ++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 4788887542 2235899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCC
Q 010329 496 IFGVD 500 (513)
Q Consensus 496 ~~~~~ 500 (513)
.+...
T Consensus 156 ~~~~~ 160 (287)
T cd07838 156 IYSFE 160 (287)
T ss_pred eccCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-22 Score=179.66 Aligned_cols=150 Identities=30% Similarity=0.574 Sum_probs=122.5
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--------
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-------- 413 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-------- 413 (513)
..|....+||+|.||.||+++. ++|+.||+|++--. ....-..-.+|+++|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3455667899999999999995 45778898875432 222234567899999999999999999988643
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
...+||++++++ +|.-+|.+ ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 247899999975 67777743 3356889999999999999999999876 99999999999999999999999999
Q ss_pred ccccCCC
Q 010329 494 ARIFGVD 500 (513)
Q Consensus 494 a~~~~~~ 500 (513)
+|.+...
T Consensus 171 ar~fs~~ 177 (376)
T KOG0669|consen 171 ARAFSTS 177 (376)
T ss_pred ccceecc
Confidence 9877543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=179.70 Aligned_cols=148 Identities=33% Similarity=0.547 Sum_probs=129.6
Q ss_pred CCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
|+..+.||+|.+|.||+|... +++.+++|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999965 58999999987653 333467889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+ ++|.+++.... ..+++..+..++.+++.||.|||+++ |+||||+|+||++++++.+||+|||+++.....
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 8 58999985421 46899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.8e-20 Score=182.75 Aligned_cols=150 Identities=33% Similarity=0.491 Sum_probs=126.3
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCC------
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 414 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------ 414 (513)
.++|++.++||+|+||.||++... +++.+++|.+..... .....+.+|+++++.++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468899999999999999999964 578999998865422 22346788999999999999999999876543
Q ss_pred --eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeecc
Q 010329 415 --EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (513)
Q Consensus 415 --~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG 492 (513)
..++|+||+.+ +|...+.. ....+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 45899999975 56666643 2346999999999999999999999987 9999999999999999999999999
Q ss_pred CccccCC
Q 010329 493 MARIFGV 499 (513)
Q Consensus 493 la~~~~~ 499 (513)
+++....
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.4e-20 Score=179.75 Aligned_cols=148 Identities=31% Similarity=0.513 Sum_probs=129.0
Q ss_pred CCcccccCccCceeEEEEEeC-CCcEEEEEEecccCcc--CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQ--GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
|...+.||+|++|.||++... +++.+++|.+...... ....+.+|+.++++++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 455678999999999999964 6888999998754322 3467889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
++ +|.+++.. ....+++..+..++.+|+.||.|||+.+ |+|+||||+||++++++.+||+|||.+..+...
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 75 88877743 2357899999999999999999999987 999999999999999999999999999877654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-20 Score=186.14 Aligned_cols=146 Identities=27% Similarity=0.489 Sum_probs=126.2
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeC----------
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG---------- 413 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---------- 413 (513)
.+|...+.||+|+||.||+|.. .++..|++|.+........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 6788899999999999999996 46889999998776656667889999999999999999999776543
Q ss_pred ----CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC-CCCCeEE
Q 010329 414 ----EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKI 488 (513)
Q Consensus 414 ----~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki 488 (513)
...++|+||++ ++|.+++. ...+++.....++.||+.||.|||+.+ |+||||||+||+++ +++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 58888873 245889999999999999999999987 99999999999997 4567899
Q ss_pred eeccCccccC
Q 010329 489 SDFGMARIFG 498 (513)
Q Consensus 489 ~DfGla~~~~ 498 (513)
+|||+++.+.
T Consensus 157 ~dfg~~~~~~ 166 (342)
T cd07854 157 GDFGLARIVD 166 (342)
T ss_pred CCcccceecC
Confidence 9999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.5e-20 Score=174.62 Aligned_cols=141 Identities=31% Similarity=0.415 Sum_probs=125.7
Q ss_pred cCccCceeEEEEEeC-CCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCCh
Q 010329 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (513)
Q Consensus 353 Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 428 (513)
||+|+||.||++... +++.+++|.+..... .....+.+|+.++++++|+||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999964 588999998875432 2346789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 999843 346899999999999999999999976 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=182.69 Aligned_cols=146 Identities=27% Similarity=0.479 Sum_probs=124.4
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC------
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 414 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------ 414 (513)
.++|...+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36788899999999999999995 46899999998653 2223456889999999999999999999987543
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..++|+||+. .+|..++ ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 4589999996 4676665 235899999999999999999999987 999999999999999999999999999
Q ss_pred cccC
Q 010329 495 RIFG 498 (513)
Q Consensus 495 ~~~~ 498 (513)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-21 Score=177.19 Aligned_cols=150 Identities=27% Similarity=0.466 Sum_probs=125.3
Q ss_pred CcccccCccCceeEEEEEeC-CCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC-----eeEEE
Q 010329 348 STDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKILV 419 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lv 419 (513)
+-.+-||-|+||.||..+.+ +|+.|++|++... +-...+.+.+|++++..++|.|++..++...-.. +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34577999999999999964 6899999998653 2233478899999999999999999988765432 46788
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+|.|. .+|..++ .....++...+.-+.+||++||+|||+.+ |.||||||.|.|++++-..||+||||+|.-+.
T Consensus 136 TELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 89885 5787777 34567888888889999999999999987 99999999999999999999999999998876
Q ss_pred CCCcc
Q 010329 500 DQTQG 504 (513)
Q Consensus 500 ~~~~~ 504 (513)
++...
T Consensus 209 d~~~h 213 (449)
T KOG0664|consen 209 RDRLN 213 (449)
T ss_pred hhhhh
Confidence 65543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.4e-20 Score=177.13 Aligned_cols=150 Identities=28% Similarity=0.413 Sum_probs=124.0
Q ss_pred CCCcccccCccCceeEEEEEeCC-CcEEEEEEeccc-----CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSAS-----SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
+|.+.++||+|+||.||++.... +..+++|.++.. .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998643 344555554431 222334577899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 420 YEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+||+++++|.+++.+. .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888532 23457999999999999999999999987 999999999999975 569999999998764
Q ss_pred C
Q 010329 499 V 499 (513)
Q Consensus 499 ~ 499 (513)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.9e-20 Score=182.78 Aligned_cols=166 Identities=26% Similarity=0.389 Sum_probs=141.0
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecc--cCccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeE
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSA--SSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~--~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~ 417 (513)
.+....|++.++||.|+.+.||++...+.+.+|+|++.. .+.+..+-|.+|+.+|.+|+ |.+|++|++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 345567888999999999999999988888899988754 34455688999999999996 999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|||||= ..+|..+|.+. .....+| .+..+..||+.++.++|+++ |||-||||.|+|+ -.|.+||+|||+|..+
T Consensus 437 mvmE~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAI 509 (677)
T ss_pred EEeecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhccc
Confidence 999976 57899999542 2333445 66778999999999999998 9999999999999 4577999999999999
Q ss_pred CCCCCccccceeeecC
Q 010329 498 GVDQTQGNTSRIVGTL 513 (513)
Q Consensus 498 ~~~~~~~~~~~~~Gt~ 513 (513)
..+.+.+.....+||+
T Consensus 510 ~~DTTsI~kdsQvGT~ 525 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTV 525 (677)
T ss_pred CccccceeeccccCcc
Confidence 9888877777778885
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.7e-20 Score=183.48 Aligned_cols=149 Identities=29% Similarity=0.464 Sum_probs=128.3
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe----
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE---- 415 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~---- 415 (513)
..++|...+.||+|++|.||+|... +++.|++|.+... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888999999999999999964 5789999988653 22334667889999999999999999998876654
Q ss_pred --eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 416 --KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 416 --~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5789888842 46899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCC
Q 010329 494 ARIFGV 499 (513)
Q Consensus 494 a~~~~~ 499 (513)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07851 165 ARHTDD 170 (343)
T ss_pred cccccc
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.4e-19 Score=163.98 Aligned_cols=139 Identities=22% Similarity=0.311 Sum_probs=107.3
Q ss_pred CcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhC-----CCCCccceeeEEEeCC---eeE-E
Q 010329 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-----QHRNLVRLLGFCLEGE---EKI-L 418 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~g~~~~~~---~~~-l 418 (513)
...+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+ +||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 2223444 68888765444567899999999999 5799999999998874 333 7
Q ss_pred EEec--CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHhHcCCCCCeeecCCcCCcEEECC----CCCeEEeec
Q 010329 419 VYEF--VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI-LYLHEDSRLRIIHRDLKASNILLDA----EMNPKISDF 491 (513)
Q Consensus 419 v~ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrdlk~~Nill~~----~~~~ki~Df 491 (513)
|+|| .++++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 568999999943 235555 35677888888 8999987 999999999999974 347999995
Q ss_pred cCcccc
Q 010329 492 GMARIF 497 (513)
Q Consensus 492 Gla~~~ 497 (513)
+.++.+
T Consensus 154 ~G~~~~ 159 (210)
T PRK10345 154 IGESTF 159 (210)
T ss_pred CCCcce
Confidence 444433
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.4e-20 Score=167.85 Aligned_cols=150 Identities=26% Similarity=0.420 Sum_probs=125.2
Q ss_pred CcccccCccCceeEEEEEe-CCCcEEEEEEeccc-CccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEEecCC
Q 010329 348 STDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
.....||.|.-|.||+.+. ..|..+|||.+... +.+..+++...++++.+-. .|.||+-+|+|......++-||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 4456799999999999996 45788999999765 4455677888888766654 8999999999999999999999984
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 502 (513)
.-++.+|.. ..+++++..+-++...+.+||.||.+++ .|+|||+||+|||+|+.|++|++|||++-++.+...
T Consensus 175 -~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 175 -TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred -HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 345566632 3456888888899999999999999876 699999999999999999999999999998865543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-20 Score=179.97 Aligned_cols=164 Identities=28% Similarity=0.347 Sum_probs=133.7
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCC-CcEEEEEEecccCc---cCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCee
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSG---QGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 416 (513)
+...+|.....||+|+||+|..+.-++ .+.+|||+++++.- ++.+--+.|-++|+.. +-|.+++++.++.+-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 334578888999999999999998543 46689999987532 2223335566777666 478899999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
|+||||+.+|+|-..+ .+-+.+.+..+..++.+||-||-|||+++ |+.||||..|||+|.+|++||+|||+++.
T Consensus 426 yFVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 9999999999998888 34567888899999999999999999998 99999999999999999999999999996
Q ss_pred cCCCCCccccceeeecC
Q 010329 497 FGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 497 ~~~~~~~~~~~~~~Gt~ 513 (513)
-..+..+ +..++||+
T Consensus 500 ni~~~~T--TkTFCGTP 514 (683)
T KOG0696|consen 500 NIFDGVT--TKTFCGTP 514 (683)
T ss_pred cccCCcc--eeeecCCC
Confidence 5444432 33488885
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=170.66 Aligned_cols=133 Identities=20% Similarity=0.191 Sum_probs=115.3
Q ss_pred cCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCChhhhhcC
Q 010329 356 GGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD 434 (513)
Q Consensus 356 G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~ 434 (513)
|.+|.||++.. .+++.+|+|.++... .+.+|...+....||||+++++++.+.+..+++|||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999995 467899999987643 234455556667799999999999999999999999999999998843
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 435 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
...+++.....++.|++.||.|||+.+ |+||||||+||++++++.++++|||++..+..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~ 137 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED 137 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence 345899999999999999999999987 99999999999999999999999998876643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.2e-21 Score=173.81 Aligned_cols=149 Identities=29% Similarity=0.403 Sum_probs=122.5
Q ss_pred CCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc-cCHHHHHHHHHHHHh-CCCCCccceeeEEEeCCeeEEEEecC
Q 010329 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG-QGAQEFKNEVVLVAK-LQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
.+....||.|.||+|+|-.. +.|+.+|||+++.... ...+++..|.+...+ -+.||||+++|.+..++..|+-||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 34456899999999999985 5689999999986543 445678888876544 46899999999999999999999999
Q ss_pred CCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 424 PNKSLDYFLYD--PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 424 ~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+ .||+.+... ..+...+++...-+|..-+..||+||.++. +|+|||+||+|||||..|.+||+|||++-.+-
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 5 677655421 123456888888889989999999998764 69999999999999999999999999998764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.5e-19 Score=164.79 Aligned_cols=148 Identities=36% Similarity=0.534 Sum_probs=132.3
Q ss_pred CCcccccCccCceeEEEEEeCC-CcEEEEEEecccCcc-CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 347 FSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999765 789999999876544 56789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCC-CCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 425 NKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+++|.+++... .. +++.....++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 99999998532 23 889999999999999999999986 999999999999999999999999999988654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.3e-20 Score=170.42 Aligned_cols=164 Identities=26% Similarity=0.311 Sum_probs=138.2
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCee
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 416 (513)
..-++|.+.+.||+|+|.+|..+++. ..+.+|+|.+++. ..++.+..+.|-.+.... +||.+|.|..++.++..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 44568899999999999999999964 5678899988763 334456677777776665 699999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++|.||+++|+|-..+ .++.+|+++.+..+..+|..+|.|||+.+ |+.||||..|||||.+|++|++|+|+++.
T Consensus 327 ffvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999997776 45667999999999999999999999998 99999999999999999999999999996
Q ss_pred cCCCCCccccceeeecC
Q 010329 497 FGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 497 ~~~~~~~~~~~~~~Gt~ 513 (513)
-..+.. .++.++||+
T Consensus 401 ~l~~gd--~tstfcgtp 415 (593)
T KOG0695|consen 401 GLGPGD--TTSTFCGTP 415 (593)
T ss_pred CCCCCc--ccccccCCC
Confidence 543332 245688885
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.3e-19 Score=189.56 Aligned_cols=150 Identities=25% Similarity=0.313 Sum_probs=107.1
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-C----CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeE------EE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-S----GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGF------CL 411 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~----~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~------~~ 411 (513)
..++|.+.++||+|+||.||+|++. + +..||||++...... +...+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568999999999999999999964 4 689999988653321 111111 1222223333332221 23
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCc
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPEKQ-----------------GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK 474 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk 474 (513)
.+...++|+||+++++|.+++...... ....+..+..|+.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999988542110 01123345679999999999999987 9999999
Q ss_pred CCcEEECC-CCCeEEeeccCccccCC
Q 010329 475 ASNILLDA-EMNPKISDFGMARIFGV 499 (513)
Q Consensus 475 ~~Nill~~-~~~~ki~DfGla~~~~~ 499 (513)
|+|||+++ ++.+||+|||+|+.+..
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~ 308 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRV 308 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccc
Confidence 99999986 57999999999987643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3e-20 Score=187.79 Aligned_cols=163 Identities=26% Similarity=0.430 Sum_probs=141.9
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
+.++|.+...+|.|+||.|||++. ..++..|+|.++....+..+-++.|+-+++.-+|+||+.++|.+...+..|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 456788889999999999999995 4678899999988776777788899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
|+.+|+|++.-+ ..+++++.++..++++.++||+|||+.+ -+|||||-.|||+++.+.+|++|||.+-.+..--
T Consensus 93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999998874 3567999999999999999999999987 6899999999999999999999999998775322
Q ss_pred CccccceeeecC
Q 010329 502 TQGNTSRIVGTL 513 (513)
Q Consensus 502 ~~~~~~~~~Gt~ 513 (513)
.....++||+
T Consensus 167 --~KrksfiGtp 176 (829)
T KOG0576|consen 167 --AKRKSFIGTP 176 (829)
T ss_pred --hhhhcccCCc
Confidence 2223466664
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-19 Score=166.84 Aligned_cols=148 Identities=26% Similarity=0.331 Sum_probs=121.4
Q ss_pred HhcCCCcc-cccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEe----CCe
Q 010329 343 ATNKFSTD-NKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE----GEE 415 (513)
Q Consensus 343 ~~~~~~~~-~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~ 415 (513)
.+++|++. ++||-|-.|+|..+.. .+++++|+|.|... ...++|+++.-.. .|+|||++++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34555543 5799999999999985 46889999988653 3457788875544 59999999999865 346
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC---CCCeEEeecc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFG 492 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DfG 492 (513)
+++|||.|+||.|...+.+ +....+++.++-.|+.||..|+.|||+.+ |.||||||+|+|... |-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999998855 34456999999999999999999999987 999999999999954 4579999999
Q ss_pred CccccCC
Q 010329 493 MARIFGV 499 (513)
Q Consensus 493 la~~~~~ 499 (513)
+|+.-..
T Consensus 210 FAK~t~~ 216 (400)
T KOG0604|consen 210 FAKETQE 216 (400)
T ss_pred cccccCC
Confidence 9997653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.5e-18 Score=156.30 Aligned_cols=143 Identities=37% Similarity=0.621 Sum_probs=127.0
Q ss_pred cCccCceeEEEEEeCC-CcEEEEEEecccCcc-CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCChhh
Q 010329 353 LGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDY 430 (513)
Q Consensus 353 Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~ 430 (513)
||+|.+|.||++...+ ++++++|.+...... ..+.+.+|+..++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999998765432 34679999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC-CCCeEEeeccCccccCCC
Q 010329 431 FLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGVD 500 (513)
Q Consensus 431 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~~~~ 500 (513)
++.... ..+++..+..++.+++++|.|||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 984321 46899999999999999999999987 999999999999999 899999999999877543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.8e-20 Score=180.30 Aligned_cols=160 Identities=26% Similarity=0.324 Sum_probs=137.9
Q ss_pred cCCCcccccCccCceeEEEEEeCCCc-EEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~-~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.++..+..||-|+||.|-.+...... .+|+|.+++. ...+.+.+..|-.+|...+.|.||+|+-.+.+.+..|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555677999999999999875433 3788877653 3344566788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|-|-||.|-..|+ .++.++..+...++..+.+|++|||.++ ||.|||||+|.|+|.+|-+||.|||+|+.+..+
T Consensus 500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999994 4677999999999999999999999987 999999999999999999999999999999866
Q ss_pred CCccccceeeecC
Q 010329 501 QTQGNTSRIVGTL 513 (513)
Q Consensus 501 ~~~~~~~~~~Gt~ 513 (513)
.. |-.++||+
T Consensus 574 ~K---TwTFcGTp 583 (732)
T KOG0614|consen 574 RK---TWTFCGTP 583 (732)
T ss_pred Cc---eeeecCCc
Confidence 64 34688885
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-18 Score=161.14 Aligned_cols=146 Identities=18% Similarity=0.215 Sum_probs=113.5
Q ss_pred CCCcccccCccCceeEEEEE--eCCCcEEEEEEecccCcc------------------------CHHHHHHHHHHHHhCC
Q 010329 346 KFSTDNKLGEGGFGEVYKGV--LPSGQEIAVKRLSASSGQ------------------------GAQEFKNEVVLVAKLQ 399 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~--~~~~~~VavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 399 (513)
-|.+.+.||+|+||.||+|. ..+|+.||+|.++..... ....+.+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 568999999998753210 0123568999999997
Q ss_pred CCC--ccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCc
Q 010329 400 HRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (513)
Q Consensus 400 H~n--Iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~N 477 (513)
+.. +.+.+++ ...++||||+++++|...+. ....+.......++.||+.+|.+||+.+ +|+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 633 4444443 24589999999988866542 2234556667889999999999999875 49999999999
Q ss_pred EEECCCCCeEEeeccCccccCCCC
Q 010329 478 ILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 478 ill~~~~~~ki~DfGla~~~~~~~ 501 (513)
|+++ +++++|+|||++.......
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCCcc
Confidence 9999 8899999999999775443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.6e-18 Score=157.93 Aligned_cols=136 Identities=21% Similarity=0.308 Sum_probs=114.7
Q ss_pred cccCccCceeEEEEEeCCCcEEEEEEecccCcc--------CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ--------GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
+.||+|++|.||+|.. .+..|++|........ ....+.+|+.++..++|++|.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999998 6778999976543211 124578899999999999998888888788889999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+++++|.+++.. ..+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~------~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINS------NGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHh------ccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 999999998832 122 78889999999999999987 99999999999999 7889999999998643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.9e-18 Score=160.62 Aligned_cols=138 Identities=32% Similarity=0.488 Sum_probs=123.9
Q ss_pred CceeEEEEEeC-CCcEEEEEEecccCccC-HHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCChhhhhcC
Q 010329 357 GFGEVYKGVLP-SGQEIAVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD 434 (513)
Q Consensus 357 ~fG~Vy~~~~~-~~~~VavK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~ 434 (513)
+||.||++... +++.+++|.+....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 48899999998765544 68899999999999999999999999999999999999999999999843
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 435 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
...+++..+..++.+++++|.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 ---RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 223899999999999999999999986 999999999999999999999999999987653
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.4e-18 Score=156.74 Aligned_cols=142 Identities=15% Similarity=0.171 Sum_probs=116.6
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHH---H------HHHHHHHHHhCCCCCccceeeEEEe
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQ---E------FKNEVVLVAKLQHRNLVRLLGFCLE 412 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~---~------~~~E~~~l~~l~H~nIv~l~g~~~~ 412 (513)
...++|...+.||+|+||.||.... ++..++||.+.+....... . +.+|+..+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999766 5778999999765332222 2 6789999999999999999888664
Q ss_pred C--------CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC
Q 010329 413 G--------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (513)
Q Consensus 413 ~--------~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~ 484 (513)
. ...+|+|||++|.+|.++. .++. ....+++.+|..||+.+ ++|||++|+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 3578999999999998774 1222 24558999999999987 99999999999999988
Q ss_pred CeEEeeccCccccCC
Q 010329 485 NPKISDFGMARIFGV 499 (513)
Q Consensus 485 ~~ki~DfGla~~~~~ 499 (513)
++|+|||..+...+
T Consensus 173 -i~liDfg~~~~~~e 186 (232)
T PRK10359 173 -LRIIDLSGKRCTAQ 186 (232)
T ss_pred -EEEEECCCcccccc
Confidence 99999999987643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.2e-18 Score=152.95 Aligned_cols=152 Identities=24% Similarity=0.402 Sum_probs=126.2
Q ss_pred HhcCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCC-CCccceeeEEEeCCeeEEEE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lv~ 420 (513)
...+|.++++||.|+||.+|.|. +.+|++||||.-+... ....+..|..+...|+| ..|..+..+..++....|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35689999999999999999998 6789999999765432 22457778999999985 67888888888999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC---CCeEEeeccCcccc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~DfGla~~~ 497 (513)
|.+ +-||+++..= =...++.++.+-++.|++.-++|+|.++ ++||||||+|+|+.-+ ..+.++|||||+.+
T Consensus 91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 988 7788887631 1235888999999999999999999988 9999999999999644 46899999999988
Q ss_pred CCCCC
Q 010329 498 GVDQT 502 (513)
Q Consensus 498 ~~~~~ 502 (513)
-+-.+
T Consensus 165 ~d~~t 169 (341)
T KOG1163|consen 165 RDIRT 169 (341)
T ss_pred ccccc
Confidence 65443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=154.99 Aligned_cols=141 Identities=20% Similarity=0.222 Sum_probs=111.3
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCcc----------------------CHHHHHHHHHHHHhCCCCC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ----------------------GAQEFKNEVVLVAKLQHRN 402 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~----------------------~~~~~~~E~~~l~~l~H~n 402 (513)
..|...+.||+|+||.||++..++|+.|+||++...... ....+..|..++..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 347778999999999999999888999999986543210 0123567888899998874
Q ss_pred --ccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE
Q 010329 403 --LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480 (513)
Q Consensus 403 --Iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill 480 (513)
+++.++ ....+++|||+++++|..... ......++.+++.++.++|+.+ |+||||||+||++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill 158 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV 158 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence 444443 245689999999999876541 0234578889999999999976 9999999999999
Q ss_pred CCCCCeEEeeccCccccCCCC
Q 010329 481 DAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 481 ~~~~~~ki~DfGla~~~~~~~ 501 (513)
++++.++|+|||++..+..+.
T Consensus 159 ~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred cCCCcEEEEECCccccCCCcc
Confidence 999999999999998776544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-18 Score=162.88 Aligned_cols=161 Identities=24% Similarity=0.387 Sum_probs=137.9
Q ss_pred chHHHHHHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceee
Q 010329 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLG 408 (513)
Q Consensus 336 ~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g 408 (513)
...++.+...+++...++.+|.||.||+|.|. +.+.|-||.++.. +..+...+..|..++..+.|||+.++.|
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 33456666778888889999999999999754 3456888988765 4445678899999999999999999999
Q ss_pred EEEeC-CeeEEEEecCCCCChhhhhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC
Q 010329 409 FCLEG-EEKILVYEFVPNKSLDYFLY-----DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482 (513)
Q Consensus 409 ~~~~~-~~~~lv~ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~ 482 (513)
++.+. +..+.++.++.-|+|+.||. +......++..+...++.|++.||+|||.++ +||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 99764 56899999999999999997 5555667888999999999999999999987 999999999999999
Q ss_pred CCCeEEeeccCccccCC
Q 010329 483 EMNPKISDFGMARIFGV 499 (513)
Q Consensus 483 ~~~~ki~DfGla~~~~~ 499 (513)
..++||+|=.|+|.+-+
T Consensus 432 ~LqVkltDsaLSRDLFP 448 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFP 448 (563)
T ss_pred heeEEeccchhccccCc
Confidence 99999999999997743
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.3e-18 Score=179.72 Aligned_cols=140 Identities=19% Similarity=0.334 Sum_probs=114.0
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEE-eccc-Cc------cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR-LSAS-SG------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~-l~~~-~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 415 (513)
...|...++||+|+||+||+|.+.+.. +++|+ +... .. ...+.+.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566789999999999999975444 33333 2221 11 113568899999999999999988888888888
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998883 45678999999999999987 9999999999999 67889999999999
Q ss_pred ccCC
Q 010329 496 IFGV 499 (513)
Q Consensus 496 ~~~~ 499 (513)
....
T Consensus 476 ~~~~ 479 (535)
T PRK09605 476 YSDL 479 (535)
T ss_pred cCCc
Confidence 7643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-18 Score=179.76 Aligned_cols=159 Identities=30% Similarity=0.401 Sum_probs=122.3
Q ss_pred CCCcccccCccCce-eEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEecC
Q 010329 346 KFSTDNKLGEGGFG-EVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG-~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
-|...+.+|.|+.| .||+|.. +|++||||++-... .+-..+|+..|..- +||||+++++.-.++...|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 34556778999887 5799998 78999999986543 24567899998887 4999999999999999999999999
Q ss_pred CCCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC---C--CCeEEeeccCcccc
Q 010329 424 PNKSLDYFLYDPEKQ-GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---E--MNPKISDFGMARIF 497 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~---~--~~~ki~DfGla~~~ 497 (513)
..+|++++...... ....-.....+..|+++||++||+-+ ||||||||.||||+. + .+++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 47999999542111 11111344677889999999999965 999999999999965 2 57999999999999
Q ss_pred CCCCCccc-cceeeec
Q 010329 498 GVDQTQGN-TSRIVGT 512 (513)
Q Consensus 498 ~~~~~~~~-~~~~~Gt 512 (513)
..+..... .+...||
T Consensus 662 ~~~~sS~~r~s~~sGt 677 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGT 677 (903)
T ss_pred CCCcchhhcccCCCCc
Confidence 87654322 2334444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=154.85 Aligned_cols=132 Identities=21% Similarity=0.351 Sum_probs=108.4
Q ss_pred ccCccCceeEEEEEeCCCcEEEEEEecccCc--------cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSASSG--------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
.||+|+||.||+|.+ ++..|++|....... ....++.+|++++..++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 578899998654321 11256778999999999988766666666777789999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++++|.+++... . ..++.+++.+|.+||+.+ ++|||++|.||+++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~~---~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEG---N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhc---H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999999887321 0 078999999999999987 99999999999999 8899999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.6e-17 Score=148.53 Aligned_cols=133 Identities=19% Similarity=0.202 Sum_probs=106.4
Q ss_pred cccccCccCceeEEEEEeCCCcEEEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEEecC
Q 010329 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ----GAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 349 ~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~----~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
....|++|+||+||.+.- .+.+++.+.+.....- ....+.+|+++|+++. |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 356899999999997765 6778888877654321 1235889999999996 5889999886 4579999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCC-cCCcEEECCCCCeEEeeccCccccCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDL-KASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdl-k~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++.+|...+. . ....+..+++.+|.++|+++ |+|||| ||.|||+++++.++|+|||++.....
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9998864431 1 11357789999999999988 999999 79999999999999999999996543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.8e-17 Score=158.99 Aligned_cols=147 Identities=24% Similarity=0.443 Sum_probs=128.2
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeC----CCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCC
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGE 414 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~----~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~ 414 (513)
+....+.|..+++||+|.|++||++.+. ..+.||+|.+...+. ...+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4455677889999999999999999853 467899999876543 356899999999996 999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC-CCeEEeeccC
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGM 493 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGl 493 (513)
...+|+||+++....+++. .++...+..+.+.+.+||.++|.++ ||||||||+|+|.+.. ++-.|.||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999999988883 3678888999999999999999998 9999999999999754 5679999999
Q ss_pred cccc
Q 010329 494 ARIF 497 (513)
Q Consensus 494 a~~~ 497 (513)
|...
T Consensus 180 A~~~ 183 (418)
T KOG1167|consen 180 AQRY 183 (418)
T ss_pred HHHH
Confidence 9854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=159.23 Aligned_cols=145 Identities=26% Similarity=0.388 Sum_probs=120.9
Q ss_pred CCCcccccCccCceeEEEEEeCCC--cEEEEEEecccCccCHHHHHHHHHHHHhCCC----CCccceeeEE-EeCCeeEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLPSG--QEIAVKRLSASSGQGAQEFKNEVVLVAKLQH----RNLVRLLGFC-LEGEEKIL 418 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~~~--~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~g~~-~~~~~~~l 418 (513)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999996543 4788887665433332367889999888873 6889999888 47778899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC-----CCeEEeeccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-----MNPKISDFGM 493 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~-----~~~ki~DfGl 493 (513)
||+.+ +.+|.++..... .+.++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 789998774433 578999999999999999999999988 9999999999999754 4699999999
Q ss_pred cc
Q 010329 494 AR 495 (513)
Q Consensus 494 a~ 495 (513)
++
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.5e-17 Score=167.17 Aligned_cols=146 Identities=27% Similarity=0.401 Sum_probs=121.2
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++.|.....+|.|+|+.|-++.. .+++..+||++..... +-.+|+.++... +|+||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 45677788899999999999984 5678899999876522 234566555554 69999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE-CCCCCeEEeeccCccccCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-DAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill-~~~~~~ki~DfGla~~~~~~ 500 (513)
++.++-|.+.+.. ..... ..+..|+.+|+.++.|||+++ ++||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988777632 22233 677789999999999999987 9999999999999 69999999999999988654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.4e-17 Score=147.77 Aligned_cols=146 Identities=25% Similarity=0.452 Sum_probs=117.9
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeE-EEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGF-CLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~-~~~~~~~~lv~e 421 (513)
+.|.+.+.||+|.||.+-.++.. ....+++|-+...- ...++|.+|...--.| .|.||+.-+++ +...+...+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 46788899999999999999965 46688888876543 2357888887654445 48999987754 455667779999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE-C-CCCCeEEeeccCccccC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-D-AEMNPKISDFGMARIFG 498 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill-~-~~~~~ki~DfGla~~~~ 498 (513)
|.|.|+|..-+. ...+-+....+++.|++.||.|+|+++ +||||||.+|||| + +..++|++|||+.+..+
T Consensus 103 ~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999987762 245777788899999999999999987 9999999999999 3 34589999999998654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=148.44 Aligned_cols=150 Identities=27% Similarity=0.390 Sum_probs=124.5
Q ss_pred cCCCcccccCccCceeEEEEE-eCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
-.|...++||+|.||.++.|+ +-+++.||||.-...+ ..-.+..|-+..+.|. .++|...+-+..++...+||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368889999999999999998 5689999999754433 2345677888888775 68999999888888899999998
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC-----CCCeEEeeccCcccc
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----EMNPKISDFGMARIF 497 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~-----~~~~ki~DfGla~~~ 497 (513)
+ +-||+++..- =...++.++...|+.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 6788877632 2346899999999999999999999987 999999999999953 345899999999999
Q ss_pred CCCCC
Q 010329 498 GVDQT 502 (513)
Q Consensus 498 ~~~~~ 502 (513)
.+..+
T Consensus 180 rDp~T 184 (449)
T KOG1165|consen 180 RDPKT 184 (449)
T ss_pred cCccc
Confidence 77654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-16 Score=153.08 Aligned_cols=159 Identities=21% Similarity=0.259 Sum_probs=129.5
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCC--C----CccceeeEEEeCC
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH--R----NLVRLLGFCLEGE 414 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H--~----nIv~l~g~~~~~~ 414 (513)
..+++|.+..++|+|.||.|-++... .+..||||+++.... -.+.-+-|++++.++.+ | -++++.+++.-.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 34788999999999999999999854 468899999876542 23455678999999942 2 2778888898899
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC------------
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA------------ 482 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~------------ 482 (513)
..++|+|.+ |-|+.++|.. ++..+++..++..|+.|++++++|||+.. ++|-||||+|||+-+
T Consensus 165 hiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred ceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 999999988 5589999954 44567899999999999999999999987 999999999999922
Q ss_pred --------CCCeEEeeccCccccCCCCCcccc
Q 010329 483 --------EMNPKISDFGMARIFGVDQTQGNT 506 (513)
Q Consensus 483 --------~~~~ki~DfGla~~~~~~~~~~~~ 506 (513)
+..+||+|||-|++..++......
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVs 271 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHHSTIVS 271 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCcceeee
Confidence 234899999999998877654433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=6e-16 Score=135.91 Aligned_cols=137 Identities=20% Similarity=0.179 Sum_probs=115.9
Q ss_pred cccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCC--CCccceeeEEEeCCeeEEEEecCCCC
Q 010329 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 349 ~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lv~ey~~~g 426 (513)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++...++..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999854 7899998865443 4678999999999986 58999999888888899999999988
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
.+..+ ++.....++.+++++|.+||......++|+|++|+||++++.+.+++.|||+++...
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 76432 566777889999999999998654569999999999999998999999999998654
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.8e-16 Score=141.41 Aligned_cols=138 Identities=20% Similarity=0.257 Sum_probs=99.6
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCcc--CHHHH----------------------HHHHHHHHhCCCCC--c
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ--GAQEF----------------------KNEVVLVAKLQHRN--L 403 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~--~~~~~----------------------~~E~~~l~~l~H~n--I 403 (513)
.+.||+|+||.||++...+++.||||.+...... ....+ ..|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987653221 11111 34566666665433 4
Q ss_pred cceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeecCCcCCcEEECC
Q 010329 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDA 482 (513)
Q Consensus 404 v~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrdlk~~Nill~~ 482 (513)
.+.++. ...++||||++++.+........ ... .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 34689999999965432211100 011 5677899999999999998 65 99999999999999
Q ss_pred CCCeEEeeccCccccCC
Q 010329 483 EMNPKISDFGMARIFGV 499 (513)
Q Consensus 483 ~~~~ki~DfGla~~~~~ 499 (513)
++.++|+|||.++....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999987754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.5e-16 Score=153.54 Aligned_cols=135 Identities=24% Similarity=0.380 Sum_probs=110.8
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-----C---CCccceeeEEEe--
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-----H---RNLVRLLGFCLE-- 412 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~g~~~~-- 412 (513)
..+|...++||.|-|++||++.. .+.+.||+|+++... .-.+.-..||++|+.++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36889999999999999999995 456789999987532 33456788999999884 3 369999999975
Q ss_pred --CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC
Q 010329 413 --GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE 483 (513)
Q Consensus 413 --~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~ 483 (513)
+...+||+|++ |.+|..+|.... .+.++...+..|+.||+.||.|||.++ +|||-||||+|||+-.+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 45789999999 567777775433 345889999999999999999999987 79999999999999544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-16 Score=148.95 Aligned_cols=146 Identities=31% Similarity=0.426 Sum_probs=119.1
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC------e
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------E 415 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~ 415 (513)
.+|.....+|.|.- .|-.+.. -.++.|++|++... .....+.-.+|..++..++|+||++++.++.-.+ +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45555667777776 4555542 25789999987643 3344577889999999999999999999987543 5
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++|||||. .+|...++ ..++-.+...|..|++.|+.|||+.+ |+||||||+||++..+...||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 689999995 67888773 45788899999999999999999987 9999999999999999999999999999
Q ss_pred ccCCC
Q 010329 496 IFGVD 500 (513)
Q Consensus 496 ~~~~~ 500 (513)
.-+.+
T Consensus 167 ~e~~~ 171 (369)
T KOG0665|consen 167 TEDTD 171 (369)
T ss_pred ccCcc
Confidence 66544
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.5e-15 Score=141.62 Aligned_cols=136 Identities=22% Similarity=0.267 Sum_probs=105.7
Q ss_pred cccC-ccCceeEEEEEeCCCcEEEEEEecccC-------------ccCHHHHHHHHHHHHhCCCCCc--cceeeEEEeCC
Q 010329 351 NKLG-EGGFGEVYKGVLPSGQEIAVKRLSASS-------------GQGAQEFKNEVVLVAKLQHRNL--VRLLGFCLEGE 414 (513)
Q Consensus 351 ~~Lg-~G~fG~Vy~~~~~~~~~VavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~g~~~~~~ 414 (513)
..|| .|+.|+||+.... +..++||+..... ......+.+|+.++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4677 8888999999874 7788988774311 1223567889999999998885 67777654432
Q ss_pred ----eeEEEEecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEe
Q 010329 415 ----EKILVYEFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (513)
Q Consensus 415 ----~~~lv~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 489 (513)
..++|+||+++ .+|.+++.+ ..++.. ...+|+.+|.+||+.+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 689888733 234543 3568999999999988 9999999999999998999999
Q ss_pred eccCccccC
Q 010329 490 DFGMARIFG 498 (513)
Q Consensus 490 DfGla~~~~ 498 (513)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999999765
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.1e-14 Score=140.84 Aligned_cols=150 Identities=35% Similarity=0.533 Sum_probs=127.7
Q ss_pred CCcccccCccCceeEEEEEeCCCcEEEEEEecccCcc---CHHHHHHHHHHHHhCCCC-CccceeeEEEeCCeeEEEEec
Q 010329 347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ---GAQEFKNEVVLVAKLQHR-NLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lv~ey 422 (513)
|...+.||.|.||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++.+.+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556788999999999999976 78899988765332 367899999999999988 799999999777778999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC-CeEEeeccCccccCCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQ 501 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~~~~ 501 (513)
+.++++.+++........+.......+..+++.++.|+|+.+ ++|||+||.||+++... .+++.|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977743211136888999999999999999999987 99999999999999988 79999999999775543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.4e-15 Score=146.73 Aligned_cols=158 Identities=21% Similarity=0.267 Sum_probs=133.9
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCC------CCCccceeeEEE
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ------HRNLVRLLGFCL 411 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~g~~~ 411 (513)
-.+....+|......|+|-|++|.+|.. ..|+.||||++.... ...+.=..|+++|++|+ .-|+++|+-.|.
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 3456678888888999999999999995 357899999998653 22355677999999995 348999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC-CeEEee
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISD 490 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~D 490 (513)
....++||+|-+ ..+|.++|.....+-.|....+..++.|+..+|..|...+ |+|.||||.|||+++.- .+||+|
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeecc
Confidence 999999999987 5689999977667777899999999999999999999877 99999999999998765 689999
Q ss_pred ccCccccCCCC
Q 010329 491 FGMARIFGVDQ 501 (513)
Q Consensus 491 fGla~~~~~~~ 501 (513)
||-|-+..+..
T Consensus 581 fGSA~~~~ene 591 (752)
T KOG0670|consen 581 FGSASFASENE 591 (752)
T ss_pred Ccccccccccc
Confidence 99998776544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.9e-15 Score=160.67 Aligned_cols=149 Identities=24% Similarity=0.331 Sum_probs=120.0
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC---CCCccceeeEEEeCCee
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~ 416 (513)
.++....|.+.++||+|+||+||+|...+|+.||+|.-+..+. .+|.-=.+++.+|+ -+-|..+.....-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3455677888899999999999999987899999998776543 23333344555555 23455555666667888
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC-------CCCCeEEe
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-------AEMNPKIS 489 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~-------~~~~~ki~ 489 (513)
+||+||.+-|+|.+++. ..+.++|.....++.|+++-++.||..+ |||+||||+|+||. ....++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999993 5667999999999999999999999987 99999999999993 23459999
Q ss_pred eccCcccc
Q 010329 490 DFGMARIF 497 (513)
Q Consensus 490 DfGla~~~ 497 (513)
|||.+-.+
T Consensus 844 DfG~siDm 851 (974)
T KOG1166|consen 844 DFGRSIDM 851 (974)
T ss_pred ecccceee
Confidence 99998654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.3e-14 Score=145.69 Aligned_cols=143 Identities=21% Similarity=0.286 Sum_probs=100.6
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCccCH----------------------------------------HHHH
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGA----------------------------------------QEFK 389 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~----------------------------------------~~~~ 389 (513)
.+.||.|++|+||+|++.+|+.||||..++...... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999866421100 0244
Q ss_pred HHHHHHHhCC----CCCccceeeEEE-eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHhHcC
Q 010329 390 NEVVLVAKLQ----HRNLVRLLGFCL-EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR-GILYLHED 463 (513)
Q Consensus 390 ~E~~~l~~l~----H~nIv~l~g~~~-~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~ 463 (513)
+|+..+.+++ |.+-+.+-.++. .....+|||||+++++|.++.... ....+ +..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 5555555542 333233222332 245679999999999998876321 11122 3456666665 46788887
Q ss_pred CCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 464 ~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+ ++|+|++|.||++++++++++.|||++..+.+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 7 999999999999999999999999999988643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.2e-12 Score=114.91 Aligned_cols=132 Identities=20% Similarity=0.163 Sum_probs=97.9
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCcc-ceeeEEEeCCeeEEEEecCCCCCh
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVPNKSL 428 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~ey~~~gsL 428 (513)
.+.|+.|.++.||+.... +..+++|....... ....+..|+.++..+.+.+++ +++... .+..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356889999999999974 77899998755432 123467899999988765544 455443 3446899999999887
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC--CCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
.... . ....+..++++.|..||... +..++|+|++|.||+++ ++.++++|||.+..-
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 5320 0 11235678999999999875 23369999999999999 668999999998854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-12 Score=135.81 Aligned_cols=145 Identities=17% Similarity=0.217 Sum_probs=94.2
Q ss_pred hcCCCcccccCccCceeEEEEEeCC-CcEEEEEEecccCcc----------------------------------CHH--
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQ----------------------------------GAQ-- 386 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~~~----------------------------------~~~-- 386 (513)
...|+. +.||+|++|+||+|++++ |++||||.+++.-.. ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 789999999999999987 999999998754210 011
Q ss_pred ----HHHHHHHHHHhCC----CCCccceeeEEEe-CCeeEEEEecCCCCChhhhhcCCCCCC----CCCHHHHHHHHHHH
Q 010329 387 ----EFKNEVVLVAKLQ----HRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQG----QLDWSRRYKIIGGI 453 (513)
Q Consensus 387 ----~~~~E~~~l~~l~----H~nIv~l~g~~~~-~~~~~lv~ey~~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~i 453 (513)
+|.+|+..+.+++ +.+.+.+-.++.+ .....|||||++|+.+.++-.- ...+ .+.......++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Q- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQ- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHH-
Confidence 1334444444442 3333333333332 4567899999999999775210 1111 1222222222333
Q ss_pred HHHHHHhHcCCCCCeeecCCcCCcEEECCCC----CeEEeeccCccccCCC
Q 010329 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFGMARIFGVD 500 (513)
Q Consensus 454 a~gL~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DfGla~~~~~~ 500 (513)
++..+ ++|+|++|.||+++.++ ++++.|||+...+.+.
T Consensus 276 ------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 ------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 34455 99999999999999888 9999999999988643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.6e-13 Score=124.29 Aligned_cols=138 Identities=25% Similarity=0.424 Sum_probs=114.5
Q ss_pred cccccCccCceeEEEEEeCCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCC
Q 010329 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 349 ~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 426 (513)
+..+|.+...|..|+|++. |..+++|.+... .....++|.+|.-.|+.+.||||+.++|.|.......++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3457888899999999994 556667766543 2233467999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEe
Q 010329 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (513)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 489 (513)
||...|++. ..-.++..+..+++.+|++||.|||+-.+ -|.---|.++.|+||++.+++|+
T Consensus 273 slynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 273 SLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee
Confidence 999999763 33457889999999999999999999863 24445699999999999998875
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=7.1e-11 Score=107.40 Aligned_cols=138 Identities=15% Similarity=0.119 Sum_probs=100.5
Q ss_pred cccCccCceeEEEEEeCC-------CcEEEEEEecccC----------------------ccCHHHHH----HHHHHHHh
Q 010329 351 NKLGEGGFGEVYKGVLPS-------GQEIAVKRLSASS----------------------GQGAQEFK----NEVVLVAK 397 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~-------~~~VavK~l~~~~----------------------~~~~~~~~----~E~~~l~~ 397 (513)
..||.|.-+.||.|.-.+ +..+|||..+... ....+.+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 4789999764310 00122233 78999998
Q ss_pred CCC--CCccceeeEEEeCCeeEEEEecCCCCChhh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHh-HcCCCCCeeecCC
Q 010329 398 LQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDY-FLYDPEKQGQLDWSRRYKIIGGIARGILYL-HEDSRLRIIHRDL 473 (513)
Q Consensus 398 l~H--~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrdl 473 (513)
+.. -++.+.+++ ...+|||||+.++.+.. .+. ...++..+...+..+++..|..| |..+ ++|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 864 567777764 56789999997654422 221 22345556677889999999999 7766 999999
Q ss_pred cCCcEEECCCCCeEEeeccCccccCCC
Q 010329 474 KASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 474 k~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
++.|||++ ++.++|+|||.+.....+
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCCC
Confidence 99999997 467999999999877543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.3e-12 Score=137.06 Aligned_cols=157 Identities=26% Similarity=0.370 Sum_probs=116.7
Q ss_pred CcccccCccCceeEEEEEeC-CCcEEEEEEec----c-cCcc-CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 348 STDNKLGEGGFGEVYKGVLP-SGQEIAVKRLS----A-SSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~----~-~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
...+.+|.|++|.|+..... .....+.|..+ . .... ....+..|..+-..+.|+|++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999977777632 22223333221 1 1111 1122566777788899999988888777777766679
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++ +|..++.. ...+....+..+..|+..|+.|||+.+ |.|||||++|+++..++.+||+|||.+..+.-+
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99988833 346888899999999999999999988 999999999999999999999999999988544
Q ss_pred CCc--cccceeee
Q 010329 501 QTQ--GNTSRIVG 511 (513)
Q Consensus 501 ~~~--~~~~~~~G 511 (513)
... .....++|
T Consensus 474 ~e~~~~~~~g~~g 486 (601)
T KOG0590|consen 474 WEKNIHESSGIVG 486 (601)
T ss_pred cchhhhhhcCccc
Confidence 333 33334444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.1e-12 Score=141.11 Aligned_cols=87 Identities=17% Similarity=0.242 Sum_probs=67.4
Q ss_pred hCCC-CCccceeeEE-------EeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCe
Q 010329 397 KLQH-RNLVRLLGFC-------LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468 (513)
Q Consensus 397 ~l~H-~nIv~l~g~~-------~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 468 (513)
.++| .||.++++++ .+.+..++++||+ +++|.++|.. ....+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 5777788876 2334567788987 5699999953 2356999999999999999999999987 9
Q ss_pred eecCCcCCcEEECCCCCeEEe
Q 010329 469 IHRDLKASNILLDAEMNPKIS 489 (513)
Q Consensus 469 vHrdlk~~Nill~~~~~~ki~ 489 (513)
+||||||+||||+..+.+|++
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~ 122 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFI 122 (793)
T ss_pred eeccCCchhEEEcccCcEEEe
Confidence 999999999999654333333
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.7e-10 Score=108.37 Aligned_cols=143 Identities=19% Similarity=0.270 Sum_probs=111.3
Q ss_pred cccCccCceeEEEEEeCCCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCC--CCccceeeEEEeCC---eeEEEEecCC
Q 010329 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQH--RNLVRLLGFCLEGE---EKILVYEFVP 424 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~---~~~lv~ey~~ 424 (513)
+.|+.|..+.||++...+|+.+++|....... .....+..|.+++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987678899998765432 134578899999999976 44677887766543 5689999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC----------------------------------------
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS---------------------------------------- 464 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 464 (513)
+.++.+.+. ...++..+...++.++++.|..||+..
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 998876552 135777888888888999998888531
Q ss_pred -------------CCCeeecCCcCCcEEECC--CCCeEEeeccCcccc
Q 010329 465 -------------RLRIIHRDLKASNILLDA--EMNPKISDFGMARIF 497 (513)
Q Consensus 465 -------------~~~ivHrdlk~~Nill~~--~~~~ki~DfGla~~~ 497 (513)
...++|+|+.+.||+++. +..+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 244799999999999998 567899999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.4e-10 Score=100.41 Aligned_cols=135 Identities=20% Similarity=0.301 Sum_probs=101.9
Q ss_pred cccCccCceeEEEEEeCCCcEEEEEEe-ccc--Ccc-----CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 351 NKLGEGGFGEVYKGVLPSGQEIAVKRL-SAS--SGQ-----GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~~~VavK~l-~~~--~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
..+++|+-..+|.+.+. |.++++|.- ++. .++ ....-.+|+.++.+++--.|..-+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999773 445666642 221 111 123457799999999866666666667788888999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+++..|.+.+... ...++..|-.-+.-||..+ |+|+||.++||++..+. +.++||||+.+-...
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~ 144 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEV 144 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccH
Confidence 9999999888432 2556667777788899988 99999999999997766 999999999976543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.3e-11 Score=125.94 Aligned_cols=144 Identities=25% Similarity=0.272 Sum_probs=115.8
Q ss_pred ccCccCceeEEEEEe----CCCcEEEEEEecccCcc--CHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEEecCC
Q 010329 352 KLGEGGFGEVYKGVL----PSGQEIAVKRLSASSGQ--GAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~----~~~~~VavK~l~~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
.+|+|.||.|+...- +.+.-.+.|.+++.... .......|..++...+ |+.++++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999997652 34556677766553211 1114456778888887 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
+|.|...+. ....++......+..+++-+++++|+.+ |+|||+|++||+++.+|.+|+.|||+++..-+..
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 999977773 3445677777778889999999999987 9999999999999999999999999999875443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.9e-11 Score=119.36 Aligned_cols=100 Identities=31% Similarity=0.540 Sum_probs=90.9
Q ss_pred HHhCCCCCccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCc
Q 010329 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK 474 (513)
Q Consensus 395 l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk 474 (513)
|+.+.|.|+.+|+|.+.++...+.|.+|++.|+|.+.+.. ....++|.-...++.+|++||.|||.-. -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568899999999999999999999999999999999965 3556999999999999999999999753 23999999
Q ss_pred CCcEEECCCCCeEEeeccCccccC
Q 010329 475 ASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 475 ~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++|+++|..+.+||+|||+..+..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999998874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.2e-11 Score=130.64 Aligned_cols=142 Identities=19% Similarity=0.195 Sum_probs=113.6
Q ss_pred CCCcccccCccCceeEEEEEeCCCcEEEEEEecccC-ccCHHHHHHHHHH--HHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS-GQGAQEFKNEVVL--VAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~-~~~~~~~~~E~~~--l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++...+.||.+.|=+|.+++.++|. |+||.+.+.. ....+.|.++++- ....+|||++++.-+-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998887 8888876543 3344555554443 5556899999998887777777888888
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
..+ +|.+.| ..+..+...+...|+.|+++||.-+|..+ |+|+|||.+||||.+..-+.|+||.-=+
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 854 576666 33455777888899999999999999987 9999999999999999999999996443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.7e-09 Score=94.63 Aligned_cols=148 Identities=23% Similarity=0.311 Sum_probs=105.5
Q ss_pred cccccCccCceeEEEEEeCCCcEEEEEEe-ccc-------CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRL-SAS-------SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 349 ~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l-~~~-------~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
....|-+|+-+.|+++.+ .|+...||.- .+. ..-..++..+|++.+.+++--.|.--.=++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456788999999999998 5666666642 221 1112356778999999987555554445666777778999
Q ss_pred ecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC---CeEEeeccCccc
Q 010329 421 EFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMARI 496 (513)
Q Consensus 421 ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DfGla~~ 496 (513)
||+++ -++.+++.........+ .....++..|-+-+.-||.++ |+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 46777775432222222 233678888888999999987 99999999999996554 458999999986
Q ss_pred cCCCC
Q 010329 497 FGVDQ 501 (513)
Q Consensus 497 ~~~~~ 501 (513)
-..+.
T Consensus 166 s~~~E 170 (229)
T KOG3087|consen 166 SRLPE 170 (229)
T ss_pred ccCcc
Confidence 64433
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.3e-08 Score=97.86 Aligned_cols=139 Identities=17% Similarity=0.144 Sum_probs=100.4
Q ss_pred cCccCceeEEEEEeCCCcEEEEEEecccCcc-----------CHHHHHHHHHHHHhCCCCC--ccceeeEEEe-----CC
Q 010329 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ-----------GAQEFKNEVVLVAKLQHRN--LVRLLGFCLE-----GE 414 (513)
Q Consensus 353 Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~-----~~ 414 (513)
+-+.....|++..+ +|+.+.||+....... ....+.+|...+.++...+ +++.+++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344677777 6778999976433211 1124778999888885444 4455666654 23
Q ss_pred eeEEEEecCCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC-------CCCe
Q 010329 415 EKILVYEFVPNK-SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-------EMNP 486 (513)
Q Consensus 415 ~~~lv~ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~-------~~~~ 486 (513)
..+||+|++++- +|.+++.+.. ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 578999999986 8988874211 234556677889999999999999998 999999999999975 5689
Q ss_pred EEeeccCccc
Q 010329 487 KISDFGMARI 496 (513)
Q Consensus 487 ki~DfGla~~ 496 (513)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.4e-09 Score=95.33 Aligned_cols=127 Identities=25% Similarity=0.343 Sum_probs=83.5
Q ss_pred eEEEEEeCCCcEEEEEEecccCc---------------------c-C----HHHHHHHHHHHHhCCCC--CccceeeEEE
Q 010329 360 EVYKGVLPSGQEIAVKRLSASSG---------------------Q-G----AQEFKNEVVLVAKLQHR--NLVRLLGFCL 411 (513)
Q Consensus 360 ~Vy~~~~~~~~~VavK~l~~~~~---------------------~-~----~~~~~~E~~~l~~l~H~--nIv~l~g~~~ 411 (513)
.||.|...+|..+|||..+.... . . .....+|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999988999999997654210 0 0 13456799999999866 56677655
Q ss_pred eCCeeEEEEecCC--CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-hHcCCCCCeeecCCcCCcEEECCCCCeEE
Q 010329 412 EGEEKILVYEFVP--NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY-LHEDSRLRIIHRDLKASNILLDAEMNPKI 488 (513)
Q Consensus 412 ~~~~~~lv~ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivHrdlk~~Nill~~~~~~ki 488 (513)
....|||||++ +..+..+... .++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 25679999998 5555443311 11133455677777776665 46766 9999999999999888 8999
Q ss_pred eeccCccccCC
Q 010329 489 SDFGMARIFGV 499 (513)
Q Consensus 489 ~DfGla~~~~~ 499 (513)
+|||.+.....
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.2e-09 Score=101.92 Aligned_cols=149 Identities=21% Similarity=0.337 Sum_probs=96.3
Q ss_pred CCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCC----------CCccceeeEEE-
Q 010329 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQH----------RNLVRLLGFCL- 411 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H----------~nIv~l~g~~~- 411 (513)
+...+.||.|+++.||.++.. ++++++||..... .....+++++|...+..+.+ -.++--++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999975 4899999976432 22345778877766655433 11221122211
Q ss_pred --------eCC--------eeEEEEecCCCCChhhhhc---CC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeec
Q 010329 412 --------EGE--------EKILVYEFVPNKSLDYFLY---DP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471 (513)
Q Consensus 412 --------~~~--------~~~lv~ey~~~gsL~~~l~---~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 471 (513)
.+. ..+++|+-+ .++|.+++. .. .....+....++.+..|+++.+++||..+ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 111 225677766 578877753 11 11223445566778899999999999998 9999
Q ss_pred CCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 472 DLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 472 dlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+|+|++++++|.++|+||+-....+.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~ 197 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT 197 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc
Confidence 9999999999999999999988876643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.6e-09 Score=104.82 Aligned_cols=91 Identities=26% Similarity=0.439 Sum_probs=70.6
Q ss_pred CCCCccceeeEEEeC---------------------------CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHH
Q 010329 399 QHRNLVRLLGFCLEG---------------------------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451 (513)
Q Consensus 399 ~H~nIv~l~g~~~~~---------------------------~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 451 (513)
+|||||+++++|.+. ..+|+||.-++ .+|..++-. ...+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 599999998877642 34678888775 578888832 2345555666888
Q ss_pred HHHHHHHHhHcCCCCCeeecCCcCCcEEE--CCCC--CeEEeeccCcccc
Q 010329 452 GIARGILYLHEDSRLRIIHRDLKASNILL--DAEM--NPKISDFGMARIF 497 (513)
Q Consensus 452 ~ia~gL~yLH~~~~~~ivHrdlk~~Nill--~~~~--~~ki~DfGla~~~ 497 (513)
|+++|+.|||.++ |.|||+|++|||| |+|. ...|+|||.+---
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd 395 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLAD 395 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeec
Confidence 9999999999998 9999999999999 4444 4789999988643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.8e-08 Score=89.81 Aligned_cols=136 Identities=21% Similarity=0.277 Sum_probs=95.8
Q ss_pred CCcccccCccCceeEEEEEeCCCcEEEEEEecccCc----------------------cCHHHHHHHHHHHHhCCCC--C
Q 010329 347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSG----------------------QGAQEFKNEVVLVAKLQHR--N 402 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~H~--n 402 (513)
..+.++||.|.-+.||.|..+.|.+++||.-+.... .......+|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345688999999999999999999999995433110 0012346788999998755 6
Q ss_pred ccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC
Q 010329 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482 (513)
Q Consensus 403 Iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~ 482 (513)
|.+.+++ +...+||||+++--|...- ++.+..-.|+..|+.-+.-+-..+ ++|+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7776665 5678999999886553221 122333334444444444444445 999999999999999
Q ss_pred CCCeEEeeccCcccc
Q 010329 483 EMNPKISDFGMARIF 497 (513)
Q Consensus 483 ~~~~ki~DfGla~~~ 497 (513)
++.+.++||=-+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999665544
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=4e-08 Score=101.67 Aligned_cols=122 Identities=19% Similarity=0.224 Sum_probs=100.3
Q ss_pred eCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHH
Q 010329 366 LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR 445 (513)
Q Consensus 366 ~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~ 445 (513)
..++.+|.|...+...........+-++.|+.+|||||++++......+..|||+|-+. -|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34678888888876655444567777899999999999999999999999999999873 46666632 23455
Q ss_pred HHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 446 ~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
....+.||+.||.|||+.+ +++|++|.-..|++++.|+.||.+|-++...
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 6667889999999999876 5999999999999999999999999888644
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.7e-08 Score=96.27 Aligned_cols=140 Identities=21% Similarity=0.312 Sum_probs=111.1
Q ss_pred eeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEe----CCeeEEEEecCCC-CChhhhh
Q 010329 359 GEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVYEFVPN-KSLDYFL 432 (513)
Q Consensus 359 G~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~ey~~~-gsL~~~l 432 (513)
.+.||+.- -+|..+++|+++............-+++++++.|.|||+|..++.. ...+.+||+|+|+ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 56788873 4789999999954433333334456788999999999999998874 3457899999985 5665554
Q ss_pred cCC------------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 433 YDP------------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 433 ~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+.. ..+...++..++.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|+..++.++
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 321 23345778899999999999999999988 888999999999999999999999999988766
Q ss_pred C
Q 010329 501 Q 501 (513)
Q Consensus 501 ~ 501 (513)
.
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 5
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.9e-09 Score=113.59 Aligned_cols=151 Identities=25% Similarity=0.368 Sum_probs=118.0
Q ss_pred cCCCcccccCccCceeEEEEEeCC--CcEEEEEEecccC--ccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPS--GQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~--~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv 419 (513)
..|...+.||+|.|+.|-...... ...+++|.+.... ....+....|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456667789999999998887533 3456666665432 223344555777666676 99999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhH-cCCCCCeeecCCcCCcEEECCCC-CeEEeeccCcccc
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH-EDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIF 497 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~ 497 (513)
.||-.++++.+.+... .....+......+..|+..++.|+| ..+ +.||||||+|.+++..+ ..|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998777211 1113455666778899999999999 766 99999999999999999 9999999999988
Q ss_pred CC
Q 010329 498 GV 499 (513)
Q Consensus 498 ~~ 499 (513)
..
T Consensus 176 ~~ 177 (601)
T KOG0590|consen 176 RN 177 (601)
T ss_pred cc
Confidence 65
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.5e-07 Score=85.89 Aligned_cols=108 Identities=27% Similarity=0.305 Sum_probs=86.1
Q ss_pred HHHHHHHHHHHHhCCC--CCccceeeEEEeCC----eeEEEEecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 010329 385 AQEFKNEVVLVAKLQH--RNLVRLLGFCLEGE----EKILVYEFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457 (513)
Q Consensus 385 ~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~----~~~lv~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL 457 (513)
.....+|...+..++. -.+++.+++..... ..++|+|++++ .+|.+++.+. ...+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 3467888888888754 44566777776633 45899999997 4799988432 1256667788999999999
Q ss_pred HHhHcCCCCCeeecCCcCCcEEECCCC---CeEEeeccCccccC
Q 010329 458 LYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMARIFG 498 (513)
Q Consensus 458 ~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DfGla~~~~ 498 (513)
.-||+.+ |+|+|++++|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999998 99999999999998887 89999999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.1e-07 Score=98.89 Aligned_cols=142 Identities=17% Similarity=0.276 Sum_probs=93.0
Q ss_pred cccCccCceeEEEEEeCCCcEEEEEEecccCccC------------------------------HH----------HHHH
Q 010329 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQG------------------------------AQ----------EFKN 390 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~------------------------------~~----------~~~~ 390 (513)
+-|+.++-|+||+|++++|++||||..++.-... .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5688999999999999999999999887631100 01 1234
Q ss_pred HHHHHHhCC-----CCCccceeeEEE-eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 010329 391 EVVLVAKLQ-----HRNLVRLLGFCL-EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464 (513)
Q Consensus 391 E~~~l~~l~-----H~nIv~l~g~~~-~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 464 (513)
|...+.+++ .++| .+=.+++ -.....|+|||++|..+.+...- +...++.+.......++. +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHH--HhcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 544444442 2222 2222333 35678899999999999887421 123355333332222222 22222234
Q ss_pred CCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 465 ~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
++|.|..|.||+++.++++.+.|||+...+.+.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999999988654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.2e-06 Score=80.02 Aligned_cols=140 Identities=16% Similarity=0.121 Sum_probs=104.2
Q ss_pred cCccCceeEEEEEeCCCcEEEEEEeccc---C---ccCHHHHHHHHHHHHhCCCC--CccceeeEEEeC----CeeEEEE
Q 010329 353 LGEGGFGEVYKGVLPSGQEIAVKRLSAS---S---GQGAQEFKNEVVLVAKLQHR--NLVRLLGFCLEG----EEKILVY 420 (513)
Q Consensus 353 Lg~G~fG~Vy~~~~~~~~~VavK~l~~~---~---~~~~~~~~~E~~~l~~l~H~--nIv~l~g~~~~~----~~~~lv~ 420 (513)
-|+|+-+.|++-.+. |..+-+|+-... + +.....|.+|...|..+... .+.+.+...... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 466888889998774 447888876521 1 44567899999999998643 355555322222 2368999
Q ss_pred ecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC--eEEeeccCcccc
Q 010329 421 EFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--PKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~--~ki~DfGla~~~ 497 (513)
|-+++ .+|.+++.+. ...+.+...+..+..+|++.+.-||+.+ +.|+|+.++||+++.++. ++++||.-++..
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 97764 6888887432 2235677788899999999999999988 999999999999986666 999999888754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=9.7e-08 Score=90.61 Aligned_cols=96 Identities=27% Similarity=0.324 Sum_probs=80.4
Q ss_pred HHHHhCCCCCccceeeEEEeC-----CeeEEEEecCCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHhHcCCCC
Q 010329 393 VLVAKLQHRNLVRLLGFCLEG-----EEKILVYEFVPNKSLDYFLYDPEK-QGQLDWSRRYKIIGGIARGILYLHEDSRL 466 (513)
Q Consensus 393 ~~l~~l~H~nIv~l~g~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 466 (513)
..|-.+.|.|||+++.|+.+. .+..+++|||+.|+|..+|++..+ +..+......+++.||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 345566799999999998754 357899999999999999965433 334777788899999999999999975 7
Q ss_pred CeeecCCcCCcEEECCCCCeEEe
Q 010329 467 RIIHRDLKASNILLDAEMNPKIS 489 (513)
Q Consensus 467 ~ivHrdlk~~Nill~~~~~~ki~ 489 (513)
+|+|+++..+-|++..++-+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccccCCcchhheeecCCceEEec
Confidence 89999999999999999988874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.2e-07 Score=97.17 Aligned_cols=149 Identities=24% Similarity=0.261 Sum_probs=117.9
Q ss_pred HhcCCCcccccCccCceeEEEEEe--CCCcEEEEEEecccCccCHHH--HHHHHHHHHhC-CCCCccceeeEEEeCCeeE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSASSGQGAQE--FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~--~~~~~VavK~l~~~~~~~~~~--~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 417 (513)
...+|.++..||.|.|+.|++... .++..+++|.+.+.......+ -..|+.+...+ .|.++++....+..-+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 445788899999999999999874 356788999877653332222 23456666665 4889999888888888888
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC-CCeEEeeccCccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARI 496 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGla~~ 496 (513)
+--||++++++...+ .-...++...++++..+++.++.++|+.. ++|+|+||+||++..+ +..++.|||....
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999987665 23345788888999999999999999876 9999999999999876 7889999999874
Q ss_pred c
Q 010329 497 F 497 (513)
Q Consensus 497 ~ 497 (513)
+
T Consensus 417 ~ 417 (524)
T KOG0601|consen 417 L 417 (524)
T ss_pred c
Confidence 3
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.7e-06 Score=78.43 Aligned_cols=139 Identities=17% Similarity=0.226 Sum_probs=85.8
Q ss_pred cccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCC--ccceeeEEEeCCeeEEEEecCCCCC-
Q 010329 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN--LVRLLGFCLEGEEKILVYEFVPNKS- 427 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lv~ey~~~gs- 427 (513)
..||+|..+.||+. .+..+++|...... ......+|.+++..+.... +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24567788766533 2355788999999886444 4677888877777889999999863
Q ss_pred hhhhh---------------------cCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHhHc-CCCCCeeecCC
Q 010329 428 LDYFL---------------------YDPEKQGQLDWSRRY-KIIG----------GIAR-GILYLHE-DSRLRIIHRDL 473 (513)
Q Consensus 428 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------~ia~-gL~yLH~-~~~~~ivHrdl 473 (513)
+...+ |.... ......... .+-. .+.. ...+|.. .....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 22111 11000 001111000 0000 0011 1122221 12345789999
Q ss_pred cCCcEEECCCCCeEEeeccCccc
Q 010329 474 KASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 474 k~~Nill~~~~~~ki~DfGla~~ 496 (513)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.6e-07 Score=81.67 Aligned_cols=62 Identities=23% Similarity=0.160 Sum_probs=53.8
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|+|.+++.+ ....++|.++..|+.||++||.|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 689999853 2446999999999999999999999864 999999999999999 9999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.4e-07 Score=95.05 Aligned_cols=150 Identities=22% Similarity=0.284 Sum_probs=117.8
Q ss_pred CCCcccccCc--cCceeEEEEEe---CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeE
Q 010329 346 KFSTDNKLGE--GGFGEVYKGVL---PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 346 ~~~~~~~Lg~--G~fG~Vy~~~~---~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~ 417 (513)
.+.....+|. |.+|.||.+.. .++..+|+|+-+.. .+.....=.+|+...++++ |+|.++....+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556677899 99999999986 35778899974432 2233333456677777775 999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHhHcCCCCCeeecCCcCCcEEECCC-CCeEEeecc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR----GILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFG 492 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfG 492 (513)
+-+|++. .+|..+.+. ....++......+..+... ||.++|... ++|-|+||.||++..+ ..++++|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999885 778777754 2334666667777777777 999999987 9999999999999998 889999999
Q ss_pred CccccCCCC
Q 010329 493 MARIFGVDQ 501 (513)
Q Consensus 493 la~~~~~~~ 501 (513)
+...+++..
T Consensus 269 ~v~~i~~~~ 277 (524)
T KOG0601|consen 269 LVSKISDGN 277 (524)
T ss_pred eeEEccCCc
Confidence 999887654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=8.4e-06 Score=74.85 Aligned_cols=140 Identities=14% Similarity=0.164 Sum_probs=93.7
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHH---------HHHHHHHHHhCCCC---CccceeeE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQE---------FKNEVVLVAKLQHR---NLVRLLGF 409 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~---------~~~E~~~l~~l~H~---nIv~l~g~ 409 (513)
....+|...+.+-......|.+-.. +|...++|..++.....++. ..+++..+.+++.. ....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4556788778887777777777776 56788888776543322222 23444445555432 33333333
Q ss_pred EEe-----CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC
Q 010329 410 CLE-----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (513)
Q Consensus 410 ~~~-----~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~ 484 (513)
... ....+|+|||++|..|.++. .++. .+...+.+.|.-||+.+ ++|+|..|+|+++..++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 322 23456899999998886654 1222 24456778899999998 99999999999998655
Q ss_pred CeEEeeccCcccc
Q 010329 485 NPKISDFGMARIF 497 (513)
Q Consensus 485 ~~ki~DfGla~~~ 497 (513)
++++||+.-+..
T Consensus 173 -i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 -IRIIDTQGKRMS 184 (229)
T ss_pred -EEEEECcccccc
Confidence 999999887643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.8e-07 Score=94.39 Aligned_cols=81 Identities=27% Similarity=0.395 Sum_probs=72.5
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..++.|+++...+|.+||.........+|...+.++.|++.|++| ++ .+|||+||.||+...+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999766667778999999999999999999 44 899999999999999999999999999
Q ss_pred cccCCCC
Q 010329 495 RIFGVDQ 501 (513)
Q Consensus 495 ~~~~~~~ 501 (513)
.......
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 8776554
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1e-05 Score=75.04 Aligned_cols=138 Identities=21% Similarity=0.256 Sum_probs=91.1
Q ss_pred ccCccCceeEEEEEeCCCcEEEEEEecccCccCH---------H---------------HHHHHHHHHHhCC--CCCccc
Q 010329 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGA---------Q---------------EFKNEVVLVAKLQ--HRNLVR 405 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~---------~---------------~~~~E~~~l~~l~--H~nIv~ 405 (513)
.|++|.-..||+|.-.++..+|||+.+....... . ....|..-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 4667888899999987899999998865321111 0 1123555555553 333444
Q ss_pred eeeEEEeCCeeEEEEecCCCCCh-hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC
Q 010329 406 LLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (513)
Q Consensus 406 l~g~~~~~~~~~lv~ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~ 484 (513)
-+++ ....|||||+....+ .-.| +.-.+.......+..++++.|.-|-... ++||+||+.=|||+. ++
T Consensus 135 Pi~~----~~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAF----RNNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceee----cCCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CC
Confidence 4433 245799999965421 1111 1112333356677788888888887633 499999999999999 88
Q ss_pred CeEEeeccCccccCCC
Q 010329 485 NPKISDFGMARIFGVD 500 (513)
Q Consensus 485 ~~ki~DfGla~~~~~~ 500 (513)
.+.|+|||-|.....+
T Consensus 204 ~p~iID~~QaV~~~hp 219 (268)
T COG1718 204 EPYIIDVSQAVTIDHP 219 (268)
T ss_pred eEEEEECccccccCCC
Confidence 8999999998876533
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.27 E-value=4.4e-06 Score=76.07 Aligned_cols=106 Identities=23% Similarity=0.210 Sum_probs=83.3
Q ss_pred HHHHHHHHhCCC-CCccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCC
Q 010329 389 KNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467 (513)
Q Consensus 389 ~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 467 (513)
.+|..++..+++ +++++++|.| ..+++.||.+.+++...-.....-...+|..+.+|+.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457888888986 6999999999 35789999988766422100011224689999999999999999999864445
Q ss_pred eeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 468 IIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 468 ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+.--|++++|+-+++++++|++|...+-...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 7889999999999999999999998776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=7.9e-07 Score=96.32 Aligned_cols=111 Identities=26% Similarity=0.391 Sum_probs=74.7
Q ss_pred hcCCCcccccCccCceeEEEEEeCC-CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
..+|..+++|..|++|.||..+.+. .+.+|+|. .+..- -.++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc---cccccCCccee------------------
Confidence 3567888999999999999998643 55677743 22110 0111 22233344333
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+-...+. .-+.++- +++.+++|||+.+ |+|||+||.|.+|..-|++|++|||+.+.-
T Consensus 136 ---gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ---chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 34334442 1222332 1278899999887 999999999999999999999999999865
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=6.1e-06 Score=85.83 Aligned_cols=141 Identities=13% Similarity=0.208 Sum_probs=91.8
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCccC-------------------------------HH------HHHHHH
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQG-------------------------------AQ------EFKNEV 392 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~-------------------------------~~------~~~~E~ 392 (513)
.+-|+.-+.|.||+|++++|+.||||..++.-... .+ +|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 35789999999999999999999999876632111 00 133344
Q ss_pred HHHHh----CCCCC------ccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 010329 393 VLVAK----LQHRN------LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462 (513)
Q Consensus 393 ~~l~~----l~H~n------Iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 462 (513)
+-..+ ++|-+ |.+++- .-.....|+||||+|..+.+... .....++...+..-+.+...-+-+-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qIf~~- 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQIFKT- 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHHHhc-
Confidence 43333 34555 333322 12346789999999988876642 12234555544444444333333333
Q ss_pred CCCCCeeecCCcCCcEEECC----CCCeEEeeccCccccCC
Q 010329 463 DSRLRIIHRDLKASNILLDA----EMNPKISDFGMARIFGV 499 (513)
Q Consensus 463 ~~~~~ivHrdlk~~Nill~~----~~~~ki~DfGla~~~~~ 499 (513)
| ++|.|-.|.||++.. ++.+.+-|||+.+.+..
T Consensus 321 -G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 -G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 4 899999999999983 67899999999987753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.4e-05 Score=74.67 Aligned_cols=141 Identities=16% Similarity=0.165 Sum_probs=86.6
Q ss_pred ccCccCc-eeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEEecCCCCChh
Q 010329 352 KLGEGGF-GEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429 (513)
Q Consensus 352 ~Lg~G~f-G~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~ 429 (513)
.|..|.. ..||+...+ +..+.||...... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 788998764 4678888775443 335677888888874 445667888877766789999999998876
Q ss_pred hhh-------------------cCCCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHhHc----C
Q 010329 430 YFL-------------------YDPEK-QGQLD--WSRRYKIIG--------------------GIARGILYLHE----D 463 (513)
Q Consensus 430 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~ 463 (513)
... |.... ...+. ......... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 442 11100 00111 000000000 01111222211 1
Q ss_pred CCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 464 ~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
..+.++|+|+.|.|||++++....|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999987789999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.4e-05 Score=75.31 Aligned_cols=145 Identities=21% Similarity=0.218 Sum_probs=86.1
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCC--CccceeeEEEeC---CeeEEEEecCC
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHR--NLVRLLGFCLEG---EEKILVYEFVP 424 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~~~~~---~~~~lv~ey~~ 424 (513)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3568899999999999866 68999987554 3446778888888888643 356777755433 34689999999
Q ss_pred CCChhh----------------hh---cCC-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHhHc
Q 010329 425 NKSLDY----------------FL---YDP-EKQGQLDWSRR---------YKI------------IGGIAR-GILYLHE 462 (513)
Q Consensus 425 ~gsL~~----------------~l---~~~-~~~~~l~~~~~---------~~i------------~~~ia~-gL~yLH~ 462 (513)
+..+.. .+ +.. .....+.+... ... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111 01111111110 000 111222 2333332
Q ss_pred ----CCCCCeeecCCcCCcEEEC-CCCCeEEeeccCcccc
Q 010329 463 ----DSRLRIIHRDLKASNILLD-AEMNPKISDFGMARIF 497 (513)
Q Consensus 463 ----~~~~~ivHrdlk~~Nill~-~~~~~ki~DfGla~~~ 497 (513)
.....++|+|+.+.|||++ +++.+.|+||+.+..-
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2345699999999999999 6666689999987643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.08 E-value=5.5e-05 Score=84.90 Aligned_cols=79 Identities=13% Similarity=0.320 Sum_probs=57.3
Q ss_pred ccccCccCceeEEEEEeCCC---cEEEEEEecccC-ccCHHHHHHHHHHHHhCC-CCCc--cceeeEEEeC---CeeEEE
Q 010329 350 DNKLGEGGFGEVYKGVLPSG---QEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ-HRNL--VRLLGFCLEG---EEKILV 419 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~---~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nI--v~l~g~~~~~---~~~~lv 419 (513)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|.++++.+. |.+| .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46788999999999887554 356777654322 123357889999999995 6665 7888888764 357899
Q ss_pred EecCCCCCh
Q 010329 420 YEFVPNKSL 428 (513)
Q Consensus 420 ~ey~~~gsL 428 (513)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00021 Score=70.31 Aligned_cols=80 Identities=14% Similarity=0.105 Sum_probs=58.6
Q ss_pred CCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCC---CCccceeeEEEeC---CeeEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH---RNLVRLLGFCLEG---EEKILV 419 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~g~~~~~---~~~~lv 419 (513)
.....+.||.|..+.||+-...++ .+.+|..+... ....+..|.+.++.+.. -.+.++++++..+ +..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 344556799999999999886555 45666643311 23578899999998853 3688899887643 568999
Q ss_pred EecCCCCCh
Q 010329 420 YEFVPNKSL 428 (513)
Q Consensus 420 ~ey~~~gsL 428 (513)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00022 Score=65.36 Aligned_cols=135 Identities=20% Similarity=0.345 Sum_probs=91.0
Q ss_pred cccccCccCceeEEEEEeCCCcEEEEEEecccC----------------ccCHHHHHHHHHHHHhCC------CCCccce
Q 010329 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS----------------GQGAQEFKNEVVLVAKLQ------HRNLVRL 406 (513)
Q Consensus 349 ~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~nIv~l 406 (513)
....||+|+.-.||.- ++.....||.+.... ....++..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3467999999888863 445567788776554 122456677776665555 8899999
Q ss_pred eeEEEeCCeeEEEEecCCC------CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE
Q 010329 407 LGFCLEGEEKILVYEFVPN------KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480 (513)
Q Consensus 407 ~g~~~~~~~~~lv~ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill 480 (513)
+|+..+....-+|+|.+.+ -+|.+++. .+.++. ...+... +--.||-+++ |+.+||+|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEE
Confidence 9999999989999998642 35667762 334555 3333333 3345666655 9999999999999
Q ss_pred CCC---C-CeEEee-ccCccc
Q 010329 481 DAE---M-NPKISD-FGMARI 496 (513)
Q Consensus 481 ~~~---~-~~ki~D-fGla~~ 496 (513)
... . .+.|+| ||-..+
T Consensus 152 ~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred EecCCCceEEEEEeCCCCccc
Confidence 432 2 466666 454443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00029 Score=62.03 Aligned_cols=130 Identities=21% Similarity=0.305 Sum_probs=87.7
Q ss_pred CcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCcc-ceeeEEEeCCeeEEEEecCCCC
Q 010329 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~ey~~~g 426 (513)
...+.|++|.+|.||+|.+ .|.++++|.-+.+++ ...+..|++++..++-.++. +++.+ ++.++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCc
Confidence 3456899999999999999 456899998766543 46789999999999876654 34444 3345569999988
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCc-C-CcEEECCCCCeEEeeccCccccC
Q 010329 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK-A-SNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk-~-~Nill~~~~~~ki~DfGla~~~~ 498 (513)
.|.+.-.. .+-++...++.. +..|+-+ +|-|+.|. | .||++ .+..+.|+||.-|++-.
T Consensus 98 ~L~~~~~~------~~rk~l~~vlE~-a~~LD~~------GI~H~El~~~~k~vlv-~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 98 PLGKLEIG------GDRKHLLRVLEK-AYKLDRL------GIEHGELSRPWKNVLV-NDRDVYIIDFDSATFKK 157 (201)
T ss_pred chhhhhhc------ccHHHHHHHHHH-HHHHHHh------ccchhhhcCCceeEEe-cCCcEEEEEccchhhcc
Confidence 88765511 133444444333 3333333 37777775 3 35555 44489999999998543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.0002 Score=67.96 Aligned_cols=73 Identities=21% Similarity=0.304 Sum_probs=45.1
Q ss_pred cccCccCce-eEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCC---CccceeeEEEeCC---eeEEEEecC
Q 010329 351 NKLGEGGFG-EVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHR---NLVRLLGFCLEGE---EKILVYEFV 423 (513)
Q Consensus 351 ~~Lg~G~fG-~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~~~~---~~~lv~ey~ 423 (513)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.+++..+... -+.+.++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456666655 58874 235667754432 2345788999999888632 3445555433322 348899999
Q ss_pred CCCChh
Q 010329 424 PNKSLD 429 (513)
Q Consensus 424 ~~gsL~ 429 (513)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00047 Score=65.30 Aligned_cols=142 Identities=19% Similarity=0.240 Sum_probs=82.1
Q ss_pred cccCccCceeEEEEEeCC--CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCc-cceeeEEEeCCeeEEEEecCCCCC
Q 010329 351 NKLGEGGFGEVYKGVLPS--GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPNKS 427 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~--~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~ey~~~gs 427 (513)
+.|..|-...+|+....+ +..+++|........ .-...+|+.++..+...++ +++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999998764 678888876543221 1233468888888854343 44444322 248999999877
Q ss_pred hhhh-------h----------cCCCCC--------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 010329 428 LDYF-------L----------YDPEKQ--------GQL-DWSRRYKIIG----------------------GIARGILY 459 (513)
Q Consensus 428 L~~~-------l----------~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~gL~y 459 (513)
+... + |..... ... .|.....+.. .+..-+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 1 111111 011 1222211111 11111111
Q ss_pred ----hHcC-CCCCeeecCCcCCcEEECC-CCCeEEeeccCcccc
Q 010329 460 ----LHED-SRLRIIHRDLKASNILLDA-EMNPKISDFGMARIF 497 (513)
Q Consensus 460 ----LH~~-~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~ 497 (513)
+... ....++|+|+.+.|||+++ +..+.|+||..|..-
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 1111 2345999999999999998 578999999888743
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00065 Score=68.98 Aligned_cols=76 Identities=14% Similarity=0.203 Sum_probs=54.7
Q ss_pred ccccCccCceeEEEEEeCCC-cEEEEEEeccc------C-ccCHHHHHHHHHHHHhCC---CCCccceeeEEEeCCeeEE
Q 010329 350 DNKLGEGGFGEVYKGVLPSG-QEIAVKRLSAS------S-GQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~-~~VavK~l~~~------~-~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~l 418 (513)
.+.||.|.+..||+....+| +.|+||.-.+. + +...+.+..|.+.|..+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35789999999999998776 48999974321 1 223456777888777763 3467778777 4456789
Q ss_pred EEecCCCCC
Q 010329 419 VYEFVPNKS 427 (513)
Q Consensus 419 v~ey~~~gs 427 (513)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00053 Score=65.93 Aligned_cols=139 Identities=16% Similarity=0.108 Sum_probs=79.8
Q ss_pred ccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCc-cceeeEEEeCCeeEEEEecCCCCChhh
Q 010329 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPNKSLDY 430 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~ey~~~gsL~~ 430 (513)
.+..|-...+|+... ++..+++|..........-...+|..+++.+....+ .++++.. ..++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 355677788998874 566788887554322211135778888888864433 4445443 2478999999876642
Q ss_pred h-----------------hcCCCC-CCCCCHHHH-HHHHHH---------HHHHHHHhHcC-----CCCCeeecCCcCCc
Q 010329 431 F-----------------LYDPEK-QGQLDWSRR-YKIIGG---------IARGILYLHED-----SRLRIIHRDLKASN 477 (513)
Q Consensus 431 ~-----------------l~~~~~-~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~ivHrdlk~~N 477 (513)
- ||.... ...++.... .....+ +..-+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111111 112222211 111111 11112222111 12358999999999
Q ss_pred EEECCCCCeEEeeccCccc
Q 010329 478 ILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 478 ill~~~~~~ki~DfGla~~ 496 (513)
|++++++ ++|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00069 Score=61.64 Aligned_cols=125 Identities=28% Similarity=0.413 Sum_probs=87.7
Q ss_pred cCCCcccccCccCc-eeEEEEEeCCCcEEEEEEecc---cCc------------------cCHHHHHHHHHHHHhCC---
Q 010329 345 NKFSTDNKLGEGGF-GEVYKGVLPSGQEIAVKRLSA---SSG------------------QGAQEFKNEVVLVAKLQ--- 399 (513)
Q Consensus 345 ~~~~~~~~Lg~G~f-G~Vy~~~~~~~~~VavK~l~~---~~~------------------~~~~~~~~E~~~l~~l~--- 399 (513)
.+++..+.||.|.. |.|||+++ +|+.+|+|..+. ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56677889999999 99999999 677999998321 100 11235788998888775
Q ss_pred CCCc--cceeeEEEeCC------------------eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 010329 400 HRNL--VRLLGFCLEGE------------------EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459 (513)
Q Consensus 400 H~nI--v~l~g~~~~~~------------------~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y 459 (513)
+.++ |+.+||..-.. ...+|.||.+... .+.. +-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4466 88888874321 1246777665432 1222 234567777889
Q ss_pred hHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 460 LH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
+|..+ |+-+|++++|.. .-||.|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999986 3489999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0019 Score=63.46 Aligned_cols=142 Identities=19% Similarity=0.156 Sum_probs=85.7
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCC--ccceeeE------EEeCCeeEEEEe
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN--LVRLLGF------CLEGEEKILVYE 421 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~------~~~~~~~~lv~e 421 (513)
.+.|..|....+|+....+ ..+++|.... .....+..|+.++..+.+.+ +.+++.. ....+..++++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778778999987644 4688887654 22345677888888875433 4454432 123445689999
Q ss_pred cCCCCChhh----hh----------cC----CC----CCCCCCHHHHHH----------HHHHHHHHHHHhHc----CCC
Q 010329 422 FVPNKSLDY----FL----------YD----PE----KQGQLDWSRRYK----------IIGGIARGILYLHE----DSR 465 (513)
Q Consensus 422 y~~~gsL~~----~l----------~~----~~----~~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~ 465 (513)
|++|..+.. .+ |. .. ......|..... ....+...+.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 11 10 00 001123322110 11123344455543 123
Q ss_pred CCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 466 LRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 466 ~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
..++|+|+.|.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 359999999999999998778899998876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0083 Score=59.66 Aligned_cols=142 Identities=17% Similarity=0.178 Sum_probs=77.4
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCC--Cccceee------EEEeCCeeEEEEe
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHR--NLVRLLG------FCLEGEEKILVYE 421 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g------~~~~~~~~~lv~e 421 (513)
.+.|+.|....+|+....+| .+++|+.... ..+....|+.++..|... .+.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34566777788999886555 6788876521 223444455666555322 2334432 1123456789999
Q ss_pred cCCCCChhh-----------hh---cCCC--------CCCCCCH-HHHHH------------HH-HHHHHHHHHhHcC--
Q 010329 422 FVPNKSLDY-----------FL---YDPE--------KQGQLDW-SRRYK------------II-GGIARGILYLHED-- 463 (513)
Q Consensus 422 y~~~gsL~~-----------~l---~~~~--------~~~~l~~-~~~~~------------i~-~~ia~gL~yLH~~-- 463 (513)
|++|..+.. .| |... ....+.| ..... .. ..+...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 11 1100 0011222 21111 11 1111122333211
Q ss_pred --CCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 464 --SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 464 --~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
-+..++|+|+.+.|||++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23459999999999999876656899999885
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0081 Score=59.20 Aligned_cols=142 Identities=26% Similarity=0.322 Sum_probs=84.2
Q ss_pred cccCccCceeEEEEEeCC-------CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCc-cceeeEEEeCCeeEEEEec
Q 010329 351 NKLGEGGFGEVYKGVLPS-------GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~-------~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~ey 422 (513)
+.|..|--..+|+....+ ++.+++|....... ...+..+|.+++..+....+ .++++.+. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 345566667899888654 47888888655432 22345778888888754333 45555553 2368999
Q ss_pred CCCCChhhh-h----------------cCCCCC--------CCCCHHHHHH--------------------------HHH
Q 010329 423 VPNKSLDYF-L----------------YDPEKQ--------GQLDWSRRYK--------------------------IIG 451 (513)
Q Consensus 423 ~~~gsL~~~-l----------------~~~~~~--------~~l~~~~~~~--------------------------i~~ 451 (513)
++|..+... + |+.... ...-|..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 1 111111 0011111111 112
Q ss_pred HHHHHHHHhHc------CCCCCeeecCCcCCcEEECCC----CCeEEeeccCcccc
Q 010329 452 GIARGILYLHE------DSRLRIIHRDLKASNILLDAE----MNPKISDFGMARIF 497 (513)
Q Consensus 452 ~ia~gL~yLH~------~~~~~ivHrdlk~~Nill~~~----~~~ki~DfGla~~~ 497 (513)
.+..-+.+|.. ..+..++|+|+.+.|||++++ +.++++||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22233444432 234568999999999999885 78999999988743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.012 Score=58.26 Aligned_cols=143 Identities=18% Similarity=0.175 Sum_probs=82.4
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCC--CccceeeEE------EeCCeeEEEEe
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHR--NLVRLLGFC------LEGEEKILVYE 421 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~~------~~~~~~~lv~e 421 (513)
.+.++.|....+|+....++ ..++|...... ..++...|..++..|... .+.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45577777788998876545 56678764421 134556677777776432 244544421 12345789999
Q ss_pred cCCCCChhhh--------------hcCCCC------C---CCCCHHHHH------------HHHHHHHHHHHHhHc----
Q 010329 422 FVPNKSLDYF--------------LYDPEK------Q---GQLDWSRRY------------KIIGGIARGILYLHE---- 462 (513)
Q Consensus 422 y~~~gsL~~~--------------l~~~~~------~---~~l~~~~~~------------~i~~~ia~gL~yLH~---- 462 (513)
|++|..+... +|.... . ..-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654210 111000 0 011222111 011123345555542
Q ss_pred CCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 463 ~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
..+..++|+|+.+.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999988877899999884
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0065 Score=59.79 Aligned_cols=143 Identities=20% Similarity=0.221 Sum_probs=98.0
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccC-----c-----------------cCH----HHHHHHHHHHHhCCCCCc
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS-----G-----------------QGA----QEFKNEVVLVAKLQHRNL 403 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~-----~-----------------~~~----~~~~~E~~~l~~l~H~nI 403 (513)
...|..|.-.-||.+.-.+|..+|||+.+..- . ..+ -....|++-|.+++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 35678899999999998899999999765420 0 001 122346777777766554
Q ss_pred cceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC
Q 010329 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE 483 (513)
Q Consensus 404 v~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~ 483 (513)
..---... ....|||+|+.... |-.-..+...++...+..+..+++.-|.-|.+.+ ++||.||.-=|+|+. +
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 42222111 23568999996332 2222223445777778888899999999998877 699999999999994 5
Q ss_pred CCeEEeeccCccccCCC
Q 010329 484 MNPKISDFGMARIFGVD 500 (513)
Q Consensus 484 ~~~ki~DfGla~~~~~~ 500 (513)
|.+.|+|.+-+...+.+
T Consensus 301 G~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHDHP 317 (520)
T ss_pred CEEEEEEccccccCCCh
Confidence 67999999887755433
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0084 Score=58.26 Aligned_cols=32 Identities=25% Similarity=0.468 Sum_probs=26.4
Q ss_pred CCeeecCCcCCcEEECCCCC-eEEeeccCcccc
Q 010329 466 LRIIHRDLKASNILLDAEMN-PKISDFGMARIF 497 (513)
Q Consensus 466 ~~ivHrdlk~~Nill~~~~~-~ki~DfGla~~~ 497 (513)
..++|+|+.+.|||++++++ .-|.||+.+.+=
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999987555 569999988753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0065 Score=59.15 Aligned_cols=76 Identities=20% Similarity=0.279 Sum_probs=48.6
Q ss_pred CCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC---CCCccceeeEEEeCCeeEEEEecC
Q 010329 347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
.+..+.|+-|....+|+.. .+++.+-||.-... ....|..|.+-|+.|. --.+++.+++....+..+|++||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445678889999999988 57788999977632 2346788888777773 455888999988888889999999
Q ss_pred CCC
Q 010329 424 PNK 426 (513)
Q Consensus 424 ~~g 426 (513)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.013 Score=58.38 Aligned_cols=79 Identities=18% Similarity=0.164 Sum_probs=50.2
Q ss_pred ccCccCceeEEEEEeCCC-cEEEEEEecc-------cCccCHHHHHHHHHHHHhCC--CC-CccceeeEEEeCCeeEEEE
Q 010329 352 KLGEGGFGEVYKGVLPSG-QEIAVKRLSA-------SSGQGAQEFKNEVVLVAKLQ--HR-NLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~~~~-~~VavK~l~~-------~~~~~~~~~~~E~~~l~~l~--H~-nIv~l~g~~~~~~~~~lv~ 420 (513)
.||.|...-||++..++| +.|+||.-.+ .-+-..++..-|...|.... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998654 5899996332 11223345556777776553 23 45556544 556677999
Q ss_pred ecCCCC-Chhhhh
Q 010329 421 EFVPNK-SLDYFL 432 (513)
Q Consensus 421 ey~~~g-sL~~~l 432 (513)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999643 333444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.015 Score=57.19 Aligned_cols=136 Identities=21% Similarity=0.336 Sum_probs=77.2
Q ss_pred eEEEEEeCCCcEEEEEEec-ccCccCHHHHHHHHHHHHhCCC--CCccceeeEEEeCC--eeEEEEecCCCCChhhhhcC
Q 010329 360 EVYKGVLPSGQEIAVKRLS-ASSGQGAQEFKNEVVLVAKLQH--RNLVRLLGFCLEGE--EKILVYEFVPNKSLDYFLYD 434 (513)
Q Consensus 360 ~Vy~~~~~~~~~VavK~l~-~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~--~~~lv~ey~~~gsL~~~l~~ 434 (513)
..|.... .+++.++++-. ...........+|..+|+.+.- --+..-++.|.++. ..|.||+|+++..+.+.+..
T Consensus 40 ~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~ 118 (321)
T COG3173 40 DTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP 118 (321)
T ss_pred ceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence 3444333 26777777211 1122334556778888887753 33445677777766 67999999987433221110
Q ss_pred C-----------------------------C-----CCCC-CCHHHHHHHHH--------HHHHHHHHhHcC-----CCC
Q 010329 435 P-----------------------------E-----KQGQ-LDWSRRYKIIG--------GIARGILYLHED-----SRL 466 (513)
Q Consensus 435 ~-----------------------------~-----~~~~-l~~~~~~~i~~--------~ia~gL~yLH~~-----~~~ 466 (513)
. . ...+ -.|....+.+. ....-..||+++ ++.
T Consensus 119 ~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 119 ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 0 0 0000 11111111000 122234455443 345
Q ss_pred CeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 467 RIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 467 ~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
.++|+|+.+.|++++.+..+=|.||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 699999999999999988899999999874
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.01 Score=59.61 Aligned_cols=141 Identities=22% Similarity=0.275 Sum_probs=81.4
Q ss_pred ccCccCceeEEEEEeCC-----CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCcc-ceeeEEEeCCeeEEEEecCCC
Q 010329 352 KLGEGGFGEVYKGVLPS-----GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~~~-----~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~ey~~~ 425 (513)
.|..|-.-.+|+..+.+ ++.+++|..........+ -.+|..+++.+...++. ++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45456667888887532 357888877654433222 36788888888654444 556665332 58999987
Q ss_pred CChhhh-----------------hcCCCCC--C-CCCHHHHHHHHHH-----------------HHHHHHHh----Hc-C
Q 010329 426 KSLDYF-----------------LYDPEKQ--G-QLDWSRRYKIIGG-----------------IARGILYL----HE-D 463 (513)
Q Consensus 426 gsL~~~-----------------l~~~~~~--~-~l~~~~~~~i~~~-----------------ia~gL~yL----H~-~ 463 (513)
.+|... +|+.... . ...|.+..++..+ +..-+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776421 1221111 1 1123333222211 11112222 22 2
Q ss_pred CCCCeeecCCcCCcEEECC-CCCeEEeeccCcccc
Q 010329 464 SRLRIIHRDLKASNILLDA-EMNPKISDFGMARIF 497 (513)
Q Consensus 464 ~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~ 497 (513)
....++|+|+++.|||+++ +..++|+||..+..-
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 2345899999999999976 468999999888743
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0024 Score=61.67 Aligned_cols=132 Identities=17% Similarity=0.199 Sum_probs=89.0
Q ss_pred CCCcccccCccCceeEEEEEeCCCcEEEEEEeccc-----------------CccCH-----HHHHHHHHHHHhCC-CC-
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS-----------------SGQGA-----QEFKNEVVLVAKLQ-HR- 401 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~-----------------~~~~~-----~~~~~E~~~l~~l~-H~- 401 (513)
-++..++||-|.-+.||.+-..+|++.++|.-+.. ....| -...+|...|+.|. |.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 35678999999999999999988999888843211 00011 12345777888875 32
Q ss_pred CccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC
Q 010329 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481 (513)
Q Consensus 402 nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~ 481 (513)
-|.+.++ ....++|||++.+-.|...- ...+..+ +...+..-+.-|..++ +||+|..-=||+|+
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 2444444 35678999999887764332 1123333 3333434455566666 99999999999999
Q ss_pred CCCCeEEeeccC
Q 010329 482 AEMNPKISDFGM 493 (513)
Q Consensus 482 ~~~~~ki~DfGl 493 (513)
++..++++||=-
T Consensus 237 dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 237 DDDKIVVIDFPQ 248 (465)
T ss_pred cCCCEEEeechH
Confidence 999999999943
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.033 Score=56.57 Aligned_cols=73 Identities=11% Similarity=0.127 Sum_probs=49.4
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEeccc----Cc---cCHHHHHHHHHHHHhCC---CCCccceeeEEEeCCeeEEE
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS----SG---QGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~----~~---~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv 419 (513)
.+.||.|....||+.... +..++||.-... +. ....+-..|...|+.+. ..++++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567899999999998864 556889875421 11 12333344566665553 357888888876 457889
Q ss_pred EecCCC
Q 010329 420 YEFVPN 425 (513)
Q Consensus 420 ~ey~~~ 425 (513)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.00054 Score=75.05 Aligned_cols=148 Identities=17% Similarity=0.169 Sum_probs=98.6
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
.+.+.+.+-+.+|.++.++.+.-. .|...++|..... .....+....+-.++-..+||-+++...-+.......|+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 345566677888899988877632 2322233322211 111122233333333334556666655555566788999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
++|..+++|...|+.. +..+..-....+..+...++|||... +.|||++|.|.|+..++..+++|||..+..
T Consensus 883 ~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999888542 34555555556667889999999864 899999999999999999999999955544
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.016 Score=58.56 Aligned_cols=74 Identities=12% Similarity=0.139 Sum_probs=49.9
Q ss_pred ccccCccCceeEEEEEeCC-CcEEEEEEecc------cCccCHHHHHHHHHHHHhCC---CCCccceeeEEEeCCeeEEE
Q 010329 350 DNKLGEGGFGEVYKGVLPS-GQEIAVKRLSA------SSGQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~------~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv 419 (513)
.+.||.|.-.-||++.+.+ ++.|+||.-.+ .-+-..++..-|.+.|+... -..+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999999743 56799986322 11233456666777777653 2356666554 55567789
Q ss_pred EecCCC
Q 010329 420 YEFVPN 425 (513)
Q Consensus 420 ~ey~~~ 425 (513)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.00097 Score=69.53 Aligned_cols=146 Identities=16% Similarity=0.095 Sum_probs=97.4
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCC-ccceeeEEEeCCeeEE
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN-LVRLLGFCLEGEEKIL 418 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~l 418 (513)
++..++-+...+.++++++++++|.+-...+....+.+... .+..-++++|.+++||| .+..++-+..++..++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 33444445555678899999999987433333334444322 45566899999999999 6777777777778899
Q ss_pred EEecCCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 419 VYEFVPNK-SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 419 v~ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+++++..+ +-.... ......+...+...+.+.-.++|+|||+.. -+||| ||+..+ ...|..||+...-+
T Consensus 312 ~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 312 PMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCccc
Confidence 99999877 221111 011112333444556667778999999853 48999 777755 66899999998877
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
...
T Consensus 382 ~~~ 384 (829)
T KOG0576|consen 382 TRT 384 (829)
T ss_pred Ccc
Confidence 543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.073 Score=52.85 Aligned_cols=136 Identities=21% Similarity=0.312 Sum_probs=80.9
Q ss_pred CceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCc------cceee----EEEeCCeeEEEEecCCCC
Q 010329 357 GFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL------VRLLG----FCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 357 ~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI------v~l~g----~~~~~~~~~lv~ey~~~g 426 (513)
.-..+|+....+|+. ++|..+.. ....++..|+..|..|.-..| ..+=| ....+...+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 445789988877776 77776654 344567778888877743222 22212 111123678899999998
Q ss_pred Chhh-hh--------------c----C-----CCCCCCCCHHH---H----------HHHHHHHHHHHHHhHcC------
Q 010329 427 SLDY-FL--------------Y----D-----PEKQGQLDWSR---R----------YKIIGGIARGILYLHED------ 463 (513)
Q Consensus 427 sL~~-~l--------------~----~-----~~~~~~l~~~~---~----------~~i~~~ia~gL~yLH~~------ 463 (513)
.+.. .- | + ........|.. . .....++...+..+.+.
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8873 11 0 0 01111234431 0 11223344444444432
Q ss_pred -CCCCeeecCCcCCcEEECCCCC-eEEeeccCcc
Q 010329 464 -SRLRIIHRDLKASNILLDAEMN-PKISDFGMAR 495 (513)
Q Consensus 464 -~~~~ivHrdlk~~Nill~~~~~-~ki~DfGla~ 495 (513)
....+||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1122899999999999998885 8999999876
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.14 Score=50.48 Aligned_cols=29 Identities=28% Similarity=0.347 Sum_probs=25.3
Q ss_pred CCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 466 LRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 466 ~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999987 668999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.08 Score=52.92 Aligned_cols=142 Identities=16% Similarity=0.227 Sum_probs=79.2
Q ss_pred cccCccCceeEEEEEeCC----CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCcc-ceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLPS----GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~----~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~ey~~~ 425 (513)
+.|..|-.-.+|+....+ +..|++|......... -.-.+|..+++.+...++. ++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 344446667788887543 2378888776543322 2235688888888655553 566665322 58999987
Q ss_pred CChhhh-------h----------cCCCCC--C-CCCHHHHHHHHHHH----------------------HHHHH----H
Q 010329 426 KSLDYF-------L----------YDPEKQ--G-QLDWSRRYKIIGGI----------------------ARGIL----Y 459 (513)
Q Consensus 426 gsL~~~-------l----------~~~~~~--~-~l~~~~~~~i~~~i----------------------a~gL~----y 459 (513)
..|..- + |+.... . .--|....++..++ ..-+. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665321 1 121100 1 11233322222111 11111 2
Q ss_pred hHc-CCCCCeeecCCcCCcEEECC-CCCeEEeeccCcccc
Q 010329 460 LHE-DSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIF 497 (513)
Q Consensus 460 LH~-~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~ 497 (513)
+.. ..+.-+.|.|+.+.|||+++ ++.++++||..|-.-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 211 12234799999999999974 578999999888643
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.29 Score=45.42 Aligned_cols=76 Identities=17% Similarity=0.240 Sum_probs=52.1
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhC---CCCCccceeeEEEeCCeeEEEEecCCCC
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL---QHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lv~ey~~~g 426 (513)
.+++.-|..-..|+... +..++-||.-.. .....|..|+.-|..+ +--++.+.+.+....+..++|+||++-|
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34555555555555443 456778886432 3346677887666555 4456888899988999999999999987
Q ss_pred Chh
Q 010329 427 SLD 429 (513)
Q Consensus 427 sL~ 429 (513)
.++
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 765
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.032 Score=51.85 Aligned_cols=31 Identities=35% Similarity=0.524 Sum_probs=21.9
Q ss_pred CCeeecCCcCCcEEE-CCCCCeEEeeccCccc
Q 010329 466 LRIIHRDLKASNILL-DAEMNPKISDFGMARI 496 (513)
Q Consensus 466 ~~ivHrdlk~~Nill-~~~~~~ki~DfGla~~ 496 (513)
.-+.|.||.+.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 348999999999999 8899999999988864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.34 Score=55.88 Aligned_cols=140 Identities=21% Similarity=0.285 Sum_probs=76.3
Q ss_pred ccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC--CCC--cccee----eE----EEe-CC--ee
Q 010329 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ--HRN--LVRLL----GF----CLE-GE--EK 416 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~--H~n--Iv~l~----g~----~~~-~~--~~ 416 (513)
.|+ |..-.+|+....+|..+++|....... ......|...|..|. ++. +.+.+ |- ... .+ ..
T Consensus 32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 32 PLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred ecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 453 345678888877788899999876432 233444555555442 122 22322 11 111 11 35
Q ss_pred EEEEecCCCCChhhhhc---------------------C---CCCCCCCCHHH-----------------HHHHHHHHHH
Q 010329 417 ILVYEFVPNKSLDYFLY---------------------D---PEKQGQLDWSR-----------------RYKIIGGIAR 455 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~---------------------~---~~~~~~l~~~~-----------------~~~i~~~ia~ 455 (513)
+-+++|++|..+.+... + ......+.|.. ...++.++..
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 67899999977754110 0 00112233421 1122222222
Q ss_pred HHH-----HhHcCCCCCeeecCCcCCcEEECCCC--CeE-EeeccCcc
Q 010329 456 GIL-----YLHEDSRLRIIHRDLKASNILLDAEM--NPK-ISDFGMAR 495 (513)
Q Consensus 456 gL~-----yLH~~~~~~ivHrdlk~~Nill~~~~--~~k-i~DfGla~ 495 (513)
... .|. .-+..+||+|+.+.|||++.+. ++. |+|||-+.
T Consensus 189 ~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 189 RFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 221 121 1234599999999999998875 555 99999875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.11 Score=51.35 Aligned_cols=72 Identities=19% Similarity=0.203 Sum_probs=54.2
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..+++|++. ++.|.. .....|++.+.|+.+.+.-++-+..+ .++-|||+.-.||||+ +|++-|+||-++
T Consensus 300 y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence 345666655 444421 22357899999988877766666553 5789999999999999 999999999999
Q ss_pred ccc
Q 010329 495 RIF 497 (513)
Q Consensus 495 ~~~ 497 (513)
|.-
T Consensus 369 Rl~ 371 (488)
T COG5072 369 RLS 371 (488)
T ss_pred ecc
Confidence 943
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.37 Score=47.66 Aligned_cols=32 Identities=25% Similarity=0.346 Sum_probs=28.2
Q ss_pred CCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 465 ~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
+..++|+|+.+.|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34599999999999999999999999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.49 E-value=1 Score=44.81 Aligned_cols=70 Identities=13% Similarity=0.115 Sum_probs=43.6
Q ss_pred ceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCC--Ccccee---e--EEEeCCeeEEEEecCCCCCh
Q 010329 358 FGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHR--NLVRLL---G--FCLEGEEKILVYEFVPNKSL 428 (513)
Q Consensus 358 fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~---g--~~~~~~~~~lv~ey~~~gsL 428 (513)
-..||+...+++..+++|..+... ....++..|++.+..|... .++..+ | ....++..+.++++++|...
T Consensus 38 eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 38 ENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 357899888778888998775332 2345677788877766422 222211 2 12224567789999987643
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.13 Score=51.53 Aligned_cols=61 Identities=18% Similarity=0.144 Sum_probs=40.7
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~ 481 (513)
...|+-+|+++.++..++.. ...+++...+++.-.++++.-+-.-. .++|.|+.|.||++-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~----~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW----KSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhc----ccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence 34577788999999888843 22344455566655556654333222 399999999999994
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.20 E-value=0.32 Score=48.93 Aligned_cols=135 Identities=15% Similarity=0.192 Sum_probs=81.8
Q ss_pred CcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEE------EeCCe-eEEE
Q 010329 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFC------LEGEE-KILV 419 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~------~~~~~-~~lv 419 (513)
...+.||+|+.+.+|--- +-..-+.|+..........+ .+..|... .||-+..=+.+- -++.. .-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 456789999999999542 11122345544433222222 12223333 455433211111 01122 4466
Q ss_pred EecCCCCC-hhhhhc---CCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEee
Q 010329 420 YEFVPNKS-LDYFLY---DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (513)
Q Consensus 420 ~ey~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D 490 (513)
|..+++.. +..++. +.......+|...++.++.++.+..-||+.+ .+-+|+.++|+|+.+++.+.|.|
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEc
Confidence 66666542 222221 2233456899999999999999999999998 67799999999999998888876
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.84 E-value=0.55 Score=47.85 Aligned_cols=74 Identities=18% Similarity=0.302 Sum_probs=43.9
Q ss_pred cccCccCceeEEEEEeCCC--cE-----EEEEEecccCccCHHHHHHHHHHHHhCCCCCcc-ceeeEEEeCCeeEEEEec
Q 010329 351 NKLGEGGFGEVYKGVLPSG--QE-----IAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~--~~-----VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~ey 422 (513)
+.|..|-...+|++...++ .. |.++.......... +-.+|.++++.+...++. ++++.+. .++++||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 3455577788999876443 12 33333222211111 235688889988766554 4555543 3699999
Q ss_pred CCCCChh
Q 010329 423 VPNKSLD 429 (513)
Q Consensus 423 ~~~gsL~ 429 (513)
+++..|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987764
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=93.42 E-value=0.094 Score=33.87 Aligned_cols=28 Identities=29% Similarity=0.527 Sum_probs=16.9
Q ss_pred cceeeeeehhHHHHHHHHHHHhhhhhhh
Q 010329 283 SSTIIAIVAPIAVAAVLFVACLCFLRRR 310 (513)
Q Consensus 283 ~~~ii~iv~~~~v~~vll~~~~~~~~~r 310 (513)
..+.++++++++++++++.+.+++++||
T Consensus 11 vaIa~~VvVPV~vI~~vl~~~l~~~~rR 38 (40)
T PF08693_consen 11 VAIAVGVVVPVGVIIIVLGAFLFFWYRR 38 (40)
T ss_pred EEEEEEEEechHHHHHHHHHHhheEEec
Confidence 3445677777777776666555544444
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=93.39 E-value=0.53 Score=44.91 Aligned_cols=79 Identities=22% Similarity=0.184 Sum_probs=54.7
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC-CCCCh
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV-PNKSL 428 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~-~~gsL 428 (513)
...+..|..+.|++++..+|.++++|........ ..+.. ....|+..+-...|++++.- .+...|++|.+ ++.+|
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~-~~E~~-g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L 82 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEA-EHEAR-GEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSL 82 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccc-hhhhh-HHhHhheeCCCCceeeeccc--cccchhhhhhccCCCch
Confidence 3456678899999999989999999987654321 11111 12457777878889998864 34567788888 55677
Q ss_pred hhhh
Q 010329 429 DYFL 432 (513)
Q Consensus 429 ~~~l 432 (513)
.+..
T Consensus 83 ~~~~ 86 (253)
T PF04655_consen 83 ASLP 86 (253)
T ss_pred hhcc
Confidence 6554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.94 E-value=0.6 Score=43.17 Aligned_cols=102 Identities=16% Similarity=0.168 Sum_probs=63.7
Q ss_pred EEEEEEecccCcc-CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHH
Q 010329 371 EIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449 (513)
Q Consensus 371 ~VavK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i 449 (513)
...+|++....-. ...-|.++.++++++. .|++|..- ..-..-++.|+|-.-.. .. .-.|
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~---~N~i 147 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF---SNFI 147 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch---hHHH
Confidence 3456666543322 3456788888888874 35555421 22234577887732111 11 1112
Q ss_pred HHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 450 ~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
..+ ++.|.-.|+.. .+.+|+|-.|+|||=|..|.+||.|-+.
T Consensus 148 ~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 148 TAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 222 36677788653 4699999999999999999999999764
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 513 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-29 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-29 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-28 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 309 bits (795), Expect = e-103
Identities = 84/202 (41%), Positives = 113/202 (55%), Gaps = 14/202 (6%)
Query: 321 ENADNDLTILESLQFDFETIEVATNKFS------TDNKLGEGGFGEVYKGVLPSGQEIAV 374
EN +++ F F ++ TN F NK+GEGGFG VYKG + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAV 59
Query: 375 KRLSA----SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDY 430
K+L+A ++ + Q+F E+ ++AK QH NLV LLGF +G++ LVY ++PN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 431 FLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490
L + L W R KI G A GI +LHE+ IHRD+K++NILLD KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 491 FGMARIFGVDQTQGNTSRIVGT 512
FG+AR TSRIVGT
Sbjct: 177 FGLARASEKFAQTVMTSRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 3e-96
Identities = 84/198 (42%), Positives = 122/198 (61%), Gaps = 4/198 (2%)
Query: 318 VPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL 377
VP E D ++ + + +F ++VA++ FS N LG GGFG+VYKG L G +AVKRL
Sbjct: 4 VPAE-EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 378 SASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD-P 435
QG + +F+ EV +++ HRNL+RL GFC+ E++LVY ++ N S+ L + P
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
E Q LDW +R +I G ARG+ YLH+ +IIHRD+KA+NILLD E + DFG+A+
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 496 IFGVDQTQGNTSRIVGTL 513
+ T T + GT+
Sbjct: 183 LMDYKDTHVTT-AVRGTI 199
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 3e-89
Identities = 79/206 (38%), Positives = 121/206 (58%), Gaps = 6/206 (2%)
Query: 309 RRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS 368
+ K N++ + + + L ES + +E ATN F +G G FG+VYKGVL
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 369 GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
G ++A+KR + S QG +EF+ E+ ++ +H +LV L+GFC E E IL+Y+++ N +L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 429 DYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487
LY + + W +R +I G ARG+ YLH + IIHRD+K+ NILLD PK
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 488 ISDFGMARIF-GVDQTQGNTSRIVGT 512
I+DFG+++ +DQT +T + GT
Sbjct: 180 ITDFGISKKGTELDQTHLST-VVKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 5e-71
Identities = 53/192 (27%), Positives = 84/192 (43%), Gaps = 17/192 (8%)
Query: 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNE 391
+ E + + G FG V+K L + +AVK Q + + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYE 68
Query: 392 VVLVAKLQHRNLVRLLGFCLEGE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
V + ++H N+++ +G G + L+ F SL FL K + W+
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELC 124
Query: 448 KIIGGIARGILYLHED-------SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
I +ARG+ YLHED + I HRD+K+ N+LL + I+DFG+A F
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 501 QTQGNTSRIVGT 512
++ G+T VGT
Sbjct: 185 KSAGDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-57
Identities = 51/199 (25%), Positives = 82/199 (41%), Gaps = 27/199 (13%)
Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNE- 391
++ + + +G G +G VYKG L + +AVK S ++ Q F NE
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEK 56
Query: 392 -VVLVAKLQHRNLVRLLGFCLEGE-----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
+ V ++H N+ R + E +LV E+ PN SL +L DW
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVS 112
Query: 446 RYKIIGGIARGILYLHED------SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF-- 497
++ + RG+ YLH + + I HRDL + N+L+ + ISDFG++
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 498 ----GVDQTQGNTSRIVGT 512
+ VGT
Sbjct: 173 NRLVRPGEEDNAAISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-51
Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 6/204 (2%)
Query: 312 KKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQE 371
++ + + + + D + +++ + K+G G FG V++ G +
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSD 62
Query: 372 IAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429
+AVK L + EF EV ++ +L+H N+V +G + +V E++ SL
Sbjct: 63 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
L+ + QLD RR + +A+G+ YLH I+HR+LK+ N+L+D + K+
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVC 181
Query: 490 DFGMARIFGVDQTQGNTSRIVGTL 513
DFG++R+ T ++ GT
Sbjct: 182 DFGLSRL--KASTFLSSKSAAGTP 203
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-47
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 11/174 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
+ + + +G G FG V K +++A+K++ S + F E+ ++++ H
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNH 60
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
N+V+L G CL LV E+ SL L+ E + ++G+ YL
Sbjct: 61 PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 461 HEDSRLRIIHRDLKASNILLDAEMN-PKISDFGMARIFGVDQTQGNTSRIVGTL 513
H +IHRDLK N+LL A KI DFG A Q + + G+
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSA 167
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-46
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 323 ADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASS 381
++ IE + ++G+GGFG V+KG L +A+K L
Sbjct: 4 GGSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 382 GQGA-------QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD 434
+G QEF+ EV +++ L H N+V+L G +V EFVP L + L D
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD 114
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-----AEMNPKIS 489
+ WS + +++ IA GI Y+ + I+HRDL++ NI L A + K++
Sbjct: 115 KAH--PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 490 DFGMARIFGVDQTQGNTSRIVGTL 513
DFG+++ + + S ++G
Sbjct: 172 DFGLSQQ-----SVHSVSGLLGNF 190
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-46
Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 6/159 (3%)
Query: 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 409
LG+G FG+ K +G+ + +K L + + F EV ++ L+H N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
+ + + E++ +L + + Q WS+R IA G+ YLH + II
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
HRDL + N L+ N ++DFG+AR+ ++TQ R
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-45
Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 7/161 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKL 398
+ + + KL E GE++KG G +I VK L S + +++F E +
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 399 QHRNLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
H N++ +LG C + ++P SL L++ +D S+ K +ARG
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARG 123
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
+ +LH L I L + ++++D +M +IS + F
Sbjct: 124 MAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-44
Identities = 57/190 (30%), Positives = 84/190 (44%), Gaps = 28/190 (14%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS----SGQGAQEFKNE 391
DF + + + +G GGFG+VY+ G E+AVK Q + + E
Sbjct: 5 DFAELTL-------EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQE 56
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
L A L+H N++ L G CL+ LV EF L+ L +
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAV 112
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--------KISDFGMARIFGVDQTQ 503
IARG+ YLH+++ + IIHRDLK+SNIL+ ++ KI+DFG+AR +
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHR 168
Query: 504 GNTSRIVGTL 513
G
Sbjct: 169 TTKMSAAGAY 178
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 54/175 (30%), Positives = 88/175 (50%), Gaps = 10/175 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKL 398
E+ + + ++G G FG VYKG ++AVK L+ + + Q Q FKNEV ++ K
Sbjct: 20 EIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
+H N++ +G+ + I V ++ SL + L+ E + + + I ARG+
Sbjct: 78 RHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMD 134
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
YLH IIHRDLK++NI L + KI DFG+A ++ G++
Sbjct: 135 YLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-42
Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 20/183 (10%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS--SGQGAQEFKNEVV 393
FE +E+ +G+G FG+VY G E+A++ + + + FK EV+
Sbjct: 31 PFEQLEI-------GELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVM 81
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
+ +H N+V +G C+ ++ ++L + D + LD ++ +I I
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEI 139
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI---V 510
+G+ YLH I+H+DLK+ N+ D I+DFG+ I GV Q ++
Sbjct: 140 VKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 511 GTL 513
G L
Sbjct: 196 GWL 198
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-40
Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 21/177 (11%)
Query: 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNE--VVLVAKLQHRNLVRLL 407
++G+G +GEV+ G G+++AVK + E + ++H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 408 GFCLEGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
++G L+ ++ N SL +L K LD K+ G+ +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 464 SRLR-----IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI--VGTL 513
I HRDLK+ NIL+ I+D G+A F D + + VGT
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 21/175 (12%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNE--VVLVAKLQHRNLVRLLG 408
+G+G +GEV++G G+ +AVK S+ + + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 409 FCLEGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
+ L+ + SL +L + LD +I+ IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 465 RLR-----IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI--VGT 512
I HRDLK+ NIL+ I+D G+A + Q + VGT
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 43/177 (24%), Positives = 76/177 (42%), Gaps = 21/177 (11%)
Query: 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNE--VVLVAKLQHRNLVRLL 407
+G+G FGEV++G G+E+AVK S+ + + + E + L+H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 408 GFCLEGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
+ LV ++ + SL +L + + K+ A G+ +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 464 -----SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI--VGTL 513
+ I HRDLK+ NIL+ I+D G+A + + VGT
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 48/158 (30%), Positives = 83/158 (52%), Gaps = 12/158 (7%)
Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
+LG+G FG V +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
G C + L+ E++P SL +L + + ++D + + I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 132
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
R IHRDL NIL++ E KI DFG+ ++ D+
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 303 CLCFLRRRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVY 362
L F + + ++ A P + + E+ ++ + +G G GEV
Sbjct: 13 NLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTR------EIEASRIHIEKIIGSGDSGEVC 66
Query: 363 KGVL--PSGQEI--AVKRL-SASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417
G L P +++ A+K L + + + ++F +E ++ + H N++RL G G +
Sbjct: 67 YGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126
Query: 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477
+V E++ N SLD FL + GQ + ++ G+ G+ YL S L +HRDL A N
Sbjct: 127 IVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARN 181
Query: 478 ILLDAEMNPKISDFGMARIFGVDQ 501
+L+D+ + K+SDFG++R+ D
Sbjct: 182 VLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 7/158 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRL-SASSGQGAQEFKNEVVLVAKL 398
+ ++G G FGEV+ G L +AVK +F E ++ +
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
H N+VRL+G C + + +V E V FL + +L +++G A G+
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGME 227
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
YL IHRDL A N L+ + KISDFGM+R
Sbjct: 228 YLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 48/158 (30%), Positives = 83/158 (52%), Gaps = 12/158 (7%)
Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
+LG+G FG V +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
G C + L+ E++P SL +L + + ++D + + I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 163
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
R IHRDL NIL++ E KI DFG+ ++ D+
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 56/166 (33%), Positives = 89/166 (53%), Gaps = 10/166 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SASSGQGAQEFKNEVVLV 395
E+ S D +G G FGEV G L PS +EI A+K L + + ++F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+ H N++RL G + + ++V E++ N SLD FL + Q + ++ GIA
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIAS 158
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
G+ YL S + +HRDL A NIL+++ + K+SDFG+ R+ D
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
++LG+G FG V +G +AVK+L S ++F+ E+ ++ L +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
G + LV E++P+ L FL + +LD SR I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
R +HRDL A NIL+++E + KI+DFG+A++ +D+
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 51/167 (30%), Positives = 95/167 (56%), Gaps = 11/167 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQE---IAVKRL-SASSGQGAQEFKNEVVL 394
E+ + + +G G FGEVYKG+L SG++ +A+K L + + + +F E +
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+ + H N++RL G + + +++ E++ N +LD FL + + G+ + ++ GIA
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIA 157
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
G+ YL + + +HRDL A NIL+++ + K+SDFG++R+ D
Sbjct: 158 AGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 13/159 (8%)
Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSASSGQGA-QEFKNEVVLVAKLQHRNLV 404
LGEG FG+V +G+++AVK L SG + K E+ ++ L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 405 RLLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ G C E L+ EF+P+ SL +L P+ + +++ ++ K I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+ +HRDL A N+L+++E KI DFG+ + D+
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 350 DNKLGEGGFGEVYKGVLPSGQE---IAVKRL-SASSGQGAQEFKNEVVLVAKLQHRNLVR 405
D +LG G FG V +GV ++ +A+K L + +E E ++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
L+G C E +LV E L FL K+ ++ S +++ ++ G+ YL
Sbjct: 75 LIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+HRDL A N+LL KISDFG+++ G D
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 44/171 (25%), Positives = 81/171 (47%), Gaps = 21/171 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRLSASSGQGAQEFKNEV 392
++ + LG+G F +++KGV E+ +K L + ++ F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
+++KL H++LV G C+ G+E ILV EFV SLD +L + + ++ + ++
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK--KNKNCINILWKLEVAKQ 121
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--------KISDFGMAR 495
+A + +L +IH ++ A NILL E + K+SD G++
Sbjct: 122 LAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 56/173 (32%), Positives = 75/173 (43%), Gaps = 23/173 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL---SASSGQGAQEFKNEVV 393
+ KLG+G FG V +G PSG+ + AVK L S + +F EV
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQ---GQL-DWSRRYK 448
+ L HRNL+RL G L + +V E P SL L + G L ++
Sbjct: 74 AMHSLDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--- 128
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+A G+ YL R IHRDL A N+LL KI DFG+ R +
Sbjct: 129 ---QVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 8/156 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
+ + +G+G FG+V G G ++AVK + + AQ F E ++ +L+H
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRH 73
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
NLV+LLG +E + + +V E++ SL +L + L K + + Y
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEY 132
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
L +HRDL A N+L+ + K+SDFG+ +
Sbjct: 133 L---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 6/161 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
+ ++ + ++G G FG V+ G + ++A+K + + ++F E ++ KL H
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+L G CLE LV EF+ + L +L G + + G+ YL
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYL 120
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+IHRDL A N L+ K+SDFGM R DQ
Sbjct: 121 ---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 12/158 (7%)
Query: 350 DNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSASSGQGA-QEFKNEVVLVAKLQHRNL 403
LG G FG VYKG+ E +A+K L ++ A +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
RLLG CL L+ + +P L ++ E + + IA+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
R++HRDL A N+L+ + KI+DFG+A++ G ++
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 350 DNKLGEGGFGEVYKGVLPSG---QEIAVKRL--SASSGQGAQEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + +AVK L A+ E E ++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
R++G C E +LV E L+ +L ++ + +++ ++ G+ YL
Sbjct: 82 RMIGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+HRDL A N+LL + KISDFG+++ D+
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 8/156 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
+ + +G+G FG+V G G ++AVK + + Q F E ++ +L+H
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 245
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
NLV+LLG +E + + +V E++ SL +L + L K + + Y
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEY 304
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
L +HRDL A N+L+ + K+SDFG+ +
Sbjct: 305 L---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 53/188 (28%), Positives = 80/188 (42%), Gaps = 17/188 (9%)
Query: 322 NADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKR 376
+ L +L D T LGEG FG+V +G+ +AVK
Sbjct: 10 HHHGALEVLFQGPGD-PT-VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA 67
Query: 377 LSASSGQGA-QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFLY 433
L A +G +K E+ ++ L H ++++ G C + LV E+VP SL +L
Sbjct: 68 LKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL- 126
Query: 434 DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
+ + ++ I G+ YLH IHRDL A N+LLD + KI DFG+
Sbjct: 127 ---PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGL 180
Query: 494 ARIFGVDQ 501
A+
Sbjct: 181 AKAVPEGH 188
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 6/167 (3%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVL 394
+ + E+ + +LG G FG V G ++A+K + S EF E +
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKV 72
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+ L H LV+L G C + ++ E++ N L +L E + + + ++ +
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVC 130
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+ YL + +HRDL A N L++ + K+SDFG++R D+
Sbjct: 131 EAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 6/156 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + +LG G FG V G ++AVK + S EF E + KL H
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+ G C + +V E++ N L +L L+ S+ ++ + G+ +L
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
+ IHRDL A N L+D ++ K+SDFGM R
Sbjct: 121 ---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 21/173 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEI--AVKRLSASSGQGAQEFKNEVVL 394
+ +LGEG FG+V+ P ++ AVK L +S Q+F+ E L
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL------------YDPEKQGQLD 442
+ LQH+++VR G C EG ++V+E++ + L+ FL + G L
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ + +A G++YL + L +HRDL N L+ + KI DFGM+R
Sbjct: 157 LGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 11/161 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SASSGQGAQEFKNEVVLV 395
+A + LGEG FGEVY+GV G++I AVK + ++F +E V++
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
L H ++V+L+G E E ++ E P L ++L + L I +
Sbjct: 68 KNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICK 124
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
+ YL + +HRD+ NIL+ + K+ DFG++R
Sbjct: 125 AMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 22/174 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASSGQGAQEFKNEVVL 394
+ +LGEG FG+V+ +AVK L + ++F+ E L
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQL 441
+ LQH ++V+ G C +G+ I+V+E++ + L+ FL + +G+L
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
S+ I IA G++YL + +HRDL N L+ A + KI DFGM+R
Sbjct: 131 GLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSA-SSGQGAQEFKNEVVLV 395
E+ + +GEG FG+V++G+ P + A+K +S ++F E + +
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+ H ++V+L+G E ++ E L FL + LD + ++
Sbjct: 71 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLST 127
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
+ YL R +HRD+ A N+L+ + K+ DFG++R
Sbjct: 128 ALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 6/162 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ 399
E+ + +KLG G +GEVY+GV +AVK L + + +EF E ++ +++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
H NLV+LLG C ++ EF+ +L +L + +Q ++ + I+ + Y
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEY 126
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
L + IHRDL A N L+ K++DFG++R+ D
Sbjct: 127 L---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 18/186 (9%)
Query: 325 NDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRL--S 378
+ L I + L+ E + + +F+ LG+G FG V + L S ++AVK L
Sbjct: 3 DSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD 62
Query: 379 ASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI------LVYEFVPNKSLDYFL 432
+ +EF E + + H ++ +L+G L K ++ F+ + L FL
Sbjct: 63 IIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL 122
Query: 433 ---YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
E L + + IA G+ YL S IHRDL A N +L +M ++
Sbjct: 123 LASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVA 179
Query: 490 DFGMAR 495
DFG++R
Sbjct: 180 DFGLSR 185
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-33
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 10/157 (6%)
Query: 349 TDNKLGEGGFGEVYKGVL-PSGQEI--AVKRL-SASSGQGAQEFKNEVVLVAKLQHRNLV 404
D +LG G FG V +GV ++I A+K L + +E E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
RL+G C E +LV E L FL K+ ++ S +++ ++ G+ YL
Sbjct: 400 RLIGVCQA-EALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+HR+L A N+LL KISDFG+++ G D
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 20/171 (11%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSASSGQGA-QEFKNEVVL 394
+ LG G FG V+KGV E + +K + SG+ + Q + ++
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ---GQL-DWSRRYKII 450
+ L H ++VRLLG C LV +++P SL + L +W
Sbjct: 69 IGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV----- 122
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
IA+G+ YL ++HR+L A N+LL + +++DFG+A + D
Sbjct: 123 -QIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 52/175 (29%), Positives = 86/175 (49%), Gaps = 23/175 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSA-SSGQGAQEFKNEVV 393
E++ + +LGE FG+VYKG L Q +A+K L + G +EF++E +
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQ 440
L A+LQH N+V LLG + + +++ + + L FL D +
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
L+ ++ IA G+ YL S ++H+DL N+L+ ++N KISD G+ R
Sbjct: 125 LEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 45/184 (24%), Positives = 83/184 (45%), Gaps = 12/184 (6%)
Query: 334 QFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR--LSASSGQGAQEFKNE 391
F+++ V +S ++G GG +V++ + Q A+K L + Q ++NE
Sbjct: 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE 76
Query: 392 VVLVAKLQHRNL--VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449
+ + KLQ + +RL + + + +V E N L+ +L +K+ +D R
Sbjct: 77 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSY 132
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI 509
+ + +H+ I+H DLK +N L+ + K+ DFG+A D T
Sbjct: 133 WKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 510 VGTL 513
VGT+
Sbjct: 189 VGTV 192
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY+GV +A+K + A+S + EF NE
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------YDPEKQGQLDWSRR 446
++ + ++VRLLG +G+ +++ E + L +L + S+
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
++ G IA G+ YL+ + +HRDL A N ++ + KI DFGM R
Sbjct: 141 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSASSGQGA-QEFKNEVVLVAKL 398
+F LG G FG VYKG+ E +A+K L ++ A +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
+ ++ RLLG CL L+ + +P L ++ E + + IA+G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
YL R++HRDL A N+L+ + KI+DFG+A++ G ++
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 6/162 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ 399
E+ + +KLG G +GEVY+GV +AVK L + + +EF E ++ +++
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 274
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
H NLV+LLG C ++ EF+ +L +L + +Q ++ + I+ + Y
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEY 333
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
L + IHR+L A N L+ K++DFG++R+ D
Sbjct: 334 L---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 11/162 (6%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SASSGQGAQEFKNEVVL 394
I ++ + +G G FG VY G L G++I AVK L + +F E ++
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 395 VAKLQHRNLVRLLGFCLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
+ H N++ LLG CL E L V ++ + L F+ + +
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQV 137
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
A+G+ YL + +HRDL A N +LD + K++DFG+AR
Sbjct: 138 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 53/156 (33%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
+ LVRL + E ++ E++ N SL FL P +L ++ + IA G+ ++
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 125
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
IHRDL+A+NIL+ ++ KI+DFG+AR+
Sbjct: 126 ---EERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR--LSASSGQGAQEFKNEVVLV 395
E I V +S ++G GG +V++ + Q A+K L + Q ++NE+ +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 396 AKLQHRNL--VRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
KLQ + +RL + ++ I +V E N L+ +L +K+ +D R
Sbjct: 62 NKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKN 116
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ + +H+ I+H DLK +N L+ + K+ DFG+A D T VGT
Sbjct: 117 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 513 L 513
+
Sbjct: 173 V 173
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 52/179 (29%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL--SASSGQG 384
E LQ E + + N LGEG FG V +G L G + AVK + SS +
Sbjct: 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE 79
Query: 385 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKILVYEFVPNKSLDYFL---YDPE 436
+EF +E + H N++RLLG C+E + +++ F+ L +L
Sbjct: 80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139
Query: 437 KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ K + IA G+ YL S +HRDL A N +L +M ++DFG+++
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 55/169 (32%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSA-SSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKI 449
+++K H+N+VR +G L+ + ++ E + L FL P + L +
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMAR 495
IA G YL IHRD+ A N LL KI DFGMAR
Sbjct: 146 ARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 6/161 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG G FGEV+ ++AVK + S + F E ++ LQH
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQH 242
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+L + E ++ EF+ SL FL E + + IA G+ ++
Sbjct: 243 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI 300
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+ IHRDL+A+NIL+ A + KI+DFG+AR+ ++
Sbjct: 301 ---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 350 DNKLGEGGFGEVYKGVLPSGQE----IAVKRLSASSGQGA-QEFKNEVVLVAKLQHRNLV 404
D +G+G FG VY G + A+K LS + + F E +L+ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 405 RLLGFCLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
L+G L E + ++ + L F+ P++ +ARG+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL--- 140
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ + +HRDL A N +LD K++DFG+AR
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 52/242 (21%), Positives = 104/242 (42%), Gaps = 15/242 (6%)
Query: 264 LSPPPPSSVIRPRGKSGISSSTIIAIVAP--IAVAAVLFVACLCFLRRRAKKKYNAVPEE 321
+ P R ++ +++ ++ +P + ++ ++ + + ++ Y
Sbjct: 4 IDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANT 63
Query: 322 NADNDLTILESLQFDFE--TIEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVK 375
+ + L + I ++ + +G G FG VY G L G++I AVK
Sbjct: 64 VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 123
Query: 376 RLSASSGQGA-QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL-VYEFVPNKSLDYFLY 433
L+ + G +F E +++ H N++ LLG CL E L V ++ + L F+
Sbjct: 124 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 183
Query: 434 DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
+ +A+G+ +L + + +HRDL A N +LD + K++DFG+
Sbjct: 184 NET--HNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGL 238
Query: 494 AR 495
AR
Sbjct: 239 AR 240
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 55/169 (32%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKI 449
+++K H+N+VR +G L+ + ++ E + L FL P + L +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMAR 495
IA G YL IHRD+ A N LL KI DFGMAR
Sbjct: 187 ARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 9/164 (5%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAK 397
+ + + KLGEGGF V L G A+KR+ Q +E + E +
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 398 LQHRNLVRLLGFCLE----GEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGG 452
H N++RL+ +CL E L+ F +L + + +G L + ++ G
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
I RG+ +H HRDLK +NILL E P + D G
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-31
Identities = 39/160 (24%), Positives = 75/160 (46%), Gaps = 11/160 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SASSGQGAQEFKNEVVLV 395
E+ + +GEG FG+V++G+ P + A+K + +S ++F E + +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+ H ++V+L+G E ++ E L FL ++ LD + ++
Sbjct: 446 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLST 502
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ YL R +HRD+ A N+L+ + K+ DFG++R
Sbjct: 503 ALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 50/173 (28%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE---IAVKRL-SASSGQGAQEFKNEVVLVA 396
+ N + +GEG FG+V K + A+KR+ +S ++F E+ ++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 397 KL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQLD 442
KL H N++ LLG C L E+ P+ +L FL L
Sbjct: 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ +ARG+ YL S+ + IHRDL A NIL+ KI+DFG++R
Sbjct: 141 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 16/210 (7%)
Query: 308 RRRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-L 366
+ K PE + + + E L+ + + ++G G FGEV++
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 367 PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426
+G + AVK++ + E+V A L +V L G EG + E +
Sbjct: 81 QTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135
Query: 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486
SL + ++ G L R +G G+ YLH RI+H D+KA N+LL ++ +
Sbjct: 136 SLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSR 189
Query: 487 -KISDFGMARIFGVDQTQGNTSR---IVGT 512
+ DFG A D + I GT
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 6/161 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRH 238
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+L E E +V E++ SL FL + L + + IA G+ Y+
Sbjct: 239 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYV 296
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
R+ +HRDL+A+NIL+ + K++DFG+AR+ ++
Sbjct: 297 ---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 12/180 (6%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR--LSASSGQGAQEFKNEVVLV 395
E I V +S ++G GG +V++ + Q A+K L + Q ++NE+ +
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 396 AKLQHRNL--VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
KLQ + +RL + + + +V E N L+ +L +K+ +D R +
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNM 164
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
+ +H+ I+H DLK +N L+ + K+ DFG+A D T VG +
Sbjct: 165 LEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 7/162 (4%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 411
LG+G +G VY G L + IA+K + + +Q E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
E + E VP SL L + + I G+ YLH++ +I+HR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 472 DLKASNILLDAEM-NPKISDFGMARIFGVDQTQGNTSRIVGT 512
D+K N+L++ KISDFG ++ T GT
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGT 186
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 50/183 (27%), Positives = 78/183 (42%), Gaps = 31/183 (16%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSG------QEIAVKRLSA-SSGQGAQEFKNEVV 393
E N +GEG FG V++ P +AVK L +S +F+ E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--------------------- 432
L+A+ + N+V+LLG C G+ L++E++ L+ FL
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 433 YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
L + + I +A G+ YL S + +HRDL N L+ M KI+DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 493 MAR 495
++R
Sbjct: 220 LSR 222
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 16/166 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRH 321
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-----QLDWSRRYKIIGGIAR 455
LV+L E E +V E++ SL FL + +D + IA
Sbjct: 322 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA------QIAS 374
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
G+ Y+ R+ +HRDL+A+NIL+ + K++DFG+AR+ ++
Sbjct: 375 GMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 26/178 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V +AVK L ++ + + +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEK 437
+ ++ + +H+N++ LLG C + ++ E+ +L +L +
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ Q+ + +ARG+ YL + + IHRDL A N+L+ KI+DFG+AR
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 25/187 (13%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQ 383
E L +D E ++ LG G FG+V + + + +AVK L ++
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 384 GAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV-YEFVPNKSLDYFL--------- 432
+ +E+ ++ + H N+V LLG C + ++V EF +L +L
Sbjct: 73 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 433 ----YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
+ + L +A+G+ +L + + IHRDL A NILL + KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 489 SDFGMAR 495
DFG+AR
Sbjct: 190 CDFGLAR 196
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 26/178 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V +AVK L ++ + + +E
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEK 437
+ ++ + +H+N++ LLG C + ++ E+ +L +L +
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ Q+ + +ARG+ YL + + IHRDL A N+L+ KI+DFG+AR
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 31/183 (16%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASSGQGA-QEFKNEVV 393
E LGEG FG+V K +AVK L ++ ++ +E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQGQLDWSRRYKIIG 451
++ ++ H ++++L G C + +L+ E+ SL FL + G L
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 452 G-------------------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
I++G+ YL + ++++HRDL A NIL+ KISDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 493 MAR 495
++R
Sbjct: 196 LSR 198
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 26/211 (12%)
Query: 308 RRRAKKKYN---AVPEENADNDLTILESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK 363
+ + K KY + E N T ++ Q + E E N LG G FG+V +
Sbjct: 5 KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 364 GVL------PSGQEIAVKRL-SASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415
+ ++AVK L S + + +E+ +++ L QH N+V LLG C G
Sbjct: 65 ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 416 KILVYEFVPNKSLDYFL-----------YDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
+++ E+ L FL +A+G+ +L +
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---A 181
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
IHRD+ A N+LL KI DFG+AR
Sbjct: 182 SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 50/178 (28%), Positives = 75/178 (42%), Gaps = 26/178 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASSGQGA-QEFKNEVV 393
E N+ S LG G FG+V + + +AVK L S+ + +E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 394 LVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL---------------YDPEK 437
+++ L H N+V LLG C G +++ E+ L FL +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ LD +A+G+ +L + IHRDL A NILL KI DFG+AR
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 49/193 (25%), Positives = 78/193 (40%), Gaps = 28/193 (14%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
+ F LG+G FG+V K + A+K++ + + +EV+L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYF---------LYD--PEKQGQLDWSRRYKIIG 451
+VR LE + V KS + LYD + +++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF------------GV 499
I + Y+H IIHRDLK NI +D N KI DFG+A+ +
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 500 DQTQGNTSRIVGT 512
+ N + +GT
Sbjct: 181 PGSSDNLTSAIGT 193
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 11/168 (6%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE-FKNEVVLVAKLQ 399
+ + + + LG+G V++G +G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 400 HRNLVRLLGF--CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
H+N+V+L K+L+ EF P SL L +P L S ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 458 LYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMARIFGVDQ 501
+L E I+HR++K NI+ D + K++DFG AR D+
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRL-SASSGQGAQEFKNE 391
E+ ++ LGEG FG+V ++AVK L S ++ + + +E
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEK 437
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ QL +ARG+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 42/173 (24%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SASSGQGAQEFKNEVVLVAKLQH 400
F + K+G G F EVY+ L G +A+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILY 459
N+++ +E E +V E L + +KQ + + +K + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+H R++HRD+K +N+ + A K+ D G+ R F T ++ +VGT
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 10/185 (5%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVA 396
+T+E+ + L EGGF VY+ + SG+E A+KRL ++ + + EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 397 KLQ-HRNLVRLLGFCL-------EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
KL H N+V+ G+ + L+ + L FL E +G L K
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
I R + ++H + IIHRDLK N+LL + K+ DFG A +++
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 509 IVGTL 513
+
Sbjct: 200 RRALV 204
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 11/168 (6%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE-FKNEVVLVAKLQ 399
+ + + + LG+G V++G +G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 400 HRNLVRLLGF--CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
H+N+V+L K+L+ EF P SL L +P L S ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 458 LYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMARIFGVDQ 501
+L E I+HR++K NI+ D + K++DFG AR D+
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 16/171 (9%)
Query: 350 DNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
D ++G G F VYKG+ + E+A + + Q FK E ++ LQH N+VR
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 407 LGFCLEGEEK----ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ +LV E + + +L +L ++ + I +G+ +LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 463 DSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ IIHRDLK NI + + KI D G+A + + ++GT
Sbjct: 148 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGT 193
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 20/151 (13%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLS----ASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
LG+GGF + ++ + + A K + Q + E+ + L H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 408 GFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHED 463
G E + + +V E +SL + +++ L +R Y + I G YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYY--LRQIVLGCQYLH-- 132
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
R R+IHRDLK N+ L+ ++ KI DFG+A
Sbjct: 133 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 17/150 (11%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLS----ASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
LG+G F VY+ + +G E+A+K + +G + +NEV + +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDS 464
E + LV E N + Y + + +R + + I G+LYLH
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEM--NRYLKNRVKPFSENEARHF--MHQIITGMLYLH--- 129
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMA 494
I+HRDL SN+LL MN KI+DFG+A
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 46/222 (20%), Positives = 85/222 (38%), Gaps = 37/222 (16%)
Query: 308 RRRAKKKY-----NAVPEENADNDLTILESLQFDFETI-EVATNKFSTDNKLGEGGFGEV 361
+ + + +Y ++DN+ ++ +++++ E LG G FG+V
Sbjct: 2 KYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKV 61
Query: 362 YKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEG 413
++AVK L + + +E+ ++ +L H N+V LLG C
Sbjct: 62 MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121
Query: 414 EEKILVYEFVPNKSLDYFL--------------------YDPEKQGQLDWSRRYKIIGGI 453
L++E+ L +L + E L + +
Sbjct: 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 182 AKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 20/151 (13%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLS----ASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
LG+GGF + ++ + + A K + Q + E+ + L H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 408 GFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHED 463
G E + + +V E +SL + +++ L +R Y + I G YLH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYY--LRQIVLGCQYLH-- 158
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
R R+IHRDLK N+ L+ ++ KI DFG+A
Sbjct: 159 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 49/193 (25%), Positives = 81/193 (41%), Gaps = 36/193 (18%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVL 394
DF+ IE +G GGFG+V+K G+ +KR+ ++ ++ + EV
Sbjct: 12 DFKEIE----------LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKA 57
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY---------------DPEKQG 439
+AKL H N+V G + ++S L+ + +
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
+LD ++ I +G+ Y+H ++I+RDLK SNI L KI DFG+
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-- 172
Query: 500 DQTQGNTSRIVGT 512
+ G +R GT
Sbjct: 173 -KNDGKRTRSKGT 184
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 39/171 (22%), Positives = 75/171 (43%), Gaps = 9/171 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHR 401
K+ K+GEG FG+ G++ +K +S S + +E + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
N+V+ E +V ++ L + +K + I + ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVH 142
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ +I+HRD+K+ NI L + ++ DFG+AR+ +GT
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 49/201 (24%), Positives = 79/201 (39%), Gaps = 37/201 (18%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS-ASSGQGAQEFKNEVV 393
DFE I+ LG GGFG V++ A+KR+ + ++ EV
Sbjct: 6 DFEPIQC----------LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 55
Query: 394 LVAKLQHRNLVRLLGFCLEGEE---------KILVY---EFVPNKSLDYFLYDPEKQGQL 441
+AKL+H +VR LE K+ +Y + ++L ++ +
Sbjct: 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+ S I IA + +LH ++HRDLK SNI + K+ DFG+ D+
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 502 TQGNT----------SRIVGT 512
+ + VGT
Sbjct: 173 EEQTVLTPMPAYARHTGQVGT 193
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 2e-26
Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 14/167 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNL 403
+ +LG GGFG V + + +G+++A+K+ +E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 404 VRLL------GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
V + +L E+ L +L E L ++ I+ +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQ 501
YLHE RIIHRDLK NI+L KI D G A+ +
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 10/176 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHR 401
+ +G G +G K G+ + K + + Q +EV L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 402 NLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGIL 458
N+VR ++ L V E+ L + K+ Q LD +++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 459 YLHE--DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
H D ++HRDLK +N+ LD + N K+ DFG+ARI D + T VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 18/175 (10%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLV 404
F + LG G G + + +++AVKR+ A EV L+ + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVI 81
Query: 405 RLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
R + + + E +Y +K ++ G+ +LH
Sbjct: 82 RYFCTE-KDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 464 SRLRIIHRDLKASNILL-----DAEMNPKISDFGMARIFGVDQ-TQGNTSRIVGT 512
L I+HRDLK NIL+ ++ ISDFG+ + V + + S + GT
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 45/170 (26%), Positives = 92/170 (54%), Gaps = 10/170 (5%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
K++ K+G+G G VY + + +GQE+A+++++ + NE++++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V L L G+E +V E++ SL D + +D + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ ++IHRD+K+ NILL + + K++DFG +Q++ +T +VGT
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLS----ASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
LGEG +G+V + + + AVK L G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 408 G-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRY--KIIGGIARGILYLHED 463
E ++K+ +V E+ + PEK+ + + Y ++I G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH-- 126
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
I+H+D+K N+LL KIS G+A
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 50/170 (29%), Positives = 81/170 (47%), Gaps = 10/170 (5%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
+ K+GEG G V SG+++AVK + Q + NEVV++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V + L GEE ++ EF+ +L D Q +L+ + + + + + YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+IHRD+K+ +ILL + K+SDFG D + + +VGT
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGT 204
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 45/172 (26%), Positives = 64/172 (37%), Gaps = 15/172 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKL-QHR 401
F ++LG G +GEV+K G+ AVK + EV K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYL 460
VRL EG L E SL E G L ++ + + + +L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
H ++H D+K +NI L K+ DFG+ G T G G
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGD 219
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 14/156 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS----ASSGQGAQEFKNEVVLVAKLQ 399
F LG+G FG VY S +A+K L +G Q + EV + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 400 HRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
H N++RL G+ ++ L+ E+ P ++ L +K + D R I +A +
Sbjct: 68 HPNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
Y H R+IHRD+K N+LL + KI+DFG +
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 8/170 (4%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
+ +LG+G FG+VYK +G A K + S + +++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+LLG + ++ EF P ++D + E L + + + + +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
RIIHRDLKA N+L+ E + +++DFG++ + ++ +GT
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT 180
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 34/178 (19%), Positives = 71/178 (39%), Gaps = 31/178 (17%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEF---------------- 388
N + L +G F ++ + A+K+ S + ++F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 389 -KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DY------FLYDPEKQG 439
KNE+ ++ +++ + G + +++ ++YE++ N S+ + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
+ + I + Y+H + I HRD+K SNIL+D K+SDFG +
Sbjct: 149 PIQVIKCI--IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 44/193 (22%), Positives = 69/193 (35%), Gaps = 33/193 (17%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKR--LSASSGQGAQEFKNEVVLVAKL-Q 399
T +F K+G G FG V+K V G A+KR + Q EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGIL 458
H ++VR E + ++ E+ SL + + + + ++ + RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNP-------------------KISDFGMARIFGV 499
Y+H ++H D+K SNI + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 500 DQTQGNTSRIVGT 512
Q + G
Sbjct: 187 PQVE------EGD 193
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 55/228 (24%), Positives = 92/228 (40%), Gaps = 54/228 (23%)
Query: 309 RRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS 368
+ N V D+ +++ L D +T E ++ +G G FG V++ L
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63
Query: 369 GQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVRLLGFCLEGEEKI------LVYE 421
E+A+K++ + FKN E+ ++ ++H N+V L F +K LV E
Sbjct: 64 SDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118
Query: 422 FVP-------------NKSLD-----YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
+VP +++ ++Y QL R + Y+H
Sbjct: 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMY------QL------------LRSLAYIH-- 158
Query: 464 SRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
+ I HRD+K N+LLD K+ DFG A+I + N S I
Sbjct: 159 -SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYIC 203
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 9e-24
Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V + + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 411 LEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHEDS 464
L E+ L D E + ++R+ +++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
+ I HRD+K N+LLD N KISDFG+A +F
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVF 155
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V + + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 411 LEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHEDS 464
L E+ L D E + ++R+ +++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
+ I HRD+K N+LLD N KISDFG+A +F
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVF 155
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 52/179 (29%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN-----EVVLVA 396
++++F KLG G + VYKG+ +G +A+K + S +G E+ L+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLMK 58
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPN--KSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+L+H N+VRL + LV+EF+ N K L+ + +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
+G+ + HE+ +I+HRDLK N+L++ K+ DFG+AR FG+ +S +V TL
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV-TL 172
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS----ASSGQGAQEFKNEVVLVAKLQ 399
+ F LG+G FG VY + +A+K L G Q + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLR 72
Query: 400 HRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARG 456
H N++R+ + ++I L+ EF P L L +K G+ S + + +A
Sbjct: 73 HPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATF--MEELADA 126
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
+ Y H ++IHRD+K N+L+ + KI+DFG
Sbjct: 127 LHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG 159
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 19/172 (11%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGA-QEFKNEVVLVAKLQHRNLV 404
F+ K+G+G FGEV+KG+ + + +A+K + + ++ + E+ ++++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YL 460
+ G L+ + ++ E++ S D + G LD I I R IL YL
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLD----ETQIATILREILKGLDYL 135
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
H + + IHRD+KA+N+LL K++DFG+A Q + NT VGT
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 53/184 (28%), Positives = 86/184 (46%), Gaps = 22/184 (11%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFK---NEV-V 393
++EV + +LG G +G V K +PSGQ +AVKR+ A+ QE K ++ +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDI 58
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-YDPEKQGQLDWSRRYKIIGG 452
+ + V G + + E + + SLD F +K + I+G
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP----EDILGK 113
Query: 453 IARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
IA I+ +LH S+L +IHRD+K SN+L++A K+ DFG++ VD +
Sbjct: 114 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID- 169
Query: 509 IVGT 512
G
Sbjct: 170 -AGC 172
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 45/188 (23%), Positives = 68/188 (36%), Gaps = 27/188 (14%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEV-VLVAKLQHRNL 403
N ++ LG G G V G+ +AVKR+ A E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNV 71
Query: 404 VRLLGFCLEGEEKI-LVYEFVPNKSLDYFL---YDPEKQGQLDWSRRYKIIGGIARGILY 459
+R + + + E D E ++ IA G+ +
Sbjct: 72 IRYYCSE-TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP-------------KISDFGMARIFGVDQT--QG 504
LH L+IIHRDLK NIL+ ISDFG+ + Q+ +
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 505 NTSRIVGT 512
N + GT
Sbjct: 188 NLNNPSGT 195
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE-FKN----EVVLVAKL 398
++ + LGEG F VYK + Q +A+K++ A++ E+ L+ +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 399 QHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
H N++ LL + I LV++F+ L+ + D L S + +G+
Sbjct: 70 SHPNIIGLLD-AFGHKSNISLVFDFME-TDLEVIIKDN--SLVLTPSHIKAYMLMTLQGL 125
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
YLH+ I+HRDLK +N+LLD K++DFG+A+ FG
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 42/176 (23%), Positives = 73/176 (41%), Gaps = 14/176 (7%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE-FKNEVVLVAKLQHR 401
+ F KLG G FG+V+ SG E +K ++ Q E + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 402 NLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
N++++ E + +V E L + + + L +++ + + Y
Sbjct: 81 NIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 460 LHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
H ++H+DLK NIL KI DFG+A +F D+ + GT
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 54/191 (28%), Positives = 83/191 (43%), Gaps = 25/191 (13%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVV 393
D + F +G G +G+VYKG + +GQ A+K + + G +E K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEIN 72
Query: 394 LVAKL-QHRNLVRLLGFCLEGEEKI------LVYEFVPNKSL-DYFLYDPEKQGQLDWSR 445
++ K HRN+ G ++ LV EF S+ D L K L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLK--- 127
Query: 446 RYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+ I I R IL +LH+ ++IHRD+K N+LL K+ DFG++
Sbjct: 128 -EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183
Query: 502 TQGNTSRIVGT 512
+ NT +GT
Sbjct: 184 GRRNT--FIGT 192
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVV---------L 394
K+ +GEG +G V K +G+ +A+K+ + +++V L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKL 77
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPN---KSLDYFLYDPEKQGQLDWSRRYKIIG 451
+ +L+H NLV LL C + + LV+EFV + L+ LD+ K +
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE------LFPNGLDYQVVQKYLF 131
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
I GI + H IIHRD+K NIL+ K+ DFG AR
Sbjct: 132 QIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-23
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 15/167 (8%)
Query: 352 KLGEGGFGEVYKG---VLPSGQEIAVK--RLSASSGQGAQE-FKNEVVLVAKLQHRNLVR 405
KLG GG VY +L ++A+K + + + F+ EV ++L H+N+V
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
++ E + LV E++ +L ++ E G L I GI + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---D 129
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+RI+HRD+K NIL+D+ KI DFG+A+ + + T+ ++GT
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGT 175
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 48/182 (26%), Positives = 77/182 (42%), Gaps = 21/182 (11%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQ-GAQEFKNEVVLVAKLQHRN 402
+ + +G G V P +++A+KR++ Q E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL-----DYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
+V + +E LV + + S+ K G LD I I R +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD----ESTIATILREV 130
Query: 458 L----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM-ARIFGVDQTQGNTSR--IV 510
L YLH++ IHRD+KA NILL + + +I+DFG+ A + N R V
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 511 GT 512
GT
Sbjct: 188 GT 189
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 7e-23
Identities = 42/168 (25%), Positives = 69/168 (41%), Gaps = 29/168 (17%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVV---------L 394
K+ K+GEG +G V+K +GQ +A+K+ + + V+ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRM 55
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPN---KSLDYFLYDPEKQGQLDWSRRYKIIG 451
+ +L+H NLV LL LV+E+ + LD Q + I
Sbjct: 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELD------RYQRGVPEHLVKSITW 109
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
+ + + H + IHRD+K NIL+ K+ DFG AR+
Sbjct: 110 QTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 7e-23
Identities = 57/185 (30%), Positives = 91/185 (49%), Gaps = 22/185 (11%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN-----EVVLVA 396
AT+++ ++G G +G VYK SG +A+K + +G G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 397 KLQ---HRNLVRLL----GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
+L+ H N+VRL+ + E K+ LV+E V ++ L +L D L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
++ RG+ +LH + I+HRDLK NIL+ + K++DFG+ARI+ T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPV 179
Query: 509 IVGTL 513
+V TL
Sbjct: 180 VV-TL 183
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 7e-23
Identities = 51/178 (28%), Positives = 85/178 (47%), Gaps = 22/178 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN--------EVVLV 395
F K+GEG +G VYK +G+ +A+K++ E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLL 56
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+L H N+V+LL + LV+EF+ + L F+ D + + + +
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQ 114
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
G+ + H R++HRDLK N+L++ E K++DFG+AR FGV + T +V TL
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TL 167
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 52/181 (28%), Positives = 75/181 (41%), Gaps = 32/181 (17%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVAKLQ 399
FS ++G G FG VY + + + +A+K++S S + Q+ EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDP----EKQGQLDWSRRYKIIGGIAR 455
H N ++ G L LV E+ + D E + I +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----------IAAVTH 161
Query: 456 GIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
G L YLH +IHRD+KA NILL K+ DFG A I N+ VG
Sbjct: 162 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS--FVG 212
Query: 512 T 512
T
Sbjct: 213 T 213
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 1e-22
Identities = 44/181 (24%), Positives = 80/181 (44%), Gaps = 28/181 (15%)
Query: 352 KLGEGGFGEVYKGV---LPSGQEIAVKRLSA----SSGQGAQEFKNEVVLVAKLQHRNLV 404
K+G G +G VYK ++ A+K++ S E+ L+ +L+H N++
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVI 81
Query: 405 RLLGFCLE-GEEKI-LVYEFVPN---KSLDYFLYDPEKQGQLDWSRRY--KIIGGIARGI 457
L L + K+ L++++ + + + + + R ++ I GI
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGV-DQTQGNTSRIVGT 512
YLH + ++HRDLK +NIL+ E KI+D G AR+F + + +V T
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 513 L 513
Sbjct: 199 F 199
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 20/163 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKN--------EVVLVA 396
K+ K+GEG +G VYK G+ +A+KR+ E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL------DAEDEGIPSTAIREISLLK 74
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
+L H N+V L+ LV+EF+ K L L + + L S+ + + RG
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE--NKTGLQDSQIKIYLYQLLRG 131
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
+ + H+ RI+HRDLK N+L++++ K++DFG+AR FG+
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 21/174 (12%)
Query: 331 ESLQFDFE-TIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEF 388
L+ E + ++G G +G V K V PSGQ +AVKR+ ++ + +E
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQ 64
Query: 389 K---NEV-VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
K ++ V++ +V+ G + + E + + S D F K
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLD 119
Query: 445 RRY--KIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
+I+G I + +L E+ L+IIHRD+K SNILLD N K+ DFG
Sbjct: 120 DVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 2e-22
Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 22/164 (13%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKN--------EVVLVA 396
K+ K+GEG +G VYK G+ A+K++ ++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL------EKEDEGIPSTTIREISILK 55
Query: 397 KLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+L+H N+V+L + ++++ LV+E + + L L +G L+ + +
Sbjct: 56 ELKHSNIVKLYD-VIHTKKRLVLVFEHLD-QDLKKLLDV--CEGGLESVTAKSFLLQLLN 111
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
GI Y H+ R++HRDLK N+L++ E KI+DFG+AR FG+
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI 152
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 16/179 (8%), Positives = 40/179 (22%), Gaps = 36/179 (20%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 408
L G V+ + ++ A+K + S + A+L +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 409 FC----------LEGEEKI----------------LVYEFVP---NKSLDYFLYDPEKQG 439
++ + L+ + +G
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
+ + + R L ++H N+ + + + D G
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 50/157 (31%), Positives = 85/157 (54%), Gaps = 27/157 (17%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK-----RLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+G+G F +V + +G+E+A+K +L+ +S Q+ EV ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS---LQKLFREVRIMKILNHPNIVKL 79
Query: 407 LGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYL 460
+E E+ + L+ E+ + DY + G++ +R +I+ + Y
Sbjct: 80 FE-VIETEKTLYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQ----YC 130
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
H + RI+HRDLKA N+LLDA+MN KI+DFG + F
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 50/189 (26%), Positives = 86/189 (45%), Gaps = 21/189 (11%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEF- 388
L + E+ + F ++LG G G V+K PSG +A K + +
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI 78
Query: 389 KNEVVLVAKLQHRNLVRLLG-FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
E+ ++ + +V G F +GE I E + SLD L +K G++
Sbjct: 79 IRELQVLHECNSPYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVL---KKAGRIP----E 130
Query: 448 KIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
+I+G ++ ++ YL E +I+HRD+K SNIL+++ K+ DFG++ +
Sbjct: 131 QILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSM 186
Query: 504 GNTSRIVGT 512
N+ VGT
Sbjct: 187 ANS--FVGT 193
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 23/165 (13%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN--------EVVLV 395
K+ K+GEG +G V+K + + +A+KR+ + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL------DDDDEGVPSSALREICLL 55
Query: 396 AKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+L+H+N+VRL L ++K+ LV+EF + L + G LD + +
Sbjct: 56 KELKHKNIVRLHD-VLHSDKKLTLVFEFCD-QDLKKYFDS--CNGDLDPEIVKSFLFQLL 111
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
+G+ + H ++HRDLK N+L++ K+++FG+AR FG+
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 24/166 (14%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--------RLSASSGQGAQEFKNEVVLVA 396
K+ST + LG G FG V+ V +E+ VK + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 397 KLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRY--KIIG 451
+++H N++++L E + LV E + LD F + ++ +L + +++
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLDLFAF-IDRHPRLDEPLASYIFRQLVS 141
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
+ YL IIHRD+K NI++ + K+ DFG A
Sbjct: 142 AVG----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-22
Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
F KLGEG +G VYK + +GQ +A+K++ QE E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+ G + + +V E+ S+ + + L I+ +G+ YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
R IHRD+KA NILL+ E + K++DFG+A + NT ++GT
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGT 188
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 53/194 (27%), Positives = 82/194 (42%), Gaps = 55/194 (28%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHR 401
++ +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 402 NLVRLLGFCLEGEEKI------LVYEFVP-------------NKSLD-----YFLYDPEK 437
N+VRL F EK LV ++VP ++L ++Y
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY---- 163
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARI 496
QL R + Y+H I HRD+K N+LLD + K+ DFG A+
Sbjct: 164 --QL------------FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206
Query: 497 FGVDQTQGNTSRIV 510
+ + N S I
Sbjct: 207 L--VRGEPNVSYIC 218
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 8e-22
Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK---RLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLG 408
LG G FG+V G +G ++AVK R S + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHE 462
+ +V E+V L DY K G++ +RR +I+ + Y H
Sbjct: 79 -VISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSAVD----YCH- 128
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
R ++HRDLK N+LLDA MN KI+DFG++ +
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 20/176 (11%)
Query: 345 NKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQEFKN-----EVVLVAKL 398
+ +KLGEG + VYKG + +A+K + +GA EV L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57
Query: 399 QHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
+H N+V L + E+ + LV+E++ +K L +L D ++ + + RG+
Sbjct: 58 KHANIVTLHD-IIHTEKSLTLVFEYL-DKDLKQYLDDC--GNIINMHNVKLFLFQLLRGL 113
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
Y H +++HRDLK N+L++ K++DFG+AR + T+ + +V TL
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TL 164
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 8e-22
Identities = 45/169 (26%), Positives = 69/169 (40%), Gaps = 17/169 (10%)
Query: 352 KLGEGGFGEVYKGVLPS-GQEIAVKRLSA--SSGQGAQE-FKNEVVLVAKLQHRNLVRLL 407
+G GG G+VY+ + +A+K +S SS + + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 408 GFCLEGEEKILVY---EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
F GE +Y + L L +QG L R I+ I + H
Sbjct: 101 DF---GEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA- 153
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
HRD+K NIL+ A+ + DFG+A D+ VGTL
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTL 199
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 38/181 (20%), Positives = 69/181 (38%), Gaps = 29/181 (16%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
+ + +LG G FG V++ V +G+ K ++ KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 403 LVRLLGFCLEGEEKILVYEFVP---------NKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
L+ L + E +L+ EF+ + E + +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM----SEAEVI-------NYMRQA 158
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVG 511
G+ ++HE I+H D+K NI+ + + KI DFG+A D+
Sbjct: 159 CEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTA 212
Query: 512 T 512
T
Sbjct: 213 T 213
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 50/183 (27%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN--------EVVLV 395
+++ KLGEG +GEVYK + + + +A+KR+ + EV L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH------EEEGVPGTAIREVSLL 87
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+LQHRN++ L L++E+ L ++ +K + + +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM---DKNPDVSMRVIKSFLYQLIN 143
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNP-----KISDFGMARIFGVDQTQGNTSRIV 510
G+ + H R +HRDLK N+LL KI DFG+AR FG+ + T I+
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII 199
Query: 511 GTL 513
TL
Sbjct: 200 -TL 201
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 36/185 (19%), Positives = 63/185 (34%), Gaps = 24/185 (12%)
Query: 344 TNKFSTDNKLGEG--GFGEVYKGV-LPSGQEIAVKR--LSASSGQGAQEFKNEVVLVAKL 398
+ +G+G V P+G+ + V+R L A S + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
H N+V + E +V F+ S D L ++ I I +G+
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMN----ELAIAYILQGV 137
Query: 458 L----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-----SR 508
L Y+H +HR +KAS+IL+ + +S +
Sbjct: 138 LKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 509 IVGTL 513
V L
Sbjct: 195 SVKVL 199
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 28/194 (14%), Positives = 57/194 (29%), Gaps = 22/194 (11%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSASSGQGAQEFKNE 391
++ + + LGEG F +VY+ + Q+ +K ++
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--YDPEKQGQLDWSRRYKI 449
+ + ++ L +LV E +L + Y + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILL-----------DAEMNPKISDFGMARIFG 498
+ I +H+ IIH D+K N +L D + D G +
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 499 VDQTQGNTSRIVGT 512
+ + T
Sbjct: 235 LFPKGTIFTAKCET 248
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 53/187 (28%), Positives = 92/187 (49%), Gaps = 32/187 (17%)
Query: 345 NKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSGQGAQEFKN--------EVVL 394
++ ++GEG +G+V+K + G+ +A+KR+ Q + EV +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV------QTGEEGMPLSTIREVAV 64
Query: 395 VAKLQ---HRNLVRLL----GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
+ L+ H N+VRL + E K+ LV+E V ++ L +L D + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
++ + RG+ +LH R++HRDLK NIL+ + K++DFG+ARI+ T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177
Query: 507 SRIVGTL 513
S +V TL
Sbjct: 178 SVVV-TL 183
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 21/154 (13%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK---RLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLG 408
LGEG FG+V + Q++A+K R + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHED 463
+ I +V E+ + DY + ++ ++ D RR+ +II I Y H
Sbjct: 77 V-ITTPTDIVMVIEYAGGELFDYIV----EKKRMTEDEGRRFFQQIICAIE----YCH-- 125
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
R +I+HRDLK N+LLD +N KI+DFG++ I
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 3e-21
Identities = 37/172 (21%), Positives = 73/172 (42%), Gaps = 11/172 (6%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
+ + +LG G FG V++ +G A K + + + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
LV L + E +++YEF+ L F ++ ++ + + + +G+ ++HE
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 463 DSRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGT 512
+H DLK NI+ + + K+ DFG+ Q + GT
Sbjct: 274 ---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGT 319
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 44/187 (23%), Positives = 76/187 (40%), Gaps = 31/187 (16%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK-----RLSASSGQGAQEFKNEVVLVAK 397
+ + +G+G F V + + +GQ+ AVK + ++S G ++ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVP---------NKSLDYFLYDPEKQGQLDWSRRYK 448
L+H ++V LL +V+EF+ ++ F+Y E
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY-SEAVAS-------H 134
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGN 505
+ I + Y H+ IIHRD+K +LL ++ N K+ FG+A G
Sbjct: 135 YMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191
Query: 506 TSRIVGT 512
VGT
Sbjct: 192 G--RVGT 196
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 23/191 (12%)
Query: 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSAS--SGQGAQEF 388
S + + +++ LG+G FGEV K + QE AVK ++ + +
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRR 446
EV L+ KL H N+++L E +V E L D + K+ + S
Sbjct: 69 LREVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEII----KRKRF--SEH 121
Query: 447 Y--KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQ 501
+II + GI Y+H+ I+HRDLK NILL + + + KI DFG++ F +
Sbjct: 122 DAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
Query: 502 TQGNTSRIVGT 512
+GT
Sbjct: 179 KM---KDRIGT 186
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 3e-21
Identities = 38/173 (21%), Positives = 67/173 (38%), Gaps = 31/173 (17%)
Query: 352 KLGEGGFGEVYKG---VLPSGQEIAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLL 407
+ GG G +Y + +G+ + +K L S AQ E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 408 GFCLEGEEKI--------LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
F E +V E+V +SL +L + + I + Y
Sbjct: 146 NF---VEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSY 197
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
LH + +++ DLK NI+L E K+ D G + + GT
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGT 240
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 51/155 (32%), Positives = 78/155 (50%), Gaps = 22/155 (14%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK---RLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLG 408
LG G FG+V G +G ++AVK R S + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHE 462
+ I +V E+V L DY K G+L SRR +I+ G+ Y H
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVD----YCH- 133
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
R ++HRDLK N+LLDA MN KI+DFG++ +
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-21
Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 23/179 (12%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQH 400
+ + KLG G +GEV + E A+K + + S + EV ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KIIGGIARG 456
N+++L F E + LV E L D + + + + II + G
Sbjct: 96 PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEII----HRMKF--NEVDAAVIIKQVLSG 148
Query: 457 ILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ YLH+ I+HRDLK N+LL + + KI DFG++ +F + +GT
Sbjct: 149 VTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGT 201
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 45/233 (19%), Positives = 77/233 (33%), Gaps = 52/233 (22%)
Query: 328 TILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK-----RLSASS 381
+ E+L F ++ K+ +G+G +G V + + A+K ++ +
Sbjct: 9 SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 382 GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFV----------------- 423
+ + K EV L+ KL H N+ RL E E+ I LV E
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDST 127
Query: 424 --------------PNKSLDYFLYDPEKQGQLDWSRRY------KIIGGIARGILYLHED 463
+ + + + I+ I + YLH
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN- 186
Query: 464 SRLRIIHRDLKASNILL--DAEMNPKISDFGMARIFGVDQTQGNT--SRIVGT 512
I HRD+K N L + K+ DFG+++ F + GT
Sbjct: 187 --QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 19/177 (10%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE--FKNEVVLVAKLQH 400
+++ LG+G FGEV K + QE AVK ++ +S + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
N+++L E +V E L D + K+ + +II + GI
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGIT 135
Query: 459 YLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
Y+H+ I+HRDLK NILL + + + KI DFG++ F + +GT
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 51/190 (26%), Positives = 95/190 (50%), Gaps = 35/190 (18%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SASSGQGAQEFKN----EVVLVA 396
+K+ K+G+G FGEV+K +GQ++A+K++ + G F E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-----FPITALREIKILQ 71
Query: 397 KLQHRNLVRLLGFCLEGEEKI--------LVYEFVPN--KSLDYFLYDPEKQGQLDWSRR 446
L+H N+V L+ C LV++F + L L + + S
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL---LSNV--LVKFTLSEI 126
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN- 505
+++ + G+ Y+H + +I+HRD+KA+N+L+ + K++DFG+AR F + +
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 506 --TSRIVGTL 513
T+R+V TL
Sbjct: 184 RYTNRVV-TL 192
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 13/171 (7%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
S LG G FG+V+K +G ++A K + + +E KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 405 RLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
+L + +LV E+V L D + + +LD + I GI ++H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL---FMKQICEGIRHMHQ- 205
Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGT 512
+ I+H DLK NIL KI DFG+AR + + GT
Sbjct: 206 --MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGT 251
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 44/175 (25%), Positives = 71/175 (40%), Gaps = 17/175 (9%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
++ +N +G G +GEV V + A K++ + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 403 LVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
++RL E I LV E L + + + S +I+ + + Y
Sbjct: 68 IIRLYETF-EDNTDIYLVMELCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYC 122
Query: 461 HEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
H+ L + HRDLK N L + K+ DFG+A F + VGT
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGT 171
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 46/205 (22%), Positives = 76/205 (37%), Gaps = 57/205 (27%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN----E 391
E ++F + G+G FG V G +G +A+K++ F+N
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQI 69
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEK-------ILVYEFVP-------------NKSLD-- 429
+ +A L H N+V+L + E+ +V E+VP +
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI 129
Query: 430 ---YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486
FL+ QL R I LH S + + HRD+K N+L++
Sbjct: 130 LIKVFLF------QL------------IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGT 170
Query: 487 -KISDFGMARIFGVDQTQGNTSRIV 510
K+ DFG A+ + N + I
Sbjct: 171 LKLCDFGSAKKLSPSEP--NVAYIC 193
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 30/183 (16%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVAKLQ 399
++++ LG+G FGEV +GQE AVK +S + EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKIIGG 452
H N+++L F + LV E L F E +II
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF---SEVDAA-------RIIRQ 134
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRI 509
+ GI Y+H+ +I+HRDLK N+LL + N +I DFG++ F +
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDK 188
Query: 510 VGT 512
+GT
Sbjct: 189 IGT 191
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 19/172 (11%)
Query: 352 KLGEGGFGEVYKG---VLPSGQEIAVK--RLSASSGQGAQE-FKNEVVLVAKLQHRNLVR 405
LG GG EV+ +++AVK R + F+ E A L H +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 406 LL--GFCLEGEEKI--LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
+ G + +V E+V +L + +G + R ++I + + + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGT 512
+ IIHRD+K +NI++ A K+ DFG+AR I + T+ ++GT
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 47/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGA---------QEFKNEVV 393
+ LG G V + + P+ +E AVK + + G + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 394 LVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIG 451
++ K+ H N+++L LV++ + L DY ++ L KI+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMR 131
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
+ I LH+ L I+HRDLK NILLD +MN K++DFG + + + G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCG 185
Query: 512 T 512
T
Sbjct: 186 T 186
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 45/187 (24%), Positives = 70/187 (37%), Gaps = 34/187 (18%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASS------GQGAQEFKNEVVLVA 396
+ + +LG G F V K +G E A K + G +E + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKI 449
++ H N++ L + +L+ E V L + E++
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEAT-------SF 120
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
I I G+ YLH +I H DLK NI+L + P K+ DFG+A
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174
Query: 506 TSRIVGT 512
I GT
Sbjct: 175 FKNIFGT 181
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 91.3 bits (226), Expect = 5e-20
Identities = 24/194 (12%), Positives = 54/194 (27%), Gaps = 38/194 (19%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGA---QEFKNEVVLVAKLQ--------- 399
LG+ + +G+ V + + ++ K EV+ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 400 -------------HRNLVRLLGFCLEGEEKILVYEFVPNKS--------LDYFLYDPEKQ 438
+++ L+ + ++ F + L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
L R ++ + R + LH ++H L+ +I+LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 499 VDQTQGNTSRIVGT 512
R
Sbjct: 263 -ASAVSPIGRGFAP 275
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 24/182 (13%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK-----RLSASSGQGAQE---FKNEVVL 394
+++ LG G GEV + +++A++ + + S + A + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGI 453
+ KL H ++++ F + E+ +V E + L D + +L + +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQM 248
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIV 510
+ YLHE IIHRDLK N+LL ++ KI+DFG ++I G +
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 302
Query: 511 GT 512
GT
Sbjct: 303 GT 304
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 29/162 (17%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN------EVVLVAKLQHR--NL 403
LG GGFG VY G+ + +A+K + E N EVVL+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 404 VRLLGFCLEGEEKI-LVYEFV-PNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARG 456
+RLL + E + L+ E P + L D+ ++G L + +R + +++ +
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVR-- 163
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIF 497
+ H ++HRD+K NIL+D K+ DFG +
Sbjct: 164 --HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 48/187 (25%), Positives = 76/187 (40%), Gaps = 34/187 (18%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK-----RLSASSGQGAQE-FKNEVVLVA 396
+ + +LG G F V K +G+E A K RLS+S ++E + EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKI 449
+++H N++ L + +L+ E V L + E + +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL---TEDEAT-------QF 113
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
+ I G+ YLH RI H DLK NI+L + P K+ DFG+A
Sbjct: 114 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--- 167
Query: 506 TSRIVGT 512
I GT
Sbjct: 168 FKNIFGT 174
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 52/182 (28%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLS-------------------ASSGQGAQEFKN-- 390
+G+G +G V A+K LS + G + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 391 -----EVVLVAKLQHRNLVRLLGFCLE-----GEEKI-LVYEFVPNKSLDYFLYDPEKQG 439
E+ ++ KL H N+V+L+ E E+ + +V+E V + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPV----MEVPTLK 132
Query: 440 QL--DWSRRY--KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
L D +R Y +I GI YLH +IIHRD+K SN+L+ + + KI+DFG++
Sbjct: 133 PLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 496 IF 497
F
Sbjct: 186 EF 187
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 6e-20
Identities = 47/187 (25%), Positives = 72/187 (38%), Gaps = 34/187 (18%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK-----RLSAS-SGQGAQEFKNEVVLVA 396
+ + +LG G F V K +G E A K + AS G +E + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKI 449
++ H N++ L + +L+ E V L + E++
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEAT-------SF 120
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
I I G+ YLH +I H DLK NI+L + P K+ DFG+A
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174
Query: 506 TSRIVGT 512
I GT
Sbjct: 175 FKNIFGT 181
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 6e-20
Identities = 35/181 (19%), Positives = 65/181 (35%), Gaps = 30/181 (16%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
K+ LG G FG V++ V S + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRN 62
Query: 403 LVRLLGFCLEGEEKILVYEFVP---------NKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
++ L EE ++++EF+ + + E++ + +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL----NEREIV-------SYVHQV 111
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVG 511
+ +LH I H D++ NI+ + KI +FG AR +
Sbjct: 112 CEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFT 165
Query: 512 T 512
Sbjct: 166 A 166
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 24/182 (13%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS--------ASSGQGAQEFKNEVVL 394
+++ LG G GEV + +++A+K +S A A + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGI 453
+ KL H ++++ F + E+ +V E + L D + +L + +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQM 123
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
+ YLHE IIHRDLK N+LL + + KI+DFG ++I G +
Sbjct: 124 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 177
Query: 511 GT 512
GT
Sbjct: 178 GT 179
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 42/182 (23%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE--------FKNEVVL 394
K+ + +G G V + V +G E AVK + ++ + + E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 395 VAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KII 450
+ ++ H +++ L+ LV++ + L DY ++ L S + I+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKVAL--SEKETRSIM 206
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
+ + +LH I+HRDLK NILLD M ++SDFG + + +
Sbjct: 207 RSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELC 260
Query: 511 GT 512
GT
Sbjct: 261 GT 262
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 23/189 (12%)
Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN- 390
L + + N ++G G G+V+K +G IAVK++ S + +E K
Sbjct: 13 LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRI 70
Query: 391 --EV-VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
++ V++ +V+ G + + + E + + QG +
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKK--RMQGPIP----E 123
Query: 448 KIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
+I+G + I+ YL E +IHRD+K SNILLD K+ DFG++ VD
Sbjct: 124 RILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKA 180
Query: 504 GNTSRIVGT 512
+ S G
Sbjct: 181 KDRS--AGC 187
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 8e-20
Identities = 46/176 (26%), Positives = 74/176 (42%), Gaps = 17/176 (9%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL--SASSGQGAQEFKNEVVLVAKLQH 400
++ + +LG+G F V + V +G E A K + S + Q+ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
N+VRL E LV++ V L + + + + I I I Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAY 120
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGT 512
H I+HR+LK N+LL ++ K++DFG+A + GT
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 50/190 (26%), Positives = 78/190 (41%), Gaps = 34/190 (17%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS-------------ASSGQGAQEFK 389
+ KLG G +GEV E A+K + + + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY 447
NE+ L+ L H N+++L E ++ LV EF L + + + +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQII----NRHKF--DECD 147
Query: 448 --KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQT 502
I+ I GI YLH+ I+HRD+K NILL ++ +N KI DFG++ F D
Sbjct: 148 AANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 503 QGNTSRIVGT 512
+GT
Sbjct: 205 L---RDRLGT 211
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 23/184 (12%), Positives = 49/184 (26%), Gaps = 37/184 (20%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE---FKNEVVLVAKLQ--------- 399
LG+ + +G+ V + + K EV+ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 400 ----------------HRNLVRLLG-FCLEGEEKILVYEFVPNKSL----DYFLYDPEKQ 438
+ ++R+ +L + L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
L R ++ + R + LH ++H L+ +I+LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 499 VDQT 502
Sbjct: 258 ARVV 261
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 47/184 (25%), Positives = 72/184 (39%), Gaps = 36/184 (19%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
F LG G F EV+ +G+ A+K + S +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 403 LVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL-DW--SRRY-------KIIG 451
+V L E LV + V G+L D R +I
Sbjct: 68 IVTLEDIY-ESTTHYYLVMQLVSG-------------GELFDRILERGVYTEKDASLVIQ 113
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSR 508
+ + YLHE I+HRDLK N+L + I+DFG++++ G S
Sbjct: 114 QVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMST 166
Query: 509 IVGT 512
GT
Sbjct: 167 ACGT 170
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 49/187 (26%), Positives = 75/187 (40%), Gaps = 34/187 (18%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK-----RLSASSGQGAQE-FKNEVVLVA 396
+ + T +LG G F V K +G + A K R +S ++E + EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKI 449
++QH N++ L + IL+ E V L + E++ +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEAT-------EF 119
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
+ I G+ YLH L+I H DLK NI+L P KI DFG+A
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173
Query: 506 TSRIVGT 512
I GT
Sbjct: 174 FKNIFGT 180
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 31/164 (18%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRL------SASSGQGAQEFKNEVVLVAKL----QHR 401
LG+GGFG V+ G L ++A+K + S + EV L+ K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 402 NLVRLLGFCLEGEEKI-LVYEF-VPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIA 454
++RLL + E +E LV E +P + L DY ++G L SR + +++ I
Sbjct: 99 GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIF 497
+ H ++HRD+K NIL+D K+ DFG +
Sbjct: 154 ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 21/178 (11%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQH 400
++ + +LG+G F V + V +G E A K ++ S + Q+ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KIIGGIARGI 457
N+VRL E LV++ V L + + + S I I I
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFY--SEADASHCIQQILESI 141
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGT 512
Y H I+HR+LK N+LL ++ K++DFG+A + GT
Sbjct: 142 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 193
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 45/180 (25%), Positives = 69/180 (38%), Gaps = 32/180 (17%)
Query: 349 TDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHR-NLV 404
T +LG G F V + + +GQE A K + E +E+ ++ + ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 405 RLLGFCLEGEEKILVYEFVP---------NKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
L E IL+ E+ + + E ++I I
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV---SENDVI-------RLIKQILE 142
Query: 456 GILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
G+ YLH+ I+H DLK NILL + KI DFGM+R G I+GT
Sbjct: 143 GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGT 196
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 36/158 (22%), Positives = 66/158 (41%), Gaps = 22/158 (13%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 411
+G G FG + + +AVK + + + E++ L+H N+VR +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKE-VI 85
Query: 412 EGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHEDSR 465
+ ++ E+ L + G+ D +R + +++ G++ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERIC----NAGRFSEDEARFFFQQLLSGVS----YCH---S 134
Query: 466 LRIIHRDLKASNILLDA--EMNPKISDFGMARIFGVDQ 501
++I HRDLK N LLD KI DFG ++ +
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 34/185 (18%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL--SASSGQGAQEFKNEVVLVAKLQH 400
T ++ +LG+G F V + V + +GQE A + S + Q+ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL-DW--SRRY-------KII 450
N+VRL E L+++ V G+L + +R Y I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLV-------------TGGELFEDIVAREYYSEADASHCI 116
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTS 507
I +L+ H+ + ++HR+LK N+LL K++DFG+A +Q
Sbjct: 117 QQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG- 172
Query: 508 RIVGT 512
GT
Sbjct: 173 -FAGT 176
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 42/211 (19%), Positives = 82/211 (38%), Gaps = 51/211 (24%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKL 398
E ++ K+S LG G FG V + + SG+ A+K++ +KN E+ ++ L
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVL 57
Query: 399 QHRNLVRLLGF---CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR--------- 446
H N+++L+ + + E K NK + +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 447 -------YKIIGG-------------------IARGILYLHEDSRLRIIHRDLKASNILL 480
+K++ + R + ++H L I HRD+K N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 481 DAEMNP-KISDFGMARIFGVDQTQGNTSRIV 510
+++ N K+ DFG A+ ++ + + I
Sbjct: 175 NSKDNTLKLCDFGSAKKL--IPSEPSVAYIC 203
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 36/193 (18%), Positives = 77/193 (39%), Gaps = 57/193 (29%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN---------EVV 393
+++ + +G G +G V + + +A+K++ + F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 394 LVAKLQHRNLVRLLGFC----LEGEEKI-LVYEFVP---------NKSLD-----YFLYD 434
++ +L H ++V++L +E +++ +V E L LY
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY- 163
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ G+ Y+H S I+HRDLK +N L++ + + K+ DFG+A
Sbjct: 164 -----N------------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLA 203
Query: 495 RIFGVDQTQGNTS 507
R + +
Sbjct: 204 RTVDYPENGNSQL 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 43/171 (25%), Positives = 68/171 (39%), Gaps = 18/171 (10%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFC 410
LGEG V + L + QE AVK + G EV ++ + Q HRN++ L+ F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 411 LEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
E + LV+E + S+ + K+ + ++ +A + +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVASALDFLHN---KGIA 133
Query: 470 HRDLKASNILL---DAEMNPKISDFGMARIF-----GVDQTQGNTSRIVGT 512
HRDLK NIL + KI DF + + G+
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 22/177 (12%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
T+ + +G G + + + + E AVK + S +E +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KIIGGIARGILY 459
++ L +G+ +V E + L D L +Q S R ++ I + + Y
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFF--SEREASAVLFTITKTVEY 131
Query: 460 LHEDSRLRIIHRDLKASNILL-DAEMNP---KISDFGMARIFGVDQTQGNTSRIVGT 512
LH ++HRDLK SNIL D NP +I DFG A+ + T T
Sbjct: 132 LHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 51/197 (25%), Positives = 81/197 (41%), Gaps = 52/197 (26%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSASSGQGAQEFKNE 391
DF+ ++ LGEG F V + +E A+K L K
Sbjct: 31 DFKFGKI----------LGEGSFSTVVLARELA---TSREYAIKILE----------KRH 67
Query: 392 VV-------------LVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEK 437
++ ++++L H V+L F + +EK+ + N L ++ K
Sbjct: 68 IIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR---K 123
Query: 438 QGQL--DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
G +R Y I + YLH IIHRDLK NILL+ +M+ +I+DFG A+
Sbjct: 124 IGSFDETCTRFY--TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK 178
Query: 496 IFGVDQTQGNTSRIVGT 512
+ + Q + VGT
Sbjct: 179 VLSPESKQARANSFVGT 195
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 15/150 (10%), Positives = 45/150 (30%), Gaps = 16/150 (10%)
Query: 352 KLGEGGFGEVYKG---VLPSGQEIAVKRLSASSGQGA---QEFKNEVVLVAKLQHRNLVR 405
G + ++ L +++A+ + QE + + ++++ + R
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
+L ++V E++ SL + + +A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---R 147
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ S + + + + ++
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 35/183 (19%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
++ F +++LG G VY+ + + A+K L + + + + E+ ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL-DW--SRRY-------KIIGG 452
+++L E LV E V G+L D + Y +
Sbjct: 110 IIKLKEIFETPTEISLVLELV-------------TGGELFDRIVEKGYYSERDAADAVKQ 156
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRI 509
I + YLHE I+HRDLK N+L + KI+DFG+++I +
Sbjct: 157 ILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTV 210
Query: 510 VGT 512
GT
Sbjct: 211 CGT 213
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 16/213 (7%)
Query: 307 LRRRAKKKYNAVPEENADNDLTILESLQFD-FETIEVATNKFSTDNKLGEGGFGEVYKGV 365
L R + + P + + + LQ+ E V N F LG+GGFGEV
Sbjct: 145 LTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQ 204
Query: 366 LPSGQEI-AVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVY 420
+ + ++ A K+L +G NE ++ K+ R +V L + E ++ + LV
Sbjct: 205 VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVL 263
Query: 421 EFVPNKSLDYFLYDPEKQG-QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 479
+ L + +Y + G + Y I G+ LH RI++RDLK NIL
Sbjct: 264 TLMNGGDLKFHIYHMGQAGFPEARAVFY--AAEICCGLEDLHR---ERIVYRDLKPENIL 318
Query: 480 LDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
LD + +ISD G+A QT VGT
Sbjct: 319 LDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 43/191 (22%), Positives = 70/191 (36%), Gaps = 34/191 (17%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGVLPSGQEIAVKRLS--ASSGQGAQE 387
+ ++ + + + G +G V GV G +A+KR+ S G+
Sbjct: 7 EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 388 FKN---------EVVLVAKLQHRNLVRLLG----FCLEGEEKI-LVYEFVPNKSLDYFLY 433
+ E+ L+ H N++ L F K+ LV E + L
Sbjct: 67 LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLA 121
Query: 434 DPEKQGQLDWSR---RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490
++ S +Y + I G+ LHE ++HRDL NILL + I D
Sbjct: 122 QVIHDQRIVISPQHIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD 177
Query: 491 FGMARIFGVDQ 501
F +AR D
Sbjct: 178 FNLAREDTADA 188
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 24/183 (13%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSA--SSGQGAQ 386
F +V + +G G +G V + SG+++A+K+LS S A+
Sbjct: 9 GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK 68
Query: 387 EFKNEVVLVAKLQHRNLVRLL-----GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQ 440
E++L+ +QH N++ LL L LV F + L
Sbjct: 69 RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKF 123
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
+ +Y ++ + +G+ Y+H ++HRDLK N+ ++ + KI DFG+AR +
Sbjct: 124 SEEKIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
Query: 501 QTQ 503
T
Sbjct: 180 MTG 182
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 37/189 (19%), Positives = 78/189 (41%), Gaps = 45/189 (23%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFK 389
ES ++ + + KLG G + EV++ + + + +++ VK L ++ K
Sbjct: 26 ESHVVEWGNQD----DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIK 78
Query: 390 NEVVLVAKLQ-HRNLVRLLGFCLEGEEK--ILVYEFVPNKSLD------------YFLYD 434
E+ ++ L+ N++ L + + LV+E V N +++Y
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY- 137
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGM 493
++ + + Y H S I+HRD+K N+++D E ++ D+G+
Sbjct: 138 -----EI------------LKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 494 ARIFGVDQT 502
A + Q
Sbjct: 178 AEFYHPGQE 186
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 6e-16
Identities = 47/185 (25%), Positives = 75/185 (40%), Gaps = 29/185 (15%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSAS---SGQGAQEFKNE 391
DF + +G GGFGEVY +G+ A+K L QG NE
Sbjct: 190 DFSVHRI----------IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 392 ---VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
+ LV+ +V + + +K+ + + + L Y L + G +
Sbjct: 240 RIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMR 295
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
I G+ ++H +++RDLK +NILLD + +ISD G+A F +
Sbjct: 296 FYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--- 349
Query: 508 RIVGT 512
VGT
Sbjct: 350 -SVGT 353
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 42/199 (21%), Positives = 73/199 (36%), Gaps = 33/199 (16%)
Query: 331 ESLQFDFETIEVATNKFS-----TDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQG 384
L+ F+ E + + LG G G+V + +GQ+ A+K L S
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---- 65
Query: 385 AQEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKI----LVYEFVPNKSL-DYFLYDPEKQ 438
+ + EV ++V +L ++ E + L ++
Sbjct: 66 -PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ----ER 120
Query: 439 GQLDWSRRY--KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGM 493
G ++ R +I+ I I +LH I HRD+K N+L + + K++DFG
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 494 ARIFGVDQTQGNTSRIVGT 512
A+ TQ T
Sbjct: 178 AKET----TQNALQTPCYT 192
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 51/185 (27%), Positives = 82/185 (44%), Gaps = 26/185 (14%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSAS---SGQGAQEFKNE 391
F V LG GGFGEV+ + + ++ A K+L+ +G Q E
Sbjct: 186 WFLDFRV----------LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL---DWSRRY 447
++AK+ R +V L + E + + LV + + Y +Y+ ++ + Y
Sbjct: 236 KKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
I G+ +LH+ II+RDLK N+LLD + N +ISD G+A QT+
Sbjct: 295 --TAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349
Query: 508 RIVGT 512
GT
Sbjct: 350 --AGT 352
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 50/243 (20%), Positives = 72/243 (29%), Gaps = 76/243 (31%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE-FKNEVV 393
DFE I+ +G GGFG V++ A+KR+ + + A+E EV
Sbjct: 7 DFEPIQC----------MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 56
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI---- 449
+AKL+H +VR LE + E D P + KI
Sbjct: 57 ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116
Query: 450 -----------IGGIARGILYLH-----------------------EDSRLRI------- 468
+ LY+ L I
Sbjct: 117 PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176
Query: 469 ---------IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS----------RI 509
+HRDLK SNI + K+ DFG+ D+ +
Sbjct: 177 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236
Query: 510 VGT 512
VGT
Sbjct: 237 VGT 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 24/185 (12%)
Query: 332 SLQFDFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSA--SSG 382
+ F ++EV + F+ + +G G G V + +A+K+LS +
Sbjct: 43 KVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ 102
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLL------GFCLEGEEKILVYEFVPNKSLDYFLYDPE 436
A+ E+VL+ + H+N++ LL E ++ LV E +D L
Sbjct: 103 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVI 157
Query: 437 KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
+ Y ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+AR
Sbjct: 158 QMELDHERMSY-LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
Query: 497 FGVDQ 501
G
Sbjct: 214 AGTSF 218
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 30/186 (16%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLS----ASSGQGAQE 387
DFE ++V +G G F EV K +GQ A+K ++ G+ +
Sbjct: 62 DFEILKV----------IGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSC- 107
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
F+ E ++ R + +L F + E + LV E+ L L ++ + +R
Sbjct: 108 FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF 166
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
Y + I I +H L +HRD+K NILLD + +++DFG D T +
Sbjct: 167 Y--LAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-S 220
Query: 507 SRIVGT 512
VGT
Sbjct: 221 LVAVGT 226
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 52/199 (26%)
Query: 332 SLQFDFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQG 384
+F ++E+ + F+ + +G G G V + +A+K+LS
Sbjct: 6 KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS------ 59
Query: 385 AQEFKN---------EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF---- 431
+ F+N E+VL+ + H+N++ LL F P KSL+ F
Sbjct: 60 -RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVY 106
Query: 432 ---------LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482
L + Y ++ + GI +LH IIHRDLK SNI++ +
Sbjct: 107 IVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 162
Query: 483 EMNPKISDFGMARIFGVDQ 501
+ KI DFG+AR G
Sbjct: 163 DCTLKILDFGLARTAGTSF 181
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 42/178 (23%), Positives = 80/178 (44%), Gaps = 24/178 (13%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN 402
+++ LG GG G V+ V + +A+K++ + Q + E+ ++ +L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 403 LVRLL--------------GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
+V++ G E +V E+ ++ L + +QG L
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLEEHARL 124
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGN 505
+ + RG+ Y+H + ++HRDLK +N+ ++ E + KI DFG+ARI +
Sbjct: 125 FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 41/198 (20%), Positives = 75/198 (37%), Gaps = 57/198 (28%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN------ 390
+ ++ F + LGEG +G V P+G+ +A+K++ F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALR 55
Query: 391 ---EVVLVAKLQHRNLVRLL-----GFCLEGEEKILVYEFVP--------NKSLD----- 429
E+ ++ +H N++ + E ++ E + + L
Sbjct: 56 TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
YF+Y Q R + LH + +IHRDLK SN+L+++ + K+
Sbjct: 116 YFIY------Q------------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC 154
Query: 490 DFGMARIFGVDQTQGNTS 507
DFG+ARI +
Sbjct: 155 DFGLARIIDESAADNSEP 172
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 43/171 (25%), Positives = 68/171 (39%), Gaps = 18/171 (10%)
Query: 348 STDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVR 405
D LGEG F K V S Q AVK +S + E+ + + H N+V+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70
Query: 406 LLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
L + LV E + L +K+ + I+ + + ++H+
Sbjct: 71 LHEVF-HDQLHTFLVMELLNGGEL---FERIKKKKHFSETEASYIMRKLVSAVSHMHD-- 124
Query: 465 RLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ ++HRDLK N+L + + KI DFG AR+ D T T
Sbjct: 125 -VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 37/194 (19%), Positives = 74/194 (38%), Gaps = 57/194 (29%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN---------EVV 393
+ + + +G G +G VY + + +A+K+++ F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREIT 77
Query: 394 LVAKLQHRNLVRLLGFCL-----EGEEKILVYEFVP---------NKSLD-----YFLYD 434
++ +L+ ++RL + + +E +V E L LY
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY- 136
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ G ++HE IIHRDLK +N LL+ + + K+ DFG+A
Sbjct: 137 -----N------------LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176
Query: 495 RIFGVDQTQGNTSR 508
R ++ +
Sbjct: 177 RTINSEKDTNIVND 190
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 36/161 (22%), Positives = 64/161 (39%), Gaps = 36/161 (22%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEV-VLVAKLQHRNLVRLLGF 409
LG G G+V + + ++ A+K L + + EV + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 410 C---LEGEEKI-LVYEFVP---------NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
G + + +V E + ++ F E++ +I+ I
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREAS-------EIMKSIGEA 129
Query: 457 ILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMA 494
I YLH + I HRD+K N+L K++DFG A
Sbjct: 130 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 42/197 (21%), Positives = 81/197 (41%), Gaps = 57/197 (28%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN----- 390
+ +++ + +GEG +G V + +A+K++S F++
Sbjct: 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQ 70
Query: 391 ----EVVLVAKLQHRNLVRLLGF----CLEGEEKI-LVYEF--------VPNKSLD---- 429
E+ ++ + +H N++ + +E + + +V + + + L
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 130
Query: 430 -YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
YFLY Q I RG+ Y+H + ++HRDLK SN+LL+ + KI
Sbjct: 131 CYFLY------Q------------ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKI 169
Query: 489 SDFGMARIFGVDQTQGN 505
DFG+AR+ D
Sbjct: 170 CDFGLARVADPDHDHTG 186
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 48/190 (25%), Positives = 79/190 (41%), Gaps = 37/190 (19%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSA--SSGQGAQ 386
F EV + +G G +G V V +G ++A+K+L S A+
Sbjct: 10 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK 69
Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LY 433
E+ L+ ++H N++ LL F P+++LD F L
Sbjct: 70 RAYRELRLLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLG 117
Query: 434 DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
K +L R ++ + +G+ Y+H IIHRDLK N+ ++ + KI DFG+
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 494 ARIFGVDQTQ 503
AR + T
Sbjct: 175 ARQADSEMTG 184
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 38/165 (23%), Positives = 68/165 (41%), Gaps = 22/165 (13%)
Query: 349 TDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEV-VLVAKLQHRNLVRL 406
T LG G G+V + + ++ A+K L + + EV + Q ++VR+
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120
Query: 407 LGFC---LEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRY--KIIGGIARGILYL 460
+ G + + +V E + L + +G ++ R +I+ I I YL
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 461 HEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQT 502
H + I HRD+K N+L K++DFG A+ +
Sbjct: 178 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 22/182 (12%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQE---FKNE 391
DFE ++V +G G FGEV L + ++ A+K L+ E F+ E
Sbjct: 75 DFEILKV----------IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
++ + + L + + + + LV ++ L L E + + +R Y +
Sbjct: 125 RDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--L 181
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
+ I +H+ L +HRD+K NIL+D + +++DFG D T +S V
Sbjct: 182 AEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAV 237
Query: 511 GT 512
GT
Sbjct: 238 GT 239
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 37/190 (19%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEF 388
F E+ + + +G G +G V +G +AVK+LS + F
Sbjct: 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPF 66
Query: 389 KN---------EVVLVAKLQHRNLVRLL-----GFCLEGEEKI-LVYEFVPNKSLDYFLY 433
++ E+ L+ ++H N++ LL LE + LV + L
Sbjct: 67 QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLN 121
Query: 434 DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
+ K +L +I I RG+ Y+H IIHRDLK SN+ ++ + KI DFG+
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178
Query: 494 ARIFGVDQTQ 503
AR + T
Sbjct: 179 ARHTADEMTG 188
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.7 bits (172), Expect = 2e-13
Identities = 30/201 (14%), Positives = 60/201 (29%), Gaps = 46/201 (22%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL--------SASSGQGAQEFKNEVV 393
+ T K K+GEG FGEV++ + +A+K + + S + +E E++
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 394 LVAKLQ---------HRNLVRLLGFCL-------------------EGEEKILVYEFVPN 425
+ +L + L +G F +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 426 KSLDYFLYDP-------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
+ ++ + + I+ + + LR HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNV 193
Query: 479 LLDAEMNPKISDFGMARIFGV 499
LL K+ + +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTI 214
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 54/197 (27%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN------ 390
K+ KLG+G +G V+K + +G+ +AVK++ F+N
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQR 54
Query: 391 ---EVVLVAKLQ-HRNLVRLLG-FCLEGEEKI-LVYEFVP--------NKSLD-----YF 431
E++++ +L H N+V LL + + + LV++++ L+ Y
Sbjct: 55 TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYV 114
Query: 432 LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
+Y Q + + I YLH S ++HRD+K SNILL+AE + K++DF
Sbjct: 115 VY------Q------------LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADF 153
Query: 492 GMARIFGVDQTQGNTSR 508
G++R F + N
Sbjct: 154 GLSRSFVNIRRVTNNIP 170
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 46/189 (24%), Positives = 77/189 (40%), Gaps = 38/189 (20%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLS----ASSGQGAQE 387
D+E ++V +G G FGEV K + + A+K LS A
Sbjct: 70 DYEVVKV----------IGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF- 115
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYD---PEKQGQLDW 443
F E ++A +V+L + + + + +V E++P L + + PE W
Sbjct: 116 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-----KW 169
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
+R Y + + +H + IHRD+K N+LLD + K++DFG +
Sbjct: 170 ARFY--TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
Query: 504 GNTSRIVGT 512
VGT
Sbjct: 225 R-CDTAVGT 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 35/173 (20%), Positives = 65/173 (37%), Gaps = 23/173 (13%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI------AVKRLSASSGQGAQEFKNEVVLVAKL 398
+ +G+GGFG +Y + S + + VK + +G E K
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-----LYDPEKQGQLDWSRR---YKII 450
Q + +R G K Y + + Q + + + K +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 451 GGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKI--SDFGMARIF 497
++ IL Y+HE +H D+KASN+LL+ + ++ D+G+A +
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 37/174 (21%), Positives = 67/174 (38%), Gaps = 19/174 (10%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASSGQG 384
E L +D E ++ LG G FG+V + + + +AVK L +
Sbjct: 8 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 67
Query: 385 A-QEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQL 441
+ +E+ +L+ H N+V LLG C + ++V EF +L +L
Sbjct: 68 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------- 118
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
S+R + + +G + + I DLK + + + S F +
Sbjct: 119 -RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+A+G+ +L + + IHRDL A NILL + KI DFG+AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 3e-11
Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 40/174 (22%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY---KGVLPSGQEI-AVKRLS-ASSGQGAQEFKN 390
FE ++V LG+G FG+V+ K +++ A+K L A+ ++
Sbjct: 25 QFELLKV----------LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-----RD 69
Query: 391 EV-------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL- 441
V +L ++ H +V+L + + E K+ L+ +F+ L L K+
Sbjct: 70 RVRTKMERDIL-VEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFT 124
Query: 442 -DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ + Y + +A + +LH L II+RDLK NILLD E + K++DFG++
Sbjct: 125 EEDVKFY--LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 32/189 (16%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY---KGVLPSGQEI-AVKRLS----ASSGQGAQE 387
+FE ++V LG G +G+V+ K ++ A+K L + +
Sbjct: 55 NFELLKV----------LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104
Query: 388 FKNE-VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DW 443
+ E VL Q LV L + + E K+ L+ +++ L L ++ +
Sbjct: 105 TRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLS---QRERFTEHE 160
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
+ Y +G I + +LH+ L II+RD+K NILLD+ + ++DFG+++ F D+T+
Sbjct: 161 VQIY--VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 504 GNTSRIVGT 512
GT
Sbjct: 216 R-AYDFCGT 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 35/171 (20%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEFKNEV-- 392
DF ++V +G+G FG+V + + AVK L + K E
Sbjct: 39 DFHFLKV----------IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK----KKEEKH 84
Query: 393 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DW 443
VL+ ++H LV L F + +K+ V +++ L Y L ++
Sbjct: 85 IMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPR 140
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+R Y IA + YLH L I++RDLK NILLD++ + ++DFG+
Sbjct: 141 ARFY--AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 46/204 (22%), Positives = 84/204 (41%), Gaps = 40/204 (19%)
Query: 319 PEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAV 374
P + + D+ FE + +G+G FG+V + + A+
Sbjct: 4 PVFDENEDVNF-----DHFEILRA----------IGKGSFGKVCIVQKND---TKKMYAM 45
Query: 375 KRLSASSGQGAQEFKN---EVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDY 430
K ++ E +N E+ ++ L+H LV L + + EE + +V + + L Y
Sbjct: 46 KYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRY 104
Query: 431 FLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
L ++ + + + I + + YL RIIHRD+K NILLD + I
Sbjct: 105 HL---QQNVHFKEETVKLF--ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHI 156
Query: 489 SDFGMARIFGVDQTQGNTSRIVGT 512
+DF +A + + + + GT
Sbjct: 157 TDFNIAAMLPRETQ---ITTMAGT 177
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 41/174 (23%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSASSGQGAQEFKNE 391
DF+ + V +G G + +V K + + A+K + + +
Sbjct: 10 DFDLLRV----------IGRGSYAKVLLVRLKK---TDRIYAMKVVK----KELVNDDED 52
Query: 392 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL- 441
+ V H LV L C + E ++ V E+V L + + +Q +L
Sbjct: 53 IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP 108
Query: 442 -DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ +R Y I+ + YLHE II+RDLK N+LLD+E + K++D+GM
Sbjct: 109 EEHARFY--SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 41/174 (23%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSASSGQGAQEFKNE 391
DF+ + V +G G + +V K + + A++ + + +
Sbjct: 53 DFDLLRV----------IGRGSYAKVLLVRLKK---TDRIYAMRVVK----KELVNDDED 95
Query: 392 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL- 441
+ V H LV L C + E ++ V E+V L + + +Q +L
Sbjct: 96 IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP 151
Query: 442 -DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ +R Y I+ + YLHE II+RDLK N+LLD+E + K++D+GM
Sbjct: 152 EEHARFY--SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 48/187 (25%), Positives = 75/187 (40%), Gaps = 37/187 (19%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSASSGQGAQEF--- 388
F+ I+ LG G FG V K SG A+K L ++
Sbjct: 42 QFDRIKT----------LGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHT 88
Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSR 445
NE ++ + LV+L F + + +V E+V + L + G+ +R
Sbjct: 89 LNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHAR 144
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
Y I YLH L +I+RDLK N+L+D + +++DFG A+ G
Sbjct: 145 FY--AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GR 194
Query: 506 TSRIVGT 512
T + GT
Sbjct: 195 TWTLCGT 201
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 42/174 (24%), Positives = 80/174 (45%), Gaps = 38/174 (21%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY---KGVLPSGQEI-AVKRLSASSGQGAQEFKNE 391
FE + V LG+GG+G+V+ K + +I A+K L + +
Sbjct: 18 CFELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKD 64
Query: 392 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL- 441
+L +++H +V L+ + + K+ L+ E++ L L ++G
Sbjct: 65 TAHTKAERNIL-EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE---REGIFM 119
Query: 442 -DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
D + Y + I+ + +LH+ II+RDLK NI+L+ + + K++DFG+
Sbjct: 120 EDTACFY--LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 32/176 (18%), Positives = 63/176 (35%), Gaps = 20/176 (11%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIA---VKRLSASSGQGAQEFKNEVVLVAKLQH 400
N++ K+G GGFG +Y ++ A VK +G E K + K
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-----LYDPEKQGQLDWSRRY--KIIGGI 453
+ + G K Y + Q + + + +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156
Query: 454 ARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKI--SDFGMARIFGVDQTQ 503
+L Y+HE+ +H D+KA+N+LL + ++ +D+G++ + +
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 8e-11
Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 41/174 (23%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSASSGQGAQEFKNE 391
DF + V LG+G FG+V KG + + AVK L + ++
Sbjct: 21 DFNFLMV----------LGKGSFGKVMLSERKG---TDELYAVKILK----KDVVIQDDD 63
Query: 392 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL- 441
V VL + L +L C + +++ V E+V L Y + + G+
Sbjct: 64 VECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFK 119
Query: 442 -DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ Y IA G+ +L II+RDLK N++LD+E + KI+DFGM
Sbjct: 120 EPHAVFY--AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 27/170 (15%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH-RN 402
N++ K+G G FG++Y G + +G+E+A+K + + E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KIIGGIARGIL- 458
+ + EG+ ++V E + SL D F R++ K + +A ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLF----NFCS-----RKFSLKTVLLLADQMIS 116
Query: 459 ---YLHEDSRLRIIHRDLKASNILLDAEMNPK---ISDFGMARIFGVDQT 502
Y+H + IHRD+K N L+ I DFG+A+ + +T
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 9e-11
Identities = 46/172 (26%), Positives = 72/172 (41%), Gaps = 37/172 (21%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSASSGQGAQEFKNE 391
DF ++ LG+G FG+V +K + Q A+K L + ++
Sbjct: 18 DFILHKM----------LGKGSFGKVFLAEFKK---TNQFFAIKALK----KDVVLMDDD 60
Query: 392 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLD 442
V VL +H L + + +E + V E++ L Y + + D
Sbjct: 61 VECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFD 116
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
SR I G+ +LH I++RDLK NILLD + + KI+DFGM
Sbjct: 117 LSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 47/171 (27%), Positives = 75/171 (43%), Gaps = 35/171 (20%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEFKNEV-- 392
+FE I V LG+G FG+V + ++ AVK L + ++V
Sbjct: 24 NFEFIRV----------LGKGSFGKVMLARVKETGDLYAVKVLK----KDVILQDDDVEC 69
Query: 393 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DW 443
+L H L +L C + +++ V EFV L + + K +
Sbjct: 70 TMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFDEAR 125
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+R Y I +++LH+ II+RDLK N+LLD E + K++DFGM
Sbjct: 126 ARFY--AAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 46/169 (27%), Positives = 71/169 (42%), Gaps = 31/169 (18%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEFKNEV-- 392
DF + V LG+G FG+V E+ AVK L + ++V
Sbjct: 342 DFNFLMV----------LGKGSFGKVMLSERKGTDELYAVKILK----KDVVIQDDDVEC 387
Query: 393 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
VL + L +L C + +++ V E+V L Y + + G+
Sbjct: 388 TMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFKEPH 443
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
IA G+ +L II+RDLK N++LD+E + KI+DFGM
Sbjct: 444 AVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 489
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 31/169 (18%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEFKNEV-- 392
+FE +++ LG+G FG+V + A+K L + K+EV
Sbjct: 149 EFEYLKL----------LGKGTFGKVILVKEKATGRYYAMKILK----KEVIVAKDEVAH 194
Query: 393 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
VL +H L L + + +++ V E+ L + L E+ D +R
Sbjct: 195 TLTENRVL-QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRAR 251
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
Y I + YLH S +++RDLK N++LD + + KI+DFG+
Sbjct: 252 FY--GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 2e-10
Identities = 42/179 (23%), Positives = 72/179 (40%), Gaps = 52/179 (29%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSASSGQGAQEFKNE 391
DF+ + LG G FG V+ + +G+ A+K L K
Sbjct: 7 DFQILRT----------LGTGSFGRVHLIRSRH---NGRYYAMKVLK----------KEI 43
Query: 392 VV-------------LVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEK 437
VV +++ + H ++R+ + ++I ++ +++ L L K
Sbjct: 44 VVRLKQVEHTNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLR---K 99
Query: 438 QGQL--DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ ++ Y + + YLH II+RDLK NILLD + KI+DFG A
Sbjct: 100 SQRFPNPVAKFY--AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 40/168 (23%), Positives = 66/168 (39%), Gaps = 31/168 (18%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH-RN 402
F K+G G FGE+ G L + + +A+K S + E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRR---YKIIGGIARGIL 458
+ ++ F G+ +V E + SL D F D R K + IA ++
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLEDLF----------DLCDRTFSLKTVLMIAIQLI 115
Query: 459 ----YLHEDSRLRIIHRDLKASNILLDAEMNPK-----ISDFGMARIF 497
Y+H + +I+RD+K N L+ N I DF +A+ +
Sbjct: 116 SRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 31/181 (17%), Positives = 62/181 (34%), Gaps = 39/181 (21%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV---------LPSGQEIAVKRLSASSGQGAQEFKNEVVLV 395
++ + G +Y+ P Q+ ++K L A G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 396 AKLQHRNLVRL-----LGF-------CLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLD 442
LQ +L L + + + LV + +SL P+
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSE- 158
Query: 443 WSRRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKI--SDFGMARI 496
+ + +A +L +LHE+ +H ++ A NI +D E ++ + +G A
Sbjct: 159 -----RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
Query: 497 F 497
+
Sbjct: 211 Y 211
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 32/169 (18%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGAQEFKNEV-- 392
DF+ +++ LG+G FG+V + A+K L + K+EV
Sbjct: 6 DFDYLKL----------LGKGTFGKVILVREKATGRYYAMKILR----KEVIIAKDEVAH 51
Query: 393 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
VL +H L L + + +++ V E+ L + L E+ + +R
Sbjct: 52 TVTESRVL-QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERAR 108
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
Y I + YLH +++RD+K N++LD + + KI+DFG+
Sbjct: 109 FY--GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 38/169 (22%), Positives = 68/169 (40%), Gaps = 33/169 (19%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHR 401
+ ++GEG FG +++G L + Q++A+K S Q E++
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR---TYKLLAGCT 66
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRR---YKIIGGIARGI 457
+ + F EG +LV + + SL D D R K + A+ +
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLEDLL----------DLCGRKFSVKTVAMAAKQM 115
Query: 458 L----YLHEDSRLRIIHRDLKASNILLDAEMNPK-----ISDFGMARIF 497
L +HE S +++RD+K N L+ + + DFGM + +
Sbjct: 116 LARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 43/171 (25%), Positives = 75/171 (43%), Gaps = 29/171 (16%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL 403
NKF K+G G FGE+Y G + + +E+A+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 404 V-RLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRR---YKIIGGIARGIL 458
+ + F +EG+ +LV + + SL D F ++ R K + +A ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLF----------NFCSRKLSLKTVLMLADQMI 113
Query: 459 ----YLHEDSRLRIIHRDLKASNILLDAEMNPK---ISDFGMARIFGVDQT 502
++H S +HRD+K N L+ I DFG+A+ + T
Sbjct: 114 NRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 53/215 (24%), Positives = 82/215 (38%), Gaps = 52/215 (24%)
Query: 306 FLRRRAKKKYNAVPEENADNDLTILESLQFDFETI--EVATNKFSTDNKLGEGGFGEVYK 363
F + KK V + D+D +D+ E +++ D+ +G+G FG+V K
Sbjct: 20 FQSMSSHKKERKVYNDGYDDD-------NYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVK 72
Query: 364 GV-LPSGQEIAVK---RLSASSGQGAQEFKNEVVLVAKLQHR------NLVRLLGF---- 409
+ +A+K A Q + EV L+ + +V L
Sbjct: 73 AYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128
Query: 410 ---CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-----LDWSRRYKIIGGIARGILYLH 461
CL V+E L Y LYD + L+ +R++ + +L+L
Sbjct: 129 NHLCL-------VFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQ--QMCTALLFLA 174
Query: 462 EDSRLRIIHRDLKASNILLDAEMNP--KISDFGMA 494
L IIH DLK NILL KI DFG +
Sbjct: 175 -TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 40/173 (23%), Positives = 73/173 (42%), Gaps = 43/173 (24%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQ--------- 399
KLG G F V+ + + +A+K R + A++ E+ L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKEDS 82
Query: 400 --HRNLVRLLG-FCLEGEEKI---LVYEFVPNKSLDYFLYDPEKQGQLDWSRRY--KIIG 451
++++LL F +G + +V+E L L K+ + R +
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYE---HRGIPLIYVK 134
Query: 452 GIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNP------KISDFGMA 494
I++ +L Y+H R IIH D+K N+L++ +P KI+D G A
Sbjct: 135 QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 2e-06
Identities = 85/616 (13%), Positives = 159/616 (25%), Gaps = 207/616 (33%)
Query: 16 LSSFQFSFTAAADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRGNGFSRGFFN 75
LS F+ +F D C D + ++ + ++ ++ S
Sbjct: 22 LSVFEDAFVDNFD-------CKDVQDMPKSILSKEEIDHIIMS----------------- 57
Query: 76 ATAGQDPNRVYSLFLCRGDQTTNSCQNCV-------------TFATRDVIGRCPVSKDTI 122
+ LF + Q V T R P S T
Sbjct: 58 ---KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ---RQP-SMMTR 110
Query: 123 VWYDECLLR-YSNRYIFSTRETTRTVYLWNTQNA---TDPVKFNDLVGSLMGEA-----A 173
+ Y E R Y++ +F+ +R + A P K + G + + A
Sbjct: 111 M-YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG--VLGSGKTWVA 167
Query: 174 SQAVNDPKKFATKMA------NFTSFQKLYALAQCTQDLSSS-DCNICLRGAIAQLPTCC 226
K KM N + + + Q L D N R
Sbjct: 168 LDVCLS-YKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS--------- 217
Query: 227 GGKQGGRVLTPSCNVRYEVYPFYNEPATPAPAPTPVLLSPPPPSS-----------VIRP 275
S N++ ++ E +L S P +
Sbjct: 218 ---------DHSSNIKLRIHSIQAELRR-------LLKSKPYENCLLVLLNVQNAKAWNA 261
Query: 276 -----------RGKSGISSSTIIAIVAPIAVAAV----------------LFVACLCFLR 308
R K + ++ + L + L
Sbjct: 262 FNLSCKILLTTRFKQ------VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL---- 311
Query: 309 RRAKKKYNAVPEENAD-NDLT---ILESLQFDFETIE----VATNKFSTD-----NKLGE 355
+ +P E N I ES++ T + V +K +T N L
Sbjct: 312 ---DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP 368
Query: 356 GGFGEVYK--GVLPSGQEIAVKRLS----ASSGQGAQEFKNEVV---LVAKLQHRNLVRL 406
+ +++ V P I LS N++ LV K + + +
Sbjct: 369 AEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428
Query: 407 ----LGFCLEGEE-----KILV--YE---------FVPNKSLDYF-------LYDPEKQG 439
L ++ E + +V Y +P YF L + E
Sbjct: 429 PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPE 488
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE--MNPKISDFGMARIF 497
++ R ++L D R + + ++ + +A + + + +
Sbjct: 489 RMTLFRM-----------VFL--D--FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPY 533
Query: 498 GVDQTQGNTSRIVGTL 513
D R+V +
Sbjct: 534 ICDN-DPKYERLVNAI 548
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 1e-05
Identities = 32/170 (18%), Positives = 61/170 (35%), Gaps = 43/170 (25%)
Query: 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH-------RN 402
D + GE + YK +L ++ V + Q+ ++ ++ H +
Sbjct: 8 DFETGEHQYQ--YKDILSVFEDAFVDNFDC---KDVQDMPKSILSKEEIDHIIMSKDAVS 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL--DY-FLYDPEKQGQLDWSRRYKIIGGIARGILY 459
L + L +++ +V +FV + L +Y FL P K Q S + +Y
Sbjct: 63 GTLRLFWTLLSKQEEMVQKFV-EEVLRINYKFLMSPIKTEQRQPSMMTR---------MY 112
Query: 460 ------LHED---------SRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
L+ D SRL+ + L+ LL+ + G+
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQPYLK-LR--QALLELRPAKNVLIDGVL 159
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 39/176 (22%), Positives = 67/176 (38%), Gaps = 41/176 (23%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SASSGQGAQEFKNEVVLVA 396
+ ++ +G+G FG+V K Q +A+K + Q E+ ++
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILE 148
Query: 397 KLQHR------NLVRLLGF-------CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ--- 440
L+ + N++ +L C+ +E L LY+ K+ +
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICM-------TFE-----LLSMNLYELIKKNKFQG 196
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--KISDFGMA 494
K I + + LH + RIIH DLK NILL + K+ DFG +
Sbjct: 197 FSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 41/184 (22%), Positives = 75/184 (40%), Gaps = 20/184 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ 399
++ ++ KLG G F V+ + + +A+K + S+ + +E+ L+ ++
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVR 91
Query: 400 --------HRNLVRLLG-FCLEGEEKI---LVYEFVPNKSLDYFLYDPEKQG-QLDWSRR 446
+V+LL F + G +V+E V L ++ QG L ++
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
II + +G+ YLH ++ RIIH D+K NILL A + +
Sbjct: 151 --IIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 507 SRIV 510
V
Sbjct: 207 GSAV 210
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 36/203 (17%), Positives = 63/203 (31%), Gaps = 37/203 (18%)
Query: 307 LRRRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL 366
+ + +K Y L L L + + +GEG V+
Sbjct: 59 VVQNRQKDYEGSTFTFIGLSLYSLHRLVRSGKVDAI-------GKLMGEGKESAVFNCYS 111
Query: 367 PSGQEIAVK--RLSASS--------GQGAQEFKNEVVLVAKLQHRNLVRLLGFC----LE 412
E VK ++ +S G F + A+ + R L +L G
Sbjct: 112 EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 171
Query: 413 GEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
E ++ E + K L + +P++ +I + I+H
Sbjct: 172 WEGNAVLMELIDAKELYRVRVENPDEV--------LDMILEEVAKFYHRG------IVHG 217
Query: 472 DLKASNILLDAEMNPKISDFGMA 494
DL N+L+ E I DF +
Sbjct: 218 DLSQYNVLVSEEG-IWIIDFPQS 239
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 40/172 (23%), Positives = 58/172 (33%), Gaps = 64/172 (37%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--------RLSASSGQGAQEFKNE 391
+ N F K+G+G FG V + + + AVK SA K E
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA---------KIE 81
Query: 392 VVLVAKLQHR-----NLVRLLGF-------CLEGEEKILVYEFVPNKSLDYFLYDPEKQG 439
++ K+Q+ N+V+ G CL ++E L LY+
Sbjct: 82 ADILKKIQNDDINNNNIVKYHGKFMYYDHMCL-------IFE-----PLGPSLYE----- 124
Query: 440 QLDWSRRYKIIG-------GIARGIL----YLHEDSRLRIIHRDLKASNILL 480
R G IL YL + + + H DLK NILL
Sbjct: 125 ---IITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILL 170
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 513 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.97 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.96 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.95 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.95 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.95 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.94 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.94 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.94 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.94 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.94 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.94 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.94 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.94 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.94 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.94 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.94 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.94 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.94 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.94 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.94 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.94 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.94 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.94 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.94 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.94 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.94 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.94 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.94 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.94 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.94 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.94 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.94 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.94 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.94 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.93 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.93 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.93 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.93 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.93 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.93 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.93 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.93 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.93 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.93 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.93 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.93 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.93 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.93 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.93 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.93 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.93 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.93 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.93 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.93 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.93 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.93 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.93 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.93 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.93 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.93 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.93 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.93 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.93 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.93 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.93 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.93 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.93 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.93 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.93 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.93 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.93 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.93 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.93 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.93 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.93 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.93 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.93 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.93 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.93 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.93 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.93 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.93 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.93 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.93 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.93 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.92 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.92 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.92 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.92 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.92 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.92 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.92 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.92 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.92 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.92 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.92 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.92 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.92 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.92 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.92 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.92 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.92 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.92 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.92 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.92 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.92 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.92 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.92 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.92 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.92 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.92 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.92 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.92 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.92 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.92 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.92 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.92 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.92 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.92 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.92 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.92 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.92 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.92 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.92 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.92 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.92 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.92 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.92 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.92 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.92 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.92 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.92 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.92 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.92 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.92 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.92 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.92 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.92 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.92 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.92 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.92 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.92 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.92 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.92 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.91 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.91 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.91 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.91 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.91 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.91 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.91 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.91 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.91 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.91 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.91 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.91 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.91 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.91 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.91 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.91 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.91 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.91 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.91 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.91 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.91 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.91 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.91 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.91 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.91 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.91 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.91 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.91 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.91 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.91 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.91 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.91 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.91 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.91 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.91 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.91 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.91 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.91 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.91 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.91 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.91 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.91 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.9 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.9 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.9 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.9 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.9 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.9 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.9 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.9 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.9 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.9 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.9 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.9 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.9 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.9 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.9 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.9 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.9 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.9 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.89 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.89 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.89 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.89 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.89 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.89 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.89 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.89 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.89 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.89 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.89 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.89 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.88 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.88 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.87 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.87 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.87 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.61 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.58 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.31 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.05 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.02 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.97 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.83 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.65 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.34 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.3 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.25 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.24 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.23 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.09 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.04 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.73 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.46 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.95 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.43 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.45 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 91.65 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.31 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 90.01 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.63 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 82.85 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.84 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.39 Aligned_cols=167 Identities=30% Similarity=0.507 Sum_probs=143.0
Q ss_pred hcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
.++|.+.++||+|+||+||+|++. ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 456788899999999999999863 46789999998777666788999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeE
Q 010329 418 LVYEFVPNKSLDYFLYDP----------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 487 (513)
|||||+++|+|.++|+.. .....++|.+++.|+.||++||.|||+++ |+||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 999999999999999642 23457999999999999999999999987 99999999999999999999
Q ss_pred EeeccCccccCCCCCccccceeeecC
Q 010329 488 ISDFGMARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~Gt~ 513 (513)
|+|||+|+..........+....||+
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~ 194 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPI 194 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECG
T ss_pred ECCcccceecCCCCceeecCceecCh
Confidence 99999999876554433344456663
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=298.64 Aligned_cols=166 Identities=30% Similarity=0.503 Sum_probs=134.7
Q ss_pred cCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
++|.+.++||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677889999999999999864 467899999988776677899999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCe
Q 010329 419 VYEFVPNKSLDYFLYDPE------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 486 (513)
||||+++|+|.++|+... ...+++|.+++.|+.||++||.|||+.+ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999996532 2346999999999999999999999987 9999999999999999999
Q ss_pred EEeeccCccccCCCCCccccceeeecC
Q 010329 487 KISDFGMARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 487 ki~DfGla~~~~~~~~~~~~~~~~Gt~ 513 (513)
||+|||+|+.+........++...||+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~ 224 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPI 224 (329)
T ss_dssp EECCCC----------------CCCCG
T ss_pred EEcccccceeccCCCcceecCcccccc
Confidence 999999999876554444444566763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=292.77 Aligned_cols=166 Identities=30% Similarity=0.461 Sum_probs=140.4
Q ss_pred cCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
.++++.++||+|+||+||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999863 46789999997653 344678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC
Q 010329 418 LVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~ 484 (513)
|||||+++|+|.++|+.... ...++|.++++|+.||++||.|||+++ |+||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999964321 346999999999999999999999987 99999999999999999
Q ss_pred CeEEeeccCccccCCCCCccccceeeecC
Q 010329 485 NPKISDFGMARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 485 ~~ki~DfGla~~~~~~~~~~~~~~~~Gt~ 513 (513)
++||+|||+|+.+........++...||+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~ 211 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPI 211 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCG
T ss_pred CEEECCcccceeccCCCceeEecccccCC
Confidence 99999999999876544433444556663
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=290.17 Aligned_cols=164 Identities=29% Similarity=0.492 Sum_probs=134.5
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
+..+++.+.++||+|+||+||+|++.+ .||||.++.. +.+..++|.+|+.+|++++|||||+++|++.+ +..+||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 445678889999999999999999753 6999998754 33445789999999999999999999998864 568999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++|+|.++|+.. ...++|.+++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999643 456999999999999999999999987 99999999999999999999999999998765
Q ss_pred CCCccccceeeecC
Q 010329 500 DQTQGNTSRIVGTL 513 (513)
Q Consensus 500 ~~~~~~~~~~~Gt~ 513 (513)
......+...+||+
T Consensus 185 ~~~~~~~~~~~GT~ 198 (307)
T 3omv_A 185 WSGSQQVEQPTGSV 198 (307)
T ss_dssp ---------CCCCT
T ss_pred CCcceeecccccCC
Confidence 44444455677875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=285.91 Aligned_cols=163 Identities=29% Similarity=0.423 Sum_probs=146.0
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|++.+.||+|+||+||+++. .+++.||||.+... .....+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3588899999999999999995 56899999999753 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|.+++. +.+.+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999994 3457999999999999999999999987 999999999999999999999999999998766
Q ss_pred CCccccceeeecC
Q 010329 501 QTQGNTSRIVGTL 513 (513)
Q Consensus 501 ~~~~~~~~~~Gt~ 513 (513)
.....+..++||+
T Consensus 186 ~~~~~~~~~~GTp 198 (311)
T 4aw0_A 186 SKQARANSFVGTA 198 (311)
T ss_dssp TTCCCBCCCCSCG
T ss_pred CCcccccCcccCc
Confidence 6555566788985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=288.54 Aligned_cols=160 Identities=28% Similarity=0.425 Sum_probs=142.9
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
+.|+..++||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 5688889999999999999996 468999999997665566677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCCc
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~ 503 (513)
++|+|.+++.+ ..+++.++..|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..+...
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999842 46999999999999999999999987 999999999999999999999999999988654332
Q ss_pred cccceeeecC
Q 010329 504 GNTSRIVGTL 513 (513)
Q Consensus 504 ~~~~~~~Gt~ 513 (513)
...++||+
T Consensus 227 --~~~~~GTp 234 (346)
T 4fih_A 227 --RKSLVGTP 234 (346)
T ss_dssp --BCCCCSCG
T ss_pred --ccccccCc
Confidence 34577874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=290.38 Aligned_cols=161 Identities=28% Similarity=0.422 Sum_probs=144.4
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.+.|+..++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 46799999999999999999996 46899999999876666667899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 502 (513)
|++|+|.+++. ...+++.++..|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999984 346999999999999999999999987 99999999999999999999999999998865433
Q ss_pred ccccceeeecC
Q 010329 503 QGNTSRIVGTL 513 (513)
Q Consensus 503 ~~~~~~~~Gt~ 513 (513)
....++||+
T Consensus 303 --~~~~~~GTp 311 (423)
T 4fie_A 303 --RRKSLVGTP 311 (423)
T ss_dssp --CBCCCEECT
T ss_pred --cccccccCc
Confidence 234578885
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=287.51 Aligned_cols=163 Identities=24% Similarity=0.375 Sum_probs=135.8
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|++.++||+|+||+||+|+. .+|+.||||.+... .....+.+.+|+.+|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999995 46899999999754 23345789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
|+++|+|.++|.. .+...+++.++..|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999954 23456899999999999999999999987 9999999999999999999999999999875332
Q ss_pred CccccceeeecC
Q 010329 502 TQGNTSRIVGTL 513 (513)
Q Consensus 502 ~~~~~~~~~Gt~ 513 (513)
. .+...+||+
T Consensus 180 ~--~~~~~~GT~ 189 (350)
T 4b9d_A 180 E--LARACIGTP 189 (350)
T ss_dssp H--HHHHHHSCC
T ss_pred c--cccccCCCc
Confidence 1 223456774
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=287.90 Aligned_cols=180 Identities=27% Similarity=0.377 Sum_probs=152.1
Q ss_pred cccccchHHHHHHhcCCCcccccCccCceeEEEEEeCC------CcEEEEEEecccCc-cCHHHHHHHHHHHHhCCC-CC
Q 010329 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQH-RN 402 (513)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~------~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H-~n 402 (513)
+.+.++..+++++.++|++.++||+|+||+||+|.+.. ++.||||+++.... ...++|.+|+.+|.+++| ||
T Consensus 50 ~~lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpn 129 (353)
T 4ase_A 50 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129 (353)
T ss_dssp GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred hcCCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCc
Confidence 34566777888899999999999999999999998532 35799999976543 345679999999999975 89
Q ss_pred ccceeeEEEeC-CeeEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCe
Q 010329 403 LVRLLGFCLEG-EEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468 (513)
Q Consensus 403 Iv~l~g~~~~~-~~~~lv~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 468 (513)
||+++|+|.+. +..++|||||++|+|.++|+... ....++|.+++.|+.|||+||+|||+++ |
T Consensus 130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---i 206 (353)
T 4ase_A 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 206 (353)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---e
Confidence 99999999775 56899999999999999996422 1345899999999999999999999987 9
Q ss_pred eecCCcCCcEEECCCCCeEEeeccCccccCCCCCccccceeeecC
Q 010329 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 469 vHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt~ 513 (513)
+||||||+||||++++.+||+|||+|+.+..+.....++...||+
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~ 251 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECG
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccc
Confidence 999999999999999999999999999887665554555667774
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=272.17 Aligned_cols=158 Identities=29% Similarity=0.418 Sum_probs=133.8
Q ss_pred CcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEe----CCeeEEEE
Q 010329 348 STDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVY 420 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~ 420 (513)
.+.++||+|+||+||+|.. .+++.||+|.+... .....+.|.+|+.+|++++|||||++++++.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5667899999999999996 45889999998654 33345679999999999999999999999875 24579999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC-CCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~DfGla~~~~~ 499 (513)
||+++|+|.+++.+ ...+++..+..|+.||+.||.|||+++ ++|+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999943 457999999999999999999999875 4599999999999997 478999999999987543
Q ss_pred CCCccccceeeecC
Q 010329 500 DQTQGNTSRIVGTL 513 (513)
Q Consensus 500 ~~~~~~~~~~~Gt~ 513 (513)
. .+..++||+
T Consensus 185 ~----~~~~~~GTp 194 (290)
T 3fpq_A 185 S----FAKAVIGTP 194 (290)
T ss_dssp T----SBEESCSSC
T ss_pred C----ccCCcccCc
Confidence 2 233567885
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=277.34 Aligned_cols=163 Identities=26% Similarity=0.352 Sum_probs=130.9
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC----eeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lv~ 420 (513)
++|.+.++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|++.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 6899999999754321 122334566667889999999999998754 579999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-----CCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-----SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
||+++|+|.++|+. ..++|..+.+|+.|+++||.|||++ +.++|+||||||+||||++++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 4689999999999999999999986 23469999999999999999999999999999
Q ss_pred ccCCCCCc--cccceeeecC
Q 010329 496 IFGVDQTQ--GNTSRIVGTL 513 (513)
Q Consensus 496 ~~~~~~~~--~~~~~~~Gt~ 513 (513)
........ ..+...+||+
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~ 176 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTK 176 (303)
T ss_dssp EEETTTTEESCC-----CCG
T ss_pred cccCCCCceeeecccccccc
Confidence 88654432 2233567774
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=274.23 Aligned_cols=154 Identities=27% Similarity=0.414 Sum_probs=127.7
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCC--------
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-------- 414 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-------- 414 (513)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3588899999999999999995 4689999999875443 33467999999999999999999999987644
Q ss_pred ----eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEee
Q 010329 415 ----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (513)
Q Consensus 415 ----~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D 490 (513)
..++||||+++|+|.+++.........++..+..|+.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976544455778889999999999999999987 99999999999999999999999
Q ss_pred ccCccccCCCC
Q 010329 491 FGMARIFGVDQ 501 (513)
Q Consensus 491 fGla~~~~~~~ 501 (513)
||+|+.+..+.
T Consensus 162 FGla~~~~~~~ 172 (299)
T 4g31_A 162 FGLVTAMDQDE 172 (299)
T ss_dssp CCCC-------
T ss_pred CccceecCCCc
Confidence 99999886543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=279.05 Aligned_cols=158 Identities=29% Similarity=0.375 Sum_probs=133.2
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
+.|...++||+|+||+||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..+|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4577788999999999999996 4689999999975432 246999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC-CeEEeeccCccccCCCCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQT 502 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~~~~~ 502 (513)
++|+|.++|.+ .+.+++..+..|+.||+.||+|||+++ |+||||||+||||+.++ ++||+|||+|+.+..+..
T Consensus 133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999943 457999999999999999999999987 99999999999999987 699999999998865432
Q ss_pred c---cccceeeecC
Q 010329 503 Q---GNTSRIVGTL 513 (513)
Q Consensus 503 ~---~~~~~~~Gt~ 513 (513)
. .....++||+
T Consensus 207 ~~~~~~~~~~~GT~ 220 (336)
T 4g3f_A 207 GKSLLTGDYIPGTE 220 (336)
T ss_dssp -------CCCCCCG
T ss_pred ccceecCCccccCc
Confidence 1 1223467884
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=266.06 Aligned_cols=159 Identities=26% Similarity=0.467 Sum_probs=126.5
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|++.+.||+|+||+||+++. .+|+.||||.+... .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999995 46899999998754 2334567999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+ +|+|.+++. +.+.+++..+..++.||+.||+|||+++ |+||||||+||||++++++||+|||+|+...+.
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 689998884 3457999999999999999999999987 999999999999999999999999999987543
Q ss_pred CCccccceeeecC
Q 010329 501 QTQGNTSRIVGTL 513 (513)
Q Consensus 501 ~~~~~~~~~~Gt~ 513 (513)
.. ....+||+
T Consensus 166 ~~---~~~~~GT~ 175 (275)
T 3hyh_A 166 NF---LKTSCGSP 175 (275)
T ss_dssp ------------C
T ss_pred Cc---cCCeeECc
Confidence 32 23467775
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=276.00 Aligned_cols=161 Identities=26% Similarity=0.290 Sum_probs=131.7
Q ss_pred cCCCcccccCccCceeEEEEEe----CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~----~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
++|++.+.||+|+||+||+++. ..++.||||.++... ......+.+|+.+|++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4689999999999999999985 246789999987542 2233468899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++|+|.+++. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999994 3457999999999999999999999987 9999999999999999999999999999775
Q ss_pred CCCCccccceeeecC
Q 010329 499 VDQTQGNTSRIVGTL 513 (513)
Q Consensus 499 ~~~~~~~~~~~~Gt~ 513 (513)
..... ....+||+
T Consensus 178 ~~~~~--~~~~~GT~ 190 (304)
T 3ubd_A 178 DHEKK--AYSFCGTV 190 (304)
T ss_dssp ---CC--CCSCCCCG
T ss_pred CCCcc--ccccccCc
Confidence 44332 23467874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=264.75 Aligned_cols=162 Identities=24% Similarity=0.406 Sum_probs=135.8
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC------Ce
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------EE 415 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~ 415 (513)
++|.+.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+|+.++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5789999999999999999995 568999999997542 23346788999999999999999999987643 56
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.||||||++ |+|.+++. ..+.+++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 67999984 3567999999999999999999999987 9999999999999999999999999999
Q ss_pred ccCCCC--CccccceeeecC
Q 010329 496 IFGVDQ--TQGNTSRIVGTL 513 (513)
Q Consensus 496 ~~~~~~--~~~~~~~~~Gt~ 513 (513)
.+.... ........+||+
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~ 226 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATR 226 (398)
T ss_dssp CC-------CCCCCSSCCCC
T ss_pred ecccCccccccccccceeCh
Confidence 875432 222334567874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=255.04 Aligned_cols=148 Identities=22% Similarity=0.343 Sum_probs=131.8
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC----CCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCee
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~----~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 416 (513)
...++|++.++||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|+.+ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34678999999999999999999842 46789999986543 346788999999998 699999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC-CCeEEeeccCcc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAR 495 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGla~ 495 (513)
++||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999982 4899999999999999999999988 9999999999999877 799999999999
Q ss_pred ccCCC
Q 010329 496 IFGVD 500 (513)
Q Consensus 496 ~~~~~ 500 (513)
...+.
T Consensus 167 ~~~~~ 171 (361)
T 4f9c_A 167 GTHDT 171 (361)
T ss_dssp ECTTC
T ss_pred ccCCc
Confidence 77543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=269.13 Aligned_cols=159 Identities=29% Similarity=0.378 Sum_probs=135.6
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHH---HHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKN---EVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~---E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
++|.+.+.||+|+||+||+++. .+|+.||||.+.+.. ........+ ++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5688999999999999999995 468999999996531 222233333 466777889999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|||||+++|+|.++|. ..+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999994 3467999999999999999999999987 999999999999999999999999999988
Q ss_pred CCCCCccccceeeecC
Q 010329 498 GVDQTQGNTSRIVGTL 513 (513)
Q Consensus 498 ~~~~~~~~~~~~~Gt~ 513 (513)
.... +..++||+
T Consensus 343 ~~~~----~~t~~GTp 354 (689)
T 3v5w_A 343 SKKK----PHASVGTH 354 (689)
T ss_dssp SSCC----CCSCCSCG
T ss_pred CCCC----CCCccCCc
Confidence 6443 23467875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=266.58 Aligned_cols=161 Identities=23% Similarity=0.421 Sum_probs=142.0
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
++|.+.+.||+|+||.||++.. .+|+.||+|.+........+.+.+|+.+|+.++|||||++++++.+.+..+|||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 5789999999999999999995 468999999998766556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC--CCeEEeeccCccccCCCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE--MNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~--~~~ki~DfGla~~~~~~~ 501 (513)
++|+|.++|.+ ..+.+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999853 3456999999999999999999999987 9999999999999854 799999999999986543
Q ss_pred CccccceeeecC
Q 010329 502 TQGNTSRIVGTL 513 (513)
Q Consensus 502 ~~~~~~~~~Gt~ 513 (513)
. ....+||+
T Consensus 312 ~---~~~~~GT~ 320 (573)
T 3uto_A 312 S---VKVTTGTA 320 (573)
T ss_dssp E---EEEECSSG
T ss_pred c---eeeeEECc
Confidence 2 23456764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=242.88 Aligned_cols=171 Identities=41% Similarity=0.701 Sum_probs=147.7
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
+++...++|...+.||+|+||.||+|.+.+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 33446688999999999999999999988899999999887766667889999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 419 VYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
||||+++|+|.+++.... ....++|..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999996432 2336999999999999999999999987 999999999999999999999999999976
Q ss_pred CCCCCccccceeeec
Q 010329 498 GVDQTQGNTSRIVGT 512 (513)
Q Consensus 498 ~~~~~~~~~~~~~Gt 512 (513)
.............||
T Consensus 190 ~~~~~~~~~~~~~gt 204 (321)
T 2qkw_B 190 TELDQTHLSTVVKGT 204 (321)
T ss_dssp SSSSCCCCBCCCEEE
T ss_pred ccccccccccccCCC
Confidence 544333233344455
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.2e-29 Score=202.77 Aligned_cols=107 Identities=20% Similarity=0.436 Sum_probs=97.0
Q ss_pred CCCccccccCCCCCccCCCChHHHHHHHHHHhcccccCCCCCccCCeeeeecCC-CCCeEEEEEecCCCCChhhhHHHHH
Q 010329 27 ADPTYVYHFCSDTANFTRNSTFESNLNRLLTSLPTNASRGNGFSRGFFNATAGQ-DPNRVYSLFLCRGDQTTNSCQNCVT 105 (513)
Q Consensus 27 ~~~~~~~~~C~~~~~~~~~s~~~~~l~~~~~~l~~~a~~~~~~~~~~~~~~~g~-~~~~vy~~~qC~~D~~~~~C~~Cl~ 105 (513)
+++.++++.|++ ++|+++++|++||+.||+.|+++++. ...+|+++..|. ++++||||+|||||+++++|..||+
T Consensus 1 A~t~~v~~~Cn~-~~~t~~s~f~~nl~~ll~~L~~~a~~---s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~ 76 (108)
T 3a2e_A 1 ANTAFVSSACNT-QKIPSGSPFNRNLRAMLADLRQNTAF---SGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLS 76 (108)
T ss_dssp CCCCEEEEEECS-SBCCTTCTHHHHHHHHHHHHHHHGGG---TTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHH
T ss_pred CCcceeeeecCC-CccCCCChHHHHHHHHHHHHHhhCcc---ccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHH
Confidence 467899999976 79999999999999999999999863 345677777664 5599999999999999999999999
Q ss_pred HHHHHHHhcCCCCcceEEEcceeEEEEecccc
Q 010329 106 FATRDVIGRCPVSKDTIVWYDECLLRYSNRYI 137 (513)
Q Consensus 106 ~a~~~~~~~C~~~~~~~~~~~~C~~ry~~~~f 137 (513)
.|+.+++++|+++++|+||++.|+||||+++|
T Consensus 77 ~a~~~~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 77 NLVNRIFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 99999999999999999999999999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=252.40 Aligned_cols=171 Identities=22% Similarity=0.270 Sum_probs=144.6
Q ss_pred chHHHHHHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEE
Q 010329 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 411 (513)
Q Consensus 336 ~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 411 (513)
.+.+++...++|++.++||+|+||+||+++.. +++.||+|+++... ....+.+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 44455566789999999999999999999975 47889999987531 122345889999999999999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeec
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df 491 (513)
+.+..++||||+++|+|.+++.+ ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999954 2456999999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCCCccccceeeec
Q 010329 492 GMARIFGVDQTQGNTSRIVGT 512 (513)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~Gt 512 (513)
|+++.+..+... .....+||
T Consensus 220 Gla~~~~~~~~~-~~~~~~GT 239 (437)
T 4aw2_A 220 GSCLKLMEDGTV-QSSVAVGT 239 (437)
T ss_dssp TTCEECCTTSCE-ECCSCCSC
T ss_pred hhhhhcccCCCc-ccccccCC
Confidence 999887654432 12234565
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=232.73 Aligned_cols=152 Identities=26% Similarity=0.467 Sum_probs=138.7
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
..++|...+.||+|+||+||++.. .+++.||||.+........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999995 5789999999987666667889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
|+++|+|.+++.+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999843 35899999999999999999999987 9999999999999999999999999999876544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-27 Score=231.62 Aligned_cols=176 Identities=47% Similarity=0.698 Sum_probs=150.8
Q ss_pred cccchHHHHHHhcCCCcc------cccCccCceeEEEEEeCCCcEEEEEEecccC----ccCHHHHHHHHHHHHhCCCCC
Q 010329 333 LQFDFETIEVATNKFSTD------NKLGEGGFGEVYKGVLPSGQEIAVKRLSASS----GQGAQEFKNEVVLVAKLQHRN 402 (513)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~------~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~----~~~~~~~~~E~~~l~~l~H~n 402 (513)
..+.+.++...+++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.+++.++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 457788888888888776 8899999999999997 68899999986532 233568999999999999999
Q ss_pred ccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC
Q 010329 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482 (513)
Q Consensus 403 Iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~ 482 (513)
|+++++++.+.+..++||||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcC
Confidence 99999999999999999999999999999975555567999999999999999999999987 999999999999999
Q ss_pred CCCeEEeeccCccccCCCCCccccceeeec
Q 010329 483 EMNPKISDFGMARIFGVDQTQGNTSRIVGT 512 (513)
Q Consensus 483 ~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt 512 (513)
++.+||+|||+++...............||
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~ 198 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGT 198 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSC
T ss_pred CCcEEEeecccccccccccccccccccCCC
Confidence 999999999999987654433223334444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=237.65 Aligned_cols=170 Identities=43% Similarity=0.780 Sum_probs=148.2
Q ss_pred ccccchHHHHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEE
Q 010329 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFC 410 (513)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 410 (513)
...+.+.+++...++|...+.||+|+||.||+|...+++.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 345788899999999999999999999999999988899999999876532 2334789999999999999999999999
Q ss_pred EeCCeeEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEe
Q 010329 411 LEGEEKILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (513)
Q Consensus 411 ~~~~~~~lv~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 489 (513)
.+.+..++||||+++|+|.+++.... ....++|..+..|+.||+.||.|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999996543 33459999999999999999999999833349999999999999999999999
Q ss_pred eccCccccCCCC
Q 010329 490 DFGMARIFGVDQ 501 (513)
Q Consensus 490 DfGla~~~~~~~ 501 (513)
|||+++.+....
T Consensus 177 Dfg~~~~~~~~~ 188 (326)
T 3uim_A 177 DFGLAKLMDYKD 188 (326)
T ss_dssp CCSSCEECCSSS
T ss_pred cCccccccCccc
Confidence 999999875443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-27 Score=232.43 Aligned_cols=147 Identities=31% Similarity=0.455 Sum_probs=135.2
Q ss_pred CCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
|...+.||+|+||.||+|+.. +|+.||||.+........+.+.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 566678999999999999975 6899999999877666778899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 127 ~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 127 GALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp CBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred CCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccC
Confidence 99999984 346999999999999999999999987 999999999999999999999999999987644
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=234.20 Aligned_cols=153 Identities=27% Similarity=0.495 Sum_probs=137.5
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.++|...+.||+|+||+||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35678889999999999999996 45889999998776666678899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999954 2456999999999999999999999987 9999999999999999999999999999875443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=235.46 Aligned_cols=151 Identities=29% Similarity=0.481 Sum_probs=136.2
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35789999999999999999996 57899999998754 3334567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999843 356999999999999999999999987 999999999999999999999999999977544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=234.93 Aligned_cols=162 Identities=29% Similarity=0.464 Sum_probs=137.1
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|++.+.||+|+||.||++... +++.||||.+..... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57889999999999999999964 788999999865432 2346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 502 (513)
+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999984 3456999999999999999999999987 99999999999999999999999999997754433
Q ss_pred ccccceeeec
Q 010329 503 QGNTSRIVGT 512 (513)
Q Consensus 503 ~~~~~~~~Gt 512 (513)
........||
T Consensus 161 ~~~~~~~~gt 170 (323)
T 3tki_A 161 ERLLNKMCGT 170 (323)
T ss_dssp ECCBCSCCSC
T ss_pred ccccCCCccC
Confidence 3222334444
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=234.07 Aligned_cols=153 Identities=25% Similarity=0.410 Sum_probs=134.8
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe-------
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE------- 415 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------- 415 (513)
++|+..+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 56888999999999999999975 789999999975433 345789999999999999999999999876542
Q ss_pred --------------------------------------------------eEEEEecCCCCChhhhhcCCCCCCCCCHHH
Q 010329 416 --------------------------------------------------KILVYEFVPNKSLDYFLYDPEKQGQLDWSR 445 (513)
Q Consensus 416 --------------------------------------------------~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~ 445 (513)
.++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 789999999999999997665556678888
Q ss_pred HHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 446 ~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 9999999999999999987 999999999999999999999999999988654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=238.81 Aligned_cols=155 Identities=28% Similarity=0.461 Sum_probs=135.4
Q ss_pred HhcCCCcccccCccCceeEEEEEeC--------CCcEEEEEEecccCc-cCHHHHHHHHHHHHhC-CCCCccceeeEEEe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE 412 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~--------~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 412 (513)
..++|.+.+.||+|+||.||+|+.. ++..||||.++.... ...+.+.+|+.+++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3467888999999999999999852 345799999976532 3456899999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEE
Q 010329 413 GEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 479 (513)
Q Consensus 413 ~~~~~lv~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nil 479 (513)
.+..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 999999999999999999996432 1245899999999999999999999987 999999999999
Q ss_pred ECCCCCeEEeeccCccccCCC
Q 010329 480 LDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 480 l~~~~~~ki~DfGla~~~~~~ 500 (513)
++.++.+||+|||+++.+...
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~ 256 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNI 256 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCC
T ss_pred ECCCCCEEEccccCCcccCcc
Confidence 999999999999999977543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=235.03 Aligned_cols=160 Identities=24% Similarity=0.296 Sum_probs=138.6
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|+..+.||+|+||+||+++.. +++.||+|.++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999964 6899999999754 2345677899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999843 456899999999999999999999987 999999999999999999999999999975433
Q ss_pred CCccccceeeec
Q 010329 501 QTQGNTSRIVGT 512 (513)
Q Consensus 501 ~~~~~~~~~~Gt 512 (513)
... .....||
T Consensus 159 ~~~--~~~~~gt 168 (337)
T 1o6l_A 159 GAT--MKTFCGT 168 (337)
T ss_dssp TCC--BCCCEEC
T ss_pred CCc--ccccccC
Confidence 222 2235565
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=239.38 Aligned_cols=178 Identities=26% Similarity=0.385 Sum_probs=146.3
Q ss_pred ccccchHHHHHHhcCCCcccccCccCceeEEEEEe------CCCcEEEEEEecccCc-cCHHHHHHHHHHHHhC-CCCCc
Q 010329 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKL-QHRNL 403 (513)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~------~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nI 403 (513)
...++...++...++|.+.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|++++.++ +||||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 34556677778889999999999999999999973 2457899999976432 3346799999999999 79999
Q ss_pred cceeeEEEeCCe-eEEEEecCCCCChhhhhcCCCC---------------------------------------------
Q 010329 404 VRLLGFCLEGEE-KILVYEFVPNKSLDYFLYDPEK--------------------------------------------- 437 (513)
Q Consensus 404 v~l~g~~~~~~~-~~lv~ey~~~gsL~~~l~~~~~--------------------------------------------- 437 (513)
+++++++.+.+. .++||||+++|+|.+++.....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 999999988654 8999999999999999965332
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 438 ------------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 438 ------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 122899999999999999999999987 99999999999999999999999999998755
Q ss_pred CCCccccceeeec
Q 010329 500 DQTQGNTSRIVGT 512 (513)
Q Consensus 500 ~~~~~~~~~~~Gt 512 (513)
+..........||
T Consensus 246 ~~~~~~~~~~~~t 258 (359)
T 3vhe_A 246 DPDYVRKGDARLP 258 (359)
T ss_dssp CTTCEEC--CEEC
T ss_pred cccchhccccCCC
Confidence 4433333334444
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=243.48 Aligned_cols=156 Identities=21% Similarity=0.266 Sum_probs=137.5
Q ss_pred HHHHHHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC
Q 010329 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (513)
Q Consensus 338 ~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 413 (513)
..++...++|.+.+.||+|+||+||+++.. +++.||+|.++.. .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344556678999999999999999999964 5889999998652 122334588999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999999843 35899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCC
Q 010329 494 ARIFGVD 500 (513)
Q Consensus 494 a~~~~~~ 500 (513)
++.+...
T Consensus 215 a~~~~~~ 221 (410)
T 3v8s_A 215 CMKMNKE 221 (410)
T ss_dssp CEECCTT
T ss_pred eEeeccC
Confidence 9987644
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=234.67 Aligned_cols=161 Identities=30% Similarity=0.533 Sum_probs=133.6
Q ss_pred HHHHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe
Q 010329 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 338 ~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 415 (513)
..+++..++|++.+.||+|+||.||++.. .++.||||.+.... ....+++.+|+.++++++||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34445567889999999999999999987 68899999987643 2334678999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||||+++|+|.+++........+++..+..++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999999965333334999999999999999999999875 349999999999999999999999999998
Q ss_pred ccCCC
Q 010329 496 IFGVD 500 (513)
Q Consensus 496 ~~~~~ 500 (513)
.....
T Consensus 188 ~~~~~ 192 (309)
T 3p86_A 188 LKAST 192 (309)
T ss_dssp -----
T ss_pred ccccc
Confidence 66443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-27 Score=235.38 Aligned_cols=151 Identities=28% Similarity=0.395 Sum_probs=133.4
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCee
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 416 (513)
...++|++.+.||+|+||+||+++.. +++.||||.++.. .....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999964 5889999999754 234456788999999988 699999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999999843 456999999999999999999999987 99999999999999999999999999986
Q ss_pred cC
Q 010329 497 FG 498 (513)
Q Consensus 497 ~~ 498 (513)
..
T Consensus 174 ~~ 175 (353)
T 3txo_A 174 GI 175 (353)
T ss_dssp SC
T ss_pred cc
Confidence 54
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=243.07 Aligned_cols=171 Identities=23% Similarity=0.259 Sum_probs=144.1
Q ss_pred chHHHHHHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEE
Q 010329 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 411 (513)
Q Consensus 336 ~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 411 (513)
.+.+.+...++|...+.||+|+||+||+++.. +++.||||+++... ....+.+.+|..++..++|+||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44455566788999999999999999999964 68999999997532 223345889999999999999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeec
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df 491 (513)
+.+..++||||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999999532 246999999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCCCccccceeeec
Q 010329 492 GMARIFGVDQTQGNTSRIVGT 512 (513)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~Gt 512 (513)
|+++.+..+... .+...+||
T Consensus 207 Gla~~~~~~~~~-~~~~~~Gt 226 (412)
T 2vd5_A 207 GSCLKLRADGTV-RSLVAVGT 226 (412)
T ss_dssp TTCEECCTTSCE-ECSSCCSC
T ss_pred hhheeccCCCcc-ccceeccc
Confidence 999987654331 12234565
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-27 Score=233.64 Aligned_cols=164 Identities=30% Similarity=0.487 Sum_probs=136.2
Q ss_pred HhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC----eeEE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKIL 418 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~l 418 (513)
..++|++.++||+|+||.||+|+.. ++.||||++..... ....+.+|+.++++++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3467889999999999999999984 78999999975432 2345667899999999999999999998754 3699
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-------CCCCeeecCCcCCcEEECCCCCeEEeec
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-------SRLRIIHRDLKASNILLDAEMNPKISDF 491 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivHrdlk~~Nill~~~~~~ki~Df 491 (513)
||||+++|+|.+++.. ..++|..+..++.||+.||.|||+. .+.+|+||||||+|||++.++.+||+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999999943 4599999999999999999999987 0113999999999999999999999999
Q ss_pred cCccccCCCCCccccceeeec
Q 010329 492 GMARIFGVDQTQGNTSRIVGT 512 (513)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~Gt 512 (513)
|+++.+.............||
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCC
T ss_pred CcccccccccCccccccCccC
Confidence 999988655443333334555
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=228.00 Aligned_cols=151 Identities=28% Similarity=0.458 Sum_probs=133.9
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|++.+.||+|+||.||++.. .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46789999999999999999995 4688999999865332 3346789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999943 456999999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 164 ~ 164 (294)
T 4eqm_A 164 T 164 (294)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=230.32 Aligned_cols=152 Identities=32% Similarity=0.581 Sum_probs=134.5
Q ss_pred hcCCCcccccCccCceeEEEEEeC----CCcEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~----~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
.++|.+.+.||+|+||.||+|.+. .+..||||.++.. .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356888899999999999999973 3456999999765 33445689999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++|+|.+++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999954 2356999999999999999999999987 9999999999999999999999999999886
Q ss_pred CC
Q 010329 499 VD 500 (513)
Q Consensus 499 ~~ 500 (513)
..
T Consensus 203 ~~ 204 (325)
T 3kul_A 203 DD 204 (325)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=229.35 Aligned_cols=149 Identities=25% Similarity=0.371 Sum_probs=134.3
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||+++.. +|+.||+|.++.. .....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999964 6899999998754 2234577889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999943 456899999999999999999999987 99999999999999999999999999997653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=230.59 Aligned_cols=151 Identities=28% Similarity=0.385 Sum_probs=135.1
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc------cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 416 (513)
.+.|.+.+.||+|+||.||++... +|+.||+|.++.... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457889999999999999999964 688999999876432 1357899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC----CeEEeecc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG 492 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DfG 492 (513)
++||||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999994 3457999999999999999999999987 99999999999998877 79999999
Q ss_pred CccccCCC
Q 010329 493 MARIFGVD 500 (513)
Q Consensus 493 la~~~~~~ 500 (513)
+++.+...
T Consensus 165 ~a~~~~~~ 172 (361)
T 2yab_A 165 LAHEIEDG 172 (361)
T ss_dssp SCEECCTT
T ss_pred CceEcCCC
Confidence 99987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-27 Score=237.25 Aligned_cols=161 Identities=25% Similarity=0.312 Sum_probs=135.8
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 418 (513)
.++|.+.+.||+|+||+||+++.. +++.||+|.++... ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457889999999999999999964 57889999997642 22335688899999887 89999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999843 456999999999999999999999987 9999999999999999999999999999643
Q ss_pred CCCCccccceeeec
Q 010329 499 VDQTQGNTSRIVGT 512 (513)
Q Consensus 499 ~~~~~~~~~~~~Gt 512 (513)
.... .+...+||
T Consensus 205 ~~~~--~~~~~~gt 216 (396)
T 4dc2_A 205 RPGD--TTSTFCGT 216 (396)
T ss_dssp CTTC--CBCCCCBC
T ss_pred cCCC--ccccccCC
Confidence 3222 12345565
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-27 Score=236.28 Aligned_cols=152 Identities=33% Similarity=0.579 Sum_probs=128.3
Q ss_pred hcCCCcccccCccCceeEEEEEeC----CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~----~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
.++|.+.+.||+|+||.||+|++. ++..||||.++... ....++|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999864 46789999997653 3345689999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++|+|.+++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999964 2346999999999999999999999987 9999999999999999999999999999876
Q ss_pred CC
Q 010329 499 VD 500 (513)
Q Consensus 499 ~~ 500 (513)
..
T Consensus 199 ~~ 200 (373)
T 2qol_A 199 DD 200 (373)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=236.07 Aligned_cols=165 Identities=18% Similarity=0.192 Sum_probs=137.7
Q ss_pred HHhcCCCcccccCccCceeEEEEE------eCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC---CCCccceeeEEEe
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLE 412 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~------~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~ 412 (513)
...++|.+.++||+|+||.||+|. ...++.||||.++.. ...++.+|+.++..++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 445778999999999999999994 446789999999764 3467888888888887 9999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC--------
Q 010329 413 GEEKILVYEFVPNKSLDYFLYDP--EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-------- 482 (513)
Q Consensus 413 ~~~~~lv~ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~-------- 482 (513)
.+..++||||+++|+|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999531 13456999999999999999999999987 999999999999998
Q ss_pred ---CCCeEEeeccCccccCCCCCccccceeeec
Q 010329 483 ---EMNPKISDFGMARIFGVDQTQGNTSRIVGT 512 (513)
Q Consensus 483 ---~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt 512 (513)
++.+||+|||+++.+.............||
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt 248 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCT
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCC
Confidence 899999999999876533222223344555
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=232.11 Aligned_cols=152 Identities=28% Similarity=0.397 Sum_probs=133.8
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCe
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 415 (513)
....++|.+.+.||+|+||.||+++.. +++.||||.++... ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999964 58899999997542 34456788899999876 89999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999843 356999999999999999999999987 9999999999999999999999999998
Q ss_pred ccC
Q 010329 496 IFG 498 (513)
Q Consensus 496 ~~~ 498 (513)
...
T Consensus 167 ~~~ 169 (345)
T 1xjd_A 167 ENM 169 (345)
T ss_dssp CCC
T ss_pred hcc
Confidence 754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=234.75 Aligned_cols=158 Identities=31% Similarity=0.534 Sum_probs=137.9
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEe
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 412 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 412 (513)
++...++|.+.+.||+|+||.||++... +++.||||.++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999964 34789999997653 3345679999999999999999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeec
Q 010329 413 GEEKILVYEFVPNKSLDYFLYDPEK---------------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471 (513)
Q Consensus 413 ~~~~~lv~ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 471 (513)
.+..++||||+++|+|.+++..... ...+++..++.|+.||++||.|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999964221 256999999999999999999999987 9999
Q ss_pred CCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 472 DLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 472 dlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||||+|||+++++.+||+|||+++.+...
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 227 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSA 227 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccC
Confidence 99999999999999999999999877543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=233.87 Aligned_cols=150 Identities=25% Similarity=0.372 Sum_probs=135.3
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57888999999999999999964 5789999998653 2344578899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999953 456999999999999999999999987 999999999999999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-27 Score=238.02 Aligned_cols=153 Identities=31% Similarity=0.491 Sum_probs=135.7
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
...++|.+.+.||+|+||.||+|.+. +++.||||.++.... ...++|.+|+.++++++||||+++++++.+++..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34567888999999999999999975 688999999876432 3345788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999953 2345899999999999999999999987 99999999999999999999999999987643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=230.95 Aligned_cols=148 Identities=26% Similarity=0.317 Sum_probs=132.2
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv 419 (513)
++|...+.||+|+||.||+++.. +++.||+|.++... ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888999999999999999964 57899999997642 23345688999999988 899999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999843 356999999999999999999999987 9999999999999999999999999998653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-26 Score=225.17 Aligned_cols=150 Identities=27% Similarity=0.408 Sum_probs=128.4
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc--------------------------cCHHHHHHHHHHHH
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG--------------------------QGAQEFKNEVVLVA 396 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~--------------------------~~~~~~~~E~~~l~ 396 (513)
.++|.+.+.||+|+||.||+|.. .+++.||||.+..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36788999999999999999985 4688999999865421 11356889999999
Q ss_pred hCCCCCccceeeEEEe--CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCc
Q 010329 397 KLQHRNLVRLLGFCLE--GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK 474 (513)
Q Consensus 397 ~l~H~nIv~l~g~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk 474 (513)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.||+.||.|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998765 3457999999999999999999999987 9999999
Q ss_pred CCcEEECCCCCeEEeeccCccccCCC
Q 010329 475 ASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 475 ~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|+|||++.++.+||+|||+++.+...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHHEEECCCCCEEEecCCCccccccc
Confidence 99999999999999999999987543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-26 Score=226.28 Aligned_cols=155 Identities=29% Similarity=0.440 Sum_probs=136.6
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC--eeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lv 419 (513)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357888999999999999999965 48899999997643 344678889999999999999999999998765 67999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE----CCCCCeEEeeccCcc
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMAR 495 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~DfGla~ 495 (513)
|||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976545555999999999999999999999987 9999999999999 888889999999999
Q ss_pred ccCCCC
Q 010329 496 IFGVDQ 501 (513)
Q Consensus 496 ~~~~~~ 501 (513)
.+....
T Consensus 165 ~~~~~~ 170 (319)
T 4euu_A 165 ELEDDE 170 (319)
T ss_dssp ECCTTC
T ss_pred ecCCCC
Confidence 876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-26 Score=221.12 Aligned_cols=150 Identities=31% Similarity=0.517 Sum_probs=136.3
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
.++|...+.||+|+||.||++...+++.||+|++.... ...+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 45788899999999999999998888999999997654 34568999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999954 3346899999999999999999999987 99999999999999999999999999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=230.14 Aligned_cols=150 Identities=25% Similarity=0.357 Sum_probs=125.5
Q ss_pred hcCCCcccccCccCceeEEEEEe----CCCcEEEEEEecccC----ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSASS----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~----~~~~~VavK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 415 (513)
.++|.+.+.||+|+||.||+++. .+++.||+|.++... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45788999999999999999986 478899999987642 2334568899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999843 456899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCC
Q 010329 496 IFGV 499 (513)
Q Consensus 496 ~~~~ 499 (513)
....
T Consensus 170 ~~~~ 173 (327)
T 3a62_A 170 ESIH 173 (327)
T ss_dssp ----
T ss_pred cccc
Confidence 6543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-27 Score=232.58 Aligned_cols=159 Identities=28% Similarity=0.488 Sum_probs=123.5
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEeCCCc----EEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEe
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ----EIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 412 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~----~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 412 (513)
++....++|.+.+.||+|+||.||+|...... .||||.++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 33455678999999999999999999965432 7999998764 33446789999999999999999999999988
Q ss_pred CCee------EEEEecCCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC
Q 010329 413 GEEK------ILVYEFVPNKSLDYFLYDPE---KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE 483 (513)
Q Consensus 413 ~~~~------~lv~ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~ 483 (513)
.... ++||||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 7665 99999999999999985321 2235899999999999999999999987 9999999999999999
Q ss_pred CCeEEeeccCccccCCC
Q 010329 484 MNPKISDFGMARIFGVD 500 (513)
Q Consensus 484 ~~~ki~DfGla~~~~~~ 500 (513)
+.+||+|||+++.+...
T Consensus 174 ~~~kl~Dfg~a~~~~~~ 190 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSG 190 (323)
T ss_dssp SCEEECCCCC-------
T ss_pred CCEEEeecccccccccc
Confidence 99999999999977544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-26 Score=225.22 Aligned_cols=150 Identities=29% Similarity=0.409 Sum_probs=134.4
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc------cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
++|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56888999999999999999964 688999999875432 23578999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC----CeEEeeccC
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFGM 493 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DfGl 493 (513)
+||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999994 3457999999999999999999999987 99999999999998887 899999999
Q ss_pred ccccCCC
Q 010329 494 ARIFGVD 500 (513)
Q Consensus 494 a~~~~~~ 500 (513)
++.+...
T Consensus 165 a~~~~~~ 171 (326)
T 2y0a_A 165 AHKIDFG 171 (326)
T ss_dssp CEECCTT
T ss_pred CeECCCC
Confidence 9987543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-26 Score=233.46 Aligned_cols=157 Identities=27% Similarity=0.445 Sum_probs=136.3
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC--------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEEE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~--------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 411 (513)
...++|.+.+.||+|+||.||+|... .+..||||+++... ....+.+.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34567888999999999999999852 23579999997653 33457799999999999 8999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcE
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Ni 478 (513)
+.+..++||||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 99999999999999999999964321 245999999999999999999999987 99999999999
Q ss_pred EECCCCCeEEeeccCccccCCCC
Q 010329 479 LLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 479 ll~~~~~~ki~DfGla~~~~~~~ 501 (513)
||++++.+||+|||+++.+....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~ 245 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHID 245 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCC
T ss_pred EEcCCCcEEEcccCccccccccc
Confidence 99999999999999999876543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=231.94 Aligned_cols=160 Identities=28% Similarity=0.435 Sum_probs=136.4
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEe------CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEEE
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~------~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 411 (513)
++...++|.+.+.||+|+||.||+|.. .++..||||.+.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445667899999999999999999995 245689999997542 33457899999999999 8999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCCCC--------------------CCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeec
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPEKQ--------------------GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 471 (513)
..+..++||||+++|+|.+++...... ..+++..+..++.||+.||.|||+++ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 999999999999999999999653221 34899999999999999999999987 9999
Q ss_pred CCcCCcEEECCCCCeEEeeccCccccCCCCC
Q 010329 472 DLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (513)
Q Consensus 472 dlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 502 (513)
||||+|||++.++.+||+|||+++.+..+..
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 227 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSN 227 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTT
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCcc
Confidence 9999999999999999999999998765543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=240.88 Aligned_cols=155 Identities=31% Similarity=0.502 Sum_probs=137.8
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
.+++..++|.+.+.||+|+||.||+|.+.++..||||.++... ...+.|.+|+.+|++++||||+++++++. .+..++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3455667889999999999999999999888999999998654 45688999999999999999999999986 667899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 260 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999999542 2235889999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 010329 499 V 499 (513)
Q Consensus 499 ~ 499 (513)
.
T Consensus 336 ~ 336 (454)
T 1qcf_A 336 D 336 (454)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=230.23 Aligned_cols=149 Identities=26% Similarity=0.310 Sum_probs=134.6
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|...+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46888899999999999999964 6899999998653 2244578899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999943 356999999999999999999999987 99999999999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-26 Score=224.78 Aligned_cols=151 Identities=23% Similarity=0.332 Sum_probs=134.7
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.++|.+.+.||+|+||.||++... +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 367889999999999999999964 57889999987543 3346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC--CCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--EMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~--~~~~ki~DfGla~~~~~~ 500 (513)
+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.+..+
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999943 2346999999999999999999999987 999999999999987 789999999999987644
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=229.22 Aligned_cols=157 Identities=29% Similarity=0.460 Sum_probs=136.7
Q ss_pred HHhcCCCcccccCccCceeEEEEEe------CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~------~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 414 (513)
...++|.+.+.||+|+||.||++.. .++..||||.++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3456788999999999999999985 245789999997643 344578899999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCC
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEK---------------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDL 473 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdl 473 (513)
..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+++ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 99999999999999999964322 234899999999999999999999987 999999
Q ss_pred cCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 474 KASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 474 k~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
||+|||+++++.+||+|||+++......
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~ 204 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEED 204 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTS
T ss_pred chheEEEcCCCCEEEccccccccccccc
Confidence 9999999999999999999999875543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=224.72 Aligned_cols=151 Identities=31% Similarity=0.506 Sum_probs=132.3
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.++|++.++||+|+||+||++...+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 367889999999999999999998899999999875432 224678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9984 78777754 3345999999999999999999999987 999999999999999999999999999987543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-27 Score=234.28 Aligned_cols=160 Identities=29% Similarity=0.451 Sum_probs=137.7
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEeCC------CcEEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEE
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 410 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~------~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 410 (513)
.++...++|.+.+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345667889999999999999999999632 2479999997653 23456799999999999 899999999999
Q ss_pred EeCCeeEEEEecCCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEE
Q 010329 411 LEGEEKILVYEFVPNKSLDYFLYDPE-----------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 479 (513)
Q Consensus 411 ~~~~~~~lv~ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nil 479 (513)
.+.+..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999985321 1346899999999999999999999987 999999999999
Q ss_pred ECCCCCeEEeeccCccccCCCC
Q 010329 480 LDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 480 l~~~~~~ki~DfGla~~~~~~~ 501 (513)
++.++.+||+|||+++.+..+.
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~ 218 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDS 218 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCT
T ss_pred ECCCCeEEECcccccccccccc
Confidence 9999999999999999775544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=222.17 Aligned_cols=150 Identities=29% Similarity=0.521 Sum_probs=130.8
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|+..++||+|+||+||++... +++.||||.+..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47888999999999999999964 688999999875432 234678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|++++ |.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~~~-l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQD-LKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEE-HHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCCC-HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 99864 5444432 2456999999999999999999999987 999999999999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=229.83 Aligned_cols=151 Identities=27% Similarity=0.332 Sum_probs=133.7
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCee
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 416 (513)
...++|.+.+.||+|+||+||+++.. +++.||||.++.. .....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34578999999999999999999975 4788999998754 234456788999999988 799999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 999999999999999843 356999999999999999999999987 99999999999999999999999999997
Q ss_pred cC
Q 010329 497 FG 498 (513)
Q Consensus 497 ~~ 498 (513)
..
T Consensus 171 ~~ 172 (353)
T 2i0e_A 171 NI 172 (353)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=219.71 Aligned_cols=153 Identities=31% Similarity=0.475 Sum_probs=137.6
Q ss_pred HhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
..++|++.+.||+|+||.||++...++..||+|.++... ...+++.+|+.++.+++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 346788899999999999999999888899999997654 3457799999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....+.
T Consensus 85 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999953 2345899999999999999999999987 9999999999999999999999999999775543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-26 Score=240.74 Aligned_cols=153 Identities=29% Similarity=0.510 Sum_probs=137.1
Q ss_pred HhcCCCcccccCccCceeEEEEEeCC-CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
..++|.+.++||+|+||.||+|.+.. +..||||.++... ...++|.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34567888999999999999999754 7899999997654 346789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|+++|+|.+++... ....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..+
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999642 2356899999999999999999999987 999999999999999999999999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=227.02 Aligned_cols=153 Identities=31% Similarity=0.558 Sum_probs=132.6
Q ss_pred HhcCCCcccccCccCceeEEEEEe-----CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--Ce
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EE 415 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-----~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~ 415 (513)
..++|++.++||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 346788899999999999999984 35789999999877666677899999999999999999999998654 45
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 89999999999999999542 335899999999999999999999987 9999999999999999999999999999
Q ss_pred ccCCC
Q 010329 496 IFGVD 500 (513)
Q Consensus 496 ~~~~~ 500 (513)
.+..+
T Consensus 163 ~~~~~ 167 (295)
T 3ugc_A 163 VLPQD 167 (295)
T ss_dssp -----
T ss_pred cccCC
Confidence 87544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=220.25 Aligned_cols=152 Identities=26% Similarity=0.451 Sum_probs=134.3
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
...++|...+.||+|+||.||++...++..||+|.++... ...+++.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 3456788899999999999999999888899999997654 345789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999542 346999999999999999999999987 99999999999999999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=234.27 Aligned_cols=153 Identities=34% Similarity=0.541 Sum_probs=132.5
Q ss_pred HhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 415 (513)
..++|.+.+.||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3467888999999999999999953 4568999999754 33445678999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC---CeEE
Q 010329 416 KILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKI 488 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki 488 (513)
.++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999996422 2346999999999999999999999987 99999999999999554 5999
Q ss_pred eeccCccccC
Q 010329 489 SDFGMARIFG 498 (513)
Q Consensus 489 ~DfGla~~~~ 498 (513)
+|||+++.+.
T Consensus 226 ~DFG~a~~~~ 235 (367)
T 3l9p_A 226 GDFGMARDIY 235 (367)
T ss_dssp CCCHHHHHHH
T ss_pred CCCccccccc
Confidence 9999998663
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=227.16 Aligned_cols=151 Identities=28% Similarity=0.421 Sum_probs=133.8
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467899999999999999999964 68899999987542 234567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC---CeEEeeccCcccc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DfGla~~~ 497 (513)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999998843 456899999999999999999999987 99999999999997654 5999999999987
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
...
T Consensus 182 ~~~ 184 (362)
T 2bdw_A 182 NDS 184 (362)
T ss_dssp TTC
T ss_pred cCC
Confidence 643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.9e-26 Score=235.36 Aligned_cols=150 Identities=29% Similarity=0.518 Sum_probs=135.6
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999964 78999999986532 234568999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....+
T Consensus 96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999994 3456999999999999999999999987 999999999999999999999999999987644
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-26 Score=229.27 Aligned_cols=154 Identities=25% Similarity=0.397 Sum_probs=133.5
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc-----CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS-----SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
.++|.+.+.||+|+||.||++.. .+++.||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35688899999999999999986 46899999998642 1224678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC---eEEeeccC
Q 010329 418 LVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGM 493 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DfGl 493 (513)
+||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988774322 2345899999999999999999999987 999999999999986654 99999999
Q ss_pred ccccCCC
Q 010329 494 ARIFGVD 500 (513)
Q Consensus 494 a~~~~~~ 500 (513)
++.+...
T Consensus 180 a~~~~~~ 186 (351)
T 3c0i_A 180 AIQLGES 186 (351)
T ss_dssp CEECCTT
T ss_pred eeEecCC
Confidence 9987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=9.8e-26 Score=229.05 Aligned_cols=152 Identities=25% Similarity=0.379 Sum_probs=135.7
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357899999999999999999964 6889999999776555566899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC--CCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--EMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~--~~~~ki~DfGla~~~~~~ 500 (513)
+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+..+
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999853 2346899999999999999999999987 999999999999974 578999999999987644
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.7e-26 Score=218.47 Aligned_cols=152 Identities=25% Similarity=0.398 Sum_probs=137.4
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.++|.+.+.||+|+||.||++... ++..|++|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457889999999999999999964 4678999999876666778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE---CCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~~~~ 499 (513)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999998843 456899999999999999999999987 9999999999999 8889999999999998764
Q ss_pred CC
Q 010329 500 DQ 501 (513)
Q Consensus 500 ~~ 501 (513)
..
T Consensus 162 ~~ 163 (277)
T 3f3z_A 162 GK 163 (277)
T ss_dssp TS
T ss_pred cc
Confidence 43
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-26 Score=221.80 Aligned_cols=149 Identities=31% Similarity=0.531 Sum_probs=133.3
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|...+.||+|+||.||++...+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688899999999999999998789999999986543 22347789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++ +|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 985 89888854 2356899999999999999999999987 99999999999999999999999999987753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=226.47 Aligned_cols=159 Identities=32% Similarity=0.476 Sum_probs=138.2
Q ss_pred HHHhcCCCcccccCccCceeEEEEEe------CCCcEEEEEEecccCc-cCHHHHHHHHHHHHhC-CCCCccceeeEEEe
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE 412 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~------~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 412 (513)
+...++|.+.+.||+|+||.||++.. .+++.||||.++.... ...+.+.+|+.+++++ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34556888999999999999999984 3467899999976533 3457799999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCc
Q 010329 413 GEEKILVYEFVPNKSLDYFLYDPEK---------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (513)
Q Consensus 413 ~~~~~lv~ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~N 477 (513)
++..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence 9999999999999999999964321 225899999999999999999999987 9999999999
Q ss_pred EEECCCCCeEEeeccCccccCCCCC
Q 010329 478 ILLDAEMNPKISDFGMARIFGVDQT 502 (513)
Q Consensus 478 ill~~~~~~ki~DfGla~~~~~~~~ 502 (513)
||++.++.+||+|||+++.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~ 200 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSN 200 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT
T ss_pred EEEcCCCCEEEcccccccccccccc
Confidence 9999999999999999998865543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=8.9e-26 Score=225.09 Aligned_cols=156 Identities=28% Similarity=0.464 Sum_probs=135.4
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC--------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccceeeEEE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~--------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 411 (513)
...++|.+.+.||+|+||.||++... ++..||||.++... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 44578899999999999999999863 46789999997653 33456789999999999 8999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcE
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Ni 478 (513)
+.+..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 99999999999999999999965332 234899999999999999999999987 99999999999
Q ss_pred EECCCCCeEEeeccCccccCCC
Q 010329 479 LLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 479 ll~~~~~~ki~DfGla~~~~~~ 500 (513)
|++.++.+||+|||+++.+...
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~ 210 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNI 210 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTT
T ss_pred EEcCCCCEEEcccccccccccc
Confidence 9999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=227.43 Aligned_cols=149 Identities=26% Similarity=0.458 Sum_probs=133.0
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||+|.. .+++.||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788999999999999999995 57899999998653 2233467899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+ +|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....+
T Consensus 89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 6888888843 456999999999999999999999987 999999999999999999999999999987544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=228.66 Aligned_cols=151 Identities=26% Similarity=0.401 Sum_probs=129.1
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe----
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE---- 415 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~---- 415 (513)
.++|.+.+.||+|+||.||++.. .+++.||||.++.... ...+.+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46789999999999999999995 5788999999976432 234578999999999999999999999876543
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 3999999999999999943 356999999999999999999999987 9999999999999999999999999999
Q ss_pred ccCCC
Q 010329 496 IFGVD 500 (513)
Q Consensus 496 ~~~~~ 500 (513)
.+...
T Consensus 165 ~~~~~ 169 (311)
T 3ork_A 165 AIADS 169 (311)
T ss_dssp -----
T ss_pred ccccc
Confidence 87544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.6e-26 Score=229.03 Aligned_cols=148 Identities=30% Similarity=0.414 Sum_probs=127.3
Q ss_pred cccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCCCC
Q 010329 349 TDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 427 (513)
Q Consensus 349 ~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gs 427 (513)
..+.||+|+||.||+|.. .+++.||+|.++.......+++.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356899999999999985 4689999999987665566789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE--CCCCCeEEeeccCccccCCCC
Q 010329 428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL--DAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill--~~~~~~ki~DfGla~~~~~~~ 501 (513)
|.+++.+ ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9988853 2345899999999999999999999987 9999999999999 677899999999999886543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=237.93 Aligned_cols=154 Identities=31% Similarity=0.402 Sum_probs=136.7
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|...+.||+|+||.||++... +|+.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888899999999999999964 6899999998653 223456789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999998643 2345999999999999999999999987 99999999999999999999999999998764
Q ss_pred CC
Q 010329 500 DQ 501 (513)
Q Consensus 500 ~~ 501 (513)
+.
T Consensus 339 ~~ 340 (576)
T 2acx_A 339 GQ 340 (576)
T ss_dssp TC
T ss_pred Cc
Confidence 43
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.93 E-value=8.7e-26 Score=234.43 Aligned_cols=150 Identities=29% Similarity=0.481 Sum_probs=133.5
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC-eeEEEE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-EKILVY 420 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lv~ 420 (513)
...++|.+.+.||+|+||.||+|.+. ++.||||.++... ..+.|.+|+.+|++++||||+++++++.+.+ ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34567888999999999999999984 7899999997653 4578999999999999999999999988765 689999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 267 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp ECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999642 2334799999999999999999999987 9999999999999999999999999999654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.93 E-value=8.9e-26 Score=227.59 Aligned_cols=148 Identities=24% Similarity=0.351 Sum_probs=130.1
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.++|.+.+.||+|+||.||++... +++.||||.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457889999999999999999964 688999999976432 346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC--eEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--PKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~--~ki~DfGla~~~~ 498 (513)
+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 999999999843 446999999999999999999999987 999999999999987765 9999999998543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=239.20 Aligned_cols=150 Identities=25% Similarity=0.285 Sum_probs=124.9
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|.+.+.||+|+||.||++.. .+++.||||.++.. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35688899999999999999995 46889999998753 333446788899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999843 4569999999999999999999998 66 9999999999999999999999999998754
Q ss_pred C
Q 010329 499 V 499 (513)
Q Consensus 499 ~ 499 (513)
.
T Consensus 301 ~ 301 (446)
T 4ejn_A 301 K 301 (446)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=225.26 Aligned_cols=169 Identities=28% Similarity=0.436 Sum_probs=143.0
Q ss_pred cccccchHHHHHHhcCCCcccccCccCceeEEEEEe------CCCcEEEEEEecccCc-cCHHHHHHHHHHHHhC-CCCC
Q 010329 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKL-QHRN 402 (513)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~------~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~n 402 (513)
+...+....++...++|.+.+.||+|+||.||++.. .+++.||||.++.... ...+.+.+|+.++.++ +|||
T Consensus 13 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 92 (316)
T 2xir_A 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92 (316)
T ss_dssp GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred hhccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCC
Confidence 344556667777788999999999999999999984 3467899999976533 3346789999999999 6999
Q ss_pred ccceeeEEEeCC-eeEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCe
Q 010329 403 LVRLLGFCLEGE-EKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468 (513)
Q Consensus 403 Iv~l~g~~~~~~-~~~lv~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 468 (513)
|+++++++...+ ..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |
T Consensus 93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i 169 (316)
T 2xir_A 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 169 (316)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 999999998755 48999999999999999965322 223889999999999999999999987 9
Q ss_pred eecCCcCCcEEECCCCCeEEeeccCccccCCCCC
Q 010329 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (513)
Q Consensus 469 vHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 502 (513)
+||||||+|||++.++.+||+|||+++.+.....
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 203 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCcc
Confidence 9999999999999999999999999998765443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-26 Score=226.75 Aligned_cols=153 Identities=30% Similarity=0.584 Sum_probs=128.1
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCc----EEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~----~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
++|+..+.||+|+||.||+|++. +++ +|++|.++.. .....+++.+|+.++++++||||+++++++.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888999999999999999953 344 4688888654 3345678999999999999999999999998754 789
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|+||+++|+|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 94 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999954 2356999999999999999999999987 9999999999999999999999999999886
Q ss_pred CCCCc
Q 010329 499 VDQTQ 503 (513)
Q Consensus 499 ~~~~~ 503 (513)
.....
T Consensus 169 ~~~~~ 173 (327)
T 3poz_A 169 AEEKE 173 (327)
T ss_dssp TTCC-
T ss_pred CCccc
Confidence 55443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.7e-27 Score=233.93 Aligned_cols=148 Identities=20% Similarity=0.284 Sum_probs=125.5
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccC--------ccCHHHHHHHHHHHHhCC---------CCCccce
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS--------GQGAQEFKNEVVLVAKLQ---------HRNLVRL 406 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~l 406 (513)
.++|.+.+.||+|+||+||+|+. +++.||||++.... ....+.+.+|+.+++.++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45678889999999999999998 78999999997542 223478999999999886 7888777
Q ss_pred eeEEE------------------------------eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 010329 407 LGFCL------------------------------EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456 (513)
Q Consensus 407 ~g~~~------------------------------~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 456 (513)
.+++. ..+..++||||+++|++.+.+. ...+++..+..|+.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 77653 2678999999999997766662 2468999999999999999
Q ss_pred HHHhH-cCCCCCeeecCCcCCcEEECCCC--------------------CeEEeeccCccccCC
Q 010329 457 ILYLH-EDSRLRIIHRDLKASNILLDAEM--------------------NPKISDFGMARIFGV 499 (513)
Q Consensus 457 L~yLH-~~~~~~ivHrdlk~~Nill~~~~--------------------~~ki~DfGla~~~~~ 499 (513)
|.||| +.+ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 99999 877 99999999999999887 899999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=219.53 Aligned_cols=147 Identities=28% Similarity=0.433 Sum_probs=127.5
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHh--CCCCCccceeeEEEeC----CeeE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAK--LQHRNLVRLLGFCLEG----EEKI 417 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~----~~~~ 417 (513)
.++|.+.+.||+|+||+||+|.. +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46789999999999999999998 6889999998653 33556677777766 7899999999997653 4578
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhH--------cCCCCCeeecCCcCCcEEECCCCCeEEe
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH--------EDSRLRIIHRDLKASNILLDAEMNPKIS 489 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrdlk~~Nill~~~~~~ki~ 489 (513)
+||||+++|+|.+++. ...+++..+..++.||+.||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999993 346999999999999999999999 655 9999999999999999999999
Q ss_pred eccCccccCCCC
Q 010329 490 DFGMARIFGVDQ 501 (513)
Q Consensus 490 DfGla~~~~~~~ 501 (513)
|||+++......
T Consensus 156 Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 156 DLGLAVMHSQST 167 (301)
T ss_dssp CCTTCEEEETTT
T ss_pred eCCCeeeccccc
Confidence 999998775543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=235.90 Aligned_cols=164 Identities=31% Similarity=0.424 Sum_probs=141.2
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|...+.||+|+||+||+++.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999974 68999999996532 234577899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999986532 2446999999999999999999999987 99999999999999999999999999998765
Q ss_pred CCCccccceeeecC
Q 010329 500 DQTQGNTSRIVGTL 513 (513)
Q Consensus 500 ~~~~~~~~~~~Gt~ 513 (513)
.... +....||+
T Consensus 342 ~~~~--~~~~~GT~ 353 (543)
T 3c4z_A 342 GQTK--TKGYAGTP 353 (543)
T ss_dssp TCCC--BCCCCSCT
T ss_pred CCcc--cccccCCc
Confidence 4322 22346663
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-25 Score=219.82 Aligned_cols=153 Identities=30% Similarity=0.531 Sum_probs=120.7
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.++|+..+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888999999999999999964 688999999875432 344778999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 422 FVPNKSLDYFLYDP---EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 422 y~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|++ |+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 6898888432 12245899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 010329 499 VD 500 (513)
Q Consensus 499 ~~ 500 (513)
..
T Consensus 160 ~~ 161 (317)
T 2pmi_A 160 IP 161 (317)
T ss_dssp SC
T ss_pred CC
Confidence 43
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=217.38 Aligned_cols=151 Identities=30% Similarity=0.462 Sum_probs=135.0
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.++|++.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356888999999999999999964 68899999987543 2345789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999843 456899999999999999999999987 999999999999999999999999999876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.9e-26 Score=235.44 Aligned_cols=149 Identities=21% Similarity=0.431 Sum_probs=122.2
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC-----Cee
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EEK 416 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~ 416 (513)
++|.+.+.||+|+||+||++... +++.||||++... .....+.+.+|+.++++++|+||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57899999999999999999854 6889999998653 233456789999999999999999999998543 468
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+ +++|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 133 ~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 9999998 4789988843 456999999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 010329 497 FGVD 500 (513)
Q Consensus 497 ~~~~ 500 (513)
+...
T Consensus 206 ~~~~ 209 (458)
T 3rp9_A 206 VDYP 209 (458)
T ss_dssp TTSC
T ss_pred ccCc
Confidence 7543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=230.29 Aligned_cols=161 Identities=26% Similarity=0.306 Sum_probs=128.1
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc---cCHHHHHHHHHH-HHhCCCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG---QGAQEFKNEVVL-VAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
++|.+.+.||+|+||+||+++.. +++.||||.++.... ...+.+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46788899999999999999964 578899999976432 233456667665 5778999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999843 456899999999999999999999987 99999999999999999999999999997543
Q ss_pred CCCccccceeeecC
Q 010329 500 DQTQGNTSRIVGTL 513 (513)
Q Consensus 500 ~~~~~~~~~~~Gt~ 513 (513)
... .+....||+
T Consensus 192 ~~~--~~~~~~gt~ 203 (373)
T 2r5t_A 192 HNS--TTSTFCGTP 203 (373)
T ss_dssp CCC--CCCSBSCCC
T ss_pred CCC--ccccccCCc
Confidence 322 223455653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.1e-26 Score=233.26 Aligned_cols=153 Identities=26% Similarity=0.361 Sum_probs=133.2
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
..++|.+.+.||+|+||.||++.. .+|+.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 356789999999999999999985 568899999987543 23346789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC---CCCCeEEeeccCccc
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMARI 496 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DfGla~~ 496 (513)
|||+++|+|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999988843 456999999999999999999999987 99999999999998 567899999999988
Q ss_pred cCCCC
Q 010329 497 FGVDQ 501 (513)
Q Consensus 497 ~~~~~ 501 (513)
+....
T Consensus 163 ~~~~~ 167 (444)
T 3soa_A 163 VEGEQ 167 (444)
T ss_dssp CCTTC
T ss_pred ecCCC
Confidence 76543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=229.28 Aligned_cols=154 Identities=29% Similarity=0.439 Sum_probs=135.7
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC--eeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lv 419 (513)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357889999999999999999965 48999999997643 344577889999999999999999999998765 67999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE----CCCCCeEEeeccCcc
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMAR 495 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~DfGla~ 495 (513)
|||+++|+|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999965444445999999999999999999999987 9999999999999 788889999999999
Q ss_pred ccCCC
Q 010329 496 IFGVD 500 (513)
Q Consensus 496 ~~~~~ 500 (513)
.+..+
T Consensus 165 ~~~~~ 169 (396)
T 4eut_A 165 ELEDD 169 (396)
T ss_dssp ECCCG
T ss_pred EccCC
Confidence 87544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=236.27 Aligned_cols=154 Identities=31% Similarity=0.522 Sum_probs=133.2
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++..++|.+.++||+|+||.||+|.+.++..||||.++... ...++|.+|+.+|++++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34556788899999999999999999888889999998654 345789999999999999999999999876 6789999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+..+
T Consensus 258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999431 2345899999999999999999999987 999999999999999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.3e-26 Score=226.23 Aligned_cols=162 Identities=25% Similarity=0.382 Sum_probs=133.0
Q ss_pred HhcCCCcccccCccCceeEEEEEeCCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCC--CCccceeeEEEeCCeeEE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQH--RNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~l 418 (513)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++.+++..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 34678899999999999999999888999999998754 23344789999999999987 999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||| +.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 568899999953 456899999999999999999999987 99999999999997 5789999999999886
Q ss_pred CCCCccccceeeec
Q 010329 499 VDQTQGNTSRIVGT 512 (513)
Q Consensus 499 ~~~~~~~~~~~~Gt 512 (513)
.+..........||
T Consensus 159 ~~~~~~~~~~~~gt 172 (343)
T 3dbq_A 159 PDTTSVVKDSQVGT 172 (343)
T ss_dssp -----------CCC
T ss_pred cccccccCCCCcCC
Confidence 55443333344555
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=229.10 Aligned_cols=159 Identities=30% Similarity=0.539 Sum_probs=137.6
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEE
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCL 411 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 411 (513)
++++..++|.+.+.||+|+||.||+|... .++.||||.+..... .....+.+|+.+++.++|+||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34456678999999999999999999854 367899999975432 33467899999999999999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPE-------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~ 484 (513)
+.+..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 9999999999999999999985321 1245799999999999999999999987 99999999999999999
Q ss_pred CeEEeeccCccccCCC
Q 010329 485 NPKISDFGMARIFGVD 500 (513)
Q Consensus 485 ~~ki~DfGla~~~~~~ 500 (513)
.+||+|||+++.....
T Consensus 176 ~~kl~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYET 191 (322)
T ss_dssp CEEECCTTCCCGGGGG
T ss_pred eEEECcCccccccccc
Confidence 9999999999877543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=222.79 Aligned_cols=150 Identities=23% Similarity=0.298 Sum_probs=132.7
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.++|.+.+.||+|+||.||+|.. .+++.||||.+..... .+.+.+|+.+++++ +|+||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46788999999999999999995 5788999999875432 34688999999999 89999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC-----eEEeeccCccc
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-----PKISDFGMARI 496 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~-----~ki~DfGla~~ 496 (513)
|+ +++|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998542 457999999999999999999999987 999999999999998887 99999999998
Q ss_pred cCCCC
Q 010329 497 FGVDQ 501 (513)
Q Consensus 497 ~~~~~ 501 (513)
+....
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 75543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-25 Score=219.57 Aligned_cols=148 Identities=26% Similarity=0.377 Sum_probs=130.5
Q ss_pred cCCCcc-cccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTD-NKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~-~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
+.|.+. +.||+|+||.||++.. .+++.||||.+........+.+.+|+.++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456664 7899999999999995 46899999999876666678899999999985 79999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC---eEEeeccCccccC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGMARIFG 498 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DfGla~~~~ 498 (513)
|+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.+.
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999953 356899999999999999999999987 999999999999988776 9999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=243.75 Aligned_cols=154 Identities=31% Similarity=0.513 Sum_probs=136.5
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
+++..++|.+.++||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++|+||+++++++.+ +..++|
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 345567788999999999999999999888889999998654 345789999999999999999999999876 678999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++|+|.++|... ....+++..++.|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+++.+..
T Consensus 340 ~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999431 2345899999999999999999999987 99999999999999999999999999997753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-26 Score=225.88 Aligned_cols=162 Identities=31% Similarity=0.475 Sum_probs=132.5
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCc----EEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~----~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
++|...+.||+|+||.||+|... +++ +|++|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56888899999999999999953 344 38888875443 333456788999999999999999999886 456889
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999999542 346899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCCCccccceeeec
Q 010329 499 VDQTQGNTSRIVGT 512 (513)
Q Consensus 499 ~~~~~~~~~~~~Gt 512 (513)
............||
T Consensus 167 ~~~~~~~~~~~~~~ 180 (325)
T 3kex_A 167 PDDKQLLYSEAKTP 180 (325)
T ss_dssp CCTTCCC-----CC
T ss_pred cccccccccCCCCc
Confidence 65544333334443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=226.82 Aligned_cols=151 Identities=17% Similarity=0.241 Sum_probs=135.0
Q ss_pred hcCCCcccccCcc--CceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 344 TNKFSTDNKLGEG--GFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 344 ~~~~~~~~~Lg~G--~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
.++|++.++||+| +||.||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578899999999 99999999965 68999999987543 3345678899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++|+|.+++... ....+++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998542 2356999999999999999999999987 9999999999999999999999999987653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=231.93 Aligned_cols=150 Identities=24% Similarity=0.437 Sum_probs=131.1
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC-----Ce
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EE 415 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 415 (513)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46799999999999999999996 45788999999754 223456889999999999999999999999876 56
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 699999843 456999999999999999999999987 9999999999999999999999999999
Q ss_pred ccCCC
Q 010329 496 IFGVD 500 (513)
Q Consensus 496 ~~~~~ 500 (513)
.....
T Consensus 178 ~~~~~ 182 (432)
T 3n9x_A 178 TINSE 182 (432)
T ss_dssp EC---
T ss_pred ccccc
Confidence 87644
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.4e-26 Score=223.85 Aligned_cols=166 Identities=28% Similarity=0.495 Sum_probs=130.2
Q ss_pred ccccchHHHHHHhcCCCcccccCccCceeEEEEEeC----CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccc
Q 010329 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVR 405 (513)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~----~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~ 405 (513)
.++.....+....++|.+.+.||+|+||.||+|... .+..||+|.++... ....+.+.+|+.++++++||||++
T Consensus 21 el~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 100 (313)
T 3brb_A 21 ELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100 (313)
T ss_dssp ---CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeee
Confidence 334444555566788999999999999999999853 34589999987542 334567999999999999999999
Q ss_pred eeeEEEeCCe-----eEEEEecCCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCc
Q 010329 406 LLGFCLEGEE-----KILVYEFVPNKSLDYFLYDP---EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (513)
Q Consensus 406 l~g~~~~~~~-----~~lv~ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~N 477 (513)
+++++.+.+. .++||||+++++|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~N 177 (313)
T 3brb_A 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARN 177 (313)
T ss_dssp CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGG
T ss_pred eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcce
Confidence 9999987653 49999999999999998432 23456999999999999999999999987 9999999999
Q ss_pred EEECCCCCeEEeeccCccccCCC
Q 010329 478 ILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 478 ill~~~~~~ki~DfGla~~~~~~ 500 (513)
||++.++.+||+|||+++.+...
T Consensus 178 Ili~~~~~~kl~Dfg~~~~~~~~ 200 (313)
T 3brb_A 178 CMLRDDMTVCVADFGLSKKIYSG 200 (313)
T ss_dssp EEECTTSCEEECSCSCC------
T ss_pred EEEcCCCcEEEeecCcceecccc
Confidence 99999999999999999877543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=215.24 Aligned_cols=152 Identities=36% Similarity=0.543 Sum_probs=125.4
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCc----cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSG----QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|+..+.||+|+||.||++.. .++.||||.++.... ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 45788899999999999999998 488999999875422 3357899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC--------CCCeEEeec
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--------EMNPKISDF 491 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~--------~~~~ki~Df 491 (513)
|||+++++|.+++. ...+++..+..++.|++.||.|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999983 346999999999999999999999987556999999999999986 778999999
Q ss_pred cCccccCCC
Q 010329 492 GMARIFGVD 500 (513)
Q Consensus 492 Gla~~~~~~ 500 (513)
|+++.+...
T Consensus 161 g~~~~~~~~ 169 (271)
T 3dtc_A 161 GLAREWHRT 169 (271)
T ss_dssp CC-------
T ss_pred Ccccccccc
Confidence 999877543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=224.35 Aligned_cols=148 Identities=27% Similarity=0.431 Sum_probs=121.3
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.++|.+.+.||+|+||.||++... +++.||||.++... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 467888999999999999999975 57899999987643 345788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC---CCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DfGla~~~~~ 499 (513)
+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999843 456899999999999999999999987 999999999999975 88999999999997754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-25 Score=219.25 Aligned_cols=149 Identities=28% Similarity=0.387 Sum_probs=133.5
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|...++||+|+||.||++... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999964 589999999865432 234678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999988843 456899999999999999999999987 99999999999999999999999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=219.52 Aligned_cols=150 Identities=31% Similarity=0.504 Sum_probs=134.1
Q ss_pred hcCCCcccccCccCceeEEEEEeCC-C-------cEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPS-G-------QEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~-~-------~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 415 (513)
.++|.+.+.||+|+||.||+|.... + ..|++|.+........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4578889999999999999998542 3 4799999987766677889999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC--------eE
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--------PK 487 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~--------~k 487 (513)
.++||||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999954 2334899999999999999999999987 999999999999998887 99
Q ss_pred EeeccCccccC
Q 010329 488 ISDFGMARIFG 498 (513)
Q Consensus 488 i~DfGla~~~~ 498 (513)
|+|||+++...
T Consensus 162 l~Dfg~~~~~~ 172 (289)
T 4fvq_A 162 LSDPGISITVL 172 (289)
T ss_dssp ECCCCSCTTTS
T ss_pred eccCccccccc
Confidence 99999998664
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=221.19 Aligned_cols=151 Identities=27% Similarity=0.310 Sum_probs=127.3
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|+..++||+|+||+||+|... +++.||||++..... .....+..|+..+.++ +|+||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357899999999999999999975 689999999865422 2233455555555554 899999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+ +++|.+++... ...++|..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 67898887542 346999999999999999999999987 99999999999999999999999999988754
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 210 ~ 210 (311)
T 3p1a_A 210 A 210 (311)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=217.17 Aligned_cols=154 Identities=35% Similarity=0.561 Sum_probs=135.4
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++..++|.+.+.||+|+||.||+|...++..||||.++... ...+.+.+|+++++.++||||+++++++. .+..++||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 86 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence 34556788999999999999999998888899999987643 34678999999999999999999999976 45689999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999999431 1236899999999999999999999987 999999999999999999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=5.4e-26 Score=228.70 Aligned_cols=150 Identities=25% Similarity=0.346 Sum_probs=133.2
Q ss_pred cCCCcccccCccCceeEEEEEe----CCCcEEEEEEecccC----ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSASS----GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~----~~~~~VavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 415 (513)
++|.+.+.||+|+||.||+++. .+++.||||.++... ....+.+.+|+.++.++ +|+||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788899999999999999996 468899999987532 23345678899999999 69999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999953 346899999999999999999999987 9999999999999999999999999999
Q ss_pred ccCCC
Q 010329 496 IFGVD 500 (513)
Q Consensus 496 ~~~~~ 500 (513)
.+...
T Consensus 208 ~~~~~ 212 (355)
T 1vzo_A 208 EFVAD 212 (355)
T ss_dssp ECCGG
T ss_pred ecccC
Confidence 77543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-26 Score=221.19 Aligned_cols=156 Identities=30% Similarity=0.513 Sum_probs=138.3
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
+...++|...+.||+|+||.||++... ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 345677888999999999999999975 47889999987543 3457899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 88 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999542 3456999999999999999999999987 99999999999999999999999999998764
Q ss_pred CC
Q 010329 500 DQ 501 (513)
Q Consensus 500 ~~ 501 (513)
+.
T Consensus 164 ~~ 165 (288)
T 3kfa_A 164 DT 165 (288)
T ss_dssp SS
T ss_pred Cc
Confidence 43
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=215.36 Aligned_cols=151 Identities=29% Similarity=0.402 Sum_probs=132.7
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
++.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345556899999999999995 5688999999987666667889999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC-CCCeEEeeccCccccCC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGV 499 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~~~ 499 (513)
+++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999965444456789999999999999999999987 999999999999987 89999999999987754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=221.49 Aligned_cols=150 Identities=26% Similarity=0.411 Sum_probs=133.9
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 56788899999999999999964 57889999986542 234567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 121 e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 121 ELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp CCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999998843 356899999999999999999999987 999999999999999999999999999987543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=242.70 Aligned_cols=164 Identities=27% Similarity=0.329 Sum_probs=139.0
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCee
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 416 (513)
...++|.+.+.||+|+||+||+++.. +++.||||+++.. .....+.+..|..++..+ +|+||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 44578999999999999999999964 5788999998753 234456788899999987 699999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
+|||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 418 ~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999953 356999999999999999999999987 99999999999999999999999999997
Q ss_pred cCCCCCccccceeeecC
Q 010329 497 FGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 497 ~~~~~~~~~~~~~~Gt~ 513 (513)
...+... +..+.||+
T Consensus 492 ~~~~~~~--~~~~~GT~ 506 (674)
T 3pfq_A 492 NIWDGVT--TKTFCGTP 506 (674)
T ss_dssp CCCTTCC--BCCCCSCS
T ss_pred cccCCcc--cccccCCC
Confidence 5433322 33456663
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=218.12 Aligned_cols=152 Identities=32% Similarity=0.571 Sum_probs=131.8
Q ss_pred cCCCcccccCccCceeEEEEEe-----CCCcEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--Cee
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK 416 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-----~~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 416 (513)
+.|+..+.||+|+||.||++++ .+++.||||.++.. .....+.+.+|+.+++.++|+||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999983 46789999999754 334567899999999999999999999999876 568
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999843 2346999999999999999999999987 99999999999999999999999999998
Q ss_pred cCCCC
Q 010329 497 FGVDQ 501 (513)
Q Consensus 497 ~~~~~ 501 (513)
+....
T Consensus 176 ~~~~~ 180 (302)
T 4e5w_A 176 IETDK 180 (302)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 76543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=224.32 Aligned_cols=153 Identities=26% Similarity=0.373 Sum_probs=134.7
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc--------cCHHHHHHHHHHHHhCCCCCccceeeEEEeC
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG--------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 413 (513)
..++|...+.||+|+||.||++.. .+++.||||.++.... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346799999999999999999985 5688999999876421 1234678899999999999999999999999
Q ss_pred CeeEEEEecCCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeecc
Q 010329 414 EEKILVYEFVPNK-SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (513)
Q Consensus 414 ~~~~lv~ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG 492 (513)
+..++||||+..| +|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99999843 446999999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCC
Q 010329 493 MARIFGVDQ 501 (513)
Q Consensus 493 la~~~~~~~ 501 (513)
+++.+..+.
T Consensus 176 ~a~~~~~~~ 184 (335)
T 3dls_A 176 SAAYLERGK 184 (335)
T ss_dssp TCEECCTTC
T ss_pred cceECCCCC
Confidence 999876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=216.27 Aligned_cols=150 Identities=25% Similarity=0.401 Sum_probs=134.1
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999965 57889999986542 23456789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998843 356899999999999999999999987 99999999999999999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=214.62 Aligned_cols=150 Identities=31% Similarity=0.542 Sum_probs=134.4
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||++.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688899999999999999996 578999999986532 233578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999954 2356899999999999999999999987 99999999999999999999999999998753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-25 Score=218.88 Aligned_cols=151 Identities=28% Similarity=0.390 Sum_probs=135.0
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc------cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 416 (513)
.++|.+.+.||+|+||.||++... +++.||+|.+..... ...+++.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999964 688999999875432 1357899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC----CeEEeecc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG 492 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DfG 492 (513)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999953 456899999999999999999999987 99999999999999888 79999999
Q ss_pred CccccCCC
Q 010329 493 MARIFGVD 500 (513)
Q Consensus 493 la~~~~~~ 500 (513)
+++.+...
T Consensus 165 ~~~~~~~~ 172 (321)
T 2a2a_A 165 LAHEIEDG 172 (321)
T ss_dssp TCEECCTT
T ss_pred cceecCcc
Confidence 99987644
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=219.61 Aligned_cols=151 Identities=34% Similarity=0.562 Sum_probs=125.0
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
++..++|++.++||+|+||.||+|... ..||||.++... ....+.+.+|+.++++++|+||+++++++ ..+..++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 345678999999999999999999864 369999987543 33457899999999999999999999965 5567899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 97 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999953 3456999999999999999999999987 9999999999999999999999999998765
Q ss_pred C
Q 010329 499 V 499 (513)
Q Consensus 499 ~ 499 (513)
.
T Consensus 172 ~ 172 (289)
T 3og7_A 172 R 172 (289)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=225.35 Aligned_cols=157 Identities=25% Similarity=0.316 Sum_probs=133.2
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc-----CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS-----SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 413 (513)
+....++|.+.+.||+|+||.||++.. .+++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445667899999999999999999996 46789999998653 234457899999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPE-------------------------------------KQGQLDWSRRYKIIGGIARG 456 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~g 456 (513)
+..++||||+++|+|.+++.... ....+++..+..|+.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999984110 01123567788999999999
Q ss_pred HHHhHcCCCCCeeecCCcCCcEEECCCC--CeEEeeccCccccCC
Q 010329 457 ILYLHEDSRLRIIHRDLKASNILLDAEM--NPKISDFGMARIFGV 499 (513)
Q Consensus 457 L~yLH~~~~~~ivHrdlk~~Nill~~~~--~~ki~DfGla~~~~~ 499 (513)
|.|||+.+ |+||||||+|||++.++ .+||+|||+++.+..
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 99999987 99999999999998776 899999999997643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=213.72 Aligned_cols=149 Identities=31% Similarity=0.505 Sum_probs=135.5
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
.++|...+.||+|+||.||++...+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 457888899999999999999988888999999976543 4578999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccc
Confidence 99999999954 2346899999999999999999999987 9999999999999999999999999998764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=227.73 Aligned_cols=152 Identities=26% Similarity=0.417 Sum_probs=128.6
Q ss_pred HHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--------ccCHHHHHHHHHHHHhCCCCCccceeeEEEe
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--------GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 412 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 412 (513)
...++|.+.+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4567899999999999999999985 457899999986532 112235889999999999999999999974
Q ss_pred CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC---CCeEEe
Q 010329 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKIS 489 (513)
Q Consensus 413 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~ 489 (513)
.+..++||||+++|+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 556899999999999999884 3457999999999999999999999987 9999999999999654 459999
Q ss_pred eccCccccCCC
Q 010329 490 DFGMARIFGVD 500 (513)
Q Consensus 490 DfGla~~~~~~ 500 (513)
|||+++.+...
T Consensus 285 DFG~a~~~~~~ 295 (419)
T 3i6u_A 285 DFGHSKILGET 295 (419)
T ss_dssp CSSTTTSCC--
T ss_pred ecccceecCCC
Confidence 99999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=227.53 Aligned_cols=161 Identities=25% Similarity=0.378 Sum_probs=132.7
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCC--CCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQ--HRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|.+.+.||+|+||.||++...+++.||||.+... .....+.+.+|+.++.+++ |+||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3568899999999999999999888999999998654 2334578999999999997 59999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|| +.+++|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 568999999953 346899999999999999999999987 99999999999995 57899999999998865
Q ss_pred CCCccccceeeec
Q 010329 500 DQTQGNTSRIVGT 512 (513)
Q Consensus 500 ~~~~~~~~~~~Gt 512 (513)
+.........+||
T Consensus 207 ~~~~~~~~~~~gt 219 (390)
T 2zmd_A 207 DTTSVVKDSQVGA 219 (390)
T ss_dssp -------CCSCCC
T ss_pred CCccccCCCCCcC
Confidence 5433323344555
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=221.51 Aligned_cols=153 Identities=31% Similarity=0.514 Sum_probs=135.5
Q ss_pred hcCCCcccccCccCceeEEEEEe-----CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEe--CCee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEK 416 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-----~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~ 416 (513)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++|+||+++++++.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35788899999999999999984 4678999999987766666789999999999999999999999874 4568
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+++++|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 8999999999999999532 335899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCCC
Q 010329 497 FGVDQ 501 (513)
Q Consensus 497 ~~~~~ 501 (513)
+....
T Consensus 177 ~~~~~ 181 (327)
T 3lxl_A 177 LPLDK 181 (327)
T ss_dssp CCTTC
T ss_pred cccCC
Confidence 75443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=223.84 Aligned_cols=149 Identities=32% Similarity=0.458 Sum_probs=131.3
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
+.|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4578889999999999999995 578899999987542 223467899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||++ |+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 678777743 2356999999999999999999999987 99999999999999999999999999987754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=216.40 Aligned_cols=153 Identities=24% Similarity=0.399 Sum_probs=132.5
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|.+.++||+|+||.||++.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5688899999999999999996 468899999987653 34567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE---CCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~~~ 498 (513)
+++|+|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999888532 12356999999999999999999999987 9999999999999 556789999999998775
Q ss_pred CC
Q 010329 499 VD 500 (513)
Q Consensus 499 ~~ 500 (513)
..
T Consensus 179 ~~ 180 (285)
T 3is5_A 179 SD 180 (285)
T ss_dssp --
T ss_pred Cc
Confidence 43
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=214.06 Aligned_cols=150 Identities=27% Similarity=0.483 Sum_probs=135.4
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.+.|...+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35688899999999999999985 468899999987543 3456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
|+++++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999983 356999999999999999999999987 999999999999999999999999999887544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-25 Score=218.08 Aligned_cols=142 Identities=29% Similarity=0.383 Sum_probs=125.5
Q ss_pred ccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEEecCCCCC
Q 010329 350 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKS 427 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey~~~gs 427 (513)
.+.||+|+||.||++... +++.||||.+... ....+.+|+.++..++ ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 6889999998653 3467889999999997 9999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC---CeEEeeccCccccCCC
Q 010329 428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMARIFGVD 500 (513)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DfGla~~~~~~ 500 (513)
|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....+
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999953 456999999999999999999999987 99999999999997665 8999999999977544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-25 Score=224.86 Aligned_cols=149 Identities=31% Similarity=0.547 Sum_probs=123.5
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCC--ee
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGE--EK 416 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~--~~ 416 (513)
..++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++..+. |+||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999985 46899999998653 3334567889999999997 999999999998654 68
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 689888843 46899999999999999999999987 99999999999999999999999999997
Q ss_pred cCC
Q 010329 497 FGV 499 (513)
Q Consensus 497 ~~~ 499 (513)
+..
T Consensus 159 ~~~ 161 (388)
T 3oz6_A 159 FVN 161 (388)
T ss_dssp SSS
T ss_pred ccc
Confidence 743
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-25 Score=214.07 Aligned_cols=155 Identities=28% Similarity=0.379 Sum_probs=134.1
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|.+.+.||+|+||.||++... +++.||||.++... .....++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457888999999999999999965 78999999987642 23456788999999999 899999999999999999999
Q ss_pred EecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC----------------
Q 010329 420 YEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---------------- 482 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~---------------- 482 (513)
|||+++++|.+++.... ....+++..+..|+.||+.||.|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999995321 1256899999999999999999999987 999999999999984
Q ss_pred ---CCCeEEeeccCccccCCCC
Q 010329 483 ---EMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 483 ---~~~~ki~DfGla~~~~~~~ 501 (513)
...+||+|||+++......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~ 188 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ 188 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC
T ss_pred cCCceEEEEcccccccccCCcc
Confidence 4479999999999876543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=215.45 Aligned_cols=147 Identities=33% Similarity=0.522 Sum_probs=130.7
Q ss_pred CCcccccCccCceeEEEEEeC-----CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--CeeEE
Q 010329 347 FSTDNKLGEGGFGEVYKGVLP-----SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL 418 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~~-----~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l 418 (513)
|++.++||+|+||.||++.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998642 57889999998653 23456799999999999999999999999884 57899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999943 34999999999999999999999987 9999999999999999999999999999886
Q ss_pred CC
Q 010329 499 VD 500 (513)
Q Consensus 499 ~~ 500 (513)
..
T Consensus 186 ~~ 187 (318)
T 3lxp_A 186 EG 187 (318)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.5e-25 Score=221.18 Aligned_cols=155 Identities=24% Similarity=0.401 Sum_probs=136.8
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--------cCHHHHHHHHHHHHhC-CCCCccceeeE
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--------QGAQEFKNEVVLVAKL-QHRNLVRLLGF 409 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--------~~~~~~~~E~~~l~~l-~H~nIv~l~g~ 409 (513)
.....++|...+.||+|+||.||++... +|+.||||.+..... ...+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445577999999999999999999975 689999999875431 1135678999999999 79999999999
Q ss_pred EEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEe
Q 010329 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (513)
Q Consensus 410 ~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 489 (513)
+...+..++||||+++++|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999853 356999999999999999999999987 9999999999999999999999
Q ss_pred eccCccccCCC
Q 010329 490 DFGMARIFGVD 500 (513)
Q Consensus 490 DfGla~~~~~~ 500 (513)
|||+++.+...
T Consensus 243 DfG~~~~~~~~ 253 (365)
T 2y7j_A 243 DFGFSCHLEPG 253 (365)
T ss_dssp CCTTCEECCTT
T ss_pred ecCcccccCCC
Confidence 99999987644
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=218.94 Aligned_cols=152 Identities=31% Similarity=0.559 Sum_probs=134.4
Q ss_pred hcCCCcccccCccCceeEEEEEe-----CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC--ee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EK 416 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-----~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~ 416 (513)
.++|.+.+.||+|+||.||++.+ .+++.||||++........+.+.+|+.++++++|+||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688899999999999999984 368899999998766666678999999999999999999999987654 67
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999542 345899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 010329 497 FGVD 500 (513)
Q Consensus 497 ~~~~ 500 (513)
+...
T Consensus 195 ~~~~ 198 (326)
T 2w1i_A 195 LPQD 198 (326)
T ss_dssp CCSS
T ss_pred cccc
Confidence 7654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.7e-25 Score=212.47 Aligned_cols=152 Identities=28% Similarity=0.425 Sum_probs=133.8
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467899999999999999999964 58899999986542 334567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC---eEEeeccCcccc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DfGla~~~ 497 (513)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||+++..
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888843 356899999999999999999999987 999999999999976655 999999999877
Q ss_pred CCCC
Q 010329 498 GVDQ 501 (513)
Q Consensus 498 ~~~~ 501 (513)
....
T Consensus 159 ~~~~ 162 (284)
T 3kk8_A 159 NDSE 162 (284)
T ss_dssp CSSC
T ss_pred ccCc
Confidence 6443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-25 Score=229.74 Aligned_cols=148 Identities=30% Similarity=0.443 Sum_probs=124.7
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC------C
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------E 414 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~ 414 (513)
.++|...+.||+|+||+||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46799999999999999999985 46889999999754 333456789999999999999999999999765 3
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..++||||++++ |.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999865 666662 24899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCC
Q 010329 495 RIFGVD 500 (513)
Q Consensus 495 ~~~~~~ 500 (513)
+.....
T Consensus 212 ~~~~~~ 217 (464)
T 3ttj_A 212 RTAGTS 217 (464)
T ss_dssp -----C
T ss_pred eecCCC
Confidence 987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-25 Score=218.39 Aligned_cols=149 Identities=34% Similarity=0.493 Sum_probs=129.6
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|+..+.||+|+||.||++... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56888999999999999999964 588999999865432 234568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999888743 446999999999999999999999987 99999999999999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-25 Score=236.95 Aligned_cols=150 Identities=31% Similarity=0.563 Sum_probs=129.7
Q ss_pred cCCCccc-ccCccCceeEEEEEeC---CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDN-KLGEGGFGEVYKGVLP---SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~-~Lg~G~fG~Vy~~~~~---~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
+++.+.+ +||+|+||.||+|.+. ++..||||.++... ....++|.+|+.+|++++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999863 45679999998653 3456889999999999999999999999976 568999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++|+|.+++.. ....+++..+..|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+++.+..
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999954 3456999999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
+
T Consensus 489 ~ 489 (613)
T 2ozo_A 489 D 489 (613)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=7.8e-25 Score=218.14 Aligned_cols=154 Identities=26% Similarity=0.414 Sum_probs=128.6
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhC--CCCCccceeeEEEeC----
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL--QHRNLVRLLGFCLEG---- 413 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~g~~~~~---- 413 (513)
.....++|++.+.||+|+||.||+|... ++.||||.+.... ...+.+|.+++..+ +|+||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445578999999999999999999984 8999999986532 24455566665554 899999999999987
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-----CCCeeecCCcCCcEEECCCCCeEE
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS-----RLRIIHRDLKASNILLDAEMNPKI 488 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrdlk~~Nill~~~~~~ki 488 (513)
...++||||+++|+|.+++.. ..+++..+..++.|++.||.|||++. +.+|+||||||+|||++.++.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 678999999999999999943 36899999999999999999999871 123999999999999999999999
Q ss_pred eeccCccccCCCC
Q 010329 489 SDFGMARIFGVDQ 501 (513)
Q Consensus 489 ~DfGla~~~~~~~ 501 (513)
+|||+++.+....
T Consensus 184 ~Dfg~a~~~~~~~ 196 (337)
T 3mdy_A 184 ADLGLAVKFISDT 196 (337)
T ss_dssp CCCTTCEECC---
T ss_pred EeCCCceeecccc
Confidence 9999998775443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-25 Score=216.42 Aligned_cols=151 Identities=23% Similarity=0.314 Sum_probs=130.4
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|.+.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999964 688999999876432 2246789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999953 356999999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 187 ~ 187 (309)
T 2h34_A 187 E 187 (309)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-25 Score=217.10 Aligned_cols=154 Identities=29% Similarity=0.394 Sum_probs=133.8
Q ss_pred HHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEe----CCee
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEK 416 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~ 416 (513)
+..++|.+.+.||+|+||.||++.. .+++.||||.+........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3456899999999999999999996 5789999999877666667789999999999999999999999973 3468
Q ss_pred EEEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 417 ILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
++||||+++|+|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 8999999999999988532 13457999999999999999999999987 9999999999999999999999999987
Q ss_pred ccC
Q 010329 496 IFG 498 (513)
Q Consensus 496 ~~~ 498 (513)
...
T Consensus 183 ~~~ 185 (317)
T 2buj_A 183 QAC 185 (317)
T ss_dssp ESC
T ss_pred hcc
Confidence 653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=215.18 Aligned_cols=152 Identities=23% Similarity=0.422 Sum_probs=124.1
Q ss_pred HhcCCCcccccCccCceeEEEEEeCC----CcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~----~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
..++|.+.+.||+|+||.||+|.... +..||+|.++... ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 44678889999999999999998643 4569999987643 33456799999999999999999999997 456789
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999953 2346899999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
...
T Consensus 167 ~~~ 169 (281)
T 1mp8_A 167 EDS 169 (281)
T ss_dssp ---
T ss_pred Ccc
Confidence 543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-24 Score=212.78 Aligned_cols=154 Identities=32% Similarity=0.555 Sum_probs=127.7
Q ss_pred HHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-----ccCHHHHHHHHHHHHhCC---CCCccceeeEEEe
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-----GQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLE 412 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-----~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~ 412 (513)
...++|++.++||+|+||+||+++. .+++.||||.+.... ......+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467899999999999999999995 568899999986432 122356777887777664 9999999999987
Q ss_pred CC-----eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeE
Q 010329 413 GE-----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (513)
Q Consensus 413 ~~-----~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 487 (513)
.. ..++||||++ ++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 65 4789999997 6999998643 2334999999999999999999999987 99999999999999999999
Q ss_pred EeeccCccccCCC
Q 010329 488 ISDFGMARIFGVD 500 (513)
Q Consensus 488 i~DfGla~~~~~~ 500 (513)
|+|||+++.+...
T Consensus 161 l~Dfg~a~~~~~~ 173 (308)
T 3g33_A 161 LADFGLARIYSYQ 173 (308)
T ss_dssp ECSCSCTTTSTTC
T ss_pred EeeCccccccCCC
Confidence 9999999977543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.2e-25 Score=220.51 Aligned_cols=159 Identities=23% Similarity=0.336 Sum_probs=133.6
Q ss_pred cchHHHHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCcc-----------CHHHHHHHHHHHHhCCCCCc
Q 010329 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ-----------GAQEFKNEVVLVAKLQHRNL 403 (513)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~nI 403 (513)
....++....++|.+.+.||+|+||.||++...+++.||||++...... ..+.+.+|+.++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3456677888999999999999999999999888999999998653221 13789999999999999999
Q ss_pred cceeeEEEeC-----CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcE
Q 010329 404 VRLLGFCLEG-----EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (513)
Q Consensus 404 v~l~g~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Ni 478 (513)
+++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 9999999653 35799999998 688888753 3446999999999999999999999987 99999999999
Q ss_pred EECCCCCeEEeeccCccccCC
Q 010329 479 LLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 479 ll~~~~~~ki~DfGla~~~~~ 499 (513)
|++.++.+||+|||+++....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTA 186 (362)
T ss_dssp EECTTCCEEECCTTC------
T ss_pred EEcCCCCEEEEecCccccccc
Confidence 999999999999999986543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-25 Score=219.01 Aligned_cols=152 Identities=30% Similarity=0.584 Sum_probs=126.3
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCc----EEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~----~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
.++|+..+.||+|+||.||+|... +++ +|++|.+... .....+.+.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367889999999999999999953 344 4688877644 3445688999999999999999999999998754 78
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+|+||+++|+|.+++.. ....+++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999854 2346999999999999999999999987 999999999999999999999999999987
Q ss_pred CCCC
Q 010329 498 GVDQ 501 (513)
Q Consensus 498 ~~~~ 501 (513)
....
T Consensus 168 ~~~~ 171 (327)
T 3lzb_A 168 GAEE 171 (327)
T ss_dssp ----
T ss_pred cCcc
Confidence 5543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=211.64 Aligned_cols=150 Identities=27% Similarity=0.417 Sum_probs=133.2
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc------cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
++|.+.+.||+|+||.||++... +++.||+|.++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999975 689999999875421 23678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC----CeEEeeccC
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFGM 493 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DfGl 493 (513)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999943 456899999999999999999999987 99999999999998877 899999999
Q ss_pred ccccCCC
Q 010329 494 ARIFGVD 500 (513)
Q Consensus 494 a~~~~~~ 500 (513)
++.+...
T Consensus 159 ~~~~~~~ 165 (283)
T 3bhy_A 159 AHKIEAG 165 (283)
T ss_dssp CEECC--
T ss_pred ceeccCC
Confidence 9977543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-25 Score=213.73 Aligned_cols=150 Identities=29% Similarity=0.444 Sum_probs=132.0
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 357888999999999999999864 56789999986532 23356789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999843 356899999999999999999999987 99999999999999999999999999976543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=7.2e-25 Score=219.66 Aligned_cols=152 Identities=30% Similarity=0.456 Sum_probs=127.1
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCccceeeEEEeCCee
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQ-----GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 416 (513)
..++|...+.||+|+||.||++... +++.||||.+...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4568999999999999999999964 5899999998753221 124688999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+++ +|..++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999985 88888843 3346889999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 010329 497 FGVD 500 (513)
Q Consensus 497 ~~~~ 500 (513)
+...
T Consensus 162 ~~~~ 165 (346)
T 1ua2_A 162 FGSP 165 (346)
T ss_dssp TTSC
T ss_pred ccCC
Confidence 7543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.4e-25 Score=211.65 Aligned_cols=151 Identities=28% Similarity=0.485 Sum_probs=135.2
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|.+.+.||+|+||.||++... +++.||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367889999999999999999975 6899999998653 223457899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999843 346899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 164 ~ 164 (276)
T 2h6d_A 164 G 164 (276)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=210.77 Aligned_cols=151 Identities=35% Similarity=0.602 Sum_probs=129.5
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccC-------HHHHHHHHHHHHhCCCCCccceeeEEEeCCe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQG-------AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 415 (513)
.++|...+.||+|+||.||++.. .+++.||+|.+....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46788899999999999999996 478899999986543221 267899999999999999999999986554
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC-----eEEee
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-----PKISD 490 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~-----~ki~D 490 (513)
++||||+++|+|.+++.+ ....+++..+..++.|++.||.|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999888854 3456999999999999999999999875 34999999999999988776 99999
Q ss_pred ccCccccCC
Q 010329 491 FGMARIFGV 499 (513)
Q Consensus 491 fGla~~~~~ 499 (513)
||+++....
T Consensus 173 fg~~~~~~~ 181 (287)
T 4f0f_A 173 FGLSQQSVH 181 (287)
T ss_dssp CTTCBCCSS
T ss_pred CCccccccc
Confidence 999986543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-25 Score=220.12 Aligned_cols=151 Identities=25% Similarity=0.367 Sum_probs=134.7
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccC-----------------HHHHHHHHHHHHhCCCCCccce
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQG-----------------AQEFKNEVVLVAKLQHRNLVRL 406 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l 406 (513)
.++|.+.+.||+|+||.||++.. +++.||||.+....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46789999999999999999999 89999999987542211 1789999999999999999999
Q ss_pred eeEEEeCCeeEEEEecCCCCChhhh------hcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeecCCcCCcEE
Q 010329 407 LGFCLEGEEKILVYEFVPNKSLDYF------LYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNIL 479 (513)
Q Consensus 407 ~g~~~~~~~~~lv~ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrdlk~~Nil 479 (513)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 532 225679999999999999999999998 76 999999999999
Q ss_pred ECCCCCeEEeeccCccccCC
Q 010329 480 LDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 480 l~~~~~~ki~DfGla~~~~~ 499 (513)
++.++.+||+|||+++....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~ 204 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVD 204 (348)
T ss_dssp ECTTSCEEECCCTTCEECBT
T ss_pred EcCCCcEEEecccccccccc
Confidence 99999999999999998654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=228.82 Aligned_cols=151 Identities=32% Similarity=0.467 Sum_probs=131.3
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-------------cCHHHHHHHHHHHHhCCCCCccceeeE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-------------QGAQEFKNEVVLVAKLQHRNLVRLLGF 409 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~g~ 409 (513)
.++|.+.++||+|+||+||++... +++.||||.+..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467889999999999999999964 578999999875321 235678999999999999999999999
Q ss_pred EEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC---Ce
Q 010329 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NP 486 (513)
Q Consensus 410 ~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ 486 (513)
+.++...++||||+++|+|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999988843 456999999999999999999999987 99999999999998775 69
Q ss_pred EEeeccCccccCCC
Q 010329 487 KISDFGMARIFGVD 500 (513)
Q Consensus 487 ki~DfGla~~~~~~ 500 (513)
||+|||+++.+..+
T Consensus 189 kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD 202 (504)
T ss_dssp EECCCTTCEECCTT
T ss_pred EEEECCCCEEcCCC
Confidence 99999999987654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=215.43 Aligned_cols=150 Identities=27% Similarity=0.463 Sum_probs=132.3
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
..++|++.+.||+|+||.||++... +++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467889999999999999999975 588999999987766677899999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 9999999998853 2346899999999999999999999987 999999999999999999999999998643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.7e-25 Score=212.66 Aligned_cols=150 Identities=29% Similarity=0.473 Sum_probs=131.8
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEe---------
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--------- 412 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--------- 412 (513)
..++|+..+.||+|+||.||++... +++.||+|.+.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457888999999999999999975 78999999997654 356789999999999999999998864
Q ss_pred -------CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC
Q 010329 413 -------GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485 (513)
Q Consensus 413 -------~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~ 485 (513)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34578999999999999999542 2356999999999999999999999987 999999999999999999
Q ss_pred eEEeeccCccccCCC
Q 010329 486 PKISDFGMARIFGVD 500 (513)
Q Consensus 486 ~ki~DfGla~~~~~~ 500 (513)
+||+|||+++.+...
T Consensus 161 ~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 161 VKIGDFGLVTSLKND 175 (284)
T ss_dssp EEECCCTTCEESSCC
T ss_pred EEECcchhheecccc
Confidence 999999999987654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=7.8e-25 Score=214.42 Aligned_cols=151 Identities=28% Similarity=0.457 Sum_probs=130.0
Q ss_pred cCCCcccccCccCceeEEEEEeCC----CcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEe-CCeeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~----~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~l 418 (513)
.+|.+.+.||+|+||.||+|...+ ...|++|.+.... ....+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 467888999999999999998632 2358999987643 3345779999999999999999999999765 457899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999954 3456899999999999999999999987 9999999999999999999999999999775
Q ss_pred CC
Q 010329 499 VD 500 (513)
Q Consensus 499 ~~ 500 (513)
..
T Consensus 180 ~~ 181 (298)
T 3f66_A 180 DK 181 (298)
T ss_dssp CG
T ss_pred cc
Confidence 43
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-25 Score=218.95 Aligned_cols=152 Identities=33% Similarity=0.592 Sum_probs=128.7
Q ss_pred hcCCCcccccCccCceeEEEEEeCC-----CcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPS-----GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~-----~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
.++|...+.||+|+||.||+|.... +..||||.++... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4567788999999999999998642 2359999997643 234567899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+||||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999953 2356999999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
...
T Consensus 198 ~~~ 200 (333)
T 1mqb_A 198 EDD 200 (333)
T ss_dssp ---
T ss_pred ccc
Confidence 544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.92 E-value=9e-25 Score=220.04 Aligned_cols=161 Identities=25% Similarity=0.309 Sum_probs=138.9
Q ss_pred cccchHHHHHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-----CCCccce
Q 010329 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-----HRNLVRL 406 (513)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l 406 (513)
..+.+.......++|.+.++||+|+||.||+++. .+++.||||.++... ...+.+..|+.+++.++ |+||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3445555566778999999999999999999996 568899999987432 33466788999999997 9999999
Q ss_pred eeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC----
Q 010329 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---- 482 (513)
Q Consensus 407 ~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~---- 482 (513)
++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 99999999999999999 89999998542 3345999999999999999999999987 999999999999976
Q ss_pred ---------------------CCCeEEeeccCccccCC
Q 010329 483 ---------------------EMNPKISDFGMARIFGV 499 (513)
Q Consensus 483 ---------------------~~~~ki~DfGla~~~~~ 499 (513)
++.+||+|||+++....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 78999999999997654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=211.31 Aligned_cols=150 Identities=32% Similarity=0.577 Sum_probs=131.1
Q ss_pred cCCCccc-ccCccCceeEEEEEeC---CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDN-KLGEGGFGEVYKGVLP---SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~-~Lg~G~fG~Vy~~~~~---~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
++|.+.+ .||+|+||.||+|... ++..||||.++... ....+.+.+|+.+++.++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 8999999999999853 57789999998653 33457899999999999999999999999 55678999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999953 3456999999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 163 ~ 163 (287)
T 1u59_A 163 D 163 (287)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=213.55 Aligned_cols=151 Identities=26% Similarity=0.413 Sum_probs=128.9
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC----ccCHHHHHHHHHHHHhCCCCCccceeeEEE--eCCee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCL--EGEEK 416 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~ 416 (513)
.++|.+.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36899999999999999999996 467899999987542 234578999999999999999999999985 34578
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||++++ |.+++.. .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 6666643 23456999999999999999999999987 99999999999999999999999999998
Q ss_pred cCC
Q 010329 497 FGV 499 (513)
Q Consensus 497 ~~~ 499 (513)
...
T Consensus 159 ~~~ 161 (305)
T 2wtk_C 159 LHP 161 (305)
T ss_dssp CCT
T ss_pred cCc
Confidence 754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.2e-25 Score=229.53 Aligned_cols=151 Identities=28% Similarity=0.433 Sum_probs=129.2
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.++|...+.||+|+||+||++... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346888999999999999999964 68899999987542 334578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC---CCeEEeeccCcccc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~DfGla~~~ 497 (513)
||+++|+|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.+
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999888843 356899999999999999999999987 9999999999999764 45999999999987
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
...
T Consensus 190 ~~~ 192 (494)
T 3lij_A 190 ENQ 192 (494)
T ss_dssp BTT
T ss_pred CCC
Confidence 644
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=212.88 Aligned_cols=149 Identities=31% Similarity=0.440 Sum_probs=129.2
Q ss_pred CCCcccccCccCceeEEEEEeC-CC---cEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCee-EEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP-SG---QEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK-ILV 419 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~-~~---~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~-~lv 419 (513)
.|...++||+|+||.||+|... ++ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3556689999999999999853 22 3799999876433 3457899999999999999999999999877665 999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+.+|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999964 3456899999999999999999999987 99999999999999999999999999987643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=216.21 Aligned_cols=154 Identities=26% Similarity=0.378 Sum_probs=134.7
Q ss_pred hHHHHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHh--CCCCCccceeeEEEeCC
Q 010329 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAK--LQHRNLVRLLGFCLEGE 414 (513)
Q Consensus 337 ~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~ 414 (513)
....+...++|.+.+.||+|+||.||++.. +++.||||.+... ..+.+.+|.+++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 334455667899999999999999999998 5899999998653 34677889998887 78999999999998876
Q ss_pred ----eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhH--------cCCCCCeeecCCcCCcEEECC
Q 010329 415 ----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH--------EDSRLRIIHRDLKASNILLDA 482 (513)
Q Consensus 415 ----~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrdlk~~Nill~~ 482 (513)
..++||||+++|+|.+++.+ ..+++..+..++.||+.||.||| +.+ |+||||||+|||++.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 78999999999999999943 46899999999999999999999 555 999999999999999
Q ss_pred CCCeEEeeccCccccCCCC
Q 010329 483 EMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 483 ~~~~ki~DfGla~~~~~~~ 501 (513)
++.+||+|||+++......
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSAT 201 (342)
T ss_dssp TSCEEECCCTTCEEEETTT
T ss_pred CCCEEEEECCCceeccccc
Confidence 9999999999998876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=217.60 Aligned_cols=158 Identities=25% Similarity=0.421 Sum_probs=121.4
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
+....++|.+.+.||+|+||.||++.. .+++.||||.+.... ....+++.+|+.++++++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 345567899999999999999999985 468899999886543 334567889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeecc
Q 010329 418 LVYEFVPNKSLDYFLYD-----PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG 492 (513)
+||||+++++|.+++.. ......+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999852 123456999999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCC
Q 010329 493 MARIFGVD 500 (513)
Q Consensus 493 la~~~~~~ 500 (513)
+++.+...
T Consensus 167 ~~~~~~~~ 174 (303)
T 2vwi_A 167 VSAFLATG 174 (303)
T ss_dssp HHHHCC--
T ss_pred chheeccC
Confidence 99877543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.6e-25 Score=222.05 Aligned_cols=152 Identities=21% Similarity=0.316 Sum_probs=126.3
Q ss_pred HhcCCCcccccCccCceeEEEEEeCC------CcEEEEEEecccCccC-----------HHHHHHHHHHHHhCCCCCccc
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSASSGQG-----------AQEFKNEVVLVAKLQHRNLVR 405 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~------~~~VavK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~ 405 (513)
..++|.+.+.||+|+||.||+|.+.. ++.||||.+....... ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 44678999999999999999998754 4689999987653211 122345666777889999999
Q ss_pred eeeEEEeC----CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC
Q 010329 406 LLGFCLEG----EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481 (513)
Q Consensus 406 l~g~~~~~----~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~ 481 (513)
+++++... ...++||||+ +++|.+++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4479999999 9999999954 2356999999999999999999999987 99999999999998
Q ss_pred --CCCCeEEeeccCccccCCC
Q 010329 482 --AEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 482 --~~~~~ki~DfGla~~~~~~ 500 (513)
.++.+||+|||+++.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGG
T ss_pred cCCCCeEEEEECCcceecccC
Confidence 8899999999999987644
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-25 Score=216.15 Aligned_cols=150 Identities=29% Similarity=0.442 Sum_probs=125.7
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
++|.+.+.||+|+||.||++.. .++.||||.+... ...+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5678889999999999999998 4788999998653 34578999999999999999999999876 45899999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC-eEEeeccCccccCC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-PKISDFGMARIFGV 499 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~-~ki~DfGla~~~~~ 499 (513)
+|+|.+++........+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||+++....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999976544446889999999999999999999943234999999999999988886 79999999987643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-25 Score=219.68 Aligned_cols=152 Identities=29% Similarity=0.507 Sum_probs=127.2
Q ss_pred HHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
...++|.+.++||+|+||+||++.. .+++.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3446799999999999999999985 4688999999875432 224567899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE-----CCCCCeEEeeccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DAEMNPKISDFGM 493 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill-----~~~~~~ki~DfGl 493 (513)
||||++ |+|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||+|||+ ++++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999998 599998843 346999999999999999999999987 9999999999999 4556699999999
Q ss_pred ccccCCC
Q 010329 494 ARIFGVD 500 (513)
Q Consensus 494 a~~~~~~ 500 (513)
++.+...
T Consensus 184 a~~~~~~ 190 (329)
T 3gbz_A 184 ARAFGIP 190 (329)
T ss_dssp HHHHC--
T ss_pred ccccCCc
Confidence 9987543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-25 Score=218.49 Aligned_cols=154 Identities=34% Similarity=0.552 Sum_probs=130.5
Q ss_pred HhcCCCcccccCccCceeEEEEEe------CCCcEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~------~~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 415 (513)
..++|.+.+.||+|+||.||+|.+ .+++.||||.+... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 456889999999999999999984 24678999999754 33445678999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC---CCCeEE
Q 010329 416 KILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKI 488 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki 488 (513)
.++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999996432 1245899999999999999999999987 999999999999984 456999
Q ss_pred eeccCccccCC
Q 010329 489 SDFGMARIFGV 499 (513)
Q Consensus 489 ~DfGla~~~~~ 499 (513)
+|||+++....
T Consensus 185 ~Dfg~~~~~~~ 195 (327)
T 2yfx_A 185 GDFGMARDIYR 195 (327)
T ss_dssp CCCHHHHHHHC
T ss_pred Ccccccccccc
Confidence 99999986643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=216.65 Aligned_cols=149 Identities=30% Similarity=0.546 Sum_probs=129.5
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeC--------
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-------- 413 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-------- 413 (513)
++|.+.+.||+|+||.||+++. .+++.||||++..... .....+.+|+.+++.++|+||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788999999999999999996 5789999999865432 2346788999999999999999999999874
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
+..++||||+++ +|.+.+.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999985 67666643 2346999999999999999999999987 99999999999999999999999999
Q ss_pred ccccCC
Q 010329 494 ARIFGV 499 (513)
Q Consensus 494 a~~~~~ 499 (513)
++.+..
T Consensus 171 a~~~~~ 176 (351)
T 3mi9_A 171 ARAFSL 176 (351)
T ss_dssp CEECCC
T ss_pred cccccc
Confidence 998753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=212.08 Aligned_cols=152 Identities=28% Similarity=0.382 Sum_probs=134.5
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc---------cCHHHHHHHHHHHHhCC-CCCccceeeEEE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG---------QGAQEFKNEVVLVAKLQ-HRNLVRLLGFCL 411 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~---------~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~ 411 (513)
..++|...+.||+|+||.||++... +++.||||.+..... ...+.+.+|+.++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3467889999999999999999964 678999999865421 22356889999999996 999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeec
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df 491 (513)
..+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999943 356899999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCC
Q 010329 492 GMARIFGVD 500 (513)
Q Consensus 492 Gla~~~~~~ 500 (513)
|+++.+...
T Consensus 169 g~~~~~~~~ 177 (298)
T 1phk_A 169 GFSCQLDPG 177 (298)
T ss_dssp TTCEECCTT
T ss_pred cchhhcCCC
Confidence 999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=216.75 Aligned_cols=148 Identities=25% Similarity=0.392 Sum_probs=128.1
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.++|.+.+.||+|+||.||++... +++.||||.+...... ..+|++++.++ +||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 457889999999999999999964 5889999999765432 35688888887 79999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC----CCeEEeeccCcccc
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----MNPKISDFGMARIF 497 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~----~~~ki~DfGla~~~ 497 (513)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+..+ +.+||+|||+++.+
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999853 456999999999999999999999987 9999999999998433 35999999999987
Q ss_pred CCCC
Q 010329 498 GVDQ 501 (513)
Q Consensus 498 ~~~~ 501 (513)
....
T Consensus 171 ~~~~ 174 (342)
T 2qr7_A 171 RAEN 174 (342)
T ss_dssp BCTT
T ss_pred cCCC
Confidence 6443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.9e-25 Score=214.45 Aligned_cols=149 Identities=27% Similarity=0.426 Sum_probs=131.1
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.++|.+.+.||+|+||.||++... +++.||+|.++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457888999999999999999964 6899999999866544556789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE---CCCCCeEEeeccCccccC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFG 498 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~~~ 498 (513)
+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999998843 346899999999999999999999987 9999999999999 788999999999998654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-25 Score=222.88 Aligned_cols=149 Identities=28% Similarity=0.482 Sum_probs=122.4
Q ss_pred CCCcccccCccCceeEEEEEeC--CC--cEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC-CeeEEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVLP--SG--QEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-EEKILV 419 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~~--~~--~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lv 419 (513)
.|...+.||+|+||.||+|.+. ++ ..||||.++... ....+.|.+|+.++++++||||+++++++.+. +..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4566789999999999999863 22 368999987543 34457899999999999999999999998654 578999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++|+|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999954 3446899999999999999999999987 99999999999999999999999999997744
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.6e-25 Score=218.97 Aligned_cols=157 Identities=31% Similarity=0.421 Sum_probs=135.1
Q ss_pred HHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CCCccceeeEEEe-------
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLE------- 412 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~------- 412 (513)
....+|.+.++||+|+||.||++.. .+++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3445788999999999999999995 468899999997766666678999999999996 9999999999953
Q ss_pred -CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeec
Q 010329 413 -GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (513)
Q Consensus 413 -~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df 491 (513)
....+++|||++ |+|.+++........+++..+..|+.||+.||.|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 334789999996 789888854344567999999999999999999999874 35999999999999999999999999
Q ss_pred cCccccCCC
Q 010329 492 GMARIFGVD 500 (513)
Q Consensus 492 Gla~~~~~~ 500 (513)
|+++.+...
T Consensus 183 g~~~~~~~~ 191 (337)
T 3ll6_A 183 GSATTISHY 191 (337)
T ss_dssp TTCBCCSSC
T ss_pred ccceecccc
Confidence 999987643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=213.98 Aligned_cols=153 Identities=22% Similarity=0.431 Sum_probs=126.4
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688889999999999999995 57899999998753 2334567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999998532 12456899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 189 ~ 189 (310)
T 2wqm_A 189 K 189 (310)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=210.82 Aligned_cols=150 Identities=22% Similarity=0.347 Sum_probs=132.4
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.++|.+.+.||+|+||.||+|.. .+++.||||.+.... ..+.+.+|+.++..+ +|+|++++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46789999999999999999995 578999999986543 234688899999999 79999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC-----eEEeeccCccc
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-----PKISDFGMARI 496 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~-----~ki~DfGla~~ 496 (513)
|+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999532 346999999999999999999999987 999999999999987776 99999999998
Q ss_pred cCCCC
Q 010329 497 FGVDQ 501 (513)
Q Consensus 497 ~~~~~ 501 (513)
+....
T Consensus 161 ~~~~~ 165 (298)
T 1csn_A 161 YRDPV 165 (298)
T ss_dssp SBCTT
T ss_pred ccccc
Confidence 86543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=228.72 Aligned_cols=151 Identities=30% Similarity=0.468 Sum_probs=133.8
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.++|.+.+.||+|+||+||++... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457889999999999999999964 6889999998643 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC---CCCCeEEeeccCcccc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DfGla~~~ 497 (513)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+
T Consensus 101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999988843 356999999999999999999999987 99999999999995 5567999999999977
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
...
T Consensus 175 ~~~ 177 (486)
T 3mwu_A 175 QQN 177 (486)
T ss_dssp CCC
T ss_pred CCC
Confidence 544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.3e-25 Score=214.43 Aligned_cols=152 Identities=30% Similarity=0.520 Sum_probs=130.4
Q ss_pred HhcCCCccc-ccCccCceeEEEEEe---CCCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCee
Q 010329 343 ATNKFSTDN-KLGEGGFGEVYKGVL---PSGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 343 ~~~~~~~~~-~Lg~G~fG~Vy~~~~---~~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 416 (513)
..++|.+.+ .||+|+||.||+|.+ ..++.||||.++.... ...+++.+|+.+++.++||||+++++++ +.+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345677777 999999999999964 3467899999876532 2357899999999999999999999999 66778
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999999953 346999999999999999999999987 99999999999999999999999999998
Q ss_pred cCCCC
Q 010329 497 FGVDQ 501 (513)
Q Consensus 497 ~~~~~ 501 (513)
+....
T Consensus 167 ~~~~~ 171 (291)
T 1xbb_A 167 LRADE 171 (291)
T ss_dssp CCTTC
T ss_pred eccCC
Confidence 75543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=211.16 Aligned_cols=149 Identities=28% Similarity=0.460 Sum_probs=133.0
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999964 5778999998653 2233567999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999843 346899999999999999999999987 99999999999999999999999999987653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.9e-25 Score=236.58 Aligned_cols=144 Identities=31% Similarity=0.520 Sum_probs=126.1
Q ss_pred cccCccCceeEEEEEeC---CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLP---SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~---~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999652 45789999997643 2345789999999999999999999999864 568899999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
|+|.+++. ....+++..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..+.
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 99999994 3456999999999999999999999987 9999999999999999999999999999886543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=221.44 Aligned_cols=145 Identities=25% Similarity=0.318 Sum_probs=122.7
Q ss_pred CCCcc-cccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHH-HhCCCCCccceeeEEEe----CCeeEE
Q 010329 346 KFSTD-NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLV-AKLQHRNLVRLLGFCLE----GEEKIL 418 (513)
Q Consensus 346 ~~~~~-~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~----~~~~~l 418 (513)
+|... +.||+|+||+||++... +++.||||+++.. ..+.+|+.++ +..+|+||+++++++.. ....++
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 45554 68999999999999964 6889999998632 4577888887 45589999999999876 556899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC---CCCeEEeeccCcc
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMAR 495 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DfGla~ 495 (513)
||||+++|+|.+++.+. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 137 v~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 99999999999999652 2346999999999999999999999987 999999999999987 7899999999999
Q ss_pred ccCC
Q 010329 496 IFGV 499 (513)
Q Consensus 496 ~~~~ 499 (513)
....
T Consensus 213 ~~~~ 216 (400)
T 1nxk_A 213 ETTS 216 (400)
T ss_dssp ECC-
T ss_pred ccCC
Confidence 7653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=212.43 Aligned_cols=152 Identities=30% Similarity=0.471 Sum_probs=130.4
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
...++|...+.||+|+||.||+|... +++.||+|.+.... ..+++.+|+.++..++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 35578999999999999999999964 58999999987643 3467899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++++|.+++.. ....+++..+..++.+|+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999842 2456899999999999999999999987 999999999999999999999999999877543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=8.2e-25 Score=220.38 Aligned_cols=149 Identities=26% Similarity=0.357 Sum_probs=133.8
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467889999999999999999964 6889999998765 33345679999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|+++++|.+++.. ...+++..+..++.+++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+.
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999943 34689999999999999999999985 5 9999999999999999999999999998663
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=219.72 Aligned_cols=148 Identities=28% Similarity=0.456 Sum_probs=124.3
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC------
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 414 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------ 414 (513)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35788899999999999999996 46899999998653 2233467899999999999999999999998763
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899999843 46899999999999999999999987 999999999999999999999999999
Q ss_pred cccCC
Q 010329 495 RIFGV 499 (513)
Q Consensus 495 ~~~~~ 499 (513)
+....
T Consensus 176 ~~~~~ 180 (367)
T 1cm8_A 176 RQADS 180 (367)
T ss_dssp EECCS
T ss_pred ccccc
Confidence 98754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=208.84 Aligned_cols=152 Identities=26% Similarity=0.384 Sum_probs=132.9
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--CeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv 419 (513)
.++|...+.||+|+||.||+|+. +++.||||.++... ....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35788899999999999999998 48899999987643 33456799999999999999999999999887 678999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
|||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ .+|+||||||+|||++.++.+||.|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999652 3336899999999999999999999864 359999999999999999999999999887654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=213.40 Aligned_cols=148 Identities=28% Similarity=0.487 Sum_probs=125.1
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEE-----------
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL----------- 411 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~----------- 411 (513)
.++|...+.||+|+||.||++... +++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367889999999999999999975 48899999998766666788999999999999999999999873
Q ss_pred ---eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC-CCCCeE
Q 010329 412 ---EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPK 487 (513)
Q Consensus 412 ---~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~-~~~~~k 487 (513)
+....++||||++ |+|.+++. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 69999983 356899999999999999999999987 99999999999997 567999
Q ss_pred EeeccCccccCC
Q 010329 488 ISDFGMARIFGV 499 (513)
Q Consensus 488 i~DfGla~~~~~ 499 (513)
|+|||+++....
T Consensus 162 l~Dfg~~~~~~~ 173 (320)
T 2i6l_A 162 IGDFGLARIMDP 173 (320)
T ss_dssp ECCCTTCBCC--
T ss_pred EccCccccccCC
Confidence 999999998753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=214.41 Aligned_cols=150 Identities=33% Similarity=0.559 Sum_probs=129.9
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcE--EEEEEeccc-CccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQE--IAVKRLSAS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~--VavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv 419 (513)
++|.+.+.||+|+||.||++... ++.. |++|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999964 4554 499988753 333456789999999999 899999999999999999999
Q ss_pred EecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCe
Q 010329 420 YEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 486 (513)
|||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 2346999999999999999999999987 9999999999999999999
Q ss_pred EEeeccCcccc
Q 010329 487 KISDFGMARIF 497 (513)
Q Consensus 487 ki~DfGla~~~ 497 (513)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999854
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-25 Score=219.07 Aligned_cols=149 Identities=30% Similarity=0.502 Sum_probs=127.6
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccC-HHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|...+.||+|+||.||++... +++.||||.+....... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999964 68899999987543221 22456799999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 97 588888853 2346899999999999999999999987 99999999999999999999999999987653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=213.57 Aligned_cols=161 Identities=28% Similarity=0.407 Sum_probs=136.9
Q ss_pred chHHHHHHhcCCCcc-cccCccCceeEEEEEeC-CCcEEEEEEeccc--CccCHHHHHHHHHHHHhCC-CCCccceeeEE
Q 010329 336 DFETIEVATNKFSTD-NKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFC 410 (513)
Q Consensus 336 ~~~~~~~~~~~~~~~-~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~ 410 (513)
.+...+...++|.+. +.||+|+||.||++... +++.||+|.++.. .......+.+|+.++..++ ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344455566677776 88999999999999964 5899999998754 2344678999999999995 69999999999
Q ss_pred EeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC---CCCeE
Q 010329 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPK 487 (513)
Q Consensus 411 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~---~~~~k 487 (513)
.+.+..++||||+++|+|.+++.. .....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 999999999999999999999854 23457999999999999999999999987 999999999999988 78999
Q ss_pred EeeccCccccCCC
Q 010329 488 ISDFGMARIFGVD 500 (513)
Q Consensus 488 i~DfGla~~~~~~ 500 (513)
|+|||+++.+...
T Consensus 175 L~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 175 IVDFGMSRKIGHA 187 (327)
T ss_dssp ECCGGGCEEC---
T ss_pred EeeCccccccCCc
Confidence 9999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=213.59 Aligned_cols=150 Identities=27% Similarity=0.405 Sum_probs=127.4
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc--------cCHHHHHHHHHHHHhCCCCCccceeeEEEeC
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG--------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 413 (513)
..++|.+.+.||+|+||.||++... +++.||||.+..... .....+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467899999999999999999964 578999999865321 2234588999999999999999999998765
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC---eEEee
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISD 490 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~D 490 (513)
+ .++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999984 3457999999999999999999999987 999999999999987664 99999
Q ss_pred ccCccccCC
Q 010329 491 FGMARIFGV 499 (513)
Q Consensus 491 fGla~~~~~ 499 (513)
||+++.+..
T Consensus 161 fg~~~~~~~ 169 (322)
T 2ycf_A 161 FGHSKILGE 169 (322)
T ss_dssp CTTCEECCC
T ss_pred Cccceeccc
Confidence 999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=226.48 Aligned_cols=152 Identities=31% Similarity=0.474 Sum_probs=135.4
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
.++|...+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888999999999999999964 78999999986532 34567899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE---CCCCCeEEeeccCccc
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARI 496 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~ 496 (513)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999998853 456999999999999999999999987 9999999999999 5678999999999998
Q ss_pred cCCCC
Q 010329 497 FGVDQ 501 (513)
Q Consensus 497 ~~~~~ 501 (513)
+....
T Consensus 179 ~~~~~ 183 (484)
T 3nyv_A 179 FEASK 183 (484)
T ss_dssp BCCCC
T ss_pred ccccc
Confidence 76443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-24 Score=208.93 Aligned_cols=143 Identities=9% Similarity=0.047 Sum_probs=126.3
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888899999999999999975 488999999976532 23478999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
||+++++|.+++.. + ....+..+|+.||+.||.|||+++ |+||||||+|||++.++.+||+++|...
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence 99999999999932 2 355678899999999999999987 9999999999999999999999877654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-24 Score=212.65 Aligned_cols=145 Identities=24% Similarity=0.437 Sum_probs=129.7
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CCCccceeeEEEe--CCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLE--GEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~lv~ 420 (513)
++|++.+.||+|+||.||++.. .+++.||||.++.. ..+.+.+|+.++++++ |+||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688899999999999999985 57889999998753 3467899999999997 9999999999988 56789999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC-CeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~~ 499 (513)
||+++++|.+++. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.+..
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999883 3889999999999999999999987 99999999999999776 899999999998764
Q ss_pred CC
Q 010329 500 DQ 501 (513)
Q Consensus 500 ~~ 501 (513)
..
T Consensus 184 ~~ 185 (330)
T 3nsz_A 184 GQ 185 (330)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=212.57 Aligned_cols=150 Identities=29% Similarity=0.457 Sum_probs=131.6
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEe----------
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE---------- 412 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~---------- 412 (513)
.++|+..+.||+|+||.||+|.. .+++.||||.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 35688899999999999999996 47899999998653 2345778999999999999999999999875
Q ss_pred ---CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEe
Q 010329 413 ---GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (513)
Q Consensus 413 ---~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 489 (513)
.+..++||||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3467899999999999999954 2345788999999999999999999987 9999999999999999999999
Q ss_pred eccCccccCC
Q 010329 490 DFGMARIFGV 499 (513)
Q Consensus 490 DfGla~~~~~ 499 (513)
|||+++....
T Consensus 159 dfg~~~~~~~ 168 (303)
T 1zy4_A 159 DFGLAKNVHR 168 (303)
T ss_dssp CCCCCSCTTC
T ss_pred eCcchhhccc
Confidence 9999987753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=218.20 Aligned_cols=150 Identities=21% Similarity=0.321 Sum_probs=123.7
Q ss_pred hcCCCcccccCccCceeEEEEEeC----CCcEEEEEEecccCcc-----------CHHHHHHHHHHHHhCCCCCccceee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSASSGQ-----------GAQEFKNEVVLVAKLQHRNLVRLLG 408 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~----~~~~VavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~g 408 (513)
.++|.+.+.||+|+||.||+|... .+..||||.+...... ....+.+|+..+..++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357888999999999999999975 5678999998764321 1234677888999999999999999
Q ss_pred EEEe----CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC
Q 010329 409 FCLE----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (513)
Q Consensus 409 ~~~~----~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~ 484 (513)
++.. ....++||||+ +++|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 9999999953 337999999999999999999999987 99999999999998887
Q ss_pred --CeEEeeccCccccCCC
Q 010329 485 --NPKISDFGMARIFGVD 500 (513)
Q Consensus 485 --~~ki~DfGla~~~~~~ 500 (513)
.+||+|||+++.+..+
T Consensus 189 ~~~~kL~Dfg~a~~~~~~ 206 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPN 206 (345)
T ss_dssp TTSEEECCCTTCEESSGG
T ss_pred CCcEEEEeCCCceecccc
Confidence 9999999999987543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=215.89 Aligned_cols=149 Identities=32% Similarity=0.521 Sum_probs=122.8
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHH--HHhCCCCCccceeeEEEe-----CCee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVL--VAKLQHRNLVRLLGFCLE-----GEEK 416 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~g~~~~-----~~~~ 416 (513)
.++|.+.+.||+|+||.||+|.. +++.||||++.... .+.+..|.++ +..++|+||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788999999999999999987 68999999987543 3444555544 445899999999986643 2256
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC------CCCeeecCCcCCcEEECCCCCeEEee
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS------RLRIIHRDLKASNILLDAEMNPKISD 490 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrdlk~~Nill~~~~~~ki~D 490 (513)
++||||+++|+|.+++.. ...++..+..|+.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 899999999999999943 34589999999999999999999881 11399999999999999999999999
Q ss_pred ccCccccCCC
Q 010329 491 FGMARIFGVD 500 (513)
Q Consensus 491 fGla~~~~~~ 500 (513)
||+++.+...
T Consensus 164 FG~a~~~~~~ 173 (336)
T 3g2f_A 164 FGLSMRLTGN 173 (336)
T ss_dssp CTTCEECSSS
T ss_pred ccceeecccc
Confidence 9999987543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=218.97 Aligned_cols=148 Identities=30% Similarity=0.449 Sum_probs=115.6
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC------C
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------E 414 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~ 414 (513)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36789999999999999999985 56889999998653 223456788999999999999999999998764 4
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..++|+||+ +++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999999 689988883 256999999999999999999999987 999999999999999999999999999
Q ss_pred cccCC
Q 010329 495 RIFGV 499 (513)
Q Consensus 495 ~~~~~ 499 (513)
+....
T Consensus 180 ~~~~~ 184 (367)
T 2fst_X 180 RHTAD 184 (367)
T ss_dssp -----
T ss_pred ccccc
Confidence 97653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=216.19 Aligned_cols=156 Identities=29% Similarity=0.478 Sum_probs=133.9
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEe----
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE---- 412 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~---- 412 (513)
.+....++|.+.+.||+|+||.||+|.. .+++.||||.+.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3344567899999999999999999996 468899999987543 3456889999999999 79999999999987
Q ss_pred --CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEee
Q 010329 413 --GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (513)
Q Consensus 413 --~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D 490 (513)
.+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence 45789999999999999999542 2356899999999999999999999987 99999999999999999999999
Q ss_pred ccCccccCC
Q 010329 491 FGMARIFGV 499 (513)
Q Consensus 491 fGla~~~~~ 499 (513)
||+++.+..
T Consensus 173 fg~~~~~~~ 181 (326)
T 2x7f_A 173 FGVSAQLDR 181 (326)
T ss_dssp CTTTC----
T ss_pred CcCceecCc
Confidence 999987753
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=209.81 Aligned_cols=150 Identities=30% Similarity=0.533 Sum_probs=130.3
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|+..+.||+|+||.||++... +++.||||.++... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57888999999999999999964 68999999987543 2334678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|++ ++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~-~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 998 6999988542 2346899999999999999999999987 99999999999999999999999999987754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=217.25 Aligned_cols=149 Identities=26% Similarity=0.440 Sum_probs=130.6
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC-----Cee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EEK 416 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~ 416 (513)
.++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357899999999999999999854 67889999997543 23346789999999999999999999999765 368
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||++ |+|.+++. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 58988884 246999999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 010329 497 FGVD 500 (513)
Q Consensus 497 ~~~~ 500 (513)
....
T Consensus 178 ~~~~ 181 (364)
T 3qyz_A 178 ADPD 181 (364)
T ss_dssp CCGG
T ss_pred cCCC
Confidence 7644
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=208.96 Aligned_cols=152 Identities=29% Similarity=0.410 Sum_probs=130.6
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEe----CCeeE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKI 417 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~ 417 (513)
+.|.+.+.||+|+||.||+|.. .++..|++|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4477788999999999999986 45788999998754 33445779999999999999999999999875 34589
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC-CCCCeEEeeccCccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARI 496 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~DfGla~~ 496 (513)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||+++.
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999943 356899999999999999999999874 3599999999999997 789999999999986
Q ss_pred cCCC
Q 010329 497 FGVD 500 (513)
Q Consensus 497 ~~~~ 500 (513)
....
T Consensus 182 ~~~~ 185 (290)
T 1t4h_A 182 KRAS 185 (290)
T ss_dssp CCTT
T ss_pred cccc
Confidence 6543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.3e-25 Score=233.10 Aligned_cols=150 Identities=19% Similarity=0.256 Sum_probs=114.4
Q ss_pred ccCccCceeEEEEE-eCCCcEEEEEEecccC----------ccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEE
Q 010329 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSASS----------GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 352 ~Lg~G~fG~Vy~~~-~~~~~~VavK~l~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv 419 (513)
..+.|.+|.+.+++ .--|+.+++|.+.... ....++|.+|+++|+++ .|+||+++++++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34556666555543 2347889999986531 22346799999999999 699999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||++|++|.++|.+ .++++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+.+..
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999953 4567654 48899999999999998 99999999999999999999999999998865
Q ss_pred CCCccccceeeec
Q 010329 500 DQTQGNTSRIVGT 512 (513)
Q Consensus 500 ~~~~~~~~~~~Gt 512 (513)
+... ....+||
T Consensus 392 ~~~~--~~t~vGT 402 (569)
T 4azs_A 392 DCSW--PTNLVQS 402 (569)
T ss_dssp --CC--SHHHHHH
T ss_pred CCcc--ccCceec
Confidence 4432 2235555
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-25 Score=225.33 Aligned_cols=151 Identities=15% Similarity=0.204 Sum_probs=124.1
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHH---HHHHhCCCCCcccee-------eE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEV---VLVAKLQHRNLVRLL-------GF 409 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------g~ 409 (513)
.++|.+.+.||+|+||.||+|+. .+|+.||||.+... .....+.+.+|+ .++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999995 56899999998743 333457889999 556666899999998 66
Q ss_pred EEeCC-----------------eeEEEEecCCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCe
Q 010329 410 CLEGE-----------------EKILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468 (513)
Q Consensus 410 ~~~~~-----------------~~~lv~ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 468 (513)
+.+.+ ..++||||+ +|+|.+++.... ....+++..+..|+.||+.||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 55543 278999999 689999995321 1123456888999999999999999987 9
Q ss_pred eecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 469 IHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 469 vHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
+||||||+||||+.++.+||+|||+++...
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 999999999999999999999999999654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-24 Score=217.86 Aligned_cols=153 Identities=25% Similarity=0.392 Sum_probs=125.7
Q ss_pred HHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC-----
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----- 414 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----- 414 (513)
+...++|...+.||+|+||.||++.. .+++.||||++..... ...+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45667899999999999999999985 5789999999875432 2346999999999999999999985532
Q ss_pred ---------------------------------eeEEEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHh
Q 010329 415 ---------------------------------EKILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYL 460 (513)
Q Consensus 415 ---------------------------------~~~lv~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yL 460 (513)
..++||||++ |+|.+.+... .....+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3789999998 5777766421 2345799999999999999999999
Q ss_pred HcCCCCCeeecCCcCCcEEEC-CCCCeEEeeccCccccCCCC
Q 010329 461 HEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 461 H~~~~~~ivHrdlk~~Nill~-~~~~~ki~DfGla~~~~~~~ 501 (513)
|+.+ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 9987 99999999999997 68899999999999875443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=209.43 Aligned_cols=152 Identities=29% Similarity=0.465 Sum_probs=130.0
Q ss_pred HhcCCCcccccCccCceeEEEEEeCC----CcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~~----~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
..++|.+.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678889999999999999998532 2369999987653 3345789999999999999999999999764 4578
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+||||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999953 2345899999999999999999999987 999999999999999999999999999977
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
...
T Consensus 164 ~~~ 166 (281)
T 3cc6_A 164 EDE 166 (281)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=235.19 Aligned_cols=148 Identities=22% Similarity=0.350 Sum_probs=128.2
Q ss_pred hcCCCcccccCccCceeEEEEEeC--CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe-----
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP--SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE----- 415 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~--~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~----- 415 (513)
.++|.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999974 58899999986543 3345678999999999999999999999987665
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||||+++++|.+++. ..++|.++..|+.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 699999999999988773 26999999999999999999999987 9999999999999886 89999999999
Q ss_pred ccCCC
Q 010329 496 IFGVD 500 (513)
Q Consensus 496 ~~~~~ 500 (513)
.+...
T Consensus 230 ~~~~~ 234 (681)
T 2pzi_A 230 RINSF 234 (681)
T ss_dssp ETTCC
T ss_pred hcccC
Confidence 87543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=220.37 Aligned_cols=151 Identities=25% Similarity=0.381 Sum_probs=125.4
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe------eE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE------KI 417 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~ 417 (513)
..+|...+.||+|+||.||++....+..||+|++...... ..+|+.+++.++|+||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3468889999999999999999877778999988654322 2369999999999999999999976443 78
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC-CCCCeEEeeccCccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARI 496 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~DfGla~~ 496 (513)
+||||++++.+............+++..+..++.||++||.|||+.+ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987655443322223457999999999999999999999987 99999999999998 799999999999998
Q ss_pred cCCCC
Q 010329 497 FGVDQ 501 (513)
Q Consensus 497 ~~~~~ 501 (513)
+..+.
T Consensus 192 ~~~~~ 196 (394)
T 4e7w_A 192 LIAGE 196 (394)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 75443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-24 Score=216.13 Aligned_cols=147 Identities=30% Similarity=0.436 Sum_probs=124.5
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC------
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 414 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------ 414 (513)
.++|...+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36789999999999999999985 46889999998753 2234467889999999999999999999998765
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..++||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6799999997 47877773 34899999999999999999999987 999999999999999999999999999
Q ss_pred cccCC
Q 010329 495 RIFGV 499 (513)
Q Consensus 495 ~~~~~ 499 (513)
+....
T Consensus 175 ~~~~~ 179 (371)
T 2xrw_A 175 RTAGT 179 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 97754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=208.86 Aligned_cols=156 Identities=26% Similarity=0.407 Sum_probs=130.7
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEe--CCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv 419 (513)
++|+..+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 57888999999999999999964 68899999987543 3345679999999999999999999998865 5678999
Q ss_pred EecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCC--CCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 420 YEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
|||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 99999999999985422 2345999999999999999999999865 12399999999999999999999999999987
Q ss_pred cCCC
Q 010329 497 FGVD 500 (513)
Q Consensus 497 ~~~~ 500 (513)
+...
T Consensus 166 ~~~~ 169 (279)
T 2w5a_A 166 LNHD 169 (279)
T ss_dssp C---
T ss_pred eccc
Confidence 7543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.90 E-value=8.9e-25 Score=212.97 Aligned_cols=154 Identities=28% Similarity=0.369 Sum_probs=121.8
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
..++|+..+.||+|+||.||++.. .+++.||||+++.... ...+.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 456788999999999999999996 5788999999876422 2223455556668889999999999999999999999
Q ss_pred EecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 420 YEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
|||++ |+|.+++... .....+++..+..++.||+.||.|||++ + |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 5887776421 2345799999999999999999999997 6 999999999999999999999999999877
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
...
T Consensus 161 ~~~ 163 (290)
T 3fme_A 161 VDD 163 (290)
T ss_dssp ---
T ss_pred ccc
Confidence 544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-24 Score=209.33 Aligned_cols=149 Identities=30% Similarity=0.480 Sum_probs=125.4
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC-eeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-EKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lv~ey 422 (513)
.++|.+.+.||+|+||.||++.. .++.||||.++... ..+.+.+|+.++++++||||+++++++.+.+ ..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46788899999999999999998 58899999987543 4578999999999999999999999976654 68999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+++++|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999998432 1223889999999999999999999987 99999999999999999999999999987653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=205.17 Aligned_cols=153 Identities=31% Similarity=0.462 Sum_probs=134.9
Q ss_pred HHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
...++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 44568999999999999999999964 68899999986542 3456789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC---CCeEEeeccCcc
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMAR 495 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~DfGla~ 495 (513)
|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999888843 346899999999999999999999987 9999999999999754 469999999999
Q ss_pred ccCCC
Q 010329 496 IFGVD 500 (513)
Q Consensus 496 ~~~~~ 500 (513)
.....
T Consensus 173 ~~~~~ 177 (287)
T 2wei_A 173 CFQQN 177 (287)
T ss_dssp TBCCC
T ss_pred eecCC
Confidence 77543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-24 Score=214.67 Aligned_cols=154 Identities=25% Similarity=0.388 Sum_probs=131.7
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCC--CCCccceeeEEEeCCe
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQ--HRNLVRLLGFCLEGEE 415 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~ 415 (513)
+....++|.+.+.||+|+||.||++...+++.||||.+... .....+.+.+|+.++.+++ |+||+++++++.+.+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 34455779999999999999999999888999999998654 2334578899999999997 5999999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||| +.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++ +.+||+|||+++
T Consensus 103 ~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence 999999 668899999953 346899999999999999999999987 999999999999964 889999999999
Q ss_pred ccCCCC
Q 010329 496 IFGVDQ 501 (513)
Q Consensus 496 ~~~~~~ 501 (513)
.+....
T Consensus 175 ~~~~~~ 180 (313)
T 3cek_A 175 QMQPDT 180 (313)
T ss_dssp C-----
T ss_pred cccCcc
Confidence 876543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.3e-24 Score=213.67 Aligned_cols=149 Identities=26% Similarity=0.432 Sum_probs=129.9
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC-----Cee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EEK 416 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~ 416 (513)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467889999999999999999964 68899999997543 23346788999999999999999999988764 568
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 689888843 46999999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 010329 497 FGVD 500 (513)
Q Consensus 497 ~~~~ 500 (513)
+...
T Consensus 162 ~~~~ 165 (353)
T 2b9h_A 162 IDES 165 (353)
T ss_dssp CC--
T ss_pred cccc
Confidence 7543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=4.3e-24 Score=219.64 Aligned_cols=148 Identities=28% Similarity=0.431 Sum_probs=121.5
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeC----C--eeE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG----E--EKI 417 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~----~--~~~ 417 (513)
.+|...+.||+|+||.||+|+.. +++.||||++..... .+.+|++++++++|+||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35788899999999999999974 589999999865432 234699999999999999999998652 2 256
Q ss_pred EEEecCCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC-CCeEEeeccCcc
Q 010329 418 LVYEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAR 495 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGla~ 495 (513)
+||||+++ +|.+++.. ......+++..+..++.||++||.|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 55555432 123457999999999999999999999987 9999999999999965 578999999999
Q ss_pred ccCCC
Q 010329 496 IFGVD 500 (513)
Q Consensus 496 ~~~~~ 500 (513)
.+..+
T Consensus 206 ~~~~~ 210 (420)
T 1j1b_A 206 QLVRG 210 (420)
T ss_dssp ECCTT
T ss_pred hcccC
Confidence 87543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=205.35 Aligned_cols=146 Identities=25% Similarity=0.315 Sum_probs=126.2
Q ss_pred cCCCcc-cccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHH-HhCCCCCccceeeEEEe----CCeeE
Q 010329 345 NKFSTD-NKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLV-AKLQHRNLVRLLGFCLE----GEEKI 417 (513)
Q Consensus 345 ~~~~~~-~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~----~~~~~ 417 (513)
++|... +.||+|+||.||++.. .+++.||+|.++.. ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 455555 7799999999999996 56889999998642 4677888887 66689999999999987 66789
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC---CCCeEEeeccCc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMA 494 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DfGla 494 (513)
+||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999642 3346999999999999999999999987 999999999999998 789999999999
Q ss_pred cccCC
Q 010329 495 RIFGV 499 (513)
Q Consensus 495 ~~~~~ 499 (513)
+....
T Consensus 168 ~~~~~ 172 (299)
T 3m2w_A 168 KETTG 172 (299)
T ss_dssp EECTT
T ss_pred ccccc
Confidence 87753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=208.51 Aligned_cols=152 Identities=35% Similarity=0.491 Sum_probs=124.1
Q ss_pred hcCCCcccccCccCceeEEEEEeC--CCc--EEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP--SGQ--EIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~--~~~--~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 416 (513)
.++|++.+.||+|+||.||+|.+. +++ .||||.++.. .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888999999999999999853 333 6899988754 2334578999999999999999999999998755 8
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++|+||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998532 345899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCCC
Q 010329 497 FGVDQ 501 (513)
Q Consensus 497 ~~~~~ 501 (513)
+....
T Consensus 171 ~~~~~ 175 (291)
T 1u46_A 171 LPQND 175 (291)
T ss_dssp CCC-C
T ss_pred ccccc
Confidence 75443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-24 Score=217.35 Aligned_cols=147 Identities=18% Similarity=0.261 Sum_probs=127.8
Q ss_pred hcCCCcccccCccCceeEEEEEeCC---------CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccc---------
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPS---------GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR--------- 405 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~---------~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~--------- 405 (513)
.++|.+.+.||+|+||.||+|+... ++.||||.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678999999999999999999753 788999998754 35789999999999999887
Q ss_pred ------eeeEEEe-CCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcE
Q 010329 406 ------LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (513)
Q Consensus 406 ------l~g~~~~-~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Ni 478 (513)
+++++.. ++..++||||+ +++|.+++... ....+++..+..|+.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6778776 67889999999 99999999542 2357999999999999999999999987 99999999999
Q ss_pred EECCCC--CeEEeeccCccccCCC
Q 010329 479 LLDAEM--NPKISDFGMARIFGVD 500 (513)
Q Consensus 479 ll~~~~--~~ki~DfGla~~~~~~ 500 (513)
|++.++ .+||+|||+++.+...
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGG
T ss_pred EEcCCCCceEEEecCcceeeccCC
Confidence 999998 9999999999987643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.8e-24 Score=212.30 Aligned_cols=158 Identities=24% Similarity=0.319 Sum_probs=119.6
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe--
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-- 415 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-- 415 (513)
......++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+..+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3455668999999999999999999996 468899999986543 233456778888999999999999999976443
Q ss_pred -----eEEEEecCCCCChhhhhc-CCCCCCCCCHHHHHHHHHHHHHHHHHhH--cCCCCCeeecCCcCCcEEECC-CCCe
Q 010329 416 -----KILVYEFVPNKSLDYFLY-DPEKQGQLDWSRRYKIIGGIARGILYLH--EDSRLRIIHRDLKASNILLDA-EMNP 486 (513)
Q Consensus 416 -----~~lv~ey~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrdlk~~Nill~~-~~~~ 486 (513)
.++||||++++ |...+. .......+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 78999999865 443332 1234567899999999999999999999 665 999999999999996 8999
Q ss_pred EEeeccCccccCCCC
Q 010329 487 KISDFGMARIFGVDQ 501 (513)
Q Consensus 487 ki~DfGla~~~~~~~ 501 (513)
||+|||+++.+....
T Consensus 172 kl~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE 186 (360)
T ss_dssp EECCCTTCBCCCTTS
T ss_pred EEeeCCCceecCCCC
Confidence 999999999876543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=213.74 Aligned_cols=148 Identities=29% Similarity=0.464 Sum_probs=114.9
Q ss_pred CCc-ccccCccCceeEEEEEeC---CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEe--CCeeEEEE
Q 010329 347 FST-DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVY 420 (513)
Q Consensus 347 ~~~-~~~Lg~G~fG~Vy~~~~~---~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~ 420 (513)
|.. .++||+|+||.||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 458999999999999964 57889999997543 23578899999999999999999999965 66789999
Q ss_pred ecCCCCChhhhhcC------CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE----CCCCCeEEee
Q 010329 421 EFVPNKSLDYFLYD------PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISD 490 (513)
Q Consensus 421 ey~~~gsL~~~l~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~D 490 (513)
||++ ++|.+++.. ......+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9997 577777641 112235999999999999999999999987 9999999999999 7788999999
Q ss_pred ccCccccCCC
Q 010329 491 FGMARIFGVD 500 (513)
Q Consensus 491 fGla~~~~~~ 500 (513)
||+++.+...
T Consensus 176 fg~a~~~~~~ 185 (405)
T 3rgf_A 176 MGFARLFNSP 185 (405)
T ss_dssp TTCCC-----
T ss_pred CCCceecCCC
Confidence 9999987543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=212.93 Aligned_cols=148 Identities=26% Similarity=0.472 Sum_probs=126.3
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCee----
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK---- 416 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~---- 416 (513)
.++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 36788899999999999999985 468899999997642 23356789999999999999999999999887655
Q ss_pred --EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 417 --ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 417 --~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
++||||++ ++|.+++ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 6888887 234899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCC
Q 010329 495 RIFGVD 500 (513)
Q Consensus 495 ~~~~~~ 500 (513)
+.....
T Consensus 192 ~~~~~~ 197 (371)
T 4exu_A 192 RHADAE 197 (371)
T ss_dssp ------
T ss_pred cccccC
Confidence 876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=209.04 Aligned_cols=152 Identities=30% Similarity=0.538 Sum_probs=127.6
Q ss_pred HhcCCCcccccCccCceeEEEEEe--CCCcEEEEEEecccCc--cCHHHHHHHHHHHHhC---CCCCccceeeEEE----
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSASSG--QGAQEFKNEVVLVAKL---QHRNLVRLLGFCL---- 411 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~--~~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~---- 411 (513)
..++|.+.+.||+|+||.||++.. .+++.||+|.++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346799999999999999999997 4678999999865322 2223566777776665 8999999999987
Q ss_pred -eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEee
Q 010329 412 -EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (513)
Q Consensus 412 -~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D 490 (513)
.....++||||++ |+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 6999998542 2345899999999999999999999987 99999999999999999999999
Q ss_pred ccCccccCC
Q 010329 491 FGMARIFGV 499 (513)
Q Consensus 491 fGla~~~~~ 499 (513)
||+++....
T Consensus 164 fg~~~~~~~ 172 (326)
T 1blx_A 164 FGLARIYSF 172 (326)
T ss_dssp CCSCCCCCG
T ss_pred CcccccccC
Confidence 999987753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.5e-24 Score=228.51 Aligned_cols=155 Identities=23% Similarity=0.423 Sum_probs=133.0
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeCC----CcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~----~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 414 (513)
.+...++|.+.+.||+|+||.||+|.+.. +..||||.++... ....+.+.+|+.++++++||||+++++++. .+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 34445678888999999999999998632 4579999987643 333468999999999999999999999984 46
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..++||||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 68999999999999999953 2346899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCC
Q 010329 495 RIFGVD 500 (513)
Q Consensus 495 ~~~~~~ 500 (513)
+.+...
T Consensus 539 ~~~~~~ 544 (656)
T 2j0j_A 539 RYMEDS 544 (656)
T ss_dssp CSCCC-
T ss_pred eecCCC
Confidence 987543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=203.56 Aligned_cols=151 Identities=24% Similarity=0.436 Sum_probs=125.9
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEE-EeCCeeEEEE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC-LEGEEKILVY 420 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lv~ 420 (513)
..++|.+.+.||+|+||.||++.. .+++.||||.+..... .+.+.+|+.+++.++|++++..++.+ ..++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999995 5788999998765432 23578899999999988877776665 5677889999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE---CCCCCeEEeeccCcccc
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~~ 497 (513)
||+ +++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999853 2346999999999999999999999987 9999999999999 78999999999999987
Q ss_pred CCCC
Q 010329 498 GVDQ 501 (513)
Q Consensus 498 ~~~~ 501 (513)
....
T Consensus 159 ~~~~ 162 (296)
T 4hgt_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cCcc
Confidence 6543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=210.07 Aligned_cols=146 Identities=26% Similarity=0.460 Sum_probs=126.6
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCe------
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE------ 415 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------ 415 (513)
++|...+.||+|+||.||+|.. .+|+.||||.+.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5788899999999999999996 468899999987542 2334678999999999999999999999987654
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 68888772 34899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCC
Q 010329 496 IFGV 499 (513)
Q Consensus 496 ~~~~ 499 (513)
....
T Consensus 175 ~~~~ 178 (353)
T 3coi_A 175 HADA 178 (353)
T ss_dssp C---
T ss_pred CCCC
Confidence 7653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-24 Score=212.55 Aligned_cols=152 Identities=27% Similarity=0.516 Sum_probs=129.1
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCee
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 416 (513)
.+++..++|...+.||+|+||.||+|...+ .|++|.++... ....+.+.+|+.++++++|+||+++++++.+.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 344556788999999999999999999753 49999887542 23345688899999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+++++|.+++.+ ....+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.
T Consensus 105 ~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999954 2346899999999999999999999987 99999999999998 67999999999886
Q ss_pred cC
Q 010329 497 FG 498 (513)
Q Consensus 497 ~~ 498 (513)
..
T Consensus 179 ~~ 180 (319)
T 2y4i_B 179 SG 180 (319)
T ss_dssp --
T ss_pred cc
Confidence 64
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-23 Score=202.04 Aligned_cols=150 Identities=24% Similarity=0.438 Sum_probs=129.1
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEE-EeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC-LEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lv~e 421 (513)
.++|.+.+.||+|+||.||+|+. .+++.||||.+..... .+.+.+|+.+++.++|++++..++.+ ..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46789999999999999999995 5789999999875432 24689999999999998877666655 56777899999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE---CCCCCeEEeeccCccccC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFG 498 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~~~ 498 (513)
|+ +++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999953 2346999999999999999999999987 9999999999999 488899999999999876
Q ss_pred CCC
Q 010329 499 VDQ 501 (513)
Q Consensus 499 ~~~ 501 (513)
...
T Consensus 160 ~~~ 162 (296)
T 3uzp_A 160 DAR 162 (296)
T ss_dssp CTT
T ss_pred ccc
Confidence 543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.4e-23 Score=215.05 Aligned_cols=150 Identities=25% Similarity=0.428 Sum_probs=129.3
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCC-CCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lv~e 421 (513)
.++|.+.++||+|+||.||+|.. .+++.||||.+..... .+++.+|++++..++| ++|..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46789999999999999999995 5689999998765432 2357889999999987 556666777788889999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE---CCCCCeEEeeccCccccC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFG 498 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~~~ 498 (513)
|+ +++|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999953 2346999999999999999999999987 9999999999999 688999999999999886
Q ss_pred CCC
Q 010329 499 VDQ 501 (513)
Q Consensus 499 ~~~ 501 (513)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-24 Score=210.86 Aligned_cols=153 Identities=27% Similarity=0.430 Sum_probs=125.1
Q ss_pred HHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCcc------CHHHHHHHHHHHHhC----CCCCccceeeEE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQ------GAQEFKNEVVLVAKL----QHRNLVRLLGFC 410 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~------~~~~~~~E~~~l~~l----~H~nIv~l~g~~ 410 (513)
...++|.+.+.||+|+||.||++.. .+++.||||.+...... ....+.+|+.++.++ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3456799999999999999999985 46889999998754321 223456789999888 899999999999
Q ss_pred EeCCeeEEEEec-CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC-CCCCeEE
Q 010329 411 LEGEEKILVYEF-VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKI 488 (513)
Q Consensus 411 ~~~~~~~lv~ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki 488 (513)
...+..++|+|| +++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++ +++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 789999999953 446999999999999999999999987 99999999999998 8899999
Q ss_pred eeccCccccCCC
Q 010329 489 SDFGMARIFGVD 500 (513)
Q Consensus 489 ~DfGla~~~~~~ 500 (513)
+|||+++.+...
T Consensus 182 ~dfg~~~~~~~~ 193 (312)
T 2iwi_A 182 IDFGSGALLHDE 193 (312)
T ss_dssp CCCSSCEECCSS
T ss_pred EEcchhhhcccC
Confidence 999999987643
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=170.95 Aligned_cols=106 Identities=25% Similarity=0.407 Sum_probs=97.1
Q ss_pred CCceeEeeCCCCCCChhhHHHHHHHHHHHHHHHhccCCCcceeeccccCCcccEEEEEecccCCChhhHHHHHHHHHhhc
Q 010329 143 TTRTVYLWNTQNATDPVKFNDLVGSLMGEAASQAVNDPKKFATKMANFTSFQKLYALAQCTQDLSSSDCNICLRGAIAQL 222 (513)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~f~~~~~~l~~~l~~~a~~~~~~fa~~~~~~~~~~~vy~l~QC~~Dl~~~~C~~Cl~~a~~~~ 222 (513)
+......||..+.++.+.|+.+++.||..|...++.++.+|++......+.++||||+||++|+++.+|..||+.|+.++
T Consensus 3 t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~ 82 (108)
T 3a2e_A 3 TAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI 82 (108)
T ss_dssp CCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred cceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence 45567889999988889999999999999999988877788887666566789999999999999999999999999999
Q ss_pred ccccCCCCCCeeeccccccccccCCC
Q 010329 223 PTCCGGKQGGRVLTPSCNVRYEVYPF 248 (513)
Q Consensus 223 ~~~~~~~~~g~v~~~~C~~r~~~~~f 248 (513)
+++|+++.||+||.++|++||+.++|
T Consensus 83 ~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 83 FSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHCCCCceEEEECCCEEEEEeCCcC
Confidence 99999999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-23 Score=212.62 Aligned_cols=150 Identities=23% Similarity=0.298 Sum_probs=129.1
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhC------CCCCccceeeEEEeCCee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKL------QHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~g~~~~~~~~ 416 (513)
..+|.+.+.||+|+||.||+|... +++.||||+++... ...+.+.+|+.++..+ .|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457899999999999999999864 58899999997542 3345678888888877 567999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC--eEEeeccCc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--PKISDFGMA 494 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~--~ki~DfGla 494 (513)
++||||++ ++|.+++... ....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 6898888542 2345999999999999999999999987 999999999999999887 999999999
Q ss_pred cccCC
Q 010329 495 RIFGV 499 (513)
Q Consensus 495 ~~~~~ 499 (513)
+....
T Consensus 250 ~~~~~ 254 (429)
T 3kvw_A 250 CYEHQ 254 (429)
T ss_dssp EETTC
T ss_pred eecCC
Confidence 87653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.7e-24 Score=213.49 Aligned_cols=150 Identities=11% Similarity=0.110 Sum_probs=112.3
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc---cCHHHHHHHHHHHHhC--CCCCcccee-------eEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG---QGAQEFKNEVVLVAKL--QHRNLVRLL-------GFC 410 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l--~H~nIv~l~-------g~~ 410 (513)
..+|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34588899999999999999995 4788999999987532 3345677885544444 699977754 444
Q ss_pred EeC-----------------CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHhHcCCCCC
Q 010329 411 LEG-----------------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR------YKIIGGIARGILYLHEDSRLR 467 (513)
Q Consensus 411 ~~~-----------------~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ 467 (513)
... ...++||||++ |+|.+++... ...+.+..+ ..|+.||+.||.|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 23799999999 8999999542 223455555 788899999999999987
Q ss_pred eeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 468 ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|+||||||+||||+.++.+||+|||+++....
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence 99999999999999999999999999997753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-23 Score=205.89 Aligned_cols=153 Identities=26% Similarity=0.360 Sum_probs=126.0
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHH-HHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVV-LVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.++|...+.||+|+||.||++... +++.||||.+..... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999974 688999999976432 23345555655 777889999999999999999999999
Q ss_pred ecCCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 421 EFVPNKSLDYFLYD--PEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 421 ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 77777632 11245789999999999999999999997 6 999999999999999999999999999877
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
...
T Consensus 177 ~~~ 179 (327)
T 3aln_A 177 VDS 179 (327)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-23 Score=203.85 Aligned_cols=151 Identities=23% Similarity=0.376 Sum_probs=130.5
Q ss_pred hcCCCcccccCccCceeEEEEEe--CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCC------ccceeeEEEeCCe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN------LVRLLGFCLEGEE 415 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~--~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~ 415 (513)
.++|.+.+.||+|+||.||++.. .+++.||||.++... ...+.+.+|+.+++.++|+| ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46889999999999999999986 367899999987543 34567889999999887654 9999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC-------------
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA------------- 482 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~------------- 482 (513)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999988542 2346899999999999999999999987 999999999999987
Q ss_pred ------CCCeEEeeccCccccCCC
Q 010329 483 ------EMNPKISDFGMARIFGVD 500 (513)
Q Consensus 483 ------~~~~ki~DfGla~~~~~~ 500 (513)
++.+||+|||+++.....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~ 190 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH 190 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC
T ss_pred ccccccCCCceEeeCcccccCccc
Confidence 678999999999976543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=207.61 Aligned_cols=153 Identities=25% Similarity=0.412 Sum_probs=132.9
Q ss_pred HHhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCcc------CHHHHHHHHHHHHhCC--CCCccceeeEEEe
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQ------GAQEFKNEVVLVAKLQ--HRNLVRLLGFCLE 412 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~ 412 (513)
...++|.+.+.||+|+||.||+|.. .+++.||||.+...... ..+.+.+|+.++++++ |+||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457799999999999999999985 56889999998764321 2245778999999996 5999999999999
Q ss_pred CCeeEEEEecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC-CCCCeEEee
Q 010329 413 GEEKILVYEFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISD 490 (513)
Q Consensus 413 ~~~~~lv~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~D 490 (513)
.+..++|+||+.+ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 899999843 456899999999999999999999987 99999999999998 788999999
Q ss_pred ccCccccCCC
Q 010329 491 FGMARIFGVD 500 (513)
Q Consensus 491 fGla~~~~~~ 500 (513)
||+++.+...
T Consensus 194 fg~~~~~~~~ 203 (320)
T 3a99_A 194 FGSGALLKDT 203 (320)
T ss_dssp CTTCEECCSS
T ss_pred Cccccccccc
Confidence 9999987643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=223.79 Aligned_cols=154 Identities=28% Similarity=0.439 Sum_probs=132.3
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEe------CCe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE------GEE 415 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~ 415 (513)
.++|.+.+.||+|+||.||++.. .+|+.||||.++.. .....+.+.+|+.++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999996 46889999998764 33445679999999999999999999998765 667
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC---eEEeecc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFG 492 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DfG 492 (513)
.++||||+++|+|.+++........+++..+..|+.+|+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555557999999999999999999999987 999999999999987665 9999999
Q ss_pred CccccCCC
Q 010329 493 MARIFGVD 500 (513)
Q Consensus 493 la~~~~~~ 500 (513)
+++.+...
T Consensus 170 ~a~~~~~~ 177 (676)
T 3qa8_A 170 YAKELDQG 177 (676)
T ss_dssp CCCBTTSC
T ss_pred cccccccc
Confidence 99987544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-23 Score=213.57 Aligned_cols=150 Identities=26% Similarity=0.308 Sum_probs=120.4
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEecC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
+.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 3455568899999999987666689999999986532 35678899999876 8999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCC----CCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC-------------CCe
Q 010329 424 PNKSLDYFLYDPEKQG----QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-------------MNP 486 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~-------------~~~ 486 (513)
+ |+|.+++....... ..++..+..|+.||+.||.|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999996432211 1133346789999999999999987 9999999999999654 589
Q ss_pred EEeeccCccccCCCC
Q 010329 487 KISDFGMARIFGVDQ 501 (513)
Q Consensus 487 ki~DfGla~~~~~~~ 501 (513)
||+|||+++.+..+.
T Consensus 168 kL~DFG~a~~~~~~~ 182 (434)
T 2rio_A 168 LISDFGLCKKLDSGQ 182 (434)
T ss_dssp EECCCTTCEECCC--
T ss_pred EEcccccceecCCCC
Confidence 999999999886543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.9e-23 Score=209.81 Aligned_cols=135 Identities=25% Similarity=0.362 Sum_probs=113.0
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCC--------CCCccceeeEEE---
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ--------HRNLVRLLGFCL--- 411 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~g~~~--- 411 (513)
.++|.+.++||+|+||.||+++. .+++.||||.++.. ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999985 46889999999754 234567889999999986 788999999987
Q ss_pred -eCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeecCCcCCcEEECCCC
Q 010329 412 -EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEM 484 (513)
Q Consensus 412 -~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrdlk~~Nill~~~~ 484 (513)
.+...++||||+. ++|.+++... ....+++..+..|+.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 4567899999994 5555555332 235699999999999999999999997 6 99999999999999775
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-22 Score=201.41 Aligned_cols=148 Identities=22% Similarity=0.281 Sum_probs=121.0
Q ss_pred hcCCCccc-ccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEe----CCeeE
Q 010329 344 TNKFSTDN-KLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKI 417 (513)
Q Consensus 344 ~~~~~~~~-~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~ 417 (513)
.++|.+.+ .||+|+||.||++... +++.||||.+.... +...+....+..++|+||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 45677754 6999999999999965 68999999986532 222333445677899999999999876 44589
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC---CCCeEEeeccCc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMA 494 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DfGla 494 (513)
+||||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999999643 3346999999999999999999999987 999999999999976 455999999999
Q ss_pred cccCC
Q 010329 495 RIFGV 499 (513)
Q Consensus 495 ~~~~~ 499 (513)
+....
T Consensus 179 ~~~~~ 183 (336)
T 3fhr_A 179 KETTQ 183 (336)
T ss_dssp EEC--
T ss_pred eeccc
Confidence 87653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-23 Score=219.02 Aligned_cols=136 Identities=19% Similarity=0.289 Sum_probs=109.6
Q ss_pred CcccccCccCceeEEEEEeCCCcEEEEEEecccCc--------cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSG--------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
...+.||+|+||.||++.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999965 578889988654221 1134589999999999999999777777788889999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++++|.+++.+ +..++.||++||.|||+++ |+||||||+|||+++ ++||+|||+++.+..
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999943 5689999999999999987 999999999999998 999999999998865
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 482 ~ 482 (540)
T 3en9_A 482 D 482 (540)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.6e-23 Score=212.49 Aligned_cols=148 Identities=24% Similarity=0.350 Sum_probs=121.0
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
..+|...+.||+|+||+||.....+++.||||++...... .+.+|+.+++.+ +||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 4467888999999999966555558899999999764332 356799999999 799999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC-----CCCCeEEeeccCcccc
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-----AEMNPKISDFGMARIF 497 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~-----~~~~~ki~DfGla~~~ 497 (513)
++ |+|.+++... ...+.+.....++.||+.||.|||+.+ |+||||||+||||+ ....+||+|||+++.+
T Consensus 100 ~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 6999998643 223455566789999999999999987 99999999999994 3346889999999987
Q ss_pred CCC
Q 010329 498 GVD 500 (513)
Q Consensus 498 ~~~ 500 (513)
..+
T Consensus 174 ~~~ 176 (432)
T 3p23_A 174 AVG 176 (432)
T ss_dssp ---
T ss_pred cCC
Confidence 644
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=200.90 Aligned_cols=151 Identities=26% Similarity=0.396 Sum_probs=116.3
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCcc-C-HHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQ-G-AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
.++|...+.||+|+||.||++... +++.||||.+...... . .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356888899999999999999974 6899999999764322 2 234555566788889999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+ ++.+..+... ....+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4555555422 245689999999999999999999985 6 99999999999999999999999999987654
Q ss_pred C
Q 010329 500 D 500 (513)
Q Consensus 500 ~ 500 (513)
.
T Consensus 178 ~ 178 (318)
T 2dyl_A 178 D 178 (318)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=195.52 Aligned_cols=144 Identities=19% Similarity=0.184 Sum_probs=116.3
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCc------------------cCHHHHHHHHHHHHhCCC
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSG------------------QGAQEFKNEVVLVAKLQH 400 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H 400 (513)
.+......|.+.+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34444566778899999999999999997799999999865321 12456899999999999
Q ss_pred CCccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE
Q 010329 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480 (513)
Q Consensus 401 ~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill 480 (513)
| +++.+++. .+..++||||+++++|.+ +.. .....++.||+.||.|||+.+ |+||||||+|||+
T Consensus 163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 5 66666543 356799999999999988 411 123469999999999999987 9999999999999
Q ss_pred CCCCCeEEeeccCccccCCC
Q 010329 481 DAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 481 ~~~~~~ki~DfGla~~~~~~ 500 (513)
+ ++.+||+|||+++.....
T Consensus 227 ~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp E-TTEEEECCCTTCEETTST
T ss_pred E-CCcEEEEECCCCeECCCC
Confidence 9 999999999999977543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4e-22 Score=199.75 Aligned_cols=151 Identities=21% Similarity=0.344 Sum_probs=127.4
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CC-cEEEEEEecccCccCHHHHHHHHHHHHhCCCCC------ccceeeEEEeCCe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SG-QEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN------LVRLLGFCLEGEE 415 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~-~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~ 415 (513)
.++|.+.+.||+|+||.||++... ++ +.||+|.++... ...+.+.+|+.+++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999963 33 689999987542 34567888999999998766 8999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE---------------
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL--------------- 480 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill--------------- 480 (513)
.++||||+ +++|.+++.. .....+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 5666666643 22346999999999999999999999987 9999999999999
Q ss_pred ----CCCCCeEEeeccCccccCCC
Q 010329 481 ----DAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 481 ----~~~~~~ki~DfGla~~~~~~ 500 (513)
+.++.+||+|||+++.....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~ 195 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH 195 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC
T ss_pred cccccCCCcEEEeecCcccccccc
Confidence 56789999999999976543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.1e-22 Score=201.09 Aligned_cols=154 Identities=26% Similarity=0.359 Sum_probs=128.8
Q ss_pred HhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CC-----CccceeeEEEeCCe
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HR-----NLVRLLGFCLEGEE 415 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~g~~~~~~~ 415 (513)
..++|.+.+.||+|+||+||+|... +++.||||.++... ...+++.+|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999964 67889999997542 33467788999888885 55 39999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEE--CCCCCeEEeeccC
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL--DAEMNPKISDFGM 493 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill--~~~~~~ki~DfGl 493 (513)
.++||||++ ++|.+++... ....+++..+..++.||+.||.|||.+. .+|+||||||+|||| +.++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 5999988543 2345899999999999999999999631 359999999999999 4578899999999
Q ss_pred ccccCCC
Q 010329 494 ARIFGVD 500 (513)
Q Consensus 494 a~~~~~~ 500 (513)
++.....
T Consensus 208 a~~~~~~ 214 (382)
T 2vx3_A 208 SCQLGQR 214 (382)
T ss_dssp CEETTCC
T ss_pred ceecccc
Confidence 9987543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-22 Score=202.89 Aligned_cols=151 Identities=21% Similarity=0.346 Sum_probs=128.4
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-----------CCCccceeeEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-----------HRNLVRLLGFCL 411 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~ 411 (513)
.++|.+.+.||+|+||.||++.. .+++.||||.+.... ...+.+.+|+.++.+++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35789999999999999999995 568899999987532 33467889999998886 899999999998
Q ss_pred eCC----eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeecCCcCCcEEEC-----
Q 010329 412 EGE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLD----- 481 (513)
Q Consensus 412 ~~~----~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrdlk~~Nill~----- 481 (513)
..+ ..++||||+ +++|.+++... ....+++..+..++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 689999999 89999998542 234599999999999999999999997 6 99999999999994
Q ss_pred -CCCCeEEeeccCccccCCC
Q 010329 482 -AEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 482 -~~~~~ki~DfGla~~~~~~ 500 (513)
..+.+||+|||+++.+...
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~ 191 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH 191 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC
T ss_pred cCcceEEEcccccccccCCC
Confidence 4458999999999987543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.83 E-value=6.2e-21 Score=195.65 Aligned_cols=152 Identities=16% Similarity=0.197 Sum_probs=115.0
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCC-CCccce---------e--
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQH-RNLVRL---------L-- 407 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H-~nIv~l---------~-- 407 (513)
...|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++..++| +|.... .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34567788999999999999994 568999999987432 2335789999999999987 322111 1
Q ss_pred ----------eEEEe-----CCeeEEEEecCCCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCe
Q 010329 408 ----------GFCLE-----GEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468 (513)
Q Consensus 408 ----------g~~~~-----~~~~~lv~ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 468 (513)
.+... ....+++|+++ +++|.+++.. ......+++..++.|+.||++||.|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111 12345666655 6899988831 123446889999999999999999999987 9
Q ss_pred eecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 469 IHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 469 vHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
+||||||+||||+.++.+||+|||+++....
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC
Confidence 9999999999999999999999999987643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=4e-20 Score=177.16 Aligned_cols=139 Identities=17% Similarity=0.175 Sum_probs=108.2
Q ss_pred CCcccccCccCceeEEEEEe-CCCcE--EEEEEecccCcc------------------------CHHHHHHHHHHHHhCC
Q 010329 347 FSTDNKLGEGGFGEVYKGVL-PSGQE--IAVKRLSASSGQ------------------------GAQEFKNEVVLVAKLQ 399 (513)
Q Consensus 347 ~~~~~~Lg~G~fG~Vy~~~~-~~~~~--VavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 399 (513)
|.+.+.||+|+||.||+|.. .+|+. ||||.++..... ....+.+|+.++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 67888 999987543211 0136889999999999
Q ss_pred CCCc--cceeeEEEeCCeeEEEEecCCC-C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhH-cCCCCCeeec
Q 010329 400 HRNL--VRLLGFCLEGEEKILVYEFVPN-K----SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH-EDSRLRIIHR 471 (513)
Q Consensus 400 H~nI--v~l~g~~~~~~~~~lv~ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHr 471 (513)
|+++ +.+++. ...+|||||+.+ | +|.++... .++.....++.||+.+|.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8864 344432 357899999942 4 66665421 234466789999999999999 876 9999
Q ss_pred CCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 472 DLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 472 dlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||||.|||++. .++|+|||+|.....+
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 99999999998 8999999999977543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.2e-17 Score=164.78 Aligned_cols=140 Identities=16% Similarity=0.193 Sum_probs=100.6
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCc--------------cCHHHH--------HHHHHHHHhCCCCC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSG--------------QGAQEF--------KNEVVLVAKLQHRN 402 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~--------------~~~~~~--------~~E~~~l~~l~H~n 402 (513)
.-|.+.+.||+|+||.||+|...+|+.||||.++.... ...... ..|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34889999999999999999998999999998754211 001111 23555666665444
Q ss_pred ccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC
Q 010329 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482 (513)
Q Consensus 403 Iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~ 482 (513)
+.....+.. ...+|||||++++.|..+... .....++.||+.+|.|||+.+ ||||||||.|||+++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 322222212 234799999999988665411 123467899999999999987 999999999999987
Q ss_pred CC----------CeEEeeccCccccC
Q 010329 483 EM----------NPKISDFGMARIFG 498 (513)
Q Consensus 483 ~~----------~~ki~DfGla~~~~ 498 (513)
++ .+.|+||+-+....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCcccccccccceEEEEeCCcccCC
Confidence 76 38999999776543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.9e-12 Score=122.45 Aligned_cols=144 Identities=19% Similarity=0.103 Sum_probs=113.1
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
-..|.....++.|+.+.||+.... ++.+++|............+.+|+.+++.+. |..+.++++++...+..++||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 346777788888889999999864 6899999987532222346889999999885 67888999999998899999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC---------------------------------------
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED--------------------------------------- 463 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------- 463 (513)
++|.+|.+.+.. ......++.++++.|..||+.
T Consensus 92 i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999876411 122346788999999999981
Q ss_pred -----------------CCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 464 -----------------SRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 464 -----------------~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
.+..++|+|+++.|||++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113489999999999998766677999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=2.5e-11 Score=115.42 Aligned_cols=130 Identities=18% Similarity=0.146 Sum_probs=98.5
Q ss_pred CccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCC--ccceeeEEEeCCeeEEEEecCCCCChhhh
Q 010329 354 GEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYF 431 (513)
Q Consensus 354 g~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lv~ey~~~gsL~~~ 431 (513)
+.|..+.||+....+|..+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+++.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456669999998877888999987654 2245788999999886544 566889888877889999999998884
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-----------------------------------------------
Q 010329 432 LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS----------------------------------------------- 464 (513)
Q Consensus 432 l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------------- 464 (513)
... .+ ...++.++++.|..||+..
T Consensus 104 ~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 211 12 2356777888888888642
Q ss_pred --------CCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 465 --------RLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 465 --------~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+..++|+|++|.|||++++..++|+|||.+..-
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 122999999999999987766779999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=3.1e-10 Score=113.63 Aligned_cols=142 Identities=17% Similarity=0.258 Sum_probs=106.9
Q ss_pred cccccCccCceeEEEEEeCCCcEEEEEEec--ccCc-cCHHHHHHHHHHHHhCC--CCCccceeeEEEeC---CeeEEEE
Q 010329 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLS--ASSG-QGAQEFKNEVVLVAKLQ--HRNLVRLLGFCLEG---EEKILVY 420 (513)
Q Consensus 349 ~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~--~~~~-~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~---~~~~lv~ 420 (513)
..+.|+.|.++.||+....+ ..+++|+.. .... .....+.+|..+++.+. +..++++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998754 678888765 3221 22346788999999997 45688899988776 3489999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC------------------------------------
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS------------------------------------ 464 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 464 (513)
||+++..+.+.. ...++..++..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874322 224678888999999999999999731
Q ss_pred -------------------CCCeeecCCcCCcEEECCCCC--eEEeeccCccc
Q 010329 465 -------------------RLRIIHRDLKASNILLDAEMN--PKISDFGMARI 496 (513)
Q Consensus 465 -------------------~~~ivHrdlk~~Nill~~~~~--~ki~DfGla~~ 496 (513)
+..++|+|+++.|||++.++. +.|+||+++..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987753 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.58 E-value=7.9e-08 Score=93.63 Aligned_cols=137 Identities=22% Similarity=0.226 Sum_probs=98.3
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CCC--ccceeeEEEeCC---eeEEEEecC
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRN--LVRLLGFCLEGE---EKILVYEFV 423 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~n--Iv~l~g~~~~~~---~~~lv~ey~ 423 (513)
.+.++.|....||+.. ..+++|..... .....+.+|..+++.+. +.. +.+.+......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568899999999853 46888875432 23467889999998884 333 445555443333 348999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC----------------------------------------
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED---------------------------------------- 463 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 463 (513)
+|.+|..... ..++..++..++.++++.|..||..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865331 2366777778888888888888851
Q ss_pred ---------------CCCCeeecCCcCCcEEECC--CCCeEEeeccCcccc
Q 010329 464 ---------------SRLRIIHRDLKASNILLDA--EMNPKISDFGMARIF 497 (513)
Q Consensus 464 ---------------~~~~ivHrdlk~~Nill~~--~~~~ki~DfGla~~~ 497 (513)
.++.++|+|+++.||++++ +..+.|+||+.+..-
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1245899999999999988 556899999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.1e-06 Score=85.60 Aligned_cols=137 Identities=22% Similarity=0.169 Sum_probs=93.5
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCC---CccceeeEEE-eCCeeEEEEecCCC
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHR---NLVRLLGFCL-EGEEKILVYEFVPN 425 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~-~~~~~~lv~ey~~~ 425 (513)
.+.++.|....||+. +..+++|.-.. ......+.+|..+|..+.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899987 56678887432 23346789999999999753 3567777764 34557899999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC------------------------------------------
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED------------------------------------------ 463 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 463 (513)
..|..... ..++..+...++.++++.|..||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88865321 1133444444555555555444432
Q ss_pred ---------------CCCCeeecCCcCCcEEECC---CCC-eEEeeccCcccc
Q 010329 464 ---------------SRLRIIHRDLKASNILLDA---EMN-PKISDFGMARIF 497 (513)
Q Consensus 464 ---------------~~~~ivHrdlk~~Nill~~---~~~-~ki~DfGla~~~ 497 (513)
.++.++|+|+++.|||++. ++. +.|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2334799999999999987 455 489999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.2e-06 Score=83.46 Aligned_cols=135 Identities=20% Similarity=0.193 Sum_probs=93.3
Q ss_pred ccCccCce-eEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEEecCCCCCh
Q 010329 352 KLGEGGFG-EVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (513)
Q Consensus 352 ~Lg~G~fG-~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 428 (513)
.+..|..+ .||+.... ++..+.+|+-... ...++.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445544 68987754 4567888876543 2456888999988885 44577899999999999999999999887
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC---------------------------------------------
Q 010329 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED--------------------------------------------- 463 (513)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 463 (513)
.+.... .......+..+++..|.-||..
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 665411 0112223444444545555431
Q ss_pred ----------CCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 464 ----------SRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 464 ----------~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
..+.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 122379999999999999877778999998874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.1e-06 Score=87.53 Aligned_cols=81 Identities=9% Similarity=0.044 Sum_probs=56.1
Q ss_pred cccc-CccCceeEEEEEeC-------CCcEEEEEEecccC---ccCHHHHHHHHHHHHhCC-C--CCccceeeEEEeC--
Q 010329 350 DNKL-GEGGFGEVYKGVLP-------SGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQ-H--RNLVRLLGFCLEG-- 413 (513)
Q Consensus 350 ~~~L-g~G~fG~Vy~~~~~-------~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~-- 413 (513)
.+.| +.|....+|+.... +++.+++|.-.... ......+.+|..+++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999998764 26678888765432 101245778888888875 2 3577888887655
Q ss_pred -CeeEEEEecCCCCChhh
Q 010329 414 -EEKILVYEFVPNKSLDY 430 (513)
Q Consensus 414 -~~~~lv~ey~~~gsL~~ 430 (513)
+..++||||+++..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=1.7e-05 Score=79.98 Aligned_cols=75 Identities=12% Similarity=0.124 Sum_probs=50.4
Q ss_pred ccccCccCceeEEEEEeC-CCcEEEEEEecccCc-------cCHHHHHHHHHHHHhCCC--C-CccceeeEEEeCCeeEE
Q 010329 350 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-------QGAQEFKNEVVLVAKLQH--R-NLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~-nIv~l~g~~~~~~~~~l 418 (513)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999754 467899997653211 123456788888887742 3 34456544 4556789
Q ss_pred EEecCCCC
Q 010329 419 VYEFVPNK 426 (513)
Q Consensus 419 v~ey~~~g 426 (513)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.02 E-value=2.4e-05 Score=76.89 Aligned_cols=141 Identities=16% Similarity=0.219 Sum_probs=80.9
Q ss_pred cccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC--CCCccceee------EEEeCCeeEEEEec
Q 010329 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ--HRNLVRLLG------FCLEGEEKILVYEF 422 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~g------~~~~~~~~~lv~ey 422 (513)
+.|+.|..+.||+....+| .+++|..... ..++..|..++..+. .-.+.+++. +....+..++++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987554 5888887652 233444555555443 123444443 22346678999999
Q ss_pred CCCCChh-----------h---hhcC----CC-C------CCCCCHHHHH------------------------------
Q 010329 423 VPNKSLD-----------Y---FLYD----PE-K------QGQLDWSRRY------------------------------ 447 (513)
Q Consensus 423 ~~~gsL~-----------~---~l~~----~~-~------~~~l~~~~~~------------------------------ 447 (513)
+++..+. . -+|. .. . ...-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 0 0111 00 0 0112343211
Q ss_pred -HHHHHHHHHHHHhHc----------CCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 448 -KIIGGIARGILYLHE----------DSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 448 -~i~~~ia~gL~yLH~----------~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
.+...+...+.+|++ ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111123445666763 1234699999999999998888899999998853
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.97 E-value=2.8e-05 Score=74.74 Aligned_cols=81 Identities=17% Similarity=0.263 Sum_probs=60.4
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCC---CCccceeeEEEeCCeeEEEE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH---RNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~g~~~~~~~~~lv~ 420 (513)
...+...+.+|.|..+.||+.++.+|+.+.+|+-..........|..|...|+.|.- --+++.+++ +..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence 345566788999999999999999999999998765544444568889999988852 234555554 2357899
Q ss_pred ecCCCCCh
Q 010329 421 EFVPNKSL 428 (513)
Q Consensus 421 ey~~~gsL 428 (513)
||++.+..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00012 Score=71.18 Aligned_cols=140 Identities=19% Similarity=0.152 Sum_probs=93.7
Q ss_pred CcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC---CCCccceeeEEEeCCeeEEEEecCC
Q 010329 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
...+.|+.|....+|+... ++..+++|.-... ....+..|...|+.|. ...+++.++++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 4456789999999999986 4678888876543 2467888988888874 3568889999888888999999999
Q ss_pred CCChhh-----------hhcCCCC---C--------C--------CCCHHHHH---HHHH----------------HHHH
Q 010329 425 NKSLDY-----------FLYDPEK---Q--------G--------QLDWSRRY---KIIG----------------GIAR 455 (513)
Q Consensus 425 ~gsL~~-----------~l~~~~~---~--------~--------~l~~~~~~---~i~~----------------~ia~ 455 (513)
+..+.. -||.... . + .-+|.... ++.. .+..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876521 1121111 0 0 12565432 1111 1111
Q ss_pred H-HHHhHc-CCCCCeeecCCcCCcEEECCCCCeEEeecc
Q 010329 456 G-ILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (513)
Q Consensus 456 g-L~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DfG 492 (513)
- ...|.. ..++.++|+|+.+.|++++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123421 2356799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00021 Score=72.54 Aligned_cols=74 Identities=15% Similarity=0.223 Sum_probs=46.5
Q ss_pred cccccCccCceeEEEEEeCCCcEEEEEEeccc------C-c--cCHHHHHHHHHHHH-hCCCCCccceeeEEEeCCeeEE
Q 010329 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS------S-G--QGAQEFKNEVVLVA-KLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 349 ~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~------~-~--~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~l 418 (513)
..+.||.|....||+... +++.++||..... . . .....+..|+..+. ...+..+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 356789999999999975 5678999943221 1 1 12233444443322 22334567777765 567899
Q ss_pred EEecC-CC
Q 010329 419 VYEFV-PN 425 (513)
Q Consensus 419 v~ey~-~~ 425 (513)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00086 Score=65.20 Aligned_cols=142 Identities=15% Similarity=0.109 Sum_probs=79.3
Q ss_pred cccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCC--ccceeeE------EEeCCeeEEEEec
Q 010329 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN--LVRLLGF------CLEGEEKILVYEF 422 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~------~~~~~~~~lv~ey 422 (513)
+.|+.|....+|+....++ .+++|...... ..+.+..|..++..+...+ +.+++.. ....+..++++||
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4566788889999987655 67788776521 1234566777777664222 3444421 1234567899999
Q ss_pred CCCCChhh----h----------hcCC----CCC--CC---CCHHHHHH------------HHHHHHHHHHHhHcC----
Q 010329 423 VPNKSLDY----F----------LYDP----EKQ--GQ---LDWSRRYK------------IIGGIARGILYLHED---- 463 (513)
Q Consensus 423 ~~~gsL~~----~----------l~~~----~~~--~~---l~~~~~~~------------i~~~ia~gL~yLH~~---- 463 (513)
+++..+.. . +|.. ... .. ..|..... +...+...+.++++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865421 0 1110 000 00 12332111 011234445555421
Q ss_pred CCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 464 ~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.+..++|+|+.+.|||++++..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23458999999999999887666899998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0014 Score=64.03 Aligned_cols=141 Identities=16% Similarity=0.162 Sum_probs=72.1
Q ss_pred cccCccCcee-EEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCC--CCccceeeEEEeCCeeEEEEecCCCCC
Q 010329 351 NKLGEGGFGE-VYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKS 427 (513)
Q Consensus 351 ~~Lg~G~fG~-Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lv~ey~~~gs 427 (513)
+.|+.|.... +|+....++..+++|....... .++..|+.++..+.. -.+.+++.+..+. -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4455554443 6677654466777775443221 233456666666542 3356677764333 378999998766
Q ss_pred hhhhhc---------------------CCCC--CCCCCHHHHH-------H-------------HHHHHHHHHHHhH---
Q 010329 428 LDYFLY---------------------DPEK--QGQLDWSRRY-------K-------------IIGGIARGILYLH--- 461 (513)
Q Consensus 428 L~~~l~---------------------~~~~--~~~l~~~~~~-------~-------------i~~~ia~gL~yLH--- 461 (513)
+.+++. .... ...++..... . ....+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 643331 1000 0112211100 0 0001111222221
Q ss_pred cCCCCCeeecCCcCCcEEECCC----CCeEEeeccCccc
Q 010329 462 EDSRLRIIHRDLKASNILLDAE----MNPKISDFGMARI 496 (513)
Q Consensus 462 ~~~~~~ivHrdlk~~Nill~~~----~~~ki~DfGla~~ 496 (513)
......++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1223469999999999999875 6799999998874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0039 Score=60.63 Aligned_cols=142 Identities=16% Similarity=0.152 Sum_probs=81.8
Q ss_pred cccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCC--CccceeeE-----EEeCCeeEEEEecC
Q 010329 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHR--NLVRLLGF-----CLEGEEKILVYEFV 423 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~-----~~~~~~~~lv~ey~ 423 (513)
..++ |....||+....+|+.+++|...... .....+..|..++..+... .+++++.. ....+..++++||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3456 77789999887677789999886432 1345677788887777422 24455443 12245567899999
Q ss_pred CCCChhh-----h---------hc----CCC--CCCCCCHHHH----------------------HHHHHHHHHHHHHhH
Q 010329 424 PNKSLDY-----F---------LY----DPE--KQGQLDWSRR----------------------YKIIGGIARGILYLH 461 (513)
Q Consensus 424 ~~gsL~~-----~---------l~----~~~--~~~~l~~~~~----------------------~~i~~~ia~gL~yLH 461 (513)
++..+.. + +| ... .....++... ...+..++..+.-+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8754421 0 11 000 1112232211 011111222222111
Q ss_pred c-CCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 462 E-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 462 ~-~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
. ..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1234589999999999999 4 899999988763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00049 Score=70.02 Aligned_cols=73 Identities=16% Similarity=0.262 Sum_probs=49.7
Q ss_pred ccccCccCceeEEEEEeCC--------CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCc-cceeeEEEeCCeeEEEE
Q 010329 350 DNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVY 420 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~--------~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~ 420 (513)
.+.|+.|-...+|+...++ +..+++|+..... ....+.+|..++..+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3567788889999998753 4788888874321 12456689988888854344 567766532 3899
Q ss_pred ecCCCCCh
Q 010329 421 EFVPNKSL 428 (513)
Q Consensus 421 ey~~~gsL 428 (513)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00097 Score=64.27 Aligned_cols=138 Identities=13% Similarity=0.116 Sum_probs=75.2
Q ss_pred ccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCc-cceeeEEEeCCeeEEEEecC-CCCC
Q 010329 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFV-PNKS 427 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~ey~-~~gs 427 (513)
.+.|+.|....+|+. ..+++|.-....... ....+|..+++.+...++ .++++. ..+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567888999999998 457888765432211 123457777776653333 456554 444567899999 6554
Q ss_pred hhhh------------------hcCCCC--CCCCCH-HHHHHHHH--------------HHHHHHH----HhHc-CCCCC
Q 010329 428 LDYF------------------LYDPEK--QGQLDW-SRRYKIIG--------------GIARGIL----YLHE-DSRLR 467 (513)
Q Consensus 428 L~~~------------------l~~~~~--~~~l~~-~~~~~i~~--------------~ia~gL~----yLH~-~~~~~ 467 (513)
+... +|.... ....+. .....+.. .+.+.+. .|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4310 111110 000111 11111100 0111111 1111 22345
Q ss_pred eeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 468 IIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 468 ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5566789999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0041 Score=63.63 Aligned_cols=74 Identities=14% Similarity=0.079 Sum_probs=47.8
Q ss_pred ccccCccCceeEEEEEeCC-CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCc-cceeeEEEeCCeeEEEEecCCCCC
Q 010329 350 DNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPNKS 427 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~ey~~~gs 427 (513)
.+.|+.|-...+|+....+ +..+++|.......... ...+|..++..|...++ .++++.+. + .+|+||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3567888889999998765 47788887644322111 12578888888875555 56777662 2 35999998755
Q ss_pred h
Q 010329 428 L 428 (513)
Q Consensus 428 L 428 (513)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0023 Score=63.82 Aligned_cols=141 Identities=22% Similarity=0.263 Sum_probs=82.7
Q ss_pred cccCccCceeEEEEEeCC--------CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCC-ccceeeEEEeCCeeEEEEe
Q 010329 351 NKLGEGGFGEVYKGVLPS--------GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN-LVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~--------~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lv~e 421 (513)
+.|..|-...+|+....+ ++.+++|+-... ......+.+|..+++.+...+ ..++++.+.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 456677778899988642 468888875332 224556778999888875323 3566666543 29999
Q ss_pred cCCCCChhhh-h----------------cCCC--CCCCCC--HHHHHHHHHHHH-------------------HHHHHh-
Q 010329 422 FVPNKSLDYF-L----------------YDPE--KQGQLD--WSRRYKIIGGIA-------------------RGILYL- 460 (513)
Q Consensus 422 y~~~gsL~~~-l----------------~~~~--~~~~l~--~~~~~~i~~~ia-------------------~gL~yL- 460 (513)
|+++..|..- + |... ...... |.++.++..++. ..+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665311 1 1111 111222 444444443332 123333
Q ss_pred ---Hc-CCCCCeeecCCcCCcEEECCC----CCeEEeeccCccc
Q 010329 461 ---HE-DSRLRIIHRDLKASNILLDAE----MNPKISDFGMARI 496 (513)
Q Consensus 461 ---H~-~~~~~ivHrdlk~~Nill~~~----~~~ki~DfGla~~ 496 (513)
.. ..+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 123458999999999999876 7899999998863
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.003 Score=62.75 Aligned_cols=73 Identities=10% Similarity=0.084 Sum_probs=43.8
Q ss_pred cccCccCceeEEEEEeCC---------CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCC-ccceeeEEEeCCeeEEEE
Q 010329 351 NKLGEGGFGEVYKGVLPS---------GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN-LVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~---------~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lv~ 420 (513)
+.|+.|..-.+|+....+ +..+++|........ ..+...|..++..+...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778788999988654 267888876543221 112356787777775334 44666543 2 37899
Q ss_pred ecCCCCCh
Q 010329 421 EFVPNKSL 428 (513)
Q Consensus 421 ey~~~gsL 428 (513)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99997544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.031 Score=54.62 Aligned_cols=33 Identities=24% Similarity=0.376 Sum_probs=28.4
Q ss_pred CCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 465 ~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+..++|+|+.+.||++++++.+.|+||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 346999999999999998888999999877643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.43 E-value=0.13 Score=51.77 Aligned_cols=141 Identities=18% Similarity=0.181 Sum_probs=83.0
Q ss_pred ccccCccCceeEEEEEeCC--------CcEEEEEEecccCccCHHHHHHHHHHHHhCCCCC-ccceeeEEEeCCeeEEEE
Q 010329 350 DNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN-LVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~--------~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lv~ 420 (513)
.+.|..|-...+|+....+ +..+++|+-...... .-...+|..+++.+...+ ..++++.+ . .++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3557778888999998753 578888876443221 112356888877775333 45666533 2 37899
Q ss_pred ecCCCCChhhh-h----------------cC--C-----C---CCCCCCHHHHHHHHHH-------------------HH
Q 010329 421 EFVPNKSLDYF-L----------------YD--P-----E---KQGQLDWSRRYKIIGG-------------------IA 454 (513)
Q Consensus 421 ey~~~gsL~~~-l----------------~~--~-----~---~~~~l~~~~~~~i~~~-------------------ia 454 (513)
||+++..|..- + |. . . ...+.-|.++.++..+ +.
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998664210 0 11 0 0 1111224443333222 12
Q ss_pred HHHHHhH---------------------cCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 455 RGILYLH---------------------EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 455 ~gL~yLH---------------------~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
..+.+|. ...+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2233332 112345899999999999 7888999999988863
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.45 E-value=0.079 Score=34.29 Aligned_cols=26 Identities=23% Similarity=0.331 Sum_probs=12.6
Q ss_pred eeehhHHHHHHHHHHHhhhhhhhccc
Q 010329 288 AIVAPIAVAAVLFVACLCFLRRRAKK 313 (513)
Q Consensus 288 ~iv~~~~v~~vll~~~~~~~~~r~~~ 313 (513)
+++.++++++++.+..++++|+|+++
T Consensus 16 gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 16 GMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 34444555555554445555554443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.65 E-value=0.076 Score=34.29 Aligned_cols=27 Identities=15% Similarity=0.404 Sum_probs=12.7
Q ss_pred eeehhHHHHHHHHHHHhhhhhhhcccc
Q 010329 288 AIVAPIAVAAVLFVACLCFLRRRAKKK 314 (513)
Q Consensus 288 ~iv~~~~v~~vll~~~~~~~~~r~~~~ 314 (513)
+++.++++++++.+..++++|+|++++
T Consensus 15 gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 15 GVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred eehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 333344444444444455555554443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.31 E-value=0.53 Score=46.91 Aligned_cols=29 Identities=28% Similarity=0.424 Sum_probs=25.0
Q ss_pred eeecCCcCCcEEE------CCCCCeEEeeccCccc
Q 010329 468 IIHRDLKASNILL------DAEMNPKISDFGMARI 496 (513)
Q Consensus 468 ivHrdlk~~Nill------~~~~~~ki~DfGla~~ 496 (513)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998863
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=90.01 E-value=0.12 Score=33.32 Aligned_cols=28 Identities=36% Similarity=0.427 Sum_probs=12.7
Q ss_pred eeeeehhHHHHHHHHHHHhhhhhhhccc
Q 010329 286 IIAIVAPIAVAAVLFVACLCFLRRRAKK 313 (513)
Q Consensus 286 ii~iv~~~~v~~vll~~~~~~~~~r~~~ 313 (513)
+++.++++++++++.+..++|+|||+.+
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence 4555555444444444344444444433
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.63 E-value=0.074 Score=54.35 Aligned_cols=62 Identities=8% Similarity=0.085 Sum_probs=19.2
Q ss_pred CcccccCccCceeEEEEEeCC-CcEEEE------EEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEe
Q 010329 348 STDNKLGEGGFGEVYKGVLPS-GQEIAV------KRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 412 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~~~-~~~Vav------K~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 412 (513)
.+.++|| ||.||+|.+.. ..+||| |+.+.. +.+....|.+|..++..++|+|+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3456676 99999999854 357888 776643 22334578889999999999999999988754
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=82.85 E-value=0.4 Score=29.93 Aligned_cols=21 Identities=19% Similarity=0.493 Sum_probs=11.2
Q ss_pred CccceeeeeehhHHHHHHHHH
Q 010329 281 ISSSTIIAIVAPIAVAAVLFV 301 (513)
Q Consensus 281 ~~~~~ii~iv~~~~v~~vll~ 301 (513)
.+...+.+++++.++.+.++.
T Consensus 8 ls~GaIAGiVvG~v~gv~li~ 28 (38)
T 2k1k_A 8 LTGGEIVAVIFGLLLGAALLL 28 (38)
T ss_dssp CCHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCceeeeehHHHHHHHHHH
Confidence 444556666666555444333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.84 E-value=4.5 Score=36.27 Aligned_cols=88 Identities=7% Similarity=-0.005 Sum_probs=61.5
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH-HhHcCCCCCeeecCCcCCc
Q 010329 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL-YLHEDSRLRIIHRDLKASN 477 (513)
Q Consensus 399 ~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivHrdlk~~N 477 (513)
.||++ -..+-.+.+...+.++--+++.=...+ ..++...+++++..|+.-.. +++. -+|--|.|.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57776 333445566666666655333222233 24778889999988877766 5543 4678899999
Q ss_pred EEECCCCCeEEeeccCccccCC
Q 010329 478 ILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 478 ill~~~~~~ki~DfGla~~~~~ 499 (513)
+++|.++.++|.-.|+-..+.+
T Consensus 115 L~f~~~~~p~i~hRGi~~~lpP 136 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESLPP 136 (219)
T ss_dssp EEECTTCCEEESCCEETTTBSS
T ss_pred EEEeCCCcEEEEEcCCcccCCC
Confidence 9999999999999998776644
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 513 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-43 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-52
Identities = 49/173 (28%), Positives = 88/173 (50%), Gaps = 6/173 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
N++ +G+ + +V ++ SL + L+ + + + + I A+G+ YL
Sbjct: 64 VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYL 120
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
H S IIHRDLK++NI L ++ KI DFG+A + ++ G++
Sbjct: 121 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-49
Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 11/175 (6%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGA-QEFKNEVVLVAK 397
+E+ + F ++LG G G V+K PSG +A K + + E+ ++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
+V G E + E + SLD L K G++ K+ + +G+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
YL + +I+HRD+K SNIL+++ K+ DFG++ + VGT
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGT 166
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-48
Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 7/173 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
+ LVRL + E ++ E++ N SL FL P +L ++ + IA G+ ++
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 125
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
E + IHRDL+A+NIL+ ++ KI+DFG+AR+ ++ +
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPI 174
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (412), Expect = 6e-47
Identities = 48/179 (26%), Positives = 88/179 (49%), Gaps = 6/179 (3%)
Query: 330 LESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEF 388
++ +++ E+ + +KLG G +GEVY+GV +AVK L + + +EF
Sbjct: 2 MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEF 60
Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
E ++ +++H NLV+LLG C ++ EF+ +L +L + +Q ++
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLY 119
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
+ I+ + YL + IHRDL A N L+ K++DFG++R+ D +
Sbjct: 120 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 7e-47
Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 16/174 (9%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQG---AQEFKNEVVLVAKLQ 399
FS ++G G FG VY + + + +A+K++S S Q Q+ EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
H N ++ G L LV E+ + D + L + G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
LH +IHRD+KA NILL K+ DFG A I + VGT
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTP 175
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-46
Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 6/157 (3%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 409
+LG+G FG+VYK + A K + S + +++ E+ ++A H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
++ EF ++D + + + L S+ + + YLH+ +II
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD---NKII 132
Query: 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
HRDLKA NIL + + K++DFG++ + ++
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (406), Expect = 6e-46
Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 19/191 (9%)
Query: 335 FDFETIEVATNKFST---------DNKLGEGGFGEVYKGVLPSGQE----IAVKRL-SAS 380
F FE A +F+ + +G G FGEV G L + +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 381 SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
+ + ++F +E ++ + H N++ L G + +++ EF+ N SLD FL + GQ
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQ 124
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
+ ++ GIA G+ YL + +HRDL A NIL+++ + K+SDFG++R D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 501 QTQGNTSRIVG 511
+ + +G
Sbjct: 182 TSDPTYTSALG 192
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-45
Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 8/171 (4%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE-FKNEVVLVAKLQHRN 402
+ LGEG +GEV V + + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+ G EG + L E+ L + E + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
+ I HRD+K N+LLD N KISDFG+A +F + + +++ GTL
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-45
Identities = 53/212 (25%), Positives = 82/212 (38%), Gaps = 27/212 (12%)
Query: 325 NDLTILESLQFDFETI-EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL 377
N+ ++ Q ++ E N+ S LG G FG+V + + +AVK L
Sbjct: 2 NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 378 SASSGQG-AQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD- 434
S+ + +E+ +++ L H N+V LLG C G +++ E+ L FL
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 435 --------------PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480
+ + LD +A+G+ +L IHRDL A NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178
Query: 481 DAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
KI DFG+AR D
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLP 210
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 4e-45
Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 31/209 (14%)
Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSGQGAQ 386
L ++E N +GEG FG V++ P +AVK L + Q
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 387 -EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG------ 439
+F+ E L+A+ + N+V+LLG C G+ L++E++ L+ FL
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 440 ---------------QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484
L + + I +A G+ YL E + +HRDL N L+ M
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177
Query: 485 NPKISDFGMARIFGVDQTQGNTSRIVGTL 513
KI+DFG++R +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPI 206
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 4e-45
Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 12/180 (6%)
Query: 340 IEVATNKFS-TDNKLGEGGFGEVYKGVL---PSGQEIAVKRLSASSGQG-AQEFKNEVVL 394
+ + + D +LG G FG V +GV ++A+K L + + +E E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+ +L + +VRL+G C + E +LV E L FL K+ ++ S +++ ++
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVS 119
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN-TSRIVGTL 513
G+ YL +HRDL A N+LL KISDFG+++ G D + S L
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-45
Identities = 40/169 (23%), Positives = 75/169 (44%), Gaps = 7/169 (4%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
+ +LG G FG V G ++A+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
+L G C + ++ E++ N L +L + + + + ++ + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
+ +HRDL A N L++ + K+SDFG++R +D ++ +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPV 165
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 9e-45
Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 8/168 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
+ + +G+G FG+V G G ++AVK + + Q F E ++ +L+H
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 59
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
NLV+LLG +E + + +V E++ SL +L + L K + + Y
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
L +HRDL A N+L+ + K+SDFG+ + Q G
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 163
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-44
Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 7/169 (4%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
++ + ++G G FG V+ G + ++A+K + + ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
+L G CLE LV+EF+ + L Y ++G + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
+IHRDL A N L+ K+SDFGM R DQ +++ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPV 166
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-43
Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 7/173 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 71
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+L E +V E++ SL FL E L + + IA G+ Y+
Sbjct: 72 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
R+ +HRDL+A+NIL+ + K++DFG+AR+ ++ +
Sbjct: 130 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPI 178
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-43
Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 17/173 (9%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 411
+G+G FGEV++G G+E+AVK S+ + + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 412 EGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED---- 463
+ LV ++ + SL +L + + K+ A G+ +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 464 -SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF--GVDQTQGNTSRIVGTL 513
+ I HRDLK+ NIL+ I+D G+A D + VGT
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-43
Identities = 46/221 (20%), Positives = 83/221 (37%), Gaps = 32/221 (14%)
Query: 322 NADNDLTILESLQFDFETI-EVATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAV 374
++DN+ ++ +++++ E LG G FG+V ++AV
Sbjct: 13 SSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV 72
Query: 375 KRLSASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
K L + +E +E+ ++ +L H N+V LLG C L++E+ L +L
Sbjct: 73 KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 132
Query: 433 YDPEKQ--------------------GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 472
++ L + +A+G+ +L +HRD
Sbjct: 133 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD 189
Query: 473 LKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
L A N+L+ KI DFG+AR D +
Sbjct: 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-43
Identities = 49/190 (25%), Positives = 99/190 (52%), Gaps = 11/190 (5%)
Query: 325 NDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQ 383
+D ILE L+ ++ K++ K+G+G G VY + + +GQE+A+++++
Sbjct: 1 SDEEILEKLR-SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 384 GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDW 443
+ NE++++ + ++ N+V L L G+E +V E++ SL + + +D
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDE 115
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
+ + + + +LH ++IHRD+K+ NILL + + K++DFG +Q++
Sbjct: 116 GQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 504 GNTSRIVGTL 513
S +VGT
Sbjct: 173 --RSTMVGTP 180
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-43
Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 8/169 (4%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGA--QEFKNEVVLVAKLQHRN 402
+ +G G +G K G+ + K L S A Q +EV L+ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 403 LVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILY 459
+VR ++ L V E+ L + K+ Q LD +++ + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 460 LHE--DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
H D ++HRDLK +N+ LD + N K+ DFG+ARI D +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-42
Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 350 DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSASSGQGA--QEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + +AVK L + A E E ++ +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
R++G C E E +LV E L+ +L + + +++ ++ G+ YL
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS-RIVGTL 513
+HRDL A N+LL + KISDFG+++ D+ +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-41
Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 346 KFSTDN-----KLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQ---EFKNEVVLVA 396
+++ ++ LG+G FG VY S +A+K L + + A + + EV + +
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
L+H N++RL G+ + L+ E+ P ++ L +K + D R I +A
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANA 118
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
+ Y H R+IHRD+K N+LL + KI+DFG + + + GTL
Sbjct: 119 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTL 168
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 6e-41
Identities = 51/182 (28%), Positives = 92/182 (50%), Gaps = 12/182 (6%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSASSGQGAQ-EFKNEV 392
T E+ + + +G G FGEVYKG+L + +A+K L A + + +F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
++ + H N++RL G + + +++ E++ N + + EK G+ + ++ G
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRG 118
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVG 511
IA G+ YL + +HRDL A NIL+++ + K+SDFG++R+ D T S
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 512 TL 513
+
Sbjct: 176 PI 177
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-41
Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 16/172 (9%)
Query: 350 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRL 406
D ++G G F VYKG+ + E+A L + Q FK E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 407 LGFCLEGEEK----ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ +LV E + + +L +L ++ + I +G+ +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 463 DSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
+ IIHRDLK NI + + KI D G+A + + ++GT
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTP 177
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 9e-41
Identities = 54/181 (29%), Positives = 71/181 (39%), Gaps = 13/181 (7%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLS---ASSGQGAQEFKNE 391
T + KLG+G FG V +G + +AVK L S + +F E
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
V + L HRNL+RL G L K+ V E P SL + QG +
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLD--RLRKHQGHFLLGTLSRYAV 118
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
+A G+ YL R IHRDL A N+LL KI DFG+ R +
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 512 T 512
Sbjct: 176 V 176
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-40
Identities = 39/165 (23%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQG-AQEFKNEVVLVAKLQHR 401
+++ + +GEG +G V + +A+K++S Q Q E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
N++ + + + ++ + LY K L + I RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
++HRDLK SN+LL+ + KI DFG+AR+ D
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 145 bits (366), Expect = 1e-39
Identities = 36/170 (21%), Positives = 73/170 (42%), Gaps = 8/170 (4%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL 403
+ + +LG G FG V++ +G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
V L + E +++YEF+ L + D + ++ + + + +G+ ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVG 511
+H DLK NI+ + + K+ DFG+ Q+ T+
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-39
Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 24/187 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSG---QEIAVKRLS-ASSGQGAQEFKNEVVLVAKL-Q 399
N + +GEG FG+V K + + A+KR+ +S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQLDWSRR 446
H N++ LLG C L E+ P+ +L FL L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
+ARG+ YL + + IHRDL A NIL+ KI+DFG++R +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 507 SRIVGTL 513
+ +
Sbjct: 184 TMGRLPV 190
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-39
Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLS-ASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY+GV +A+K ++ A+S + EF NE
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 75
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------DPEKQGQLDWSRR 446
++ + ++VRLLG +G+ +++ E + L +L + S+
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
++ G IA G+ YL+ + + +HRDL A N ++ + KI DFGM R
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 507 SRIVGT 512
+ +
Sbjct: 193 GKGLLP 198
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-39
Identities = 50/173 (28%), Positives = 87/173 (50%), Gaps = 12/173 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQE----IAVKRLS-ASSGQGAQEFKNEVVLVAKLQH 400
F LG G FG VYKG+ +P G++ +A+K L A+S + +E +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
++ RLLG CL +++ LDY E + + IA+G+ YL
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
R++HRDL A N+L+ + KI+DFG+A++ G ++ + + +
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-39
Identities = 40/177 (22%), Positives = 76/177 (42%), Gaps = 12/177 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSASSGQGAQE-FKNEVVLV 395
E+ + +GEG FG+V++G+ S +A+K + +E F E + +
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+ H ++V+L+G E ++ E L + ++ LD + ++
Sbjct: 63 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLST 119
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ YL R +HRD+ A N+L+ + K+ DFG++R D T S+
Sbjct: 120 ALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 172
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-38
Identities = 47/170 (27%), Positives = 71/170 (41%), Gaps = 10/170 (5%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVAKLQHR 401
F LGEG F V L + +E A+K L E ++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
V+L + E+ + N L ++ K G D + I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
IIHRDLK NILL+ +M+ +I+DFG A++ + Q + VG
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (359), Expect = 1e-38
Identities = 44/166 (26%), Positives = 70/166 (42%), Gaps = 13/166 (7%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLS---ASSGQGAQEFKNEVV---LVAK 397
N FS +G GGFGEVY +G+ A+K L QG NE + LV+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
+V + ++ + + + L Y L + G + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
++H +++RDLK +NILLD + +ISD G+A F +
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 2e-38
Identities = 48/203 (23%), Positives = 75/203 (36%), Gaps = 25/203 (12%)
Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSASSGQGAQ 386
L +D E ++ LG G FG+V + + + +AVK L +
Sbjct: 1 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 60
Query: 387 E--FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLY---------- 433
+L+ H N+V LLG C + + ++ EF +L +L
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 434 ---DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490
+ + L +A+G+ +L + IHRDL A NILL + KI D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICD 177
Query: 491 FGMARIFGVDQTQGNTSRIVGTL 513
FG+AR D L
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPL 200
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-38
Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 11/165 (6%)
Query: 350 DNKLGEGGFGEVYKGVLP----SGQEIAVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLV 404
+ +G G FG VY G L AVK L+ + G +F E +++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 405 RLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
LLG CL E +V ++ + L F+ + + + + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFL 146
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
+ + +HRDL A N +LD + K++DFG+AR + ++
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 140 bits (353), Expect = 6e-38
Identities = 37/161 (22%), Positives = 71/161 (44%), Gaps = 8/161 (4%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL 403
+ + +LG G FG V++ V +G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
+ L + E +L+ EF+ L + + ++ + + G+ ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHE- 145
Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQT 502
I+H D+K NI+ + + KI DFG+A D+
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (335), Expect = 4e-36
Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 8/164 (4%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRN 402
K+ K+GEG +G VYK G+ A+K RL E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+L + +LV+E + +G L+ + + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
R++HRDLK N+L++ E KI+DFG+AR FG+ +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 3e-35
Identities = 35/160 (21%), Positives = 64/160 (40%), Gaps = 9/160 (5%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
K+ LG G FG V++ V S + K + G K E+ ++ +HRN++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNIL 64
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
L EE ++++EF+ + + +L+ + + + +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS-- 120
Query: 465 RLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQT 502
I H D++ NI+ + KI +FG AR
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-35
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 15/168 (8%)
Query: 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
++ +G G FG VY+ L SG+ +A+K++ Q + E+ ++ KL H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCLEGEEK------ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
L F EK LV ++VP + + L + + R + Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 460 LHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNT 506
+H I HRD+K N+LLD + K+ DFG A+ + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 7e-35
Identities = 45/196 (22%), Positives = 82/196 (41%), Gaps = 26/196 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSA-SSGQGAQEFKNE 391
E+ ++ LGEG FG+V ++AVK L + ++ + + +E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------------DPEK 437
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
+ QL +ARG+ YL + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 498 GVDQTQGNTSRIVGTL 513
T+ +
Sbjct: 186 HHIDYYKKTTNGRLPV 201
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 129 bits (325), Expect = 1e-34
Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 20/178 (11%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGA---------QEFKNEVVLV 395
+ LG G V + + P+ +E AVK + + G + EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 396 AKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
K+ H N+++L LV++ + L +L ++ L KI+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
I LH+ L I+HRDLK NILLD +MN K++DFG + + + GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 172
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (323), Expect = 4e-34
Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE-FKNEVVL 394
++ E + + + LG G F EV + + +A+K ++ + +G + +NE+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+ K++H N+V L G L+ + V L + ++G ++I +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVL 117
Query: 455 RGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
+ YLH+ I+HRDLK N+L D + ISDFG++++ S G
Sbjct: 118 DAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACG 171
Query: 512 TL 513
T
Sbjct: 172 TP 173
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (323), Expect = 5e-34
Identities = 36/162 (22%), Positives = 66/162 (40%), Gaps = 10/162 (6%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVAKLQH 400
F LG G FG V+ +G+ A+K L + + +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
++R+ G + ++ ++ +++ L L ++ + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
II+RDLK NILLD + KI+DFG A+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 125 bits (315), Expect = 3e-33
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 15/178 (8%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGA---QEFKNEVVLVAKLQ 399
++++ LG GG EV+ L +++AVK L A + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 400 HRNLVRLLGFCLE----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
H +V + G +V E+V +L ++ +G + R ++I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG-NTSRIVGT 512
+ + H+ IIHRD+K +NI++ A K+ DFG+AR T+ ++GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-32
Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 14/168 (8%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE-----FKNEVVLVAKLQHRNLV 404
+ LGEG F VYK + Q +A+K++ A++ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
LL LV++F+ + L S + +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
I+HRDLK +N+LLD K++DFG+A+ FG + V T
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVT 163
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-32
Identities = 48/173 (27%), Positives = 71/173 (41%), Gaps = 13/173 (7%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---ASSGQGAQEFKNEV-VLVAKLQ 399
F LG+G FG+V+ + Q A+K L + E VL +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
H L + E V E++ L Y + + + D SR I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQF 118
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
LH I++RDLK NILLD + + KI+DFGM + + + NT GT
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-32
Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 8/164 (4%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRN 402
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+LL + LV+EF+ + D + + + +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
R++HRDLK N+L++ E K++DFG+AR FGV
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-31
Identities = 45/182 (24%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGA--QEFKNEVVLVAKLQHR 401
+K+ K+G+G FGEV+K +GQ++A+K++ + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 402 NLVRLLGFCLEGEEKI--------LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
N+V L+ C LV++F + + S +++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQML 126
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT--SRIVG 511
G L+ R +I+HRD+KA+N+L+ + K++DFG+AR F + + + V
Sbjct: 127 LNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 512 TL 513
TL
Sbjct: 184 TL 185
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 6e-31
Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 16/181 (8%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSGQGAQE--FKNEVVLVAKL 398
A ++ ++GEG +G+V+K + G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 399 ---QHRNLVRLLGFCLEGEEKILVYEFVPNKSLD---YFLYDPEKQGQLDWSRRYKIIGG 452
+H N+VRL C + + +D D + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ RG+ +LH R++HRDLK NIL+ + K++DFG+ARI+ + +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178
Query: 513 L 513
L
Sbjct: 179 L 179
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (299), Expect = 7e-31
Identities = 39/179 (21%), Positives = 72/179 (40%), Gaps = 18/179 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL 403
N++ K+G G FG++Y G + +G+E+A+K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 404 VRLLGFCL-EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ + +C EG+ ++V E + D F + + + + I Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 463 DSRLRIIHRDLKASNIL---LDAEMNPKISDFGMARIFGVDQTQGN-----TSRIVGTL 513
IHRD+K N L I DFG+A+ + +T + + GT
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-30
Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 9/164 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHR 401
K+ K+GEG +G V+K + + +A+K RL E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
N+VRL ++ LV+EF YF G LD + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
++HRDLK N+L++ K+++FG+AR FG+ +
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-30
Identities = 39/178 (21%), Positives = 68/178 (38%), Gaps = 19/178 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQE------FKNEVVLVAK 397
+++ LG GGFG VY G+ + +A+K + E EVVL+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 398 LQ--HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+ ++RLL + + +L+ E + ++G L +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ + H ++HRD+K NIL+D K+ DFG + + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGT 172
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 3e-29
Identities = 39/164 (23%), Positives = 67/164 (40%), Gaps = 18/164 (10%)
Query: 349 TDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL-QHRNLVRL 406
T LG G G+V + + ++ A+K L Q + + EV L + Q ++VR+
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRI 70
Query: 407 LGFCLEGEEK----ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ ++V E + L + D Q +I+ I I YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS 129
Query: 463 DSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQ 503
+ I HRD+K N+L ++ K++DFG A+ +
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 4e-29
Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 17/167 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL--SASSGQGAQEFKNEVVLVAKLQHR 401
+ +G G +G V V +G ++A+K+L S A+ E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 402 NLVRLLGFCLEGE------EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
N++ LL E + LV F+ K +L R ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
G+ Y+H IIHRDLK N+ ++ + KI DFG+AR + T
Sbjct: 133 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 115 bits (288), Expect = 6e-29
Identities = 39/157 (24%), Positives = 63/157 (40%), Gaps = 10/157 (6%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVAKLQH 400
++F LG G FG V SG A+K L + + NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+L + +V E+V + L + G+ I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
H L +I+RDLK N+L+D + +++DFG A+
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 113 bits (283), Expect = 8e-29
Identities = 33/181 (18%), Positives = 67/181 (37%), Gaps = 20/181 (11%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRN- 402
+ ++GEG FG +++G L + Q++A+K S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ + F EG +LV + + D + + + +HE
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 463 DSRLRIIHRDLKASNILLDAEMNP-----KISDFGMARIFGVDQTQGN-----TSRIVGT 512
+++RD+K N L+ + + DFGM + + T+ + + GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 513 L 513
Sbjct: 177 A 177
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 9e-29
Identities = 38/176 (21%), Positives = 63/176 (35%), Gaps = 12/176 (6%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVAK 397
V N F LG+G FG+V +G+ A+K L + E ++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
+H L L + V E+ L + L ++ R I
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA- 117
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513
L +++RD+K N++LD + + KI+DFG+ + D GT
Sbjct: 118 --LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTP 169
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 3e-28
Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 20/179 (11%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL------SASSGQGAQEFKNEVVLVAK 397
+ + T +LG G F V K +G + A K + S+ G ++ + EV ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
+QH N++ L + IL+ E V L FL ++ L + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG- 125
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSRIVGT 512
++ L+I H DLK NI+L P KI DFG+A I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 179
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 109 bits (274), Expect = 3e-27
Identities = 39/186 (20%), Positives = 80/186 (43%), Gaps = 23/186 (12%)
Query: 335 FDFETIEVAT---NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN 390
+D+E+ V + + KLG G + EV++ + + + +++ VK L ++ K
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKR 78
Query: 391 EVVLVAKLQ-HRNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
E+ ++ L+ N++ L + + LV+E V N L
Sbjct: 79 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIR 132
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNT 506
+ I + + Y H + I+HRD+K N+++D E ++ D+G+A + Q
Sbjct: 133 FYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--- 186
Query: 507 SRIVGT 512
+ V +
Sbjct: 187 NVRVAS 192
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 104 bits (260), Expect = 1e-26
Identities = 30/155 (19%), Positives = 53/155 (34%), Gaps = 20/155 (12%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASS----------GQGAQEFKNEVVLVAKLQH 400
+GEG V+ E VK G F + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
R L +L G + VY + N ++ L D ++ ++ +++ I +
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ I+H DL N+L+ E I DF +
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-26
Identities = 52/193 (26%), Positives = 84/193 (43%), Gaps = 27/193 (13%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLS--ASSGQGAQ 386
F ++EV + F+ + +G G G V + +A+K+LS + A+
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCL------EGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
E+VL+ + H+N++ LL E ++ LV E + Q +
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QME 115
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
LD R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+AR G
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 501 QTQGNTSRIVGTL 513
+ V T
Sbjct: 173 FM---MTPYVVTR 182
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 2e-25
Identities = 41/183 (22%), Positives = 77/183 (42%), Gaps = 15/183 (8%)
Query: 330 LESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLS----ASS 381
L + +V F LG G +G+V+ +G+ A+K L
Sbjct: 9 LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 68
Query: 382 GQGAQEFKNEVVLVAKLQHR-NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
+ + + E ++ ++ LV L + L+ +++ L L E+
Sbjct: 69 AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--- 125
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
+G I + +LH+ L II+RD+K NILLD+ + ++DFG+++ F D
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182
Query: 501 QTQ 503
+T+
Sbjct: 183 ETE 185
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 6e-25
Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 7/176 (3%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSAS--SGQGAQEFKNEVVL 394
+TI ++ + +G G +G V +G +AVK+LS S A+ E+ L
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 395 VAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
+ ++H N++ LL ++ + L + K +L +I I
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI 509
RG+ Y+H IIHRDLK SN+ ++ + KI DFG+AR + T +R
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW 183
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 92.0 bits (227), Expect = 6e-21
Identities = 33/184 (17%), Positives = 69/184 (37%), Gaps = 23/184 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL 403
++ KLG G F V+ + + +A+K + + ++E+ L+ ++ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADN 71
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKII 450
+ K+L + + + + E + + +I
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP------KISDFGMARIFGVDQTQG 504
+ G+ Y+H R IIH D+K N+L++ +P KI+D G A + T
Sbjct: 132 KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 505 NTSR 508
+R
Sbjct: 190 IQTR 193
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 513 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.98 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.98 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.98 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.97 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.97 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.97 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.96 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.96 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.96 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.95 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.95 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.95 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.95 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.95 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.95 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.94 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.94 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.94 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.94 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.94 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.93 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.93 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.93 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.84 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.6 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.93 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.51 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.68 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-34 Score=274.16 Aligned_cols=163 Identities=29% Similarity=0.459 Sum_probs=141.2
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|++.++||+|+||+||+|+. .+|+.||||.+.... .+..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4688899999999999999996 468999999987543 23346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 502 (513)
+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..+..
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999994 3457999999999999999999999987 99999999999999999999999999998865554
Q ss_pred ccccceeeecC
Q 010329 503 QGNTSRIVGTL 513 (513)
Q Consensus 503 ~~~~~~~~Gt~ 513 (513)
....+..+||+
T Consensus 159 ~~~~~~~~GT~ 169 (271)
T d1nvra_ 159 ERLLNKMCGTL 169 (271)
T ss_dssp ECCBCCCCSCG
T ss_pred cccccceeeCc
Confidence 44445677874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-34 Score=278.22 Aligned_cols=159 Identities=30% Similarity=0.496 Sum_probs=141.1
Q ss_pred HHHHHhcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 339 ~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
++++..++|++.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.+|++++|||||+++|++.+++..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 34455678888999999999999999975 58899999987643 45678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+||||+++|+|.+++... ....++|..++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+..
T Consensus 90 iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999998542 3457999999999999999999999987 999999999999999999999999999988
Q ss_pred CCCCC
Q 010329 498 GVDQT 502 (513)
Q Consensus 498 ~~~~~ 502 (513)
..+..
T Consensus 166 ~~~~~ 170 (287)
T d1opja_ 166 TGDTY 170 (287)
T ss_dssp CSSSS
T ss_pred CCCCc
Confidence 65443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-33 Score=270.62 Aligned_cols=161 Identities=27% Similarity=0.476 Sum_probs=142.8
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.++|+..++||+|+||+||+|+. .+|+.||||+++.......+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35799999999999999999995 56899999999876656678899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 502 (513)
+++|+|.+++.+ +.+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+.+..+..
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999998842 46999999999999999999999987 99999999999999999999999999998865443
Q ss_pred ccccceeeecC
Q 010329 503 QGNTSRIVGTL 513 (513)
Q Consensus 503 ~~~~~~~~Gt~ 513 (513)
. ....+||+
T Consensus 172 ~--~~~~~gt~ 180 (293)
T d1yhwa1 172 K--RSTMVGTP 180 (293)
T ss_dssp C--BCCCCSCG
T ss_pred c--ccccccCC
Confidence 2 23456663
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-34 Score=274.70 Aligned_cols=165 Identities=32% Similarity=0.524 Sum_probs=134.4
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
++..++|.+.++||+|+||+||+|+++ ..||||+++.. +....+.|.+|+.++++++||||++++|++.+ +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 345678999999999999999999874 36999998754 33456789999999999999999999998754 56899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
||||+++|+|.+++.. ....++|..++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 81 v~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999964 3356999999999999999999999987 9999999999999999999999999999886
Q ss_pred CCCCccccceeeecC
Q 010329 499 VDQTQGNTSRIVGTL 513 (513)
Q Consensus 499 ~~~~~~~~~~~~Gt~ 513 (513)
..........+.||+
T Consensus 156 ~~~~~~~~~~~~gt~ 170 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSI 170 (276)
T ss_dssp ----------CCCCG
T ss_pred ccCCcccccccccCc
Confidence 554444444566663
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-34 Score=273.64 Aligned_cols=155 Identities=35% Similarity=0.567 Sum_probs=136.5
Q ss_pred HHHhcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 341 ~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++..++|++.++||+|+||+||+|.+++++.||||+++... ...++|.+|+.++++++|||||+++|++.+ +..++||
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 34456788899999999999999999888899999997644 446789999999999999999999998754 5679999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|.+++... ....++|..++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+.+.
T Consensus 87 Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence 999999999987432 2335999999999999999999999987 999999999999999999999999999988654
Q ss_pred C
Q 010329 501 Q 501 (513)
Q Consensus 501 ~ 501 (513)
.
T Consensus 163 ~ 163 (272)
T d1qpca_ 163 E 163 (272)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-33 Score=268.59 Aligned_cols=151 Identities=32% Similarity=0.529 Sum_probs=131.2
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
++|++.++||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++||||++++|++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5688889999999999999999888999999997643 446789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
+|+|.+++.. ....++|..++.|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+++.+....
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999854 3456899999999999999999999987 9999999999999999999999999999876543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.4e-33 Score=269.83 Aligned_cols=149 Identities=28% Similarity=0.431 Sum_probs=136.6
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
+.|++.+.||+|+||+||+|+. .+++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4688899999999999999996 468899999998776666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++|+|.+++.+ ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+.+.
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccC
Confidence 99999998743 2356999999999999999999999987 9999999999999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=8.5e-33 Score=266.88 Aligned_cols=163 Identities=29% Similarity=0.423 Sum_probs=138.6
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|++.+.||+|+||+||+|+. .+++.||||.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688999999999999999996 46899999998653 2345578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999884 3457999999999999999999999987 999999999999999999999999999988765
Q ss_pred CCccccceeeecC
Q 010329 501 QTQGNTSRIVGTL 513 (513)
Q Consensus 501 ~~~~~~~~~~Gt~ 513 (513)
.........+||+
T Consensus 162 ~~~~~~~~~~GT~ 174 (288)
T d1uu3a_ 162 SKQARANSFVGTA 174 (288)
T ss_dssp --------CCCCG
T ss_pred CcccccccccCCc
Confidence 5544455567774
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.7e-32 Score=258.36 Aligned_cols=151 Identities=26% Similarity=0.464 Sum_probs=137.9
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 424 (513)
++|++.++||+|+||+||+|++++++.||||.++... ...++|.+|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6788999999999999999999888899999998654 346789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
+|+|..++.. ....+++..+.+|+.||++||.|||+++ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999754 3456899999999999999999999987 9999999999999999999999999999876543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=9.7e-33 Score=268.33 Aligned_cols=153 Identities=32% Similarity=0.572 Sum_probs=126.2
Q ss_pred cCCCcccccCccCceeEEEEEeCC-C---cEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPS-G---QEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~-~---~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
++|++.++||+|+||+||+|.+.. + ..||||++... .....++|.+|+.+|++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 567778999999999999999642 2 25899988754 334457899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++|+|.+++.. ..+.++|.+++.|+.||++||.|||+++ |+||||||+||||++++++||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998854 3456999999999999999999999987 99999999999999999999999999998865
Q ss_pred CCC
Q 010329 500 DQT 502 (513)
Q Consensus 500 ~~~ 502 (513)
+..
T Consensus 181 ~~~ 183 (299)
T d1jpaa_ 181 DTS 183 (299)
T ss_dssp ---
T ss_pred CCC
Confidence 443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.4e-32 Score=260.32 Aligned_cols=159 Identities=30% Similarity=0.468 Sum_probs=138.9
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|++.+.||+|+||+||+|+. .+++.||+|.+... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4688889999999999999996 46889999998643 2344678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|.+++. ....+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999984 3456999999999999999999999987 999999999999999999999999999877543
Q ss_pred CCccccceeeecC
Q 010329 501 QTQGNTSRIVGTL 513 (513)
Q Consensus 501 ~~~~~~~~~~Gt~ 513 (513)
.. ....||+
T Consensus 160 ~~----~~~~Gt~ 168 (263)
T d2j4za1 160 RR----TTLCGTL 168 (263)
T ss_dssp CC----EETTEEG
T ss_pred cc----cccCCCC
Confidence 32 2345663
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.4e-33 Score=266.50 Aligned_cols=152 Identities=30% Similarity=0.508 Sum_probs=131.9
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
.++|++.+.||+|+||+||+|.++++++||||+++... ...+.|.+|+.++++++|+|||+++|++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 45788999999999999999999888899999997543 45678999999999999999999999985 46689999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
++|+|..++... ....++|.+++.|+.||+.||.|||+++ |+||||||+||||++++++||+|||+++.+.+..
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999888542 2346999999999999999999999987 9999999999999999999999999999875443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-32 Score=269.45 Aligned_cols=171 Identities=26% Similarity=0.376 Sum_probs=141.1
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeCC-C-----cEEEEEEeccc-CccCHHHHHHHHHHHHhC-CCCCccceeeEEE
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPS-G-----QEIAVKRLSAS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~~-~-----~~VavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 411 (513)
+++..++|++.++||+|+||+||+|++.. + ..||||.+... .....+.+.+|+.+|.++ +|||||+++|++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 34566789999999999999999998632 2 36999998654 334456899999999998 8999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeec
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPEK--------------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 471 (513)
+.+..++||||+++|+|.++|+.... ...++|..++.|+.||++||.|||+++ |+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 99999999999999999999965322 245899999999999999999999987 9999
Q ss_pred CCcCCcEEECCCCCeEEeeccCccccCCCCCccccceeeecC
Q 010329 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 472 dlk~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt~ 513 (513)
||||+|||++.++.+||+|||+|+...............||+
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 230 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECG
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCC
Confidence 999999999999999999999999887665544444556663
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.9e-33 Score=273.54 Aligned_cols=161 Identities=27% Similarity=0.363 Sum_probs=139.1
Q ss_pred HhcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 343 ~~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
..++|++.++||+|+||+||+|+. .+|+.||+|+++.... ...+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356899999999999999999995 5689999999876533 33467999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++|+|.+++.+ .+.+++..+..++.||+.||.|||+. + |+||||||+||||++++++||+|||+|+.+.+
T Consensus 84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999953 45699999999999999999999974 5 99999999999999999999999999998753
Q ss_pred CCCccccceeeecC
Q 010329 500 DQTQGNTSRIVGTL 513 (513)
Q Consensus 500 ~~~~~~~~~~~Gt~ 513 (513)
.. ....+||+
T Consensus 158 ~~----~~~~~GT~ 167 (322)
T d1s9ja_ 158 SM----ANSFVGTR 167 (322)
T ss_dssp HT----C---CCSS
T ss_pred Cc----cccccCCc
Confidence 32 22456764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=3.4e-32 Score=265.06 Aligned_cols=172 Identities=28% Similarity=0.464 Sum_probs=143.2
Q ss_pred HHHHHHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEE
Q 010329 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFC 410 (513)
Q Consensus 338 ~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 410 (513)
.++|.+.++|++.+.||+|+||+||+|++. +++.||||+++.... +..++|.+|+.++++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345667789999999999999999999863 356899999976533 3356899999999999999999999999
Q ss_pred EeCCeeEEEEecCCCCChhhhhcCC---------------------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCee
Q 010329 411 LEGEEKILVYEFVPNKSLDYFLYDP---------------------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469 (513)
Q Consensus 411 ~~~~~~~lv~ey~~~gsL~~~l~~~---------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 469 (513)
.+.+..+++|||+++|+|.++++.. .....++|..++.|+.||+.||+|||+++ |+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 9999999999999999999998532 12235899999999999999999999987 99
Q ss_pred ecCCcCCcEEECCCCCeEEeeccCccccCCCCCccccceeeec
Q 010329 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512 (513)
Q Consensus 470 Hrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt 512 (513)
||||||+|||||.++.+||+|||+|+.+.+.......+...||
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~ 205 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP 205 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBC
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcC
Confidence 9999999999999999999999999987655444333344444
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=258.60 Aligned_cols=151 Identities=32% Similarity=0.566 Sum_probs=130.6
Q ss_pred cCCCccc-ccCccCceeEEEEEeC---CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDN-KLGEGGFGEVYKGVLP---SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~-~Lg~G~fG~Vy~~~~~---~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
+++.+.+ +||+|+||+||+|.+. ++..||||.++... ....++|.+|+++|++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4455556 4999999999999853 34579999997653 3445789999999999999999999999864 568999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++|+|.+++.. ....+++..+..|+.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999843 3456999999999999999999999987 99999999999999999999999999998865
Q ss_pred CC
Q 010329 500 DQ 501 (513)
Q Consensus 500 ~~ 501 (513)
..
T Consensus 162 ~~ 163 (285)
T d1u59a_ 162 DD 163 (285)
T ss_dssp CS
T ss_pred cc
Confidence 43
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.4e-32 Score=261.85 Aligned_cols=153 Identities=33% Similarity=0.591 Sum_probs=128.6
Q ss_pred hcCCCcccccCccCceeEEEEEeCCC-----cEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSG-----QEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~-----~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
.+.|+..++||+|+||+||+|.+.+. ..||||++.... ....++|.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35678889999999999999986532 369999997543 333467999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+||||+.++++.+++.. ....++|.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999988753 3456999999999999999999999987 999999999999999999999999999988
Q ss_pred CCCC
Q 010329 498 GVDQ 501 (513)
Q Consensus 498 ~~~~ 501 (513)
....
T Consensus 161 ~~~~ 164 (283)
T d1mqba_ 161 EDDP 164 (283)
T ss_dssp ----
T ss_pred cCCC
Confidence 6543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=255.66 Aligned_cols=158 Identities=29% Similarity=0.420 Sum_probs=132.8
Q ss_pred CcccccCccCceeEEEEEeC-CCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEe----CCeeEEEE
Q 010329 348 STDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVY 420 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~ 420 (513)
++.++||+|+||+||+|+.. +++.||+|.+... .....+.|.+|+++|++++||||+++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999964 6889999998754 33345679999999999999999999999875 34578999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC-CCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~DfGla~~~~~ 499 (513)
||+++|+|.+++.+ ...+++..+..++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999943 457999999999999999999999875 4599999999999996 578999999999997643
Q ss_pred CCCccccceeeecC
Q 010329 500 DQTQGNTSRIVGTL 513 (513)
Q Consensus 500 ~~~~~~~~~~~Gt~ 513 (513)
.. ....+||+
T Consensus 168 ~~----~~~~~GT~ 177 (270)
T d1t4ha_ 168 SF----AKAVIGTP 177 (270)
T ss_dssp TS----BEESCSSC
T ss_pred Cc----cCCcccCc
Confidence 32 23456774
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=2.3e-31 Score=263.78 Aligned_cols=161 Identities=23% Similarity=0.417 Sum_probs=141.0
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
++|.+.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4789999999999999999996 468999999998766666678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC--CCCCeEEeeccCccccCCCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~--~~~~~ki~DfGla~~~~~~~ 501 (513)
++|+|.+++.+ ..+.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999853 3456999999999999999999999987 99999999999995 46789999999999886543
Q ss_pred CccccceeeecC
Q 010329 502 TQGNTSRIVGTL 513 (513)
Q Consensus 502 ~~~~~~~~~Gt~ 513 (513)
. .....||+
T Consensus 181 ~---~~~~~gT~ 189 (350)
T d1koaa2 181 S---VKVTTGTA 189 (350)
T ss_dssp C---EEEECSCT
T ss_pred c---cceecCcc
Confidence 2 22345553
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-32 Score=260.96 Aligned_cols=167 Identities=26% Similarity=0.406 Sum_probs=127.8
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEe--CCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv 419 (513)
++|++.+.||+|+||+||+|+. .+|+.||||.+.... ....+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5688899999999999999985 568999999987643 3345678999999999999999999999975 3457999
Q ss_pred EecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCC--CCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 420 YEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
|||+++|+|.+++.+. .....+++..+..++.||+.||.|||+.+ ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998532 23457999999999999999999999854 23599999999999999999999999999998
Q ss_pred cCCCCCccccceeeecC
Q 010329 497 FGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 497 ~~~~~~~~~~~~~~Gt~ 513 (513)
+..+... .....||+
T Consensus 164 ~~~~~~~--~~~~~gt~ 178 (269)
T d2java1 164 LNHDTSF--AKAFVGTP 178 (269)
T ss_dssp C-------------CCC
T ss_pred cccCCCc--cccCCCCc
Confidence 8654322 23456664
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-31 Score=262.30 Aligned_cols=161 Identities=24% Similarity=0.298 Sum_probs=141.6
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|.+.+.||+|+||+||+++. .+|+.||||.++.. .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688899999999999999995 57899999999753 2345678899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999984 3457899999999999999999999987 999999999999999999999999999977544
Q ss_pred CCccccceeeecC
Q 010329 501 QTQGNTSRIVGTL 513 (513)
Q Consensus 501 ~~~~~~~~~~Gt~ 513 (513)
... ....+||+
T Consensus 159 ~~~--~~~~~GT~ 169 (337)
T d1o6la_ 159 GAT--MKTFCGTP 169 (337)
T ss_dssp TCC--BCCCEECG
T ss_pred Ccc--cccceeCH
Confidence 332 33467774
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=9.8e-32 Score=262.02 Aligned_cols=149 Identities=32% Similarity=0.464 Sum_probs=133.2
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc---cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
+.|+..++||+|+||+||+|+. .+++.||||.+..... ...+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4588899999999999999995 5688999999875432 33467899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+++|+|..++. ....+++.++..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987663 3457999999999999999999999987 99999999999999999999999999997754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=3.7e-31 Score=262.55 Aligned_cols=152 Identities=25% Similarity=0.386 Sum_probs=137.0
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
++|++.+.||+|+||+||+|+. .+|+.||||.++.......+.+.+|+.+|++++||||+++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4689999999999999999995 568999999998765555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC--CCCCeEEeeccCccccCCCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~--~~~~~ki~DfGla~~~~~~~ 501 (513)
++|+|.+++.. ....+++.++..|+.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|+.+..+.
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999888743 3446999999999999999999999987 99999999999997 67899999999999886543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=256.41 Aligned_cols=145 Identities=30% Similarity=0.515 Sum_probs=125.6
Q ss_pred cccCccCceeEEEEEeCC---CcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecCCC
Q 010329 351 NKLGEGGFGEVYKGVLPS---GQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~---~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 425 (513)
++||+|+||+||+|.+.+ ++.||||+++... ....++|.+|+.+|++++|||||+++|++.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 4679999997542 2335689999999999999999999999864 567899999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCCC
Q 010329 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (513)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~ 502 (513)
|+|.+++.. ...++|..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 999999853 456999999999999999999999987 99999999999999999999999999998865543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=5.5e-31 Score=252.76 Aligned_cols=151 Identities=28% Similarity=0.407 Sum_probs=135.2
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCcc---------CHHHHHHHHHHHHhCC-CCCccceeeEEEeC
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQ---------GAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEG 413 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~---------~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~ 413 (513)
++|++.+.||+|+||+||+++. .+++.||||+++..... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6789999999999999999995 57889999998754221 1245889999999997 99999999999999
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
+..+|||||+++|+|.+++. ..+.+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999995 3457999999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCC
Q 010329 494 ARIFGVDQ 501 (513)
Q Consensus 494 a~~~~~~~ 501 (513)
++.+.++.
T Consensus 157 a~~~~~~~ 164 (277)
T d1phka_ 157 SCQLDPGE 164 (277)
T ss_dssp CEECCTTC
T ss_pred eeEccCCC
Confidence 99886543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=4e-31 Score=257.57 Aligned_cols=161 Identities=25% Similarity=0.368 Sum_probs=123.7
Q ss_pred hcCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
.+.|++.+.||+|+||+||+|+.. +++.||||.+..... ...+.+.+|+.+|++++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 466899999999999999999964 688999999875432 234568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC---CCCCeEEeeccCccccC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMARIFG 498 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DfGla~~~~ 498 (513)
|+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999953 457999999999999999999999987 99999999999994 57899999999999875
Q ss_pred CCCCccccceeeecC
Q 010329 499 VDQTQGNTSRIVGTL 513 (513)
Q Consensus 499 ~~~~~~~~~~~~Gt~ 513 (513)
.... ....+||+
T Consensus 162 ~~~~---~~~~~GT~ 173 (307)
T d1a06a_ 162 PGSV---LSTACGTP 173 (307)
T ss_dssp --------------C
T ss_pred CCCe---eeeeeeCc
Confidence 4432 22456764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=6.1e-31 Score=257.35 Aligned_cols=158 Identities=25% Similarity=0.365 Sum_probs=139.1
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999996 56899999998753 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
||+++|+|..++. ....+++.....++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999998884 3456889999999999999999999987 999999999999999999999999999987543
Q ss_pred CCccccceeeecC
Q 010329 501 QTQGNTSRIVGTL 513 (513)
Q Consensus 501 ~~~~~~~~~~Gt~ 513 (513)
. ..+.||+
T Consensus 158 ~-----~~~~Gt~ 165 (316)
T d1fota_ 158 T-----YTLCGTP 165 (316)
T ss_dssp B-----CCCCSCT
T ss_pred c-----ccccCcc
Confidence 2 2356664
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-30 Score=251.85 Aligned_cols=152 Identities=29% Similarity=0.427 Sum_probs=135.4
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC------ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCee
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS------GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 416 (513)
.++|.+.+.||+|+||+||+|+. .+|+.||||.++... ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35789999999999999999996 568999999986432 12357899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC----CeEEeecc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG 492 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DfG 492 (513)
++||||+++|+|.+++.+ .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999843 457999999999999999999999987 99999999999998776 49999999
Q ss_pred CccccCCCC
Q 010329 493 MARIFGVDQ 501 (513)
Q Consensus 493 la~~~~~~~ 501 (513)
+++.+....
T Consensus 163 ~a~~~~~~~ 171 (293)
T d1jksa_ 163 LAHKIDFGN 171 (293)
T ss_dssp TCEECTTSC
T ss_pred hhhhcCCCc
Confidence 999886543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.4e-31 Score=257.82 Aligned_cols=176 Identities=27% Similarity=0.377 Sum_probs=136.0
Q ss_pred cchHHHHHHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhC-CCCCccce
Q 010329 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKL-QHRNLVRL 406 (513)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l 406 (513)
++..++++..++|++.++||+|+||.||+|.+. +++.||||+++... ....+.+.+|...+.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 345566677788999999999999999999853 24689999997543 33456788888887776 68999999
Q ss_pred eeEEEeCC-eeEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecC
Q 010329 407 LGFCLEGE-EKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 472 (513)
Q Consensus 407 ~g~~~~~~-~~~lv~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrd 472 (513)
++++.+.+ ..++||||+++|+|.++++... ....+++.+++.++.||++||.|||+++ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 99987654 5899999999999999996422 2345899999999999999999999987 99999
Q ss_pred CcCCcEEECCCCCeEEeeccCccccCCCCCccccceeeecC
Q 010329 473 LKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 473 lk~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt~ 513 (513)
|||+||||++++.+||+|||+|+...........+...||+
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 200 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 200 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGG
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCc
Confidence 99999999999999999999999887665555555667763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.2e-31 Score=258.82 Aligned_cols=170 Identities=28% Similarity=0.480 Sum_probs=143.1
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEeC------CCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEe
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 412 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~~------~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 412 (513)
+++..++|.+.++||+|+||+||+|.+. ++..||||+++... ......|.+|+.++++++||||++++|++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3445578888999999999999999863 25689999997543 3334578999999999999999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC
Q 010329 413 GEEKILVYEFVPNKSLDYFLYDP-------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485 (513)
Q Consensus 413 ~~~~~lv~ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~ 485 (513)
.+..++||||+++|+|.+++... .....+++..+.+|+.|+++||.|||+++ |+||||||+||||+++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence 99999999999999999988531 22345799999999999999999999986 999999999999999999
Q ss_pred eEEeeccCccccCCCCCccccceeeec
Q 010329 486 PKISDFGMARIFGVDQTQGNTSRIVGT 512 (513)
Q Consensus 486 ~ki~DfGla~~~~~~~~~~~~~~~~Gt 512 (513)
+||+|||+++.+.............||
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t 198 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLP 198 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEEC
T ss_pred EEEeecccceeccCCcceeeccceecc
Confidence 999999999988665544444444555
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-30 Score=255.80 Aligned_cols=163 Identities=28% Similarity=0.529 Sum_probs=132.3
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCc----EEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~----~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 418 (513)
.+|++.++||+|+||+||+|.+. +|+ +||+|+++.. +....++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 45888999999999999999863 343 6899998754 345568899999999999999999999999865 5678
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~ 498 (513)
++||+.+|+|.+++.. ....+++..+++|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8899999999988754 3457999999999999999999999987 9999999999999999999999999999987
Q ss_pred CCCCccccceeeecC
Q 010329 499 VDQTQGNTSRIVGTL 513 (513)
Q Consensus 499 ~~~~~~~~~~~~Gt~ 513 (513)
.......+....||+
T Consensus 163 ~~~~~~~~~~~~gt~ 177 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPI 177 (317)
T ss_dssp TTCC--------CCT
T ss_pred cccccccccccccCc
Confidence 665554444556663
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-30 Score=255.71 Aligned_cols=170 Identities=30% Similarity=0.416 Sum_probs=144.3
Q ss_pred HHHHhcCCCcccccCccCceeEEEEEe------CCCcEEEEEEecccCc-cCHHHHHHHHHHHHhC-CCCCccceeeEEE
Q 010329 340 IEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASSG-QGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (513)
Q Consensus 340 ~~~~~~~~~~~~~Lg~G~fG~Vy~~~~------~~~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 411 (513)
+++..++|++.++||+|+||.||+|++ ..++.||||+++.... ....+|.+|+.+++++ +|||||+++|++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 445667888999999999999999985 2456899999976533 3456799999999999 6999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCC
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPE---------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~ 476 (513)
+++..++||||+++|+|.++++... ....+++..+..|+.||++||.|||+++ |+||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence 9999999999999999999986422 2336899999999999999999999987 999999999
Q ss_pred cEEECCCCCeEEeeccCccccCCCCCccccceeeec
Q 010329 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512 (513)
Q Consensus 477 Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt 512 (513)
|||++.++.+||+|||+++...............||
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccC
Confidence 999999999999999999988765554444455665
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.7e-30 Score=250.13 Aligned_cols=151 Identities=23% Similarity=0.331 Sum_probs=133.8
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
.++|.+.+.||+|+||+||+|.. .+++.||||.++.... ....+.+|+++|+.++||||+++++++.+++..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 36789999999999999999996 4688999999976543 345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCC--CCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE--MNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~--~~~ki~DfGla~~~~~~ 500 (513)
+++|+|.+++.+ ....+++.++..|+.||+.||.|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999943 2346999999999999999999999987 9999999999999754 58999999999987543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=3.9e-30 Score=255.03 Aligned_cols=149 Identities=26% Similarity=0.311 Sum_probs=135.1
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 420 (513)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4688899999999999999996 46899999998643 2344578899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
||+.+|+|..++.. .+.+++..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999843 457999999999999999999999987 99999999999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.5e-31 Score=251.90 Aligned_cols=153 Identities=23% Similarity=0.424 Sum_probs=124.9
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCC----CcEEEEEEecccCc-cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCee
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~----~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 416 (513)
+..++|++.+.||+|+||.||+|.+.. +..||||.++.... ...+.|.+|+.++++++||||++++|++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345678999999999999999998642 34689999875433 33567999999999999999999999985 4678
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 417 ~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999988743 3456999999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 010329 497 FGVD 500 (513)
Q Consensus 497 ~~~~ 500 (513)
+...
T Consensus 158 ~~~~ 161 (273)
T d1mp8a_ 158 MEDS 161 (273)
T ss_dssp ----
T ss_pred ccCC
Confidence 7543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.4e-30 Score=250.27 Aligned_cols=152 Identities=34% Similarity=0.561 Sum_probs=131.7
Q ss_pred cCCCcccccCccCceeEEEEEeCC-Cc--EEEEEEeccc-CccCHHHHHHHHHHHHhC-CCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPS-GQ--EIAVKRLSAS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~-~~--~VavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv 419 (513)
++|++.++||+|+||+||+|++.+ +. .||||+++.. ..+..++|.+|+++|.++ +||||++++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 577888999999999999999743 33 5788888654 334556899999999999 799999999999999999999
Q ss_pred EecCCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCe
Q 010329 420 YEFVPNKSLDYFLYDP-------------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 486 (513)
|||+++|+|.++|+.. .....++|..+.+++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999653 23467999999999999999999999987 9999999999999999999
Q ss_pred EEeeccCccccCC
Q 010329 487 KISDFGMARIFGV 499 (513)
Q Consensus 487 ki~DfGla~~~~~ 499 (513)
||+|||+++....
T Consensus 167 kl~DfG~a~~~~~ 179 (309)
T d1fvra_ 167 KIADFGLSRGQEV 179 (309)
T ss_dssp EECCTTCEESSCE
T ss_pred EEccccccccccc
Confidence 9999999987653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.5e-30 Score=250.71 Aligned_cols=161 Identities=27% Similarity=0.376 Sum_probs=129.3
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHH--HHHHHHhCCCCCccceeeEEEeCC----eeEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKN--EVVLVAKLQHRNLVRLLGFCLEGE----EKIL 418 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~--E~~~l~~l~H~nIv~l~g~~~~~~----~~~l 418 (513)
++|.+.++||+|+||+||+|++ +|+.||||+++... .+++.. |+..+..++||||++++|++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4567788999999999999997 68899999986543 233334 455556789999999999998754 5789
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-----CCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-----SRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
||||+++|+|.++|++ ..++|..+++++.|++.||.|||+. +..+|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999953 3699999999999999999999974 124599999999999999999999999999
Q ss_pred ccccCCCCCc--cccceeeecC
Q 010329 494 ARIFGVDQTQ--GNTSRIVGTL 513 (513)
Q Consensus 494 a~~~~~~~~~--~~~~~~~Gt~ 513 (513)
++.+...... .......||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~ 176 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTK 176 (303)
T ss_dssp CEEEETTTTEECC----CCSCG
T ss_pred cccccCCCcceeccccceeccc
Confidence 9988654332 2233456663
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=5.7e-30 Score=255.22 Aligned_cols=159 Identities=29% Similarity=0.377 Sum_probs=134.2
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHH---HHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKN---EVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~---E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
++|++.++||+|+||.||+|+. .+|+.||||.+.... ......+.+ |+.+++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5788999999999999999996 468999999986431 222333444 466777888999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+||||+++|+|.++|.. ...+++..+..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999943 456899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCCccccceeeecC
Q 010329 498 GVDQTQGNTSRIVGTL 513 (513)
Q Consensus 498 ~~~~~~~~~~~~~Gt~ 513 (513)
..... ....||+
T Consensus 158 ~~~~~----~~~~GT~ 169 (364)
T d1omwa3 158 SKKKP----HASVGTH 169 (364)
T ss_dssp SSSCC----CSCCSCG
T ss_pred CCCcc----ccccccc
Confidence 65432 2345663
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.6e-30 Score=248.02 Aligned_cols=152 Identities=28% Similarity=0.488 Sum_probs=130.7
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|++.++||+|+||+||+|+. .+++.||||+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999995 568999999996543 2335789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
|+.++.+..... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....+.
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 997654443332 23456999999999999999999999987 9999999999999999999999999999876543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.9e-30 Score=250.10 Aligned_cols=168 Identities=26% Similarity=0.396 Sum_probs=136.8
Q ss_pred HHhcCCCcccccCccCceeEEEEEeCC--------CcEEEEEEecccCc-cCHHHHHHHHHHHHhC-CCCCccceeeEEE
Q 010329 342 VATNKFSTDNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSASSG-QGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (513)
Q Consensus 342 ~~~~~~~~~~~Lg~G~fG~Vy~~~~~~--------~~~VavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 411 (513)
+..++|.+.++||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 455678889999999999999998522 24799999976543 3457888999988888 7999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcE
Q 010329 412 EGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (513)
Q Consensus 412 ~~~~~~lv~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Ni 478 (513)
+++..++||||+++|+|.++|.... ....+++.+++.++.||+.||+|||+++ |+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 9999999999999999999996532 2346899999999999999999999987 99999999999
Q ss_pred EECCCCCeEEeeccCccccCCCCCccccceeeec
Q 010329 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512 (513)
Q Consensus 479 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt 512 (513)
|++.++.+||+|||+++...............||
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 200 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 200 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCG
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCC
Confidence 9999999999999999988765544444444554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.2e-29 Score=245.76 Aligned_cols=147 Identities=28% Similarity=0.487 Sum_probs=128.3
Q ss_pred ccccCccCceeEEEEEeCCC----cEEEEEEeccc-CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC-CeeEEEEecC
Q 010329 350 DNKLGEGGFGEVYKGVLPSG----QEIAVKRLSAS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-EEKILVYEFV 423 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~~----~~VavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lv~ey~ 423 (513)
.++||+|+||+||+|++.++ ..||||+++.. +....++|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997432 25899999753 444567899999999999999999999998864 5789999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
++|+|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++.+....
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999864 3446889999999999999999999987 9999999999999999999999999999876543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-29 Score=249.05 Aligned_cols=161 Identities=28% Similarity=0.407 Sum_probs=136.7
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc---CccCHHHHHHHHHHHH-hCCCCCccceeeEEEeCCeeEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS---SGQGAQEFKNEVVLVA-KLQHRNLVRLLGFCLEGEEKILV 419 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~---~~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lv 419 (513)
++|.+.+.||+|+||+||+|+. .+++.||||+++.. .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5788999999999999999996 46889999999753 2334556677777655 68999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCC
Q 010329 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (513)
Q Consensus 420 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~ 499 (513)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999994 3456899999999999999999999987 99999999999999999999999999997754
Q ss_pred CCCccccceeeecC
Q 010329 500 DQTQGNTSRIVGTL 513 (513)
Q Consensus 500 ~~~~~~~~~~~Gt~ 513 (513)
.... .+...||+
T Consensus 156 ~~~~--~~~~~gt~ 167 (320)
T d1xjda_ 156 GDAK--TNTFCGTP 167 (320)
T ss_dssp TTCC--BCCCCSCG
T ss_pred cccc--ccccCCCC
Confidence 3322 23456663
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3e-30 Score=247.29 Aligned_cols=152 Identities=35% Similarity=0.490 Sum_probs=124.2
Q ss_pred cCCCcccccCccCceeEEEEEeC--CC--cEEEEEEeccc---CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP--SG--QEIAVKRLSAS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~--~~--~~VavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 417 (513)
++|++.+.||+|+||+||+|++. ++ ..||||+++.. ..+..++|.+|+.+|++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888999999999999999853 22 37899988754 23345789999999999999999999999965 4678
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999988753 3446999999999999999999999987 999999999999999999999999999988
Q ss_pred CCCCC
Q 010329 498 GVDQT 502 (513)
Q Consensus 498 ~~~~~ 502 (513)
.....
T Consensus 162 ~~~~~ 166 (273)
T d1u46a_ 162 PQNDD 166 (273)
T ss_dssp CC-CC
T ss_pred ccCCC
Confidence 65543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-29 Score=247.24 Aligned_cols=146 Identities=30% Similarity=0.412 Sum_probs=125.7
Q ss_pred ccccCccCceeEEEEEe-CCCcEEEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEecC
Q 010329 350 DNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQ-----GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 423 (513)
.++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999996 46899999998654321 1246889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
+++++..++ .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 988777666 33456899999999999999999999987 9999999999999999999999999999876543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.6e-30 Score=247.43 Aligned_cols=150 Identities=29% Similarity=0.472 Sum_probs=126.0
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeC-CeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-EEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lv~ey 422 (513)
.++|++.+.||+|+||.||+|.+ .|.+||||+++... ..++|.+|++++++++||||++++|++.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35677889999999999999998 57899999997543 457899999999999999999999999764 557999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+++|+|.++|... ....++|..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999999999542 2235899999999999999999999986 999999999999999999999999999976543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.96 E-value=1.3e-29 Score=245.04 Aligned_cols=150 Identities=29% Similarity=0.503 Sum_probs=135.1
Q ss_pred cCCCcccccCccCceeEEEEEeCCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
++|.+.++||+|+||+||+|+.++|+.||||+++... ....+.+.+|+.+|++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788999999999999999999899999999986543 33357899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~ 500 (513)
+.++.+..+. ...+.+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9888777766 33567999999999999999999999987 999999999999999999999999999987543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.96 E-value=1.7e-29 Score=242.90 Aligned_cols=164 Identities=26% Similarity=0.385 Sum_probs=132.3
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC---ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC----e
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----E 415 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~ 415 (513)
.++|++.+.||+|+||+||+|+. .+|+.||||.++... ....+.|.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999995 578999999997543 233467999999999999999999999998654 3
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||||+++++|.+++. ..+.+++.++..|+.||+.||+|||+++ |+||||||+|||++.++..+|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999998884 3457999999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCCC-ccccceeeecC
Q 010329 496 IFGVDQT-QGNTSRIVGTL 513 (513)
Q Consensus 496 ~~~~~~~-~~~~~~~~Gt~ 513 (513)
....... .......+||+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~ 178 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTA 178 (277)
T ss_dssp ECC----------------
T ss_pred hhccccccccccccccCcc
Confidence 7754332 22333456663
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.8e-28 Score=241.68 Aligned_cols=148 Identities=24% Similarity=0.322 Sum_probs=126.2
Q ss_pred cCCCccc-ccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHh-CCCCCccceeeEEEe----CCeeE
Q 010329 345 NKFSTDN-KLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAK-LQHRNLVRLLGFCLE----GEEKI 417 (513)
Q Consensus 345 ~~~~~~~-~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~----~~~~~ 417 (513)
++|.+.. .||+|+||+||+|+. .+++.||||+++.. +.+.+|+.++.+ .+||||+++++++.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4677664 599999999999995 57899999998642 467889988765 489999999999875 35689
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC---CCCeEEeeccCc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMA 494 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DfGla 494 (513)
+||||+++|+|.++|.+ .....+++.++..|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHS-CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHh-cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 99999999999999964 23356999999999999999999999987 999999999999975 557999999999
Q ss_pred cccCCCC
Q 010329 495 RIFGVDQ 501 (513)
Q Consensus 495 ~~~~~~~ 501 (513)
+......
T Consensus 162 ~~~~~~~ 168 (335)
T d2ozaa1 162 KETTSHN 168 (335)
T ss_dssp EECCCCC
T ss_pred eeccCCC
Confidence 9876544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7e-29 Score=237.93 Aligned_cols=159 Identities=25% Similarity=0.403 Sum_probs=132.9
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc------cCHHHHHHHHHHHHhCC--CCCccceeeEEEeCCe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG------QGAQEFKNEVVLVAKLQ--HRNLVRLLGFCLEGEE 415 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~ 415 (513)
++|++.++||+|+||+||+|+. .+|+.||||+++.... .....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5789999999999999999995 5789999999875321 11234678999999997 8999999999999999
Q ss_pred eEEEEecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC-CCCeEEeeccC
Q 010329 416 KILVYEFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGM 493 (513)
Q Consensus 416 ~~lv~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGl 493 (513)
.++||||+.+ +++.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 67777773 3457999999999999999999999987 999999999999985 47999999999
Q ss_pred ccccCCCCCccccceeeecC
Q 010329 494 ARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 494 a~~~~~~~~~~~~~~~~Gt~ 513 (513)
|+...... .+...||+
T Consensus 158 a~~~~~~~----~~~~~GT~ 173 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTR 173 (273)
T ss_dssp CEECCSSC----BCCCCSCG
T ss_pred ceeccccc----ccccccCC
Confidence 99765432 22356663
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3e-28 Score=242.06 Aligned_cols=149 Identities=28% Similarity=0.420 Sum_probs=124.0
Q ss_pred CCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC------eeEE
Q 010329 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------EKIL 418 (513)
Q Consensus 346 ~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~l 418 (513)
+|+..++||+|+||+||+|+. .+|+.||||+++..... +.+|+.+|++++|+||+++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 477788999999999999996 46899999999765422 347999999999999999999986532 3689
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC-CeEEeeccCcccc
Q 010329 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIF 497 (513)
Q Consensus 419 v~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~ 497 (513)
||||++++.+..+.........+++.++..|+.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755444432234567999999999999999999999987 99999999999999775 8999999999987
Q ss_pred CCCC
Q 010329 498 GVDQ 501 (513)
Q Consensus 498 ~~~~ 501 (513)
....
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 5443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.9e-28 Score=241.72 Aligned_cols=151 Identities=25% Similarity=0.419 Sum_probs=127.4
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC-ccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC----eeE
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKI 417 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~ 417 (513)
+.+|++.++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35689999999999999999985 579999999997543 334567899999999999999999999997653 235
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcccc
Q 010329 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (513)
Q Consensus 418 lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~ 497 (513)
++++|+.+|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 5667778999999984 246999999999999999999999987 999999999999999999999999999987
Q ss_pred CCCC
Q 010329 498 GVDQ 501 (513)
Q Consensus 498 ~~~~ 501 (513)
....
T Consensus 160 ~~~~ 163 (345)
T d1pmea_ 160 DPDH 163 (345)
T ss_dssp CGGG
T ss_pred cCCC
Confidence 5543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.8e-28 Score=233.50 Aligned_cols=151 Identities=29% Similarity=0.511 Sum_probs=135.4
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCc--cCHHHHHHHHHHHHhCCCCCccceeeEEEeCCeeEEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 421 (513)
++|++.++||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+.+++.++|+||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5789999999999999999995 5788999999865432 335789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCccccCCCC
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~ 501 (513)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988874 3457899999999999999999999987 9999999999999999999999999999876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.95 E-value=1.3e-27 Score=235.50 Aligned_cols=145 Identities=24% Similarity=0.434 Sum_probs=127.6
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CCCccceeeEEEeC--CeeEEEE
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEG--EEKILVY 420 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lv~ 420 (513)
++|++.++||+|+||+||+|+. .+++.||||+++.. ..+.+.+|+.+|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 56899999998754 3467899999999995 99999999999754 4588999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCC-CeEEeeccCccccCC
Q 010329 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGV 499 (513)
Q Consensus 421 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~~ 499 (513)
||+++++|..+. +.+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+.+
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997664 35899999999999999999999987 99999999999998655 699999999998865
Q ss_pred CC
Q 010329 500 DQ 501 (513)
Q Consensus 500 ~~ 501 (513)
+.
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 44
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.5e-27 Score=232.37 Aligned_cols=150 Identities=28% Similarity=0.522 Sum_probs=127.6
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeC--------
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-------- 413 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-------- 413 (513)
++|++.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|++++|+||+++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6789999999999999999996 57899999998643 333457789999999999999999999998653
Q ss_pred CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccC
Q 010329 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (513)
Q Consensus 414 ~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl 493 (513)
...++||||++++.+..+. .....++......++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 3578999999988776555 34556889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCC
Q 010329 494 ARIFGVD 500 (513)
Q Consensus 494 a~~~~~~ 500 (513)
++.+...
T Consensus 164 ~~~~~~~ 170 (318)
T d3blha1 164 ARAFSLA 170 (318)
T ss_dssp CEECCC-
T ss_pred eeecccc
Confidence 9877543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.9e-27 Score=236.03 Aligned_cols=150 Identities=28% Similarity=0.456 Sum_probs=124.8
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEeccc--CccCHHHHHHHHHHHHhCCCCCccceeeEEEeCC------
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 414 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------ 414 (513)
.++|+..++||+|+||+||+|.. .+|+.||||+++.. +....+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46799999999999999999995 46899999999753 2233567899999999999999999999998765
Q ss_pred eeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCc
Q 010329 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (513)
Q Consensus 415 ~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla 494 (513)
..++||||+ +.+|..++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 567777763 356999999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCC
Q 010329 495 RIFGVDQ 501 (513)
Q Consensus 495 ~~~~~~~ 501 (513)
+......
T Consensus 169 ~~~~~~~ 175 (346)
T d1cm8a_ 169 RQADSEM 175 (346)
T ss_dssp EECCSSC
T ss_pred eccCCcc
Confidence 9876443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=9.8e-28 Score=235.10 Aligned_cols=151 Identities=24% Similarity=0.346 Sum_probs=132.7
Q ss_pred cCCCcccccCccCceeEEEEEe----CCCcEEEEEEeccc----CccCHHHHHHHHHHHHhCCC-CCccceeeEEEeCCe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSAS----SGQGAQEFKNEVVLVAKLQH-RNLVRLLGFCLEGEE 415 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~----~~~~~VavK~l~~~----~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~ 415 (513)
++|++.+.||+|+||+||+|+. .+|+.||||.++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5689999999999999999984 24789999998653 22345678899999999977 899999999999999
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.+++|||+.+|+|.+++. ..+.+.......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999984 3446788899999999999999999987 9999999999999999999999999999
Q ss_pred ccCCCC
Q 010329 496 IFGVDQ 501 (513)
Q Consensus 496 ~~~~~~ 501 (513)
.+....
T Consensus 178 ~~~~~~ 183 (322)
T d1vzoa_ 178 EFVADE 183 (322)
T ss_dssp ECCGGG
T ss_pred hhcccc
Confidence 875443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.94 E-value=1.3e-26 Score=224.40 Aligned_cols=162 Identities=22% Similarity=0.347 Sum_probs=135.1
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCC-CCccceeeEEEeCCeeEEEEe
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lv~e 421 (513)
.++|++.++||+|+||+||+|+. .+|+.||||.+..... .+.+.+|++.++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46799999999999999999995 4688999998865432 2457889999999975 899999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECC-----CCCeEEeeccCccc
Q 010329 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----EMNPKISDFGMARI 496 (513)
Q Consensus 422 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~-----~~~~ki~DfGla~~ 496 (513)
|+ +++|.+++.. ....+++.+...++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 6899888853 3346999999999999999999999987 999999999999964 56799999999998
Q ss_pred cCCCCCc-----cccceeeecC
Q 010329 497 FGVDQTQ-----GNTSRIVGTL 513 (513)
Q Consensus 497 ~~~~~~~-----~~~~~~~Gt~ 513 (513)
+.+.... .....++||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~ 177 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTA 177 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCT
T ss_pred cccCccccceeecccCceEEch
Confidence 8654322 1233567774
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.7e-27 Score=227.92 Aligned_cols=162 Identities=28% Similarity=0.486 Sum_probs=128.5
Q ss_pred hcCCCcccccCccCceeEEEEEe-CC-CcEEEEEEecccC--ccCHHHHHHHHHHHHhC---CCCCccceeeEEEeC---
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PS-GQEIAVKRLSASS--GQGAQEFKNEVVLVAKL---QHRNLVRLLGFCLEG--- 413 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~-~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~--- 413 (513)
.++|++.++||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999996 34 5679999986532 22233566777766655 899999999998642
Q ss_pred --CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeec
Q 010329 414 --EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (513)
Q Consensus 414 --~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df 491 (513)
...+++|||++++++..... .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 35789999999887765543 24456899999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCCCccccceeeecC
Q 010329 492 GMARIFGVDQTQGNTSRIVGTL 513 (513)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~Gt~ 513 (513)
|+++....... .....||+
T Consensus 161 g~~~~~~~~~~---~~~~~gT~ 179 (305)
T d1blxa_ 161 GLARIYSFQMA---LTSVVVTL 179 (305)
T ss_dssp CSCCCCCGGGG---GCCCCCCC
T ss_pred hhhhhhccccc---CCCcccCh
Confidence 99987653332 23456664
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1e-26 Score=230.95 Aligned_cols=149 Identities=28% Similarity=0.411 Sum_probs=126.4
Q ss_pred hcCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC-----Ce
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EE 415 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 415 (513)
.++|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+|+.++|+||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999995 579999999997543 23346788999999999999999999998643 34
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++++||+.+|+|.+++. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 577788889999999983 346999999999999999999999987 9999999999999999999999999998
Q ss_pred ccCC
Q 010329 496 IFGV 499 (513)
Q Consensus 496 ~~~~ 499 (513)
....
T Consensus 170 ~~~~ 173 (348)
T d2gfsa1 170 HTDD 173 (348)
T ss_dssp CCTG
T ss_pred ccCc
Confidence 7643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.93 E-value=3e-26 Score=222.59 Aligned_cols=161 Identities=24% Similarity=0.384 Sum_probs=128.1
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCccce-eeEEEeCCeeEEEEec
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL-LGFCLEGEEKILVYEF 422 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l-~g~~~~~~~~~lv~ey 422 (513)
++|++.++||+|+||.||+|+. .+|+.||||.+..... .+++..|+++++.++|+|++.. .++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999995 5688999998876432 2457889999999987765554 5556778889999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEEC---CCCCeEEeeccCccccCC
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMARIFGV 499 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DfGla~~~~~ 499 (513)
+. ++|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 556555532 3456999999999999999999999987 99999999999985 455799999999998865
Q ss_pred CCCcc-----ccceeeecC
Q 010329 500 DQTQG-----NTSRIVGTL 513 (513)
Q Consensus 500 ~~~~~-----~~~~~~Gt~ 513 (513)
..... ....+.||+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~ 177 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTA 177 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCS
T ss_pred cccccceeccccCCcCCCc
Confidence 44321 223456764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=5.1e-26 Score=226.24 Aligned_cols=147 Identities=31% Similarity=0.452 Sum_probs=120.6
Q ss_pred cCCCcccccCccCceeEEEEEeC-CCcEEEEEEecccC--ccCHHHHHHHHHHHHhCCCCCccceeeEEEeC------Ce
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------EE 415 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~~-~~~~VavK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~ 415 (513)
++|++.++||+|+||+||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999964 68999999997542 33446789999999999999999999999643 57
Q ss_pred eEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 416 ~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
.++||||+.++.+. .+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~-----~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hh-----hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999766554 44 235899999999999999999999987 9999999999999999999999999999
Q ss_pred ccCCC
Q 010329 496 IFGVD 500 (513)
Q Consensus 496 ~~~~~ 500 (513)
.....
T Consensus 168 ~~~~~ 172 (355)
T d2b1pa1 168 TAGTS 172 (355)
T ss_dssp -----
T ss_pred ccccc
Confidence 77543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=3.5e-22 Score=180.40 Aligned_cols=135 Identities=20% Similarity=0.222 Sum_probs=106.7
Q ss_pred CcccccCccCceeEEEEEeCCCcEEEEEEecccCc------------------cCHHHHHHHHHHHHhCCCCCccceeeE
Q 010329 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSG------------------QGAQEFKNEVVLVAKLQHRNLVRLLGF 409 (513)
Q Consensus 348 ~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~g~ 409 (513)
.+.++||+|+||+||+|...+|++||||.++.... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999988899999998753211 001234568889999999999988765
Q ss_pred EEeCCeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCCeEEe
Q 010329 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (513)
Q Consensus 410 ~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 489 (513)
. ..+++|||+++..+.. +++.....++.|++++|.|||+++ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 3479999998876543 233445678999999999999987 99999999999998655 8999
Q ss_pred eccCccccCCC
Q 010329 490 DFGMARIFGVD 500 (513)
Q Consensus 490 DfGla~~~~~~ 500 (513)
|||+|+....+
T Consensus 145 DFG~a~~~~~~ 155 (191)
T d1zara2 145 DFPQSVEVGEE 155 (191)
T ss_dssp CCTTCEETTST
T ss_pred ECCCcccCCCC
Confidence 99999877544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.84 E-value=2.3e-21 Score=192.97 Aligned_cols=153 Identities=20% Similarity=0.266 Sum_probs=120.4
Q ss_pred cCCCcccccCccCceeEEEEEe-CCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-----------CCCccceeeEEEe
Q 010329 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-----------HRNLVRLLGFCLE 412 (513)
Q Consensus 345 ~~~~~~~~Lg~G~fG~Vy~~~~-~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~~ 412 (513)
.+|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3589999999999999999995 578999999997543 23467788998888875 5789999998865
Q ss_pred C--CeeEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeecCCcCCcEEECCCCC-----
Q 010329 413 G--EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN----- 485 (513)
Q Consensus 413 ~--~~~~lv~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~Nill~~~~~----- 485 (513)
. ...+++++++..+..............+++..+..++.||+.||.|||+.. +|+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence 3 456677777665544333333345567899999999999999999999732 4999999999999986653
Q ss_pred -eEEeeccCccccCCC
Q 010329 486 -PKISDFGMARIFGVD 500 (513)
Q Consensus 486 -~ki~DfGla~~~~~~ 500 (513)
+||+|||.++.....
T Consensus 170 ~~kl~dfg~s~~~~~~ 185 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH 185 (362)
T ss_dssp EEEECCCTTCEETTBC
T ss_pred eeeEeecccccccccc
Confidence 999999999876543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=1.9e-07 Score=86.34 Aligned_cols=144 Identities=19% Similarity=0.111 Sum_probs=97.4
Q ss_pred hcCCCcccccCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC-CCCccceeeEEEeCCeeEEEEec
Q 010329 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF 422 (513)
Q Consensus 344 ~~~~~~~~~Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey 422 (513)
-..|+..+..+-++...||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+...++..++|||+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 34566555544445578999875 55677888876554444456778888887774 44477888888888899999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC---------------------------------------
Q 010329 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED--------------------------------------- 463 (513)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------- 463 (513)
+++..+....... .. ...++.++++.|..||+.
T Consensus 92 l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 92 ADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred ccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9998886554211 11 122334444444444431
Q ss_pred -----------------CCCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 464 -----------------SRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 464 -----------------~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 112279999999999999877677999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=1.3e-05 Score=73.22 Aligned_cols=142 Identities=16% Similarity=0.107 Sum_probs=85.6
Q ss_pred ccCccCc-eeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCC--CCCccceeeEEEeCCeeEEEEecCCCCCh
Q 010329 352 KLGEGGF-GEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ--HRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (513)
Q Consensus 352 ~Lg~G~f-G~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 428 (513)
.+..|.. ..||+...+++..+.+|.-..... ..+..|...++.+. .-.+.+++++..+++..++||||+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444443 678999987888888897655432 34667777777664 33467788888888889999999998765
Q ss_pred hhhh-----------------cCCC-CCCCC--CHHHHHHHHH--------------------HHHHHHHHhHcC----C
Q 010329 429 DYFL-----------------YDPE-KQGQL--DWSRRYKIIG--------------------GIARGILYLHED----S 464 (513)
Q Consensus 429 ~~~l-----------------~~~~-~~~~l--~~~~~~~i~~--------------------~ia~gL~yLH~~----~ 464 (513)
.+.. |... ....+ .+.....-.. .....+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 3321 0000 00000 0000000000 011122222221 2
Q ss_pred CCCeeecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 465 ~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
++.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 22379999999999999877778999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.60 E-value=0.00014 Score=70.74 Aligned_cols=76 Identities=13% Similarity=0.135 Sum_probs=49.0
Q ss_pred ccccCccCceeEEEEEeCC-CcEEEEEEeccc-------CccCHHHHHHHHHHHHhCC-C--CCccceeeEEEeCCeeEE
Q 010329 350 DNKLGEGGFGEVYKGVLPS-GQEIAVKRLSAS-------SGQGAQEFKNEVVLVAKLQ-H--RNLVRLLGFCLEGEEKIL 418 (513)
Q Consensus 350 ~~~Lg~G~fG~Vy~~~~~~-~~~VavK~l~~~-------~~~~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~~~~~l 418 (513)
.+.||.|....||+....+ ++.|+||.-... .+...++...|.+.|..+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998654 678999964321 1112334566777776653 2 345566554 5667789
Q ss_pred EEecCCCCC
Q 010329 419 VYEFVPNKS 427 (513)
Q Consensus 419 v~ey~~~gs 427 (513)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.93 E-value=0.002 Score=60.52 Aligned_cols=135 Identities=16% Similarity=0.129 Sum_probs=78.4
Q ss_pred eeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCcc--cee-----eEEEeCCeeEEEEecCCCCChhh-
Q 010329 359 GEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV--RLL-----GFCLEGEEKILVYEFVPNKSLDY- 430 (513)
Q Consensus 359 G~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv--~l~-----g~~~~~~~~~lv~ey~~~gsL~~- 430 (513)
-.||+...++|+.+++|..+... ...+++.+|...+..|....|. ..+ ......+..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999999999999999876542 2346788898888887533322 111 12234566788999998644321
Q ss_pred ---hh----------c----C--CCCCCCCCHHH----------------------HHHHHHHHHHHHHHh-HcCCCCCe
Q 010329 431 ---FL----------Y----D--PEKQGQLDWSR----------------------RYKIIGGIARGILYL-HEDSRLRI 468 (513)
Q Consensus 431 ---~l----------~----~--~~~~~~l~~~~----------------------~~~i~~~ia~gL~yL-H~~~~~~i 468 (513)
.+ | . ......+++.. ....+.++...+.-+ .+..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 0 0 01111222211 112222232222221 22234458
Q ss_pred eecCCcCCcEEECCCCCeEEeeccCccc
Q 010329 469 IHRDLKASNILLDAEMNPKISDFGMARI 496 (513)
Q Consensus 469 vHrdlk~~Nill~~~~~~ki~DfGla~~ 496 (513)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899988763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.51 E-value=0.0041 Score=59.95 Aligned_cols=72 Identities=17% Similarity=0.272 Sum_probs=47.7
Q ss_pred cccCccCceeEEEEEeCCC--------cEEEEEEecccCccCHHHHHHHHHHHHhCCCCCc-cceeeEEEeCCeeEEEEe
Q 010329 351 NKLGEGGFGEVYKGVLPSG--------QEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYE 421 (513)
Q Consensus 351 ~~Lg~G~fG~Vy~~~~~~~--------~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~e 421 (513)
+.|+.|-.=.+|+...+++ +.|.++..-. ........+|..+++.+.-.++ .++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 5677788889999986543 4566665542 2233456678888888753344 57777764 268999
Q ss_pred cCCCCCh
Q 010329 422 FVPNKSL 428 (513)
Q Consensus 422 y~~~gsL 428 (513)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.68 E-value=0.12 Score=47.39 Aligned_cols=156 Identities=12% Similarity=0.046 Sum_probs=78.3
Q ss_pred hHHHHHHhcCCCcccc-----cCccCceeEEEEEeCCCcEEEEEEecccCccCHHHHHHHHHHHHhCCCCCcc--ceee-
Q 010329 337 FETIEVATNKFSTDNK-----LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV--RLLG- 408 (513)
Q Consensus 337 ~~~~~~~~~~~~~~~~-----Lg~G~fG~Vy~~~~~~~~~VavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv--~l~g- 408 (513)
.++++..-.+|.+.+. |..|---+.|+...++| ..++|....... .+++..|+.++..|.+.++. ..+-
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhcccccccccee
Confidence 3445555566765433 44565677899887665 478887754322 23455567777766433221 1111
Q ss_pred -----EEEeCCeeEEEEecCCCCChhhhh--------------c----C--CCCCCCCCHH------------------H
Q 010329 409 -----FCLEGEEKILVYEFVPNKSLDYFL--------------Y----D--PEKQGQLDWS------------------R 445 (513)
Q Consensus 409 -----~~~~~~~~~lv~ey~~~gsL~~~l--------------~----~--~~~~~~l~~~------------------~ 445 (513)
+.........++.++.+......- + . ........+. .
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 112234556667777654332110 0 0 0000000000 0
Q ss_pred HHHHHHHHHHHHHHhHc-CCCCCeeecCCcCCcEEECCCCCeEEeeccCcc
Q 010329 446 RYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (513)
Q Consensus 446 ~~~i~~~ia~gL~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~ 495 (513)
....+..+..-+.-.+. .-+..++|+|+.+.||+++.+...-|.||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11112222222222221 123458999999999999988877899999886
|